<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>US10799595B2 - Pyrrolobenzodiazepine conjugates 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US10799595B2/en">
    <meta name="description" content="
     A compound of formula (I): (I) and its conjugates. 
     
       
         
         
             
             
         
       
     
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Pyrrolobenzodiazepine conjugates 
       ">
    <meta name="DC.date" content="2017-10-13" scheme="dateSubmitted">
    <meta name="DC.description" content="
     A compound of formula (I): (I) and its conjugates. 
     
       
         
         
             
             
         
       
     
   
   ">
    <meta name="citation_patent_application_number" content="US:16/340,973">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/91/e5/4e/1731ca243de740/US10799595.pdf">
    <meta name="citation_patent_number" content="US:10799595">
    <meta name="DC.date" content="2020-10-13" scheme="issue">
    <meta name="DC.contributor" content="Philip Wilson Howard" scheme="inventor">
    <meta name="DC.contributor" content="Stephen John Gregson" scheme="inventor">
    <meta name="DC.contributor" content="MedImmune Ltd" scheme="assignee">
    <meta name="DC.relation" content="US:3361742" scheme="references">
    <meta name="DC.relation" content="US:3523941" scheme="references">
    <meta name="DC.relation" content="US:3524849" scheme="references">
    <meta name="DC.relation" content="FR:2027356:A1" scheme="references">
    <meta name="DC.relation" content="GB:1299198:A" scheme="references">
    <meta name="DC.relation" content="US:3794644" scheme="references">
    <meta name="DC.relation" content="JP:S5382792:A" scheme="references">
    <meta name="DC.relation" content="US:4185016" scheme="references">
    <meta name="DC.relation" content="US:4239683" scheme="references">
    <meta name="DC.relation" content="GB:2053894:A" scheme="references">
    <meta name="DC.relation" content="US:4309437" scheme="references">
    <meta name="DC.relation" content="JP:S57131791:A" scheme="references">
    <meta name="DC.relation" content="US:4353827" scheme="references">
    <meta name="DC.relation" content="US:4382032" scheme="references">
    <meta name="DC.relation" content="US:4386028" scheme="references">
    <meta name="DC.relation" content="US:4405516" scheme="references">
    <meta name="DC.relation" content="US:4405517" scheme="references">
    <meta name="DC.relation" content="US:4407752" scheme="references">
    <meta name="DC.relation" content="JP:S58180487:A" scheme="references">
    <meta name="DC.relation" content="US:4427588" scheme="references">
    <meta name="DC.relation" content="US:4427587" scheme="references">
    <meta name="DC.relation" content="US:4701325" scheme="references">
    <meta name="DC.relation" content="US:4816567" scheme="references">
    <meta name="DC.relation" content="FR:2586683:A1" scheme="references">
    <meta name="DC.relation" content="US:5583024" scheme="references">
    <meta name="DC.relation" content="US:5674713" scheme="references">
    <meta name="DC.relation" content="US:4923984" scheme="references">
    <meta name="DC.relation" content="WO:1991002536:A1" scheme="references">
    <meta name="DC.relation" content="JP:H053790:A" scheme="references">
    <meta name="DC.relation" content="US:5792616" scheme="references">
    <meta name="DC.relation" content="WO:1992007574:A1" scheme="references">
    <meta name="DC.relation" content="WO:1992017497:A1" scheme="references">
    <meta name="DC.relation" content="US:5440021" scheme="references">
    <meta name="DC.relation" content="US:5561119" scheme="references">
    <meta name="DC.relation" content="WO:1992019620:A1" scheme="references">
    <meta name="DC.relation" content="EP:0522868:A1" scheme="references">
    <meta name="DC.relation" content="US:5854399" scheme="references">
    <meta name="DC.relation" content="US:5362852" scheme="references">
    <meta name="DC.relation" content="US:6011146" scheme="references">
    <meta name="DC.relation" content="US:6153408" scheme="references">
    <meta name="DC.relation" content="US:5976551" scheme="references">
    <meta name="DC.relation" content="WO:1993018045:A1" scheme="references">
    <meta name="DC.relation" content="US:5418241" scheme="references">
    <meta name="DC.relation" content="WO:1994010312:A1" scheme="references">
    <meta name="DC.relation" content="US:5644033" scheme="references">
    <meta name="DC.relation" content="US:5869445" scheme="references">
    <meta name="DC.relation" content="US:6214345" scheme="references">
    <meta name="DC.relation" content="WO:1994028931:A1" scheme="references">
    <meta name="DC.relation" content="WO:1995004718:A1" scheme="references">
    <meta name="DC.relation" content="US:5773223" scheme="references">
    <meta name="DC.relation" content="US:5621002" scheme="references">
    <meta name="DC.relation" content="US:20030109676:A1" scheme="references">
    <meta name="DC.relation" content="US:6518404" scheme="references">
    <meta name="DC.relation" content="WO:1996030514:A1" scheme="references">
    <meta name="DC.relation" content="US:5700670" scheme="references">
    <meta name="DC.relation" content="US:20020193567:A1" scheme="references">
    <meta name="DC.relation" content="WO:1997007198:A2" scheme="references">
    <meta name="DC.relation" content="EP:1295944:A2" scheme="references">
    <meta name="DC.relation" content="US:6218519" scheme="references">
    <meta name="DC.relation" content="WO:1997044452:A1" scheme="references">
    <meta name="DC.relation" content="WO:1998013059:A1" scheme="references">
    <meta name="DC.relation" content="US:6759509" scheme="references">
    <meta name="DC.relation" content="WO:1998037193:A1" scheme="references">
    <meta name="DC.relation" content="US:20030157089:A1" scheme="references">
    <meta name="DC.relation" content="US:20030185830:A1" scheme="references">
    <meta name="DC.relation" content="US:20010055751:A1" scheme="references">
    <meta name="DC.relation" content="WO:1998040403:A1" scheme="references">
    <meta name="DC.relation" content="US:20030105292:A1" scheme="references">
    <meta name="DC.relation" content="US:6555339" scheme="references">
    <meta name="DC.relation" content="EP:0875569:A1" scheme="references">
    <meta name="DC.relation" content="WO:1998051805:A1" scheme="references">
    <meta name="DC.relation" content="US:20040018553:A1" scheme="references">
    <meta name="DC.relation" content="WO:1998051824:A1" scheme="references">
    <meta name="DC.relation" content="US:6602677" scheme="references">
    <meta name="DC.relation" content="US:20030060612:A1" scheme="references">
    <meta name="DC.relation" content="US:20020034749:A1" scheme="references">
    <meta name="DC.relation" content="WO:1999028468:A1" scheme="references">
    <meta name="DC.relation" content="WO:1999046284:A2" scheme="references">
    <meta name="DC.relation" content="US:6534482" scheme="references">
    <meta name="DC.relation" content="WO:1999058658:A2" scheme="references">
    <meta name="DC.relation" content="US:6835807" scheme="references">
    <meta name="DC.relation" content="US:20030064397:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000003291:A1" scheme="references">
    <meta name="DC.relation" content="US:7265105" scheme="references">
    <meta name="DC.relation" content="WO:2000012130:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000012506:A2" scheme="references">
    <meta name="DC.relation" content="US:7704924" scheme="references">
    <meta name="DC.relation" content="US:20040198722:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000012508:A2" scheme="references">
    <meta name="DC.relation" content="US:7049311" scheme="references">
    <meta name="DC.relation" content="WO:2000012507:A2" scheme="references">
    <meta name="DC.relation" content="US:20030195196:A1" scheme="references">
    <meta name="DC.relation" content="US:6608192" scheme="references">
    <meta name="DC.relation" content="US:7067511" scheme="references">
    <meta name="DC.relation" content="WO:2000012509:A2" scheme="references">
    <meta name="DC.relation" content="US:6562806" scheme="references">
    <meta name="DC.relation" content="US:6747144" scheme="references">
    <meta name="DC.relation" content="WO:2000014228:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000020579:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000022129:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000032752:A1" scheme="references">
    <meta name="DC.relation" content="US:20030124140:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000036107:A2" scheme="references">
    <meta name="DC.relation" content="WO:2000040614:A2" scheme="references">
    <meta name="DC.relation" content="US:20030065143:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000044899:A1" scheme="references">
    <meta name="DC.relation" content="WO:2000053216:A2" scheme="references">
    <meta name="DC.relation" content="WO:2000055351:A1" scheme="references">
    <meta name="DC.relation" content="US:20030119122:A1" scheme="references">
    <meta name="DC.relation" content="US:6268488" scheme="references">
    <meta name="DC.relation" content="US:6677435" scheme="references">
    <meta name="DC.relation" content="WO:2000075655:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001000244:A2" scheme="references">
    <meta name="DC.relation" content="US:20030062401:A1" scheme="references">
    <meta name="DC.relation" content="US:20030119128:A1" scheme="references">
    <meta name="DC.relation" content="US:20030119129:A1" scheme="references">
    <meta name="DC.relation" content="US:20030119130:A1" scheme="references">
    <meta name="DC.relation" content="US:6909006" scheme="references">
    <meta name="DC.relation" content="WO:2001016104:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001016318:A2" scheme="references">
    <meta name="DC.relation" content="US:20030129192:A1" scheme="references">
    <meta name="DC.relation" content="US:20030206918:A1" scheme="references">
    <meta name="DC.relation" content="US:20030232056:A1" scheme="references">
    <meta name="DC.relation" content="US:20030165504:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001040309:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001038490:A2" scheme="references">
    <meta name="DC.relation" content="US:20040101899:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001040269:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001041787:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001046261:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001046232:A2" scheme="references">
    <meta name="DC.relation" content="US:20020042366:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001048204:A1" scheme="references">
    <meta name="DC.relation" content="US:20040005320:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001045746:A2" scheme="references">
    <meta name="DC.relation" content="US:20030119131:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001053463:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001057188:A2" scheme="references">
    <meta name="DC.relation" content="US:20030186372:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001062794:A2" scheme="references">
    <meta name="DC.relation" content="US:20030219806:A1" scheme="references">
    <meta name="DC.relation" content="WO:2001066689:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001072962:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001072830:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001075177:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001077172:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001088133:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001090304:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001094641:A2" scheme="references">
    <meta name="DC.relation" content="WO:2001098351:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002002587:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002002634:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002002624:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002006339:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002006317:A2" scheme="references">
    <meta name="DC.relation" content="US:20040044179:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002010187:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002010382:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002012341:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002013847:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002014503:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002016413:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002016429:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002022660:A2" scheme="references">
    <meta name="DC.relation" content="US:20030119121:A1" scheme="references">
    <meta name="DC.relation" content="US:20030186373:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002022153:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002022636:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002024909:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002022808:A2" scheme="references">
    <meta name="DC.relation" content="US:6660742" scheme="references">
    <meta name="DC.relation" content="WO:2002026822:A2" scheme="references">
    <meta name="DC.relation" content="US:20040005598:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002030268:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002038766:A2" scheme="references">
    <meta name="DC.relation" content="US:20020150573:A1" scheme="references">
    <meta name="DC.relation" content="US:20040018194:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002061087:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002054940:A2" scheme="references">
    <meta name="DC.relation" content="US:20030119126:A1" scheme="references">
    <meta name="DC.relation" content="US:20030119125:A1" scheme="references">
    <meta name="DC.relation" content="US:20030118592:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002059377:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002060317:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002064798:A1" scheme="references">
    <meta name="DC.relation" content="US:20040052793:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002072596:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002071928:A2" scheme="references">
    <meta name="DC.relation" content="US:20040121940:A1" scheme="references">
    <meta name="DC.relation" content="US:7223837" scheme="references">
    <meta name="DC.relation" content="WO:2002078524:A2" scheme="references">
    <meta name="DC.relation" content="US:6362331" scheme="references">
    <meta name="DC.relation" content="WO:2002081646:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003008537:A2" scheme="references">
    <meta name="DC.relation" content="US:20040005538:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002083866:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002086443:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002088170:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002088172:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002089747:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002092836:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002094852:A2" scheme="references">
    <meta name="DC.relation" content="US:20040044180:A1" scheme="references">
    <meta name="DC.relation" content="US:20030096961:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002098358:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003000842:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002099074:A2" scheme="references">
    <meta name="DC.relation" content="WO:2002099122:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002101075:A2" scheme="references">
    <meta name="DC.relation" content="US:20040005563:A1" scheme="references">
    <meta name="DC.relation" content="WO:2002102235:A2" scheme="references">
    <meta name="DC.relation" content="US:20030091580:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003004989:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003002717:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003004529:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003003906:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003003984:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003055439:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003009814:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003014294:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003016475:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003016494:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003018621:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003029262:A2" scheme="references">
    <meta name="DC.relation" content="US:20030124579:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003022995:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003023013:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003025138:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003025228:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003024392:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003025148:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003026577:A2" scheme="references">
    <meta name="DC.relation" content="US:20030096743:A1" scheme="references">
    <meta name="DC.relation" content="US:20030130189:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003026493:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003029277:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003029421:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003034984:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003035846:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003055443:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003077836:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003042661:A2" scheme="references">
    <meta name="DC.relation" content="US:20030232350:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003043583:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003045422:A1" scheme="references">
    <meta name="DC.relation" content="EP:2298817:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003048202:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003054152:A2" scheme="references">
    <meta name="DC.relation" content="US:20030134790:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003060612:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003062401:A2" scheme="references">
    <meta name="DC.relation" content="US:20030143557:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003072036:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003072035:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003083047:A2" scheme="references">
    <meta name="DC.relation" content="US:6660856" scheme="references">
    <meta name="DC.relation" content="WO:2004000997:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003081210:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003083041:A2" scheme="references">
    <meta name="DC.relation" content="EP:1347046:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003089624:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003083074:A2" scheme="references">
    <meta name="DC.relation" content="US:20030194704:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003087306:A2" scheme="references">
    <meta name="DC.relation" content="US:20040101874:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003087768:A2" scheme="references">
    <meta name="DC.relation" content="US:20030228319:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003088808:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003089904:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004042346:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003093444:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003097803:A2" scheme="references">
    <meta name="DC.relation" content="US:20030224454:A1" scheme="references">
    <meta name="DC.relation" content="WO:2003101400:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003101283:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003104270:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003104275:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003104399:A2" scheme="references">
    <meta name="DC.relation" content="WO:2003105758:A2" scheme="references">
    <meta name="DC.relation" content="US:20040249130:A1" scheme="references">
    <meta name="DC.relation" content="US:20040022727:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004000221:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004001004:A2" scheme="references">
    <meta name="DC.relation" content="US:20040001827:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004005598:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004009622:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004011611:A2" scheme="references">
    <meta name="DC.relation" content="US:20080213289:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004032828:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004015426:A1" scheme="references">
    <meta name="DC.relation" content="EP:1394274:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004016225:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004020583:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004020595:A2" scheme="references">
    <meta name="DC.relation" content="US:20050271615:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004022778:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004022709:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004040000:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004027049:A2" scheme="references">
    <meta name="DC.relation" content="JP:2004113151:A" scheme="references">
    <meta name="DC.relation" content="WO:2004031238:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004032842:A2" scheme="references">
    <meta name="DC.relation" content="US:20040138269:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004043361:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004044178:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004043963:A1" scheme="references">
    <meta name="DC.relation" content="US:20060116422:A1" scheme="references">
    <meta name="DC.relation" content="US:7407951" scheme="references">
    <meta name="DC.relation" content="WO:2004045516:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004045520:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004045553:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004046342:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004047749:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004048938:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004053079:A2" scheme="references">
    <meta name="DC.relation" content="EP:1439393:A2" scheme="references">
    <meta name="DC.relation" content="US:20040197325:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004058309:A1" scheme="references">
    <meta name="DC.relation" content="WO:2004063709:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004063355:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004063362:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004065577:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004065576:A2" scheme="references">
    <meta name="DC.relation" content="WO:2004074320:A2" scheme="references">
    <meta name="DC.relation" content="US:20030224411:A1" scheme="references">
    <meta name="DC.relation" content="US:6884799" scheme="references">
    <meta name="DC.relation" content="WO:2005023814:A1" scheme="references">
    <meta name="DC.relation" content="US:7429658" scheme="references">
    <meta name="DC.relation" content="WO:2005040170:A2" scheme="references">
    <meta name="DC.relation" content="US:7244724" scheme="references">
    <meta name="DC.relation" content="US:20090149449:A1" scheme="references">
    <meta name="DC.relation" content="US:20070072846:A1" scheme="references">
    <meta name="DC.relation" content="US:7511032" scheme="references">
    <meta name="DC.relation" content="WO:2005042535:A1" scheme="references">
    <meta name="DC.relation" content="WO:2005079479:A2" scheme="references">
    <meta name="DC.relation" content="US:7375078" scheme="references">
    <meta name="DC.relation" content="WO:2005082023:A2" scheme="references">
    <meta name="DC.relation" content="WO:2005085250:A1" scheme="references">
    <meta name="DC.relation" content="US:20110160192:A1" scheme="references">
    <meta name="DC.relation" content="US:7741319" scheme="references">
    <meta name="DC.relation" content="US:7557099" scheme="references">
    <meta name="DC.relation" content="WO:2005085177:A2" scheme="references">
    <meta name="DC.relation" content="US:20070191349:A1" scheme="references">
    <meta name="DC.relation" content="WO:2005085259:A2" scheme="references">
    <meta name="DC.relation" content="WO:2005085251:A1" scheme="references">
    <meta name="DC.relation" content="US:20070249591:A1" scheme="references">
    <meta name="DC.relation" content="US:20070185336:A1" scheme="references">
    <meta name="DC.relation" content="US:7528126" scheme="references">
    <meta name="DC.relation" content="WO:2005085260:A1" scheme="references">
    <meta name="DC.relation" content="WO:2005105113:A2" scheme="references">
    <meta name="DC.relation" content="US:20070232592:A1" scheme="references">
    <meta name="DC.relation" content="US:8034808" scheme="references">
    <meta name="DC.relation" content="US:20110039969:A1" scheme="references">
    <meta name="DC.relation" content="WO:2005110423:A2" scheme="references">
    <meta name="DC.relation" content="US:20080090812:A1" scheme="references">
    <meta name="DC.relation" content="US:7521541" scheme="references">
    <meta name="DC.relation" content="US:20080092940:A1" scheme="references">
    <meta name="DC.relation" content="US:20080206239:A1" scheme="references">
    <meta name="DC.relation" content="US:20090148942:A1" scheme="references">
    <meta name="DC.relation" content="US:20100113425:A1" scheme="references">
    <meta name="DC.relation" content="WO:2006111759:A1" scheme="references">
    <meta name="DC.relation" content="US:7612062" scheme="references">
    <meta name="DC.relation" content="CN:101171257:A" scheme="references">
    <meta name="DC.relation" content="US:8633185" scheme="references">
    <meta name="DC.relation" content="US:20080214525:A1" scheme="references">
    <meta name="DC.relation" content="WO:2007039752:A1" scheme="references">
    <meta name="DC.relation" content="US:20070154906:A1" scheme="references">
    <meta name="DC.relation" content="US:8637664" scheme="references">
    <meta name="DC.relation" content="WO:2007044515:A1" scheme="references">
    <meta name="DC.relation" content="EP:1813614:A1" scheme="references">
    <meta name="DC.relation" content="US:20090036431:A1" scheme="references">
    <meta name="DC.relation" content="WO:2007085930:A1" scheme="references">
    <meta name="DC.relation" content="US:8163736" scheme="references">
    <meta name="DC.relation" content="US:20100047257:A1" scheme="references">
    <meta name="DC.relation" content="WO:2008010101:A2" scheme="references">
    <meta name="DC.relation" content="WO:2008022152:A2" scheme="references">
    <meta name="DC.relation" content="US:20080112961:A1" scheme="references">
    <meta name="DC.relation" content="US:20090304710:A1" scheme="references">
    <meta name="DC.relation" content="WO:2008047242:A2" scheme="references">
    <meta name="DC.relation" content="WO:2008050140:A2" scheme="references">
    <meta name="DC.relation" content="WO:2008070593:A2" scheme="references">
    <meta name="DC.relation" content="US:7723485" scheme="references">
    <meta name="DC.relation" content="EP:2019104:A1" scheme="references">
    <meta name="DC.relation" content="WO:2009016516:A2" scheme="references">
    <meta name="DC.relation" content="US:20100316656:A1" scheme="references">
    <meta name="DC.relation" content="WO:2009052249:A1" scheme="references">
    <meta name="DC.relation" content="WO:2009060208:A1" scheme="references">
    <meta name="DC.relation" content="WO:2009060215:A1" scheme="references">
    <meta name="DC.relation" content="WO:2009117531:A1" scheme="references">
    <meta name="DC.relation" content="US:8321774" scheme="references">
    <meta name="DC.relation" content="US:20090274713:A1" scheme="references">
    <meta name="DC.relation" content="US:20100028346:A1" scheme="references">
    <meta name="DC.relation" content="US:8501934" scheme="references">
    <meta name="DC.relation" content="WO:2010010347:A1" scheme="references">
    <meta name="DC.relation" content="US:8487092" scheme="references">
    <meta name="DC.relation" content="US:8592576" scheme="references">
    <meta name="DC.relation" content="WO:2010043880:A1" scheme="references">
    <meta name="DC.relation" content="US:9624227" scheme="references">
    <meta name="DC.relation" content="US:20110196148:A1" scheme="references">
    <meta name="DC.relation" content="US:20150111880:A1" scheme="references">
    <meta name="DC.relation" content="US:20110201803:A1" scheme="references">
    <meta name="DC.relation" content="WO:2010043877:A1" scheme="references">
    <meta name="DC.relation" content="US:8940733" scheme="references">
    <meta name="DC.relation" content="US:20130266596:A1" scheme="references">
    <meta name="DC.relation" content="WO:2010091150:A1" scheme="references">
    <meta name="DC.relation" content="US:20100203007:A1" scheme="references">
    <meta name="DC.relation" content="WO:2010095031:A2" scheme="references">
    <meta name="DC.relation" content="JP:5382792:B2" scheme="references">
    <meta name="DC.relation" content="US:20140155590:A1" scheme="references">
    <meta name="DC.relation" content="WO:2011023883:A1" scheme="references">
    <meta name="DC.relation" content="US:20110091372:A1" scheme="references">
    <meta name="DC.relation" content="US:20110070227:A1" scheme="references">
    <meta name="DC.relation" content="WO:2011038159:A2" scheme="references">
    <meta name="DC.relation" content="WO:2011100227:A1" scheme="references">
    <meta name="DC.relation" content="US:20110195022:A1" scheme="references">
    <meta name="DC.relation" content="US:20110195021:A1" scheme="references">
    <meta name="DC.relation" content="WO:2011130616:A1" scheme="references">
    <meta name="DC.relation" content="WO:2011128650:A1" scheme="references">
    <meta name="DC.relation" content="WO:2011130598:A1" scheme="references">
    <meta name="DC.relation" content="EP:2528625:A1" scheme="references">
    <meta name="DC.relation" content="US:20130028919:A1" scheme="references">
    <meta name="DC.relation" content="US:20130028917:A1" scheme="references">
    <meta name="DC.relation" content="WO:2011130613:A1" scheme="references">
    <meta name="DC.relation" content="US:20180134717:A1" scheme="references">
    <meta name="DC.relation" content="US:9732084" scheme="references">
    <meta name="DC.relation" content="US:20140066435:A1" scheme="references">
    <meta name="DC.relation" content="US:9592240" scheme="references">
    <meta name="DC.relation" content="US:9242013" scheme="references">
    <meta name="DC.relation" content="US:20110256157:A1" scheme="references">
    <meta name="DC.relation" content="US:8697688" scheme="references">
    <meta name="DC.relation" content="US:8829184" scheme="references">
    <meta name="DC.relation" content="WO:2011130615:A2" scheme="references">
    <meta name="DC.relation" content="WO:2011133039:A2" scheme="references">
    <meta name="DC.relation" content="WO:2012014147:A1" scheme="references">
    <meta name="DC.relation" content="US:20130137659:A1" scheme="references">
    <meta name="DC.relation" content="WO:2012064733:A2" scheme="references">
    <meta name="DC.relation" content="WO:2012128868:A1" scheme="references">
    <meta name="DC.relation" content="US:20130302359:A1" scheme="references">
    <meta name="DC.relation" content="US:20140088089:A1" scheme="references">
    <meta name="DC.relation" content="WO:2012112708:A1" scheme="references">
    <meta name="DC.relation" content="WO:2012112687:A1" scheme="references">
    <meta name="DC.relation" content="US:20120238731:A1" scheme="references">
    <meta name="DC.relation" content="US:20120233172:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013041606:A1" scheme="references">
    <meta name="DC.relation" content="US:20150158869:A1" scheme="references">
    <meta name="DC.relation" content="US:9399641" scheme="references">
    <meta name="DC.relation" content="US:9387259" scheme="references">
    <meta name="DC.relation" content="US:20130266595:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013053872:A1" scheme="references">
    <meta name="DC.relation" content="US:20170290924:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013053873:A1" scheme="references">
    <meta name="DC.relation" content="US:9713647" scheme="references">
    <meta name="DC.relation" content="US:9707301" scheme="references">
    <meta name="DC.relation" content="WO:2013055990:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013055987:A1" scheme="references">
    <meta name="DC.relation" content="US:9526798" scheme="references">
    <meta name="DC.relation" content="US:9399073" scheme="references">
    <meta name="DC.relation" content="US:9388187" scheme="references">
    <meta name="DC.relation" content="WO:2013055993:A1" scheme="references">
    <meta name="DC.relation" content="US:20170298137:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013053871:A1" scheme="references">
    <meta name="DC.relation" content="US:20140302066:A1" scheme="references">
    <meta name="DC.relation" content="US:20140286970:A1" scheme="references">
    <meta name="DC.relation" content="US:20140274907:A1" scheme="references">
    <meta name="DC.relation" content="US:20140275522:A1" scheme="references">
    <meta name="DC.relation" content="US:9102704" scheme="references">
    <meta name="DC.relation" content="US:20140234346:A1" scheme="references">
    <meta name="DC.relation" content="US:20130244171:A1" scheme="references">
    <meta name="DC.relation" content="US:9321774" scheme="references">
    <meta name="DC.relation" content="WO:2013164593:A1" scheme="references">
    <meta name="DC.relation" content="US:20150133435:A1" scheme="references">
    <meta name="DC.relation" content="US:20150126495:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013164592:A1" scheme="references">
    <meta name="DC.relation" content="US:9376440" scheme="references">
    <meta name="DC.relation" content="US:20130304357:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013177481:A1" scheme="references">
    <meta name="DC.relation" content="US:20140030279:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014011518:A1" scheme="references">
    <meta name="DC.relation" content="US:20140030280:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014011519:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014022679:A2" scheme="references">
    <meta name="DC.relation" content="US:9464141" scheme="references">
    <meta name="DC.relation" content="US:20150183883:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014031566:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057074:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057113:A1" scheme="references">
    <meta name="DC.relation" content="US:9889207" scheme="references">
    <meta name="DC.relation" content="US:20150297746:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057072:A1" scheme="references">
    <meta name="DC.relation" content="US:20140120118:A1" scheme="references">
    <meta name="DC.relation" content="US:9745303" scheme="references">
    <meta name="DC.relation" content="US:9415117" scheme="references">
    <meta name="DC.relation" content="US:20140127239:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057114:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057117:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057118:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057122:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057119:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057115:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057120:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014057073:A1" scheme="references">
    <meta name="DC.relation" content="US:20150265722:A1" scheme="references">
    <meta name="DC.relation" content="US:20150273078:A1" scheme="references">
    <meta name="DC.relation" content="US:20150274737:A1" scheme="references">
    <meta name="DC.relation" content="US:20150273077:A1" scheme="references">
    <meta name="DC.relation" content="US:20150283262:A1" scheme="references">
    <meta name="DC.relation" content="US:20150283263:A1" scheme="references">
    <meta name="DC.relation" content="US:20150283258:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014080251:A1" scheme="references">
    <meta name="DC.relation" content="US:20150344482:A1" scheme="references">
    <meta name="DC.relation" content="US:9562049" scheme="references">
    <meta name="DC.relation" content="WO:2014096368:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014096365:A1" scheme="references">
    <meta name="DC.relation" content="US:20150315196:A1" scheme="references">
    <meta name="DC.relation" content="US:20160015828:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014130879:A2" scheme="references">
    <meta name="DC.relation" content="WO:2014159981:A2" scheme="references">
    <meta name="DC.relation" content="US:9649390" scheme="references">
    <meta name="DC.relation" content="US:20140294868:A1" scheme="references">
    <meta name="DC.relation" content="US:20160144052:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014140862:A2" scheme="references">
    <meta name="DC.relation" content="WO:2014140174:A1" scheme="references">
    <meta name="DC.relation" content="US:20160031887:A1" scheme="references">
    <meta name="DC.relation" content="US:20180125997:A1" scheme="references">
    <meta name="DC.relation" content="WO:2014174111:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015031693:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052333:A1" scheme="references">
    <meta name="DC.relation" content="US:20160250344:A1" scheme="references">
    <meta name="DC.relation" content="US:20160250345:A1" scheme="references">
    <meta name="DC.relation" content="US:20160250346:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052533:A1" scheme="references">
    <meta name="DC.relation" content="US:20160256561:A1" scheme="references">
    <meta name="DC.relation" content="US:20160263242:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052532:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052321:A1" scheme="references">
    <meta name="DC.relation" content="US:9956298" scheme="references">
    <meta name="DC.relation" content="WO:2015052334:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052335:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052322:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052534:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052535:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015052332:A1" scheme="references">
    <meta name="DC.relation" content="US:20160310611:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015095124:A1" scheme="references">
    <meta name="DC.relation" content="WO:2015159076:A1" scheme="references">
    <meta name="DC.relation" content="US:20170340752:A1" scheme="references">
    <meta name="DC.relation" content="WO:2016037644:A1" scheme="references">
    <meta name="DC.relation" content="US:20170239365:A1" scheme="references">
    <meta name="DC.relation" content="US:20160075787:A1" scheme="references">
    <meta name="DC.relation" content="WO:2016040868:A1" scheme="references">
    <meta name="DC.relation" content="US:20160074527:A1" scheme="references">
    <meta name="DC.relation" content="WO:2016044560:A1" scheme="references">
    <meta name="citation_reference" content="Adair; et al., &quot;Antibody-drug conjugates-a perfect synergy,&quot; Exp. Opin. Biol. Ther. (2012), pp. 1-16." scheme="references">
    <meta name="citation_reference" content="Adair; et al., “Antibody-drug conjugates—a perfect synergy,” Exp. Opin. Biol. Ther. (2012), pp. 1-16." scheme="references">
    <meta name="citation_reference" content="Adams et al., &quot;Molecular modelling of a sequence-specific DNA-binding agent based on the pyrrolo[2,1-c][1,4]benzodiazepines,&quot; Pharm. Pharmacol. Commun. (1999) 5:555-560." scheme="references">
    <meta name="citation_reference" content="Aird, R.E. et al., &quot;ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136,&quot; Pharmacogenomics Journal (2008) 8(4):289-296." scheme="references">
    <meta name="citation_reference" content="Alley, M.C. et al., &quot;&quot;SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations,&quot;&quot; Cancer Res. (2004) 64:6700-6706." scheme="references">
    <meta name="citation_reference" content="Alley, M.C., &quot;Efficacy evaluations of SJG-136 (NSC 694501), a novel pyrrolobenzodiazepine dimer with broad spectrum antitumor activity,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2002) 43:63." scheme="references">
    <meta name="citation_reference" content="Alley, S. C., &quot;Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates&quot; Bioconjugate Chem 2008, 19, 759-765." scheme="references">
    <meta name="citation_reference" content="Althius, T. H. and Hess, H. J., &quot;Synthesis and Identification of the Major Metabolites of Prazosin Formed in Dog and Rat,&quot; J. Medicinal Chem. (1977) 20(1):146-148." scheme="references">
    <meta name="citation_reference" content="Altuvia et al., &quot;Ranking potential binding peptides to MHC molecules by a computational threading approach.&quot; J. Mol. Biol., 249, 244-250 (1995)." scheme="references">
    <meta name="citation_reference" content="Amiel J., et al., &quot;Heterozygous endothelin receptor B {EDNRB) mutations in isolated Hirschsprung disease,&quot; Hum. Mol. Genet. 5, 355-357, 1996." scheme="references">
    <meta name="citation_reference" content="Amir et al., &quot;Self-Immolative Dendrimers,&quot; (2003) Angew. Chem. Int. Ed. 42:4494-4499." scheme="references">
    <meta name="citation_reference" content="Amsberry, et al, &quot;The Lactonization of 2′-Hydroxyhydrocinnamic Acid Amides: A Potential Prodrug for Amines,&quot; (1990) J. Org. Chem. 55:5867-5877." scheme="references">
    <meta name="citation_reference" content="Antonow, D. et al., &quot;&quot;Synthesis of DNA-Interactive Pyrrolo [2,1-c][1,4] benzodiazepines (PBDs)&quot;&quot; Chemical Reviews, 2011, 111(4):2815-2864." scheme="references">
    <meta name="citation_reference" content="Antonow, D. et al., &quot;Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents.&quot;J Med Chem. Apr. 8, 2010;53(7):2927-41." scheme="references">
    <meta name="citation_reference" content="Antonow, D. et al.,&quot;Parallel synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) library,&quot; J. Comb. Chem. (2007) 9:437-445." scheme="references">
    <meta name="citation_reference" content="Arai H., et al., &quot;&quot;Molecular cloning of human endothelin receptors and their expressiOn in vascular endothelial cells and smooth muscle cells,&quot;&quot; Jpn. Circ. J. 56, 1303-1307, 1992." scheme="references">
    <meta name="citation_reference" content="Arai H., et al., &quot;The Human Endotbelin-B Receptor Gene. Structural Organization and Chromosomal Assignment,&quot; J. Biol. Chem. 268, 3463-3470, 1993." scheme="references">
    <meta name="citation_reference" content="Arima et al., &quot;Studies on Tomaymycin, a New Antibiotic. I. Isolation and Properties of Tomaymycin,&quot; J. Antibiotics (1972) 25:437-444." scheme="references">
    <meta name="citation_reference" content="Arnould, S., &quot;&quot;Impact on the cell cycle and involvement of ATM, ATR, chk1 and chk2 kinases in the cytotoxicity of SJG-136, a new pyrrolobenzodiazepine dimer,&quot;&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:1298, Abstract No. 5618." scheme="references">
    <meta name="citation_reference" content="Arnould, S., &quot;Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling,&quot; Mol. Canc. Therap. 5(6):1602-1609 (2006)." scheme="references">
    <meta name="citation_reference" content="Attie T., et al., &quot;Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease,&quot; Hum. Mol. Genet. 4, 2407-2409, 1995." scheme="references">
    <meta name="citation_reference" content="Auricchio A., et al., &quot;Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population,&quot; Hum. Mol. Genet. 5:351-354, 1996." scheme="references">
    <meta name="citation_reference" content="Axup et al., &quot;Synthesis of site-specific antibody-drug conjugates using unnatural amino acids.&quot; Proc Natl Acad Sci U S A. Oct. 2, 2012; 109(40)1 6101-6." scheme="references">
    <meta name="citation_reference" content="Bahrenberg et al., &quot;&quot;Reduced Expression of PSCA, a Member of the LY-6 Family of Cell Surface Antigens, in Bladder, Esophagus, and Stomach Tumors,&quot;&quot; Biochem. Biophys. Res. Commun. (2000) 275(3):783-788." scheme="references">
    <meta name="citation_reference" content="Banker, G.S. et al., &quot;Modern Pharmaceutics&quot;, Third edition, Marcel Dekker, New York (1996) 451 and 596." scheme="references">
    <meta name="citation_reference" content="Barel M., et al., &quot;Evidence for a new transcript of the Epstein-Barr virus/C3d receptor (CR2, CD21) which is due to alternative exon usage,&quot; Mol. Immunol. 35, 1025-1031, 1998." scheme="references">
    <meta name="citation_reference" content="Barella et al., &quot;Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation,&quot; (1995) Biochem. J. 309:773-779." scheme="references">
    <meta name="citation_reference" content="Barnett T., et al., &quot;Carcinoembryonic Antigen Family: Characterization of cDNAs Coding for NCA and CEA and Suggestion of Nonrandom Sequence Variation in Their Conserved Loop-Domains,&quot; Genomics 3, 59-66, 1988." scheme="references">
    <meta name="citation_reference" content="Batisse, et al., &quot;A new delivery system for Auristatin in STxB-drug conjugate therapy.&quot; European J. Medicinal Chemistry, 2015, 95: 483-491." scheme="references">
    <meta name="citation_reference" content="Beck et al., &quot;DNA Sequence Analysis of 66 kb of the Human MHC Class II Region Encoding a Cluster of Genes for Antigen Processing,&quot; (1992) J. Mol. Biol. 228:433-441." scheme="references">
    <meta name="citation_reference" content="Beck et al., &quot;Evolutionary Dynamics of Non-coding Sequences Within the Class II Region of the Human MHC,&quot; (1996) J. Mol. Biol. 25 255:1-13." scheme="references">
    <meta name="citation_reference" content="Berge et al., &quot;Pharmaceutical Salts,&quot; J. Pharm. Sci. (1977) 66:1-19." scheme="references">
    <meta name="citation_reference" content="Berry, J. M. et al., &quot;Solid-phase synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines,&quot; Tetrahedron Letters (2000) 41:6171-6174." scheme="references">
    <meta name="citation_reference" content="Berry, J.M. et al., &quot;Synthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrug,&quot; Bioorg. Med. Chem. Lett. (2002) 12:1413-1416." scheme="references">
    <meta name="citation_reference" content="Blanc et al., &quot;SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies,&quot; Clin Cancer Res., 2011, 17(20):6448-58." scheme="references">
    <meta name="citation_reference" content="Blumberg H., et al., &quot;&quot;Interleukin 20: Discovery, Receptor Identification, and Role in Epidermal Function,&quot;&quot; Cell 104, 9-19, 2001." scheme="references">
    <meta name="citation_reference" content="Bose et al., &quot;New Approaches to Pyrrolo[2,1-c][1,4]benzodiazepines: Synthesis, DNA-binding and cytotoxicity of DC-81,&quot; Tetrahedron, 48, 751-758 (1992)." scheme="references">
    <meta name="citation_reference" content="Bose, D.S. et al., &quot;Effect of linker length on DNA-binding affinity, cross-linking efficiency and cytotoxicity of C8 linked pyrrolobenzodiazepine dimers,&quot; J. Chem. Soc. Chem. Commun. (1992) 20:1518-1520." scheme="references">
    <meta name="citation_reference" content="Bose, D.S. et al., &quot;Rational Design of a Highly Efficient Irreversible DNA Interstrand Cross-Linking Agent Based on the Pyrrolobenzodiazepine Ring System,&quot; J. Am. Chem. Soc., 114, 4939-4941 (1992)." scheme="references">
    <meta name="citation_reference" content="Bourgeois C., et al., &quot;Endothelin-1 and ETA Receptor Expression in Vascular Smooth Muscle Cells from Human Placenta: A New ETA Receptor Messenger Ribonucleic Acid Is Generated by Alternative Splicing of Exon 3,&quot; J. Clin. Endocrinol. Metab. 82, 3116-3123, 1997." scheme="references">
    <meta name="citation_reference" content="Brand et al., Prospect for anti-HER2 receptor therapy in breast cancer. Anticancer Res. Jan.-Feb. 2006;26(1B):463-70." scheme="references">
    <meta name="citation_reference" content="Brinster et al., &quot;Introits increase transcriptional efficiency in transgenic mice,&quot;(1988) Proc. Natl. Acad. Sci. USA 85:836-840." scheme="references">
    <meta name="citation_reference" content="Buchman et al., &quot;Comparison of Intron-Dependent and Intron-Independent Gene Expression,&quot; (1988) Mol. Cell. Biol. 8:4395-4405." scheme="references">
    <meta name="citation_reference" content="Buhrow, S.A., &quot;LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501),&quot; J. Chromat. B: Anal. Tech. Biomed. Life Sci. (2006) 840(1):56-62." scheme="references">
    <meta name="citation_reference" content="Burke, P.J. et al., &quot;Anti-CD70 antibody-drug conjugates containing pyrrolobenzodiazepine dimers demonstrate robust antitumor activity,&quot; AACR National Meeting, Apr. 2012, Chicago, Illinois, Abstract No. 4631." scheme="references">
    <meta name="citation_reference" content="Burke, P.J. et al., &quot;Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system,&quot; Bioorg. Med. Chem. Lett., Apr. 2009, 19(10):2650-2653." scheme="references">
    <meta name="citation_reference" content="Calcutt, M.W., &quot;Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study,&quot; J. Mass Spectrom. (2008) 43(1):42-52." scheme="references">
    <meta name="citation_reference" content="Carl et al., &quot;A Novel Connector Linkage Applicable in Prodrug Design,&quot; (1981) J. Med. Chem. 24:479-480." scheme="references">
    <meta name="citation_reference" content="Carlsson et al., &quot;Protein Thiolation and Reversible Protein-Protein Conjugation,&quot; (1978) Biochem. J. 173:723-737." scheme="references">
    <meta name="citation_reference" content="Carter, P., &quot;Potent antibody therapeutics by design,&quot; (2006) Nature Reviews Immunology 6:343-357." scheme="references">
    <meta name="citation_reference" content="Casset et al., &quot;A peptide mimetic of an anti-CD4 monoclonal antibody by rational design.&quot; Biochem Biophys Res Commun. Jul. 18, 2003; 307(1):198-205." scheme="references">
    <meta name="citation_reference" content="CellTiter-Glo Luminescent Cell Viability Assay, Promega Corp. Technical Bulletin TB288, dated Jan. 13, 2012 (14 pages)." scheme="references">
    <meta name="citation_reference" content="Chakravarty et al., &quot;Plasmin-Activated Prodrugs for Cancer Chemotherapy. 2. Synthesis and Biological Activity of Peptidyl Derivatives of Doxorubicin,&quot; (1983) J. Med. Chern. 26:638-644." scheme="references">
    <meta name="citation_reference" content="Chan, J. and Watt, V.M., &quot;eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases,&quot; Oncogene 6 (6), 1057-1061 (1991)." scheme="references">
    <meta name="citation_reference" content="Chang et al., &quot;Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers,&quot; Proc. Natl. Acad. Sci. U.S.A. 93 (1):136-140 (1996)." scheme="references">
    <meta name="citation_reference" content="Chen, Z. et al., &quot;&quot;A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1- c][1,4]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents,&quot;&quot; Biorg. Med. Chem. Lett. (2004) 14:1547-1549." scheme="references">
    <meta name="citation_reference" content="Cheung, A., &quot;Direct liquid chromatography determination of the reactive imine SJG-136 (NSC 694501),&quot; J. Chromat. B: Anal. Techn. Biomed. Life Sci. (2005) 822(1-2):10-20." scheme="references">
    <meta name="citation_reference" content="Child et al., &quot;Translational Control by an Upstream Open Reading Frame in the HER-2/neu Transcript,&quot; (1999) J. Bioi. Chern. 274: 24335-24341." scheme="references">
    <meta name="citation_reference" content="Cho et al., &quot;Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab,&quot; Nature 421, 756-760, 2003." scheme="references">
    <meta name="citation_reference" content="Ciccodicola, et al., &quot;Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells,&quot; EMBO J. 8 (7):1987-1991 (1989)." scheme="references">
    <meta name="citation_reference" content="Ciccodicola, et al., “Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells,” EMBO J. 8 (7):1987-1991 (1989)." scheme="references">
    <meta name="citation_reference" content="Cipolla, L., &quot;Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs,&quot; Anti-Cancer Agents in Medicinal Chemistry (Jan. 2009) 9(1):1-31." scheme="references">
    <meta name="citation_reference" content="Clackson et al., &quot;Making antibody fragments using phage display libraries,&quot; (1991) Nature, 352:624-628." scheme="references">
    <meta name="citation_reference" content="Clark H.F., et al., &quot;The Secreted Protein Discovery Initiative (SPDI], a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment,&quot; Genome Res. 13, 2265-2270, 2003." scheme="references">
    <meta name="citation_reference" content="Clingen, P.H., &quot;The role of nucleotide excision repair and homologous recomination in the sensitivity of mammalian cells to the minor groove crosslinking pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136 (NSC694501),&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Jul. 2003) 44:524." scheme="references">
    <meta name="citation_reference" content="Clingen, P.H., &quot;The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136,&quot; Nucl. Acids Res. (2005) 33(10):3283-3291." scheme="references">
    <meta name="citation_reference" content="Clinical Trial, &quot;Translational research: 4 ways to fix the clinical trial.&quot; 2011, http://www.nature.com/news/2011/110928/ful1/477526a.html." scheme="references">
    <meta name="citation_reference" content="Collins, &quot;Generation and initial analysis of more than 15,000 full-length human and mouse eDNA sequences,&quot; Proc. Natl. Acad. Sci. U.S.A. 99 (26):16899-16903 (2002)." scheme="references">
    <meta name="citation_reference" content="Cooper, N. et al., &quot;Synthesis of novel PBDs as anti-tumour agents,&quot; Chem. Commun. (2002) 16:1764-1765." scheme="references">
    <meta name="citation_reference" content="Cooper, N., &quot;Design, Synthesis and Evaluation of Novel C2-Aryl Pyrrolobenzodiazepines as Potential Anticancer Agents,&quot; Thesis submitted to School of Pharmacy, University of London, Dated Oct. 5, 2006." scheme="references">
    <meta name="citation_reference" content="Corey et al., &quot;LuCap35: a new model of prostate cancer progression to androgen independence.&quot; The Prostate 2003; 55:239-46." scheme="references">
    <meta name="citation_reference" content="Courtney, S. M. et al., &quot;A new convenient procedure for the synthesis of pyrrolo[2,1-c][1,4]benzodiazepines&quot;, Tetrahedron Letters, vol. 34, No. 33, 5327-28 (1993)." scheme="references">
    <meta name="citation_reference" content="Coussens L., et al., &quot;Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location With neu Oncogene,&quot; Science (1985) 230(4730):1132-1139." scheme="references">
    <meta name="citation_reference" content="Cragg et al., &quot;The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis,&quot; Blood (2002) 100 (9):3068-3076." scheme="references">
    <meta name="citation_reference" content="Cree et al., &quot;Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay,&quot; (1995) AntiCancer Drugs 6:398-404." scheme="references">
    <meta name="citation_reference" content="Crouch et al., &quot;The use⋅ of ATP bioluminescence as a measure of cell proliferation and cytotoxicity,&quot; (1993) J. Immunol. Meth. 160:81-88." scheme="references">
    <meta name="citation_reference" content="Dall'Acqua, W. F. et al., &quot;Antibody humanization by framework shuffling&quot; Methods, 36, 43-60 (2005)." scheme="references">
    <meta name="citation_reference" content="Dattolo, G. et al., &quot;Polycondensed nitrogen heterocycles. IX. 5,6-dihydro-7H-pyrrolo[1,2- d][1,4]benzodiazepin-6-one,&quot; J. Heterocyclic. Chem. (1980) 17:701-703." scheme="references">
    <meta name="citation_reference" content="Davis et al., &quot;Identification of a family of Fe receptor homo logs with preferential B cell expression,&quot; (2001) Proc. Natl. Acad. Sci. USA 98(17):9772-9777." scheme="references">
    <meta name="citation_reference" content="De Groot et al., &quot;Cascade-Release Dendrimers &quot;Liberate All End Groups upon a Single Triggering Event in the Dendritic Core,&quot;&quot; (2003) Angew. Chern. Int. Ed. 42:4490-4494." scheme="references">
    <meta name="citation_reference" content="De Groot et al., &quot;Elongated Multiple Electronic Cascade and Cyclization Spacer Systems in Activatible Anticancer Prodrug for Enhanced Drug Release,&quot; (2001) J. Org. Chern. 66:8815-8830." scheme="references">
    <meta name="citation_reference" content="De Pascalis et al., &quot;Grafting of &quot;abbreviated&quot; complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.&quot; J Immunol. Sep. 15, 2002;169(6):3076-84." scheme="references">
    <meta name="citation_reference" content="Dennis et al., (2002) &quot;Albumin Binding As a General Strategy for Improving the Pharmacokinetics of Proteins&quot; J Biol Chem. 277:35035-35043." scheme="references">
    <meta name="citation_reference" content="Dijke, P., et al., &quot;Characterization of Type I Receptors for Transforming Growth Factor-beta and Activin,&quot; Science 264 (5155):101-104 (1994)." scheme="references">
    <meta name="citation_reference" content="Dobner et al., &quot;Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma,&quot; (1992) Eur. J. Immunol. 22:2795-2799." scheme="references">
    <meta name="citation_reference" content="Dong, Q. et al., &quot;Reductive cleavage of TROC groups under neutral conditions with cadmium-lead couple,&quot; Tetrahedron Lett. (1995) 36(32):5681-5682." scheme="references">
    <meta name="citation_reference" content="Dono et al., &quot;Isolation and Characterization of the CRI PTO Autosomal Gene and Its X-linked Related Sequence,&quot; Am. J. Hum. Genet. 49:555-565, 1991." scheme="references">
    <meta name="citation_reference" content="Dornan et al., &quot;Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma,&quot; (2009) Blood 114(13):2721-2729." scheme="references">
    <meta name="citation_reference" content="Doronina et al., &quot;Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity,&quot; (2006) Bioconj. Chem. 17:114-124." scheme="references">
    <meta name="citation_reference" content="Doronina, S.O. et al., &quot;Development of potent monoclonal antibody auristatin conjugates for cancer therapy,&quot; Nature Biotech. (2003) 21:778-784." scheme="references">
    <meta name="citation_reference" content="Dorwald, F.Z., Side Reactions in Organic Synthesis: a Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmbH &amp; Co., KGaA (2005) Preface." scheme="references">
    <meta name="citation_reference" content="Doyle, M., &quot;Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer,&quot; J. Antimicrob. Chemo., Aug. 2009, 64(5):949-959." scheme="references">
    <meta name="citation_reference" content="Dubowchik et al, &quot;Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin.&quot; Bioorg Med Chem Lett. Dec. 1, 1998; 8(23):3341-6." scheme="references">
    <meta name="citation_reference" content="Dubowchik et al, &quot;Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin.&quot; Bioorganic &amp; Medicinal Chemistry Letters, 8:3347-3352, (1998)." scheme="references">
    <meta name="citation_reference" content="Dubowchik et al., &quot;Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity,&quot; Bioconjugate Chem. (2002) 13, 855-869." scheme="references">
    <meta name="citation_reference" content="Dubowchik et al., &quot;Monomethoxytrityl (MMT) as a Versatile Amino Protecting Group for Complex Prodrugs of Anticancer Compounds Sensitive to Strong Acids, Bases and Nucleophiles,&quot; (1997) Tetrahedron Letters. 38:5257-5260." scheme="references">
    <meta name="citation_reference" content="Dumoutier L., et al., &quot;Cutting Edge: STAT Activation by IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types,&quot; J. Immunol. 167, 3545-3549, 2001." scheme="references">
    <meta name="citation_reference" content="Dupont, C. et al., &quot;Synthesis of rhazinilam analogue acting as an inhibitor of tubulin assembly,&quot; Tetrahedron Lett. (2000) 41:5853-5856." scheme="references">
    <meta name="citation_reference" content="Ehsani A., et al., &quot;Characterization of a New Allele of the Human ERBB2 Gene by Allele-Specific Competition Hybridization,&quot; (1993) Genomics 15, 426-429." scheme="references">
    <meta name="citation_reference" content="Eliel et al., Stereochemistry of Organic Compounds, John Wiley &amp; Sons, Inc., New York (1994)." scheme="references">
    <meta name="citation_reference" content="Elshourbagy N.A., et al., &quot;Molecular Characterization and Regulation of the Human Endothelin Receptors,&quot; J. Biol. Chem. 268, 3873-3879, 1993." scheme="references">
    <meta name="citation_reference" content="Erickson et al., &quot;Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing,&quot; (2006) Cancer Res. 66(8): 4426-4433." scheme="references">
    <meta name="citation_reference" content="Farmer, J.D. et al., &quot;DNA binding properties of a new class of linked anthramycin analogs,&quot;, Chemical Abstracts, Abstract No. 239940r, vol. 114, No. 25, 25 899-903 (1991)." scheme="references">
    <meta name="citation_reference" content="Farmer, J.D. et al., &quot;Synthesis and DNA crosslinking ability of a dimeric anthramycin analog,&quot; Tetrahedron Letters (1988) 29(40):5105-5108, Abstract only." scheme="references">
    <meta name="citation_reference" content="Feild, J.A., et al., &quot;Cloning and Functional Characterization of a Sodium-Dependent Phosphate Transporter Expressed in Human Lung and Small Intestine,&quot; (1999) Biochem. Biophys. Res. Commun. 258 (3):578-582." scheme="references">
    <meta name="citation_reference" content="Fey, T. et al., &quot;Silica-supported TEMPO catalyst: synthesis and application in the anelli oxidation of alcohols,&quot; J. Org. Chem. (2001) 66:8154-8159." scheme="references">
    <meta name="citation_reference" content="Fields, G. and Noble, R. (1990) &quot;Solid phase peptide synthesis utilizing 9-fluoroenylmethoxycarbonyl amino acids&quot;, Int. J. Peptide Protein Res. 35:161-214." scheme="references">
    <meta name="citation_reference" content="Firsching, A. et al., &quot;Antiproliferative and angiostatic activity of suramin analogues,&quot; Cancer Res. (1995) 55:4957-4961." scheme="references">
    <meta name="citation_reference" content="Flanagan et al., &quot;The ephrins and Eph receptors in neural development,&quot; Annu. Rev. Neurosci. 21:309-345 (1998)." scheme="references">
    <meta name="citation_reference" content="Flygare, &quot;Antibody-drug conjugates for the treatment of cancer,&quot; Chem. Biol. &amp; Drug Design (2013) 81(1):113-121." scheme="references">
    <meta name="citation_reference" content="Foloppe, M.P. et al., &quot;DNA-binding properties of pyrrolo[2,1-c][1,4]benzodiazephine N10-C11 amidines,&quot; Eur. J. Med. Chem., 31, 407-410 (1996)." scheme="references">
    <meta name="citation_reference" content="Fox et al., &quot;cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases,&quot; Oncogene 10 (5):897-905 (1995)." scheme="references">
    <meta name="citation_reference" content="Fuchs S., et al., &quot;Functional Characterization of Three Mutations of the Endothelin B Receptor Gene in Patients With Hirschsprung's Disease: Evidence for Selective Loss of Gi Coupling,&quot; Mol. Med. 7, 115-124, 2001." scheme="references">
    <meta name="citation_reference" content="Fujisaku et al., &quot;Genomic Organization and Polymorphisms of the Human C3d/Epstein-Barr Virus Receptor,&quot; (1989) J. Biol. Chem. 264 (4):2118-2125." scheme="references">
    <meta name="citation_reference" content="Fujisawa Pharmaceutical Co. Ltd., &quot;Benzodiazepine derivatives,&quot; SciFinder Scholar, 2-3 (2002)." scheme="references">
    <meta name="citation_reference" content="Fujisawa Pharmaceutical Co., Ltd., Abstract No. 139983k, &quot;Benzodiazepine derivatives&quot;, Chemical Abstracts, vol. 99, No. 17, 603 (1983)." scheme="references">
    <meta name="citation_reference" content="Fujisawa Pharmaceutical Co., Ltd., Abstract No. 72145x, &quot;Benzodiazepine derivatives&quot;, Chemical Abstracts, vol. 98, No. 9, 638 (1983)." scheme="references">
    <meta name="citation_reference" content="Fukuyama, T. et al., &quot;Total Synthesis of (+)-Porothramycin B,&quot; Tetrahedron Letters, vol. 34, 16, 2577-2580 (1993)." scheme="references">
    <meta name="citation_reference" content="Gallmeier, E., &quot;Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options,&quot; Gastroenterology (2006) 130(7):2145-2154." scheme="references">
    <meta name="citation_reference" content="Gary S.C., et al., &quot;cDNA cloning chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma,&quot; Gene 256, 139-147, 2000." scheme="references">
    <meta name="citation_reference" content="Gaugitsch, H.W., et al., &quot;A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA.,&quot; (1992) J. Biol. Chem. 267 (16):11267-11273." scheme="references">
    <meta name="citation_reference" content="Gavezzotti, A., &quot;Are crystal structures predictable?&quot; Acc. Chem. Res. (1994) 27:309-314." scheme="references">
    <meta name="citation_reference" content="Geiser et al &quot;Automation of solid-phase peptide synthesis&quot; in Macromolecular Sequencing and Synthesis, Alan R. Liss, Inc., 1988, pp. 199-218." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. 11038674 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. 20 NM_006424 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AB040878 (2001)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AF116456 (1999)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AF179274 (2001)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AF361486 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AF369794 (2001)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AF397453 (2001)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AF455138 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AJ297436 (2008)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AK026467 (2006)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AK089756 (2010)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AK090423 (2006)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AK090475 (2006)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AL834187 (2008)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AX092328 (2001)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AY158090 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AY260763 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AY275463 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AY358085 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession no. AY358628 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AY358907 (2003)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. AY506558 (2004)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. BC017023 (2006)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. CAA76847.1 (2001)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. CAF85723 (2004)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. CQ782436 (2004)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. M11730 (1995)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. M18728 (1995)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. M26004 (1993)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_000626 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_001178098.1 (2012)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_001203 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_003212 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_003486 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_004442 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_005823 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_012449 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_017636 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NM_030764 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. Np 002111.1 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_001171569.1 (1992)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_001194 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_001707.1 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_001773.1 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_001774.10 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_002552.2 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_003203 (2013)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_005573.1 (2007)." scheme="references">
    <meta name="citation_reference" content="Genbank accession No. NP_112571.1 (2007)." scheme="references">
    <meta name="citation_reference" content="Geoghegan &amp; Stroh, &quot;Site-Directed Conjugation of Nonpeptide Groups to Peptides and Proteins via Periodate Oxidation of a 2-Amino Alcohol. Application to Modification at N-Terminal Serine,&quot; (1992) Bioconjugate Chem. 3:138-146." scheme="references">
    <meta name="citation_reference" content="Getz Et al., &quot;A Comparison between the Sulfhydryl Reductants Tris(2-carboxyethyl)phosphine and Dithiothreitol for Use in Protein Biochemistry,&quot; (1999) Anal. Biochem. vol. 273:73-80." scheme="references">
    <meta name="citation_reference" content="Glynne-Jones et al., &quot;TENB2, a proteogl ycan identified in prostate cancer that is associated with disease progression and androgen independence,&quot; (2001) Int J Cancer. Oct. 15; 94(2): 178-184." scheme="references">
    <meta name="citation_reference" content="Gordon et al., &quot;Somatic hypermutation of the B cell receptor genes B29 (Igβ, CD79b) and mb1 (Igα, CD79a),&quot; PNAS, Apr. 11, 2003, vol. 100, No. 7, 4126-4131." scheme="references">
    <meta name="citation_reference" content="Greene, T.W. and Wuts, P.G.M., Protective Groups in Organic Synthesis, John Wiley &amp; Sons, 2nd ed., Ch 7, 315-345 (1991)." scheme="references">
    <meta name="citation_reference" content="Greene, T.W. et al., Protective Groups in Organic Synthesis, John Wiley &amp; Sons (1999) 3rd Edition, 23-200." scheme="references">
    <meta name="citation_reference" content="Greene, T.W. et al., Protective Groups in Organic Synthesis, John Wiley &amp; Sons (1999) 3rd Edition, 503-549." scheme="references">
    <meta name="citation_reference" content="Gregson, S. et al., &quot;Synthesis of a novel C2/C2′-exo unsaturated pyrrolobenzodiazepine cross-linking agent with remarkable DNA binding affinity and cytotoxicity,&quot; Chemical Communications, 797-798 (1999)." scheme="references">
    <meta name="citation_reference" content="Gregson, S.J. et al., &quot;Design, Synthesis and Evaluation of a Novel Pyrrolobenzodiazepine DNA-Interactive Agent with Highly Efficient Cross-Linking Ability and Potent Cytotoxicity&quot;, J. Med. Chem., 44: 737-748 (2001)." scheme="references">
    <meta name="citation_reference" content="Gregson, S.J. et al., &quot;Effect of C2/C3-endo unsaturation on the cytotoxicity and DNA-binding reactivity of pyrrolo-[2,1-c][1,4]-benzodiazepines,&quot; Bioorg. Med. Chem. Lett. (2000) 10(16):1849-1851." scheme="references">
    <meta name="citation_reference" content="Gregson, S.J. et al., &quot;Effect of C2-exo Unsaturation on the Cytotoxicity and DNA-Binding Reactivity of Pyrrolo[2,1-c]1,4]benzodiazepines&quot;, Bioorganic &amp; Medicinal Chemistry Letters, 10: 1845-1847 (2000)." scheme="references">
    <meta name="citation_reference" content="Gregson, S.J. et al., &quot;Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8′ ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers,&quot; J. Med. Chem. (2004) 1161-1174." scheme="references">
    <meta name="citation_reference" content="Gregson, S.J. et al., &quot;Synthesis of the first example of a C2-C3/C2′-C3′-endo unsaturated pyrrolo[2,1- c][1,4]benzodiazepine dimer,&quot; Biorg. Med. Chem. Lett. (2001) 11:2859-2862." scheme="references">
    <meta name="citation_reference" content="Gregson, S.J. et al., &quot;Synthesis of the first examples of A-C8/C-C2 amide-linked pyrrolo[2,1-c][1,4]benzodiazepine dimers,&quot; Biorg. Med. Chem. Lett. (2003) 13:2277-2280." scheme="references">
    <meta name="citation_reference" content="Gu Z., et al., &quot;Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer,&quot; Oncogene 19, 1288-1296, 2000." scheme="references">
    <meta name="citation_reference" content="Guichard, S.M., &quot;Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136,&quot; Eur. J. Cancer (2005) 41(12):1811-1818." scheme="references">
    <meta name="citation_reference" content="Guiotto, A. et al., &quot;Synthesis of novel C7-aryl substituted pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) via Pro-N10-troc protection and suzuki coupling,&quot; Bioorganic &amp; Medicinal Chemistry Letters, 8, No. 21, 3017-3018 (1998)." scheme="references">
    <meta name="citation_reference" content="Guselnikov et al., &quot;A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1,&quot; Immunogenetics 54 (2):87-95 (2002)." scheme="references">
    <meta name="citation_reference" content="Ha et al., &quot;molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene,&quot; (1992) J. Immunol. 148(5):1526-1531." scheme="references">
    <meta name="citation_reference" content="Hadjivassileva, T., &quot;Antibacterial activity of pyrrolobenzodiazepine dimers, a novel group of DNA-binding compounds,&quot; Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct.-Nov. 2004) 44:202." scheme="references">
    <meta name="citation_reference" content="Hadjivassileva, T., &quot;Interactions of pyrrolobenzodiazepine dimers and duplex DNA from methicillin-resistant Staphylococcus aureus,&quot; Int. J. Antimicrob. Agents (2007) 29(6):672-678." scheme="references">
    <meta name="citation_reference" content="Hadjivassileva, T., &quot;Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria,&quot; J. Antimicrob. Chemo. (2005) 56(3):513-518." scheme="references">
    <meta name="citation_reference" content="Haendler B., et al., &quot;Molecular Cloning of Human Endothelin (ET) Receptors ETA and ETB,&quot; J. Cardiovasc. Pharmacal. 20, s1-S4, 1992." scheme="references">
    <meta name="citation_reference" content="Haisma et al., &quot;Comparison of two antracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer.&quot; Cell biophysics, Humana Press Inc. 1994, 24/25: 185-192." scheme="references">
    <meta name="citation_reference" content="Hamaguchi, A., &quot;DNA cross-linking and in vivo antitumour activity of the extended pyrrolo[2,1- c][1,4]benzodiazepine dimer SG2057 (DRG-16),&quot; EJC Supplements (Nov. 2006) 4(12):96." scheme="references">
    <meta name="citation_reference" content="Hamann P. &quot;Monoclonal antibody-drug conjugates,&quot; (2005) Expert Opin. Ther. Patents 15(9):1087-1103." scheme="references">
    <meta name="citation_reference" content="Hamblett et al., &quot;Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate,&quot; (2004) Clin. Cancer Res. 10:7063-7070." scheme="references">
    <meta name="citation_reference" content="Handbook of Food Additives, 2nd Ed. (eds. M. Ash and I. Ash), Synapse Information Resources, Inc., Endicott, New York, USA (2001)." scheme="references">
    <meta name="citation_reference" content="Handbook of Pharmaceutical Excipients, 2nd edition, 1994, Edited by Ainley Wade and Paul J. Weller." scheme="references">
    <meta name="citation_reference" content="Hara et al., &quot;DC 102, a new glycosidic pyrrolo(1,4)benzodiazepine antibiotic produced by streptomyces sp.&quot;, J. Antibiotics, 41, 702-704 (1988)." scheme="references">
    <meta name="citation_reference" content="Hartley J A: &quot;The development of pyrrolobenzodiazepines as antitumour agents&quot;, Expert Opinion on Investigational Drugs, Ashley Publications Ltd., vol. 28, No. 6, Jan. 1, 2011, pp. 733-744." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A. et al., &quot;Abstract 2856: pyrrolobenzodiazepine (PBD) dimers-potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors,&quot; Cancer Res. (2013) 78(8)Supp 1:2856." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A. et al., &quot;SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activity,&quot; Cancer Res., Sep. 2010, 70(17):6849-6858." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A. et al., &quot;SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity,&quot; Cancer Res. (2004) 64:6693-6699." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A. et al., “Abstract 2856: pyrrolobenzodiazepine (PBD) dimers—potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors,” Cancer Res. (2013) 78(8)Supp 1:2856." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A., &quot;In vitro antitumor activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501),&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2002) 43:489." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A., &quot;SJG-136 (NSC-D694501)-a novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2000) 41:425." scheme="references">
    <meta name="citation_reference" content="Hartley, J.A., “SJG-136 (NSC-D694501)—a novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity,” Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2000) 41:425." scheme="references">
    <meta name="citation_reference" content="Hashimoto et al., &quot;Chromosomal localization, genomic structure, and allelic polymorphism of the human CD79a (Ig-alpha/mb-1) gene,&quot; (1994) Immunogenetics 40(4 ):287-295." scheme="references">
    <meta name="citation_reference" content="Hay et al., &quot;A 2-nitroimidazole carbamate prodrug of 5-amin0-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydr0-3h-benz[e]indole (amino-seco-cbi-tmi) for use with adept and gdept,&quot; (1999) Bioorg. Med. Chem. Lett. 9:2237-2242." scheme="references">
    <meta name="citation_reference" content="Herdwijn et al., &quot;Synthesis of trans(+ )6-phenoxyacetamido-1-methylene- 3,3-dicarboxymethyl-1-carbapenam,&quot; Canadian Journal of Chemistry. 1982, 60, 2903-2907." scheme="references">
    <meta name="citation_reference" content="Hermanson, G.T., &quot;Heterobifunctional Cross-linkers,&quot; (1996) Bioconjugate Techniques; Academic Press: New York, p. 228-286." scheme="references">
    <meta name="citation_reference" content="Hochhauser, D., &quot;Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors,&quot; Clin. Cancer Res., Mar. 2009, 15(6):2140-2147." scheme="references">
    <meta name="citation_reference" content="Hochlowski, J. et al., &quot;Abbeymycin, a new anthramycin-type antibiotic produced by a streptomycete,&quot; J. Antibiotics, 40, 145-148 (1987)." scheme="references">
    <meta name="citation_reference" content="Hofstra R.M.W., et al., &quot;A homozygous mUtation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome)&quot; Nat. Genet. 12, 445-447, 1996." scheme="references">
    <meta name="citation_reference" content="Hofstra R.M.W., et al., &quot;Mutations in Hirschsprung Disease: When Does a Mutation Contribute to the Phenotype,&quot; Eur. J. Hum. Genet. 5, 180-185, 1997." scheme="references">
    <meta name="citation_reference" content="Horie et al., &quot;Identification and Characterization of TMEFF2, a Novel Surviv Factor for Hippocampal and Mesencephalic Neurons,&quot; (2000) Genomics 67: 146-152." scheme="references">
    <meta name="citation_reference" content="Howard, P.W. et al., &quot;Design, synthesis and biological evaluation of ZC-423, a novel C2-aryl substituted pyrrolobenzodiazepine (PBD) dimer,&quot; Clinical Cancer Research (2005) 11(23):9015S-9016S (A205)." scheme="references">
    <meta name="citation_reference" content="Howard, P.W. et al., &quot;Synthesis of a novel C2/C2′-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate,&quot; Bioorg. Med. Chem., Sep. 2009, In Press, 4 pages now: Sep. 2009, 19:6463-6466." scheme="references">
    <meta name="citation_reference" content="Howard, P.W. et al., &quot;The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1- c][1,4]benzodiazepine dimers,&quot; EJC Supplements (2006) 4(12):95-Poster Abstract 301." scheme="references">
    <meta name="citation_reference" content="Howard, P.W. et al., “The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1- c][1,4]benzodiazepine dimers,” EJC Supplements (2006) 4(12):95—Poster Abstract 301." scheme="references">
    <meta name="citation_reference" content="Howard, P.W., &quot;Design, synthesis and biological evaluation of novel C2-aryl-substituted pyrrolo[2,1- c][1,4]benzodiazepine monomers,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Apr. 2006) 47:132." scheme="references">
    <meta name="citation_reference" content="Hubert, R.S., et al., &quot;STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors,&quot; (1999) Proc. Natl. Acad. Sci. U.S.A. 96 (25):14523-14528." scheme="references">
    <meta name="citation_reference" content="Hurley, L. and Needham-Vandevanter, D., &quot;Covalent Binding of Antitumor Antibiotics in the Minor Groove of DNA. Mechanism of Action of CC-1065 and the yrrolo(1,4)benzodiazepines,&quot; Acc. Chem. Res., 19, 230-237 (1986)." scheme="references">
    <meta name="citation_reference" content="Ide et al., &quot;Cloning of human bone morphogenetic protein type IB receptor (BMPRIB) and its expression in prostate cancer in comparison with other BMPRs,&quot; Oncogene (1997) 14, 1377-1382." scheme="references">
    <meta name="citation_reference" content="Iida, H. et al. &quot;Design and synthesis of pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-polyaminoalkyl conjugates by the use of SNA4 reaction 2-nitro-5-fluorobenzoate precursor as key reaction,&quot; Heterocycles (2004) 62:693-711." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/EP2012/070233 dated Jan. 28, 2013 (8 pages)." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/EP2013/071346 dated Feb. 5, 2014 (11 pages)." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/EP2014/054958 dated Jul. 2, 2014 (13 pages)." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/GB2015/052629 dated Nov. 2, 2015 (12 pages)." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/US2011/032664 dated Aug. 19, 2011 (13 pages)." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/US2011/032668 dated May 26, 2011 (12 pages)." scheme="references">
    <meta name="citation_reference" content="International Search Report and Written Opinion for Application No. PCT/US2015/050634 dated Jan. 29, 2016 (14 pages)." scheme="references">
    <meta name="citation_reference" content="Itoh et al., &quot;Sibanomicin, a new pyrrolo(1,4)benzodiazepine antitumor antibiotic produced by a micromonospora sp.&quot; J. Antibiotics, 41, 1281-1284 (1988)." scheme="references">
    <meta name="citation_reference" content="Janjigian, Y.Y., &quot;A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors,&quot; Cancer Chemotherapy and Pharmacology , Aug. 2009, 65(5):833-838." scheme="references">
    <meta name="citation_reference" content="Jeffrey et al., &quot;Development and properties of beta-glucuronide linkers for monoclonal antibody-drug conjugates.&quot; Bioconjugate Chemistry, 5, 2006, 17, 831-840. (Abstract)." scheme="references">
    <meta name="citation_reference" content="Jeffrey, S.C. et al., &quot;Development of Pyrrolobenzodiazepine-Based Antibody-Drug Conjugates for Cancer,&quot; AACR Annual Meeting 2013, Abstract No. 4321." scheme="references">
    <meta name="citation_reference" content="Jeffrey, S.C., &quot;Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates,&quot; J. Med. Chem. (2005) 48(5):1344-1358." scheme="references">
    <meta name="citation_reference" content="Jespers, L. S., &quot;Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen&quot; Nature Biotech., 12, 899-903 (1994)." scheme="references">
    <meta name="citation_reference" content="Jia, L., &quot;Interspecies differences in pharmacokinetics and time-dissociated toxicokinetics of SJG-136,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:487." scheme="references">
    <meta name="citation_reference" content="Jia, L., &quot;Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:452-453." scheme="references">
    <meta name="citation_reference" content="Johnson &amp; Goldin, &quot;The clinical impact of screening and other experimental tumor studies.&quot; Cancer Treat Rev. Mar. 1975; 2(1):1-31." scheme="references">
    <meta name="citation_reference" content="Jordan, V.C., &quot;Tamoxifen: a most unlikely pioneering medicine,&quot; Nature Reviews: Drug Discovery (2003) 2:205-213." scheme="references">
    <meta name="citation_reference" content="Junutula et al., &quot;Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs,&quot; (2008) Jour of Immun. Methods 332:41-52." scheme="references">
    <meta name="citation_reference" content="Junutula, et al., &quot;Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index,&quot; 2008b Nature Biotech., 26(8):925-932." scheme="references">
    <meta name="citation_reference" content="Kamal et a., &quot;Pyrrolo[2,1-c][1,4]benzodiazepine-β-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies&quot; Bioorganic &amp; Medicinal Chemistry Letters 2008, 18:3769-3773." scheme="references">
    <meta name="citation_reference" content="Kamal et al., &quot;Synthesis and DNA-binding affinity of A-C8/C-C2 alkoxyamido-linked pyrrolo[2,1- c][1,4]benzodiazepine dimers&quot; Biorg. Med. Chem. Lett. (2003) 13(22): 3955-3958." scheme="references">
    <meta name="citation_reference" content="Kamal, A. et al., &quot;Design, synthesis and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity,&quot; J. Med. Chem. (2002) 45:4679-4688." scheme="references">
    <meta name="citation_reference" content="Kamal, A., &quot;Development of pyrrolo[2,1-c][1,4]benzodiazepine beta-galactoside prodrugs for selective therapy of cancer by ADEPT and PMT,&quot; Chemmedchem (2008) 3:794-802." scheme="references">
    <meta name="citation_reference" content="Kamal, A., &quot;Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1- c][1,4]benzodiazepine-naphthalamide conjugates linked through piperazine side-armed alkane spacers,&quot; Bioorg. Med. Chem. (2008) 16(15):7218-7224." scheme="references">
    <meta name="citation_reference" content="Kamal, A., &quot;Remarkable enhancement in the DNA-binding ability of C2-fluoro substituted pyrrolo[2,1- c][1,4]benzodiazepines and their anticancer potential,&quot; Bioorg. Med. Chem., Jan. 2009, 17(4):1557-1572." scheme="references">
    <meta name="citation_reference" content="Kamal, A., &quot;Synthesis of fluorinated analogues of SJG-136 and their DNA-binding potential,&quot; Bioorg. Med. Chem. Lett (2004) 14(22):5699-5702." scheme="references">
    <meta name="citation_reference" content="Kamal, A., et al., &quot;An Efficient Synthesis of Pyrrolo[2,1-c][1,4] Benzodiazepine Antibiotics via Reductive Cyclization,&quot; Bioorg. Med. Chem. Ltrs, 7, No. 14, 1825-1828 (1997)." scheme="references">
    <meta name="citation_reference" content="Kamal, A., et al., &quot;Synthesis of Pyrrolo [2,1-c][1,4]-Benzodiazepene Antibiotics: Oxidation of Cyclic Secondary Amine with TPAP&quot;, Tetrahedron, v. 53, No. 9, 3223-3230 (1997)." scheme="references">
    <meta name="citation_reference" content="Kamal, et al., &quot;Synthesis of pyrrolo[2,1-c][1,4]benzodiazepines via reductive cyclization of w-azido carbonyl compounds by TMSI: an efficient preparation of antibiotic DC-81 and its dimers,&quot; Biorg. Med. Chem. Lett. (2000) 10:2311-2313." scheme="references">
    <meta name="citation_reference" content="Kaneko, T. et al., &quot;Bicyclic and tricyclic analogues of anthramycin,&quot; J. Med. Chem. (1985) 28:388-392." scheme="references">
    <meta name="citation_reference" content="Kang, G.-D. et al., &quot;Synthesis of a novel C2-aryl substituted 1,2-unsaturated pyrrolobenzodiazepine,&quot; Chem. Commun. (2003) 1680-1689." scheme="references">
    <meta name="citation_reference" content="Kasahara et al., &quot;Nucleotide sequence of a chimpanzee DOB eDNA clone,&quot; (1989) Immunogenetics 30(1):66-68." scheme="references">
    <meta name="citation_reference" content="King et al., &quot;Facile synthesis of maleimide bifunctional Jinkers,&quot; (2002) Tetrahedron Letters 43:1987-1990." scheme="references">
    <meta name="citation_reference" content="Kingsbury et al., &quot;&quot;Novel Peptide Delivery System Involving Peptidase Activated Prodrugs as Antimicrobial Agents. Synthesis and Biological Activity of Peptidyl Derivatives of 5 Fluorouracil,&quot;&quot; (1984) J. Med. Chern. 27:1447-1451." scheme="references">
    <meta name="citation_reference" content="Kohler et al., &quot;Continuous cultures of fused cells secreting antibody of predefined specificity,&quot; (1975) Nature 256:495-497." scheme="references">
    <meta name="citation_reference" content="Kohn, K., &quot;Anthramycin,&quot; Antibiotics III, Springer-Verlag, NY, 3-11 (1975)." scheme="references">
    <meta name="citation_reference" content="Kojima et al., &quot;Molecular Cloning and Expression of Megakaryocyte Potentiating Factor eDNA,&quot; The Journal of Biological Chemistry, vol. 270, No. 37, Issue of Sep. 15, pp. 21984-21990, 1995." scheme="references">
    <meta name="citation_reference" content="Konishi, M. et al., &quot;Chicamycin, a new antitumor antibiotic II. Structure determination of chicamycins A and B,&quot; J. Antibiotics, 37, 200-206 (1984)." scheme="references">
    <meta name="citation_reference" content="Kovtun et al., &quot;Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target Antigen,&quot; (2006) Cancer Res. 66(6):3214-3121." scheme="references">
    <meta name="citation_reference" content="Kuhns J.J., et al., &quot;Poor Binding of a HER-2/neu Epitope (GP2) to HLA-A2.1 Is due to a Lack of Interactions with the Center of the Peptide,&quot; J. Biol. Chem. 274, 36422-36427, 1999." scheme="references">
    <meta name="citation_reference" content="Kunimoto et al., &quot;Mazethramycin, a new member of anthramycin group antibiotics,&quot; J. Antibiotics, 33, 665-667 (1980)." scheme="references">
    <meta name="citation_reference" content="Kurebayashi et al., &quot;Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin.6,&quot; (1999) Brit. Jour. Cancer 79(5-6):707-717." scheme="references">
    <meta name="citation_reference" content="Lambert, &quot;Drug-conjugated monoclonal antibodies for the treatment of cancer,&quot; (2005) Current Opin. In Pharmacal. 5:543-549." scheme="references">
    <meta name="citation_reference" content="Langley, D.R. and Thurston, D.E., &quot;A versatile and efficient synthesis of carbinolamine-containing pyrrolo[1,4]benzodiazepines via the cyclization of N-92-aminobenzoyl)pyrrolidine-2-carboxaldehyde diethyl thioacetals: total synthesis of prothracarcin,&quot; J. Org. Chem., 52, 91-97 (1987)." scheme="references">
    <meta name="citation_reference" content="Langlois, N. et al., &quot;Synthesis and cytotoxicity on sensitive and doxorubicin-resistant cell lines of new pyrrolo[2,1-c][1,4]benzodiazepines related to anthramycin,&quot; J. Med. Chem. (2001) 44:3754-3757." scheme="references">
    <meta name="citation_reference" content="Larhammar et al., &quot;Sequence of Gene and eDNA Encoding Murine Major Histocompatibility Complex Class II Gene AP2*,&quot; (1985) J. Biol. Chem. 260(26):14111-14119." scheme="references">
    <meta name="citation_reference" content="Launay et al., &quot;TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization,&quot; Cell 109 (3):397-407 (2002)." scheme="references">
    <meta name="citation_reference" content="Law et al., &quot;Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates,&quot; (2006) Cancer Res. 66(4):2328-2337." scheme="references">
    <meta name="citation_reference" content="Lazar et al., &quot;A molecular immunology approach to antibody humanization and functional optimization&quot; Molecular Immunology, 2007, 44(8), 1986-1998." scheme="references">
    <meta name="citation_reference" content="Le et al., &quot;Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system,&quot; (1997) FEBS Lett. 418(1-2):195-199." scheme="references">
    <meta name="citation_reference" content="Leabman; et al., &quot;Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys.&quot; MAbs. Nov.-Dec. 2013; 5(6):896-903." scheme="references">
    <meta name="citation_reference" content="Leber, J.D. et al., &quot;A revised structure for sibiromycin,&quot; J. Am. Chem. Soc., 110, 2992-2993 (1988)." scheme="references">
    <meta name="citation_reference" content="Leimgruber, W. et al., &quot;Isolation and characterization of anthramycin, a new antitumor antibiotic,&quot; J. Am. Chem. Soc., 87, 5791-5793 (1965)." scheme="references">
    <meta name="citation_reference" content="Leimgruber, W. et al., &quot;The structure of anthramycin,&quot; J. Am. Chem. Soc., 87, 5793-5795 (1965)." scheme="references">
    <meta name="citation_reference" content="Leimgruber, W. et al., &quot;Total synthesis of anthramycin,&quot; J. Am. Chem. Soc., 90, 5641-5643 (1968)." scheme="references">
    <meta name="citation_reference" content="Leonard et al., &quot;Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma,&quot; J. Clin. Oncology (2003) 21(16):3051-3059." scheme="references">
    <meta name="citation_reference" content="Leonard et al., &quot;Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies,&quot; Oncogene (2007) 26:3704-3713." scheme="references">
    <meta name="citation_reference" content="Leung et al., &quot;Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2,&quot; Mol. Immunol. (1995) 32(17-18):1413-1427." scheme="references">
    <meta name="citation_reference" content="Levenson et al., &quot;MCF-7: The First Hormone-responsive Breast Cancer Cell Line,&quot; (1997) Cancer Res. 57(15):3071-3078." scheme="references">
    <meta name="citation_reference" content="Lewis Phillips et al., &quot;Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate,&quot; Cancer Res, 2008, 68: (22)." scheme="references">
    <meta name="citation_reference" content="Lewis Phillips et al., “Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody—Cytotoxic Drug Conjugate,” Cancer Res, 2008, 68: (22)." scheme="references">
    <meta name="citation_reference" content="Liang et al., &quot;The Gene for a Novel Transmembrane Protein Containing Epidermal Growth Factor and Follistatin Domains Is Frequently Hypermethylated in Human Tumor Cells,&quot; (2000) Cancer Res. 60:4907-4912." scheme="references">
    <meta name="citation_reference" content="Linden et al., &quot;Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab,&quot; J. Clin. Cancer Res. (2005) 11:5215-5222." scheme="references">
    <meta name="citation_reference" content="Lonberg, &quot;Fully Human antibodies from transgenic mouse and phage display platforms&quot; Curr. Opinion, 20(4), 450-459 (2008)." scheme="references">
    <meta name="citation_reference" content="Lown et al., &quot;Molecular Mechanism of Binding of Pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid-anthramycin and tomaymycin,&quot; Biochem. Pharmacol. (1979), 28 (13), 2017-2026." scheme="references">
    <meta name="citation_reference" content="Lown et al., “Molecular Mechanism of Binding of Pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid—anthramycin and tomaymycin,” Biochem. Pharmacol. (1979), 28 (13), 2017-2026." scheme="references">
    <meta name="citation_reference" content="Manfre et al., &quot;Syntheses of Proline Analogues as Potential Mechanism-Based Inhibitors of Proline Dehydrogenase: 4-Methylene-L-, (E)- and (Z)-4-(Fluoromethylene)-L-, cis- and trans-5-Ethynyl-(±)-, and cis- and trans-5-Vinyl-L-proline,&quot; J. Org. Chem. 1992, 57, 2060-2065." scheme="references">
    <meta name="citation_reference" content="Marin, D., &quot;Voltammetric studies of the interaction of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) monomers and dimers with DNA,&quot; J. Electroanal. Chem. (2006) 593(1-2):241-246." scheme="references">
    <meta name="citation_reference" content="Marks et al., &quot;By-passing Immunization, Human Antibodies from V-gene Libraries Displayed on Phage,&quot; (1991) J. Mol. Biol., 222:581-597." scheme="references">
    <meta name="citation_reference" content="Martin, C. et al., &quot;Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies,&quot; Biochem. (2005) 44(11):4135-4147." scheme="references">
    <meta name="citation_reference" content="Mastroberardino et al., &quot;Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family,&quot; Nature 395 (6699):288-291 (1998)." scheme="references">
    <meta name="citation_reference" content="Matsumoto, K. et al., &quot;Synthesis of polyaminoalkyl substituted conjugates of pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-polyaminoalkyl involving SNA4 reaction of 2-nitro-5-fluorobenzoate precursors,&quot; Heterocycles (2000) 52(3):1015-1020." scheme="references">
    <meta name="citation_reference" content="McDonagh, &quot;Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment,&quot; (2006) Protein Eng. Design &amp; Sel. 19(7): 299-307." scheme="references">
    <meta name="citation_reference" content="Mendoza et al., &quot;Inhibition of Ligand-mediated HER2 Activation in Androgen-independent Prostate Cancer,&quot; (2002) Cancer Res. 62:5485-5488." scheme="references">
    <meta name="citation_reference" content="Miller et al., &quot;Design, Construction, and in Vitro Analyses of Multivalent Antibodies,&quot; (2003) Jour. of Immunology 170:4854-4861." scheme="references">
    <meta name="citation_reference" content="Miller et al., &quot;IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells,&quot; Blood 99 (8):2662-2669 (2002)." scheme="references">
    <meta name="citation_reference" content="Miura et al., &quot;Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64).&quot; Genomics. Dec. 15, 1996; 38(3):299-304." scheme="references">
    <meta name="citation_reference" content="Miura et al., &quot;RPIOS Is Associated With MD-1 and Transmits an Activation Signal in Human B Cells,&quot; (1998) Blood 92:2815-2822." scheme="references">
    <meta name="citation_reference" content="Moore M., et al., &quot;Molecular cloning of the eDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes,&quot; Proc. Natl. Acad. Sci. U.S.A. 84, 9194-9198, 1987." scheme="references">
    <meta name="citation_reference" content="Mori, M. et al., &quot;Total syntheses of prothracarcin and tomaymycin by use of palladium catalyzed carbonylation,&quot; Tetrahedron (1986) 42(14):3793-3806." scheme="references">
    <meta name="citation_reference" content="Morrison et al., &quot;Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains,&quot; (1984) Proc. Natl. Acad. Sci. USA, 81:6851-6855." scheme="references">
    <meta name="citation_reference" content="Mountzouris, J.A. et al., &quot;Comparison of a DSB-120 DNA interstrand cross-linked adduct with the corresponding bis-Tomamycin adduct,&quot; J. Med. Chem. (1994) 37:3132-3140." scheme="references">
    <meta name="citation_reference" content="Muller et al., &quot;Cloning and sequencing of the eDNA encoding the human homologue of the murine immunoglobulin-associated protein B29,&quot; (1992) Eur. J. Immunol. 22 (6): 1621-1625." scheme="references">
    <meta name="citation_reference" content="Mungall A.J., et al., &quot;The DNA sequence and analysis of human chromosome 6,&quot; Nature 425, 805-811, 2003." scheme="references">
    <meta name="citation_reference" content="Nadler et al., &quot;B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes,&quot; Journal of Immunology, 1983, 131(1):244-250." scheme="references">
    <meta name="citation_reference" content="Nagasaka, T. and Koseki, Y, &quot;Stereoselective Synthesis of Tilivalline,&quot; Journal of Organic Chemistry, vol. 63, No. 20, 6797-6801 (1998)." scheme="references">
    <meta name="citation_reference" content="Nagasaka, T. et al., &quot;Stereoselective Synthesis of Tilivalline,&quot; Tetrahedron Letters, 30:14, 1871-1872 (1989)." scheme="references">
    <meta name="citation_reference" content="Nagase T., et al., &quot;Prediction of the Coding Sequences of Unidentified Human Genes. XVII. The Complete Sequences of 100 New eDNA Clones from Brain Which Code for Large Proteins in vitro,&quot; (2000) DNA Res. 7 (2):143-150." scheme="references">
    <meta name="citation_reference" content="Nakamuta M., et al., &quot;Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor,&quot; Biochem. Biophys. Res. Commun. 177, 34-39, 1991." scheme="references">
    <meta name="citation_reference" content="Nakayama et al., &quot;Altered Gene Expression upon BCR Cross-Linking in Burkitt's Lymphoma B Cell Line,&quot; (2000) Biochem. Biophys. Res. Commun. 277(1):124-127." scheme="references">
    <meta name="citation_reference" content="Narayanaswamy, M., &quot;A novel HPLC/MS assay to measure DNA interstrand cross-linking efficacy in oligonucleotides of varying sequence,&quot; EJC Supplements (Nov. 2006) 4(12):92-93." scheme="references">
    <meta name="citation_reference" content="Narayanaswamy, M., &quot;An assay combinding high-performance liquid chromatography and mass spectrometry to measure DNA interstrand cross-linking efficiency in oligonucleotides of varying sequences,&quot; Anal. Biochem. (2008) 374(1):173-181." scheme="references">
    <meta name="citation_reference" content="Narayanaswamy, M., &quot;Use of HPLC-MS to characterize novel mono and intrastrand cross-linked DNA adducts formed by the sequence-selective DNA-interactive agent SJG-136,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Apr. 2007) 48:760-761." scheme="references">
    <meta name="citation_reference" content="Narukawa, Y., &quot;General and efficient synthesis of 2-alkylcarbapenems synthesis of dethia carba analogs of clinically useful carbapenems via palladium-catalyzed cross-coupling reaction,&quot; Tetrahedron (1997) 53:539-556." scheme="references">
    <meta name="citation_reference" content="Naruse et al., &quot;The HLA-DOB gene displays limited polymorphism with only one amino acid substitution,&quot; (2002) Tissue Antigens 59:512-519." scheme="references">
    <meta name="citation_reference" content="Neuberger and Williams, &quot;The intron requirement for immunoglobulin gene expression is dependent upon the promoter,&quot; (1988) Nucleic Acids Res. 16:6713-6724." scheme="references">
    <meta name="citation_reference" content="Nicolaou et al., &quot;Calicheamicin θ: A Rationally Designed Molecule with Extremely Potent and Selective DNA Cleaving Properties and Apoptosis Inducing Activity,&quot; Angew Chem. Intl. Ed. Engl. (1994) 33:183-186." scheme="references">
    <meta name="citation_reference" content="Nilius et al., &quot;Voltage Dependence of the Ca2+ -activated Cation Channel TRPM4,&quot; The Journal of Biological Chemistry, vol. 278, No. 33, Issue of Aug. 15, pp. 30813-30820, 2003." scheme="references">
    <meta name="citation_reference" content="Ogawa Y., et al., &quot;Molecular Cloning of a Non-Isopeptide-Selective Human Endothelin Receptor,&quot; Biochem. Biophys. Res. Commun. 178, 248-255, 1991." scheme="references">
    <meta name="citation_reference" content="Okamoto Y., et al. &quot;Palmitoylation of Human Endothelin B,&quot; Biol. Chem. 272, 21589-21596, 1997." scheme="references">
    <meta name="citation_reference" content="O'Neil, Chemical Abstract No. 171573p, &quot;The synthesis of Functionalized Pyrrolo-[2,1-c][1,4]-Benzodiazepines&quot;, Chemical Abstracts, vol. 126, No. 13, 618 (1997)." scheme="references">
    <meta name="citation_reference" content="O'Neil, I.A. et al., &quot;DPPE: A Convenient Replacement for Triphenylphosphine in the Staudinger and Mitsunobu Reactions&quot;, Tetrahedron Letters, vol. 39, No. 42, 7787-7790 (1998)." scheme="references">
    <meta name="citation_reference" content="O'Neil, I.A., et al., &quot;The Synthesis of Functionalized Pyrrolo-[2,1-c][1,4]-Benzodiazepines,&quot; Synlett, 75-78 (1997)." scheme="references">
    <meta name="citation_reference" content="Parrish-Novak J., et al., &quot;Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes,&quot; J. Biol. Chem. 277, 47517-47523, 2002." scheme="references">
    <meta name="citation_reference" content="Paul, Fundamental Immunology, 3rd Edition, pp. 292-295." scheme="references">
    <meta name="citation_reference" content="Payne, G. &quot;Progress in immunoconjugate cancer therapeutics,&quot; (2003) Cancer Cell 3:207-212." scheme="references">
    <meta name="citation_reference" content="PCT/US2012/059864 International Search Report and Written Opinion dated Dec. 21, 2012 (7 pages)." scheme="references">
    <meta name="citation_reference" content="Pepper, C., &quot;Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells,&quot; Br. J. Cancer (2007) 97(2):253-259." scheme="references">
    <meta name="citation_reference" content="Pepper, C.J. et al., &quot;The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill,&quot; Cancer Res. (2004) 64:6750-6755." scheme="references">
    <meta name="citation_reference" content="Phillips et al., &quot;Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate,&quot; (2008) Cancer Res. 68(22):9280-9290." scheme="references">
    <meta name="citation_reference" content="Pingault V., et al., &quot;SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism,&quot; (2002) Hum. Genet. 111, 198-206." scheme="references">
    <meta name="citation_reference" content="Pletnev S., et al., &quot;Characterization of the Recombinant Extracellular Domains of Human Interleukin-20 Receptors and Their Complexe with Interleukin-19 and Interleukin-20,&quot; (2003) Biochemistry 42:12617-12624." scheme="references">
    <meta name="citation_reference" content="Porkaa et al., &quot;Cloning and Characterization of a Novel Six-Transmembrane Protein STEAP2, Expressed in Normal and Malignant Prostate,&quot; Lab. Invest. 82 (11):1573-1582 (2002)." scheme="references">
    <meta name="citation_reference" content="Prasad et al.,&quot;Human LAT1, a Subunit of System L Amino Acid Transporter: Molecular Cloning and Transport Function,&quot; Biochem. Biophys. Res. Commun. 255 (2), 283-288 (1999)." scheme="references">
    <meta name="citation_reference" content="Preud'Homme et al., &quot;Structure and expression of the mb-1 transcript in human lymphoid cells,&quot; (1992) Clin. Exp. Immunol. 90(1):141-146." scheme="references">
    <meta name="citation_reference" content="Puffenberger E.G., et al., &quot;A Missense Mutation of the Endothelin-B Receptor Gene in Multigenic Hirschsprung's Disease,&quot; Cell 79, 1257-1266, 1994." scheme="references">
    <meta name="citation_reference" content="Purser, et al., &quot;Fluorine in Medicinal Chemistry.&quot; Chem. Soc. Rev., 2008, 37, 320-330." scheme="references">
    <meta name="citation_reference" content="Puzanov, I., &quot;Phase I and pharmacokinetic trial of SJG-136 administered on a daily x5 schedule,&quot; EJC Supplements (Nov. 2006) 4(12):93." scheme="references">
    <meta name="citation_reference" content="Quintas-Cardama, A., &quot;Sequencing of subcloned PCR products facilitates earlier detetction of BCR-ABL1 and other mutants compared to direct sequencing of the ABL1 kinase domain,&quot; Leukemia (2008) 22(4):877-878." scheme="references">
    <meta name="citation_reference" content="Rahman et al. &quot;Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates.&quot; J Antimicrob Chemother. Jul. 2012; 67(7):1683-96." scheme="references">
    <meta name="citation_reference" content="Rahman, K.M., &quot;Effect of microwave irradiation on covalent ligand-DNA interactions,&quot; Chem. Commun. (Cambridge, UK), Apr. 2009, 20:2875-2877." scheme="references">
    <meta name="citation_reference" content="Rahman, K.M., &quot;Rules of DNA adduct formation for pyrrolobenzodiazepine (PBD) dimers,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Apr. 2010) 51:851." scheme="references">
    <meta name="citation_reference" content="Rahman, K.M., &quot;The pyrrolobenzodiazepine dimer SJG-136 forms sequence-dependent intrastrand DNA cross-lins and monoalkylated adducts in addition to interstrand cross-links,&quot; J. Am. Chem. Soc., Sep. 2009, 131(38):13756-13766." scheme="references">
    <meta name="citation_reference" content="Rao et al., &quot;Influence of diet on mammary cancer in transgenic mice bearing an oncogene expressed in mammary tissue,&quot; (1997) Breast Cancer Res. and Treatment 45:149-158." scheme="references">
    <meta name="citation_reference" content="Reid, J.M., &quot;LC-MS/MS assay and rat pharmacokinetics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:1248." scheme="references">
    <meta name="citation_reference" content="Reiter R.E., et al., &quot;Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer,&quot; Proc. Natl. Acad. Sci. U.S.A. 95, 1735-1740, 1998." scheme="references">
    <meta name="citation_reference" content="Remmers et al., &quot;Conformations of complexes between pyrrolo[1,4]benzodiazepines and DNA segments,&quot; J Med Chem. Dec. 1986;29(12):2492-2503." scheme="references">
    <meta name="citation_reference" content="Rich, I.N., &quot;Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay,&quot; Toxicological Sci. (2005) 87(2):427-441." scheme="references">
    <meta name="citation_reference" content="Rodrigues et al., &quot;Synthesis and beta-lactamase-mediated activation of a cephalosporin-taxol prodrug,&quot; (1995) Chemistry Biology 2:223-227." scheme="references">
    <meta name="citation_reference" content="Roguska et al., &quot;A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing,&quot; Protein Eng, 1996, 9(10):895-904." scheme="references">
    <meta name="citation_reference" content="Roguska et al., &quot;Humanization of murine monoclonal antibodies through variable domain resurfacing,&quot; PNAS, 1994, 91(3):969-973." scheme="references">
    <meta name="citation_reference" content="Ross et al., &quot;Prostate Stem Cell Antigen as Therapy Target: Tissue Expression and in Vivo Efficacy of an Immunoconjugate,&quot; (2002) Cancer Res. 62:2546-2553." scheme="references">
    <meta name="citation_reference" content="Rudikoff et al., Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. Mar. 1982; 79(6):1979-83." scheme="references">
    <meta name="citation_reference" content="Sagnou, M.J. et al., &quot;Design and Synthesis of Novel Pyrrolobenzodiazepine (PDB) Prodrugs for ADEPT and GDEPT,&quot; Bioorganic &amp; Medicinal Chemistry Letters, 10, 2083-2086 (2000)." scheme="references">
    <meta name="citation_reference" content="Sakaguchi et al., &quot;8 lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties,&quot; (1988) EMBO J. 7(11):3457-3464." scheme="references">
    <meta name="citation_reference" content="Sakamoto A, Yanagisawa M., et al., &quot;Cloning and Functional Expression of Human cDNA for the ETB Endothelin Receptor,&quot; Biochem. Biophys. Res. Commun. 178, 656-663, 1991." scheme="references">
    <meta name="citation_reference" content="Sanderson et al., &quot;In vivo Drug-Linker Stability of an Anti-CD30 Dipeptide-Linked Auristatin Immunoconjugate,&quot; (2005) Clin. Cancer Res. 11:843-852." scheme="references">
    <meta name="citation_reference" content="Scholler et al., &quot;Soluble member(s) of the mesothelin/ megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma,&quot; Proc. Natl. Acad. Sci. USA vol. 96, pp. 11531-11536, Sep. 1999." scheme="references">
    <meta name="citation_reference" content="Schroder and Lubke, The Peptides, vol. 1. pp. 76-136 (1965) Academic Press." scheme="references">
    <meta name="citation_reference" content="Schweikart, K., &quot;In vitro myelosuppression of SJG-136, a pyrrolobenzodiazepine dimer: comparison to bizelesin,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:486." scheme="references">
    <meta name="citation_reference" content="Segawa et al., &quot;Growth-related Renal Type II Na/Pi Cotransporter,&quot; The Journal of Biolocjcal Chemistry, vol. 277. No. 22, Issue of May 31, pp. 19665-19672, 2002." scheme="references">
    <meta name="citation_reference" content="Semba K., et al., &quot;A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1 /epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma,&quot; 15 Proc. Natl. Acad. Sci. U.S.A 82, 6497-6501, 1985." scheme="references">
    <meta name="citation_reference" content="Servenius et al., &quot;Class II Genes of the Human Major Histocompatibility Complex, the DOBeta Gene Is a Divergent Member of the Class II P Gene Family,&quot; (1987) J. Biol. Chem. 262:8759-8766." scheme="references">
    <meta name="citation_reference" content="Shamis et al., &quot;Bioactivation of Self-Immolative Dendritic Prodrugs by Catalytic Antibody 38C2,&quot; (2004) J . Am. Chem. Soc. 126:1726-1731." scheme="references">
    <meta name="citation_reference" content="Sharkey et al., &quot;Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies,&quot; Mol. Cancer Ther. (2012) 11(1):224-234." scheme="references">
    <meta name="citation_reference" content="Sheikh F., et al., &quot;Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 21,&quot; (2004) J.Immunol, 172, 2006-2010." scheme="references">
    <meta name="citation_reference" content="Shen et al., &quot;Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates,&quot; (2012) Nature Biotech., 30(2):184-191." scheme="references">
    <meta name="citation_reference" content="Shimizu, K et al., &quot;Prothracarcin, a Novel Antitumor Antibiotic,&quot; J. Antibiotics, 35, 972-978 (1982)." scheme="references">
    <meta name="citation_reference" content="Sinha S.K., et al., &quot;Characterization of the EBV /C3d Receptor on the Human Jurkat T Cell Line: Evidence for a Novel Transcript,&quot; (1993) J. Immunol. 150, 5311-5320." scheme="references">
    <meta name="citation_reference" content="Smellie, M. et al., &quot;Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents,&quot; Br. J. Cancer (1994) 70:48-53." scheme="references">
    <meta name="citation_reference" content="Smellie, M. et al., &quot;Sequence selective recognition of duplex DNA through covalent interstrand cross-linking,&quot; Biochem. (2003) 42:8232-8239." scheme="references">
    <meta name="citation_reference" content="Smith, P. K. et al., &quot;Measurement of protein using bicinchoninic acid.&quot; Anal Biochem. Oct. 1985; 150(1):76-85." scheme="references">
    <meta name="citation_reference" content="Souillac, P. et al., &quot;Characterization of delivery systems, differential scanning calorimetry,&quot; Encyclopedia of Controlled Drug Delivery (1999) 212-227 (pp. 217-218)." scheme="references">
    <meta name="citation_reference" content="Storm et al., &quot;Effect of Small Changes in Orientation on Reaction Rate,&quot; (1972) J. Amer. Chem. Soc. 94:5815-5825." scheme="references">
    <meta name="citation_reference" content="Strausberg et al., &quot;Generation and initial analysis of more than 15,000 full-length human and mouse Edna sequences,&quot; (2002) Proc. Natl. Acad. Sci USA 99:16899-16903." scheme="references">
    <meta name="citation_reference" content="Suggitt, M., &quot;The hollow fibre model-facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare,&quot; Int. J. Oncol. (2006) 29(6):1493-1499." scheme="references">
    <meta name="citation_reference" content="Suggitt, M., “The hollow fibre model—facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare,” Int. J. Oncol. (2006) 29(6):1493-1499." scheme="references">
    <meta name="citation_reference" content="Suggs, J.W. et al., &quot;Synthesis and structure of anthramycin analogs via hydride reduction of dilactams,&quot; Tetrahedron Letters, 26, No. 40, 4871-4874 (1985)." scheme="references">
    <meta name="citation_reference" content="Sun et al., &quot;Enabling ScFvs as Multi-Drug Carriers: A Dendritic Approach,&quot; (2003) Bioorganic &amp; Medicinal Chemistry 11:1761-1768." scheme="references">
    <meta name="citation_reference" content="Sun et al., &quot;Syntheses of Dendritic Linkers Containing Chlorambucil Residues for the Preparation of Antibody-Multidrug Immunoconjugates,&quot; (2002) Bioorganic &amp; Medicinal Chemistry Letters 12:2213-2215." scheme="references">
    <meta name="citation_reference" content="Sun et al., “Syntheses of Dendritic Linkers Containing Chlorambucil Residues for the Preparation of Antibody—Multidrug Immunoconjugates,” (2002) Bioorganic &amp; Medicinal Chemistry Letters 12:2213-2215." scheme="references">
    <meta name="citation_reference" content="Sutherland, M.S.K. et al., &quot;SGN-CD33A: a novel CD33-directed antibody-drug conjugate, utilizing pyrrolobenzodiazepine dimers, demonstrates preclinical anti-tumor activity against multi-drug resistant human AML,&quot; American Society of Hematology (Dec. 8-12, 2012) Atlanta, Georgia, Abstract No. 3589." scheme="references">
    <meta name="citation_reference" content="Svensson P.J., et al., &quot;Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B),&quot; Hum. Genet. 103, 145-148, 1998." scheme="references">
    <meta name="citation_reference" content="Swiercz J.M., et al., &quot;Plexin-81 /RhoGEF-mediated Rho A activation involves the receptor tyrosine kinase ErbB-2,&quot; J. Cell Biol. 165, 869-880, 2004." scheme="references">
    <meta name="citation_reference" content="Syrigos and Epenetos, &quot;Antibody Directed Enzyme Prodrug Therapy (ADEPT): A Review of the Experimental and Clinical Considerations,&quot; (1999) Anticancer Research 19:605-614." scheme="references">
    <meta name="citation_reference" content="Takeuchi, T. et al., &quot;Neothramycins A and B, New Antitumor Antibiotics,&quot; J. Antibiotics, 29, 93-96 (1976)." scheme="references">
    <meta name="citation_reference" content="Tawaragi Y., et al., &quot;Primary structure of nonspecific crossreacting antigen (NCA), a member of carcinoembryonic antigen (cea) gene family, deduced from cdna sequence,&quot; Biochem. Biophys. Res. Commun. 150, 89-96, 1988." scheme="references">
    <meta name="citation_reference" content="Tercel, M. et al., &quot;Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores,&quot; J. Med. Chem. (2003) 46:2132-2151." scheme="references">
    <meta name="citation_reference" content="Thompson J.S., et al., &quot;Baff-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF,&quot; Science 293 (5537), 2108-2111 (2001)." scheme="references">
    <meta name="citation_reference" content="Thurston, &quot;Advances in the study of Pyrrolo[2,1-c][1,4] benzodiazepine (PBD) Antitumour Antibiotics&quot;, Molecular Aspects of Anticancer Drug-DNA Interaction, Neidle, S. and Waring, M.J., Eds.; Macmillan Press Ltd, 1:54-88 (1993)." scheme="references">
    <meta name="citation_reference" content="Thurston, D.E. and Bose, D.S., &quot;Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines,&quot; Chem. Rev., 94:433-465 (1994)." scheme="references">
    <meta name="citation_reference" content="Thurston, D.E. and Thompson, A.S., &quot;The molecular recognition of DNA,&quot; Chem. Brit., 26, 767-772 (1990)." scheme="references">
    <meta name="citation_reference" content="Thurston, D.E. et al., &quot;Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c][1,4]benzodiazepines&quot;, Journal of Medicinal Chemistry, 42:1951-1964 (1999)." scheme="references">
    <meta name="citation_reference" content="Thurston, D.E. et al., &quot;Synthesis of a novel GC-specific covalent-binding DNA affinity-cleavage agent based on pyrrolobenzodiazepines (PBDs),&quot; Chemical Communications, 563-565 (1996)." scheme="references">
    <meta name="citation_reference" content="Thurston, D.E. et al., &quot;Synthesis of Sequence-selective C8-linked Pyrrolo [2,1-c][1,4] Benzodiazepine DNA Interstrand Cross-linking Agent,&quot; J. Org. Chem., 61:8141-8147 (1996)." scheme="references">
    <meta name="citation_reference" content="Thurston, D.E., &quot;Nucleic acid targeting: therapeutic strategies for the 21st century,&quot; Brit. J. Cancer (1999) 80(1):65-85." scheme="references">
    <meta name="citation_reference" content="Tiberghien, A.C. et al., &quot;Application of the stille coupling reaction to the synthesis of C2-substituted endo-exo unsaturated pyrrolo[2,1-c][1,4]benzodiazepines (PBDs),&quot; Biorg. Med. Chem. Lett. (2004) 14:5041-5044." scheme="references">
    <meta name="citation_reference" content="Tiberghien, A.C., &quot;Application of the stille coupling reaction to the synthesis of C2-substituted endo-exo unsaturated pyrrolo[2,1-c][1,4]benzodiazepines (PBDs),&quot; Bioorg. Med. Chem. Lett. (2008) 18(6):2073-2077." scheme="references">
    <meta name="citation_reference" content="Toki et al., &quot;Protease-Mediated Fragmentation of p-Amidobenzyl Ethers: A New Strategy for the Activation of Anticancer Prodrugs,&quot; (2002) J. Org. Chem. 67:1866-1872." scheme="references">
    <meta name="citation_reference" content="Tonnelle et al., &quot;DO Beta a new chain gene in HLA-D with a distinct regulation of expression,&quot; (1985) EMBO J. 4(11):2839-2847." scheme="references">
    <meta name="citation_reference" content="Touchman et al., &quot;The Genomic Region Encompassing the Nephropathic Cystinosis Gene (CTNS): Complete Sequencing of a 200-kb Segment and Discovery of a Novel Gene within the Common Cystinosis-Causing Deletion,&quot; (2000) Genome Res. 10:165-173." scheme="references">
    <meta name="citation_reference" content="Tozuka et al., &quot;Studies on tomaymycin. II. Total synthesis of the antitumor antibiotics, E-and Z-tomaymycins,&quot; J. Antibiotics (Tokyo) (1983) 36:276-282." scheme="references">
    <meta name="citation_reference" content="Trail et al., &quot;Monoclonal antibody drug immunoconjugates for targeted treatment of cancer,&quot; (2003) Cancer Immunol. Immunother. 52:328-337." scheme="references">
    <meta name="citation_reference" content="Tsunakawa, M. et al., &quot;Porothramycin, a new antibiotic of the anthramycin group: Production, isolation, structure and biological activity,&quot; J. Antibiotics, 41:1366-1373 (1988)." scheme="references">
    <meta name="citation_reference" content="Tsutsumi M., et al., &quot;Novel endothelin B receptor transcripts with the potential of generating a new receptor,&quot; Gene 228, 43-49, 1999." scheme="references">
    <meta name="citation_reference" content="Uchida et al., &quot;A Novel Epidermal Growth Factor-like Molecule Containing Two Follistatin Modules Stimulates Tyrosine Phosphorylation of erbB-4 in MKN28 Gastric Cancer Cells,&quot; (1999) Biochem. Biophys. Res. Commun. 266:593-602." scheme="references">
    <meta name="citation_reference" content="Umezawa, H. et al. &quot;Mazethramycins,&quot; SciFinder Scholar, 2-3 (2002)." scheme="references">
    <meta name="citation_reference" content="Umezawa, H. et al., Chemical Abstract No. 4427a, &quot;Mazethramycins&quot; Chemical Abstracts, vol. 90, No. 1, 428 (1979)." scheme="references">
    <meta name="citation_reference" content="Verheij J.B., et al., &quot;ABCD Syndrome Is Caused by a Homozygous Mutation in the EDNRB Gene,&quot; Am. J. Med. 15 Genet. 108, 223-225, 2002." scheme="references">
    <meta name="citation_reference" content="Vippagunta, S.R. et al., &quot;Crystalline solids,&quot; Adv. Drug Delivery Rev. (2001) 48:3-26." scheme="references">
    <meta name="citation_reference" content="Von Hoegen et al., &quot;Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA,&quot; (1990) J. Immunol. 144(12):4870-4877." scheme="references">
    <meta name="citation_reference" content="Wang, J.H., &quot;Determination of antitumor agent AJG-136 in human serum by HPLC with tandem mass spectrometric detection (HPLC-MS/MS),&quot; Abstracts of Papers American Chemical Society (Mar. 13, 2005) 229(1):U119." scheme="references">
    <meta name="citation_reference" content="Webster et al., &quot;Mammary tumorigenesis and metastasis in transgenic mice,&quot; (1994) Semin. Cancer Biol. 5:69-76." scheme="references">
    <meta name="citation_reference" content="Weidner-Wells, M.A. et al., &quot;Photochemical approach to the synthesis of the pyrrolo[1,4]benzodiazepine antibiotics,&quot; J. Org. Chem. (1989) 54:5746-5758." scheme="references">
    <meta name="citation_reference" content="Weis J.J., et al., &quot;Identification of a partial eDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: Homology with the receptor for fragments C3b and C4b of the third and fourth components of complement,&quot; Proc. Natl. Acad. Sci. U.S.A. 83, 5639-5643, 1986." scheme="references">
    <meta name="citation_reference" content="Weis J.J., et al., &quot;Structure of the human b lymphocyte receptor for c3d and the epstein-barr virus and relatedness to other members of the family of C3/C4 binding proteins,&quot; J. Exp. Med. 167, 1047-1066, 1988." scheme="references">
    <meta name="citation_reference" content="Wells, G. et al., &quot;Design, synthesis and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates,&quot; J. Med. Chem. (2006) 49:5442-5461." scheme="references">
    <meta name="citation_reference" content="Wikipedia, &quot;How many types of cancer are there?&quot;, 2012, 3 pages; http://wiki.answers.com/Q/How-many-different-types_of_cancer_ are_there." scheme="references">
    <meta name="citation_reference" content="Wikipedia, &quot;Management of Cancer,&quot; 2012, 1 page; http://en.wikipedia.org/wiki/Management of cancer." scheme="references">
    <meta name="citation_reference" content="Wilkinson &quot;Eph Receptors and Ephrins: Regulators of Guidance and Assembly,&quot; Int. Rev. Cytol. 196:177-244 (2000)." scheme="references">
    <meta name="citation_reference" content="Wilkinson, G.P., &quot;Pharmacokinetics and intracellular pharmacological characteristics of the novel pyrrolobenzodiazepine (PBD) dimer SJG-136,&quot; Proceedings of the American Association for Cancer Research Annual Meeting (Jul. 2003) 44:320." scheme="references">
    <meta name="citation_reference" content="Wilkinson, G.P., &quot;Pharmacokinetics, metabolism and glutathione reactivity of SJG-136,&quot; Br. J. Cancer (2003) 88(Supp. 1):S29." scheme="references">
    <meta name="citation_reference" content="Wilkinson, G.P., &quot;Preliminary pharmacokinetic and bioanalytical studies of SJG-136 (NSC 694501), a sequence-selective pyrrolobenzodiazepine dimer DNA-cross-linking agent,&quot; Investigational New Drugs (2004) 22(3):231-240." scheme="references">
    <meta name="citation_reference" content="Wilson et al., &quot;eDNA Cloning of the B Cell Membrane Protein CD22: A Mediator of B-B Cell Interactions,&quot; (1991) J. Exp. Med. 173:137-146." scheme="references">
    <meta name="citation_reference" content="Wilson, S.C. et al., &quot;Design and Synthesis of a Novel Epoxide-Containing Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) via a New Cyclization Procedure,&quot; Tetrahedron Letters, 36, No. 35, 6333-6336 (1995)." scheme="references">
    <meta name="citation_reference" content="Wilson, S.C. et al., &quot;Design, Synthesis, and Evaluation of a Novel Sequence-Selective Epoxide-Containing DNA Cross-Linking Agent Based on the Pyrrolo[2,1-c][1,4]benzodiazepine System&quot;, J. Med. Chem. 42: 4028-4041 (1999)." scheme="references">
    <meta name="citation_reference" content="Wolff, M.E., Burger's Medicinal Chemistry, 4th Edition, Part I, Wiley: New York (1979) 336-337." scheme="references">
    <meta name="citation_reference" content="Wolff, M.E., Burger's Medicinal Chemistry, 5th Edition, Part I, John Wiley &amp; Sons (1995) 975-977." scheme="references">
    <meta name="citation_reference" content="Workman, P. et al., &quot;United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition),&quot; Br. J. Cancer (1998) 77(1):1-10." scheme="references">
    <meta name="citation_reference" content="Wu et al., &quot;Arming antibodies: prospects and challenges for immunoconjugates,&quot; (2005) Nature Biotech. 23(9):1137-1145." scheme="references">
    <meta name="citation_reference" content="Xie et al., &quot;In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer,&quot; (2006) Expert. Opin Biol. Ther. 6(3):281-291." scheme="references">
    <meta name="citation_reference" content="Xie, G. et al., &quot;Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerasel, and biological evaluation,&quot; J. Med. Chem. (1996) 39:1049-1055." scheme="references">
    <meta name="citation_reference" content="Xu et al., &quot;Molecular Cloning, Functional Characterization, Tissue Distribution, and Chromosomal Localization of a Human, Small Intestinal Sodium-Phosphate (Na + -Pi) Transporter (SLC34A2),&quot; Genomics 62 (2):281-284 (1999)." scheme="references">
    <meta name="citation_reference" content="Xu, M.J., et al., &quot;Molecular Cloning and Characterization of SPAP1, an Inhibitory Receptor,&quot; (2001) Biochem. Biophys. Res. Commun. 280 (3):768-775." scheme="references">
    <meta name="citation_reference" content="Xu, X.Z., et al., &quot;Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform,&quot; Proc. Natl. Acad. Sci. U.S.A. 98 (19):10692-10697 (2001)." scheme="references">
    <meta name="citation_reference" content="Yamaguchi, N., et al., &quot;A Novel Cytokine Exhibiting Megakaryocyte Potentiating Activity From a Human Pancreatic Tumor Cell Line HPC-Y5,&quot; Biol. Chem. 269 (2), 805-808 (1994)." scheme="references">
    <meta name="citation_reference" content="Yamamoto T., et al., &quot;Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor,&quot; Nature 319, 230-234, 1986." scheme="references">
    <meta name="citation_reference" content="Yang et al., &quot;Murine Six-Transmembrane Epithelial Antigen of the Prostate, Prostate Stem Cell Antigen, and Prostate-specific Membrane Antigen: Prostate-specific Cell-Surface Antigens Highly Expressed in Prostate Cancer of Transgenic Adenocarcinoma Mouse Prostate Mice,&quot; Cancer Research, 61, 5857-5860. Aug. 1, 2001." scheme="references">
    <meta name="citation_reference" content="Yin &amp; Lloyd, &quot;Molecular Cloning of the CA125 Ovarian Cancer Antigen,&quot; J. Biol. Chem. 276 (29):27371-27375 (2001)." scheme="references">
    <meta name="citation_reference" content="Younes et al., &quot;Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma,&quot; J Clin Oncol., 2012, 30(22):2776-82." scheme="references">
    <meta name="citation_reference" content="Yu et al., &quot;Human mb-1 gene: complete edna sequence and its expression in b cells bearing membrane Ig of various isotypes,&quot; (1992) J. Immunol. 148(2) 633-637." scheme="references">
    <meta name="citation_reference" content="Zammarchi et al., &quot;Pre-Clinical Development of Adct-402, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate (ADC) Targeting CD19-Expressing B-Cell Malignancies,&quot; Blood, 2015, 126:1564, Abstract." scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Pyrrolobenzodiazepine conjugates 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA417404955" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div id="p-0001" num="0000" class="abstract style-scope patent-text">A compound of formula (I): (I) and its conjugates.</div>
    <div id="p-0002" num="0000" class="abstract style-scope patent-text">
      <chemistry id="CHEM-US-00001" num="00001" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/50/51/44/daabb8cafaf308/US10799595-20201013-C00001.png" class="style-scope patent-text"><img id="EMI-C00001" he="41.15mm" wi="76.12mm" file="US10799595-20201013-C00001.TIF" alt="Figure US10799595-20201013-C00001" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="304" height="165" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/50/51/44/daabb8cafaf308/US10799595-20201013-C00001.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00001" attachment-type="cdx" file="US10799595-20201013-C00001.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00001" attachment-type="mol" file="US10799595-20201013-C00001.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">2</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a1/3a/53/6fb613f5e3d128/US10799595-20201013-D00001.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/6f/bd/d8/fe4ca3c8fe1d1b/US10799595-20201013-D00002.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/20"><a id="link" href="#" class="style-scope state-modifier">C07H15/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Carbocyclic rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07H15/203"><a id="link" href="#" class="style-scope state-modifier">C07H15/203</a></state-modifier>
                  <span class="description style-scope classification-tree">Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/54"><a id="link" href="#" class="style-scope state-modifier">A61K47/54</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/55"><a id="link" href="#" class="style-scope state-modifier">A61K47/55</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6801"><a id="link" href="#" class="style-scope state-modifier">A61K47/6801</a></state-modifier>
                  <span class="description style-scope classification-tree">Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6803"><a id="link" href="#" class="style-scope state-modifier">A61K47/6803</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6835"><a id="link" href="#" class="style-scope state-modifier">A61K47/6835</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6851"><a id="link" href="#" class="style-scope state-modifier">A61K47/6851</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6855"><a id="link" href="#" class="style-scope state-modifier">A61K47/6855</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6835"><a id="link" href="#" class="style-scope state-modifier">A61K47/6835</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6851"><a id="link" href="#" class="style-scope state-modifier">A61K47/6851</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6863"><a id="link" href="#" class="style-scope state-modifier">A61K47/6863</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6889"><a id="link" href="#" class="style-scope state-modifier">A61K47/6889</a></state-modifier>
                  <span class="description style-scope classification-tree">Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P43/00"><a id="link" href="#" class="style-scope state-modifier">A61P43/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 7 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">US10799595B2</h2>
                  <p class="tagline style-scope patent-result">United States</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent ( having previously published pre-grant publication)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/91/e5/4e/1731ca243de740/US10799595.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;group&quot;,&quot;alkyl&quot;,&quot;antibody&quot;,&quot;methyl&quot;,&quot;genbank&quot;]" data-before="20161014"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/US10799595B2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Philip Wilson Howard"><a id="link" href="#" class="style-scope state-modifier">Philip Wilson Howard</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Stephen John Gregson"><a id="link" href="#" class="style-scope state-modifier">Stephen John Gregson</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    MedImmune Ltd
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2016</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/GB201617466D0/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">GB</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: GBGB1617466.6A</div>
                <div class="style-scope application-timeline">Filing date: 2016-10-14</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2017</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MY190504A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">MY</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MYPI2019002020A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK3525830T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK17791980.0T</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP3525830B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP17791980.0A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PT3525830T/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PT177919800T</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EA038662B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">EA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EA201990615A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP6678821B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2019520387A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US10799595B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US16/340,973</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112019007612A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR112019007612A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Search and Examination</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2018069490A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP2017/076162</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Search and Examination</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2017343793B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2017343793A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HUE054461T2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">HU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HUE17791980A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RS61925B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">RS</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RS20210689A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ752526A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ752526A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2874699T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES17791980T</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN109843335B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201780063470.4A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/LT3525830T/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">LT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: LTEP17791980.0T</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR102253480B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1020197012975A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA3039832C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA3039832A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SI3525830T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">SI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SI201730788T</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MX2019004292A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MX2019004292A</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PL3525830T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PL17791980T</div>
                <div class="style-scope application-timeline">Filing date: 2017-10-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2019</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ZA201902081B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">ZA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ZA201902081A</div>
                <div class="style-scope application-timeline">Filing date: 2019-04-03</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IL265919B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">IL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IL265919A</div>
                <div class="style-scope application-timeline">Filing date: 2019-04-08</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CL2019000992A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CL2019000992A</div>
                <div class="style-scope application-timeline">Filing date: 2019-04-12</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CO2019003709A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CONC2019/0003709A</div>
                <div class="style-scope application-timeline">Filing date: 2019-04-12</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2021</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HRP20210868T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">HR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HRP20210868TT</div>
                <div class="style-scope application-timeline">Filing date: 2021-06-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CY1124385T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CY</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CY20211100492T</div>
                <div class="style-scope application-timeline">Filing date: 2021-06-04</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application US16/340,973 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2017-10-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="MedImmune Ltd"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by MedImmune Ltd</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">2019-06-04</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="MEDIMMUNE LIMITED"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to MEDIMMUNE LIMITED</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</div><div class="description-item style-scope application-timeline">Assignors: GREGSON, STEPHEN JOHN, HOWARD, PHILIP WILSON</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2019-09-19</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20190282705A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US20190282705A1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2020-10-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2020-10-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US10799595B2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US10799595B2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Active</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2037-10-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (406)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (451)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (23)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;p=1&amp;u=/netahtml/PTO/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;d=PALL&amp;s1=10799595.PN.">USPTO</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentcenter.uspto.gov/applications/16340973">USPTO PatentCenter</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=10799595">USPTO Assignment</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=10799595B2&amp;KC=B2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/patent/US/10799595/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/US10799595">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES276416771" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <heading id="h-0001" class="style-scope patent-text">CROSS REFERENCE TO RELATED APPLICATIONS</heading>
    <div id="p-0003" num="0001" class="description-paragraph style-scope patent-text">The present application is a national phase application under 35 U.S.C. § 371 of PCT International Application No. PCT/EP2017/076162, filed Oct. 13, 2017, which claims priority to Great Britain Application No. 1617466.6, filed Oct. 14, 2016, each of which are hereby incorporated by reference in its entirety.</div>
    <div id="p-0004" num="0002" class="description-paragraph style-scope patent-text">The present invention relates to conjugates comprising pyrrolobenzodiazepines and related dimers (PBDs), and the precursor drug linkers used to make such conjugates.</div>
    <heading id="h-0002" class="style-scope patent-text">BACKGROUND TO THE INVENTION</heading>
    <div id="p-0005" num="0003" class="description-paragraph style-scope patent-text">Some pyrrolobenzodiazepines (PBDs) have the ability to recognise and bond to specific sequences of DNA; the preferred sequence is PuGPu. The first PBD antitumour antibiotic, anthramycin, was discovered in 1965 (Leimgruber, et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>87, 5793-5795 (1965); Leimgruber, et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>87, 5791-5793 (1965)). Since then, a number of naturally occurring PBDs have been reported, and over 10 synthetic routes have been developed to a variety of analogues (Thurston, et al., <i class="style-scope patent-text">Chem. Rev. </i>1994, 433-465 (1994)). Family members include abbeymycin (Hochlowski, et al., <i class="style-scope patent-text">J. Antibiotics, </i>40, 145-148 (1987)), chicamycin (Konishi, et al., <i class="style-scope patent-text">J. Antibiotics, </i>37, 200-206 (1984)), DC-81 (Japanese Patent 58-180 487; Thurston, et al., <i class="style-scope patent-text">Chem. Brit., </i>26, 767-772 (1990); Bose, et al., <i class="style-scope patent-text">Tetrahedron, </i>48, 751-758 (1992)), mazethramycin (Kuminoto, et al., <i class="style-scope patent-text">J. Antibiotics, </i>33, 665-667 (1980)), neothramycins A and B (Takeuchi, et al., <i class="style-scope patent-text">J. Antibiotics, </i>29, 93-96 (1976)), porothramycin (Tsunakawa, et al., <i class="style-scope patent-text">J. Antibiotics, </i>41, 1366-1373 (1988)), prothracarcin (Shimizu, et al, <i class="style-scope patent-text">J. Antibiotics, </i>29, 2492-2503 (1982); Langley and Thurston, <i class="style-scope patent-text">J. Org. Chem., </i>52, 91-97 (1987)), sibanomicin (DC-102)(Hara, et al., <i class="style-scope patent-text">J. Antibiotics, </i>41, 702-704 (1988); Itoh, et al., <i class="style-scope patent-text">J. Antibiotics, </i>41, 1281-1284 (1988)), sibiromycin (Leber, et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>110, 2992-2993 (1988)) and tomamycin (Arima, et al., <i class="style-scope patent-text">J. Antibiotics, </i>25, 437-444 (1972)). PBDs are of the general structure:</div>
    <div id="p-0006" num="0004" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00002" num="00002" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5d/b5/83/e2faf512bc3a39/US10799595-20201013-C00002.png" class="style-scope patent-text"><img id="EMI-C00002" he="23.96mm" wi="32.26mm" file="US10799595-20201013-C00002.TIF" alt="Figure US10799595-20201013-C00002" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="129" height="96" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5d/b5/83/e2faf512bc3a39/US10799595-20201013-C00002.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00002" attachment-type="cdx" file="US10799595-20201013-C00002.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00002" attachment-type="mol" file="US10799595-20201013-C00002.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0007" num="0005" class="description-paragraph style-scope patent-text">They differ in the number, type and position of substituents, in both their aromatic A rings and pyrrolo C rings, and in the degree of saturation of the C ring. In the B-ring there is either an imine (N═C), a carbinolamine (NH—CH(OH)), or a carbinolamine methyl ether (NH—CH(OMe)) at the N10-C11 position which is the electrophilic centre responsible for alkylating DNA. All of the known natural products have an (S)-configuration at the chiral C11a position which provides them with a right-handed twist when viewed from the C ring towards the A ring. This gives them the appropriate three-dimensional shape for isohelicity with the minor groove of B-form DNA, leading to a snug fit at the binding site (Kohn, In <i class="style-scope patent-text">Antibiotics III</i>. Springer-Verlag, New York, pp. 3-11 (1975); Hurley and Needham-VanDeventer, <i class="style-scope patent-text">Acc. Chem. Res., </i>19, 230-237 (1986)). Their ability to form an adduct in the minor groove, enables them to interfere with DNA processing, hence their use as antitumour agents.</div>
    <div id="p-0008" num="0006" class="description-paragraph style-scope patent-text">It has been previously disclosed that the biological activity of this molecules can be potentiated by joining two PBD units together through their C8/C′-hydroxyl functionalities via a flexible alkylene linker (Bose, D. S., et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>114, 4939-4941 (1992); Thurston, D. E., et al., <i class="style-scope patent-text">J. Org. Chem., </i>61, 8141-8147 (1996)). The PBD dimers are thought to form sequence-selective DNA lesions such as the palindromic 5′-Pu-GATC-Py-3′ interstrand cross-link (Smellie, M., et al., <i class="style-scope patent-text">Biochemistry, </i>42, 8232-8239 (2003); Martin, C., et al., <i class="style-scope patent-text">Biochemistry, </i>44, 4135-4147) which is thought to be mainly responsible for their biological activity.</div>
    <div id="p-0009" num="0007" class="description-paragraph style-scope patent-text">One example of a PBD dimer is SG2000 (SJG-136):</div>
    <div id="p-0010" num="0008" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00003" num="00003" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7c/29/41/b4ee37b816f009/US10799595-20201013-C00003.png" class="style-scope patent-text"><img id="EMI-C00003" he="19.98mm" wi="97.37mm" file="US10799595-20201013-C00003.TIF" alt="Figure US10799595-20201013-C00003" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="389" height="80" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7c/29/41/b4ee37b816f009/US10799595-20201013-C00003.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00003" attachment-type="cdx" file="US10799595-20201013-C00003.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00003" attachment-type="mol" file="US10799595-20201013-C00003.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
(Gregson, S., et al., <i class="style-scope patent-text">J. Med. Chem., </i>44, 737-748 (2001); Alley, M. C., et al., <i class="style-scope patent-text">Cancer Research, </i>64, 6700-6706 (2004); Hartley, J. A., et al., <i class="style-scope patent-text">Cancer Research, </i>64, 6693-6699 (2004)) which has been involved in clinical trials as a standalone agent, for example, NCT02034227 investigating its use in treating Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia (see: https://www.clinicaltrials.gov/ct2/show/NCT02034227).
</div>
    <div id="p-0011" num="0009" class="description-paragraph style-scope patent-text">Dimeric PBD compounds bearing C2 aryl substituents, such as SG2202 (ZC-207), are disclosed in WO 2005/085251:</div>
    <div id="p-0012" num="0010" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00004" num="00004" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9a/eb/9d/98dc19b56ab110/US10799595-20201013-C00004.png" class="style-scope patent-text"><img id="EMI-C00004" he="28.36mm" wi="145.71mm" file="US10799595-20201013-C00004.TIF" alt="Figure US10799595-20201013-C00004" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="583" height="113" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9a/eb/9d/98dc19b56ab110/US10799595-20201013-C00004.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00004" attachment-type="cdx" file="US10799595-20201013-C00004.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00004" attachment-type="mol" file="US10799595-20201013-C00004.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
and in WO2006/111759, bisulphites of such PBD compounds, for example SG2285 (ZC-423):
</div>
    <div id="p-0013" num="0011" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00005" num="00005" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/73/94/54/ce71c3a79a1cef/US10799595-20201013-C00005.png" class="style-scope patent-text"><img id="EMI-C00005" he="31.83mm" wi="144.86mm" file="US10799595-20201013-C00005.TIF" alt="Figure US10799595-20201013-C00005" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="579" height="127" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/73/94/54/ce71c3a79a1cef/US10799595-20201013-C00005.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00005" attachment-type="cdx" file="US10799595-20201013-C00005.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00005" attachment-type="mol" file="US10799595-20201013-C00005.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0014" num="0012" class="description-paragraph style-scope patent-text">These compounds have been shown to be highly useful cytotoxic agents (Howard, P. W., et al., <i class="style-scope patent-text">Bioorg. Med. Chem</i>. (2009), doi: 10.1016/j.bmcl.2009.09.012).</div>
    <div id="p-0015" num="0013" class="description-paragraph style-scope patent-text">WO 2007/085930 describes the preparation of dimer PBD compounds having linker groups for connection to a cell binding agent, such as an antibody. The linker is present in the bridge linking the monomer PBD units of the dimer.</div>
    <div id="p-0016" num="0014" class="description-paragraph style-scope patent-text">Dimer PBD compounds having linker groups for connection to a cell binding agent, such as an antibody, are described in WO 2011/130598. The linker in these compounds is attached to one of the available N10 positions, and are generally cleaved by action of an enzyme on the linker group. If the non-bound N10 position is protected with a capping group, the capping groups exemplified have the same cleavage trigger as the linker to the antibody.</div>
    <div id="p-0017" num="0015" class="description-paragraph style-scope patent-text">WO 2014/057074 describes two specific PBD dimer conjugates bound via the N10 position on one monomer, the other PBD monomer being in imine form.</div>
    <div id="p-0018" num="0016" class="description-paragraph style-scope patent-text">WO 2015/052322 describes a specific PBD dimer conjugate bound via the N10 position on one monomer, the other PBD monomer being in imine form. It also describes a specific PBD dimer conjugate bound via the N10 position on one monomer, the other PBD monomer having a capping group with the same cleavage trigger as the linker to the antibody:</div>
    <div id="p-0019" num="0017" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00006" num="00006" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f5/4b/48/1dda659bcc342b/US10799595-20201013-C00006.png" class="style-scope patent-text"><img id="EMI-C00006" he="102.70mm" wi="157.99mm" file="US10799595-20201013-C00006.TIF" alt="Figure US10799595-20201013-C00006" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="632" height="411" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f5/4b/48/1dda659bcc342b/US10799595-20201013-C00006.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00006" attachment-type="cdx" file="US10799595-20201013-C00006.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00006" attachment-type="mol" file="US10799595-20201013-C00006.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0003" class="style-scope patent-text">DISCLOSURE OF THE INVENTION</heading>
    <div id="p-0020" num="0018" class="description-paragraph style-scope patent-text">The present invention provides PBD and related dimer conjugates where the N10-C11 group that is not bound to the ligand unit is a β-glucuronide capping group. The cleavage trigger for the linking unit to the ligand unit is non-glucuronide cleavable.</div>
    <div id="p-0021" num="0019" class="description-paragraph style-scope patent-text">Use of the glucuronide capping unit in these conjugates is believed to be advantageous, as if the conjugate is cleaved from the antibody outside the target cell, the released protected compound remains inactive as it is unable to permeate cell membranes due to its hydrophilicity.</div>
    <div id="p-0022" num="0020" class="description-paragraph style-scope patent-text">The present invention also provided PBD and related dimer drug linkers, suitable for conjugating to a ligand unit, where the N10-C11 group that is not intended to be bound to the ligand unit is a glucuronide capping group. The cleavage trigger for the linking unit is a non-glucuronide capping unit.</div>
    <div id="p-0023" num="0021" class="description-paragraph style-scope patent-text">Use of the glucuronide capping unit in these drug linkers is believed to be advantageous, as it increases the hydrophilicity of the generally hydrophobic drug linker, making the drug linkers easier to conjugate to a ligand unit.</div>
    <div id="p-0024" num="0022" class="description-paragraph style-scope patent-text">A first aspect of the present invention comprises a compound with the formula I:</div>
    <div id="p-0025" num="0023" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00007" num="00007" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/92/e9/d4/76766881f7825b/US10799595-20201013-C00007.png" class="style-scope patent-text"><img id="EMI-C00007" he="58.08mm" wi="119.46mm" file="US10799595-20201013-C00007.TIF" alt="Figure US10799595-20201013-C00007" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="478" height="232" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/92/e9/d4/76766881f7825b/US10799595-20201013-C00007.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00007" attachment-type="cdx" file="US10799595-20201013-C00007.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00007" attachment-type="mol" file="US10799595-20201013-C00007.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
and salts and solvates thereof, wherein:
<br class="style-scope patent-text">
the square brackets indicate the NO<sub class="style-scope patent-text">2 </sub>group is optional;
<br class="style-scope patent-text">
D represents either group D1 or D2:
</div>
    <div id="p-0026" num="0024" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00008" num="00008" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/c6/9f/ffc7a53645ef1a/US10799595-20201013-C00008.png" class="style-scope patent-text"><img id="EMI-C00008" he="55.88mm" wi="69.93mm" file="US10799595-20201013-C00008.TIF" alt="Figure US10799595-20201013-C00008" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="224" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/c6/9f/ffc7a53645ef1a/US10799595-20201013-C00008.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00008" attachment-type="cdx" file="US10799595-20201013-C00008.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00008" attachment-type="mol" file="US10799595-20201013-C00008.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
the dotted line indicates the optional presence of a double bond between C2 and C3;
<br class="style-scope patent-text">
when there is a double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>is selected from the group consisting of:
<br class="style-scope patent-text">
(ia) C<sub class="style-scope patent-text">5-10 </sub>aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, carboxy, ester, C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl and bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene;
<br class="style-scope patent-text">
(ib) C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl;
<br class="style-scope patent-text">
(ic) C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl;
</div>
    <div id="p-0027" num="0025" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00009" num="00009" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/48/b6/e3/7ee76c51891626/US10799595-20201013-C00009.png" class="style-scope patent-text"><img id="EMI-C00009" he="19.30mm" wi="69.93mm" file="US10799595-20201013-C00009.TIF" alt="Figure US10799595-20201013-C00009" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="77" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/48/b6/e3/7ee76c51891626/US10799595-20201013-C00009.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00009" attachment-type="cdx" file="US10799595-20201013-C00009.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00009" attachment-type="mol" file="US10799595-20201013-C00009.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein each of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">2 </sup>group is no more than 5;
</div>
    <div id="p-0028" num="0026" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00010" num="00010" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6c/21/8a/d8b374df20bbc5/US10799595-20201013-C00010.png" class="style-scope patent-text"><img id="EMI-C00010" he="15.07mm" wi="69.93mm" file="US10799595-20201013-C00010.TIF" alt="Figure US10799595-20201013-C00010" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="60" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6c/21/8a/d8b374df20bbc5/US10799595-20201013-C00010.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00010" attachment-type="cdx" file="US10799595-20201013-C00010.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00010" attachment-type="mol" file="US10799595-20201013-C00010.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein one of R<sup class="style-scope patent-text">15a </sup>and R<sup class="style-scope patent-text">15b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and
</div>
    <div id="p-0029" num="0027" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00011" num="00011" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/84/4c/f5/48e410cd86ee4e/US10799595-20201013-C00011.png" class="style-scope patent-text"><img id="EMI-C00011" he="17.70mm" wi="69.93mm" file="US10799595-20201013-C00011.TIF" alt="Figure US10799595-20201013-C00011" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="71" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/84/4c/f5/48e410cd86ee4e/US10799595-20201013-C00011.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00011" attachment-type="cdx" file="US10799595-20201013-C00011.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00011" attachment-type="mol" file="US10799595-20201013-C00011.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">14 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl;
<br class="style-scope patent-text">
when there is a single bond present between C2 and C3,
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">2 </sup>is selected from H, OH, F, diF and
</div>
    <div id="p-0030" num="0028" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00012" num="00012" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/48/61/b7/7966963c9ada70/US10799595-20201013-C00012.png" class="style-scope patent-text"><img id="EMI-C00012" he="14.56mm" wi="16.93mm" file="US10799595-20201013-C00012.TIF" alt="Figure US10799595-20201013-C00012" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="68" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/48/61/b7/7966963c9ada70/US10799595-20201013-C00012.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00012" attachment-type="cdx" file="US10799595-20201013-C00012.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00012" attachment-type="mol" file="US10799595-20201013-C00012.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>are independently selected from H, F, C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C<sub class="style-scope patent-text">1-4 </sub>alkyl amido and C<sub class="style-scope patent-text">1-4 </sub>alkyl ester; or, when one of R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>is H, the other is selected from nitrile and a C<sub class="style-scope patent-text">1-4 </sub>alkyl ester;
<br class="style-scope patent-text">
D′ represents either group D′1 or D′2:
</div>
    <div id="p-0031" num="0029" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00013" num="00013" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e7/99/cc/c56b171c1c522f/US10799595-20201013-C00013.png" class="style-scope patent-text"><img id="EMI-C00013" he="55.96mm" wi="69.93mm" file="US10799595-20201013-C00013.TIF" alt="Figure US10799595-20201013-C00013" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="224" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e7/99/cc/c56b171c1c522f/US10799595-20201013-C00013.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00013" attachment-type="cdx" file="US10799595-20201013-C00013.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00013" attachment-type="mol" file="US10799595-20201013-C00013.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein the dotted line indicates the optional presence of a double bond between C2′ and C3′;
<br class="style-scope patent-text">
when there is a double bond present between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>is selected from the group consisting of:
<br class="style-scope patent-text">
(iia) C<sub class="style-scope patent-text">5-10 </sub>aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, carboxy, ester, C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl and bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene;
<br class="style-scope patent-text">
(iib) C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl;
<br class="style-scope patent-text">
(iic) C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl;
</div>
    <div id="p-0032" num="0030" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00014" num="00014" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e5/66/eb/e80034c205ce47/US10799595-20201013-C00014.png" class="style-scope patent-text"><img id="EMI-C00014" he="19.30mm" wi="69.93mm" file="US10799595-20201013-C00014.TIF" alt="Figure US10799595-20201013-C00014" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="77" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e5/66/eb/e80034c205ce47/US10799595-20201013-C00014.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00014" attachment-type="cdx" file="US10799595-20201013-C00014.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00014" attachment-type="mol" file="US10799595-20201013-C00014.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12 </sup>group is no more than 5;
</div>
    <div id="p-0033" num="0031" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00015" num="00015" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d7/bd/bf/b7c79556ee8c18/US10799595-20201013-C00015.png" class="style-scope patent-text"><img id="EMI-C00015" he="14.05mm" wi="69.93mm" file="US10799595-20201013-C00015.TIF" alt="Figure US10799595-20201013-C00015" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="56" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d7/bd/bf/b7c79556ee8c18/US10799595-20201013-C00015.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00015" attachment-type="cdx" file="US10799595-20201013-C00015.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00015" attachment-type="mol" file="US10799595-20201013-C00015.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein one of R<sup class="style-scope patent-text">25a </sup>and R<sup class="style-scope patent-text">25b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and
</div>
    <div id="p-0034" num="0032" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00016" num="00016" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8f/36/7d/bd4df3cce0519f/US10799595-20201013-C00016.png" class="style-scope patent-text"><img id="EMI-C00016" he="13.55mm" wi="69.93mm" file="US10799595-20201013-C00016.TIF" alt="Figure US10799595-20201013-C00016" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="54" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8f/36/7d/bd4df3cce0519f/US10799595-20201013-C00016.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00016" attachment-type="cdx" file="US10799595-20201013-C00016.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00016" attachment-type="mol" file="US10799595-20201013-C00016.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">24 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl;
<br class="style-scope patent-text">
when there is a single bond present between C2′ and C3′,
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">12 </sup>is selected from H, OH, F, diF and
</div>
    <div id="p-0035" num="0033" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00017" num="00017" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f4/55/d4/6b9b572a737110/US10799595-20201013-C00017.png" class="style-scope patent-text"><img id="EMI-C00017" he="10.84mm" wi="14.65mm" file="US10799595-20201013-C00017.TIF" alt="Figure US10799595-20201013-C00017" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="59" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f4/55/d4/6b9b572a737110/US10799595-20201013-C00017.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00017" attachment-type="cdx" file="US10799595-20201013-C00017.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00017" attachment-type="mol" file="US10799595-20201013-C00017.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are independently selected from H, F, C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C<sub class="style-scope patent-text">1-4 </sub>alkyl amido and C<sub class="style-scope patent-text">1-4 </sub>alkyl ester; or,
<br class="style-scope patent-text">
when one of R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>is H, the other is selected from nitrile and a C<sub class="style-scope patent-text">1-4 </sub>alkyl ester;
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">6 </sup>and R<sup class="style-scope patent-text">9 </sup>are independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR′, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;
<br class="style-scope patent-text">
where R and R′ are independently selected from optionally substituted C<sub class="style-scope patent-text">1-12 </sub>alkyl, C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl and C<sub class="style-scope patent-text">5-20 </sub>aryl groups;
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">7 </sup>is selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR′, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;
<br class="style-scope patent-text">
R″ is a C<sub class="style-scope patent-text">3-12 </sub>alkylene group, which chain may be interrupted by one or more heteroatoms, e.g. O, S, NR<sup class="style-scope patent-text">N2 </sup>(where R<sup class="style-scope patent-text">N2 </sup>is H or C<sub class="style-scope patent-text">1-4 </sub>alkyl), and/or aromatic rings, e.g. benzene or pyridine;
<br class="style-scope patent-text">
Y and Y′ are selected from O, S, or NH;
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup> are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7 </sup>and R<sup class="style-scope patent-text">9 </sup>respectively;
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">11b </sup>is selected from OH, OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A </sup>is C<sub class="style-scope patent-text">1-4 </sub>alkyl; and
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">L </sup>is a linker for connection to a cell binding agent, which is selected from:
<br class="style-scope patent-text">
(iiia):
</div>
    <div id="p-0036" num="0034" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00018" num="00018" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/be/79/6e/e2434ebb59ff69/US10799595-20201013-C00018.png" class="style-scope patent-text"><img id="EMI-C00018" he="26.84mm" wi="69.93mm" file="US10799595-20201013-C00018.TIF" alt="Figure US10799595-20201013-C00018" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="107" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/be/79/6e/e2434ebb59ff69/US10799595-20201013-C00018.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00018" attachment-type="cdx" file="US10799595-20201013-C00018.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00018" attachment-type="mol" file="US10799595-20201013-C00018.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein
<br class="style-scope patent-text">
Q is:
</div>
    <div id="p-0037" num="0035" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00019" num="00019" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/4d/7f/31636bc47cb5e5/US10799595-20201013-C00019.png" class="style-scope patent-text"><img id="EMI-C00019" he="15.49mm" wi="37.00mm" file="US10799595-20201013-C00019.TIF" alt="Figure US10799595-20201013-C00019" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="148" height="62" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/4d/7f/31636bc47cb5e5/US10799595-20201013-C00019.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00019" attachment-type="cdx" file="US10799595-20201013-C00019.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00019" attachment-type="mol" file="US10799595-20201013-C00019.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where Q<sup class="style-scope patent-text">X </sup>is such that Q is an amino-acid residue, a dipeptide residue or a tripeptide residue;
<br class="style-scope patent-text">
X is:
</div>
    <div id="p-0038" num="0036" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00020" num="00020" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/38/59/23/0ef435b1952a3a/US10799595-20201013-C00020.png" class="style-scope patent-text"><img id="EMI-C00020" he="13.89mm" wi="66.80mm" file="US10799595-20201013-C00020.TIF" alt="Figure US10799595-20201013-C00020" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="267" height="56" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/38/59/23/0ef435b1952a3a/US10799595-20201013-C00020.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00020" attachment-type="cdx" file="US10799595-20201013-C00020.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00020" attachment-type="mol" file="US10799595-20201013-C00020.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where a=0 to 5, b=0 to 16, c=0 or 1, d=0 to 5;
<br class="style-scope patent-text">
G<sup class="style-scope patent-text">L </sup>is a linker for connecting to a Ligand Unit; and
<br class="style-scope patent-text">
(iiib):
</div>
    <div id="p-0039" num="0037" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00021" num="00021" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e2/3b/ed/d162d1dea738d9/US10799595-20201013-C00021.png" class="style-scope patent-text"><img id="EMI-C00021" he="19.73mm" wi="69.85mm" file="US10799595-20201013-C00021.TIF" alt="Figure US10799595-20201013-C00021" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="79" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e2/3b/ed/d162d1dea738d9/US10799595-20201013-C00021.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00021" attachment-type="cdx" file="US10799595-20201013-C00021.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00021" attachment-type="mol" file="US10799595-20201013-C00021.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>are independently selected from H and methyl, or together with the carbon atom to which they are bound form a cyclopropylene or cyclobutylene group;
<br class="style-scope patent-text">
and e is 0 or 1.
<br class="style-scope patent-text">
A second aspect of the present invention provides Conjugates of formula II:
<br class="style-scope patent-text">
L-(D<sup class="style-scope patent-text">L</sup>)<sub class="style-scope patent-text">p</sub>  (II)
<br class="style-scope patent-text">
wherein L is a Ligand unit (i.e., a targeting agent), D<sup class="style-scope patent-text">L </sup>is a Drug Linker unit of formula I′:
</div>
    <div id="p-0040" num="0038" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00022" num="00022" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/16/a4/9a/7622de7c52f0a3/US10799595-20201013-C00022.png" class="style-scope patent-text"><img id="EMI-C00022" he="54.02mm" wi="117.94mm" file="US10799595-20201013-C00022.TIF" alt="Figure US10799595-20201013-C00022" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="472" height="216" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/16/a4/9a/7622de7c52f0a3/US10799595-20201013-C00022.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00022" attachment-type="cdx" file="US10799595-20201013-C00022.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00022" attachment-type="mol" file="US10799595-20201013-C00022.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein D, R<sup class="style-scope patent-text">2</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">11b</sup>, Y, R″, Y′, D′, R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup> and R<sup class="style-scope patent-text">12 </sup>(including the presence or absence of double bonds between C2 and C3 and C2′ and C3′ respectively, and the NO<sub class="style-scope patent-text">2 </sub>group) are as defined in the first aspect of the invention;
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">LL </sup>is a linker for connection to a cell binding agent, which is selected from:
<br class="style-scope patent-text">
(iiia):
</div>
    <div id="p-0041" num="0039" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00023" num="00023" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/35/c5/89/527d8f5e0d2c9a/US10799595-20201013-C00023.png" class="style-scope patent-text"><img id="EMI-C00023" he="26.92mm" wi="69.85mm" file="US10799595-20201013-C00023.TIF" alt="Figure US10799595-20201013-C00023" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="108" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/35/c5/89/527d8f5e0d2c9a/US10799595-20201013-C00023.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00023" attachment-type="cdx" file="US10799595-20201013-C00023.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00023" attachment-type="mol" file="US10799595-20201013-C00023.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where Q and X are as defined in the first aspect and G<sup class="style-scope patent-text">LL </sup>is a linker connected to a Ligand Unit; and
<br class="style-scope patent-text">
(iiib):
</div>
    <div id="p-0042" num="0040" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00024" num="00024" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ce/96/94/776c0fcd76beeb/US10799595-20201013-C00024.png" class="style-scope patent-text"><img id="EMI-C00024" he="18.29mm" wi="69.85mm" file="US10799595-20201013-C00024.TIF" alt="Figure US10799595-20201013-C00024" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="73" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ce/96/94/776c0fcd76beeb/US10799595-20201013-C00024.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00024" attachment-type="cdx" file="US10799595-20201013-C00024.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00024" attachment-type="mol" file="US10799595-20201013-C00024.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>are as defined in the first aspect;
<br class="style-scope patent-text">
wherein p is an integer of from 1 to 20.
</div>
    <div id="p-0043" num="0041" class="description-paragraph style-scope patent-text">The Ligand unit, described more fully below, is a targeting agent that binds to a target moiety. The Ligand unit can, for example, specifically bind to a cell component (a Cell Binding Agent) or to other target molecules of interest. The Ligand unit can be, for example, a protein, polypeptide or peptide, such as an antibody, an antigen-binding fragment of an antibody, or other binding agent, such as an Fc fusion protein.</div>
    <div id="p-0044" num="0042" class="description-paragraph style-scope patent-text">A third aspect of the present invention provides the use of a conjugate of the second aspect of the invention in the manufacture of a medicament for treating a proliferative disease. The third aspect also provides a conjugate of the second aspect of the invention for use in the treatment of a proliferative disease. The third aspect also provides a method of treating a proliferative disease comprising administering a therapeutically effective amount of a conjugate of the second aspect of the invention to a patient in need thereof.</div>
    <div id="p-0045" num="0043" class="description-paragraph style-scope patent-text">One of ordinary skill in the art is readily able to determine whether or not a candidate conjugate treats a proliferative condition for any particular cell type. For example, assays which may conveniently be used to assess the activity offered by a particular compound are described in the examples below.</div>
    <div id="p-0046" num="0044" class="description-paragraph style-scope patent-text">A fourth aspect of the present invention provides the synthesis of a conjugate of the second aspect of the invention comprising conjugating a compound (drug linker) of the first aspect of the invention with a Ligand Unit.</div>
    
    
    <description-of-drawings class="style-scope patent-text">
      <heading id="h-0004" class="style-scope patent-text">BRIEF DESCRIPTION OF FIGURES</heading>
      <div id="p-0047" num="0045" class="description-paragraph style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref> shows the effect on viability of SKOV3 cells following incubation with a conjugate of the present invention;</div>
      <div id="p-0048" num="0046" class="description-paragraph style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref> shows the effect on viability of SKOV3 cells following incubation with a different conjugate of the present invention;</div>
      <div id="p-0049" num="0047" class="description-paragraph style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref> shows the effect on volume of a NCI-N87 xenograft tumour following treatment with a different conjugate of the present invention;</div>
      <div id="p-0050" num="0048" class="description-paragraph style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 4</figref> shows the effect on volume of a JIMT-1 xenograft tumour following treatment with the same conjugate of the present invention as in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>.</div>
    </description-of-drawings>
    
    
    <heading id="h-0005" class="style-scope patent-text">DEFINITIONS</heading>
    <div id="h-0006" num="0000" class="description-paragraph style-scope patent-text">Substituents</div>
    <div id="p-0051" num="0049" class="description-paragraph style-scope patent-text">The phrase “optionally substituted” as used herein, pertains to a parent group which may be unsubstituted or which may be substituted.</div>
    <div id="p-0052" num="0050" class="description-paragraph style-scope patent-text">Unless otherwise specified, the term “substituted” as used herein, pertains to a parent group which bears one or more substituents. The term “substituent” is used herein in the conventional sense and refers to a chemical moiety which is covalently attached to, or if appropriate, fused to, a parent group. A wide variety of substituents are well known, and methods for their formation and introduction into a variety of parent groups are also well known.</div>
    <div id="p-0053" num="0051" class="description-paragraph style-scope patent-text">Examples of substituents are described in more detail below.</div>
    <div id="p-0054" num="0052" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">1-12 </sub>alkyl: The term “C<sub class="style-scope patent-text">1-12 </sub>alkyl” as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from a carbon atom of a hydrocarbon compound having from 1 to 12 carbon atoms, which may be aliphatic or alicyclic, and which may be saturated or unsaturated (e.g. partially unsaturated, fully unsaturated). The term “C<sub class="style-scope patent-text">1-4 </sub>alkyl” as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from a carbon atom of a hydrocarbon compound having from 1 to 4 carbon atoms, which may be aliphatic or alicyclic, and which may be saturated or unsaturated (e.g. partially unsaturated, fully unsaturated). Thus, the term “alkyl” includes the sub-classes alkenyl, alkynyl, cycloalkyl, etc., discussed below.</div>
    <div id="p-0055" num="0053" class="description-paragraph style-scope patent-text">Examples of saturated alkyl groups include, but are not limited to, methyl (C<sub class="style-scope patent-text">1</sub>), ethyl (C<sub class="style-scope patent-text">2</sub>), propyl (C<sub class="style-scope patent-text">3</sub>), butyl (C<sub class="style-scope patent-text">4</sub>), pentyl (C<sub class="style-scope patent-text">5</sub>), hexyl (C<sub class="style-scope patent-text">6</sub>) and heptyl (C<sub class="style-scope patent-text">7</sub>).</div>
    <div id="p-0056" num="0054" class="description-paragraph style-scope patent-text">Examples of saturated linear alkyl groups include, but are not limited to, methyl (C<sub class="style-scope patent-text">1</sub>), ethyl (C<sub class="style-scope patent-text">2</sub>), n-propyl (C<sub class="style-scope patent-text">3</sub>), n-butyl (C<sub class="style-scope patent-text">4</sub>), n-pentyl (amyl) (C<sub class="style-scope patent-text">5</sub>), n-hexyl (C<sub class="style-scope patent-text">6</sub>) and n-heptyl (C<sub class="style-scope patent-text">7</sub>).</div>
    <div id="p-0057" num="0055" class="description-paragraph style-scope patent-text">Examples of saturated branched alkyl groups include iso-propyl (C<sub class="style-scope patent-text">3</sub>), iso-butyl (C<sub class="style-scope patent-text">4</sub>), sec-butyl (C<sub class="style-scope patent-text">4</sub>), tert-butyl (C<sub class="style-scope patent-text">4</sub>), iso-pentyl (C<sub class="style-scope patent-text">5</sub>), and neo-pentyl (C<sub class="style-scope patent-text">5</sub>).</div>
    <div id="p-0058" num="0056" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">2-12 </sub>Alkenyl: The term “C<sub class="style-scope patent-text">2-12 </sub>alkenyl” as used herein, pertains to an alkyl group having one or more carbon-carbon double bonds.</div>
    <div id="p-0059" num="0057" class="description-paragraph style-scope patent-text">Examples of unsaturated alkenyl groups include, but are not limited to, ethenyl (vinyl, —CH═CH<sub class="style-scope patent-text">2</sub>), 1-propenyl (—CH═CH—CH<sub class="style-scope patent-text">3</sub>), 2-propenyl (allyl, —CH—CH═CH<sub class="style-scope patent-text">2</sub>), isopropenyl (1-methylvinyl, —C(CH<sub class="style-scope patent-text">3</sub>)═CH<sub class="style-scope patent-text">2</sub>), butenyl (C<sub class="style-scope patent-text">4</sub>), pentenyl (C<sub class="style-scope patent-text">5</sub>), and hexenyl (C<sub class="style-scope patent-text">6</sub>).</div>
    <div id="p-0060" num="0058" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">2-12 </sub>alkynyl: The term “C<sub class="style-scope patent-text">2-12 </sub>alkynyl” as used herein, pertains to an alkyl group having one or more carbon-carbon triple bonds.</div>
    <div id="p-0061" num="0059" class="description-paragraph style-scope patent-text">Examples of unsaturated alkynyl groups include, but are not limited to, ethynyl (—C≡CH) and 2-propynyl (propargyl, —CH<sub class="style-scope patent-text">2</sub>—C≡CH).</div>
    <div id="p-0062" num="0060" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3-12 </sub>cycloalkyl: The term “C<sub class="style-scope patent-text">3-12 </sub>cycloalkyl” as used herein, pertains to an alkyl group which is also a cyclyl group; that is, a monovalent moiety obtained by removing a hydrogen atom from an alicyclic ring atom of a cyclic hydrocarbon (carbocyclic) compound, which moiety has from 3 to 7 carbon atoms, including from 3 to 7 ring atoms.</div>
    <div id="p-0063" num="0061" class="description-paragraph style-scope patent-text">Examples of cycloalkyl groups include, but are not limited to, those derived from:
</div> <ul class="style-scope patent-text"> <li id="ul0001-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0002-0001" num="0062" class="style-scope patent-text">saturated monocyclic hydrocarbon compounds:
<br class="style-scope patent-text">
cyclopropane (C<sub class="style-scope patent-text">3</sub>), cyclobutane (C<sub class="style-scope patent-text">4</sub>), cyclopentane (C<sub class="style-scope patent-text">5</sub>), cyclohexane (C<sub class="style-scope patent-text">6</sub>), cycloheptane (C<sub class="style-scope patent-text">7</sub>), methylcyclopropane (C<sub class="style-scope patent-text">4</sub>), dimethylcyclopropane (C<sub class="style-scope patent-text">5</sub>), methylcyclobutane (C<sub class="style-scope patent-text">5</sub>), dimethylcyclobutane (C<sub class="style-scope patent-text">6</sub>), methylcyclopentane (C<sub class="style-scope patent-text">6</sub>), dimethylcyclopentane (C<sub class="style-scope patent-text">7</sub>) and methylcyclohexane (C<sub class="style-scope patent-text">7</sub>);
</li> <li id="ul0002-0002" num="0063" class="style-scope patent-text">unsaturated monocyclic hydrocarbon compounds:
<br class="style-scope patent-text">
cyclopropene (C<sub class="style-scope patent-text">3</sub>), cyclobutene (C<sub class="style-scope patent-text">4</sub>), cyclopentene (C<sub class="style-scope patent-text">5</sub>), cyclohexene (C<sub class="style-scope patent-text">6</sub>), methylcyclopropene (C<sub class="style-scope patent-text">4</sub>), dimethylcyclopropene (C<sub class="style-scope patent-text">5</sub>), methylcyclobutene (C<sub class="style-scope patent-text">5</sub>), dimethylcyclobutene (C<sub class="style-scope patent-text">6</sub>), methylcyclopentene (C<sub class="style-scope patent-text">6</sub>), dimethylcyclopentene (C<sub class="style-scope patent-text">7</sub>) and methylcyclohexene (C<sub class="style-scope patent-text">7</sub>); and
</li> <li id="ul0002-0003" num="0064" class="style-scope patent-text">saturated polycyclic hydrocarbon compounds:
<br class="style-scope patent-text">
norcarane (C<sub class="style-scope patent-text">7</sub>), norpinane (C<sub class="style-scope patent-text">7</sub>), norbornane (C<sub class="style-scope patent-text">7</sub>).
<br class="style-scope patent-text">
C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl: The term “C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl” as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from a ring atom of a heterocyclic compound, which moiety has from 3 to 20 ring atoms, of which from 1 to 10 are ring heteroatoms. Preferably, each ring has from 3 to 7 ring atoms, of which from 1 to 4 are ring heteroatoms.
</li> </ul> </li> </ul>

    <div id="p-0064" num="0065" class="description-paragraph style-scope patent-text">In this context, the prefixes (e.g. C<sub class="style-scope patent-text">3-20</sub>, C<sub class="style-scope patent-text">3-7</sub>, C<sub class="style-scope patent-text">5-6</sub>, etc.) denote the number of ring atoms, or range of number of ring atoms, whether carbon atoms or heteroatoms. For example, the term “C<sub class="style-scope patent-text">5-6</sub>heterocyclyl”, as used herein, pertains to a heterocyclyl group having 5 or 6 ring atoms.</div>
    <div id="p-0065" num="0066" class="description-paragraph style-scope patent-text">Examples of monocyclic heterocyclyl groups include, but are not limited to, those derived from:</div>
    <div id="p-0066" num="0067" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>: aziridine (C<sub class="style-scope patent-text">3</sub>), azetidine (C<sub class="style-scope patent-text">4</sub>), pyrrolidine (tetrahydropyrrole) (C<sub class="style-scope patent-text">5</sub>), pyrroline (e.g., 3-pyrroline, 2,5-dihydropyrrole) (C<sub class="style-scope patent-text">5</sub>), 2H-pyrrole or 3H-pyrrole (isopyrrole, isoazole) (C<sub class="style-scope patent-text">5</sub>), piperidine (C<sub class="style-scope patent-text">6</sub>), dihydropyridine (C<sub class="style-scope patent-text">6</sub>), tetrahydropyridine (C<sub class="style-scope patent-text">6</sub>), azepine (C<sub class="style-scope patent-text">7</sub>);
<br class="style-scope patent-text">
O<sub class="style-scope patent-text">1</sub>: oxirane (C<sub class="style-scope patent-text">3</sub>), oxetane (C<sub class="style-scope patent-text">4</sub>), oxolane (tetrahydrofuran) (C<sub class="style-scope patent-text">5</sub>), oxole (dihydrofuran) (C<sub class="style-scope patent-text">5</sub>), oxane (tetrahydropyran) (C<sub class="style-scope patent-text">6</sub>), dihydropyran (C<sub class="style-scope patent-text">6</sub>), pyran (C<sub class="style-scope patent-text">6</sub>), oxepin (C<sub class="style-scope patent-text">7</sub>);
<br class="style-scope patent-text">
S<sub class="style-scope patent-text">1</sub>: thiirane (C<sub class="style-scope patent-text">3</sub>), thietane (C<sub class="style-scope patent-text">4</sub>), thiolane (tetrahydrothiophene) (C<sub class="style-scope patent-text">5</sub>), thiane (tetrahydrothiopyran) (C<sub class="style-scope patent-text">5</sub>), thiepane (C<sub class="style-scope patent-text">7</sub>);
<br class="style-scope patent-text">
O<sub class="style-scope patent-text">2</sub>: dioxolane (C<sub class="style-scope patent-text">5</sub>), dioxane (C<sub class="style-scope patent-text">6</sub>), and dioxepane (C<sub class="style-scope patent-text">7</sub>);
<br class="style-scope patent-text">
O<sub class="style-scope patent-text">3</sub>: trioxane (C<sub class="style-scope patent-text">6</sub>);
<br class="style-scope patent-text">
N<sub class="style-scope patent-text">2</sub>: imidazolidine (C<sub class="style-scope patent-text">5</sub>), pyrazolidine (diazolidine) (C<sub class="style-scope patent-text">5</sub>), imidazoline (C<sub class="style-scope patent-text">5</sub>), pyrazoline (dihydropyrazole) (C<sub class="style-scope patent-text">5</sub>), piperazine (C<sub class="style-scope patent-text">6</sub>);
<br class="style-scope patent-text">
N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>: tetrahydrooxazole (C<sub class="style-scope patent-text">5</sub>), dihydrooxazole (C<sub class="style-scope patent-text">5</sub>), tetrahydroisoxazole (C<sub class="style-scope patent-text">5</sub>), dihydroisoxazole (C<sub class="style-scope patent-text">5</sub>), morpholine (C<sub class="style-scope patent-text">6</sub>), tetrahydrooxazine (C<sub class="style-scope patent-text">6</sub>), dihydrooxazine (C<sub class="style-scope patent-text">6</sub>), oxazine (C<sub class="style-scope patent-text">6</sub>);
<br class="style-scope patent-text">
N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: thiazoline (C<sub class="style-scope patent-text">5</sub>), thiazolidine (C<sub class="style-scope patent-text">5</sub>), thiomorpholine (C<sub class="style-scope patent-text">6</sub>);
<br class="style-scope patent-text">
N<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">1</sub>: oxadiazine (C<sub class="style-scope patent-text">6</sub>);
<br class="style-scope patent-text">
O<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: oxathiole (C<sub class="style-scope patent-text">5</sub>) and oxathiane (thioxane) (C<sub class="style-scope patent-text">6</sub>); and,
<br class="style-scope patent-text">
N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: oxathiazine (C<sub class="style-scope patent-text">6</sub>).
</div>
    <div id="p-0067" num="0068" class="description-paragraph style-scope patent-text">Examples of substituted monocyclic heterocyclyl groups include those derived from saccharides, in cyclic form, for example, furanoses (C<sub class="style-scope patent-text">5</sub>), such as arabinofuranose, lyxofuranose, ribofuranose, and xylofuranse, and pyranoses (C<sub class="style-scope patent-text">6</sub>), such as allopyranose, altropyranose, glucopyranose, mannopyranose, gulopyranose, idopyranose, galactopyranose, and talopyranose.</div>
    <div id="p-0068" num="0069" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">5-20 </sub>aryl: The term “C<sub class="style-scope patent-text">5-20 </sub>aryl”, as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from an aromatic ring atom of an aromatic compound, which moiety has from 3 to 20 ring atoms. The term “C<sub class="style-scope patent-text">5-7 </sub>aryl”, as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from an aromatic ring atom of an aromatic compound, which moiety has from 5 to 7 ring atoms and the term “C<sub class="style-scope patent-text">5-10 </sub>aryl”, as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from an aromatic ring atom of an aromatic compound, which moiety has from 5 to 10 ring atoms. Preferably, each ring has from 5 to 7 ring atoms.</div>
    <div id="p-0069" num="0070" class="description-paragraph style-scope patent-text">In this context, the prefixes (e.g. C<sub class="style-scope patent-text">3-20</sub>, C<sub class="style-scope patent-text">5-7</sub>, C<sub class="style-scope patent-text">5-6</sub>, C<sub class="style-scope patent-text">5-10</sub>, etc.) denote the number of ring atoms, or range of number of ring atoms, whether carbon atoms or heteroatoms. For example, the term “C<sub class="style-scope patent-text">5-6 </sub>aryl” as used herein, pertains to an aryl group having 5 or 6 ring atoms.</div>
    <div id="p-0070" num="0071" class="description-paragraph style-scope patent-text">The ring atoms may be all carbon atoms, as in “carboaryl groups”.</div>
    <div id="p-0071" num="0072" class="description-paragraph style-scope patent-text">Examples of carboaryl groups include, but are not limited to, those derived from benzene (i.e. phenyl) (C<sub class="style-scope patent-text">6</sub>), naphthalene (C<sub class="style-scope patent-text">10</sub>), azulene (C<sub class="style-scope patent-text">10</sub>), anthracene (C<sub class="style-scope patent-text">14</sub>), phenanthrene (C<sub class="style-scope patent-text">14</sub>), naphthacene (C<sub class="style-scope patent-text">18</sub>), and pyrene (C<sub class="style-scope patent-text">16</sub>).</div>
    <div id="p-0072" num="0073" class="description-paragraph style-scope patent-text">Examples of aryl groups which comprise fused rings, at least one of which is an aromatic ring, include, but are not limited to, groups derived from indane (e.g. 2,3-dihydro-1H-indene) (C<sub class="style-scope patent-text">9</sub>), indene (C<sub class="style-scope patent-text">9</sub>), isoindene (C<sub class="style-scope patent-text">9</sub>), tetraline (1,2,3,4-tetrahydronaphthalene (C<sub class="style-scope patent-text">10</sub>), acenaphthene (C<sub class="style-scope patent-text">12</sub>), fluorene (C<sub class="style-scope patent-text">13</sub>), phenalene (C<sub class="style-scope patent-text">13</sub>), acephenanthrene (C<sub class="style-scope patent-text">15</sub>), and aceanthrene (C<sub class="style-scope patent-text">16</sub>).</div>
    <div id="p-0073" num="0074" class="description-paragraph style-scope patent-text">Alternatively, the ring atoms may include one or more heteroatoms, as in “heteroaryl groups”. Examples of monocyclic heteroaryl groups include, but are not limited to, those derived from:</div>
    <div id="h-0007" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>: pyrrole (azole) (C<sub class="style-scope patent-text">5</sub>), pyridine (azine) (C<sub class="style-scope patent-text">6</sub>);</div>
    <div id="h-0008" num="0000" class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">1</sub>: furan (oxole) (C<sub class="style-scope patent-text">5</sub>);</div>
    <div id="h-0009" num="0000" class="description-paragraph style-scope patent-text">S<sub class="style-scope patent-text">1</sub>: thiophene (thiole) (C<sub class="style-scope patent-text">5</sub>);</div>
    <div id="h-0010" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>: oxazole (C<sub class="style-scope patent-text">5</sub>), isoxazole (C<sub class="style-scope patent-text">5</sub>), isoxazine (C<sub class="style-scope patent-text">6</sub>);</div>
    <div id="h-0011" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">1</sub>: oxadiazole (furazan) (C<sub class="style-scope patent-text">5</sub>);</div>
    <div id="h-0012" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>O<sub class="style-scope patent-text">1</sub>: oxatriazole (C<sub class="style-scope patent-text">5</sub>);</div>
    <div id="h-0013" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>: thiazole (C<sub class="style-scope patent-text">5</sub>), isothiazole (C<sub class="style-scope patent-text">5</sub>);</div>
    <div id="h-0014" num="0000" class="description-paragraph style-scope patent-text">N2: imidazole (1,3-diazole) (C<sub class="style-scope patent-text">5</sub>), pyrazole (1,2-diazole) (C<sub class="style-scope patent-text">5</sub>), pyridazine (1,2-diazine) (C<sub class="style-scope patent-text">6</sub>), pyrimidine (1,3-diazine) (C<sub class="style-scope patent-text">6</sub>) (e.g., cytosine, thymine, uracil), pyrazine (1,4-diazine) (C<sub class="style-scope patent-text">6</sub>);</div>
    <div id="h-0015" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>: triazole (C<sub class="style-scope patent-text">5</sub>), triazine (C<sub class="style-scope patent-text">6</sub>); and,</div>
    <div id="h-0016" num="0000" class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">4</sub>: tetrazole (C<sub class="style-scope patent-text">5</sub>).</div>
    <div id="p-0074" num="0075" class="description-paragraph style-scope patent-text">Examples of heteroaryl which comprise fused rings, include, but are not limited to:
</div> <ul class="style-scope patent-text"> <li id="ul0003-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0004-0001" num="0076" class="style-scope patent-text">C<sub class="style-scope patent-text">9 </sub>(with 2 fused rings) derived from benzofuran (O<sub class="style-scope patent-text">1</sub>), isobenzofuran (O<sub class="style-scope patent-text">1</sub>), indole (N<sub class="style-scope patent-text">1</sub>), isoindole (N<sub class="style-scope patent-text">1</sub>), indolizine (N<sub class="style-scope patent-text">1</sub>), indoline (N<sub class="style-scope patent-text">1</sub>), isoindoline (N<sub class="style-scope patent-text">1</sub>), purine (N<sub class="style-scope patent-text">4</sub>) (e.g., adenine, guanine), benzimidazole (N<sub class="style-scope patent-text">2</sub>), indazole (N<sub class="style-scope patent-text">2</sub>), benzoxazole (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), benzisoxazole (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), benzodioxole (C<sub class="style-scope patent-text">2</sub>), benzofurazan (N<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">1</sub>), benzotriazole (N<sub class="style-scope patent-text">3</sub>), benzothiofuran (S<sub class="style-scope patent-text">1</sub>), benzothiazole (N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>), benzothiadiazole (N<sub class="style-scope patent-text">2</sub>S);</li> <li id="ul0004-0002" num="0077" class="style-scope patent-text">C<sub class="style-scope patent-text">10 </sub>(with 2 fused rings) derived from chromene (O<sub class="style-scope patent-text">1</sub>), isochromene (O<sub class="style-scope patent-text">1</sub>), chroman (O<sub class="style-scope patent-text">1</sub>), isochroman (O<sub class="style-scope patent-text">1</sub>), benzodioxan (C<sub class="style-scope patent-text">2</sub>), quinoline (N<sub class="style-scope patent-text">1</sub>), isoquinoline (N<sub class="style-scope patent-text">1</sub>), quinolizine (N<sub class="style-scope patent-text">1</sub>), benzoxazine (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), benzodiazine (N<sub class="style-scope patent-text">2</sub>), pyridopyridine (N<sub class="style-scope patent-text">2</sub>), quinoxaline (N<sub class="style-scope patent-text">2</sub>), quinazoline (N<sub class="style-scope patent-text">2</sub>), cinnoline (N<sub class="style-scope patent-text">2</sub>), phthalazine (N<sub class="style-scope patent-text">2</sub>), naphthyridine (N<sub class="style-scope patent-text">2</sub>), pteridine (N<sub class="style-scope patent-text">4</sub>);</li> <li id="ul0004-0003" num="0078" class="style-scope patent-text">C<sub class="style-scope patent-text">11 </sub>(with 2 fused rings) derived from benzodiazepine (N<sub class="style-scope patent-text">2</sub>);</li> <li id="ul0004-0004" num="0079" class="style-scope patent-text">C<sub class="style-scope patent-text">13 </sub>(with 3 fused rings) derived from carbazole (N<sub class="style-scope patent-text">1</sub>), dibenzofuran (O<sub class="style-scope patent-text">1</sub>), dibenzothiophene (S<sub class="style-scope patent-text">1</sub>), carboline (N<sub class="style-scope patent-text">2</sub>), perimidine (N<sub class="style-scope patent-text">2</sub>), pyridoindole (N<sub class="style-scope patent-text">2</sub>); and,</li> <li id="ul0004-0005" num="0080" class="style-scope patent-text">C<sub class="style-scope patent-text">14 </sub>(with 3 fused rings) derived from acridine (N<sub class="style-scope patent-text">1</sub>), xanthene (O<sub class="style-scope patent-text">1</sub>), thioxanthene (S<sub class="style-scope patent-text">1</sub>), oxanthrene (C<sub class="style-scope patent-text">2</sub>), phenoxathiin (O<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>), phenazine (N<sub class="style-scope patent-text">2</sub>), phenoxazine (N<sub class="style-scope patent-text">1</sub>O<sub class="style-scope patent-text">1</sub>), phenothiazine (N<sub class="style-scope patent-text">1</sub>S<sub class="style-scope patent-text">1</sub>), thianthrene (S<sub class="style-scope patent-text">2</sub>), phenanthridine (N<sub class="style-scope patent-text">1</sub>), phenanthroline (N<sub class="style-scope patent-text">2</sub>), phenazine (N<sub class="style-scope patent-text">2</sub>).</li> </ul> </li> </ul>

    <div id="p-0075" num="0081" class="description-paragraph style-scope patent-text">The above groups, whether alone or part of another substituent, may themselves optionally be substituted with one or more groups selected from themselves and the additional substituents listed below.</div>
    <div id="p-0076" num="0082" class="description-paragraph style-scope patent-text">Halo: —F, —Cl, —Br, and —I.</div>
    <div id="p-0077" num="0083" class="description-paragraph style-scope patent-text">Hydroxy: —OH.</div>
    <div id="p-0078" num="0084" class="description-paragraph style-scope patent-text">Ether: —OR, wherein R is an ether substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group (also referred to as a C<sub class="style-scope patent-text">1-7 </sub>alkoxy group, discussed below), a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group (also referred to as a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyloxy group), or a C<sub class="style-scope patent-text">5-20 </sub>aryl group (also referred to as a C<sub class="style-scope patent-text">5-20 </sub>aryloxy group), preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group.</div>
    <div id="p-0079" num="0085" class="description-paragraph style-scope patent-text">Alkoxy: —OR, wherein R is an alkyl group, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of C<sub class="style-scope patent-text">1-7 </sub>alkoxy groups include, but are not limited to, —OMe (methoxy), —OEt (ethoxy), —O(nPr) (n-propoxy), —O(iPr) (isopropoxy), —O(nBu) (n-butoxy), —O(sBu) (sec-butoxy), —O(iBu) (isobutoxy), and —O(tBu) (tert-butoxy).</div>
    <div id="p-0080" num="0086" class="description-paragraph style-scope patent-text">Acetal: —CH(OR<sup class="style-scope patent-text">1</sup>)(OR<sup class="style-scope patent-text">2</sup>), wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently acetal substituents, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or, in the case of a “cyclic” acetal group, R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2</sup>, taken together with the two oxygen atoms to which they are attached, and the carbon atoms to which they are attached, form a heterocyclic ring having from 4 to 8 ring atoms. Examples of acetal groups include, but are not limited to, —CH(OMe)<sub class="style-scope patent-text">2</sub>, —CH(OEt)<sub class="style-scope patent-text">2</sub>, and —CH(OMe)(OEt).</div>
    <div id="p-0081" num="0087" class="description-paragraph style-scope patent-text">Hemiacetal: —CH(OH)(OR<sup class="style-scope patent-text">1</sup>), wherein R<sup class="style-scope patent-text">1 </sup>is a hemiacetal substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of hemiacetal groups include, but are not limited to, —CH(OH)(OMe) and —CH(OH)(OEt).</div>
    <div id="p-0082" num="0088" class="description-paragraph style-scope patent-text">Ketal: —CR(OR<sup class="style-scope patent-text">1</sup>)(OR<sup class="style-scope patent-text">2</sup>), where R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are as defined for acetals, and R is a ketal substituent other than hydrogen, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples ketal groups include, but are not limited to, —C(Me)(OMe)<sub class="style-scope patent-text">2</sub>, —C(Me)(OEt)<sub class="style-scope patent-text">2</sub>, —C(Me)(OMe)(OEt), —C(Et)(OMe)<sub class="style-scope patent-text">2</sub>, —C(Et)(OEt)<sub class="style-scope patent-text">2</sub>, and —C(Et)(OMe)(OEt).</div>
    <div id="p-0083" num="0089" class="description-paragraph style-scope patent-text">Hemiketal: —CR(OH)(OR<sup class="style-scope patent-text">1</sup>), where R<sup class="style-scope patent-text">1 </sup>is as defined for hemiacetals, and R is a hemiketal substituent other than hydrogen, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of hemiacetal groups include, but are not limited to, —C(Me)(OH)(OMe), —C(Et)(OH)(OMe), —C(Me)(OH)(OEt), and —C(Et)(OH)(OEt).</div>
    <div id="p-0084" num="0090" class="description-paragraph style-scope patent-text">Oxo (keto, -one): ═O.</div>
    <div id="p-0085" num="0091" class="description-paragraph style-scope patent-text">Thione (thioketone): ═S.</div>
    <div id="p-0086" num="0092" class="description-paragraph style-scope patent-text">Imino (imine): ═NR, wherein R is an imino substituent, for example, hydrogen, C<sub class="style-scope patent-text">1-7</sub>,alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably hydrogen or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of ester groups include, but are not limited to, ═NH, ═NMe, ═NEt, and ═NPh.</div>
    <div id="p-0087" num="0093" class="description-paragraph style-scope patent-text">Formyl (carbaldehyde, carboxaldehyde): —C(═O)H.</div>
    <div id="p-0088" num="0094" class="description-paragraph style-scope patent-text">Acyl (keto): —C(═O)R, wherein R is an acyl substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group (also referred to as C<sub class="style-scope patent-text">1-7 </sub>alkylacyl or C<sub class="style-scope patent-text">1-7 </sub>alkanoyl), a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group (also referred to as C<sub class="style-scope patent-text">3-20 </sub>heterocyclylacyl), or a C<sub class="style-scope patent-text">5-20 </sub>aryl group (also referred to as C<sub class="style-scope patent-text">5-20 </sub>arylacyl), preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of acyl groups include, but are not limited to, —C(═O)CH<sub class="style-scope patent-text">3 </sub>(acetyl), —C(═O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(propionyl), —C(═O)O(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3 </sub>(t-butyryl), and —C(═O)Ph (benzoyl, phenone).</div>
    <div id="p-0089" num="0095" class="description-paragraph style-scope patent-text">Carboxy (carboxylic acid): —C(═O)OH.</div>
    <div id="p-0090" num="0096" class="description-paragraph style-scope patent-text">Thiocarboxy (thiocarboxylic acid): —C(═S)SH.</div>
    <div id="p-0091" num="0097" class="description-paragraph style-scope patent-text">Thiolocarboxy (thiolocarboxylic acid): —C(═O)SH.</div>
    <div id="p-0092" num="0098" class="description-paragraph style-scope patent-text">Thionocarboxy (thionocarboxylic acid): —C(═S)OH.</div>
    <div id="p-0093" num="0099" class="description-paragraph style-scope patent-text">Imidic acid: —C(═NH)OH.</div>
    <div id="p-0094" num="0100" class="description-paragraph style-scope patent-text">Hydroxamic acid: —C(═NOH)OH.</div>
    <div id="p-0095" num="0101" class="description-paragraph style-scope patent-text">Ester (carboxylate, carboxylic acid ester, oxycarbonyl): —C(═O)OR, wherein R is an ester substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of ester groups include, but are not limited to, —C(═O)OCH<sub class="style-scope patent-text">3</sub>, —C(═O)OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, —C(═O)OC(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>, and —C(═O)OPh.</div>
    <div id="p-0096" num="0102" class="description-paragraph style-scope patent-text">Acyloxy (reverse ester): —OC(═O)R, wherein R is an acyloxy substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of acyloxy groups include, but are not limited to, —OC(═O)CH<sub class="style-scope patent-text">3 </sub>(acetoxy), —OC(═O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, —OC(═O)C(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>, —OC(═O)Ph, and —OC(═O)CH<sub class="style-scope patent-text">2</sub>Ph.</div>
    <div id="p-0097" num="0103" class="description-paragraph style-scope patent-text">Oxycarboyloxy: —OC(═O)OR, wherein R is an ester substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of ester groups include, but are not limited to, —OC(═O)OCH<sub class="style-scope patent-text">3</sub>, —OC(═O)OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, —OC(═O)OC(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>, and —OC(═O)OPh.</div>
    <div id="p-0098" num="0104" class="description-paragraph style-scope patent-text">Amino: —NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently amino substituents, for example, hydrogen, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group (also referred to as C<sub class="style-scope patent-text">1-7 </sub>alkylamino or di-C<sub class="style-scope patent-text">1-7 </sub>alkylamino), a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably H or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or, in the case of a “cyclic” amino group, R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2</sup>, taken together with the nitrogen atom to which they are attached, form a heterocyclic ring having from 4 to 8 ring atoms. Amino groups may be primary (—NH<sub class="style-scope patent-text">2</sub>), secondary (—NHR<sup class="style-scope patent-text">1</sup>), or tertiary (—NHR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>), and in cationic form, may be quaternary (—<sup class="style-scope patent-text">+</sup>NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>R<sup class="style-scope patent-text">3</sup>). Examples of amino groups include, but are not limited to, —NH<sub class="style-scope patent-text">2</sub>, —NHCH<sub class="style-scope patent-text">3</sub>, —NHC(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and —NHPh. Examples of cyclic amino groups include, but are not limited to, aziridino, azetidino, pyrrolidino, piperidino, piperazino, morpholino, and thiomorpholino.</div>
    <div id="p-0099" num="0105" class="description-paragraph style-scope patent-text">Amido (carbamoyl, carbamyl, aminocarbonyl, carboxamide): —C(═O)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently amino substituents, as defined for amino groups. Examples of amido groups include, but are not limited to, —C(═O)NH<sub class="style-scope patent-text">2</sub>, —C(═O)NHCH<sub class="style-scope patent-text">3</sub>, —C(═O)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —C(═O)NHCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, and —C(═O)N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, as well as amido groups in which R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2</sup>, together with the nitrogen atom to which they are attached, form a heterocyclic structure as in, for example, piperidinocarbonyl, morpholinocarbonyl, thiomorpholinocarbonyl, and piperazinocarbonyl.</div>
    <div id="p-0100" num="0106" class="description-paragraph style-scope patent-text">Thioamido (thiocarbamyl): —C(═S)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently amino substituents, as defined for amino groups. Examples of amido groups include, but are not limited to, —C(═S)NH<sub class="style-scope patent-text">2</sub>, —C(═S)NHCH<sub class="style-scope patent-text">3</sub>, —C(═S)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and —C(═S)NHCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0101" num="0107" class="description-paragraph style-scope patent-text">Acylamido (acylamino): —NR<sup class="style-scope patent-text">1</sup>C(═O)R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>is an amide substituent, for example, hydrogen, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably hydrogen or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, and R<sup class="style-scope patent-text">2 </sup>is an acyl substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably hydrogen or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of acylamide groups include, but are not limited to, —NHC(═O)CH<sub class="style-scope patent-text">3</sub>, —NHC(═O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, and —NHC(═O)Ph. R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>may together form a cyclic structure, as in, for example, succinimidyl, maleimidyl, and phthalimidyl:</div>
    <div id="p-0102" num="0108" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00025" num="00025" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1c/73/26/1e8092ec2c2c6f/US10799595-20201013-C00025.png" class="style-scope patent-text"><img id="EMI-C00025" he="61.47mm" wi="45.89mm" file="US10799595-20201013-C00025.TIF" alt="Figure US10799595-20201013-C00025" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="184" height="246" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1c/73/26/1e8092ec2c2c6f/US10799595-20201013-C00025.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00025" attachment-type="cdx" file="US10799595-20201013-C00025.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00025" attachment-type="mol" file="US10799595-20201013-C00025.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0103" num="0109" class="description-paragraph style-scope patent-text">Aminocarbonyloxy: —OC(═O)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently amino substituents, as defined for amino groups. Examples of aminocarbonyloxy groups include, but are not limited to, —OC(═O)NH<sub class="style-scope patent-text">2</sub>, —OC(═O)NHMe, —OC(═O)NMe<sub class="style-scope patent-text">2</sub>, and —OC(═O)NEt<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0104" num="0110" class="description-paragraph style-scope patent-text">Ureido: —N(R<sup class="style-scope patent-text">1</sup>)CONR<sup class="style-scope patent-text">2</sup>R<sup class="style-scope patent-text">3 </sup>wherein R<sup class="style-scope patent-text">2 </sup>and R<sup class="style-scope patent-text">3 </sup>are independently amino substituents, as defined for amino groups, and R<sup class="style-scope patent-text">1 </sup>is a ureido substituent, for example, hydrogen, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably hydrogen or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of ureido groups include, but are not limited to, —NHCONH<sub class="style-scope patent-text">2</sub>, —NHCONHMe, —NHCONHEt, —NHCONMe<sub class="style-scope patent-text">2</sub>, —NHCONEt<sub class="style-scope patent-text">2</sub>, —NMeCONH<sub class="style-scope patent-text">2</sub>, —NMeCONHMe, —NMeCONHEt, —NMeCONMe<sub class="style-scope patent-text">2</sub>, and —NMeCONEt<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0105" num="0111" class="description-paragraph style-scope patent-text">Guanidino: —NH—C(═NH)NH<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0106" num="0112" class="description-paragraph style-scope patent-text">Tetrazolyl: a five membered aromatic ring having four nitrogen atoms and one carbon atom,</div>
    <div id="p-0107" num="0113" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00026" num="00026" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bd/2c/c7/3b9cd2fd8beddb/US10799595-20201013-C00026.png" class="style-scope patent-text"><img id="EMI-C00026" he="12.78mm" wi="15.32mm" file="US10799595-20201013-C00026.TIF" alt="Figure US10799595-20201013-C00026" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="61" height="51" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bd/2c/c7/3b9cd2fd8beddb/US10799595-20201013-C00026.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00026" attachment-type="cdx" file="US10799595-20201013-C00026.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00026" attachment-type="mol" file="US10799595-20201013-C00026.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0108" num="0114" class="description-paragraph style-scope patent-text">Imino: ═NR, wherein R is an imino substituent, for example, for example, hydrogen, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably H or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of imino groups include, but are not limited to, ═NH, ═NMe, and =NEt.</div>
    <div id="p-0109" num="0115" class="description-paragraph style-scope patent-text">Amidine (amidino): —C(═NR)NR<sub class="style-scope patent-text">2</sub>, wherein each R is an amidine substituent, for example, hydrogen, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably H or a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of amidine groups include, but are not limited to, —C(═NH)NH<sub class="style-scope patent-text">2</sub>, —C(═NH)NMe<sub class="style-scope patent-text">2</sub>, and —C(═NMe)NMe<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0110" num="0116" class="description-paragraph style-scope patent-text">Nitro: —NO<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0111" num="0117" class="description-paragraph style-scope patent-text">Nitroso: —NO.</div>
    <div id="p-0112" num="0118" class="description-paragraph style-scope patent-text">Azido: —N<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0113" num="0119" class="description-paragraph style-scope patent-text">Cyano (nitrile, carbonitrile): —CN.</div>
    <div id="p-0114" num="0120" class="description-paragraph style-scope patent-text">Isocyano: —NC.</div>
    <div id="p-0115" num="0121" class="description-paragraph style-scope patent-text">Cyanato: —OCN.</div>
    <div id="p-0116" num="0122" class="description-paragraph style-scope patent-text">Isocyanato: —NCO.</div>
    <div id="p-0117" num="0123" class="description-paragraph style-scope patent-text">Thiocyano (thiocyanato): —SCN.</div>
    <div id="p-0118" num="0124" class="description-paragraph style-scope patent-text">Isothiocyano (isothiocyanato): —NCS.</div>
    <div id="p-0119" num="0125" class="description-paragraph style-scope patent-text">Sulfhydryl (thiol, mercapto): —SH.</div>
    <div id="p-0120" num="0126" class="description-paragraph style-scope patent-text">Thioether (sulfide): —SR, wherein R is a thioether substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group (also referred to as a C<sub class="style-scope patent-text">1-7 </sub>alkylthio group), a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of C<sub class="style-scope patent-text">1-7 </sub>alkylthio groups include, but are not limited to, —SCH<sub class="style-scope patent-text">3 </sub>and —SCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0121" num="0127" class="description-paragraph style-scope patent-text">Disulfide: —SS—R, wherein R is a disulfide substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group (also referred to herein as C<sub class="style-scope patent-text">1-7 </sub>alkyl disulfide). Examples of C<sub class="style-scope patent-text">1-7 </sub>alkyl disulfide groups include, but are not limited to, —SSCH<sub class="style-scope patent-text">3 </sub>and —SSCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0122" num="0128" class="description-paragraph style-scope patent-text">Sulfine (sulfinyl, sulfoxide): —S(═O)R, wherein R is a sulfine substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfine groups include, but are not limited to, —S(═O)CH<sub class="style-scope patent-text">3 </sub>and —S(═O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0123" num="0129" class="description-paragraph style-scope patent-text">Sulfone (sulfonyl): —S(═O)<sub class="style-scope patent-text">2</sub>R, wherein R is a sulfone substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, including, for example, a fluorinated or perfluorinated C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfone groups include, but are not limited to, —S(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(methanesulfonyl, mesyl), —S(═O)<sub class="style-scope patent-text">2</sub>CF<sub class="style-scope patent-text">3 </sub>(triflyl), —S(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(esyl), —S(═O)<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">4</sub>F<sub class="style-scope patent-text">9 </sub>(nonaflyl), —S(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CF<sub class="style-scope patent-text">3 </sub>(tresyl), —S(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2 </sub>(tauryl), —S(═O)<sub class="style-scope patent-text">2</sub>Ph (phenylsulfonyl, besyl), 4-methylphenylsulfonyl (tosyl), 4-chlorophenylsulfonyl (closyl), 4-bromophenylsulfonyl (brosyl), 4-nitrophenyl (nosyl), 2-naphthalenesulfonate (napsyl), and 5-dimethylamino-naphthalen-1-ylsulfonate (dansyl).</div>
    <div id="p-0124" num="0130" class="description-paragraph style-scope patent-text">Sulfinic acid (sulfino): —S(═O)OH, —SO<sub class="style-scope patent-text">2</sub>H.</div>
    <div id="p-0125" num="0131" class="description-paragraph style-scope patent-text">Sulfonic acid (sulfo): —S(═O)<sub class="style-scope patent-text">2</sub>OH, —SO<sub class="style-scope patent-text">3</sub>H.</div>
    <div id="p-0126" num="0132" class="description-paragraph style-scope patent-text">Sulfinate (sulfinic acid ester): —S(═O)OR; wherein R is a sulfinate substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfinate groups include, but are not limited to, —S(═O)OCH<sub class="style-scope patent-text">3 </sub>(methoxysulfinyl; methyl sulfinate) and —S(═O)OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(ethoxysulfinyl; ethyl sulfinate).</div>
    <div id="p-0127" num="0133" class="description-paragraph style-scope patent-text">Sulfonate (sulfonic acid ester): —S(═O)<sub class="style-scope patent-text">2</sub>OR, wherein R is a sulfonate substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfonate groups include, but are not limited to, —S(═O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">3 </sub>(methoxysulfonyl; methyl sulfonate) and —S(═O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(ethoxysulfonyl; ethyl sulfonate).</div>
    <div id="p-0128" num="0134" class="description-paragraph style-scope patent-text">Sulfinyloxy: —OS(═O)R, wherein R is a sulfinyloxy substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group.</div>
    <div id="p-0129" num="0135" class="description-paragraph style-scope patent-text">Examples of sulfinyloxy groups include, but are not limited to, —OS(═O)CH<sub class="style-scope patent-text">3 </sub>and —OS(═O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0130" num="0136" class="description-paragraph style-scope patent-text">Sulfonyloxy: —OS(═O)<sub class="style-scope patent-text">2</sub>R, wherein R is a sulfonyloxy substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfonyloxy groups include, but are not limited to, —OS(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(mesylate) and —OS(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>(esylate).</div>
    <div id="p-0131" num="0137" class="description-paragraph style-scope patent-text">Sulfate: —OS(═O)<sub class="style-scope patent-text">2</sub>OR; wherein R is a sulfate substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfate groups include, but are not limited to, —OS(═O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">3 </sub>and —SO(═O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div id="p-0132" num="0138" class="description-paragraph style-scope patent-text">Sulfamyl (sulfamoyl; sulfinic acid amide; sulfinamide): —S(═O)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently amino substituents, as defined for amino groups. Examples of sulfamyl groups include, but are not limited to, —S(═O)NH<sub class="style-scope patent-text">2</sub>, —S(═O)NH(CH<sub class="style-scope patent-text">3</sub>), —S(═O)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —S(═O)NH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>), —S(═O)N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and —S(═O)NHPh.</div>
    <div id="p-0133" num="0139" class="description-paragraph style-scope patent-text">Sulfonamido (sulfinamoyl; sulfonic acid amide; sulfonamide): —S(═O)<sub class="style-scope patent-text">2</sub>NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are independently amino substituents, as defined for amino groups. Examples of sulfonamido groups include, but are not limited to, —S(═O)<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2</sub>, —S(═O)<sub class="style-scope patent-text">2</sub>NH(CH<sub class="style-scope patent-text">3</sub>), —S(═O)<sub class="style-scope patent-text">2</sub>N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —S(═O)<sub class="style-scope patent-text">2</sub>NH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>), —S(═O)<sub class="style-scope patent-text">2</sub>N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and —S(═O)<sub class="style-scope patent-text">2</sub>NHPh.</div>
    <div id="p-0134" num="0140" class="description-paragraph style-scope patent-text">Sulfamino: —NR<sup class="style-scope patent-text">1</sup>S(═O)<sub class="style-scope patent-text">2</sub>OH, wherein R<sup class="style-scope patent-text">1 </sup>is an amino substituent, as defined for amino groups. Examples of sulfamino groups include, but are not limited to, —NHS(═O)<sub class="style-scope patent-text">2</sub>OH and —N(CH<sub class="style-scope patent-text">3</sub>)S(═O)<sub class="style-scope patent-text">2</sub>OH.</div>
    <div id="p-0135" num="0141" class="description-paragraph style-scope patent-text">Sulfonamino: —NR<sup class="style-scope patent-text">1</sup>S(═O)<sub class="style-scope patent-text">2</sub>R, wherein R<sup class="style-scope patent-text">1 </sup>is an amino substituent, as defined for amino groups, and R is a sulfonamino substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfonamino groups include, but are not limited to, —NHS(═O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3 </sub>and —N(CH<sub class="style-scope patent-text">3</sub>)S(═O)<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">6</sub>H<sub class="style-scope patent-text">5</sub>.</div>
    <div id="p-0136" num="0142" class="description-paragraph style-scope patent-text">Sulfinamino: —NR<sup class="style-scope patent-text">1</sup>S(═O)R, wherein R<sup class="style-scope patent-text">1 </sup>is an amino substituent, as defined for amino groups, and R is a sulfinamino substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group. Examples of sulfinamino groups include, but are not limited to, —NHS(═O)CH<sub class="style-scope patent-text">3 </sub>and —N(CH<sub class="style-scope patent-text">3</sub>)S(═O)C<sub class="style-scope patent-text">6</sub>H<sub class="style-scope patent-text">5</sub>.</div>
    <div id="p-0137" num="0143" class="description-paragraph style-scope patent-text">Phosphino (phosphine): —PR<sub class="style-scope patent-text">2</sub>, wherein R is a phosphino substituent, for example, —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphino groups include, but are not limited to, —PH<sub class="style-scope patent-text">2</sub>, —P(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —P(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —P(t-Bu)<sub class="style-scope patent-text">2</sub>, and —P(Ph)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0138" num="0144" class="description-paragraph style-scope patent-text">Phospho: —P(═O)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0139" num="0145" class="description-paragraph style-scope patent-text">Phosphinyl (phosphine oxide): —P(═O)R<sup class="style-scope patent-text">2</sup>, wherein R is a phosphinyl substituent, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably a C<sub class="style-scope patent-text">1-7 </sub>alkyl group or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphinyl groups include, but are not limited to, —P(═O)(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —P(═O)(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —P(═O)(t-Bu)<sub class="style-scope patent-text">2</sub>, and —P(═O)(Ph)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0140" num="0146" class="description-paragraph style-scope patent-text">Phosphonic acid (phosphono): —P(═O)(OH)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0141" num="0147" class="description-paragraph style-scope patent-text">Phosphonate (phosphono ester): —P(═O)(OR)<sub class="style-scope patent-text">2</sub>, where R is a phosphonate substituent, for example, —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphonate groups include, but are not limited to, —P(═O)(OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —P(═O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —P(═O)(O-t-Bu)<sub class="style-scope patent-text">2</sub>, and —P(═O)(OPh)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0142" num="0148" class="description-paragraph style-scope patent-text">Phosphoric acid (phosphonooxy): —OP(═O)(OH)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0143" num="0149" class="description-paragraph style-scope patent-text">Phosphate (phosphonooxy ester): —OP(═O)(OR)<sub class="style-scope patent-text">2</sub>, where R is a phosphate substituent, for example, —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphate groups include, but are not limited to, —OP(═O)(OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —OP(═O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —OP(═O)(O-t-Bu)<sub class="style-scope patent-text">2</sub>, and —OP(═O)(OPh)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0144" num="0150" class="description-paragraph style-scope patent-text">Phosphorous acid: —OP(OH)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0145" num="0151" class="description-paragraph style-scope patent-text">Phosphite: —OP(OR)<sub class="style-scope patent-text">2</sub>, where R is a phosphite substituent, for example, —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphite groups include, but are not limited to, —OP(OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —OP(O-t-Bu)<sub class="style-scope patent-text">2</sub>, and —OP(OPh)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0146" num="0152" class="description-paragraph style-scope patent-text">Phosphoramidite: —OP(OR<sup class="style-scope patent-text">1</sup>)—NR<sup class="style-scope patent-text">2</sup> <sub class="style-scope patent-text">2</sub>, where R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are phosphoramidite substituents, for example, —H, a (optionally substituted) C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphoramidite groups include, but are not limited to, —OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)—N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)—N(i-Pr)<sub class="style-scope patent-text">2</sub>, and —OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CN)—N(i-Pr)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="p-0147" num="0153" class="description-paragraph style-scope patent-text">Phosphoramidate: —OP(═O)(OR<sup class="style-scope patent-text">1</sup>)—NR<sup class="style-scope patent-text">2</sup> <sub class="style-scope patent-text">2</sub>, where R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2 </sup>are phosphoramidate substituents, for example, —H, a (optionally substituted) C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group, preferably —H, a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, or a C<sub class="style-scope patent-text">5-20 </sub>aryl group. Examples of phosphoramidate groups include, but are not limited to, —OP(═O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)—N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, —OP(═O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)—N(i-Pr)<sub class="style-scope patent-text">2</sub>, and —OP(═O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CN)—N(i-Pr)<sub class="style-scope patent-text">2</sub>.</div>
    <div id="h-0017" num="0000" class="description-paragraph style-scope patent-text">Alkylene</div>
    <div id="p-0148" num="0154" class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3-12 </sub>alkylene: The term “C<sub class="style-scope patent-text">3-12 </sub>alkylene”, as used herein, pertains to a bidentate moiety obtained by removing two hydrogen atoms, either both from the same carbon atom, or one from each of two different carbon atoms, of a hydrocarbon compound having from 3 to 12 carbon atoms (unless otherwise specified), which may be aliphatic or alicyclic, and which may be saturated, partially unsaturated, or fully unsaturated. Thus, the term “alkylene” includes the sub-classes alkenylene, alkynylene, cycloalkylene, etc., discussed below.</div>
    <div id="p-0149" num="0155" class="description-paragraph style-scope patent-text">Examples of linear saturated C<sub class="style-scope patent-text">3-12 </sub>alkylene groups include, but are not limited to, —(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>— where n is an integer from 3 to 12, for example, —CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>— (propylene), —CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>— (butylene), —CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>— (pentylene) and —CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH—<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>— (heptylene).</div>
    <div id="p-0150" num="0156" class="description-paragraph style-scope patent-text">Examples of branched saturated C<sub class="style-scope patent-text">3-12 </sub>alkylene groups include, but are not limited to, —CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>—, —CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>—, —CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>—, —CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>—, —CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>—, —CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)—, —CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>—, and —CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>—.</div>
    <div id="p-0151" num="0157" class="description-paragraph style-scope patent-text">Examples of linear partially unsaturated C<sub class="style-scope patent-text">3-12 </sub>alkylene groups (C<sub class="style-scope patent-text">3-12 </sub>alkenylene, and alkynylene groups) include, but are not limited to, —CH═CH—CH<sub class="style-scope patent-text">2</sub>—, —CH<sub class="style-scope patent-text">2</sub>—CH═CH<sub class="style-scope patent-text">2</sub>—, —CH═CH—CH<sub class="style-scope patent-text">2</sub>—CH<sub class="style-scope patent-text">2</sub>—, —CH═CH—CH<sub class="style-scope patent-text">2</sub>—CH<sub class="style-scope patent-text">2</sub>—CH<sub class="style-scope patent-text">2</sub>—, —CH═CH—CH═CH—, —CH═CH—CH═CH—CH<sub class="style-scope patent-text">2</sub>—, —CH═CH—CH═CH—CH<sub class="style-scope patent-text">2</sub>—CH<sub class="style-scope patent-text">2</sub>—, —CH═CH—CH<sub class="style-scope patent-text">2</sub>—CH═CH—, —CH═CH—CH<sub class="style-scope patent-text">2</sub>—CH<sub class="style-scope patent-text">2</sub>—CH═CH—, and —CH<sub class="style-scope patent-text">2</sub>—C≡C—CH<sub class="style-scope patent-text">2</sub>—.</div>
    <div id="p-0152" num="0158" class="description-paragraph style-scope patent-text">Examples of branched partially unsaturated C<sub class="style-scope patent-text">3-12 </sub>alkylene groups (C<sub class="style-scope patent-text">3-12 </sub>alkenylene and alkynylene groups) include, but are not limited to, —C(CH<sub class="style-scope patent-text">3</sub>)═CH—, —C(CH<sub class="style-scope patent-text">3</sub>)═CH—CH<sub class="style-scope patent-text">2</sub>—, —CH═CH—CH(CH<sub class="style-scope patent-text">3</sub>)— and —C≡C—CH(CH<sub class="style-scope patent-text">3</sub>)—.</div>
    <div id="p-0153" num="0159" class="description-paragraph style-scope patent-text">Examples of alicyclic saturated C<sub class="style-scope patent-text">3-12 </sub>alkylene groups (C<sub class="style-scope patent-text">3-12 </sub>cycloalkylenes) include, but are not limited to, cyclopentylene (e.g. cyclopent-1,3-ylene), and cyclohexylene (e.g. cyclohex-1,4-ylene).</div>
    <div id="p-0154" num="0160" class="description-paragraph style-scope patent-text">Examples of alicyclic partially unsaturated C<sub class="style-scope patent-text">3-12 </sub>alkylene groups (C<sub class="style-scope patent-text">3-12 </sub>cycloalkylenes) include, but are not limited to, cyclopentenylene (e.g. 4-cyclopenten-1,3-ylene), cyclohexenylene (e.g. 2-cyclohexen-1,4-ylene; 3-cyclohexen-1,2-ylene; 2,5-cyclohexadien-1,4-ylene).</div>
    <div id="h-0018" num="0000" class="description-paragraph style-scope patent-text">Ligand Unit</div>
    <div id="p-0155" num="0161" class="description-paragraph style-scope patent-text">The Ligand Unit may be of any kind, and include a protein, polypeptide, peptide and a non-peptidic agent that specifically binds to a target molecule. In some embodiments, the Ligand unit may be a protein, polypeptide or peptide. In some embodiments, the Ligand unit may be a cyclic polypeptide. These Ligand units can include antibodies or a fragment of an antibody that contains at least one target molecule-binding site, lymphokines, hormones, growth factors, or any other cell binding molecule or substance that can specifically bind to a target.</div>
    <div id="p-0156" num="0162" class="description-paragraph style-scope patent-text">The terms “specifically binds” and “specific binding” refer to the binding of an antibody or other protein, polypeptide or peptide to a predetermined molecule (e.g., an antigen).</div>
    <div id="p-0157" num="0163" class="description-paragraph style-scope patent-text">Typically, the antibody or other molecule binds with an affinity of at least about 1×10<sup class="style-scope patent-text">7 </sup>M<sup class="style-scope patent-text">−1</sup>, and binds to the predetermined molecule with an affinity that is at least two-fold greater than its affinity for binding to a non-specific molecule (e.g., BSA, casein) other than the predetermined molecule or a closely-related molecule.</div>
    <div id="p-0158" num="0164" class="description-paragraph style-scope patent-text">Examples of Ligand units include those agents described for use in WO 2007/085930, which is incorporated herein.</div>
    <div id="p-0159" num="0165" class="description-paragraph style-scope patent-text">In some embodiments, the Ligand unit is a Cell Binding Agent that binds to an extracellular target on a cell. Such a Cell Binding Agent can be a protein, polypeptide, peptide or a non-peptidic agent. In some embodiments, the Cell Binding Agent may be a protein, polypeptide or peptide. In some embodiments, the Cell Binding Agent may be a cyclic polypeptide. The Cell Binding Agent also may be antibody or an antigen-binding fragment of an antibody. Thus, in one embodiment, the present invention provides an antibody-drug conjugate (ADC).</div>
    <div id="h-0019" num="0000" class="description-paragraph style-scope patent-text">Cell Binding Agent</div>
    <div id="p-0160" num="0166" class="description-paragraph style-scope patent-text">A cell binding agent may be of any kind, and include peptides and non-peptides. These can include antibodies or a fragment of an antibody that contains at least one binding site, lymphokines, hormones, hormone mimetics, vitamins, growth factors, nutrient-transport molecules, or any other cell binding molecule or substance.</div>
    <div id="h-0020" num="0000" class="description-paragraph style-scope patent-text">Peptides</div>
    <div id="p-0161" num="0167" class="description-paragraph style-scope patent-text">In one embodiment, the cell binding agent is a linear or cyclic peptide comprising 4-30, preferably 6-20, contiguous amino acid residues. In this embodiment, it is preferred that one cell binding agent is linked to one monomer or dimer pyrrolobenzodiazepine compound.</div>
    <div id="p-0162" num="0168" class="description-paragraph style-scope patent-text">In one embodiment the cell binding agent comprises a peptide that binds integrin α<sub class="style-scope patent-text">v</sub>β<sub class="style-scope patent-text">6</sub>. The peptide may be selective for α<sub class="style-scope patent-text">v</sub>β<sub class="style-scope patent-text">6 </sub>over XYS.</div>
    <div id="p-0163" num="0169" class="description-paragraph style-scope patent-text">In one embodiment the cell binding agent comprises the A20FMDV-Cys polypeptide. The A20FMDV-Cys has the sequence: NAVPNLRGDLQVLAQKVARTC. Alternatively, a variant of the A20FMDV-Cys sequence may be used wherein one, two, three, four, five, six, seven, eight, nine or ten amino acid residues are substituted with another amino acid residue. Furthermore, the polypeptide may have the sequence NAVXXXXXXXXXXXXXXXRTC.</div>
    <div id="h-0021" num="0000" class="description-paragraph style-scope patent-text">Antibodies</div>
    <div id="p-0164" num="0170" class="description-paragraph style-scope patent-text">The term “antibody” herein is used in the broadest sense and specifically covers monoclonal antibodies, polyclonal antibodies, dimers, multimers, multispecific antibodies (e.g., bispecific antibodies), and antibody fragments, so long as they exhibit the desired biological activity (Miller et al (2003) <i class="style-scope patent-text">Jour. of Immunology </i>170:4854-4861). Antibodies may be murine, human, humanized, chimeric, or derived from other species. An antibody is a protein generated by the immune system that is capable of recognizing and binding to a specific antigen. (Janeway, C., Travers, P., Walport, M., Shlomchik (2001) <i class="style-scope patent-text">Immuno Biology, </i>5th Ed., Garland Publishing, New York). A target antigen generally has numerous binding sites, also called epitopes, recognized by CDRs on multiple antibodies. Each antibody that specifically binds to a different epitope has a different structure. Thus, one antigen may have more than one corresponding antibody. An antibody includes a full-length immunoglobulin molecule or an immunologically active portion of a full-length immunoglobulin molecule, i.e., a molecule that contains an antigen binding site that immunospecifically binds an antigen of a target of interest or part thereof, such targets including but not limited to, cancer cell or cells that produce autoimmune antibodies associated with an autoimmune disease. The immunoglobulin can be of any type (e.g. IgG, IgE, IgM, IgD, and IgA), class (e.g. IgG1, IgG2, IgG3, IgG4, IgA1 and IgA2) or subclass of immunoglobulin molecule. The immunoglobulins can be derived from any species, including human, murine, or rabbit origin.</div>
    <div id="p-0165" num="0171" class="description-paragraph style-scope patent-text">“Antibody fragments” comprise a portion of a full length antibody, generally the antigen binding or variable region thereof. Examples of antibody fragments include Fab, Fab′, F(ab′)<sub class="style-scope patent-text">2</sub>, and scFv fragments; diabodies; linear antibodies; fragments produced by a Fab expression library, anti-idiotypic (anti-Id) antibodies, CDR (complementary determining region), and epitope-binding fragments of any of the above which immunospecifically bind to cancer cell antigens, viral antigens or microbial antigens, single-chain antibody molecules; and multispecific antibodies formed from antibody fragments.</div>
    <div id="p-0166" num="0172" class="description-paragraph style-scope patent-text">The term “monoclonal antibody” as used herein refers to an antibody obtained from a population of substantially homogeneous antibodies, i.e. the individual antibodies comprising the population are identical except for possible naturally occurring mutations that may be present in minor amounts. Monoclonal antibodies are highly specific, being directed against a single antigenic site. Furthermore, in contrast to polyclonal antibody preparations which include different antibodies directed against different determinants (epitopes), each monoclonal antibody is directed against a single determinant on the antigen. In addition to their specificity, the monoclonal antibodies are advantageous in that they may be synthesized uncontaminated by other antibodies. The modifier “monoclonal” indicates the character of the antibody as being obtained from a substantially homogeneous population of antibodies, and is not to be construed as requiring production of the antibody by any particular method. For example, the monoclonal antibodies to be used in accordance with the present invention may be made by the hybridoma method first described by Kohler et al (1975) <i class="style-scope patent-text">Nature </i>256:495, or may be made by recombinant DNA methods (see, U.S. Pat. No. 4,816,567). The monoclonal antibodies may also be isolated from phage antibody libraries using the techniques described in Clackson et al (1991) <i class="style-scope patent-text">Nature, </i>352:624-628; Marks et al (1991) <i class="style-scope patent-text">J. Mol. Biol., </i>222:581-597 or from transgenic mice carrying a fully human immunoglobulin system (Lonberg (2008) <i class="style-scope patent-text">Curr. Opinion </i>20(4):450-459).</div>
    <div id="p-0167" num="0173" class="description-paragraph style-scope patent-text">The monoclonal antibodies herein specifically include “chimeric” antibodies in which a portion of the heavy and/or light chain is identical with or homologous to corresponding sequences in antibodies derived from a particular species or belonging to a particular antibody class or subclass, while the remainder of the chain(s) is identical with or homologous to corresponding sequences in antibodies derived from another species or belonging to another antibody class or subclass, as well as fragments of such antibodies, so long as they exhibit the desired biological activity (U.S. Pat. No. 4,816,567; and Morrison et al (1984) <i class="style-scope patent-text">Proc. Natl. Acad. Sci. USA, </i>81:6851-6855). Chimeric antibodies include “primatized” antibodies comprising variable domain antigen-binding sequences derived from a non-human primate (e.g. Old World Monkey or Ape) and human constant region sequences.</div>
    <div id="p-0168" num="0174" class="description-paragraph style-scope patent-text">An “intact antibody” herein is one comprising a VL and VH domains, as well as a light chain constant domain (CL) and heavy chain constant domains, CH1, CH2 and CH3. The constant domains may be native sequence constant domains (e.g. human native sequence constant domains) or amino acid sequence variant thereof. The intact antibody may have one or more “effector functions” which refer to those biological activities attributable to the Fc region (a native sequence Fc region or amino acid sequence variant Fc region) of an antibody. Examples of antibody effector functions include C1q binding; complement dependent cytotoxicity; Fc receptor binding; antibody-dependent cell-mediated cytotoxicity (ADCC); phagocytosis; and down regulation of cell surface receptors such as B cell receptor and BCR.</div>
    <div id="p-0169" num="0175" class="description-paragraph style-scope patent-text">Depending on the amino acid sequence of the constant domain of their heavy chains, intact antibodies can be assigned to different “classes.” There are five major classes of intact antibodies: IgA, IgD, IgE, IgG, and IgM, and several of these may be further divided into “subclasses” (isotypes), e.g., IgG1, IgG2, IgG3, IgG4, IgA, and IgA2. The heavy-chain constant domains that correspond to the different classes of antibodies are called α, δ, ε, γ, and μ, respectively. The subunit structures and three-dimensional configurations of different classes of immunoglobulins are well known.</div>
    <div id="h-0022" num="0000" class="description-paragraph style-scope patent-text">Humanisation</div>
    <div id="p-0170" num="0176" class="description-paragraph style-scope patent-text">Techniques to reduce the in vivo immunogenicity of a non-human antibody or antibody fragment include those termed “humanisation”.</div>
    <div id="p-0171" num="0177" class="description-paragraph style-scope patent-text">A “humanized antibody” refers to a polypeptide comprising at least a portion of a modified variable region of a human antibody wherein a portion of the variable region, preferably a portion substantially less than the intact human variable domain, has been substituted by the corresponding sequence from a non-human species and wherein the modified variable region is linked to at least another part of another protein, preferably the constant region of a human antibody. The expression “humanized antibodies” includes human antibodies in which one or more complementarity determining region (“CDR”) amino acid residues and/or one or more framework region (“FW” or “FR”) amino acid residues are substituted by amino acid residues from analogous sites in rodent or other non-human antibodies. The expression “humanized antibody” also includes an immunoglobulin amino acid sequence variant or fragment thereof that comprises an FR having substantially the amino acid sequence of a human immunoglobulin and a CDR having substantially the amino acid sequence of a non-human immunoglobulin.</div>
    <div id="p-0172" num="0178" class="description-paragraph style-scope patent-text">“Humanized” forms of non-human (e.g., murine) antibodies are chimeric antibodies that contain minimal sequence derived from non-human immunoglobulin. Or, looked at another way, a humanized antibody is a human antibody that also contains selected sequences from non-human (e.g. murine) antibodies in place of the human sequences. A humanized antibody can include conservative amino acid substitutions or non-natural residues from the same or different species that do not significantly alter its binding and/or biologic activity. Such antibodies are chimeric antibodies that contain minimal sequence derived from non-human immunoglobulins.</div>
    <div id="p-0173" num="0179" class="description-paragraph style-scope patent-text">There are a range of humanisation techniques, including ‘CDR grafting’, ‘guided selection’, ‘deimmunization’, ‘resurfacing’ (also known as ‘veneering’), ‘composite antibodies’, ‘Human String Content Optimisation’ and framework shuffling.</div>
    <div id="h-0023" num="0000" class="description-paragraph style-scope patent-text">CDR Grafting</div>
    <div id="p-0174" num="0180" class="description-paragraph style-scope patent-text">In this technique, the humanized antibodies are human immunoglobulins (recipient antibody) in which residues from a complementary-determining region (CDR) of the recipient antibody are replaced by residues from a CDR of a non-human species (donor antibody) such as mouse, rat, camel, bovine, goat, or rabbit having the desired properties (in effect, the non-human CDRs are ‘grafted’ onto the human framework). In some instances, framework region (FR) residues of the human immunoglobulin are replaced by corresponding non-human residues (this may happen when, for example, a particular FR residue has significant effect on antigen binding).</div>
    <div id="p-0175" num="0181" class="description-paragraph style-scope patent-text">Furthermore, humanized antibodies can comprise residues that are found neither in the recipient antibody nor in the imported CDR or framework sequences. These modifications are made to further refine and maximize antibody performance. Thus, in general, a humanized antibody will comprise all of at least one, and in one aspect two, variable domains, in which all or all of the hypervariable loops correspond to those of a non-human immunoglobulin and all or substantially all of the FR regions are those of a human immunoglobulin sequence. The humanized antibody optionally also will comprise at least a portion of an immunoglobulin constant region (Fc), or that of a human immunoglobulin.</div>
    <div id="h-0024" num="0000" class="description-paragraph style-scope patent-text">Guided Selection</div>
    <div id="p-0176" num="0182" class="description-paragraph style-scope patent-text">The method consists of combining the V<sub class="style-scope patent-text">H </sub>or V<sub class="style-scope patent-text">L </sub>domain of a given non-human antibody specific for a particular epitope with a human V<sub class="style-scope patent-text">H </sub>or V<sub class="style-scope patent-text">L </sub>library and specific human V domains are selected against the antigen of interest. This selected human VH is then combined with a VL library to generate a completely human VH×VL combination. The method is described in Nature Biotechnology (N.Y.) 12, (1994) 899-903.</div>
    <div id="h-0025" num="0000" class="description-paragraph style-scope patent-text">Composite Antibodies</div>
    <div id="p-0177" num="0183" class="description-paragraph style-scope patent-text">In this method, two or more segments of amino acid sequence from a human antibody are combined within the final antibody molecule. They are constructed by combining multiple human VH and VL sequence segments in combinations which limit or avoid human T cell epitopes in the final composite antibody V regions. Where required, T cell epitopes are limited or avoided by, exchanging V region segments contributing to or encoding a T cell epitope with alternative segments which avoid T cell epitopes. This method is described in US 2008/0206239 A1.</div>
    <div id="h-0026" num="0000" class="description-paragraph style-scope patent-text">Deimmunization</div>
    <div id="p-0178" num="0184" class="description-paragraph style-scope patent-text">This method involves the removal of human (or other second species) T-cell epitopes from the V regions of the therapeutic antibody (or other molecule). The therapeutic antibodies V-region sequence is analysed for the presence of MHC class II-binding motifs by, for example, comparison with databases of MHC-binding motifs (such as the “motifs” database hosted at www.wehi.edu.au). Alternatively, MHC class II-binding motifs may be identified using computational threading methods such as those devised by Altuvia et al. (J. Mol. Biol. 249 244-250 (1995)); in these methods, consecutive overlapping peptides from the V-region sequences are testing for their binding energies to MHC class II proteins. This data can then be combined with information on other sequence features which relate to successfully presented peptides, such as amphipathicity, Rothbard motifs, and cleavage sites for cathepsin B and other processing enzymes.</div>
    <div id="p-0179" num="0185" class="description-paragraph style-scope patent-text">Once potential second species (e.g. human) T-cell epitopes have been identified, they are eliminated by the alteration of one or more amino acids. The modified amino acids are usually within the T-cell epitope itself, but may also be adjacent to the epitope in terms of the primary or secondary structure of the protein (and therefore, may not be adjacent in the primary structure). Most typically, the alteration is by way of substitution but, in some circumstances amino acid addition or deletion will be more appropriate.</div>
    <div id="p-0180" num="0186" class="description-paragraph style-scope patent-text">All alterations can be accomplished by recombinant DNA technology, so that the final molecule may be prepared by expression from a recombinant host using well established methods such as Site Directed Mutagenesis. However, the use of protein chemistry or any other means of molecular alteration is also possible.</div>
    <div id="h-0027" num="0000" class="description-paragraph style-scope patent-text">Resurfacing</div>
    <div id="p-0181" num="0187" class="description-paragraph style-scope patent-text">This method involves:
</div> <ul class="style-scope patent-text"> <li id="ul0005-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0006-0001" num="0188" class="style-scope patent-text">(a) determining the conformational structure of the variable region of the non-human (e.g. rodent) antibody (or fragment thereof) by constructing a three-dimensional model of the non-human antibody variable region;</li> <li id="ul0006-0002" num="0189" class="style-scope patent-text">(b) generating sequence alignments using relative accessibility distributions from x-ray crystallographic structures of a sufficient number of non-human and human antibody variable region heavy and light chains to give a set of heavy and light chain framework positions wherein the alignment positions are identical in 98% of the sufficient number of non-human antibody heavy and light chains;</li> <li id="ul0006-0003" num="0190" class="style-scope patent-text">(c) defining for the non-human antibody to be humanized, a set of heavy and light chain surface exposed amino acid residues using the set of framework positions generated in step (b);</li> <li id="ul0006-0004" num="0191" class="style-scope patent-text">(d) identifying from human antibody amino acid sequences a set of heavy and light chain surface exposed amino acid residues that is most closely identical to the set of surface exposed amino acid residues defined in step (c), wherein the heavy and light chain from the human antibody are or are not naturally paired;</li> <li id="ul0006-0005" num="0192" class="style-scope patent-text">(e) substituting, in the amino acid sequence of the non-human antibody to be humanized, the set of heavy and light chain surface exposed amino acid residues defined in step (c) with the set of heavy and light chain surface exposed amino acid residues identified in step (d);</li> <li id="ul0006-0006" num="0193" class="style-scope patent-text">(f) constructing a three-dimensional model of the variable region of the non-human antibody resulting from the substituting specified in step (e);</li> <li id="ul0006-0007" num="0194" class="style-scope patent-text">(g) identifying, by comparing the three-dimensional models constructed in steps (a) and (f), any amino acid residues from the sets identified in steps (c) or (d), that are within 5 Angstroms of any atom of any residue of the complementarity determining regions of the non-human antibody to be humanized; and</li> <li id="ul0006-0008" num="0195" class="style-scope patent-text">(h) changing any residues identified in step (g) from the human to the original non-human amino acid residue to thereby define a non-human antibody humanizing set of surface exposed amino acid residues; with the proviso that step (a) need not be conducted first, but must be conducted prior to step (g).
<br class="style-scope patent-text">
Superhumanization
</li> </ul> </li> </ul>

    <div id="p-0182" num="0196" class="description-paragraph style-scope patent-text">The method compares the non-human sequence with the functional human germline gene repertoire. Those human genes encoding canonical structures identical or closely related to the non-human sequences are selected. Those selected human genes with highest homology within the CDRs are chosen as FR donors. Finally, the non-human CDRs are grafted onto these human FRs. This method is described in patent WO 2005/079479 A2.</div>
    <div id="h-0028" num="0000" class="description-paragraph style-scope patent-text">Human String Content Optimization</div>
    <div id="p-0183" num="0197" class="description-paragraph style-scope patent-text">This method compares the non-human (e.g. mouse) sequence with the repertoire of human germline genes and the differences are scored as Human String Content (HSC) that quantifies a sequence at the level of potential MHC/T-cell epitopes. The target sequence is then humanized by maximizing its HSC rather than using a global identity measure to generate multiple diverse humanized variants (described in Molecular Immunology, 44, (2007) 1986-1998).</div>
    <div id="h-0029" num="0000" class="description-paragraph style-scope patent-text">Framework Shuffling</div>
    <div id="p-0184" num="0198" class="description-paragraph style-scope patent-text">The CDRs of the non-human antibody are fused in-frame to cDNA pools encompassing all known heavy and light chain human germline gene frameworks. Humanised antibodies are then selected by e.g. panning of the phage displayed antibody library. This is described in <i class="style-scope patent-text"> <figure-callout id="36" label="Methods" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Methods</a></figure-callout> </i>36, 43-60 (2005).</div>
    <div id="p-0185" num="0199" class="description-paragraph style-scope patent-text">Examples of cell binding agents include those agents described for use in WO 2007/085930, which is incorporated herein.</div>
    <div id="p-0186" num="0200" class="description-paragraph style-scope patent-text">Tumour-associate antigens and cognate antibodies for use in embodiments of the present invention are listed below.</div>
    <div id="h-0030" num="0000" class="description-paragraph style-scope patent-text">Tumor-Associated Antigens and Cognate Antibodies</div>
    <div id="h-0031" num="0000" class="description-paragraph style-scope patent-text">(1) BMPR1B (Bone Morphogenetic Protein Receptor-Type IB)</div>
    <div id="h-0032" num="0000" class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div id="h-0033" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no. NM_001203</div>
    <div id="h-0034" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. NM_001203.2 GI:169790809</div>
    <div id="h-0035" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:06 PM</div>
    <div id="h-0036" num="0000" class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div id="h-0037" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no. NP_001194</div>
    <div id="h-0038" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. NP_001194.1 GI:4502431</div>
    <div id="h-0039" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:06 PM</div>
    <div id="h-0040" num="0000" class="description-paragraph style-scope patent-text">Cross-References</div>
    <div id="p-0187" num="0201" class="description-paragraph style-scope patent-text">ten Dijke, P., et al <i class="style-scope patent-text">Science </i>264 (5155): 101-104 (1994), <i class="style-scope patent-text">Oncogene </i>14 (11):1377-1382 (1997)); WO2004/063362 (claim 2); WO2003/042661 (Claim 12); US2003/134790-A1 (Page 38-39); WO2002/102235 (Claim 13; Page 296); WO2003/055443 (Page 91-92); WO2002/99122 (Example 2; Page 528-530); WO2003/029421 (Claim 6); WO2003/024392 (Claim 2; FIG. 112); WO2002/98358 (Claim 1; Page 183); WO2002/54940 (Page 100-101); WO2002/59377 (Page 349-350); WO2002/30268 (<figure-callout id="27" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 27; Page 376); WO2001/48204 (Example; FIG. 4); NP_001194 bone morphogenetic protein receptor, type IB/pid=NP_001194.1; MIM:603248; AY065994
<br class="style-scope patent-text">
(2) E16 (LAT1, SLC7A5)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_003486
<br class="style-scope patent-text">
Genbank version no. NM_003486.5 GI:71979931
<br class="style-scope patent-text">
Genbank record update date: Jun. 27, 2012 12:06 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_003477
<br class="style-scope patent-text">
Genbank version no. NP_003477.4 GI:71979932
<br class="style-scope patent-text">
Genbank record update date: Jun. 27, 2012 12:06 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
<i class="style-scope patent-text">Biochem. Biophys. Res. </i>
<br class="style-scope patent-text">
<i class="style-scope patent-text">Commun. </i>255 (2), 283-288 (1999), <i class="style-scope patent-text">Nature </i>395 (6699):288-291 (1998), Gaugitsch, H. W., et al (1992) <i class="style-scope patent-text">J. Biol. Chem. </i>267 (16):11267-11273); WO2004/048938 (Example 2); WO2004/032842 (Example IV); WO2003/042661 (Claim 12); WO2003/016475 (Claim 1); WO2002/78524 (Example 2); WO2002/99074 (<figure-callout id="19" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 19; Page 127-129); WO2002/86443 (<figure-callout id="27" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 27; Pages 222, 393); WO2003/003906 (<figure-callout id="10" label="Claim" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 10; Page 293); WO2002/64798 (<figure-callout id="33" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 33; Page 93-95); WO2000/14228 (Claim 5; Page 133-136); US2003/224454 (FIG. 3); WO2003/025138 (<figure-callout id="12" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 12; Page 150); NP_003477 solute carrier family 7 (cationic amino acid transporter, y+system), member 5/pid=NP_003477.3-<i class="style-scope patent-text">Homo sapiens</i>; MIM:600182; NM_015923.
<br class="style-scope patent-text">
(3) STEAP1 (Six Transmembrane Epithelial Antigen of Prostate)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_012449
<br class="style-scope patent-text">
Genbank version no. NM_012449.2 GI:22027487
<br class="style-scope patent-text">
Genbank record update date: Sep. 9, 2012 02:57 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_036581
<br class="style-scope patent-text">
Genbank version no. NP_036581.1 GI:9558759
<br class="style-scope patent-text">
Genbank record update date: Sep. 9, 2012 02:57 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
<i class="style-scope patent-text">Cancer Res. </i>61 (15), 5857-5860 (2001), Hubert, R. S., et al (1999) <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>96 (25):14523-14528); WO2004/065577 (Claim 6); WO2004/027049 (FIG. 1L); EP1394274 (Example 11); WO2004/016225 (Claim 2); WO2003/042661 (Claim 12); US2003/157089 (Example 5); US2003/185830 (Example 5); US2003/064397 (FIG. 2); WO2002/89747 (Example 5; Page 618-619); WO2003/022995 (Example 9; FIG. 13A, Example 53; Page 173, Example 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2A</figref>); six transmembrane epithelial antigen of the prostate; MIM:604415.
<br class="style-scope patent-text">
(4) 0772P (CA125, MUC16)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AF361486
<br class="style-scope patent-text">
Genbank version no. AF361486.3 GI:34501466
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 07:56 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAK74120
<br class="style-scope patent-text">
Genbank version no. AAK74120.3 GI:34501467
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 07:56 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
<i class="style-scope patent-text">J. Biol. Chem. </i>276 (29):27371-27375 (2001)); WO2004/045553 (Claim 14); WO2002/92836 (<figure-callout id="6" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 6; FIG. 12); WO2002/83866 (Claim 15; Page 116-121); US2003/124140 (Example 16); 61:34501467;
<br class="style-scope patent-text">
(5) MPF (MPF, MSLN, SMR, Megakaryocyte Potentiating Factor, Mesothelin)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_005823
<br class="style-scope patent-text">
Genbank version no. NM_005823.5 GI:293651528
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:47 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_005814
<br class="style-scope patent-text">
Genbank version no. NP 005814.2 GI:53988378
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:47 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Yamaguchi, N., et al <i class="style-scope patent-text">Biol. Chem. </i>269 (2), 805-808 (1994), <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>96 (20):11531-11536 (1999), <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>93 (1):136-140 (1996), <i class="style-scope patent-text">J. Biol. Chem. </i>270 (37):21984-21990 (1995)); WO2003/101283 (Claim 14); (WO2002/102235 (Claim 13; Page 287-288); WO2002/101075 (<figure-callout id="4" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 4; Page 308-309); WO2002/71928 (Page 320-321); WO94/10312 (Page 52-57); IM:601051.
<br class="style-scope patent-text">
(6) Napi3b (NAPI-3B, NPTIIb, SLC34A2, Solute Carrier Family 34 (Sodium Phosphate), Member 2, Type II Sodium-Dependent Phosphate Transporter 3b)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_006424
<br class="style-scope patent-text">
Genbank version no. NM_006424.2 GI:110611905
<br class="style-scope patent-text">
Genbank record update date: Jul. 22, 2012 03:39 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_006415
<br class="style-scope patent-text">
Genbank version no. NP_006415.2 GI:110611906
<br class="style-scope patent-text">
Genbank record update date: Jul. 22, 2012 03:39 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
<i class="style-scope patent-text">J. Biol. Chem. </i>277 (22):19665-19672 (2002), <i class="style-scope patent-text">Genomics </i>62 (2):281-284 (1999), Feild, J. A., et al (1999) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>258 (3):578-582); WO2004/022778 (Claim 2); EP1394274 (Example 11); WO2002/102235 (Claim 13; Page 326); EP0875569 (Claim 1; Page 17-19); WO2001/57188 (<figure-callout id="20" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 20; Page 329); WO2004/032842 (Example IV); WO2001/75177 (<figure-callout id="24" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 24; Page 139-140); MIM:604217.
<br class="style-scope patent-text">
(7) Sema 5b (FLJ10372, KIAA1445, Mm. 42015, SEMA58, SEMAG, Semaphorin 5b Hlog, Sema Domain, Seven Thrombospondin Repeats (Type 1 and Type 1-Like), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 58)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AB040878
<br class="style-scope patent-text">
Genbank version no. AB040878.1 GI:7959148
<br class="style-scope patent-text">
Genbank record update date: Aug. 2, 2006 05:40 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. BAA95969
<br class="style-scope patent-text">
Genbank version no. BAA95969.1 GI:7959149
<br class="style-scope patent-text">
Genbank record update date: Aug. 2, 2006 05:40 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Nagase T., et al (2000) <i class="style-scope patent-text">DNA Res. </i>7 (2):143-150); WO2004/000997 (Claim 1); WO2003/003984 (Claim 1); WO2002/06339 (Claim 1; Page 50); WO2001/88133 (Claim 1; Page 41-43, 48-58); WO2003/054152 (Claim 20); WO2003/101400 (Claim 11); Accession: Q9P283; Genew; HGNC:10737
<br class="style-scope patent-text">
(8) PSCA hlg (2700050C12Rik, C530008O16Rik, RIKEN cDNA 2700050C12, RIKEN cDNA 2700050C12 gene)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AY358628
<br class="style-scope patent-text">
Genbank version no. AY358628.1 GI:37182377
<br class="style-scope patent-text">
Genbank record update date: Dec. 1, 2009 04:15 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAQ88991
<br class="style-scope patent-text">
Genbank version no. AAQ88991.1 GI:37182378
<br class="style-scope patent-text">
Genbank record update date: Dec. 1, 2009 04:15 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Ross et al (2002) <i class="style-scope patent-text">Cancer Res. </i>62:2546-2553; US2003/129192 (Claim 2); US2004/044180 (Claim 12); US2004/044179 (Claim 11); US2003/096961 (Claim 11); US2003/232056 (Example 5); WO2003/105758 16 (Claim 12); US2003/206918 (Example 5); EP1347046 (Claim 1); WO2003/025148 (Claim 20); GI:37182378.
<br class="style-scope patent-text">
(9) ETBR (Endothelin Type B Receptor)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AY275463
<br class="style-scope patent-text">
Genbank version no. AY275463.1 GI:30526094
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 02:26 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAP32295
<br class="style-scope patent-text">
Genbank version no. AAP32295.1 GI:30526095
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 02:26 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Nakamuta M., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>177, 34-39, 1991; Ogawa Y., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>178, 248-255, 1991; Arai H., et al <i class="style-scope patent-text">Jpn. Circ. J. </i>56, 1303-1307, 1992; Arai H., et al <i class="style-scope patent-text">J. Biol. Chem. </i>268, 3463-3470, 1993; Sakamoto A., Yanagisawa M., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>178, 656-663, 1991; Elshourbagy N. A., et al J. <i class="style-scope patent-text">Biol. Chem. </i>268, 3873-3879, 1993; Haendler B., et al <i class="style-scope patent-text">J. Cardiovasc. Pharmacol. </i>20, s1-S4, 1992; Tsutsumi M., et al <i class="style-scope patent-text">Gene </i>228, 43-49, 1999; Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99, 16899-16903, 2002; Bourgeois C., et al <i class="style-scope patent-text">J. Clin. Endocrinol. Metab. </i>82, 3116-3123, 1997; Okamoto Y., et al <i class="style-scope patent-text">Biol. Chem. </i>272, 21589-21596, 1997; Verheij J. B., et al <i class="style-scope patent-text">Am. J. Med. Genet. </i>108, 223-225, 2002; Hofstra R. M. W., et al <i class="style-scope patent-text">Eur. J. Hum. Genet. </i>5, 180-185, 1997; Puffenberger E. G., et al <i class="style-scope patent-text">Cell </i>79, 1257-1266, 1994; Attie T., et al, <i class="style-scope patent-text">Hum. Mol. Genet. </i>4, 2407-2409, 1995; Auricchio A., et al <i class="style-scope patent-text">Hum. Mol. Genet. </i>5:351-354, 1996; Amiel J., et al <i class="style-scope patent-text">Hum. Mol. Genet. </i>5, 355-357, 1996; Hofstra R. M. W., et al <i class="style-scope patent-text">Nat. Genet. </i>12, 445-447, 1996; Svensson P. J., et al <i class="style-scope patent-text">Hum. Genet. </i>103, 145-148, 1998; Fuchs S., et al <i class="style-scope patent-text">Mol. Med. </i>7, 115-124, 2001; Pingault V., et al (2002) <i class="style-scope patent-text">Hum. Genet. </i>111, 198-206; WO2004/045516 (Claim 1); WO2004/048938 (Example 2); WO2004/040000 (Claim 151); WO2003/087768 (Claim 1); WO2003/016475 (Claim 1); WO2003/016475 (Claim 1); WO2002/61087 (FIG. 1); WO2003/016494 (FIG. 6); WO2003/025138 (<figure-callout id="12" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 12; Page 144); WO2001/98351 (Claim 1; (Page 124-125); EP0522868 (<figure-callout id="8" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 8; FIG. 2); WO2001/77172 (Claim 1; Page 297-299); US2003/109676; U.S. Pat. No. 6,518,404 (FIG. 3); U.S. Pat. No. 5,773,223 (Claim 1a; Col 31-34); WO2004/001004.
<br class="style-scope patent-text">
(10) MSG783 (RNF124, Hypothetical Protein FLJ20315)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_017763
<br class="style-scope patent-text">
Genbank version no. NM_017763.4 GI:167830482
<br class="style-scope patent-text">
Genbank record update date: Jul. 22, 2012 12:34 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_060233
<br class="style-scope patent-text">
Genbank version no. NP_060233.3 GI:56711322
<br class="style-scope patent-text">
Genbank record update date: Jul. 22, 2012 12:34 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
WO2003/104275 (Claim 1); WO2004/046342 (Example 2); WO2003/042661 (Claim 12); WO2003/083074 (Claim 14; Page 61); WO2003/018621 (Claim 1); WO2003/024392 (Claim 2; FIG. 93); WO2001/66689 (Example 6); LocusID: 54894.
<br class="style-scope patent-text">
(11) STEAP2 (HGNC 8639, IPCA-1, PCANAP1, STAMP1, STEAP2, STMP, Prostate Cancer
<br class="style-scope patent-text">
Associated Gene 1, Prostate Cancer Associated Protein 1, Six Transmembrane Epithelial Antigen of Prostate 2, Six Transmembrane Prostate Protein)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AF455138
<br class="style-scope patent-text">
Genbank version no. AF455138.1 GI:22655487
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 01:54 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAN04080
<br class="style-scope patent-text">
Genbank version no. AAN04080.1 GI:22655488
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 01:54 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Lab. Invest. 82 (11):1573-1582 (2002)); WO2003/087306; US2003/064397 (Claim 1; FIG. 1); WO2002/72596 (Claim 13; Page 54-55); WO2001/72962 (Claim 1; FIG. 4B); WO2003/104270 (Claim 11); WO2003/104270 (Claim 16); US2004/005598 (Claim 22); WO2003/042661 (Claim 12); US2003/060612 (<figure-callout id="12" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 12; FIG. 10); WO2002/26822 (Claim 23; FIG. 2); WO2002/16429 (<figure-callout id="12" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 12; FIG. 10); GI:22655488.
<br class="style-scope patent-text">
(12) TrpM4 (BR22450, FLJ20041, TRPM4, TRPM4B, Transient Receptor Potential Cation 5 Channel, Subfamily M, Member 4)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_017636
<br class="style-scope patent-text">
Genbank version no. NM_017636.3 GI:304766649
<br class="style-scope patent-text">
Genbank record update date: Jun. 29, 2012 11:27 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_060106
<br class="style-scope patent-text">
Genbank version no. NP_060106.2 GI:21314671
<br class="style-scope patent-text">
Genbank record update date: Jun. 29, 2012 11:27 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Xu, X. Z., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>98 (19):10692-10697 (2001), <i class="style-scope patent-text">Cell </i>109 (3):397-407 (2002), <i class="style-scope patent-text">J. Biol. Chem. </i>278 (33):30813-30820 (2003)); US2003/143557 (Claim 4); WO2000/40614 (Claim 14; Page 100-103); WO2002/10382 (Claim 1; FIG. 9A); WO2003/042661 (Claim 12); WO2002/30268 (<figure-callout id="27" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 27; Page 391); US2003/219806 (Claim 4); WO2001/62794 (Claim 14; FIGS. 1A-D); MIM:606936.
<br class="style-scope patent-text">
(13) CRIPTO (CR, CR1, CRGF, CRIPTO, TDGF1, Teratocarcinoma-Derived Growth Factor)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_003212
<br class="style-scope patent-text">
Genbank version no. NM_003212.3 GI:292494881
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:27 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_003203
<br class="style-scope patent-text">
Genbank version no. NP_003203.1 GI:4507425
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:27 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Ciccodicola, A., et al <i class="style-scope patent-text">EMBO J. </i>8 (7):1987-1991 (1989), <i class="style-scope patent-text">Am. J. Hum. Genet. </i>49 (3):555-565 (1991)); US2003/224411 (Claim 1); WO2003/083041 (Example 1); WO2003/034984 (Claim 12); WO2002/88170 (Claim 2; Page 52-53); WO2003/024392 (Claim 2; FIG. 58); WO2002/16413 (Claim 1; Page 94-95, 105); WO2002/22808 (Claim 2; FIG. 1); U.S. Pat. No. 5,854,399 (Example 2; Col 17-18); U.S. Pat. No. 5,792,616 (FIG. 2); MIM:187395.
<br class="style-scope patent-text">
(14) CD21 (CR2 (Complement receptor 2) or C3DR (C3d/Epstein Barr virus receptor) or Hs. 73792)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no M26004
<br class="style-scope patent-text">
Genbank version no. M26004.1 GI:181939
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA35786
<br class="style-scope patent-text">
Genbank version no. AAA35786.1 GI:181940
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Fujisaku et al (1989) <i class="style-scope patent-text">J. Biol. Chem. </i>264 (4):2118-2125); Weis J. J., et al <i class="style-scope patent-text">J. Exp. Med. </i>167, 1047-1066, 1988; Moore M., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>84, 9194-9198, 1987; Barel M., et al <i class="style-scope patent-text">Mol. Immunol. </i>35, 1025-1031, 1998; Weis J. J., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>83, 5639-5643, 1986; Sinha S. K., et al (1993) <i class="style-scope patent-text">J. Immunol. </i>150, 5311-5320; WO2004/045520 (Example 4); US2004/005538 (Example 1); WO2003/062401 (Claim 9); WO2004/045520 (Example 4); WO91/02536 (FIGS. 9.1-9.9); WO2004/020595 (Claim 1); Accession: P20023; Q13866; Q14212; EMBL; M26004; AAA35786.1.
<br class="style-scope patent-text">
(15) CD79b (CD79B, CD79β, IGb (immunoglobulin-associated beta), 829)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_000626
<br class="style-scope patent-text">
Genbank version no. NM_000626.2 GI:90193589
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 01:53 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_000617
<br class="style-scope patent-text">
Genbank version no. NP_000617.1 GI:11038674
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 01:53 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
<i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A</i>. (2003) 100 (7):4126-4131<i class="style-scope patent-text">, Blood </i>(2002) 100 (9):3068-3076, Muller et al (1992) <i class="style-scope patent-text">Eur. J. Immunol. </i>22 (6):1621-1625); WO2004/016225 (claim 2, FIG. 140); WO2003/087768, US2004/101874 (claim 1, page 102); WO2003/062401 (claim 9); WO2002/78524 (Example 2); US2002/150573 (claim 5, page 15); U.S. Pat. No. 5,644,033; WO2003/048202 (claim 1, pages 306 and 309); WO 99/58658, U.S. Pat. No. 6,534,482 (claim 13, FIGS. 17A/B); WO2000/55351 (claim 11, pages 1145-1146); MIM:147245
<br class="style-scope patent-text">
(16) FcRH2 (IFGP4, IRTA4, SPAP1A (SH2 Domain Containing Phosphatase Anchor Protein 51a), SPAP1B, SPAP1C)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_030764
<br class="style-scope patent-text">
Genbank version no. NM_030764.3 GI:227430280
<br class="style-scope patent-text">
Genbank record update date: Jun. 30, 2012 12:30 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_110391
<br class="style-scope patent-text">
Genbank version no. NP_110391.2 GI:19923629
<br class="style-scope patent-text">
Genbank record update date: Jun. 30, 2012 12:30 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
AY358130); <i class="style-scope patent-text">Genome Res. </i>13 (10):2265-2270 (2003), <i class="style-scope patent-text">Immunogenetics </i>54 (2):87-95 (2002), <i class="style-scope patent-text">Blood </i>99 (8):2662-2669 (2002), <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>98 (17)9772-9777 (2001), Xu, M. J., et al (2001) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>280 (3):768-775; WO2004/016225 (Claim 2); WO2003/077836; WO2001/38490 (Claim 5; FIGS. 18D-1-18D-2); WO2003/097803 (Claim 12); WO2003/089624 (Claim 25): MIM:606509.
<br class="style-scope patent-text">
(17) HER2 (ErbB2)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no M11730
<br class="style-scope patent-text">
Genbank version no. M11730.1 GI:183986
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA75493
<br class="style-scope patent-text">
Genbank version no. AAA75493.1 GI:306840
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Coussens L., et al <i class="style-scope patent-text">Science </i>(1985) 230(4730):1132-1139); Yamamoto T., et al <i class="style-scope patent-text">Nature </i>319, 230-234, 1986; Semba K., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>82, 6497-6501, 1985; Swiercz J. M., et al <i class="style-scope patent-text">J. Cell Biol. </i>165, 869-880, 2004; Kuhns J. J., et al <i class="style-scope patent-text">J. Biol. Chem. </i>274, 36422-36427, 1999; Cho H.-S., et al <i class="style-scope patent-text">Nature </i>421, 756-760, 2003; Ehsani A., et al (1993) <i class="style-scope patent-text">Genomics </i>15, 426-429; WO2004/048938 (Example 2); WO2004/027049 (FIG. 11); WO2004/009622; WO2003/081210; WO2003/089904 (Claim 9); WO2003/016475 (Claim 1); US2003/118592; WO2003/008537 (Claim 1); WO2003/055439 (Claim 29; FIGS. 1A-B); WO2003/025228 (Claim 37; FIG. 5C); WO2002/22636 (Example 13; Page 95-107); WO2002/12341 (<figure-callout id="68" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 68; FIG. 7); WO2002/13847 (Page 71-74); WO2002/14503 (Page 114-117); WO2001/53463 (Claim 2; Page 41-46); WO2001/41787 (Page 15); WO2000/44899 (<figure-callout id="52" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 52; FIG. 7); WO2000/20579 (Claim 3; FIG. 2); U.S. Pat. No. 5,869,445 (Claim 3; Col 31-38); WO9630514 (Claim 2; Page 56-61); EP1439393 (Claim 7); WO2004/043361 (Claim 7); WO2004/022709; WO2001/00244 (Example 3; FIG. 4); Accession: P04626; EMBL; M11767; AAA35808.1. EMBL; M11761; AAA35808.1
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Abbott: US20110177095
</div> <ul class="style-scope patent-text"> <li id="ul0007-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0008-0001" num="0202" class="style-scope patent-text">For example, an antibody comprising CDRs having overall at least 80% sequence identity to CDRs having amino acid sequences of SEQ ID NO:3 (CDR-H1), SEQ ID NO:4 (CDR-H2), SEQ ID NO:5 (CDR-H3), SEQ ID NO:104 and/or SEQ ID NO:6 (CDR-L1), SEQ ID NO:7 (CDR-L2), and SEQ ID NO:8 (CDR-L3), wherein the anti-HER2 antibody or anti-HER2 binding fragment has reduced immunogenicity as compared to an antibody having a VH of SEQ ID NO:1 and a VL of SEQ ID NO:2.
<br class="style-scope patent-text">
Biogen: US20100119511
</li> <li id="ul0008-0002" num="0203" class="style-scope patent-text">For example, ATCC accession numbers: PTA-10355, PTA-10356, PTA-10357, PTA-10358</li> <li id="ul0008-0003" num="0204" class="style-scope patent-text">For example, a purified antibody molecule that binds to HER2 comprising a all six CDR's from an antibody selected from the group consisting of BIIB71F10 (SEQ ID NOs:11, 13), BIIB69A09 (SEQ ID NOs:15, 17); BIIB67F10 (SEQ ID NOs:19, 21); BIIB67F11 (SEQ ID NOs:23, 25), BIIB66A12 (SEQ ID NOs:27, 29), BIIB66C01 (SEQ ID NOs:31, 33), BIIB65C10 (SEQ ID NOs:35, 37), BIIB65H09 (SEQ ID NOs:39, 41) and BIIB65B03 (SEQ ID NOs:43, 45), or CDRs which are identical or which have no more than two alterations from said CDRs.
<br class="style-scope patent-text">
Herceptin (Genentech)—U.S. Pat. No. 6,054,297; ATCC accession no. CRL-10463 (Genentech)
<br class="style-scope patent-text">
Pertuzumab (Genentech)
</li> <li id="ul0008-0004" num="0205" class="style-scope patent-text">US20110117097
        <ul class="style-scope patent-text"> <li id="ul0009-0001" num="0206" class="style-scope patent-text">for example, see SEQ IDs No. 15&amp;16, SEQ IDs No. 17&amp;18, SEQ IDs No. 23&amp;24 &amp; ATCC accession numbers HB-12215, HB-12216, CRL 10463, HB-12697.</li> </ul>
        </li> <li id="ul0008-0005" num="0207" class="style-scope patent-text">US20090285837</li> <li id="ul0008-0006" num="0208" class="style-scope patent-text">US20090202546
        <ul class="style-scope patent-text"> <li id="ul0010-0001" num="0209" class="style-scope patent-text">for example, ATCC accession numbers: HB-12215, HB-12216, CRL 10463, HB-12698.</li> </ul>
        </li> <li id="ul0008-0007" num="0210" class="style-scope patent-text">US20060088523
        <ul class="style-scope patent-text"> <li id="ul0011-0001" num="0211" class="style-scope patent-text">for example, ATCC accession numbers: HB-12215, HB-12216</li> <li id="ul0011-0002" num="0212" class="style-scope patent-text">for example, an antibody comprising the variable light and variable heavy amino acid sequences in SEQ ID Nos. 3 and 4, respectively.</li> <li id="ul0011-0003" num="0213" class="style-scope patent-text">for example, an antibody comprising a light chain amino acid sequence selected from SEQ ID No. 15 and 23, and a heavy chain amino acid sequence selected from SEQ ID No. 16 and 24</li> </ul>
        </li> <li id="ul0008-0008" num="0214" class="style-scope patent-text">US20060018899
        <ul class="style-scope patent-text"> <li id="ul0012-0001" num="0215" class="style-scope patent-text">for example, ATCC accession numbers: (7C2) HB-12215, (7F3) HB-12216, (4D5) CRL-10463, (2C4) HB-12697.</li> <li id="ul0012-0002" num="0216" class="style-scope patent-text">for example, an antibody comprising the amino acid sequence in SEQ ID No. 23, or a deamidated and/or oxidized variant thereof.</li> </ul>
        </li> <li id="ul0008-0009" num="0217" class="style-scope patent-text">US2011/0159014
        <ul class="style-scope patent-text"> <li id="ul0013-0001" num="0218" class="style-scope patent-text">for example, an antibody having a light chain variable domain comprising the hypervariable regions of SEQ ID NO: 1″.</li> <li id="ul0013-0002" num="0219" class="style-scope patent-text">For example, an antibody having a heavy chain variable domain comprising the hypervariable regions of SEQ ID NO: 2.</li> </ul>
        </li> <li id="ul0008-0010" num="0220" class="style-scope patent-text">US20090187007
<br class="style-scope patent-text">
Glycotope: TrasGEX antibody http://www.glycotope.com/pipeline
</li> <li id="ul0008-0011" num="0221" class="style-scope patent-text">For example, see International Joint Cancer Institute and Changhai Hospital Cancer Cent: HMTI-Fc Ab—Gao J., et al <i class="style-scope patent-text">BMB Rep. </i>2009 Oct. 31; 42(10):636-41.
<br class="style-scope patent-text">
Symphogen: US20110217305
<br class="style-scope patent-text">
Union Stem Cell &amp; Gene Engineering, China—Liu HQ., et al <i class="style-scope patent-text">Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. </i>2010 May; 26(5):456-8.
<br class="style-scope patent-text">
(18) NCA (CEACAM6)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no M18728
<br class="style-scope patent-text">
Genbank version no. M18728.1 GI:189084
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:48 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA59907
<br class="style-scope patent-text">
Genbank version no. AAA59907.1 GI:189085
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:48 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Barnett T., et al <i class="style-scope patent-text">Genomics </i>3, 59-66, 1988; Tawaragi Y., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>150, 89-96, 1988; Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99:16899-16903, 2002; WO2004/063709; EP1439393 (Claim 7); WO2004/044178 (Example 4); WO2004/031238; WO2003/042661 (Claim 12); WO2002/78524 (Example 2); WO2002/86443 (<figure-callout id="27" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 27; Page 427); WO2002/60317 (Claim 2); Accession: P40199; Q14920; EMBL; M29541; AAA59915.1. EMBL; M18728.
<br class="style-scope patent-text">
(19) MDP (DPEP1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no BC017023
<br class="style-scope patent-text">
Genbank version no. BC017023.1 GI:16877538
<br class="style-scope patent-text">
Genbank record update date: Mar. 6, 2012 01:00 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAH17023
<br class="style-scope patent-text">
Genbank version no. AAH17023.1 GI: 6877539
<br class="style-scope patent-text">
Genbank record update date: Mar. 6, 2012 01:00 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
<i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99 (26):16899-16903 (2002)); WO2003/016475 (Claim 1); WO2002/64798 (<figure-callout id="33" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 33; Page 85-87); JP05003790 (FIG. 6-8); WO99/46284 (FIG. 9); MIM:179780.
<br class="style-scope patent-text">
(20) IL20R-alpha (IL20Ra, ZCYTOR7)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AF184971
<br class="style-scope patent-text">
Genbank version no. AF184971.1 GI:6013324
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 10:00 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAF01320
<br class="style-scope patent-text">
Genbank version no. AAF01320.1 GI:6013325
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 10:00 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Clark H. F., et al <i class="style-scope patent-text">Genome Res. </i>13, 2265-2270, 2003; Mungall A. J., et al <i class="style-scope patent-text">Nature </i>425, 805-811, 2003; Blumberg H., et al <i class="style-scope patent-text">Cell </i>104, 9-19, 2001; Dumoutier L., et al <i class="style-scope patent-text">J. Immunol. </i>167, 3545-3549, 2001; Parrish-Novak J., et al <i class="style-scope patent-text">J. Biol. Chem. </i>277, 47517-47523, 2002; Pletnev S., et al (2003) <i class="style-scope patent-text">Biochemistry </i>42:12617-12624; Sheikh F., et al (2004) <i class="style-scope patent-text">J. Immunol. </i>172, 2006-2010; EP1394274 (Example 11); US2004/005320 (Example 5); WO2003/029262 (Page 74-75); WO2003/002717 (Claim 2; Page 63); WO2002/22153 (Page 45-47); US2002/042366 (Page 20-21); WO2001/46261 (Page 57-59); WO2001/46232 (Page 63-65); WO98/37193 (Claim 1; Page 55-59); Accession: Q9UHF4; Q6UWA9; Q96SH8; EMBL; AF184971; AAF01320.1.
<br class="style-scope patent-text">
(21) Brevican (BCAN, BEHAB)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AF229053
<br class="style-scope patent-text">
Genbank version no. AF229053.1 GI:10798902
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 12:58 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAG23135
<br class="style-scope patent-text">
Genbank version no. AAG23135.1 GI:10798903
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 12:58 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Gary S. C., et al <i class="style-scope patent-text">Gene </i>256, 139-147, 2000; Clark H. F., et al <i class="style-scope patent-text">Genome Res. </i>13, 2265-2270, 2003; Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99, 16899-16903, 2002; US2003/186372 (Claim 11); US2003/186373 (Claim 11); US2003/119131 (Claim 1; FIG. 52); US2003/119122 (Claim 1; FIG. 52); US2003/119126 (Claim 1); US2003/119121 (Claim 1; FIG. 52); US2003/119129 (Claim 1); US2003/119130 (Claim 1); US2003/119128 (Claim 1; FIG. 52); US2003/119125 (Claim 1); WO2003/016475 (Claim 1); WO2002/02634 (Claim 1)
<br class="style-scope patent-text">
(22) EphB2R (DRT, ERK, Hek5, EPHT3, Tyro5)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_004442
<br class="style-scope patent-text">
Genbank version no. NM_004442.6 GI:111118979
<br class="style-scope patent-text">
Genbank record update date: Sep. 8, 2012 04:43 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_004433
<br class="style-scope patent-text">
Genbank version no. NP_004433.2 GI:21396504
<br class="style-scope patent-text">
Genbank record update date: Sep. 8, 2012 04:43 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Chan, J. and Watt, V. M., Oncogene 6 (6), 1057-1061 (1991) Oncogene 10 (5):897-905 (1995), Annu. Rev. Neurosci. 21:309-345 (1998), Int. Rev. Cytol. 196:177-244 (2000)); WO2003042661 (Claim 12); WO200053216 (Claim 1; Page 41); WO2004065576 (Claim 1); WO2004020583 (Claim 9); WO2003004529 (Page 128-132); WO200053216 (Claim 1; Page 42); MIM:600997.
<br class="style-scope patent-text">
(23) ASLG659 (B7 h)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AX092328
<br class="style-scope patent-text">
Genbank version no. AX092328.1 GI:13444478
<br class="style-scope patent-text">
Genbank record update date: Jan. 26, 2011 07:37 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
US2004/0101899 (Claim 2); WO2003104399 (Claim 11); WO2004000221 (FIG. 3); US2003/165504 (Claim 1); US2003/124140 (Example 2); US2003/065143 (FIG. 60); WO2002/102235 (Claim 13; Page 299); US2003/091580 (Example 2); WO2002/10187 (<figure-callout id="6" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 6; FIG. 10); WO2001/94641 (<figure-callout id="12" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 12; FIG. 7b); WO2002/02624 (Claim 13; FIGS. 1A-1B); US2002/034749 (<figure-callout id="54" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 54; Page 45-46); WO2002/06317 (Example 2; Page 320-321, Claim 34; Page 321-322); WO2002/71928 (Page 468-469); WO2002/02587 (Example 1; FIG. 1); WO2001/40269 (Example 3; Pages 190-192); WO2000/36107 (Example 2; Page 205-207); WO2004/053079 (Claim 12); WO2003/004989 (Claim 1); WO2002/71928 (Page 233-234, 452-453); WO 01/16318.
<br class="style-scope patent-text">
(24) PSCA (Prostate Stem Cell Antigen Precursor)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AJ297436
<br class="style-scope patent-text">
Genbank version no. AJ297436.1 GI:9367211
<br class="style-scope patent-text">
Genbank record update date: Feb. 1, 2011 11:25 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAB97347
<br class="style-scope patent-text">
Genbank version no. CAB97347.1 GI:9367212
<br class="style-scope patent-text">
Genbank record update date: Feb. 1, 2011 11:25 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Reiter R. E., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>95, 1735-1740, 1998; Gu Z., et al <i class="style-scope patent-text"> <figure-callout id="19" label="Oncogene" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Oncogene</a></figure-callout> </i>19, 1288-1296, 2000<i class="style-scope patent-text">; Biochem. Biophys. Res. Commun</i>. (2000) 275(3):783-788; WO2004/022709; EP1394274 (Example 11); US2004/018553 (Claim 17); WO2003/008537 (Claim 1); WO2002/81646 (Claim 1; Page 164); WO2003/003906 (<figure-callout id="10" label="Claim" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 10; Page 288); WO2001/40309 (Example 1; FIG. 17); US2001/055751 (Example 1; FIG. 1b); WO2000/32752 (<figure-callout id="18" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 18; FIG. 1); WO98/51805 (Claim 17; Page 97); WO98/51824 (<figure-callout id="10" label="Claim" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 10; Page 94); WO98/40403 (Claim 2; FIG. 1B); Accession: 043653; EMBL; AF043498; AAC39607.1
<br class="style-scope patent-text">
(25) GEDA
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AY260763
<br class="style-scope patent-text">
Genbank version no. AY260763.1 GI:30102448
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 02:24 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAP14954
<br class="style-scope patent-text">
Genbank version no. AAP14954.1 GI:30102449
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 02:24 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
AP14954 lipoma HMGIC fusion-partnerlike protein/pid=AAP14954.1-<i class="style-scope patent-text">Homo sapiens </i>(human); WO2003/054152 (Claim 20); WO2003/000842 (Claim 1); WO2003/023013 (Example 3, Claim 20); US2003/194704 (Claim 45); GI:30102449;
<br class="style-scope patent-text">
(26) BAFF-R (B Cell-Activating Factor Receptor, BLyS Receptor 3, BR3)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AF116456
<br class="style-scope patent-text">
Genbank version no. AF116456.1 GI:4585274
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 09:44 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAD25356
<br class="style-scope patent-text">
Genbank version no. AAD25356.1 GI:4585275
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 09:44 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
BAFF receptor/pid=NP_443177.1-<i class="style-scope patent-text">Homo sapiens</i>: Thompson, J. S., et al <i class="style-scope patent-text">Science </i>293 (5537), 2108-2111 (2001); WO2004/058309; WO2004/011611; WO2003/045422 (Example; Page 32-33); WO2003/014294 (Claim 35; FIG. 6B); WO2003/035846 (Claim 70; Page 615-616); WO2002/94852 (Col 136-137); WO2002/38766 (Claim 3; Page 133); WO2002/24909 (Example 3; FIG. 3); MIM:606269; NP_443177.1; NM_052945_1; AF132600
<br class="style-scope patent-text">
(27) CD22 (B-Cell Receptor CD22-Bisoform, BL-CAM, Lyb-8, Lyb8, SIGLEC-2, FLJ22814)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AK026467
<br class="style-scope patent-text">
Genbank version no. AK026467.1 GI:10439337
<br class="style-scope patent-text">
Genbank record update date: Sep. 11, 2006 11:24 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. BAB15489
<br class="style-scope patent-text">
Genbank version no. BAB15489.1 GI:10439338
<br class="style-scope patent-text">
Genbank record update date: Sep. 11, 2006 11:24 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Wilson et al (1991) <i class="style-scope patent-text">J. Exp. Med. </i>173:137-146; WO2003/072036 (Claim 1; FIG. 1); IM:107266; NP_001762.1; NM_0017711.
<br class="style-scope patent-text">
(27a) CD22 (CD22 Molecule)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no X52785
<br class="style-scope patent-text">
Genbank version no. X52785.1 GI:29778
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:09 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAA36988
<br class="style-scope patent-text">
Genbank version no. CAA36988.1 GI:29779
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:09 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Stamenkovic I. et al., <i class="style-scope patent-text">Nature </i>345 (6270), 74-77 (1990)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD22
<br class="style-scope patent-text">
Other Aliases: SIGLEC-2, SIGLEC2
<br class="style-scope patent-text">
Other Designations: B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
G5/44 (Inotuzumab): DiJoseph J F., et al <i class="style-scope patent-text">Cancer. Immunol Immunother. </i>2005 January; 54(1):11-24.
<br class="style-scope patent-text">
Epratuzumab-Goldenberg D M., et al <i class="style-scope patent-text">Expert Rev Anticancer Ther. </i>6(10): 1341-53, 2006.
<br class="style-scope patent-text">
(28) CD79a (CD79A, CD79alpha), Immunoglobulin-Associated Alpha, a B Cell-Specific Protein that Covalently Interacts with Ig Beta (CD79B) and Forms a Complex on the Surface with Ig M Molecules, Transduces a Signal Involved in B-Cell Differentiation), pl: 4.84, MW: 25028 TM: 2 [P] <i class="style-scope patent-text">Gene Chromosome: </i>19q13.2).
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_001783
<br class="style-scope patent-text">
Genbank version no. NM_001783.3 GI:90193587
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 01:48 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_001774
<br class="style-scope patent-text">
Genbank version no. NP_001774.1 GI:4502685
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 01:48 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
WO2003/088808, US2003/0228319; WO2003/062401 (claim 9); US2002/150573 (<figure-callout id="4" label="claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 4, pages 13-14); WO99/58658 (claim 13, FIG. 16); WO92/07574 (FIG. 1); U.S. Pat. No. 5,644,033; Ha et al (1992) <i class="style-scope patent-text">J. Immunol. </i>148(5):1526-1531; Müller et al (1992) <i class="style-scope patent-text">Eur. J. Immunol. </i>22:1621-1625; Hashimoto et al (1994) <i class="style-scope patent-text">Immunogenetics </i>40(4):287-295; Preud'homme et al (1992) <i class="style-scope patent-text">Clin. Exp. Immunol. </i>90(1):141-146; Yu et al (1992) <i class="style-scope patent-text">J. Immunol. </i>148(2) 633-637; Sakaguchi et al (1988) <i class="style-scope patent-text">EMBO J. </i>7(11):3457-3464
<br class="style-scope patent-text">
(29) CXCR5 (Burkitt's Lymphoma Receptor 1, a G Protein-Coupled Receptor that is Activated by the CXCL13 Chemokine, Functions in Lymphocyte Migration and Humoral Defense, Plays a Role in HIV-2 Infection and Perhaps Development of AIDS, Lymphoma, Myeloma, and Leukemia); 372 aa, pl: 8.54 MW: 41959 TM: 7 [P] <i class="style-scope patent-text">Gene Chromosome: </i>11q23.3,
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_001716
<br class="style-scope patent-text">
Genbank version no. NM_001716.4 GI:342307092
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:49 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_001707
<br class="style-scope patent-text">
Genbank version no. NP_001707.1 GI:4502415
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:49 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
WO2004/040000; WO2004/015426; US2003/105292 (Example 2); U.S. Pat. No. 6,555,339 (Example 2); WO2002/61087 (FIG. 1); WO2001/57188 (<figure-callout id="20" label="Claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Claim</a></figure-callout> 20, page 269); WO2001/72830 (pages 12-13); WO2000/22129 (Example 1, pages 152-153, Example 2, pages 254-256); WO99/28468 (claim 1, page 38); U.S. Pat. No. 5,440,021 (Example 2, col 49-52); WO94/28931 (pages 56-58); WO92/17497 (claim 7, FIG. 5); Dobner et al (1992) <i class="style-scope patent-text">Eur. J. Immunol. </i>22:2795-2799; Barella et al (1995) <i class="style-scope patent-text">Biochem. J. </i>309:773-779
<br class="style-scope patent-text">
(30) HLA-DOB (Beta Subunit of MHC Class II Molecule (La Antigen) that Binds Peptides and Presents them to CD4+ T Lymphocytes); 273 aa, pl: 6.56, MW: 30820. TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>6p21.3)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_002120
<br class="style-scope patent-text">
Genbank version no. NM_002120.3 GI:118402587
<br class="style-scope patent-text">
Genbank record update date: Sep. 8, 2012 04:46 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP 002111
<br class="style-scope patent-text">
Genbank version no. NP_002111.1 GI:4504403
<br class="style-scope patent-text">
Genbank record update date: Sep. 8, 2012 04:46 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Tonnelle et al (1985) <i class="style-scope patent-text">EMBO J. </i>4(11):2839-2847; Jonsson et al (1989) <i class="style-scope patent-text">Immunogenetics </i>29(6):411-413; Beck et al (1992) <i class="style-scope patent-text">J. Mol. Biol. </i>228:433-441; Strausberg et al (2002) <i class="style-scope patent-text">Proc. Natl. Acad. Sci USA </i>99:16899-16903; Servenius et al (1987) <i class="style-scope patent-text">J. Biol. Chem. </i>262:8759-8766; Beck et al (1996) <i class="style-scope patent-text">J. Mol. Biol. </i>255:1-13; Naruse et al (2002) <i class="style-scope patent-text">Tissue Antigens </i>59:512-519; WO99/58658 (claim 13, FIG. 15); U.S. Pat. No. 6,153,408 (Col 35-38); U.S. Pat. No. 5,976,551 (col 168-170); U.S. Pat. No. 6,011,146 (col 145-146); Kasahara et al (1989) <i class="style-scope patent-text">Immunogenetics </i>30(1):66-68; Larhammar et al (1985) <i class="style-scope patent-text">J. Biol. Chem. </i>260(26):14111-14119
<br class="style-scope patent-text">
(31) P2X5 (Purinergic Receptor P2X Ligand-Gated Ion Channel 5, an Ion Channel Gated by Extracellular ATP, May be Involved in Synaptic Transmission and Neurogenesis, Deficiency May Contribute to the Pathophysiology of Idiopathic Detrusor Instability); 422 Aa), pl: 7.63, MW: 47206 TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>17p13.3).
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_002561
<br class="style-scope patent-text">
Genbank version no. NM_002561.3 GI:325197202
<br class="style-scope patent-text">
Genbank record update date: Jun. 27, 2012 12:41 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP 002552
<br class="style-scope patent-text">
Genbank version no. NP_002552.2 GI:28416933
<br class="style-scope patent-text">
Genbank record update date: Jun. 27, 2012 12:41 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Le et al (1997) <i class="style-scope patent-text">FEBS Lett. </i>418(1-2):195-199; WO2004/047749; WO2003/072035 (claim 10); Touchman et al (2000) <i class="style-scope patent-text">Genome Res. </i>10:165-173; WO2002/22660 (claim 20); WO2003/093444 (claim 1); WO2003/087768 (claim 1); WO2003/029277 (page 82)
<br class="style-scope patent-text">
(32) CD72 (B-Cell Differentiation Antigen CD72, Lyb-2); 359 Aa, pl: 8.66, MW: 40225, TM: 1 5 [P] <i class="style-scope patent-text">Gene Chromosome: </i>9p13.3).
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_001782
<br class="style-scope patent-text">
Genbank version no. NM_001782.2 GI:194018444
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 01:43 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_001773
<br class="style-scope patent-text">
Genbank version no. NP_001773.1 GI:4502683
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 01:43 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
WO2004042346 (claim 65); WO2003/026493 (pages 51-52, 57-58); WO2000/75655 (pages 105-106); Von Hoegen et al (1990) <i class="style-scope patent-text">J. Immunol. </i>144(12):4870-4877; Strausberg et al (2002) <i class="style-scope patent-text">Proc. Natl. Acad. Sci USA </i>99:16899-16903.
<br class="style-scope patent-text">
(33) LY64 (Lymphocyte Antigen 64 (RP105), Type I Membrane Protein of the Leucine Rich Repeat (LRR) Family, Regulates B-Cell Activation and Apoptosis, Loss of Function is Associated with Increased Disease Activity in Patients with Systemic Lupus Erythematosis); 661 aa, pl: 6.20, MW: 74147 TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>5q12).
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_005582
<br class="style-scope patent-text">
Genbank version no. NM_005582.2 GI:167555126
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:50 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP 005573
<br class="style-scope patent-text">
Genbank version no. NP_005573.2 GI:167555127
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:50 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
US2002/193567; WO97/07198 (claim 11, pages 39-42); Miura et al (1996) <i class="style-scope patent-text">Genomics </i>38(3):299-304; Miura et al (1998) <i class="style-scope patent-text">Blood </i>92:2815-2822; WO2003/083047; WO97/44452 (<figure-callout id="8" label="claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 8, pages 57-61); WO2000/12130 (pages 24-26).
<br class="style-scope patent-text">
(34) FcRH1 (Fc Receptor-Like Protein 1, a Putative Receptor for the Immunoglobulin Fc Domain that Contains C2 Type Ig-Like and ITAM Domains, May have a Role in B-Lymphocyte Differentiation); 429 aa, pl: 5.28, MW: 46925 TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>1q21-1q22)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no NM_052938
<br class="style-scope patent-text">
Genbank version no. NM_052938.4 GI:226958543
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:43 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_443170
<br class="style-scope patent-text">
Genbank version no. NP_443170.1 GI:16418419
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:43 PM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
WO2003/077836; WO2001/38490 (<figure-callout id="6" label="claim" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 6, FIGS. 18E-1-18-E-2); Davis et al (2001) <i class="style-scope patent-text">Proc. Natl. Acad. Sci USA </i>98(17):9772-9777; WO2003/089624 (claim 8); EP1347046 (claim 1); WO2003/089624 (claim 7).
<br class="style-scope patent-text">
(35) IRTA2 (Immunoglobulin Superfamily Receptor Translocation Associated 2, a Putative Immunoreceptor with Possible Roles in B Cell Development and Lymphoma Genesis; Deregulation of the Gene by Translocation Occurs in Some B Cell Malignancies); 977 aa, pl: 6.88, MW: 106468, TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>1q21)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AF343662
<br class="style-scope patent-text">
Genbank version no. AF343662.1 GI:13591709
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 01:16 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAK31325
<br class="style-scope patent-text">
Genbank version no. AAK31325.1 GI:13591710
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 01:16 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
AF343663, AF343664, AF343665, AF369794, AF397453, AK090423, AK090475, AL834187, AY358085; Mouse:AK089756, AY158090, AY506558; NP_112571.1; WO2003/024392 (claim 2, FIG. 97); Nakayama et al (2000) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>277(1):124-127; WO2003/077836; WO2001/38490 (claim 3, FIG. 18B-1-18B-2).
<br class="style-scope patent-text">
(36) TENB2 (TMEFF2, Tomoregulin, TPEF, HPP1, TR, Putative Transmembrane Proteoglycan, Related to the EGF/Heregulin Family of Growth Factors and Follistatin); 374 aa)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no AF179274
<br class="style-scope patent-text">
Genbank version no. AF179274.2 GI:12280939
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 01:05 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAD55776
<br class="style-scope patent-text">
Genbank version no. AAD55776.2 GI:12280940
<br class="style-scope patent-text">
Genbank record update date: Mar. 11, 2010 01:05 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
NCBI Accession: AAD55776, AAF91397, AAG49451, NCBI RefSeq: NP_057276; NCBI Gene: 23671; OMIM: 605734; SwissProt Q9UIK5; AY358907, CAF85723, CQ782436; WO2004/074320; JP2004113151; WO2003/042661; WO2003/009814; EP1295944 (pages 69-70); WO2002/30268 (page 329); WO2001/90304; US2004/249130; US2004/022727; WO2004/063355; US2004/197325; US2003/232350; US2004/005563; US2003/124579; Horie et al (2000) <i class="style-scope patent-text">Genomics </i>67:146-152; Uchida et al (1999) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>266:593-602; Liang et al (2000) <i class="style-scope patent-text">Cancer Res. </i>60:4907-12; Glynne-Jones et al (2001) <i class="style-scope patent-text">Int J Cancer</i>. October 15; 94(2):178-84.
<br class="style-scope patent-text">
(37) PSMA—FOLH1 (Folate Hydrolase (Prostate-Specific Membrane Antigen) 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no M99487
<br class="style-scope patent-text">
Genbank version no. M99487.1 GI:190663
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:48 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA60209
<br class="style-scope patent-text">
Genbank version no. AAA60209.1 GI:190664
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:48 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Israeli R. S., et al <i class="style-scope patent-text">Cancer Res. </i>53 (2), 227-230 (1993)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: FOLH1
<br class="style-scope patent-text">
Other Aliases: GIG27, FGCP, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, mGCP
<br class="style-scope patent-text">
Other Designations: N-acetylated alpha-linked acidic dipeptidase 1; N-acetylated-alpha-linked acidic dipeptidase I; NAALADase I; cell growth-inhibiting <figure-callout id="27" label="gene" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">gene</a></figure-callout> 27 protein; folylpoly-gamma-glutamate carboxypeptidase; glutamate carboxylase II; glutamate carboxypeptidase 2; glutamate carboxypeptidase II; membrane glutamate carboxypeptidase; prostate specific membrane antigen variant F; pteroylpoly-gamma-glutamate carboxypeptidase
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
U.S. Pat. No. 7,666,425:
<br class="style-scope patent-text">
Antibodies produces by Hybridomas having the following ATCC references: ATCC accession No. HB-12101, ATCC accession No. HB-12109, ATCC accession No. HB-12127 and ATCC accession No. HB-12126.
<br class="style-scope patent-text">
Proscan: a monoclonal antibody selected from the group consisting of 8H12, 3E11, 17G1, 2964, 30C1 and 20F2 (U.S. Pat. No. 7,811,564; Moffett S., et al Hybridoma (Larchmt). 2007 December; 26(6):363-72).
<br class="style-scope patent-text">
Cytogen: monoclonal antibodies 7E11-05 (ATCC accession No. HB 10494) and 9H10-A4 (ATCC accession No. H611430)—U.S. Pat. No. 5,763,202
<br class="style-scope patent-text">
GlycoMimetics: NUH2—ATCC accession No. HB 9762 (U.S. Pat. No. 7,135,301)
<br class="style-scope patent-text">
Human Genome Science: HPRAJ70-ATCC accession No. 97131 (U.S. Pat. No. 6,824,993); Amino acid sequence encoded by the cDNA clone (HPRAJ70) deposited as American Type Culture Collection (“ATCC”) Deposit No. 97131
<br class="style-scope patent-text">
Medarex: Anti-PSMA antibodies that lack fucosyl residues—U.S. Pat. No. 7,875,278
<br class="style-scope patent-text">
Mouse anti-PSMA antibodies include the 3F5.4G6, 3D7.1.1, 4E10-1.14, 3E11, 4D8, 3E6, 3C9, 2C7, 1G3, 3C4, 3C6, 4D4, 1G9, 5C869, 3G6, 4C8B9, and monoclonal antibodies. Hybridomas secreting 3F5.4G6, 3D7.1.1, 4E10-1.14, 3E11, 4D8, 3E6, 3C9, 2C7, 1G3, 3C4, 3C6, 4D4, 1G9, 5C8B9, 3G6 or 4C8B9 have been publicly deposited and are described in U.S. Pat. No. 6,159,508. Relevant hybridomas have been publicly deposited and are described in U.S. Pat. No. 6,107,090. Moreover, humanized anti-PSMA antibodies, including a humanized version of J591, are described in further detail in PCT Publication WO 02/098897.
<br class="style-scope patent-text">
Other mouse anti-human PSMA antibodies have been described in the art, such as mAb 107-1A4 (Wang, S. et al. (2001) Int. J. Cancer 92:871-876) and mAb 2C9 (Kato, K. et al. (2003) Int. J. Urol. 10:439-444).
<br class="style-scope patent-text">
Examples of human anti-PSMA monoclonal antibodies include the 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 antibodies, isolated and structurally characterized as originally described in PCT Publications WO 01/09192 and WO 03/064606 and in U.S. Provisional Application Ser. No. 60/654,125, entitled “Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA)”, filed on Feb. 18, 2005. The V.sub.H amino acid sequences of 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 are shown in SEQ ID NOs: 1-9, respectively. The V.sub.L amino acid sequences of 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 are shown in SEQ ID NOs: 10-18, respectively.
<br class="style-scope patent-text">
Other human anti-PSMA antibodies include the antibodies disclosed in PCT Publication WO 03/034903 and US Application No. 2004/0033229.
<br class="style-scope patent-text">
NW Biotherapeutics: A hybridoma cell line selected from the group consisting of 3F5.4G6 having ATCC accession number HB12060, 3D7-1.l. having ATCC accession number HB12309, 4E10-1.14 having ATCC accession number HB12310, 3E11 (ATCC HB12488), 4D8 (ATCC HB12487), 3E6 (ATCC HB12486), 3C9 (ATCC HB12484), 2C7 (ATCC HB12490), 1G3 (ATCC HB12489), 3C4 (ATCC HB12494), 3C6 (ATCC HB12491), 4D4 (ATCC HB12493), 1G9 (ATCC HB12495), 5C8B9 (ATCC HB12492) and 3G6 (ATCC HB12485)—see U.S. Pat. No. 6,150,508
<br class="style-scope patent-text">
PSMA Development Company/Progenics/Cytogen—Seattle Genetics: mAb 3.9, produced by the hybridoma deposited under ATCC Accession No. PTA-3258 or mAb 10.3, produced by the hybridoma deposited under ATCC Accession No. PTA-3347—U.S. Pat. No. 7,850,971
<br class="style-scope patent-text">
PSMA Development Company—Compositions of PSMA antibodies (US 20080286284, Table 1)
</li> </ul> </li> </ul>

    <div id="p-0188" num="0222" class="description-paragraph style-scope patent-text">This application is a divisional of U.S. patent application Ser. No. 10/395,894, filed on Mar. 21, 2003 (U.S. Pat. No. 7,850,971)</div>
    <div id="h-0041" num="0000" class="description-paragraph style-scope patent-text">University Hospital Freiburg, Germany—mAbs 3/A12, 3/E7, and 3/F11 (Wolf P., et al <i class="style-scope patent-text">Prostate. </i>2010 Apr. 1; 70(5):562-9).</div>
    <div id="h-0042" num="0000" class="description-paragraph style-scope patent-text">(38) SST (Somatostatin Receptor; Note that there are 5 Subtypes)</div>
    <div id="h-0043" num="0000" class="description-paragraph style-scope patent-text">(38.1) SSTR2 (Somatostatin Receptor 2)</div>
    <div id="h-0044" num="0000" class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div id="h-0045" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no NM_001050</div>
    <div id="h-0046" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. NM_001050.2 GI:44890054</div>
    <div id="h-0047" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Aug. 19, 2012 01:37 PM</div>
    <div id="h-0048" num="0000" class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div id="h-0049" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no. NP_001041</div>
    <div id="h-0050" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. NP_001041.1 GI:4557859</div>
    <div id="h-0051" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Aug. 19, 2012 01:37 PM</div>
    <div id="h-0052" num="0000" class="description-paragraph style-scope patent-text">Cross References</div>
    <div id="h-0053" num="0000" class="description-paragraph style-scope patent-text">Yamada Y., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>89 (1), 251-255 (1992); Susini C., et al <i class="style-scope patent-text">Ann Oncol. </i>2006 December; 17(12):1733-42</div>
    <div id="h-0054" num="0000" class="description-paragraph style-scope patent-text">Other Information</div>
    <div id="h-0055" num="0000" class="description-paragraph style-scope patent-text">Official Symbol: SSTR2</div>
    <div id="h-0056" num="0000" class="description-paragraph style-scope patent-text">Other Designations: SRIF-1; SS2R; somatostatin receptor type 2</div>
    <div id="h-0057" num="0000" class="description-paragraph style-scope patent-text">(38.2) SSTR5 (Somatostatin Receptor 5)</div>
    <div id="h-0058" num="0000" class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div id="h-0059" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no D16827</div>
    <div id="h-0060" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. D16827.1 GI:487683</div>
    <div id="h-0061" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Aug. 1, 2006 12:45 PM</div>
    <div id="h-0062" num="0000" class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div id="h-0063" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no. BAA04107</div>
    <div id="h-0064" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. BAA04107.1 GI:487684</div>
    <div id="h-0065" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Aug. 1, 2006 12:45 PM</div>
    <div id="h-0066" num="0000" class="description-paragraph style-scope patent-text">Cross References</div>
    <div id="h-0067" num="0000" class="description-paragraph style-scope patent-text">Yamada, Y., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>195 (2), 844-852 (1993)</div>
    <div id="h-0068" num="0000" class="description-paragraph style-scope patent-text">Other Information</div>
    <div id="h-0069" num="0000" class="description-paragraph style-scope patent-text">Official Symbol: SSTR5</div>
    <div id="h-0070" num="0000" class="description-paragraph style-scope patent-text">Other Aliases: SS-5-R</div>
    <div id="h-0071" num="0000" class="description-paragraph style-scope patent-text">Other Designations: Somatostatin receptor subtype 5; somatostatin receptor type 5</div>
    <div id="h-0072" num="0000" class="description-paragraph style-scope patent-text">(38.3) SSTR1</div>
    <div id="h-0073" num="0000" class="description-paragraph style-scope patent-text">(38.4) SSTR3</div>
    <div id="h-0074" num="0000" class="description-paragraph style-scope patent-text">(38.5) SSTR4</div>
    <div id="h-0075" num="0000" class="description-paragraph style-scope patent-text">AvB6—Both Subunits (39+40)</div>
    <div id="h-0076" num="0000" class="description-paragraph style-scope patent-text">(39) ITGAV (Integrin, Alpha V;</div>
    <div id="h-0077" num="0000" class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div id="h-0078" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no M14648 J02826 M18365</div>
    <div id="h-0079" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. M14648.1 GI:340306</div>
    <div id="h-0080" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:56 AM</div>
    <div id="h-0081" num="0000" class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div id="h-0082" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no. AAA36808</div>
    <div id="h-0083" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. AAA36808.1 GI:340307</div>
    <div id="h-0084" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:56 AM</div>
    <div id="h-0085" num="0000" class="description-paragraph style-scope patent-text">Cross References</div>
    <div id="h-0086" num="0000" class="description-paragraph style-scope patent-text">Suzuki S., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>83 (22), 8614-8618 (1986)</div>
    <div id="h-0087" num="0000" class="description-paragraph style-scope patent-text">Other Information</div>
    <div id="h-0088" num="0000" class="description-paragraph style-scope patent-text">Official Symbol: ITGAV</div>
    <div id="h-0089" num="0000" class="description-paragraph style-scope patent-text">Other Aliases: CD51, MSK8, VNRA, VTNR</div>
    <div id="h-0090" num="0000" class="description-paragraph style-scope patent-text">Other Designations: antigen identified by monoclonal antibody L230; integrin alpha-V; integrin alphaVbeta3; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); vitronectin receptor subunit alpha</div>
    <div id="h-0091" num="0000" class="description-paragraph style-scope patent-text">(40) ITGB6 (Integrin, Beta 6)</div>
    <div id="h-0092" num="0000" class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div id="h-0093" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no NM_000888</div>
    <div id="h-0094" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. NM_000888.3 GI:9966771</div>
    <div id="h-0095" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:46 AM</div>
    <div id="h-0096" num="0000" class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div id="h-0097" num="0000" class="description-paragraph style-scope patent-text">Genbank accession no. NP_000879</div>
    <div id="h-0098" num="0000" class="description-paragraph style-scope patent-text">Genbank version no. NP_000879.2 GI:9625002</div>
    <div id="h-0099" num="0000" class="description-paragraph style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:46 AM</div>
    <div id="h-0100" num="0000" class="description-paragraph style-scope patent-text">Cross References</div>
    <div id="h-0101" num="0000" class="description-paragraph style-scope patent-text">Sheppard D. J., et al <i class="style-scope patent-text">Biol. Chem. </i>265 (20), 11502-11507 (1990)</div>
    <div id="h-0102" num="0000" class="description-paragraph style-scope patent-text">Other Information</div>
    <div id="h-0103" num="0000" class="description-paragraph style-scope patent-text">Official Symbol: ITGB6</div>
    <div id="h-0104" num="0000" class="description-paragraph style-scope patent-text">Other Designations: integrin beta-6</div>
    <div id="h-0105" num="0000" class="description-paragraph style-scope patent-text">Antibodies</div>
    <div id="h-0106" num="0000" class="description-paragraph style-scope patent-text">Biogen: U.S. Pat. No. 7,943,742—Hybridoma clones 6.3G9 and 6.8G6 were deposited with the ATCC, accession numbers ATCC PTA-3649 and -3645, respectively.</div>
    <div id="h-0107" num="0000" class="description-paragraph style-scope patent-text">Biogen: U.S. Pat. No. 7,465,449—In some embodiments, the antibody comprises the same heavy and light chain polypeptide sequences as an antibody produced by hybridoma 6.1A8, 6.3G9, 6.8G6, 6.2B1, 6.2B10, 6.2A1, 6.2E5, 7.1G10, 7.7G5, or 7.1C5.</div>
    <div id="h-0108" num="0000" class="description-paragraph style-scope patent-text">Centocor (J&amp;J): U.S. Pat. Nos. 7,550,142; 7,163,681</div>
    <div id="p-0189" num="0000" class="description-paragraph style-scope patent-text">
      </div> <ul class="style-scope patent-text">
        <li id="ul0014-0001" num="0000" class="style-scope patent-text">
          <ul class="style-scope patent-text">
            <li id="ul0015-0001" num="0223" class="style-scope patent-text">For example in U.S. Pat. No. 7,550,142—an antibody having human heavy chain and human light chain variable regions comprising the amino acid sequences shown in SEQ ID NO: 7 and SEQ ID NO: 8.
<br class="style-scope patent-text">
Seattle Genetics: 15H3 (Ryan M C., et al Cancer Res Apr. 15, 2012; 72(8 Supplement): 4630)
<br class="style-scope patent-text">
(41) CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no M17303
<br class="style-scope patent-text">
Genbank version no. M17303.1 GI:178676
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AA659513
<br class="style-scope patent-text">
Genbank version no. AA659513.1 GI:178677
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Beauchemin N., et al <i class="style-scope patent-text">Mol. Cell. Biol. </i>7 (9), 3221-3230 (1987)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CEACAM5
<br class="style-scope patent-text">
Other Aliases: CD66e, CEA
<br class="style-scope patent-text">
Other Designations: <figure-callout id="100" label="meconium antigen" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">meconium antigen</a></figure-callout> 100
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
AstraZeneca-MedImmune:US 20100330103; US20080057063;
</li>
            <li id="ul0015-0002" num="0224" class="style-scope patent-text">US20020142359
        <ul class="style-scope patent-text"> <li id="ul0016-0001" num="0225" class="style-scope patent-text">for example an antibody having complementarity determining regions (CDRs) with the following sequences: heavy chain; CDR1—DNYMH, CDR2—WIDPENGDTE YAPKFRG, CDR3—LIYAGYLAMD Y; and light chain CDR1—SASSSVTYMH, CDR2—STSNLAS, CDR3—QQRSTYPLT.</li> <li id="ul0016-0002" num="0226" class="style-scope patent-text">Hybridoma 806.077 deposited as European Collection of Cell Cultures (ECACC) deposit no. 96022936.
<br class="style-scope patent-text">
Research Corporation Technologies, Inc.: U.S. Pat. No. 5,047,507
<br class="style-scope patent-text">
Bayer Corporation: U.S. Pat. No. 6,013,772
<br class="style-scope patent-text">
BioAlliance: U.S. Pat. Nos. 7,982,017; 7,674,605
</li> </ul>
        </li>
            <li id="ul0015-0003" num="0227" class="style-scope patent-text">U.S. Pat. No. 7,674,605
        <ul class="style-scope patent-text"> <li id="ul0017-0001" num="0228" class="style-scope patent-text">an antibody comprising the heavy chain variable region sequence from the amino acid sequence of SEQ ID NO: 1, and the light chain variable region sequence from the amino acid sequence of SEQ ID NO:2.</li> <li id="ul0017-0002" num="0229" class="style-scope patent-text">an antibody comprising the heavy chain variable region sequence from the amino acid sequence of SEQ ID NO:5, and the light chain variable region sequence from the amino acid sequence of SEQ ID NO:6.
<br class="style-scope patent-text">
Celltech Therapeutics Limited: U.S. Pat. No. 5,877,293
<br class="style-scope patent-text">
The Dow Chemical Company: U.S. Pat. Nos. 5,472,693; 6,417,337; 6,333,405
</li> </ul>
        </li>
            <li id="ul0015-0004" num="0230" class="style-scope patent-text">U.S. Pat. No. 5,472,693—for example, ATCC No. CRL-11215</li>
            <li id="ul0015-0005" num="0231" class="style-scope patent-text">U.S. Pat. No. 6,417,337—for example, ATCC CRL-12208</li>
            <li id="ul0015-0006" num="0232" class="style-scope patent-text">U.S. Pat. No. 6,333,405—for example, ATCC CRL-12208
<br class="style-scope patent-text">
Immunomedics, Inc: U.S. Pat. Nos. 7,534,431; 7,230,084; 7,300,644; 6,730,300;
</li>
            <li id="ul0015-0007" num="0233" class="style-scope patent-text">US20110189085
        <ul class="style-scope patent-text"> <li id="ul0018-0001" num="0234" class="style-scope patent-text">an antibody having CDRs of the light chain variable region comprise: CDR1 comprises KASQDVGTSVA (SEQ ID NO: 20); CDR2 comprises WTSTRHT (SEQ ID NO: 21); and CDR3 comprises QQYSLYRS (SEQ ID NO: 22); and the CDRs of the heavy chain variable region of said anti-CEA antibody comprise: CDR1 comprises TYWMS (SEQ ID NO: 23); CDR2 comprises EIHPDSSTINYAPSLKD (SEQ ID NO: 24); and CDR3 comprises LYFGFPWFAY (SEQ ID NO: 25).</li> </ul>
        </li>
            <li id="ul0015-0008" num="0235" class="style-scope patent-text">US20100221175; US20090092598; US20070202044; US20110064653; US20090185974; US20080069775.
<br class="style-scope patent-text">
(42) MET (Met Proto-Oncogene; Hepatocyte Growth Factor Receptor)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no M35073
<br class="style-scope patent-text">
Genbank version no. M35073.1 GI:187553
<br class="style-scope patent-text">
Genbank record update date: Mar. 6, 2012 11:12 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA59589
<br class="style-scope patent-text">
Genbank version no. AAA59589.1 GI:553531
<br class="style-scope patent-text">
Genbank record update date: Mar. 6, 2012 11:12 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Dean M., et al <i class="style-scope patent-text">Nature </i>318 (6044), 385-388 (1985)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: MET
<br class="style-scope patent-text">
Other Aliases: AUTS9, HGFR, RCCP2, c-Met
<br class="style-scope patent-text">
Other Designations: HGF Receptor; HGF/SF Receptor; SF Receptor; Hepatocyte Growth Factor Receptor; Met Proto-Oncogene Tyrosine Kinase; Proto-Oncogene c-Met; Scatter Factor receptor; tyrosine-protein kinase Met
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Abgenix/Pfizer: US20100040629
</li>
            <li id="ul0015-0009" num="0236" class="style-scope patent-text">for example, the antibody produced by hybridoma 13.3.2 having American Type Culture Collection (ATCC) accession number PTA-5026; the antibody produced by hybridoma 9.1.2 having ATCC accession number PTA-5027; the antibody produced by hybridoma 8.70.2 having ATCC accession number PTA-5028; or the antibody produced by hybridoma 6.90.3 having ATCC accession number PTA-5029.
<br class="style-scope patent-text">
Amgen/Pfizer: US20050054019
</li>
            <li id="ul0015-0010" num="0237" class="style-scope patent-text">for example, an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 2 where X2 is glutamate and X4 is serine and a light chain having the amino acid sequence set forth in SEQ ID NO: 4 where X8 is alanine, without the signal sequences; an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 6 and a light chain having the amino acid sequence set forth in SEQ ID NO: 8, without the signal sequences; an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: and a light chain having the amino acid sequence set forth in SEQ ID NO: 12, without the signal sequences; or an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 14 and a light chain having the amino acid sequence set forth in SEQ ID NO: 16, without the signal sequences.
<br class="style-scope patent-text">
Agouron Pharmaceuticals (Now Pfizer): US20060035907
<br class="style-scope patent-text">
Eli Lilly: US20100129369
<br class="style-scope patent-text">
Genentech: U.S. Pat. No. 5,686,292; US20100028337; US20100016241; US20070129301; US20070098707; US20070092520, US20060270594; US20060134104; US20060035278; US20050233960; US20050037431
</li>
            <li id="ul0015-0011" num="0238" class="style-scope patent-text">U.S. Pat. No. 5,686,292—for example, ATCC HB-11894 and ATCC HB-11895</li>
            <li id="ul0015-0012" num="0239" class="style-scope patent-text">US 20100016241—for example, ATCC HB-11894 (hybridoma 1A3.3.13) or HB-11895 (hybridoma 5D5.11.6)
<br class="style-scope patent-text">
National Defense Medical Center, Taiwan: Lu R M., et al Biomaterials. 2011 April; 32(12):3265-74.
<br class="style-scope patent-text">
Novartis: US20090175860
</li>
            <li id="ul0015-0013" num="0240" class="style-scope patent-text">for example, an antibody comprising the sequences of CDR1, CDR2 and CDR3 of heavy chain 4687, wherein the sequences of CDR1, CDR2, and CDR3 of heavy chain 4687 are residues 26-35, 50-65, and 98-102, respectively, of SEQ ID NO: 58; and the sequences of CDR1, CDR2, and CDR3 of light chain 5097, wherein the sequences of CDR1, CDR2, and CDR3 of light chain 5097 are residues 24-39, 55-61, and 94-100 of SEQ ID NO: 37.
<br class="style-scope patent-text">
Pharmacia Corporation: US20040166544
<br class="style-scope patent-text">
Pierre Fabre: US20110239316, US20110097262, US20100115639
<br class="style-scope patent-text">
Sumsung: US 20110129481—for example a monoclonal antibody produced from a hybridoma cell having accession number KCLRF-BP-00219 or accession number of KCLRF-BP-00223.
<br class="style-scope patent-text">
Samsung: US 20110104176—for example an antibody produced by a hybridoma cell having Accession Number: KCLRF-BP-00220.
<br class="style-scope patent-text">
University of Turin Medical School: DN-30 Pacchiana G., et al <i class="style-scope patent-text">J Biol Chem. </i>2010 Nov. 12; 285(46):36149-57
<br class="style-scope patent-text">
Van Andel Research Institute: Jiao Y., et al <i class="style-scope patent-text">Mol Biotechnol. </i>2005 September; 31(1):41-54.
<br class="style-scope patent-text">
(43) MUC1 (Mucin 1, Cell Surface Associated)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no J05581
<br class="style-scope patent-text">
Genbank version no. J05581.1 GI:188869
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:48 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA59876
<br class="style-scope patent-text">
Genbank version no. AAA59876.1 GI:188870
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:48 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Gendler S. J., et al <i class="style-scope patent-text">J. Biol. Chem. </i>265 (25), 15286-15293 (1990)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: MUC1
<br class="style-scope patent-text">
Other Aliases: RP11-263K19.2, CD227, EMA, H23AG, KL-6, MAM6, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM
<br class="style-scope patent-text">
Other Designations: DF3 antigen; H23 antigen; breast carcinoma-associated antigen DF3; carcinoma-associated mucin; episialin; krebs von den Lungen-6; mucin 1, transmembrane; mucin-1; peanut-reactive urinary mucin; polymorphic epithelial mucin; tumor associated epithelial mucin; tumor-associated epithelial membrane antigen; tumor-associated mucin
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
AltaRex—Quest Pharma Tech: U.S. Pat. No. 6,716,966—for example an Alt-1 antibody produced by the hybridoma ATCC No PTA-975.
<br class="style-scope patent-text">
AltaRex—Quest Pharma Tech: U.S. Pat. No. 7,147,850
<br class="style-scope patent-text">
CRT: 5E5—Sorensen A L., et al <i class="style-scope patent-text">Glycobiology </i>vol. 16 no. 2 pp. 96-107, 2006; HMFG2—Burchell J., et al <i class="style-scope patent-text">Cancer Res., </i>47, 5476-5482 (1987); see WO2015/159076
<br class="style-scope patent-text">
Glycotope GT-MAB: GT-MAB 2.5-GEX (Website:
<br class="style-scope patent-text">
http://www.glycotope.com/pipeline/pankomab-gex)
<br class="style-scope patent-text">
Immunogen: U.S. Pat. No. 7,202,346
</li>
            <li id="ul0015-0014" num="0241" class="style-scope patent-text">for example, antibody MJ-170: hybridoma cell line MJ-170 ATCC accession no. PTA-5286Monoclonal antibody MJ-171: hybridoma cell line MJ-171 ATCC accession no. PTA-5287; monoclonal antibody MJ-172: hybridoma cell line MJ-172 ATCC accession no. PTA-5288; or monoclonal antibody MJ-173: hybridoma cell line MJ-173 ATCC accession no. PTA-5302
<br class="style-scope patent-text">
Immunomedics: U.S. Pat. No. 6,653,104
<br class="style-scope patent-text">
Ramot Tel Aviv Uni: U.S. Pat. No. 7,897,351
<br class="style-scope patent-text">
Regents Uni. CA: U.S. Pat. No. 7,183,388; US20040005647; US20030077676.
<br class="style-scope patent-text">
Roche GlycArt: U.S. Pat. No. 8,021,856
<br class="style-scope patent-text">
Russian National Cancer Research Center: Imuteran-Ivanov P K., et al <i class="style-scope patent-text">Biotechnol J. </i>2007 July; 2(7):863-70
<br class="style-scope patent-text">
Technische Univ Braunschweig: (11136, HT186-B7, HT186-D11, HT186-G2, HT200-3A-C1, HT220-M-D1, HT220-M-G8)—Thie H., et al <i class="style-scope patent-text">PLoS One. </i>2011 Jan. 14; 6(1):e15921 (44) CA9 (Carbonic anhydrase IX)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. X66839
<br class="style-scope patent-text">
Genbank version no. X66839.1 GI:1000701
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:15 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAA47315
<br class="style-scope patent-text">
Genbank version no. CAA47315.1 GI:1000702
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:15 AM
<br class="style-scope patent-text">
Cross References
<br class="style-scope patent-text">
Pastorek J., et al <i class="style-scope patent-text">Oncogene </i>9 (10), 2877-2888 (1994)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CA9
<br class="style-scope patent-text">
Other Aliases: CAIX, MN
<br class="style-scope patent-text">
Other Designations: CA-IX; P54/58N; RCC-associated antigen G250; RCC-associated protein G250; carbonate dehydratase IX; <figure-callout id="9" label="carbonic anhydrase" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbonic anhydrase</a></figure-callout> 9; carbonic dehydratase; membrane antigen MN; pMW1; renal cell carcinoma-associated antigen G250
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Abgenix/Amgen: US20040018198
<br class="style-scope patent-text">
Affibody: Anti-CAIX Affibody molecules
</li>
            <li id="ul0015-0015" num="0242" class="style-scope patent-text">(http://www.affibody.com/en/Product-Portfolio/Pipeline/)
<br class="style-scope patent-text">
Bayer: U.S. Pat. No. 7,462,696
<br class="style-scope patent-text">
Bayer/Morphosys: 3ee9 mAb—Petrul H M., et al <i class="style-scope patent-text">Mol Cancer Ther. </i>2012 February; 11(2):340-9
<br class="style-scope patent-text">
Harvard Medical School: Antibodies G10, G36, G37, G39, G45, G57, G106, G119, G6, G27, G40 and G125. Xu C., et al <i class="style-scope patent-text">PLoS One. </i>2010 Mar. 10; 5(3):e9625
<br class="style-scope patent-text">
Institute of Virology, Slovak Academy of Sciences (Bayer)—U.S. Pat. No. 5,955,075
</li>
            <li id="ul0015-0016" num="0243" class="style-scope patent-text">for example, M75—ATCC Accession No. HB 11128 or MN12—ATCC Accession No. HB 11647
<br class="style-scope patent-text">
Institute of Virology, Slovak Academy of Sciences: U.S. Pat. No. 7,816,493
</li>
            <li id="ul0015-0017" num="0244" class="style-scope patent-text">for example the M75 monoclonal antibody that is secreted from the hybridoma VU-M75, which was deposited at the American Type Culture Collection under ATCC No. HB 11128; or the V/10 monoclonal antibody secreted from the hybridoma V/10-VU, which was deposited at the International Depository Authority of the Belgian Coordinated Collection of Microorganisms (BCCM) at the Laboratorium voor Moleculaire Bioloqie-Plasmidencollectie (LMBP) at the Universeit Gent in Gent, Belgium, under Accession No. LMBP 6009CB.
<br class="style-scope patent-text">
Institute of Virology, Slovak Academy of Sciences US20080177046; US20080176310; US20080176258; US20050031623
<br class="style-scope patent-text">
Novartis: US20090252738
<br class="style-scope patent-text">
Wilex: U.S. Pat. No. 7,691,375—for example the antibody produced by the hybridoma cell line DSM ASC 2526.
<br class="style-scope patent-text">
Wilex: US20110123537; Rencarex: Kennett R H., et al <i class="style-scope patent-text">Curr Opin Mol Ther. </i>2003 February; 5(1):70-5
<br class="style-scope patent-text">
Xencor: US20090162382
<br class="style-scope patent-text">
(45) EGFRvIII (Epidermal Growth Factor Receptor (EGFR), Transcript Variant 3,
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_201283
<br class="style-scope patent-text">
Genbank version no. NM_201283.1 GI:41327733
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:47 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_958440
<br class="style-scope patent-text">
Genbank version no. NP_958440.1 GI:41327734
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:47 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Batra S K., et al <i class="style-scope patent-text">Cell Growth Differ </i>1995; 6:1251-1259.
<br class="style-scope patent-text">
Antibodies:
<br class="style-scope patent-text">
U.S. Pat. Nos. 7,628,986 and 7,736,644 (Amgen)
</li>
            <li id="ul0015-0018" num="0245" class="style-scope patent-text">For example, a heavy chain variable region amino acid sequence selected from the group consisting of SEQ ID NO: 142 and variants &amp; a light chain variable region amino acid sequence selected from the group consisting of: SEQ ID NO: 144 and variants.
<br class="style-scope patent-text">
US20100111979 (Amgen)
</li>
            <li id="ul0015-0019" num="0246" class="style-scope patent-text">For example, an antibody comprising a heavy chain amino acid sequence comprising:</li>
            <li id="ul0015-0020" num="0247" class="style-scope patent-text">CDR1 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR1 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17); CDR2 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR2 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17); and</li>
            <li id="ul0015-0021" num="0248" class="style-scope patent-text">CDR3 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR3 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).
<br class="style-scope patent-text">
US20090240038 (Amgen)
</li>
            <li id="ul0015-0022" num="0249" class="style-scope patent-text">For example, an antibody having at least one of the heavy or light chain polypeptides comprises an amino acid sequence that is at least 90% identical to the amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 19, SEQ ID NO: 142, SEQ ID NO: 144, and any combination thereof.
<br class="style-scope patent-text">
US20090175887 (Amgen)
</li>
            <li id="ul0015-0023" num="0250" class="style-scope patent-text">For example, an antibody having a heavy chain amino acid sequence selected from the group consisting of the heavy chain amino acid sequence of antibody 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).
<br class="style-scope patent-text">
US20090156790 (Amgen)
</li>
            <li id="ul0015-0024" num="0251" class="style-scope patent-text">For example, antibody having heavy chain polypeptide and a light chain polypeptide, wherein at least one of the heavy or light chain polypeptides comprises an amino acid sequence that is at least 90% identical to the amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 19, SEQ ID NO: 142, SEQ ID NO: 144, and any combination thereof.
<br class="style-scope patent-text">
US20090155282, US20050059087 and US20050053608 (Amgen)
</li>
            <li id="ul0015-0025" num="0252" class="style-scope patent-text">For example, an antibody heavy chain amino acid sequence selected from the group consisting of the heavy chain amino acid sequence of antibody 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).
<br class="style-scope patent-text">
MR1-1 (U.S. Pat. No. 7,129,332; Duke)
</li>
            <li id="ul0015-0026" num="0253" class="style-scope patent-text">For example, a variant antibody having the sequence of SEQ ID NO. 18 with the substitutions S98P-T99Y in the CDR3 VH, and F92W in CDR3 VL.
<br class="style-scope patent-text">
L8A4, H10, Y10 (Wikstrand C J., et al <i class="style-scope patent-text">Cancer Res. </i>1995 Jul. 15; 55(14):3140-8; Duke)
<br class="style-scope patent-text">
US20090311803 (Harvard University)
</li>
            <li id="ul0015-0027" num="0254" class="style-scope patent-text">For example, SEQ ID NO:9 for antibody heavy chain variable region, and SEQ ID NO: 3 for light chain variable region amino acid sequences
<br class="style-scope patent-text">
US20070274991 (EMD72000, also known as matuzumab; Harvard University)
</li>
            <li id="ul0015-0028" num="0255" class="style-scope patent-text">For example, SEQ ID NOs: 3 &amp; 9 for light chain and heavy chain respectively
<br class="style-scope patent-text">
U.S. Pat. No. 6,129,915 (Schering)
</li>
            <li id="ul0015-0029" num="0256" class="style-scope patent-text">For example, SEQ. ID NOs: 1, 2, 3, 4, 5 and 6.
<br class="style-scope patent-text">
mAb CH12—Wang H., et al <i class="style-scope patent-text">FASEB J. </i>2012 January; 26(1):73-80 (Shanghai Cancer Institute).
</li>
            <li id="ul0015-0030" num="0257" class="style-scope patent-text">RAbDMvIII—Gupta P., et al <i class="style-scope patent-text">BMC Biotechnol. </i>2010 Oct. 7; 10:72 (Stanford University Medical Center).
<br class="style-scope patent-text">
mAb Ua30—Ohman L., et al <i class="style-scope patent-text">Tumour Biol. </i>2002 March-April; 23(2):61-9 (Uppsala University).
<br class="style-scope patent-text">
Han D G., et al <i class="style-scope patent-text">Nan Fang Yi Ke Da Xue Xue Bao. </i>2010 January; 30(1):25-9 (Xi'an Jiaotong University).
<br class="style-scope patent-text">
(46) Cd33 (Cd33 Molecule)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. M_23197
<br class="style-scope patent-text">
Genbank version no. NM_23197.1 GI:180097
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA51948
<br class="style-scope patent-text">
Genbank version no. AAA51948.1 GI:188098
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Simmons D., et al <i class="style-scope patent-text">J. Immunol. </i>141 (8), 2797-2800 (1988)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD33
<br class="style-scope patent-text">
Other Aliases: SIGLEC-3, SIGLEC3, p67
<br class="style-scope patent-text">
Other Designations: CD33 antigen (gp67); gp67; myeloid cell surface antigen CD33; sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
H195 (Lintuzumab)—Raza A., et al <i class="style-scope patent-text">Leuk Lymphoma. </i>2009 August; 50(8):1336-44; U.S. Pat. No. 6,759,045 (Seattle Genetics/Immunomedics)
<br class="style-scope patent-text">
mAb OKT9: Sutherland, D. R. et al. <i class="style-scope patent-text">Proc Natl Acad Sci USA </i>78(7): 4515-4519 1981, Schneider, C., et al <i class="style-scope patent-text">J Biol Chem </i>257, 8516-8522 (1982)
<br class="style-scope patent-text">
mAb E6: Hoogenboom, H. R., et al <i class="style-scope patent-text">J Immunol </i>144, 3211-3217 (1990)
<br class="style-scope patent-text">
U.S. Pat. No. 6,590,088 (Human Genome Sciences)
</li>
            <li id="ul0015-0031" num="0258" class="style-scope patent-text">For example, SEQ ID NOs: 1 and 2 and ATCC accession no. 97521
<br class="style-scope patent-text">
U.S. Pat. No. 7,557,189 (Immunogen)
</li>
            <li id="ul0015-0032" num="0259" class="style-scope patent-text">For example, an antibody or fragment thereof comprising a heavy chain variable region which comprises three CDRs having the amino acid sequences of SEQ ID NOs:1-3 and a light chain variable region comprising three CDRs having the amino acid sequences of SEQ ID NOs:4-6.
<br class="style-scope patent-text">
(47) CD19 (CD19 Molecule)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_001178098
<br class="style-scope patent-text">
Genbank version no. NM_001178098.1 GI:296010920
<br class="style-scope patent-text">
Genbank record update date: Sep. 10, 2012 12:43 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_001171569
<br class="style-scope patent-text">
Genbank version no. NP_001171569.1 GI:296010921
<br class="style-scope patent-text">
Genbank record update date: Sep. 10, 2012 12:43 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Tedder T F., et al J. Immunol. 143 (2): 712-7 (1989)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD19
<br class="style-scope patent-text">
Other Aliases: B4, CVID3
<br class="style-scope patent-text">
Other Designations: B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; T-cell surface antigen Leu-12; differentiation antigen CD19
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Immunogen: HuB4—Al-Katib A M., et al <i class="style-scope patent-text">Clin Cancer Res. </i>2009 Jun. 15; 15(12):4038-45.
<br class="style-scope patent-text">
4G7: Kügler M., et al <i class="style-scope patent-text">Protein Eng Des Sel. </i>2009 March; 22(3):135-47
</li>
            <li id="ul0015-0033" num="0260" class="style-scope patent-text">For example, sequences in FIG. 3 of of Knappik, A. et al. <i class="style-scope patent-text">J Mol Biol </i>2000 February; 296(1):57-86
<br class="style-scope patent-text">
AstraZeneca/MedImmune: MEDI-551—Herbst R., et al <i class="style-scope patent-text">J Pharmacol Exp Ther. </i>2010 October; 335(1):213-22
<br class="style-scope patent-text">
Glenmark Pharmaceuticals: GBR-401—Hou S., et al <i class="style-scope patent-text">Mol Cancer Ther </i>November 2011 (Meeting Abstract Supplement) C164
<br class="style-scope patent-text">
U.S. Pat. No. 7,109,304 (Immunomedics)
</li>
            <li id="ul0015-0034" num="0261" class="style-scope patent-text">For example, an antibody comprising the sequence of hA19Vk (SEQ ID NO:7) and the sequence of hA19VH (SEQ ID NO:10)
<br class="style-scope patent-text">
U.S. Pat. No. 7,902,338 (Immunomedics)
</li>
            <li id="ul0015-0035" num="0262" class="style-scope patent-text">For example, an antibody or antigen-binding fragment thereof that comprises the light chain complementarity determining region CDR sequences CDR1 of SEQ ID NO: 16 (KASQSVDYDGDSYLN); CDR2 of SEQ ID NO: 17 (DASNLVS); and CDR3 of SEQ ID NO: 18 (QQSTEDPWT) and the heavy chain CDR sequences CDR1 of SEQ ID NO: 19 (SYWMN); CDR2 of SEQ ID NO: 20 (QIWPGDGDTNYNGKFKG) and CDR3 of SEQ ID NO: 21 (RETTTVGRYYYAMDY) and also comprises human antibody framework (FR) and constant region sequences with one or more framework region amino acid residues substituted from the corresponding framework region sequences of the parent murine antibody, and wherein said substituted FR residues comprise the substitution of serine for phenylalanine at Kabat residue 91 of the heavy chain variable region.
<br class="style-scope patent-text">
Medarex: MDX-1342—Cardarelli P M., et al <i class="style-scope patent-text">Cancer Immunol Immunother. </i>2010 February; 59(2):257-65.
<br class="style-scope patent-text">
MorphoSys/Xencor: MOR-208/XmAb-5574—Zalevsky J., et al <i class="style-scope patent-text">Blood. </i>2009 Apr. 16; 113(16):3735-43
<br class="style-scope patent-text">
U.S. Pat. No. 7,968,687 (Seattle Genetics)
</li>
            <li id="ul0015-0036" num="0263" class="style-scope patent-text">An antibody or antigen-binding fragment comprising a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO:9 and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 24.
<br class="style-scope patent-text">
4G7 chim—Lang P., et al <i class="style-scope patent-text">Blood. </i>2004 May 15; 103(10):3982-5 (University of Tübingen)
</li>
            <li id="ul0015-0037" num="0264" class="style-scope patent-text">For example, FIG. 6 and SEQ ID No: 80 of US20120082664
<br class="style-scope patent-text">
Zhejiang University School of Medicine: 2E8—Zhang J., et al <i class="style-scope patent-text">J Drug Target. </i>2010 November; 18(9):675-8
<br class="style-scope patent-text">
(48) IL2RA (Interleukin 2 Receptor, Alpha); NCBI Reference Sequence: NM_000417.2);
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_000417
<br class="style-scope patent-text">
Genbank version no. NM_000417.2 GI:269973860
<br class="style-scope patent-text">
Genbank record update date: Sep. 9, 2012 04:59 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_000408
<br class="style-scope patent-text">
Genbank version no. NP_000408.1 GI:4557667
<br class="style-scope patent-text">
Genbank record update date: Sep. 9, 2012 04:59 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Kuziel W. A., et al <i class="style-scope patent-text">J. Invest. Dermatol. </i>94 (6 SUPPL), 27S-32S (1990)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: IL2RA
<br class="style-scope patent-text">
Other Aliases: RP11-536K7.1, CD25, IDDM10, IL2R, TCGFR
<br class="style-scope patent-text">
Other Designations: FIL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA; TAC antigen; interleukin-2 receptor subunit alpha; p55
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
U.S. Pat. No. 6,383,487 (Novartis/UCL: Baxilisimab [Simulect])
<br class="style-scope patent-text">
U.S. Pat. No. 6,521,230 (Novartis/UCL: Baxilisimab [Simulect])
</li>
            <li id="ul0015-0038" num="0265" class="style-scope patent-text">For example, an antibody having an antigen binding site comprises at least one domain which comprises CDR1 having the amino acid sequence in SEQ. ID. NO: 7, CDR2 having the amino acid sequence in SEQ. ID. NO: 8, and CDR3 having the amino acid sequence in SEQ. ID. NO: 9; or said CDR1, CDR2 and CDR3 taken in sequence as a whole comprise an amino acid sequence which is at least 90% identical to SEQ. ID. NOs: 7, 8 and 9 taken in sequence as a whole.
<br class="style-scope patent-text">
Daclizumab—Rech A J., et al <i class="style-scope patent-text">Ann NY Acad Sci. </i>2009 September; 1174:99-106 (Roche)
<br class="style-scope patent-text">
(49) AXL (AXL Receptor Tyrosine Kinase)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. M76125
<br class="style-scope patent-text">
Genbank version no. M76125.1 GI:292869
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:53 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA61243
<br class="style-scope patent-text">
Genbank version no. AAA61243.1 GI:29870
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:53 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
O'Bryan J. P., et al <i class="style-scope patent-text">Mol. Cell. Biol. </i>11 (10), 5016-5031 (1991); Bergsagel P. L., et al <i class="style-scope patent-text">J. Immunol. </i>148 (2), 590-596 (1992)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: AXL
<br class="style-scope patent-text">
Other Aliases: JTK11, UFO
<br class="style-scope patent-text">
Other Designations: AXL oncogene; AXL transforming sequence/gene; oncogene AXL; tyrosine-protein kinase receptor UFO
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
YW327.652—Ye X., et al <i class="style-scope patent-text">Oncogene. </i>2010 Sep. 23; 29(38):5254-64. (Genentech)
<br class="style-scope patent-text">
Bergen Bio: BGB324 (http://www.bergenbio.com/BGB324)
<br class="style-scope patent-text">
(50) CD30—TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. M83554
<br class="style-scope patent-text">
Genbank version no. M83554.1 GI:180095
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:53 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA51947
<br class="style-scope patent-text">
Genbank version no. AAA51947.1 GI:180096
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:53 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Durkop H., et al <i class="style-scope patent-text">Cell </i>68 (3), 421-427 (1992)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: TNFRSF8
<br class="style-scope patent-text">
Other Aliases: CD30, D1S166E, Ki-1
<br class="style-scope patent-text">
Other Designations: CD30L receptor; Ki-1 antigen; cytokine receptor CD30; lymphocyte activation antigen CD30; tumor necrosis factor <figure-callout id="8" label="receptor superfamily member" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">receptor superfamily member</a></figure-callout> 8
<br class="style-scope patent-text">
(51) BCMA (B-Cell Maturation Antigen)—TNFRSF17 (Tumor Necrosis Factor Receptor Superfamily, Member 17)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. Z29574
<br class="style-scope patent-text">
Genbank version no. Z29574.1 GI:471244
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:40 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAA82690
<br class="style-scope patent-text">
Genbank version no. CAA82690.1 GI:471245
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:40 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Laabi Y., et al Nucleic Acids Res. 22 (7), 1147-1154 (1994)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: TNFRSF17
<br class="style-scope patent-text">
Other Aliases: BCM, BCMA, CD269
<br class="style-scope patent-text">
Other Designations: B cell maturation antigen; B-cell maturation factor; B-cell maturation protein; tumor necrosis factor receptor superfamily member 17
<br class="style-scope patent-text">
(52) CT Ags—CTA (Cancer Testis Antigens)
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Fratta E., et al. <i class="style-scope patent-text">Mol Oncol. </i>2011 April; 5(2):164-82; Lim S H., at al <i class="style-scope patent-text">Am J Blood Res. </i>2012; 2(1):29-35.
<br class="style-scope patent-text">
(53) CD174 (Lewis Y)—FUT3 (Fucosyltransferase 3 (Galactoside 3(4)-L-fucosyltransferase, Lewis Blood Group)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM000149
<br class="style-scope patent-text">
Genbank version no. NM000149.3 GI:148277008
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 04:49 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_000140
<br class="style-scope patent-text">
Genbank version no. NP_000140.1 GI:4503809
<br class="style-scope patent-text">
Genbank record update date: Jun. 26, 2012 04:49 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Kukowska-Latallo, J. F., et al <i class="style-scope patent-text">Genes Dev. </i>4 (8), 1288-1303 (1990)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: FUT3
<br class="style-scope patent-text">
Other Aliases: CD174, FT3B, FucT-III, LE, Les
<br class="style-scope patent-text">
Other Designations: Lewis FT; alpha-(1,3/1,4)-fucosyltransferase; blood group Lewis alpha-4-fucosyltransferase; fucosyltransferase III; galactoside 3(4)-L-fucosyltransferase
<br class="style-scope patent-text">
(54) CLEC14A (C-Type Lectin Domain Family 14, Member A; Genbank Accession No. NM175060)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM175060
<br class="style-scope patent-text">
Genbank version no. NM175060.2 GI:371123930
<br class="style-scope patent-text">
Genbank record update date: Apr. 1, 2012 03:34 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_778230
<br class="style-scope patent-text">
Genbank version no. NP_778230.1 GI:28269707
<br class="style-scope patent-text">
Genbank record update date: Apr. 1, 2012 03:34 PM
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CLEC14A
<br class="style-scope patent-text">
Other Aliases: UNQ236/PRO269, C14orf27, CEG1, EGFR-5
<br class="style-scope patent-text">
Other Designations: C-type lectin domain family 14 member A; CIECT and EGF-like domain containing protein; epidermal growth factor receptor 5
<br class="style-scope patent-text">
(55) GRP78—HSPA5 (Heat Shock 70 kDa Protein 5 (Glucose-Regulated Protein, 78 kDa)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM005347
<br class="style-scope patent-text">
Genbank version no. NM005347.4 GI:305855105
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:42 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_005338
<br class="style-scope patent-text">
Genbank version no. NP_005338.1 GI:16507237
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:42 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Ting J., et al DNA 7 (4), 275-286 (1988)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: HSPA5
<br class="style-scope patent-text">
Other Aliases: BIP, GRP78, MIF2
<br class="style-scope patent-text">
Other Designations: 78 kDa glucose-regulated protein; endoplasmic reticulum lumenal Ca(2+)-binding protein grp78; immunoglobulin heavy chain-binding protein
<br class="style-scope patent-text">
(56) CD70 (CD70 Molecule) L08096
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. L08096
<br class="style-scope patent-text">
Genbank version no. L08096.1 GI:307127
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2012 08:54 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA36175
<br class="style-scope patent-text">
Genbank version no. AAA36175.1 GI:307128
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2012 08:54 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Goodwin R. G., et al <i class="style-scope patent-text">Cell </i>73 (3), 447-456 (1993)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD70
<br class="style-scope patent-text">
Other Aliases: CD27L, CD27LG, TNFSF7
<br class="style-scope patent-text">
Other Designations: CD27 ligand; CD27-L; CD70 antigen; Ki-24 antigen; surface antigen CD70; tumor necrosis factor (ligand) superfamily, member 7; tumor necrosis factor ligand superfamily member 7
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
MDX-1411 against CD70 (Medarex)
<br class="style-scope patent-text">
h1F6 (Oflazoglu, E., et al, Clin Cancer Res. 2008 Oct. 1; 14(19):6171-80; Seattle Genetics)
</li>
            <li id="ul0015-0039" num="0266" class="style-scope patent-text">For example, see US20060083736 SEQ ID NOs: 1, 2, 11 and 12 and <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>.
<br class="style-scope patent-text">
(57) Stem Cell Specific Antigens. For Example:
</li>
            <li id="ul0015-0040" num="0267" class="style-scope patent-text">5T4 (see entry (63) below)</li>
            <li id="ul0015-0041" num="0268" class="style-scope patent-text">CD25 (see entry (48) above)</li>
            <li id="ul0015-0042" num="0269" class="style-scope patent-text">CD32
        <ul class="style-scope patent-text"> <li id="ul0019-0001" num="0270" class="style-scope patent-text">Polypeptide
            <ul class="style-scope patent-text"> <li id="ul0020-0001" num="0271" class="style-scope patent-text">Genbank accession no. ABK42161</li> <li id="ul0020-0002" num="0272" class="style-scope patent-text">Genbank version no. ABK42161.1 GI:117616286</li> <li id="ul0020-0003" num="0273" class="style-scope patent-text">Genbank record update date: Jul. 25, 2007 03:00 PM</li> </ul>
            </li> </ul>
        </li>
            <li id="ul0015-0043" num="0274" class="style-scope patent-text">LGR5/GPR49
        <ul class="style-scope patent-text"> <li id="ul0021-0001" num="0275" class="style-scope patent-text">Nucleotide
            <ul class="style-scope patent-text"> <li id="ul0022-0001" num="0276" class="style-scope patent-text">Genbank accession no. NM_003667</li> <li id="ul0022-0002" num="0277" class="style-scope patent-text">Genbank version no. NM_003667.2 GI:24475886</li> <li id="ul0022-0003" num="0278" class="style-scope patent-text">Genbank record update date: Jul. 22, 2012 03:38 PM</li> </ul>
            </li> <li id="ul0021-0002" num="0279" class="style-scope patent-text">Polypeptide
            <ul class="style-scope patent-text"> <li id="ul0023-0001" num="0280" class="style-scope patent-text">Genbank accession no. NP_003658</li> <li id="ul0023-0002" num="0281" class="style-scope patent-text">Genbank version no. NP_003658.1 GI:4504379</li> <li id="ul0023-0003" num="0282" class="style-scope patent-text">Genbank record update date: Jul. 22, 2012 03:38 PM</li> </ul>
            </li> </ul>
        </li>
            <li id="ul0015-0044" num="0283" class="style-scope patent-text">Prominin/CD133
        <ul class="style-scope patent-text"> <li id="ul0024-0001" num="0284" class="style-scope patent-text">Nucleotide
            <ul class="style-scope patent-text"> <li id="ul0025-0001" num="0285" class="style-scope patent-text">Genbank accession no. NM_006017</li> <li id="ul0025-0002" num="0286" class="style-scope patent-text">Genbank version no. NM_006017.2 GI:224994187</li> <li id="ul0025-0003" num="0287" class="style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</li> </ul>
            </li> <li id="ul0024-0002" num="0288" class="style-scope patent-text">Polypeptide
            <ul class="style-scope patent-text"> <li id="ul0026-0001" num="0289" class="style-scope patent-text">Genbank accession no. NP_006008</li> <li id="ul0026-0002" num="0290" class="style-scope patent-text">Genbank version no. NP_006008.1 GI:5174387</li> <li id="ul0026-0003" num="0291" class="style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM
<br class="style-scope patent-text">
(58) ASG-5
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
(Smith L. M., et. al <i class="style-scope patent-text">AACR </i>2010 <i class="style-scope patent-text">Annual Meeting </i>(abstract #2590); Gudas J. M., et. al. <i class="style-scope patent-text">AACR </i>2010 <i class="style-scope patent-text">Annual Meeting </i>(abstract #4393)
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Anti-AGS-5 Antibody: M6.131 (Smith, L. M., et. al <i class="style-scope patent-text">AACR </i>2010 <i class="style-scope patent-text">Annual Meeting </i>(abstract #2590)
<br class="style-scope patent-text">
(59) ENPP3 (Ectonucleotide pyrophosphatase/phosphodiesterase 3)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AF005632
<br class="style-scope patent-text">
Genbank version no. AF005632.2 GI:4432589
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 09:41 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAC51813
<br class="style-scope patent-text">
Genbank version no. AAC51813.1 GI:2465540
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 09:41 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Jin-Hua P., et al <i class="style-scope patent-text">Genomics </i>45 (2), 412-415 (1997)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: ENPP3
<br class="style-scope patent-text">
Other Aliases: RP5-988G15.3, B10, CD203c, NPP3, PD-IBETA, PDNP3
<br class="style-scope patent-text">
Other Designations: E-NPP 3; dJ1005H11.3 (phosphodiesterase I/nucleotide pyrophosphatase 3); dJ914N13.3 (phosphodiesterase I/nucleotide pyrophosphatase 3); ectonucleotide pyrophosphatase/phosphodiesterase family member 3; gp130RB13-6; phosphodiesterase I beta; phosphodiesterase I/nucleotide pyrophosphatase 3; phosphodiesterase-I beta
<br class="style-scope patent-text">
(60) PRR4 (Proline Rich 4 (Lacrimal))
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_007244
<br class="style-scope patent-text">
Genbank version no. NM_007244.2 GI:154448885
<br class="style-scope patent-text">
Genbank record update date: Jun. 28, 2012 12:39 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_009175
<br class="style-scope patent-text">
Genbank version no. NP_009175.2 GI:154448886
<br class="style-scope patent-text">
Genbank record update date: Jun. 28, 2012 12:39 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Dickinson D. P., et al <i class="style-scope patent-text">Invest. Ophthalmol. Vis. Sci. </i>36 (10), 2020-2031 (1995)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: PRR4
<br class="style-scope patent-text">
Other Aliases: LPRP, PROL4
<br class="style-scope patent-text">
Other Designations: lacrimal proline-rich protein; nasopharyngeal carcinoma-associated proline-<figure-callout id="4" label="rich protein" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rich protein</a></figure-callout> 4; proline-<figure-callout id="4" label="rich polypeptide" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rich polypeptide</a></figure-callout> 4; proline-<figure-callout id="4" label="rich protein" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rich protein</a></figure-callout> 4
<br class="style-scope patent-text">
(61) GCC—GUCY2C (Guanylate Cyclase 2C (Heat Stable Enterotoxin Receptor)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_004963
<br class="style-scope patent-text">
Genbank version no. NM_004963.3 GI:222080082
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:50 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_004954
<br class="style-scope patent-text">
Genbank version no. NP_004954.2 GI:222080083
<br class="style-scope patent-text">
Genbank record update date: Sep. 2, 2012 01:50 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
De Sauvage F. J., et al <i class="style-scope patent-text">J. Biol. Chem. </i>266 (27), 17912-17918 (1991); Singh S., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>179 (3), 1455-1463 (1991)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: GUCY2C
<br class="style-scope patent-text">
Other Aliases: DIAR6, GUC2C, MUCIL, STAR
<br class="style-scope patent-text">
Other Designations: GC-C; STA receptor; guanylyl cyclase C; hSTAR; heat-stable enterotoxin receptor; intestinal guanylate cyclase
<br class="style-scope patent-text">
(62) Liv-1—SLC39A6 (Solute Carrier Family 39 (Zinc Transporter), Member 6)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. U41060
<br class="style-scope patent-text">
Genbank version no. U41060.2 GI:12711792
<br class="style-scope patent-text">
Genbank record update date: Nov. 30, 2009 04:35 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA96258
<br class="style-scope patent-text">
Genbank version no. AAA96258.2 GI:12711793
<br class="style-scope patent-text">
Genbank record update date: Nov. 30, 2009 04:35 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Taylor K M., et al <i class="style-scope patent-text">Biochim Biophys Acta. </i>2003 Apr. 1; 1611(1-2):16-30
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: SLC39A6
<br class="style-scope patent-text">
Other Aliases: LIV-1
<br class="style-scope patent-text">
Other Designations: LIV-1 protein, estrogen regulated; ZIP-6; estrogen-regulated protein LIV-1; solute carrier family 39 (metal ion transporter), <figure-callout id="6" label="member" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">member</a></figure-callout> 6; <figure-callout id="39" label="solute carrier family" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">solute carrier family</a></figure-callout> 39 <figure-callout id="6" label="member" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">member</a></figure-callout> 6; zinc transporter ZIP6; zrt- and Irt-<figure-callout id="6" label="like protein" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">like protein</a></figure-callout> 6
<br class="style-scope patent-text">
(63) 5T4, Trophoblast Glycoprotein, TPBG-TPBG (Trophoblast Glycoprotein)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AJ012159
<br class="style-scope patent-text">
Genbank version no. AJ012159.1 GI:3805946
<br class="style-scope patent-text">
Genbank record update date: Feb. 1, 2011 10:27 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAA09930
<br class="style-scope patent-text">
Genbank version no. CAA09930.1 GI:3805947
<br class="style-scope patent-text">
Genbank record update date: Feb. 1, 2011 10:27 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
King K. W., et al <i class="style-scope patent-text">Biochim. Biophys. Acta </i>1445 (3), 257-270 (1999)
<br class="style-scope patent-text">
Other Information
</li> </ul>
            </li> </ul>
        </li>
            <li id="ul0015-0045" num="0292" class="style-scope patent-text">Official Symbol: TPBG</li>
            <li id="ul0015-0046" num="0293" class="style-scope patent-text">Other Aliases: 5T4, 5T4AG, M6P1</li>
            <li id="ul0015-0047" num="0294" class="style-scope patent-text">Other Designations: 5T4 oncofetal antigen; 5T4 oncofetal trophoblast glycoprotein; 5T4 oncotrophoblast glycoprotein</li>
            <li id="ul0015-0048" num="0295" class="style-scope patent-text">See WO2015/155345
<br class="style-scope patent-text">
(64) CD56—NCMA1 (Neural Cell Adhesion Molecule 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_000615
<br class="style-scope patent-text">
Genbank version no. NM_000615.6 GI:336285433
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:32 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_000606
<br class="style-scope patent-text">
Genbank version no. NP_000606.3 GI:94420689
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:32 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Dickson, G., et al, <i class="style-scope patent-text">Cell </i>50 (7), 1119-1130 (1987)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: NCAM1
<br class="style-scope patent-text">
Other Aliases: CD56, MSK39, NCAM
<br class="style-scope patent-text">
Other Designations: antigen recognized by monoclonal antibody 5.1H11; neural cell adhesion molecule, NCAM
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Immunogen: HuN901 (Smith S V., et al <i class="style-scope patent-text">Curr Opin Mol Ther. </i>2005 August; 7(4):394-401)
</li>
            <li id="ul0015-0049" num="0296" class="style-scope patent-text">For example, see humanized from murine N901 antibody. See FIGS. 1b and 1e of Roguska, M. A., et al. <i class="style-scope patent-text">Proc Natl Acad Sci USA </i>February 1994; 91:969-973.
<br class="style-scope patent-text">
(65) CanAg (Tumor Associated Antigen CA242)
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Haglund C., et al <i class="style-scope patent-text">Br J Cancer </i>60:845-851, 1989; Baeckstrom D., et al <i class="style-scope patent-text">J Biol Chem </i>266:21537-21547, 1991
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
huC242 (Tolcher A W et al., <i class="style-scope patent-text">J Clin Oncol. </i>2003 Jan. 15; 21(2):211-22; Immunogen)
</li>
            <li id="ul0015-0050" num="0297" class="style-scope patent-text">For example, see US20080138898A1 SEQ ID NO: 1 and 2
<br class="style-scope patent-text">
(66) FOLR1 (Folate Receptor 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. J05013
<br class="style-scope patent-text">
Genbank version no. J05013.1 GI:182417
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA35823
<br class="style-scope patent-text">
Genbank version no. AAA35823.1 GI:182418
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Elwood P. C., et al <i class="style-scope patent-text">J. Biol. Chem. </i>264 (25), 14893-14901 (1989)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: FOLR1
<br class="style-scope patent-text">
Other Aliases: FBP, FOLR
<br class="style-scope patent-text">
Other Designations: FR-alpha; KB cells FBP; adult folate-binding protein; folate binding protein; folate receptor alpha; folate receptor, adult; ovarian tumor-associated antigen MOv18
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
M9346A—Whiteman K R., et al <i class="style-scope patent-text">Cancer Res </i>Apr. 15, 2012; 72(8 Supplement): 4628 (Immunogen)
<br class="style-scope patent-text">
(67) GPNMB (Glycoprotein (Transmembrane) Nmb)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. X76534
<br class="style-scope patent-text">
Genbank version no. X76534.1 GI:666042
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:10 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAA54044
<br class="style-scope patent-text">
Genbank version no. CAA54044.1 GI:666043
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:10 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Weterman M. A., et al <i class="style-scope patent-text">Int. J. Cancer </i>60 (1), 73-81 (1995)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: GPNMB
<br class="style-scope patent-text">
Other Aliases: UNQ1725/PRO9925, HGFIN, NMB
<br class="style-scope patent-text">
Other Designations: glycoprotein NMB; glycoprotein nmb-like protein; osteoactivin; transmembrane glycoprotein HGFIN; transmembrane glycoprotein NMB
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Celldex Therapeutics: CR011 (Tse K F., et al <i class="style-scope patent-text">Clin Cancer Res. </i>2006 Feb. 15; 12(4):1373-82)
</li>
            <li id="ul0015-0051" num="0298" class="style-scope patent-text">For example, see EP1827492B1 SEQ ID NO: 22, 24, 26, 31, 33 and 35
<br class="style-scope patent-text">
(68) TIM-1—HAVCR1 (Hepatitis a Virus Cellular Receptor 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AF043724
<br class="style-scope patent-text">
Genbank version no. AF043724.1 GI:2827453
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 06:24 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAC39862
<br class="style-scope patent-text">
Genbank version no. AAC39862.1 GI:2827454
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 06:24 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Feigelstock D., et al <i class="style-scope patent-text">J. Virol. </i>72 (8), 6621-6628 (1998)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: HAVCR1
<br class="style-scope patent-text">
Other Aliases: HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1
<br class="style-scope patent-text">
Other Designations: T cell immunoglobin domain and mucin domain protein 1; T-cell membrane protein 1; kidney injury molecule 1
<br class="style-scope patent-text">
(69) RG-1/Prostate Tumor Target Mindin—Mindin/RG-1
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Parry R., et al <i class="style-scope patent-text">Cancer Res. </i>2005 Sep. 15; 65(18):8397-405 (70) 87-H4—VTCN1 (V-set domain containing T cell activation inhibitor 1
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. BX648021
<br class="style-scope patent-text">
Genbank version no. BX648021.1 GI:34367180
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 08:40 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Sica G L., et al <i class="style-scope patent-text">Immunity. </i>2003 June; 18(6):849-61
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: VTCN1
<br class="style-scope patent-text">
Other Aliases: RP11-229A19.4, B7-H4, B7H4, B7S1, B7X, B7 h.5, PRO1291, VCTN1
<br class="style-scope patent-text">
Other Designations: B7 family member, H4; B7 superfamily member 1; T cell costimulatory molecule B7x; T-cell costimulatory molecule B7x; V-set domain-containing T-cell activation inhibitor 1; immune costimulatory protein B7-H4
<br class="style-scope patent-text">
(71) PTK7 (PTK7 Protein Tyrosine Kinase 7)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AF447176
<br class="style-scope patent-text">
Genbank version no. AF447176.1 GI:17432420
<br class="style-scope patent-text">
Genbank record update date: Nov. 28, 2008 01:51 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAL39062
<br class="style-scope patent-text">
Genbank version no. AAL39062.1 GI:17432421
<br class="style-scope patent-text">
Genbank record update date: Nov. 28, 2008 01:51 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Park S. K., et al <i class="style-scope patent-text">J. Biochem. </i>119 (2), 235-239 (1996)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: PTK7
<br class="style-scope patent-text">
Other Aliases: CCK-4, CCK4
<br class="style-scope patent-text">
Other Designations: <figure-callout id="4" label="colon carcinoma kinase" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">colon carcinoma kinase</a></figure-callout> 4; inactive tyrosine-protein kinase 7; pseudo tyrosine kinase receptor 7; tyrosine-protein kinase-like 7
<br class="style-scope patent-text">
(72) CD37 (CD37 Molecule)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_001040031
<br class="style-scope patent-text">
Genbank version no. NM_001040031.1 GI:91807109
<br class="style-scope patent-text">
Genbank record update date: Jul. 29, 2012 02:08 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_001035120
<br class="style-scope patent-text">
Genbank version no. NP_001035120.1 GI:91807110
<br class="style-scope patent-text">
Genbank record update date: Jul. 29, 2012 02:08 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Schwartz-Albiez R., et al <i class="style-scope patent-text">J. Immunol. </i>140 (3), 905-914 (1988)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD37
<br class="style-scope patent-text">
Other Aliases: GP52-40, TSPAN26
<br class="style-scope patent-text">
Other Designations: CD37 antigen; cell differentiation antigen 37; leukocyte antigen CD37; leukocyte surface antigen CD37; tetraspanin-26; tspan-26
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Boehringer Ingelheim: mAb 37.1 (Heider K H., et al <i class="style-scope patent-text">Blood. </i>2011 Oct. 13; 118(15):4159-68)
<br class="style-scope patent-text">
Trubion: CD37-SMIP (G28-1 scFv-Ig) ((Zhao X., et al <i class="style-scope patent-text">Blood. </i>2007; 110: 2569-2577)
</li>
            <li id="ul0015-0052" num="0299" class="style-scope patent-text">For example, see US20110171208A1 SEQ ID NO: 253
<br class="style-scope patent-text">
Immunogen: K7153A (Deckert J., et al <i class="style-scope patent-text">Cancer Res </i>Apr. 15, 2012; 72(8 Supplement): 4625)
<br class="style-scope patent-text">
(73) CD138—SDC1 (Syndecan 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AJ551176
<br class="style-scope patent-text">
Genbank version no. AJ551176.1 GI:29243141
<br class="style-scope patent-text">
Genbank record update date: Feb. 1, 2011 12:09 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CAD80245
<br class="style-scope patent-text">
Genbank version no. CAD80245.1 GI:29243142
<br class="style-scope patent-text">
Genbank record update date: Feb. 1, 2011 12:09 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
O'Connell F P., et al <i class="style-scope patent-text">Am J Clin Pathol. </i>2004 February; 121(2):254-63
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: SDC1
<br class="style-scope patent-text">
Other Aliases: CD138, SDC, SYND1, syndecan
<br class="style-scope patent-text">
Other Designations: CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; syndecan proteoglycan 1; syndecan-1
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Biotest: chimerized MAb (nBT062)—(Jagannath S., et al Poster ASH #3060, 2010; WIPO Patent Application WO/2010/128087)
</li>
            <li id="ul0015-0053" num="0300" class="style-scope patent-text">For example, see US20090232810 SEQ ID NO: 1 and 2
<br class="style-scope patent-text">
Immunogen: B-B4 (Tassone P., et al <i class="style-scope patent-text">Blood </i>104_3688-3696)
</li>
            <li id="ul0015-0054" num="0301" class="style-scope patent-text">For example, see US20090175863A1 SEQ ID NO: 1 and 2
<br class="style-scope patent-text">
(74) CD74 (CD74 Molecule, Major Histocompatibility Complex, Class II Invariant Chain)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_004355
<br class="style-scope patent-text">
Genbank version no. NM_004355.1 GI:343403784
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:30 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_004346
<br class="style-scope patent-text">
Genbank version no. NP_004346.1 GI:10835071
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:30 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Kudo, J., et al <i class="style-scope patent-text">Nucleic Acids Res. </i>13 (24), 8827-8841 (1985)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD74
<br class="style-scope patent-text">
Other Aliases: DHLAG, HLADG, II, Ia-GAMMA
<br class="style-scope patent-text">
Other Designations: CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); HLA class II histocompatibility antigen gamma chain; HLA-DR antigens-associated invariant chain; HLA-DR-gamma; Ia-associated invariant chain; MHC HLA-DR gamma chain; gamma chain of class II antigens; p33
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Immunomedics: hLL1 (Milatuzumab,)—Berkova Z., et al <i class="style-scope patent-text">Expert Opin Investig Drugs. </i>2010 January; 19(1):141-9)
</li>
            <li id="ul0015-0055" num="0302" class="style-scope patent-text">For example, see US20040115193 SEQ ID NOs: 19, 20, 21, 22, 23 and 24
<br class="style-scope patent-text">
Genmab: HuMax-CD74 (see website)
<br class="style-scope patent-text">
(75) Claudins—CLs (Claudins)
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Offner S., et al <i class="style-scope patent-text">Cancer Immunol Immunother. </i>2005 May; 54(5):431-45, Suzuki H., et al <i class="style-scope patent-text">Ann N Y Acad Sci. </i>2012 July; 1258:65-70)
<br class="style-scope patent-text">
In humans, 24 members of the family have been described—see literature reference.
<br class="style-scope patent-text">
(76) EGFR (Epidermal Growth Factor Receptor)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_005228
<br class="style-scope patent-text">
Genbank version no. NM_005228.3 GI:41927737
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:47 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_005219
<br class="style-scope patent-text">
Genbank version no. NP_005219.2 GI:29725609
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:47 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Dhomen N S., et al <i class="style-scope patent-text">Crit Rev Oncog. </i>2012; 17(1):31-50
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: EGFR
<br class="style-scope patent-text">
Other Aliases: ERBB, ERBB1, HER1, PIG61, mENA
<br class="style-scope patent-text">
Other Designations: avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell <figure-callout id="40" label="growth inhibiting protein" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">growth inhibiting protein</a></figure-callout> 40; cell proliferation-inducing protein 61; proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
BMS: Cetuximab (Erbitux)—Broadbridge Vt., et al <i class="style-scope patent-text">Expert Rev Anticancer Ther. </i>2012 May; 12(5):555-65.
</li>
            <li id="ul0015-0056" num="0303" class="style-scope patent-text">For example, see U.S. Pat. No. 6,217,866—ATTC deposit No. 9764.
<br class="style-scope patent-text">
Amgen: Panitumumab (Vectibix)—Argiles G., et al <i class="style-scope patent-text">Future Oncol. </i>2012 April; 8(4):373-89
</li>
            <li id="ul0015-0057" num="0304" class="style-scope patent-text">For example, see U.S. Pat. No. 6,235,883 SEQ ID NOs: 23-38.
<br class="style-scope patent-text">
Genmab: Zalutumumab—Rivera F., et al <i class="style-scope patent-text">Expert Opin Biol Ther. </i>2009 May; 9(5):667-74.
<br class="style-scope patent-text">
YM Biosciences: Nimotuzumab—Ramakrishnan M S., et al MAbs. 2009 January-February; 1(1):41-8.
</li>
            <li id="ul0015-0058" num="0305" class="style-scope patent-text">For example, see U.S. Pat. No. 5,891,996 SEQ ID NOs: 27-34.
<br class="style-scope patent-text">
(77) Her3 (ErbB3)—ERBB3 (v-Erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (Avian))
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. M34309
<br class="style-scope patent-text">
Genbank version no. M34309.1 GI:183990
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA35979
<br class="style-scope patent-text">
Genbank version no. AAA35979.1 GI:306841
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:47 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Plowman, G. D., et al., <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>87 (13), 4905-4909 (1990)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: ERBB3
<br class="style-scope patent-text">
Other Aliases: ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3
<br class="style-scope patent-text">
Other Designations: proto-oncogene-like protein c-ErbB-3; receptor tyrosine-protein kinase erbB-3; tyrosine kinase-type cell surface receptor HER3
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Merimack Pharma: MM-121 (Schoeberl B., et al <i class="style-scope patent-text">Cancer Res. </i>2010 Mar. 15; 70(6):2485-2494)
</li>
            <li id="ul0015-0059" num="0306" class="style-scope patent-text">For example, see US2011028129 SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7 and 8.
<br class="style-scope patent-text">
(78) RON—MST1R (Macrophage Stimulating 1 Receptor (c-Met-Related Tyrosine Kinase))
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. X70040
<br class="style-scope patent-text">
Genbank version no. X70040.1 GI:36109
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:17 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CCA49634
<br class="style-scope patent-text">
Genbank version no. CCA49634.1 GI:36110
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:17 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Ronsin C., et al <i class="style-scope patent-text">Oncogene </i>8 (5), 1195-1202 (1993)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: MST1R
<br class="style-scope patent-text">
Other Aliases: CD136, CDw136, PTK8, RON
<br class="style-scope patent-text">
Other Designations: MSP receptor; MST1R variant RON30; MST1R variant RON62; PTK8 <figure-callout id="8" label="protein tyrosine kinase" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">protein tyrosine kinase</a></figure-callout> 8; RON variant E2E3; c-met-related tyrosine kinase; macrophage-stimulating protein receptor; p185-Ron; soluble RON variant 1; soluble RON variant 2; soluble RON variant 3; <figure-callout id="4" label="soluble RONvariant" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">soluble RONvariant</a></figure-callout> 4
<br class="style-scope patent-text">
(79) EPHA2 (EPH Receptor A2)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. BC037166
<br class="style-scope patent-text">
Genbank version no. BC037166.2 GI:33879863
<br class="style-scope patent-text">
Genbank record update date: Mar. 6, 2012 01:59 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAH37166
<br class="style-scope patent-text">
Genbank version no. AAH37166.1 GI:22713539
<br class="style-scope patent-text">
Genbank record update date: Mar. 6, 2012 01:59 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99 (26), 16899-16903 (2002)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: EPHA2
<br class="style-scope patent-text">
Other Aliases: ARCC2, CTPA, CTPP1, ECK
<br class="style-scope patent-text">
Other Designations: ephrin type-A receptor 2; epithelial cell receptor protein tyrosine kinase; soluble EPHA2 variant 1; tyrosine-protein kinase receptor ECK
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Medimmune: 1C1 (Lee J W., et al <i class="style-scope patent-text">Clin Cancer Res. </i>2010 May 1; 16(9):2562-2570)
</li>
            <li id="ul0015-0060" num="0307" class="style-scope patent-text">For example, see US20090304721A1 FIGS. 7 and 8.
<br class="style-scope patent-text">
(80) CD20—MS4A1 (Membrane-Spanning 4-Domains, Subfamily A, Member 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. M27394
<br class="style-scope patent-text">
Genbank version no. M27394.1 GI:179307
<br class="style-scope patent-text">
Genbank record update date: Nov. 30, 2009 11:16 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA35581
<br class="style-scope patent-text">
Genbank version no. AAA35581.1 GI:179308
<br class="style-scope patent-text">
Genbank record update date: Nov. 30, 2009 11:16 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Tedder T. F., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>85 (1), 208-212 (1988)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: MS4A1
<br class="style-scope patent-text">
Other Aliases: B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
<br class="style-scope patent-text">
Other Designations: B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1;
<br class="style-scope patent-text">
CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Genentech/Roche: Rituximab—Abdulla N E., et al <i class="style-scope patent-text">BioDrugs. </i>2012 Apr. 1; 26(2):71-82.
</li>
            <li id="ul0015-0061" num="0308" class="style-scope patent-text">For example, see U.S. Pat. No. 5,736,137, ATCC deposit No. HB-69119.
<br class="style-scope patent-text">
GSK/Genmab: Ofatumumab—Nightingale G., et al Ann Pharmacother. 2011 October; 45(10):1248-55.
</li>
            <li id="ul0015-0062" num="0309" class="style-scope patent-text">For example, see US20090169550A1 SEQ ID NOs: 2, 4 and 5.
<br class="style-scope patent-text">
Immunomedics: Veltuzumab—Goldenberg D M., et al <i class="style-scope patent-text">Leuk Lymphoma. </i>2010 May; 51(5):747-55.
</li>
            <li id="ul0015-0063" num="0310" class="style-scope patent-text">For example, see U.S. Pat. No. 7,919,273B2 SEQ ID NOs: 1, 2, 3, 4, 5 and 6.
<br class="style-scope patent-text">
(81) Tenascin C—TNC (Tenascin C)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_002160
<br class="style-scope patent-text">
Genbank version no. NM_002160.3 GI:340745336
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:33 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_002151
<br class="style-scope patent-text">
Genbank version no. NP_002151.2 GI:153946395
<br class="style-scope patent-text">
Genbank record update date: Sep. 23, 2012 02:33 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Nies D. E., et al J. Biol. Chem. 266 (5), 2818-2823 (1991); Sin A., et al Nucleic Acids Res. 19 (3), 525-531 (1991)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: TNC
<br class="style-scope patent-text">
Other Aliases: 150-225, GMEM, GP, HXB, JI, TN, TN-C
<br class="style-scope patent-text">
Other Designations: GP 150-225; cytotactin; glioma-associated-extracellular matrix antigen; hexabrachion (tenascin); myotendinous antigen; neuronectin; tenascin; tenascin-C isoform 14/AD1/16
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Philogen: G11 (von Lukowicz T., et al <i class="style-scope patent-text">J Nucl Med. </i>2007 April; 48(4):582-7) and F16 (Pedretti M., et al Lung Cancer. 2009 April; 64(1):28-33)
</li>
            <li id="ul0015-0064" num="0311" class="style-scope patent-text">For example, see U.S. Pat. No. 7,968,685 SEQ ID NOs: 29, 35, 45 and 47.
<br class="style-scope patent-text">
(82) FAP (Fibroblast Activation Protein, Alpha)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. U09278
<br class="style-scope patent-text">
Genbank version no. U09278.1 GI:1888315
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 09:22 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAB49652
<br class="style-scope patent-text">
Genbank version no. AAB49652.1 GI:1888316
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 09:22 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Scanlan, M. J., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>91 (12), 5657-5661 (1994)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: FAP
<br class="style-scope patent-text">
Other Aliases: DPPIV, FAPA
<br class="style-scope patent-text">
Other Designations: 170 kDa melanoma membrane-bound gelatinase; integral membrane serine protease; seprase
<br class="style-scope patent-text">
(83) DKK-1 (Dickkopf 1 Homolog (<i class="style-scope patent-text">Xenopus laevis</i>)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_012242
<br class="style-scope patent-text">
Genbank version no. NM_012242.2 GI:61676924
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:48 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_036374
<br class="style-scope patent-text">
Genbank version no. NP_036374.1 GI:7110719
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:48 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Fedi P. et al <i class="style-scope patent-text">J. Biol. Chem. </i>274 (27), 19465-19472 (1999)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: DKK1
<br class="style-scope patent-text">
Other Aliases: UNQ492/PRO1008, DKK-1, SK
<br class="style-scope patent-text">
Other Designations: dickkopf related protein-1; dickkopf-1 like; dickkopf-like protein 1; dickkopf-related protein 1; hDkk-1
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Novartis: BHQ880 (Fulciniti M., et al <i class="style-scope patent-text">Blood. </i>2009 Jul. 9; 114(2):371-379)
</li>
            <li id="ul0015-0065" num="0312" class="style-scope patent-text">For example, see US20120052070A1 SEQ ID NOs: 100 and 108.
<br class="style-scope patent-text">
(84) Cd52 (Cd52 Molecule)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_001803
<br class="style-scope patent-text">
Genbank version no. NM_001803.2 GI:68342029
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:48 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_001794
<br class="style-scope patent-text">
Genbank version no. NP_001794.2 GI:68342030
<br class="style-scope patent-text">
Genbank record update date: Sep. 30, 2012 01:48 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Xia M. Q., et al <i class="style-scope patent-text">Eur. J. Immunol. </i>21 (7), 1677-1684 (1991)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: CD52
<br class="style-scope patent-text">
Other Aliases: CDW52
<br class="style-scope patent-text">
Other Designations: CAMPATH-1 antigen; CD52 antigen (CAMPATH-1 antigen); CDW52 antigen (CAMPATH-1 antigen); cambridge pathology 1 antigen; epididymal secretory protein E5; he5; human epididymis-specific protein 5
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
Alemtuzumab (Campath)—Skoetz N., et al <i class="style-scope patent-text">Cochrane Database Syst Rev. </i>2012 Feb. 15; 2:CD008078.
</li>
            <li id="ul0015-0066" num="0313" class="style-scope patent-text">For example, see Drugbank Acc. No. DB00087 (BIOD00109, BTD00109)
<br class="style-scope patent-text">
(85) CS1—SLAMF7 (SLAM family member 7)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. NM_021181
<br class="style-scope patent-text">
Genbank version no. NM_021181.3 GI:1993571
<br class="style-scope patent-text">
Genbank record update date: Jun. 29, 2012 11:24 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. NP_067004
<br class="style-scope patent-text">
Genbank version no. NP_067004.3 GI:19923572
<br class="style-scope patent-text">
Genbank record update date: Jun. 29, 2012 11:24 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Boles K. S., et al <i class="style-scope patent-text">Immunogenetics </i>52 (3-4), 302-307 (2001)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: SLAMF7
<br class="style-scope patent-text">
Other Aliases: UNQ576/PRO1138, 19A, CD319, CRACC, CS1
<br class="style-scope patent-text">
Other Designations: 19A24 protein; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CD2-like receptor-activating cytotoxic cells; membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; protein 19A
<br class="style-scope patent-text">
Antibodies
<br class="style-scope patent-text">
BMS: elotuzumab/HuLuc63 (Benson D M., et al <i class="style-scope patent-text">J Clin Oncol. </i>2012 Jun. 1; 30(16):2013-2015)
</li>
            <li id="ul0015-0067" num="0314" class="style-scope patent-text">For example, see US20110206701 SEQ ID NOs: 9, 10, 11, 12, 13, 14, 15 and 16.
<br class="style-scope patent-text">
(86) Endoglin—ENG (Endoglin)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. AF035753
<br class="style-scope patent-text">
Genbank version no. AF035753.1 GI:3452260
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 06:36 PM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAC32802
<br class="style-scope patent-text">
Genbank version no. AAC32802.1 GI:3452261
<br class="style-scope patent-text">
Genbank record update date: Mar. 10, 2010 06:36 PM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Rius C., et al <i class="style-scope patent-text">Blood </i>92 (12), 4677-4690 (1998)
<br class="style-scope patent-text">
Official Symbol: ENG
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Other Aliases: RP11-228B15.2, CD105, END, HHT1, ORW, ORW1
<br class="style-scope patent-text">
Other Designations: CD105 antigen
<br class="style-scope patent-text">
(87) Annexin A1—ANXA1 (Annexin A1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. X05908
<br class="style-scope patent-text">
Genbank version no. X05908.1 GI:34387
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:02 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. CCA29338
<br class="style-scope patent-text">
Genbank version no. CCA29338.1 GI:34388
<br class="style-scope patent-text">
Genbank record update date: Feb. 2, 2011 10:02 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Wallner B. P., et al <i class="style-scope patent-text">Nature </i>320 (6057), 77-81 (1986)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol: ANXA1
<br class="style-scope patent-text">
Other Aliases: RP11-71A24.1, ANX1, LPC1
<br class="style-scope patent-text">
Other Designations: annexin I (lipocortin I); annexin-1; calpactin II; calpactin-2; chromobindin-9; lipocortin I; p35; phospholipase A2 inhibitory protein
<br class="style-scope patent-text">
(88) V-CAM (CD106)—VCAM1 (Vascular Cell Adhesion Molecule 1)
<br class="style-scope patent-text">
Nucleotide
<br class="style-scope patent-text">
Genbank accession no. M60335
<br class="style-scope patent-text">
Genbank version no. M60335.1 GI:340193
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:56 AM
<br class="style-scope patent-text">
Polypeptide
<br class="style-scope patent-text">
Genbank accession no. AAA61269
<br class="style-scope patent-text">
Genbank version no. AAA61269.1 GI:340194
<br class="style-scope patent-text">
Genbank record update date: Jun. 23, 2010 08:56 AM
<br class="style-scope patent-text">
Cross-References
<br class="style-scope patent-text">
Hession C., et al <i class="style-scope patent-text">J. Biol. Chem. </i>266 (11), 6682-6685 (1991)
<br class="style-scope patent-text">
Other Information
<br class="style-scope patent-text">
Official Symbol VCAM1
<br class="style-scope patent-text">
Other Aliases: CD106, INCAM-100
<br class="style-scope patent-text">
Other Designations: CD106 antigen; vascular cell adhesion protein 1
<br class="style-scope patent-text">
Antibody Sequences
</li>
          </ul>
        </li>
      </ul>
    
    <div id="p-0190" num="0315" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00001" num="00001" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" pgwide="1" tabstyle="monospace" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-Integrin avB6</td>
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHAB6.2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGSELKKPGASVKISCKASGFAFTDSYMHWVRQAPGQGLEWMGWIDPENGDT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EYAPKFQGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCTRGTPTAVPNLRGDLQVLAQKVA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">GPYPFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHCB6.2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGYTFIDSYMHWVRQAPGQRLEWMGWIDPENGDT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EYAPKFQGRVTITTDTSASTAYMELSSLRSEDTAVYYCARGTPTAVPNLRGDLQVLAQKV</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">AGPYPFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGFNFIDSYMHWVRQAPGQRLEWMGWIDPENGD</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">TEYAPKFQGRVTFTTDTSASTAYMELSSLRSEDTAVYYCNEGTPTGPYYFDYWGQGTLV</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">TVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHFB6</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGFNFIDSYMHWVRQAPGQRLEWMGWIDPENGD</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">TEYAPKFQGRVTFTTDTSASTAYMELSSLRSEDTAVYYCNEGTPTAVPNLRGDLQVLAQK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAGPYYFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHAY100bP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGSELKKPGASVKISCKASGFAFTDSYMHWVRQAPGQGLEWMGWIDPENGDT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EYAPKFQGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCTRGTPTGPYPFDYWGQGTLVTV</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">SS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RKF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ENVLTQSPGTLSLSPGERATLSCSASSSVSYMHWFQQKPGQAPRLLIYSTSNLASGIPDR</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">FSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYPLTFGGGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RKFL36L50</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ENVLTQSPGTLSLSPGERATLSCSASSSVSYMHWLQQKPGQAPRLLIYLTSNLASGIPDR</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">FSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYPLTFGGGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RKC</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EIVLTQSPGTLSLSPGERATLSCSASSSVSYMHWFQQKPGQAPRLLIYSTSNLASGIPDRF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">SGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYPLTFGGGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-CD33</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD33 Hum195 VH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">GYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD33 Hum195 VK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">GVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-CD19</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD19 B4 resurfaced VH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQRPGQGLEWIGEIDPSDSYT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NYNQNFKGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSV</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">TVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD19 B4 resurfaced VK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-Her2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Herceptin VH chain</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTR</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Herceptin VL chain</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-CD25</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Simulect VK (also known as Basiliximab)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Simulect VH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-PSMA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH ′1</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVQSGPEVKKPGATVKISCKTSGYTFTEYTIHWVKQAPGKGLEWIGNINPNNGGTTY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NQKFEDKATLTVDKSTDTAYMELSSLRSEDTAVYYCAAGWNFDYWGQGTLLTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK ′1</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSLSTSVGDRVTLTCKASQDVGTAVDWYQQKPGPSPKLLIYWASTRHTGIPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSGTDFTLTISSLQPEDFADYYCQQYNSYPLTFGPGTKVDIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH1 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNN</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">FATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTGVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH2 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH3 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH4 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRFTISRDDSKSIVYLQMNNLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK1 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQFPSSMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DRFTGSGSATDFTLTISSLQTEDLADYYCGQSYTFPYTFGQGTKLEMK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK2 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQFPSSMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DRFSGSGSGTDFTLTISSLQAEDLADYYCGQSYTFPYTFGQGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK3 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIQMTQFPSAMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DRFSGSGSGTDFTLTISSLQAEDLADYYCGQSYTFPYTFGQGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK4 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIQMTQFPSAMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DRFSGSGSGTDFTLTISSLQAEDEADYYCGQSYTFPYTFGQGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK DI ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQFPKSMSASAGERMTLTCKASENVGTYVSWYQQKPTQSPKMLIYGASNRFTGVP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DRFSGSGSGTDFILTISSVQAEDLVDYYCGQSYTFPYTFGGGTKLEMK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH DI ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLEESGGGLVQPGGSMKISCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVIISRDDSKSSVYLQMNSLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHA ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVGEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRFTISRDDSKNTAYLQMNSLKTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHB ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHC ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHD ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVGEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHE ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRFTISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHF ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVIISRDDSKNTAYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RHG ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATHYAESVKGRVIISRDDSKNTAYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKA ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLLIYGASNRFTGVPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKB ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLLIYGASNRFTGVPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKC ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKD ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKE ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLLIYGASNRFTGVPD</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFTGSGSATDFILTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKF ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFSGSGSATDFILTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised RKG ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPD</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RFTGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div id="p-0191" num="0316" class="description-paragraph style-scope patent-text">The parent antibody may also be a fusion protein comprising an albumin-binding peptide (ABP) sequence (Dennis et al. (2002) “Albumin Binding As A General Strategy For Improving The Pharmacokinetics Of Proteins” <i class="style-scope patent-text">J Biol Chem. </i>277:35035-35043; WO 01/45746). Antibodies of the invention include fusion proteins with ABP sequences taught by: (i) Dennis et al (2002) <i class="style-scope patent-text">J Biol Chem. </i>277:35035-35043 at Tables III and IV, page 35038; (ii) US 2004/0001827 at [0076]; and (iii) WO 01/45746 at pages 12-13, and all of which are incorporated herein by reference.</div>
    <div id="p-0192" num="0317" class="description-paragraph style-scope patent-text">In one embodiment, the antibody has been raised to target specific the tumour related antigen α<sub class="style-scope patent-text">v</sub>β<sub class="style-scope patent-text">6</sub>.</div>
    <div id="p-0193" num="0318" class="description-paragraph style-scope patent-text">The cell binding agent may be labelled, for example to aid detection or purification of the agent either prior to incorporation as a conjugate, or as part of the conjugate. The label may be a biotin label. In another embodiment, the cell binding agent may be labelled with a radioisotope.</div>
    <div id="h-0109" num="0000" class="description-paragraph style-scope patent-text">Connection of Linker Unit to Ligand Unit</div>
    <div id="p-0194" num="0319" class="description-paragraph style-scope patent-text">The Ligand unit is connected to the Linker unit through a disulfide bond.</div>
    <div id="p-0195" num="0320" class="description-paragraph style-scope patent-text">In one embodiment, the connection between the Ligand unit and the Drug Linker is formed between a thiol group of a cysteine residue of the Ligand unit and a maleimide group of the Drug Linker unit.</div>
    <div id="p-0196" num="0321" class="description-paragraph style-scope patent-text">The cysteine residues of the Ligand unit may be available for reaction with the functional group of the Linker unit to form a connection. In other embodiments, for example where the Ligand unit is an antibody, the thiol groups of the antibody may participate in interchain disulfide bonds. These interchain bonds may be converted to free thiol groups by e.g. treatment of the antibody with DTT prior to reaction with the functional group of the Linker unit.</div>
    <div id="p-0197" num="0322" class="description-paragraph style-scope patent-text">In some embodiments, the cysteine residue is an introduced into the heavy or light chain of an antibody. Positions for cysteine insertion by substitution in antibody heavy or light chains include those described in Published U.S. Application No. 2007-0092940 and International Patent Publication WO2008070593, which are incorporated herein.</div>
    <div id="h-0110" num="0000" class="description-paragraph style-scope patent-text">Methods of Treatment</div>
    <div id="p-0198" num="0323" class="description-paragraph style-scope patent-text">The compounds of the present invention may be used in a method of therapy. Also provided is a method of treatment, comprising administering to a subject in need of treatment a therapeutically-effective amount of a conjugate of formula II. The term “therapeutically effective amount” is an amount sufficient to show benefit to a patient. Such benefit may be at least amelioration of at least one symptom. The actual amount administered, and rate and time-course of administration, will depend on the nature and severity of what is being treated. Prescription of treatment, e.g. decisions on dosage, is within the responsibility of general practitioners and other medical doctors.</div>
    <div id="p-0199" num="0324" class="description-paragraph style-scope patent-text">A conjugate may be administered alone or in combination with other treatments, either simultaneously or sequentially dependent upon the condition to be treated. Examples of treatments and therapies include, but are not limited to, chemotherapy (the administration of active agents, including, e.g. drugs; surgery; and radiation therapy.</div>
    <div id="p-0200" num="0325" class="description-paragraph style-scope patent-text">Pharmaceutical compositions according to the present invention, and for use in accordance with the present invention, may comprise, in addition to the active ingredient, i.e. a conjugate of formula I, a pharmaceutically acceptable excipient, carrier, buffer, stabiliser or other materials well known to those skilled in the art. Such materials should be non-toxic and should not interfere with the efficacy of the active ingredient. The precise nature of the carrier or other material will depend on the route of administration, which may be oral, or by injection, e.g. cutaneous, subcutaneous, or intravenous.</div>
    <div id="p-0201" num="0326" class="description-paragraph style-scope patent-text">Pharmaceutical compositions for oral administration may be in tablet, capsule, powder or liquid form. A tablet may comprise a solid carrier or an adjuvant. Liquid pharmaceutical compositions generally comprise a liquid carrier such as water, petroleum, animal or vegetable oils, mineral oil or synthetic oil. Physiological saline solution, dextrose or other saccharide solution or glycols such as ethylene glycol, propylene glycol or polyethylene glycol may be included. A capsule may comprise a solid carrier such a gelatin.</div>
    <div id="p-0202" num="0327" class="description-paragraph style-scope patent-text">For intravenous, cutaneous or subcutaneous injection, or injection at the site of affliction, the active ingredient will be in the form of a parenterally acceptable aqueous solution which is pyrogen-free and has suitable pH, isotonicity and stability. Those of relevant skill in the art are well able to prepare suitable solutions using, for example, isotonic vehicles such as Sodium Chloride Injection, Ringer's Injection, Lactated Ringer's Injection. Preservatives, stabilisers, buffers, antioxidants and/or other additives may be included, as required.</div>
    <div id="p-0203" num="0328" class="description-paragraph style-scope patent-text">The Conjugates can be used to treat proliferative disease and autoimmune disease. The term “proliferative disease” pertains to an unwanted or uncontrolled cellular proliferation of excessive or abnormal cells which is undesired, such as, neoplastic or hyperplastic growth, whether in vitro or in vivo.</div>
    <div id="p-0204" num="0329" class="description-paragraph style-scope patent-text">Examples of proliferative conditions include, but are not limited to, benign, pre-malignant, and malignant cellular proliferation, including but not limited to, neoplasms and tumours (e.g., histocytoma, glioma, astrocyoma, osteoma), cancers (e.g. lung cancer, small cell lung cancer, gastrointestinal cancer, bowel cancer, colon cancer, breast carinoma, ovarian carcinoma, prostate cancer, testicular cancer, liver cancer, kidney cancer, bladder cancer, pancreatic cancer, brain cancer, sarcoma, osteosarcoma, Kaposi's sarcoma, melanoma), leukemias, psoriasis, bone diseases, fibroproliferative disorders (e.g. of connective tissues), and atherosclerosis. Other cancers of interest include, but are not limited to, haematological; malignancies such as leukemias and lymphomas, such as non-Hodgkin lymphoma, and subtypes such as DLBCL, marginal zone, mantle zone, and follicular, Hodgkin lymphoma, AML, and other cancers of B or T cell origin.</div>
    <div id="p-0205" num="0330" class="description-paragraph style-scope patent-text">Examples of autoimmune disease include the following: rheumatoid arthritis, autoimmune demyelinative diseases (e.g., multiple sclerosis, allergic encephalomyelitis), psoriatic arthritis, endocrine ophthalmopathy, uveoretinitis, systemic lupus erythematosus, myasthenia gravis, Graves' disease, glomerulonephritis, autoimmune hepatological disorder, inflammatory bowel disease (e.g., Crohn's disease), anaphylaxis, allergic reaction, Sjögren's syndrome, type I diabetes mellitus, primary biliary cirrhosis, Wegener's granulomatosis, fibromyalgia, polymyositis, dermatomyositis, multiple endocrine failure, Schmidt's syndrome, autoimmune uveitis, Addison's disease, adrenalitis, thyroiditis, Hashimoto's thyroiditis, autoimmune thyroid disease, pernicious anemia, gastric atrophy, chronic hepatitis, lupoid hepatitis, atherosclerosis, subacute cutaneous lupus erythematosus, hypoparathyroidism, Dressler's syndrome, autoimmune thrombocytopenia, idiopathic thrombocytopenic purpura, hemolytic anemia, pemphigus vulgaris, pemphigus, dermatitis herpetiformis, alopecia arcata, pemphigoid, scleroderma, progressive systemic sclerosis, CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia), male and female autoimmune infertility, ankylosing spondolytis, ulcerative colitis, mixed connective tissue disease, polyarteritis nedosa, systemic necrotizing vasculitis, atopic dermatitis, atopic rhinitis, Goodpasture's syndrome, Chagas' disease, sarcoidosis, rheumatic fever, asthma, recurrent abortion, anti-phospholipid syndrome, farmer's lung, erythema multiforme, post cardiotomy syndrome, Cushing's syndrome, autoimmune chronic active hepatitis, bird-fancier's lung, toxic epidermal necrolysis, Alport's syndrome, alveolitis, allergic alveolitis, fibrosing alveolitis, interstitial lung disease, erythema nodosum, pyoderma gangrenosum, transfusion reaction, Takayasu's arteritis, polymyalgia rheumatica, temporal arteritis, schistosomiasis, giant cell arteritis, ascariasis, aspergillosis, Sampter's syndrome, eczema, lymphomatoid granulomatosis, Behcet's disease, Caplan's syndrome, Kawasaki's disease, dengue, encephalomyelitis, endocarditis, endomyocardial fibrosis, endophthalmitis, erythema elevatum et diutinum, psoriasis, erythroblastosis fetalis, eosinophilic faciitis, Shulman's syndrome, Felty's syndrome, filariasis, cyclitis, chronic cyclitis, heterochronic cyclitis, Fuch's cyclitis, IgA nephropathy, Henoch-Schonlein purpura, graft versus host disease, transplantation rejection, cardiomyopathy, Eaton-Lambert syndrome, relapsing polychondritis, cryoglobulinemia, Waldenstrom's macroglobulemia, Evan's syndrome, and autoimmune gonadal failure.</div>
    <div id="p-0206" num="0331" class="description-paragraph style-scope patent-text">In some embodiments, the autoimmune disease is a disorder of B lymphocytes (e.g., systemic lupus erythematosus, Goodpasture's syndrome, rheumatoid arthritis, and type I diabetes), Th1-lymphocytes (e.g., rheumatoid arthritis, multiple sclerosis, psoriasis, Sjögren's syndrome, Hashimoto's thyroiditis, Graves' disease, primary biliary cirrhosis, Wegener's granulomatosis, tuberculosis, or graft versus host disease), or Th2-lymphocytes (e.g., atopic dermatitis, systemic lupus erythematosus, atopic asthma, rhinoconjunctivitis, allergic rhinitis, Omenn's syndrome, systemic sclerosis, or chronic graft versus host disease). Generally, disorders involving dendritic cells involve disorders of Th1-lymphocytes or Th2-lymphocytes. In some embodiments, the autoimmune disorder is a T cell-mediated immunological disorder.</div>
    <div id="p-0207" num="0332" class="description-paragraph style-scope patent-text">In some embodiments, the amount of the Conjugate administered ranges from about 0.01 to about 10 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.01 to about 5 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.05 to about 5 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 5 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 4 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.05 to about 3 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 3 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 2 mg/kg per dose.</div>
    <div id="h-0111" num="0000" class="description-paragraph style-scope patent-text">Drug Loading</div>
    <div id="p-0208" num="0333" class="description-paragraph style-scope patent-text">The drug loading (p) is the average number of PBD drugs per cell binding agent, e.g. antibody. Where the compounds of the invention are bound to cysteines, drug loading may range from 1 to 8 drugs (D) per cell binding agent, i.e. where 1, 2, 3, 4, 5, 6, 7, and 8 drug moieties are covalently attached to the cell binding agent. Compositions of conjugates include collections of cell binding agents, e.g. antibodies, conjugated with a range of drugs, from 1 to 8. Where the compounds of the invention are bound to lysines, drug loading may range from 1 to 80 drugs (D) per cell binding agent, although an upper limit of 40, 20, 10 or 8 may be preferred. Compositions of conjugates include collections of cell binding agents, e.g. antibodies, conjugated with a range of drugs, from 1 to 80, 1 to 40, 1 to 20, 1 to 10 or 1 to 8.</div>
    <div id="p-0209" num="0334" class="description-paragraph style-scope patent-text">The average number of drugs per antibody in preparations of ADC from conjugation reactions may be characterized by conventional means such as UV, reverse phase HPLC,</div>
    <div id="p-0210" num="0335" class="description-paragraph style-scope patent-text">HIC, mass spectroscopy, ELISA assay, and electrophoresis. The quantitative distribution of ADC in terms of p may also be determined. By ELISA, the averaged value of p in a particular preparation of ADC may be determined (Hamblett et al (2004) Clin. Cancer Res. 10:7063-7070; Sanderson et al (2005) Clin. Cancer Res. 11:843-852). However, the distribution of p (drug) values is not discernible by the antibody-antigen binding and detection limitation of ELISA. Also, ELISA assay for detection of antibody-drug conjugates does not determine where the drug moieties are attached to the antibody, such as the heavy chain or light chain fragments, or the particular amino acid residues. In some instances, separation, purification, and characterization of homogeneous ADC where p is a certain value from ADC with other drug loadings may be achieved by means such as reverse phase HPLC or electrophoresis. Such techniques are also applicable to other types of conjugates.</div>
    <div id="p-0211" num="0336" class="description-paragraph style-scope patent-text">For some antibody-drug conjugates, p may be limited by the number of attachment sites on the antibody. For example, an antibody may have only one or several cysteine thiol groups, or may have only one or several sufficiently reactive thiol groups through which a linker may be attached. Higher drug loading, e.g. p&gt;5, may cause aggregation, insolubility, toxicity, or loss of cellular permeability of certain antibody-drug conjugates.</div>
    <div id="p-0212" num="0337" class="description-paragraph style-scope patent-text">Typically, fewer than the theoretical maximum of drug moieties are conjugated to an antibody during a conjugation reaction. An antibody may contain, for example, many lysine residues that do not react with the Drug Linker. Only the most reactive lysine groups may react with an amine-reactive linker reagent. Also, only the most reactive cysteine thiol groups may react with a thiol-reactive linker reagent. Generally, antibodies do not contain many, if any, free and reactive cysteine thiol groups which may be linked to a drug moiety. Most cysteine thiol residues in the antibodies of the compounds exist as disulfide bridges and must be reduced with a reducing agent such as dithiothreitol (DTT) or TCEP, under partial or total reducing conditions. The loading (drug/antibody ratio) of an ADC may be controlled in several different manners, including: (i) limiting the molar excess of Drug Linker relative to antibody, (ii) limiting the conjugation reaction time or temperature, and (iii) partial or limiting reductive conditions for cysteine thiol modification.</div>
    <div id="p-0213" num="0338" class="description-paragraph style-scope patent-text">Certain antibodies have reducible interchain disulfides, i.e. cysteine bridges. Antibodies may be made reactive for conjugation with linker reagents by treatment with a reducing agent such as DTT (dithiothreitol). Each cysteine bridge will thus form, theoretically, two reactive thiol nucleophiles. Additional nucleophilic groups can be introduced into antibodies through the reaction of lysines with 2-iminothiolane (Traut's reagent) resulting in conversion of an amine into a thiol. Reactive thiol groups may be introduced into the antibody (or fragment thereof) by engineering one, two, three, four, or more cysteine residues (e.g., preparing mutant antibodies comprising one or more non-native cysteine amino acid residues). U.S. Pat. No. 7,521,541 teaches engineering antibodies by introduction of reactive cysteine amino acids.</div>
    <div id="p-0214" num="0339" class="description-paragraph style-scope patent-text">Cysteine amino acids may be engineered at reactive sites in an antibody and which do not form intrachain or intermolecular disulfide linkages (Junutula, et al., 2008b Nature Biotech., 26(8):925-932; Dornan et al (2009) Blood 114(13):2721-2729; U.S. Pat. Nos. 7,521,541; 7,723,485; WO2009/052249). The engineered cysteine thiols may react with linker reagents or the drug-linker reagents of the present invention which have thiol-reactive, electrophilic groups such as maleimide or alpha-halo amides to form ADC with cysteine engineered antibodies and the PBD drug moieties. The location of the drug moiety can thus be designed, controlled, and known. The drug loading can be controlled since the engineered cysteine thiol groups typically react with thiol-reactive linker reagents or drug-linker reagents in high yield. Engineering an IgG antibody to introduce a cysteine amino acid by substitution at a single site on the heavy or light chain gives two new cysteines on the symmetrical antibody. A drug loading near 2 can be achieved with near homogeneity of the conjugation product ADC.</div>
    <div id="p-0215" num="0340" class="description-paragraph style-scope patent-text">Where more than one nucleophilic or electrophilic group of the antibody reacts with a drug-linker intermediate, or linker reagent followed by drug moiety reagent, then the resulting product is a mixture of ADC compounds with a distribution of drug moieties attached to an antibody, e.g. 1, 2, 3, etc. Liquid chromatography methods such as polymeric reverse phase (PLRP) and hydrophobic interaction (HIC) may separate compounds in the mixture by drug loading value. Preparations of ADC with a single drug loading value (p) may be isolated, however, these single loading value ADCs may still be heterogeneous mixtures because the drug moieties may be attached, via the linker, at different sites on the antibody.</div>
    <div id="p-0216" num="0341" class="description-paragraph style-scope patent-text">Thus the antibody-drug conjugate compositions of the invention include mixtures of antibody-drug conjugate compounds where the antibody has one or more PBD drug moieties and where the drug moieties may be attached to the antibody at various amino acid residues.</div>
    <div id="p-0217" num="0342" class="description-paragraph style-scope patent-text">In one embodiment, the average number of dimer pyrrolobenzodiazepine groups per cell binding agent is in the range 1 to 20. In some embodiments the range is selected from 1 to 8, 2 to 8, 2 to 6, 2 to 4, and 4 to 8.</div>
    <div id="p-0218" num="0343" class="description-paragraph style-scope patent-text">In some embodiments, there is one dimer pyrrolobenzodiazepine group per cell binding agent.</div>
    <div id="h-0112" num="0000" class="description-paragraph style-scope patent-text">General Synthetic Routes</div>
    <div id="p-0219" num="0344" class="description-paragraph style-scope patent-text">The synthesis of PBD compounds is extensively discussed in the following references, which discussions are incorporated herein by reference:</div>
    <div id="h-0113" num="0000" class="description-paragraph style-scope patent-text">a) WO 00/12508 (pages 14 to 30);</div>
    <div id="h-0114" num="0000" class="description-paragraph style-scope patent-text">b) WO 2005/023814 (pages 3 to 10);</div>
    <div id="h-0115" num="0000" class="description-paragraph style-scope patent-text">c) WO 2004/043963 (<figure-callout id="28" label="pages" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pages</a></figure-callout> 28 to 29); and</div>
    <div id="h-0116" num="0000" class="description-paragraph style-scope patent-text">d) WO 2005/085251 (<figure-callout id="30" label="pages" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pages</a></figure-callout> 30 to 39).</div>
    <div id="h-0117" num="0000" class="description-paragraph style-scope patent-text">Synthesis Route</div>
    <div id="p-0220" num="0345" class="description-paragraph style-scope patent-text">Compounds of the present invention of formula I:</div>
    <div id="p-0221" num="0346" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00027" num="00027" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2f/d1/a0/d7a3b15942ae89/US10799595-20201013-C00027.png" class="style-scope patent-text"><img id="EMI-C00027" he="53.93mm" wi="117.35mm" file="US10799595-20201013-C00027.TIF" alt="Figure US10799595-20201013-C00027" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="469" height="216" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2f/d1/a0/d7a3b15942ae89/US10799595-20201013-C00027.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00027" attachment-type="cdx" file="US10799595-20201013-C00027.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00027" attachment-type="mol" file="US10799595-20201013-C00027.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
can be synthesised from a compound of Formula II:
</div>
    <div id="p-0222" num="0347" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00028" num="00028" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ed/df/8b/bb8a31fdcba13f/US10799595-20201013-C00028.png" class="style-scope patent-text"><img id="EMI-C00028" he="53.93mm" wi="126.75mm" file="US10799595-20201013-C00028.TIF" alt="Figure US10799595-20201013-C00028" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="507" height="216" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ed/df/8b/bb8a31fdcba13f/US10799595-20201013-C00028.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00028" attachment-type="cdx" file="US10799595-20201013-C00028.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00028" attachment-type="mol" file="US10799595-20201013-C00028.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">2</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup>, R<sup class="style-scope patent-text">11b</sup>, R<sup class="style-scope patent-text">12</sup>, Y, Y′ and R″ are as defined for compounds of formula I, and R<sup class="style-scope patent-text">LL </sup>is a precursor of R<sup class="style-scope patent-text">L</sup>—this method is particularly applicable to compounds of formula I where R<sup class="style-scope patent-text">L </sup>is of formula IIIa. For these compounds, R<sup class="style-scope patent-text">LL </sup>will typically be a portion of R<sup class="style-scope patent-text">L</sup>, such as a group of formula IIIa′:
</div>
    <div id="p-0223" num="0348" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00029" num="00029" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a0/93/b4/60587c62ab8cdf/US10799595-20201013-C00029.png" class="style-scope patent-text"><img id="EMI-C00029" he="26.92mm" wi="69.85mm" file="US10799595-20201013-C00029.TIF" alt="Figure US10799595-20201013-C00029" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="108" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a0/93/b4/60587c62ab8cdf/US10799595-20201013-C00029.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00029" attachment-type="cdx" file="US10799595-20201013-C00029.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00029" attachment-type="mol" file="US10799595-20201013-C00029.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
In such as case, the reaction involves adding the group G.
</div>
    <div id="p-0224" num="0349" class="description-paragraph style-scope patent-text">The compounds of Formula 2 may be made by deprotecting compounds of Formula 3:</div>
    <div id="p-0225" num="0350" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00030" num="00030" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/86/ee/0f/72a8af9f7f551e/US10799595-20201013-C00030.png" class="style-scope patent-text"><img id="EMI-C00030" he="53.93mm" wi="129.12mm" file="US10799595-20201013-C00030.TIF" alt="Figure US10799595-20201013-C00030" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="516" height="216" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/86/ee/0f/72a8af9f7f551e/US10799595-20201013-C00030.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00030" attachment-type="cdx" file="US10799595-20201013-C00030.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00030" attachment-type="mol" file="US10799595-20201013-C00030.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">2</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup>, R<sup class="style-scope patent-text">11b</sup>, R<sup class="style-scope patent-text">12</sup>, Y, Y′ and R″ are as defined for compounds of formula I, R<sup class="style-scope patent-text">LL-Prot </sup>is a protected version of R<sup class="style-scope patent-text">LL</sup>, and the Prot represents an appropriate carboxy/hydroxy protecting group.
</div>
    <div id="p-0226" num="0351" class="description-paragraph style-scope patent-text">Compounds of formula 3 may be made by ring-closure of compounds of Formula 4:</div>
    <div id="p-0227" num="0352" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00031" num="00031" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8a/bb/6d/70154370ff9a71/US10799595-20201013-C00031.png" class="style-scope patent-text"><img id="EMI-C00031" he="53.93mm" wi="129.12mm" file="US10799595-20201013-C00031.TIF" alt="Figure US10799595-20201013-C00031" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="516" height="216" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8a/bb/6d/70154370ff9a71/US10799595-20201013-C00031.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00031" attachment-type="cdx" file="US10799595-20201013-C00031.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00031" attachment-type="mol" file="US10799595-20201013-C00031.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where the ring closure is carried out by oxidation, e.g. Swern.
</div>
    <div id="p-0228" num="0353" class="description-paragraph style-scope patent-text">Compounds of formula 4 can be synthesised from compounds of formula 5:</div>
    <div id="p-0229" num="0354" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00032" num="00032" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b0/d7/93/e576131942eb0e/US10799595-20201013-C00032.png" class="style-scope patent-text"><img id="EMI-C00032" he="29.38mm" wi="75.95mm" file="US10799595-20201013-C00032.TIF" alt="Figure US10799595-20201013-C00032" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="304" height="118" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b0/d7/93/e576131942eb0e/US10799595-20201013-C00032.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00032" attachment-type="cdx" file="US10799595-20201013-C00032.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00032" attachment-type="mol" file="US10799595-20201013-C00032.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
by step-wise addition of the two amino protecting groups. Step-wise addition can be achieved by simple protection of one amino group (e.g. by Fmoc), followed by installation of a desired protecting group at the other amino group. This can be followed by removal of the simple protecting group, and then installation of the other desired amino protecting group.
</div>
    <div id="p-0230" num="0355" class="description-paragraph style-scope patent-text">Compounds of formula I where R<sup class="style-scope patent-text">L </sup>is of formula IIIb, may be synthesised in a similar manner, although the complete R<sup class="style-scope patent-text">L </sup>group may be installed starting from a compound of Formula 5, rather than with the use of a protected precursor.</div>
    <div id="p-0231" num="0356" class="description-paragraph style-scope patent-text">Compounds of Formula 5 can be synthesised by known methods, such as those disclosed in WO 2011/130598.</div>
    <div id="h-0118" num="0000" class="description-paragraph style-scope patent-text">Synthesis of Drug Conjugates</div>
    <div id="p-0232" num="0357" class="description-paragraph style-scope patent-text">Conjugates can be prepared as previously described. Antibodies can be conjugated to the Drug Linker compound as described in Doronina et al., Nature Biotechnology, 2003, 21, 778-784). Briefly, antibodies (4-5 mg/mL) in PBS containing 50 mM sodium borate at pH 7.4 are reduced with tris(carboxyethyl)phosphine hydrochloride (TCEP) at 37° C. The progress of the reaction, which reduces interchain disulfides, is monitored by reaction with 5,5′-dithiobis(2-nitrobenzoic acid) and allowed to proceed until the desired level of thiols/mAb is achieved. The reduced antibody is then cooled to 0° C. and alkylated with 1.5 equivalents of maleimide drug-linker per antibody thiol. After 1 hour, the reaction is quenched by the addition of 5 equivalents of N-acetyl cysteine. Quenched drug-linker is removed by gel filtration over a PD-10 column. The ADC is then sterile-filtered through a 0.22 μm syringe filter. Protein concentration can be determined by spectral analysis at 280 nm and 329 nm, respectively, with correction for the contribution of drug absorbance at 280 nm. Size exclusion chromatography can be used to determine the extent of antibody aggregation, and RP-HPLC can be used to determine the levels of remaining NAC-quenched drug-linker.</div>
    <div id="h-0119" num="0000" class="description-paragraph style-scope patent-text">Further Preferences</div>
    <div id="p-0233" num="0358" class="description-paragraph style-scope patent-text">The following preferences may apply to all aspects of the invention as described above, or may relate to a single aspect. The preferences may be combined together in any combination.</div>
    <div id="p-0234" num="0359" class="description-paragraph style-scope patent-text">In some embodiments, the NO<sub class="style-scope patent-text">2 </sub>group is present. In other embodiments, the NO<sub class="style-scope patent-text">2 </sub>is absent.</div>
    <div id="p-0235" num="0360" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup>, and Y′ are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, and Y respectively. In some of these embodiments, R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup>, and Y′ are the same as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, and Y respectively.</div>
    <div id="p-0236" num="0361" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12 </sup>is the same as R<sup class="style-scope patent-text">2</sup>.</div>
    <div id="h-0120" num="0000" class="description-paragraph style-scope patent-text">Dimer Link</div>
    <div id="p-0237" num="0362" class="description-paragraph style-scope patent-text">In some embodiments, Y and Y′ are both O.</div>
    <div id="p-0238" num="0363" class="description-paragraph style-scope patent-text">In some embodiments, R″ is a C<sub class="style-scope patent-text">3-7 </sub>alkylene group with no substituents. In some of these embodiments, R″ is a C<sub class="style-scope patent-text">3</sub>, C<sub class="style-scope patent-text">5 </sub>or C<sub class="style-scope patent-text">7 </sub>alkylene. In particular, R″ may be a C<sub class="style-scope patent-text">3 </sub>or C<sub class="style-scope patent-text">5 </sub>alkylene.</div>
    <div id="p-0239" num="0364" class="description-paragraph style-scope patent-text">In other embodiments, R″ is a group of formula:</div>
    <div id="p-0240" num="0365" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00033" num="00033" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/55/00/54/03d138b6dd53ec/US10799595-20201013-C00033.png" class="style-scope patent-text"><img id="EMI-C00033" he="13.63mm" wi="35.39mm" file="US10799595-20201013-C00033.TIF" alt="Figure US10799595-20201013-C00033" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="142" height="55" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/55/00/54/03d138b6dd53ec/US10799595-20201013-C00033.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00033" attachment-type="cdx" file="US10799595-20201013-C00033.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00033" attachment-type="mol" file="US10799595-20201013-C00033.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where r is 1 or 2.
<br class="style-scope patent-text">
R<sup class="style-scope patent-text">6 </sup>to R<sup class="style-scope patent-text">9 </sup>
</div>
    <div id="p-0241" num="0366" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">9 </sup>is H.</div>
    <div id="p-0242" num="0367" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">6 </sup>is selected from H, OH, OR, SH, NH<sub class="style-scope patent-text">2</sub>, nitro and halo, and may be selected from H or halo. In some of these embodiments R<sup class="style-scope patent-text">6 </sup>is H.</div>
    <div id="p-0243" num="0368" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">7 </sup>is selected from H, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR′, and halo. In some of these embodiments R<sup class="style-scope patent-text">7 </sup>is selected from H, OH and OR, where R is selected from optionally substituted C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-10 </sub>heterocyclyl and C<sub class="style-scope patent-text">5-10 </sub>aryl groups. R may be more preferably a C<sub class="style-scope patent-text">1-4 </sub>alkyl group, which may or may not be substituted. A substituent of interest is a C<sub class="style-scope patent-text">5-6 </sub>aryl group (e.g. phenyl). Particularly preferred substituents at the 7-positions are OMe and OCH<sub class="style-scope patent-text">2</sub>Ph. Other substituents of particular interest are dimethylamino (i.e. —NMe<sub class="style-scope patent-text">2</sub>); —(OC<sub class="style-scope patent-text">2</sub>H<sub class="style-scope patent-text">4</sub>)<sub class="style-scope patent-text">q</sub>OMe, where q is from 0 to 2; nitrogen-containing C<sub class="style-scope patent-text">6 </sub>heterocyclyls, including morpholino, piperidinyl and N-methyl-piperazinyl.</div>
    <div id="p-0244" num="0369" class="description-paragraph style-scope patent-text">These embodiments and preferences apply to R<sup class="style-scope patent-text">9′</sup>, R<sup class="style-scope patent-text">6′</sup> and R<sup class="style-scope patent-text">7′</sup> respectively.</div>
    <div id="h-0121" num="0000" class="description-paragraph style-scope patent-text">D and D′</div>
    <div id="p-0245" num="0370" class="description-paragraph style-scope patent-text">In some embodiments, D and D′ are D1 and D′1 respectively.</div>
    <div id="p-0246" num="0371" class="description-paragraph style-scope patent-text">In some embodiments, D and D′ are D2 and D′2 respectively.</div>
    <div id="h-0122" num="0000" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2 </sup> </div>
    <div id="p-0247" num="0372" class="description-paragraph style-scope patent-text">When there is a double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>is selected from:</div>
    <div id="h-0123" num="0000" class="description-paragraph style-scope patent-text">(a) C<sub class="style-scope patent-text">5-10 </sub>aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl and bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene;</div>
    <div id="h-0124" num="0000" class="description-paragraph style-scope patent-text">(b) C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl;</div>
    <div id="h-0125" num="0000" class="description-paragraph style-scope patent-text">(c) C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl;</div>
    <div id="p-0248" num="0373" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00034" num="00034" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a8/26/98/a5320ed85467ab/US10799595-20201013-C00034.png" class="style-scope patent-text"><img id="EMI-C00034" he="19.30mm" wi="69.85mm" file="US10799595-20201013-C00034.TIF" alt="Figure US10799595-20201013-C00034" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="77" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a8/26/98/a5320ed85467ab/US10799595-20201013-C00034.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00034" attachment-type="cdx" file="US10799595-20201013-C00034.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00034" attachment-type="mol" file="US10799595-20201013-C00034.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein each of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">2 </sup>group is no more than 5;
</div>
    <div id="p-0249" num="0374" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00035" num="00035" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/28/21/3a/639a31b26c4883/US10799595-20201013-C00035.png" class="style-scope patent-text"><img id="EMI-C00035" he="14.99mm" wi="69.85mm" file="US10799595-20201013-C00035.TIF" alt="Figure US10799595-20201013-C00035" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="60" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/28/21/3a/639a31b26c4883/US10799595-20201013-C00035.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00035" attachment-type="cdx" file="US10799595-20201013-C00035.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00035" attachment-type="mol" file="US10799595-20201013-C00035.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein one of R<sup class="style-scope patent-text">15a </sup>and R<sup class="style-scope patent-text">15b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl; and
</div>
    <div id="p-0250" num="0375" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00036" num="00036" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fc/ba/1b/7c7e0dc3afc15f/US10799595-20201013-C00036.png" class="style-scope patent-text"><img id="EMI-C00036" he="20.40mm" wi="69.85mm" file="US10799595-20201013-C00036.TIF" alt="Figure US10799595-20201013-C00036" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="82" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fc/ba/1b/7c7e0dc3afc15f/US10799595-20201013-C00036.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00036" attachment-type="cdx" file="US10799595-20201013-C00036.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00036" attachment-type="mol" file="US10799595-20201013-C00036.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">14 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl.
</div>
    <div id="p-0251" num="0376" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group, it may be a C<sub class="style-scope patent-text">5-7 </sub>aryl group. A C<sub class="style-scope patent-text">5-7 </sub>aryl group may be a phenyl group or a C<sub class="style-scope patent-text">5-7 </sub>heteroaryl group, for example furanyl, thiophenyl and pyridyl. In some embodiments, R<sup class="style-scope patent-text">2 </sup>is preferably phenyl. In other embodiments, R<sup class="style-scope patent-text">2 </sup>is preferably thiophenyl, for example, thiophen-2-yl and thiophen-3-yl.</div>
    <div id="p-0252" num="0377" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group, it may be a C<sub class="style-scope patent-text">8-10 </sub>aryl, for example a quinolinyl or isoquinolinyl group. The quinolinyl or isoquinolinyl group may be bound to the PBD core through any available ring position. For example, the quinolinyl may be quinolin-2-yl, quinolin-3-yl, quinolin-4yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl and quinolin-8-yl. Of these quinolin-3-yl and quinolin-6-yl may be preferred. The isoquinolinyl may be isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl and isoquinolin-8-yl. Of these isoquinolin-3-yl and isoquinolin-6-yl may be preferred.</div>
    <div id="p-0253" num="0378" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group, it may bear any number of substituent groups. It preferably bears from 1 to 3 substituent groups, with 1 and 2 being more preferred, and singly substituted groups being most preferred. The substituents may be any position.</div>
    <div id="p-0254" num="0379" class="description-paragraph style-scope patent-text">Where R<sup class="style-scope patent-text">2 </sup>is C<sub class="style-scope patent-text">5-7 </sub>aryl group, a single substituent is preferably on a ring atom that is not adjacent the bond to the remainder of the compound, i.e. it is preferably β or γ to the bond to the remainder of the compound. Therefore, where the C<sub class="style-scope patent-text">5-7 </sub>aryl group is phenyl, the substituent is preferably in the meta- or para-positions, and more preferably is in the para-position.</div>
    <div id="p-0255" num="0380" class="description-paragraph style-scope patent-text">Where R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">8-10 </sub>aryl group, for example quinolinyl or isoquinolinyl, it may bear any number of substituents at any position of the quinoline or isoquinoline rings. In some embodiments, it bears one, two or three substituents, and these may be on either the proximal and distal rings or both (if more than one substituent).</div>
    <div id="h-0126" num="0000" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2 </sup>Substituents, when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>Aryl Group</div>
    <div id="p-0256" num="0381" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">2 </sup>when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is halo, it is preferably F or Cl, more preferably Cl.</div>
    <div id="p-0257" num="0382" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">2 </sup>when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is ether, it may in some embodiments be an alkoxy group, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkoxy group (e.g. methoxy, ethoxy) or it may in some embodiments be a C<sub class="style-scope patent-text">5-7 </sub>aryloxy group (e.g phenoxy, pyridyloxy, furanyloxy). The alkoxy group may itself be further substituted, for example by an amino group (e.g. dimethylamino).</div>
    <div id="p-0258" num="0383" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">2 </sup>when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is C<sub class="style-scope patent-text">1-7 </sub>alkyl, it may preferably be a C<sub class="style-scope patent-text">1-4 </sub>alkyl group (e.g. methyl, ethyl, propyl, butyl).</div>
    <div id="p-0259" num="0384" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">2 </sup>when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl, it may in some embodiments be C<sub class="style-scope patent-text">6 </sub>nitrogen containing heterocyclyl group, e.g. morpholino, thiomorpholino, piperidinyl, piperazinyl. These groups may be bound to the rest of the PBD moiety via the nitrogen atom. These groups may be further substituted, for example, by C<sub class="style-scope patent-text">1-4 </sub>alkyl groups. If the C<sub class="style-scope patent-text">6 </sub>nitrogen containing heterocyclyl group is piperazinyl, the said further substituent may be on the second nitrogen ring atom.</div>
    <div id="p-0260" num="0385" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">2 </sup>when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene, this is preferably bis-oxy-methylene or bis-oxy-ethylene.</div>
    <div id="p-0261" num="0386" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">2 </sup>when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is ester, this is preferably methyl ester or ethyl ester.</div>
    <div id="p-0262" num="0387" class="description-paragraph style-scope patent-text">Particularly preferred substituents when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group include methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl. Other particularly preferred substituents for R<sup class="style-scope patent-text">2 </sup>are dimethylaminopropyloxy and carboxy.</div>
    <div id="p-0263" num="0388" class="description-paragraph style-scope patent-text">Particularly preferred substituted R<sup class="style-scope patent-text">2 </sup>groups when R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group include, but are not limited to, 4-methoxy-phenyl, 3-methoxyphenyl, 4-ethoxy-phenyl, 3-ethoxy-phenyl, 4-fluoro-phenyl, 4-chloro-phenyl, 3,4-bisoxymethylene-phenyl, 4-methylthiophenyl, 4-cyanophenyl, 4-phenoxyphenyl, quinolin-3-yl and quinolin-6-yl, isoquinolin-3-yl and isoquinolin-6-yl, 2-thienyl, 2-furanyl, methoxynaphthyl, and naphthyl. Another possible substituted R<sup class="style-scope patent-text">12 </sup>group is 4-nitrophenyl. R<sup class="style-scope patent-text">12 </sup>groups of particular interest include 4-(4-methylpiperazin-1-yl)phenyl and 3,4-bisoxymethylene-phenyl.</div>
    <div id="p-0264" num="0389" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl, it may be methyl, ethyl, propyl, butyl or pentyl. In some embodiments, it may be methyl, ethyl or propyl (n-pentyl or isopropyl). In some of these embodiments, it may be methyl. In other embodiments, it may be butyl or pentyl, which may be linear or branched.</div>
    <div id="p-0265" num="0390" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl, it may be cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. In some embodiments, it may be cyclopropyl.</div>
    <div id="p-0266" num="0391" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is</div>
    <div id="p-0267" num="0392" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00037" num="00037" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/de/33/95/3f733fa5b395d6/US10799595-20201013-C00037.png" class="style-scope patent-text"><img id="EMI-C00037" he="16.43mm" wi="20.83mm" file="US10799595-20201013-C00037.TIF" alt="Figure US10799595-20201013-C00037" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="83" height="66" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/de/33/95/3f733fa5b395d6/US10799595-20201013-C00037.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00037" attachment-type="cdx" file="US10799595-20201013-C00037.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00037" attachment-type="mol" file="US10799595-20201013-C00037.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
each of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">2 </sup>group is no more than 5. In some embodiments, the total number of carbon atoms in the R<sup class="style-scope patent-text">2 </sup>group is no more than 4 or no more than 3.
</div>
    <div id="p-0268" num="0393" class="description-paragraph style-scope patent-text">In some embodiments, one of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>is H, with the other two groups being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl.</div>
    <div id="p-0269" num="0394" class="description-paragraph style-scope patent-text">In other embodiments, two of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are H, with the other group being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl.</div>
    <div id="p-0270" num="0395" class="description-paragraph style-scope patent-text">In some embodiments, the groups that are not H are selected from methyl and ethyl. In some of these embodiments, the groups that re not H are methyl.</div>
    <div id="p-0271" num="0396" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11 </sup>is H.</div>
    <div id="p-0272" num="0397" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12 </sup>is H.</div>
    <div id="p-0273" num="0398" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">13 </sup>is H.</div>
    <div id="p-0274" num="0399" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11 </sup>and R<sup class="style-scope patent-text">12 </sup>are H.</div>
    <div id="p-0275" num="0400" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11 </sup>and R<sup class="style-scope patent-text">13 </sup>are H.</div>
    <div id="p-0276" num="0401" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are H.</div>
    <div id="p-0277" num="0402" class="description-paragraph style-scope patent-text">An R<sup class="style-scope patent-text">2 </sup>group of particular interest is:</div>
    <div id="p-0278" num="0403" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00038" num="00038" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/54/e7/92/bd553ec93d11b9/US10799595-20201013-C00038.png" class="style-scope patent-text"><img id="EMI-C00038" he="10.16mm" wi="19.64mm" file="US10799595-20201013-C00038.TIF" alt="Figure US10799595-20201013-C00038" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="79" height="41" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/54/e7/92/bd553ec93d11b9/US10799595-20201013-C00038.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00038" attachment-type="cdx" file="US10799595-20201013-C00038.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00038" attachment-type="mol" file="US10799595-20201013-C00038.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0279" num="0404" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is</div>
    <div id="p-0280" num="0405" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00039" num="00039" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/33/ee/80/ea6420522b3857/US10799595-20201013-C00039.png" class="style-scope patent-text"><img id="EMI-C00039" he="12.11mm" wi="21.76mm" file="US10799595-20201013-C00039.TIF" alt="Figure US10799595-20201013-C00039" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="87" height="48" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/33/ee/80/ea6420522b3857/US10799595-20201013-C00039.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00039" attachment-type="cdx" file="US10799595-20201013-C00039.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00039" attachment-type="mol" file="US10799595-20201013-C00039.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
one of R<sup class="style-scope patent-text">15a </sup>and R<sup class="style-scope patent-text">15b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl. In some embodiments, the group which is not H is optionally substituted phenyl. If the phenyl optional substituent is halo, it is preferably fluoro. In some embodiment, the phenyl group is unsubstituted.
</div>
    <div id="p-0281" num="0406" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">2 </sup>is</div>
    <div id="p-0282" num="0407" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00040" num="00040" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/0e/35/be4014c3dd9a99/US10799595-20201013-C00040.png" class="style-scope patent-text"><img id="EMI-C00040" he="17.53mm" wi="19.56mm" file="US10799595-20201013-C00040.TIF" alt="Figure US10799595-20201013-C00040" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="78" height="70" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/0e/35/be4014c3dd9a99/US10799595-20201013-C00040.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00040" attachment-type="cdx" file="US10799595-20201013-C00040.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00040" attachment-type="mol" file="US10799595-20201013-C00040.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
R<sup class="style-scope patent-text">14 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl. If the phenyl optional substituent is halo, it is preferably fluoro. In some embodiment, the phenyl group is unsubstituted. In some embodiments, R<sup class="style-scope patent-text">14 </sup>is selected from H, methyl, ethyl, ethenyl and ethynyl. In some of these embodiments, R<sup class="style-scope patent-text">14 </sup>is selected from H and methyl.
</div>
    <div id="p-0283" num="0408" class="description-paragraph style-scope patent-text">When there is a single bond present between C2 and C3,</div>
    <div id="p-0284" num="0409" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2 </sup>is H or</div>
    <div id="p-0285" num="0410" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00041" num="00041" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5c/a5/51/4a106c8ed7dc42/US10799595-20201013-C00041.png" class="style-scope patent-text"><img id="EMI-C00041" he="14.48mm" wi="16.85mm" file="US10799595-20201013-C00041.TIF" alt="Figure US10799595-20201013-C00041" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="67" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5c/a5/51/4a106c8ed7dc42/US10799595-20201013-C00041.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00041" attachment-type="cdx" file="US10799595-20201013-C00041.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00041" attachment-type="mol" file="US10799595-20201013-C00041.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>are independently selected from H, F, C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C<sub class="style-scope patent-text">1-4 </sub>alkyl amido and C<sub class="style-scope patent-text">1-4 </sub>alkyl ester; or, when one of R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>is H, the other is selected from nitrile and a C<sub class="style-scope patent-text">1-4 </sub>alkyl ester.
</div>
    <div id="p-0286" num="0411" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">2 </sup>is H.</div>
    <div id="p-0287" num="0412" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">2 </sup>is</div>
    <div id="p-0288" num="0413" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00042" num="00042" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/d0/13/23a9c6001a823f/US10799595-20201013-C00042.png" class="style-scope patent-text"><img id="EMI-C00042" he="14.48mm" wi="16.85mm" file="US10799595-20201013-C00042.TIF" alt="Figure US10799595-20201013-C00042" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="67" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/d0/13/23a9c6001a823f/US10799595-20201013-C00042.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00042" attachment-type="cdx" file="US10799595-20201013-C00042.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00042" attachment-type="mol" file="US10799595-20201013-C00042.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0289" num="0414" class="description-paragraph style-scope patent-text">In some embodiments, it is preferred that R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>are both H.</div>
    <div id="p-0290" num="0415" class="description-paragraph style-scope patent-text">In other embodiments, it is preferred that R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>are both methyl.</div>
    <div id="p-0291" num="0416" class="description-paragraph style-scope patent-text">In further embodiments, it is preferred that one of R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>is H, and the other is selected from C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted. In these further embodiment, it may be further preferred that the group which is not H is selected from methyl and ethyl.</div>
    <div id="h-0127" num="0000" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12 </sup> </div>
    <div id="p-0292" num="0417" class="description-paragraph style-scope patent-text">When there is a double bond present between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>is selected from:</div>
    <div id="h-0128" num="0000" class="description-paragraph style-scope patent-text">(a) C<sub class="style-scope patent-text">5-10 </sub>aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl and bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene;</div>
    <div id="h-0129" num="0000" class="description-paragraph style-scope patent-text">(b) C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl;</div>
    <div id="h-0130" num="0000" class="description-paragraph style-scope patent-text">(c) C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl;</div>
    <div id="p-0293" num="0418" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00043" num="00043" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/98/b9/fd/abd4a5cfc157e0/US10799595-20201013-C00043.png" class="style-scope patent-text"><img id="EMI-C00043" he="19.30mm" wi="69.85mm" file="US10799595-20201013-C00043.TIF" alt="Figure US10799595-20201013-C00043" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="77" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/98/b9/fd/abd4a5cfc157e0/US10799595-20201013-C00043.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00043" attachment-type="cdx" file="US10799595-20201013-C00043.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00043" attachment-type="mol" file="US10799595-20201013-C00043.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12 </sup>group is no more than 5;
</div>
    <div id="p-0294" num="0419" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00044" num="00044" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5f/a9/86/16769cc6da0b73/US10799595-20201013-C00044.png" class="style-scope patent-text"><img id="EMI-C00044" he="14.05mm" wi="69.85mm" file="US10799595-20201013-C00044.TIF" alt="Figure US10799595-20201013-C00044" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="56" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5f/a9/86/16769cc6da0b73/US10799595-20201013-C00044.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00044" attachment-type="cdx" file="US10799595-20201013-C00044.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00044" attachment-type="mol" file="US10799595-20201013-C00044.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein one of R<sup class="style-scope patent-text">25a </sup>and R<sup class="style-scope patent-text">25b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl; and
</div>
    <div id="p-0295" num="0420" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00045" num="00045" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/17/a0/2b0eda94ee06ac/US10799595-20201013-C00045.png" class="style-scope patent-text"><img id="EMI-C00045" he="17.10mm" wi="69.85mm" file="US10799595-20201013-C00045.TIF" alt="Figure US10799595-20201013-C00045" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="68" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/17/a0/2b0eda94ee06ac/US10799595-20201013-C00045.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00045" attachment-type="cdx" file="US10799595-20201013-C00045.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00045" attachment-type="mol" file="US10799595-20201013-C00045.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">24 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl.
</div>
    <div id="p-0296" num="0421" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group, it may be a C<sub class="style-scope patent-text">5-7 </sub>aryl group. A C<sub class="style-scope patent-text">5-7 </sub>aryl group may be a phenyl group or a C<sub class="style-scope patent-text">5-7 </sub>heteroaryl group, for example furanyl, thiophenyl and pyridyl. In some embodiments, R<sup class="style-scope patent-text">12 </sup>is preferably phenyl. In other embodiments, R<sup class="style-scope patent-text">12 </sup>is preferably thiophenyl, for example, thiophen-2-yl and thiophen-3-yl.</div>
    <div id="p-0297" num="0422" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group, it may be a C<sub class="style-scope patent-text">8-10 </sub>aryl, for example a quinolinyl or isoquinolinyl group. The quinolinyl or isoquinolinyl group may be bound to the PBD core through any available ring position. For example, the quinolinyl may be quinolin-2-yl, quinolin-3-yl, quinolin-4yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl and quinolin-8-yl. Of these quinolin-3-yl and quinolin-6-yl may be preferred. The isoquinolinyl may be isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl and isoquinolin-8-yl. Of these isoquinolin-3-yl and isoquinolin-6-yl may be preferred.</div>
    <div id="p-0298" num="0423" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group, it may bear any number of substituent groups. It preferably bears from 1 to 3 substituent groups, with 1 and 2 being more preferred, and singly substituted groups being most preferred. The substituents may be any position.</div>
    <div id="p-0299" num="0424" class="description-paragraph style-scope patent-text">Where R<sup class="style-scope patent-text">12 </sup>is C<sub class="style-scope patent-text">5-7 </sub>aryl group, a single substituent is preferably on a ring atom that is not adjacent the bond to the remainder of the compound, i.e. it is preferably β or γ to the bond to the remainder of the compound. Therefore, where the C<sub class="style-scope patent-text">5-7 </sub>aryl group is phenyl, the substituent is preferably in the meta- or para-positions, and more preferably is in the para-position.</div>
    <div id="p-0300" num="0425" class="description-paragraph style-scope patent-text">Where R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">8-10 </sub>aryl group, for example quinolinyl or isoquinolinyl, it may bear any number of substituents at any position of the quinoline or isoquinoline rings. In some embodiments, it bears one, two or three substituents, and these may be on either the proximal and distal rings or both (if more than one substituent).</div>
    <div id="h-0131" num="0000" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12 </sup>Substituents, when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>Aryl Group</div>
    <div id="p-0301" num="0426" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12 </sup>when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is halo, it is preferably F or Cl, more preferably Cl.</div>
    <div id="p-0302" num="0427" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12 </sup>when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is ether, it may in some embodiments be an alkoxy group, for example, a C<sub class="style-scope patent-text">1-7 </sub>alkoxy group (e.g. methoxy, ethoxy) or it may in some embodiments be a C<sub class="style-scope patent-text">5-7 </sub>aryloxy group (e.g phenoxy, pyridyloxy, furanyloxy). The alkoxy group may itself be further substituted, for example by an amino group (e.g. dimethylamino).</div>
    <div id="p-0303" num="0428" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12 </sup>when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is C<sub class="style-scope patent-text">1-7 </sub>alkyl, it may preferably be a C<sub class="style-scope patent-text">1-4 </sub>alkyl group (e.g. methyl, ethyl, propyl, butyl).</div>
    <div id="p-0304" num="0429" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12 </sup>when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl, it may in some embodiments be C<sub class="style-scope patent-text">6 </sub>nitrogen containing heterocyclyl group, e.g. morpholino, thiomorpholino, piperidinyl, piperazinyl. These groups may be bound to the rest of the PBD moiety via the nitrogen atom. These groups may be further substituted, for example, by C<sub class="style-scope patent-text">1-4 </sub>alkyl groups. If the C<sub class="style-scope patent-text">6 </sub>nitrogen containing heterocyclyl group is piperazinyl, the said further substituent may be on the second nitrogen ring atom.</div>
    <div id="p-0305" num="0430" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12 </sup>when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene, this is preferably bis-oxy-methylene or bis-oxy-ethylene.</div>
    <div id="p-0306" num="0431" class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12 </sup>when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group is ester, this is preferably methyl ester or ethyl ester.</div>
    <div id="p-0307" num="0432" class="description-paragraph style-scope patent-text">Particularly preferred substituents when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group include methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl. Other particularly preferred substituents for R<sup class="style-scope patent-text">12 </sup>are dimethylaminopropyloxy and carboxy.</div>
    <div id="p-0308" num="0433" class="description-paragraph style-scope patent-text">Particularly preferred substituted R<sup class="style-scope patent-text">12 </sup>groups when R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-10 </sub>aryl group include, but are not limited to, 4-methoxy-phenyl, 3-methoxyphenyl, 4-ethoxy-phenyl, 3-ethoxy-phenyl, 4-fluoro-phenyl, 4-chloro-phenyl, 3,4-bisoxymethylene-phenyl, 4-methylthiophenyl, 4-cyanophenyl, 4-phenoxyphenyl, quinolin-3-yl and quinolin-6-yl, isoquinolin-3-yl and isoquinolin-6-yl, 2-thienyl, 2-furanyl, methoxynaphthyl, and naphthyl. Another possible substituted R<sup class="style-scope patent-text">12 </sup>group is 4-nitrophenyl. R<sup class="style-scope patent-text">12 </sup>groups of particular interest include 4-(4-methylpiperazin-1-yl)phenyl and 3,4-bisoxymethylene-phenyl.</div>
    <div id="p-0309" num="0434" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl, it may be methyl, ethyl, propyl, butyl or pentyl. In some embodiments, it may be methyl, ethyl or propyl (n-pentyl or isopropyl). In some of these embodiments, it may be methyl. In other embodiments, it may be butyl or pentyl, which may be linear or branched.</div>
    <div id="p-0310" num="0435" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl, it may be cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. In some embodiments, it may be cyclopropyl.</div>
    <div id="p-0311" num="0436" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is</div>
    <div id="p-0312" num="0437" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00046" num="00046" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6e/61/cf/484d2f9bd1da4f/US10799595-20201013-C00046.png" class="style-scope patent-text"><img id="EMI-C00046" he="16.43mm" wi="18.63mm" file="US10799595-20201013-C00046.TIF" alt="Figure US10799595-20201013-C00046" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="75" height="66" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6e/61/cf/484d2f9bd1da4f/US10799595-20201013-C00046.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00046" attachment-type="cdx" file="US10799595-20201013-C00046.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00046" attachment-type="mol" file="US10799595-20201013-C00046.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12 </sup>group is no more than 5. In some embodiments, the total number of carbon atoms in the R<sup class="style-scope patent-text">12 </sup>group is no more than 4 or no more than 3.
</div>
    <div id="p-0313" num="0438" class="description-paragraph style-scope patent-text">In some embodiments, one of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>is H, with the other two groups being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl.</div>
    <div id="p-0314" num="0439" class="description-paragraph style-scope patent-text">In other embodiments, two of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are H, with the other group being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl.</div>
    <div id="p-0315" num="0440" class="description-paragraph style-scope patent-text">In some embodiments, the groups that are not H are selected from methyl and ethyl. In some of these embodiments, the groups that re not H are methyl.</div>
    <div id="p-0316" num="0441" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21 </sup>is H.</div>
    <div id="p-0317" num="0442" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">22 </sup>is H.</div>
    <div id="p-0318" num="0443" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">23 </sup>is H.</div>
    <div id="p-0319" num="0444" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21 </sup>and R<sup class="style-scope patent-text">22 </sup>are H.</div>
    <div id="p-0320" num="0445" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21 </sup>and R<sup class="style-scope patent-text">23 </sup>are H.</div>
    <div id="p-0321" num="0446" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are H.</div>
    <div id="p-0322" num="0447" class="description-paragraph style-scope patent-text">An R<sup class="style-scope patent-text">12 </sup>group of particular interest is:</div>
    <div id="p-0323" num="0448" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00047" num="00047" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/25/17/16/e9aa82b573a7d6/US10799595-20201013-C00047.png" class="style-scope patent-text"><img id="EMI-C00047" he="10.16mm" wi="19.64mm" file="US10799595-20201013-C00047.TIF" alt="Figure US10799595-20201013-C00047" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="79" height="41" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/25/17/16/e9aa82b573a7d6/US10799595-20201013-C00047.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00047" attachment-type="cdx" file="US10799595-20201013-C00047.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00047" attachment-type="mol" file="US10799595-20201013-C00047.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0324" num="0449" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is</div>
    <div id="p-0325" num="0450" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00048" num="00048" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/51/23/14/b2d0940e983734/US10799595-20201013-C00048.png" class="style-scope patent-text"><img id="EMI-C00048" he="11.18mm" wi="19.56mm" file="US10799595-20201013-C00048.TIF" alt="Figure US10799595-20201013-C00048" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="78" height="45" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/51/23/14/b2d0940e983734/US10799595-20201013-C00048.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00048" attachment-type="cdx" file="US10799595-20201013-C00048.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00048" attachment-type="mol" file="US10799595-20201013-C00048.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
one of R<sup class="style-scope patent-text">25a </sup>and R<sup class="style-scope patent-text">25b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl. In some embodiments, the group which is not H is optionally substituted phenyl. If the phenyl optional substituent is halo, it is preferably fluoro. In some embodiment, the phenyl group is unsubstituted.
</div>
    <div id="p-0326" num="0451" class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12 </sup>is</div>
    <div id="p-0327" num="0452" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00049" num="00049" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/12/c9/2e/83aa37f0bdeaaf/US10799595-20201013-C00049.png" class="style-scope patent-text"><img id="EMI-C00049" he="10.67mm" wi="18.63mm" file="US10799595-20201013-C00049.TIF" alt="Figure US10799595-20201013-C00049" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="75" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/12/c9/2e/83aa37f0bdeaaf/US10799595-20201013-C00049.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00049" attachment-type="cdx" file="US10799595-20201013-C00049.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00049" attachment-type="mol" file="US10799595-20201013-C00049.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
R<sup class="style-scope patent-text">24 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl. If the phenyl optional substituent is halo, it is preferably fluoro. In some embodiment, the phenyl group is unsubstituted.
</div>
    <div id="p-0328" num="0453" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">24 </sup>is selected from H, methyl, ethyl, ethenyl and ethynyl. In some of these embodiments, R<sup class="style-scope patent-text">24 </sup>is selected from H and methyl.</div>
    <div id="p-0329" num="0454" class="description-paragraph style-scope patent-text">When there is a single bond present between C2′ and C3′,</div>
    <div id="p-0330" num="0455" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12 </sup>is H or</div>
    <div id="p-0331" num="0456" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00050" num="00050" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ea/1e/bc/9a832c5b5a57de/US10799595-20201013-C00050.png" class="style-scope patent-text"><img id="EMI-C00050" he="10.75mm" wi="14.65mm" file="US10799595-20201013-C00050.TIF" alt="Figure US10799595-20201013-C00050" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="59" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ea/1e/bc/9a832c5b5a57de/US10799595-20201013-C00050.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00050" attachment-type="cdx" file="US10799595-20201013-C00050.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00050" attachment-type="mol" file="US10799595-20201013-C00050.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are independently selected from H, F, C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C<sub class="style-scope patent-text">1-4 </sub>alkyl amido and C<sub class="style-scope patent-text">1-4 </sub>alkyl ester; or, when one of R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>is H, the other is selected from nitrile and a C<sub class="style-scope patent-text">1-4 </sub>alkyl ester.
</div>
    <div id="p-0332" num="0457" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12 </sup>is H.</div>
    <div id="p-0333" num="0458" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12 </sup>is</div>
    <div id="p-0334" num="0459" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00051" num="00051" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/31/67/6a/e28d9127c47eb7/US10799595-20201013-C00051.png" class="style-scope patent-text"><img id="EMI-C00051" he="10.75mm" wi="14.65mm" file="US10799595-20201013-C00051.TIF" alt="Figure US10799595-20201013-C00051" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="59" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/31/67/6a/e28d9127c47eb7/US10799595-20201013-C00051.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00051" attachment-type="cdx" file="US10799595-20201013-C00051.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00051" attachment-type="mol" file="US10799595-20201013-C00051.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0335" num="0460" class="description-paragraph style-scope patent-text">In some embodiments, it is preferred that R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are both H.</div>
    <div id="p-0336" num="0461" class="description-paragraph style-scope patent-text">In other embodiments, it is preferred that R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are both methyl.</div>
    <div id="p-0337" num="0462" class="description-paragraph style-scope patent-text">In further embodiments, it is preferred that one of R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>is H, and the other is selected from C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted. In these further embodiment, it may be further preferred that the group which is not H is selected from methyl and ethyl.</div>
    <div id="h-0132" num="0000" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">11b </sup> </div>
    <div id="p-0338" num="0463" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11b </sup>is OH.</div>
    <div id="p-0339" num="0464" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">11b </sup>is OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A </sup>is C<sub class="style-scope patent-text">1-4 </sub>alkyl. In some of these embodiments, R<sup class="style-scope patent-text">A </sup>is methyl.</div>
    <div id="p-0340" num="0465" class="description-paragraph style-scope patent-text">In some embodiments of the first aspect of the present invention are of formula Ia-1, Ia-2 or Ia-3:</div>
    <div id="p-0341" num="0466" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00052" num="00052" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2a/a5/90/52095d2318504c/US10799595-20201013-C00052.png" class="style-scope patent-text"><img id="EMI-C00052" he="192.96mm" wi="144.19mm" file="US10799595-20201013-C00052.TIF" alt="Figure US10799595-20201013-C00052" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="577" height="772" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2a/a5/90/52095d2318504c/US10799595-20201013-C00052.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00052" attachment-type="cdx" file="US10799595-20201013-C00052.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00052" attachment-type="mol" file="US10799595-20201013-C00052.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where R<sup class="style-scope patent-text">2a </sup>and R<sup class="style-scope patent-text">12a </sup>are the same and are selected from:
</div>
    <div id="p-0342" num="0467" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00053" num="00053" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/be/93/0e/29e294145a0eb8/US10799595-20201013-C00053.png" class="style-scope patent-text"><img id="EMI-C00053" he="157.14mm" wi="69.85mm" file="US10799595-20201013-C00053.TIF" alt="Figure US10799595-20201013-C00053" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="629" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/be/93/0e/29e294145a0eb8/US10799595-20201013-C00053.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00053" attachment-type="cdx" file="US10799595-20201013-C00053.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00053" attachment-type="mol" file="US10799595-20201013-C00053.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
R<sup class="style-scope patent-text">1a </sup>is selected from methyl and benzyl;
</div>
    <div id="p-0343" num="0468" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L </sup>and R<sup class="style-scope patent-text">11b </sup>are as defined above.</div>
    <div id="p-0344" num="0469" class="description-paragraph style-scope patent-text">In some embodiments of the present invention both R<sup class="style-scope patent-text">2 </sup>and R<sup class="style-scope patent-text">12 </sup>comprise no more than 3 carbon atoms.</div>
    <div id="p-0345" num="0470" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is a double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>may be selected from:</div>
    <div id="p-0346" num="0471" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00054" num="00054" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/20/3e/f1ad38b9fd285d/US10799595-20201013-C00054.png" class="style-scope patent-text"><img id="EMI-C00054" he="114.81mm" wi="69.85mm" file="US10799595-20201013-C00054.TIF" alt="Figure US10799595-20201013-C00054" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="459" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/20/3e/f1ad38b9fd285d/US10799595-20201013-C00054.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00054" attachment-type="cdx" file="US10799595-20201013-C00054.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00054" attachment-type="mol" file="US10799595-20201013-C00054.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0347" num="0472" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is no double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>may be selected from:</div>
    <div id="p-0348" num="0473" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00055" num="00055" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/65/25/5f0a431fb417a6/US10799595-20201013-C00055.png" class="style-scope patent-text"><img id="EMI-C00055" he="84.50mm" wi="69.85mm" file="US10799595-20201013-C00055.TIF" alt="Figure US10799595-20201013-C00055" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="338" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/65/25/5f0a431fb417a6/US10799595-20201013-C00055.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00055" attachment-type="cdx" file="US10799595-20201013-C00055.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00055" attachment-type="mol" file="US10799595-20201013-C00055.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0349" num="0474" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is a double bond present between C2′ and C3′,</div>
    <div id="p-0350" num="0475" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12 </sup>may be selected from:</div>
    <div id="p-0351" num="0476" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00056" num="00056" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a2/74/0c/11a374e6d20a01/US10799595-20201013-C00056.png" class="style-scope patent-text"><img id="EMI-C00056" he="114.81mm" wi="69.85mm" file="US10799595-20201013-C00056.TIF" alt="Figure US10799595-20201013-C00056" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="459" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a2/74/0c/11a374e6d20a01/US10799595-20201013-C00056.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00056" attachment-type="cdx" file="US10799595-20201013-C00056.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00056" attachment-type="mol" file="US10799595-20201013-C00056.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0352" num="0477" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is no double bond present between C2′ and C3′,</div>
    <div id="p-0353" num="0478" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12 </sup>may be selected from:</div>
    <div id="p-0354" num="0479" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00057" num="00057" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a9/4d/cd/92ae00721b973c/US10799595-20201013-C00057.png" class="style-scope patent-text"><img id="EMI-C00057" he="84.50mm" wi="69.85mm" file="US10799595-20201013-C00057.TIF" alt="Figure US10799595-20201013-C00057" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="338" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a9/4d/cd/92ae00721b973c/US10799595-20201013-C00057.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00057" attachment-type="cdx" file="US10799595-20201013-C00057.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00057" attachment-type="mol" file="US10799595-20201013-C00057.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0355" num="0480" class="description-paragraph style-scope patent-text">In some of these embodiments both R<sup class="style-scope patent-text">2 </sup>and R<sup class="style-scope patent-text">12 </sup>comprise no more than 2 carbon atoms.</div>
    <div id="p-0356" num="0481" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is a double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>may be selected from:</div>
    <div id="p-0357" num="0482" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00058" num="00058" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/17/86/3b/ced72ccd69b1f5/US10799595-20201013-C00058.png" class="style-scope patent-text"><img id="EMI-C00058" he="88.48mm" wi="69.85mm" file="US10799595-20201013-C00058.TIF" alt="Figure US10799595-20201013-C00058" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="354" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/17/86/3b/ced72ccd69b1f5/US10799595-20201013-C00058.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00058" attachment-type="cdx" file="US10799595-20201013-C00058.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00058" attachment-type="mol" file="US10799595-20201013-C00058.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0358" num="0483" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is no double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>may be selected from:</div>
    <div id="p-0359" num="0484" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00059" num="00059" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ad/77/63/3305f102de7b02/US10799595-20201013-C00059.png" class="style-scope patent-text"><img id="EMI-C00059" he="58.25mm" wi="69.85mm" file="US10799595-20201013-C00059.TIF" alt="Figure US10799595-20201013-C00059" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="233" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ad/77/63/3305f102de7b02/US10799595-20201013-C00059.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00059" attachment-type="cdx" file="US10799595-20201013-C00059.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00059" attachment-type="mol" file="US10799595-20201013-C00059.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0360" num="0485" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is a double bond present between C2′ and C3′,</div>
    <div id="p-0361" num="0486" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12 </sup>may be selected from:</div>
    <div id="p-0362" num="0487" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00060" num="00060" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b1/1d/ba/3e7e80f7515e78/US10799595-20201013-C00060.png" class="style-scope patent-text"><img id="EMI-C00060" he="88.48mm" wi="69.85mm" file="US10799595-20201013-C00060.TIF" alt="Figure US10799595-20201013-C00060" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="354" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b1/1d/ba/3e7e80f7515e78/US10799595-20201013-C00060.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00060" attachment-type="cdx" file="US10799595-20201013-C00060.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00060" attachment-type="mol" file="US10799595-20201013-C00060.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0363" num="0488" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is no double bond present between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>may be selected from:</div>
    <div id="p-0364" num="0489" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00061" num="00061" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ca/29/e7/d649fcfd17e64b/US10799595-20201013-C00061.png" class="style-scope patent-text"><img id="EMI-C00061" he="58.25mm" wi="69.85mm" file="US10799595-20201013-C00061.TIF" alt="Figure US10799595-20201013-C00061" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="233" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ca/29/e7/d649fcfd17e64b/US10799595-20201013-C00061.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00061" attachment-type="cdx" file="US10799595-20201013-C00061.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00061" attachment-type="mol" file="US10799595-20201013-C00061.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0365" num="0490" class="description-paragraph style-scope patent-text">In further of these embodiments both R<sup class="style-scope patent-text">2 </sup>and R<sup class="style-scope patent-text">12 </sup>comprise no more than 1 carbon atom.</div>
    <div id="p-0366" num="0491" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is a double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>may be methyl. Thus in these embodiments where there is no double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>may be selected from:</div>
    <div id="p-0367" num="0492" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00062" num="00062" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b8/c0/1f/a5528d0f868dc1/US10799595-20201013-C00062.png" class="style-scope patent-text"><img id="EMI-C00062" he="25.06mm" wi="69.93mm" file="US10799595-20201013-C00062.TIF" alt="Figure US10799595-20201013-C00062" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="100" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b8/c0/1f/a5528d0f868dc1/US10799595-20201013-C00062.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00062" attachment-type="cdx" file="US10799595-20201013-C00062.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00062" attachment-type="mol" file="US10799595-20201013-C00062.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0368" num="0493" class="description-paragraph style-scope patent-text">Thus in these embodiments where there is a double bond present between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>may be methyl. Thus in these embodiments where there is no double bond present between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>may be selected from:</div>
    <div id="p-0369" num="0494" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00063" num="00063" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/ce/90/e3900d42bc2528/US10799595-20201013-C00063.png" class="style-scope patent-text"><img id="EMI-C00063" he="25.06mm" wi="69.93mm" file="US10799595-20201013-C00063.TIF" alt="Figure US10799595-20201013-C00063" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="100" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/ce/90/e3900d42bc2528/US10799595-20201013-C00063.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00063" attachment-type="cdx" file="US10799595-20201013-C00063.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00063" attachment-type="mol" file="US10799595-20201013-C00063.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0370" num="0495" class="description-paragraph style-scope patent-text">Without wishing to be bound by theory, where the substituent at the C<sub class="style-scope patent-text">2 </sub>position of the PBD dimers are small, the use of the glucuronide capping unit in these drug linkers is believed to be particularly advantageous, as it significantly increases the hydrophilicity of the drug linker, making the drug linkers easier to conjugate to a ligand unit.</div>
    <div id="p-0371" num="0496" class="description-paragraph style-scope patent-text">These embodiments and preferences also apply to the second aspect of the invention.</div>
    <div id="h-0133" num="0000" class="description-paragraph style-scope patent-text">Linker (R<sup class="style-scope patent-text">L</sup>)</div>
    <div id="p-0372" num="0497" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">L </sup>is of formula IIIa.</div>
    <div id="p-0373" num="0498" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">LL </sup>is of formula IIIa′.</div>
    <div id="h-0134" num="0000" class="description-paragraph style-scope patent-text">G<sup class="style-scope patent-text">L </sup> </div>
    <div id="p-0374" num="0499" class="description-paragraph style-scope patent-text">GL may be selected from</div>
    <div id="p-0375" num="0500" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00064" num="00064" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3b/f2/68/afc50b9449927d/US10799595-20201013-C00064.png" class="style-scope patent-text"><img id="EMI-C00064" he="229.28mm" wi="69.93mm" file="US10799595-20201013-C00064.TIF" alt="Figure US10799595-20201013-C00064" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="917" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3b/f2/68/afc50b9449927d/US10799595-20201013-C00064.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00064" attachment-type="cdx" file="US10799595-20201013-C00064.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00064" attachment-type="mol" file="US10799595-20201013-C00064.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
      <chemistry id="CHEM-US-00065" num="00065" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3b/c1/ec/136c4697f13801/US10799595-20201013-C00065.png" class="style-scope patent-text"><img id="EMI-C00065" he="234.78mm" wi="69.93mm" file="US10799595-20201013-C00065.TIF" alt="Figure US10799595-20201013-C00065" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="939" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3b/c1/ec/136c4697f13801/US10799595-20201013-C00065.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00065" attachment-type="cdx" file="US10799595-20201013-C00065.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00065" attachment-type="mol" file="US10799595-20201013-C00065.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0376" num="0501" class="description-paragraph style-scope patent-text">In some embodiments, G<sup class="style-scope patent-text">L </sup>is selected from G<sup class="style-scope patent-text">L1-1 </sup>and G<sup class="style-scope patent-text">L1-2</sup>. In some of these embodiments, G<sup class="style-scope patent-text">L </sup>is G<sup class="style-scope patent-text">L1-1</sup>.</div>
    <div id="h-0135" num="0000" class="description-paragraph style-scope patent-text">G<sup class="style-scope patent-text">LL </sup> </div>
    <div id="p-0377" num="0502" class="description-paragraph style-scope patent-text">G<sup class="style-scope patent-text">LL </sup>may be selected from:</div>
    <div id="p-0378" num="0503" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00066" num="00066" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/95/e4/77/83fe39d8059ff6/US10799595-20201013-C00066.png" class="style-scope patent-text"><img id="EMI-C00066" he="237.32mm" wi="69.93mm" file="US10799595-20201013-C00066.TIF" alt="Figure US10799595-20201013-C00066" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="949" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/95/e4/77/83fe39d8059ff6/US10799595-20201013-C00066.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00066" attachment-type="cdx" file="US10799595-20201013-C00066.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00066" attachment-type="mol" file="US10799595-20201013-C00066.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
      <chemistry id="CHEM-US-00067" num="00067" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/71/a2/1d/b9f790893c6aea/US10799595-20201013-C00067.png" class="style-scope patent-text"><img id="EMI-C00067" he="154.86mm" wi="69.93mm" file="US10799595-20201013-C00067.TIF" alt="Figure US10799595-20201013-C00067" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="619" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/71/a2/1d/b9f790893c6aea/US10799595-20201013-C00067.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00067" attachment-type="cdx" file="US10799595-20201013-C00067.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00067" attachment-type="mol" file="US10799595-20201013-C00067.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0379" num="0504" class="description-paragraph style-scope patent-text">In some embodiments, G<sup class="style-scope patent-text">LL </sup>is selected from G<sup class="style-scope patent-text">LL1-1 </sup>and G<sup class="style-scope patent-text">LL1-2</sup>. In some of these embodiments, G<sup class="style-scope patent-text">LL </sup>is G<sup class="style-scope patent-text">LL1-1</sup>.</div>
    <div id="h-0136" num="0000" class="description-paragraph style-scope patent-text">X</div>
    <div id="p-0380" num="0505" class="description-paragraph style-scope patent-text">X is:</div>
    <div id="p-0381" num="0506" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00068" num="00068" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/00/21/93/fad1ae2bd1f06e/US10799595-20201013-C00068.png" class="style-scope patent-text"><img id="EMI-C00068" he="16.26mm" wi="64.69mm" file="US10799595-20201013-C00068.TIF" alt="Figure US10799595-20201013-C00068" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="259" height="65" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/00/21/93/fad1ae2bd1f06e/US10799595-20201013-C00068.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00068" attachment-type="cdx" file="US10799595-20201013-C00068.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00068" attachment-type="mol" file="US10799595-20201013-C00068.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
where a=0 to 5, b=0 to 16, c=0 or 1, d=0 to 5.
<br class="style-scope patent-text">
a may be 0, 1, 2, 3, 4 or 5. In some embodiments, a is 0 to 3. In some of these embodiments, a is 0 or 1. In further embodiments, a is 0.
<br class="style-scope patent-text">
b may be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16. In some embodiments, b is 0 to 12. In some of these embodiments, b is 0 to 8, and may be 0, 2, 4 or 8.
<br class="style-scope patent-text">
c may be 0 or 1.
<br class="style-scope patent-text">
d may be 0, 1, 2, 3, 4 or 5. In some embodiments, d is 0 to 3. In some of these embodiments, d is 1 or 2. In further embodiments, d is 2.
</div>
    <div id="p-0382" num="0507" class="description-paragraph style-scope patent-text">In some embodiments of X, a is 0, c is 1 and d is 2, and b may be from 0 to 8. In some of these embodiments, b is 0, 4 or 8.</div>
    <div id="h-0137" num="0000" class="description-paragraph style-scope patent-text">Q<sup class="style-scope patent-text">X </sup> </div>
    <div id="p-0383" num="0508" class="description-paragraph style-scope patent-text">In one embodiment, Q<sup class="style-scope patent-text">X </sup>is an amino acid residue. The amino acid may a natural amino acids or a non-natural amino acid.</div>
    <div id="p-0384" num="0509" class="description-paragraph style-scope patent-text">In one embodiment, Q<sup class="style-scope patent-text">X </sup>is selected from: Phe, Lys, Val, Ala, Cit, Leu, Ile, Arg, and Trp, where Cit is citrulline.</div>
    <div id="p-0385" num="0510" class="description-paragraph style-scope patent-text">In one embodiment, Q<sup class="style-scope patent-text">X </sup>comprises a dipeptide residue. The amino acids in the dipeptide may be any combination of natural amino acids and non-natural amino acids. In some embodiments, the dipeptide comprises natural amino acids. Where the linker is a cathepsin labile linker, the dipeptide is the site of action for cathepsin-mediated cleavage. The dipeptide then is a recognition site for cathepsin.</div>
    <div id="p-0386" num="0511" class="description-paragraph style-scope patent-text">In one embodiment, Q<sup class="style-scope patent-text">X </sup>is selected from:
</div> <ul class="style-scope patent-text"> <li id="ul0027-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0028-0001" num="0512" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Lys-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0002" num="0513" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Ala-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0003" num="0514" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Lys-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0004" num="0515" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Ala-Lys-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0005" num="0516" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Cit-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0006" num="0517" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Cit-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0007" num="0518" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Leu-Cit-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0008" num="0519" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Ile-Cit-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0028-0009" num="0520" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Arg-<sup class="style-scope patent-text">NH</sup>, and</li> <li id="ul0028-0010" num="0521" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Trp-Cit-<sup class="style-scope patent-text">NH</sup>;
<br class="style-scope patent-text">
where Cit is citrulline.
</li> </ul> </li> </ul>

    <div id="p-0387" num="0522" class="description-paragraph style-scope patent-text">Preferably, Q<sup class="style-scope patent-text">X </sup>is selected from:
</div> <ul class="style-scope patent-text"> <li id="ul0029-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0030-0001" num="0523" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Lys-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0030-0002" num="0524" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Ala-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0030-0003" num="0525" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Lys-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0030-0004" num="0526" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Ala-Lys-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0030-0005" num="0527" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Cit-<sup class="style-scope patent-text">NH</sup>.</li> </ul> </li> </ul>

    <div id="p-0388" num="0528" class="description-paragraph style-scope patent-text">Most preferably, Q<sup class="style-scope patent-text">X </sup>is selected from <sup class="style-scope patent-text">CO</sup>-Phe-Lys-<sup class="style-scope patent-text">NH</sup>, <sup class="style-scope patent-text">CO</sup>-Val-Cit-<sup class="style-scope patent-text">NH </sup>and <sup class="style-scope patent-text">CO</sup>-Val-Ala-<sup class="style-scope patent-text">NH</sup>.</div>
    <div id="p-0389" num="0529" class="description-paragraph style-scope patent-text">Other dipeptide combinations of interest include:
</div> <ul class="style-scope patent-text"> <li id="ul0031-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0032-0001" num="0530" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Gly-Gly-<sup class="style-scope patent-text">NH</sup>,</li> <li id="ul0032-0002" num="0531" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Pro-Pro-<sup class="style-scope patent-text">NH</sup>, and</li> <li id="ul0032-0003" num="0532" class="style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Glu-<sup class="style-scope patent-text">NH</sup>.</li> </ul> </li> </ul>

    <div id="p-0390" num="0533" class="description-paragraph style-scope patent-text">Other dipeptide combinations may be used, including those described by Dubowchik et al., <i class="style-scope patent-text">Bioconjugate Chemistry, </i>2002, 13, 855-869, which is incorporated herein by reference.</div>
    <div id="p-0391" num="0534" class="description-paragraph style-scope patent-text">In some embodiments, Q<sup class="style-scope patent-text">X </sup>is a tripeptide residue. The amino acids in the tripeptide may be any combination of natural amino acids and non-natural amino acids. In some embodiments, the tripeptide comprises natural amino acids. Where the linker is a cathepsin labile linker, the tripeptide is the site of action for cathepsin-mediated cleavage. The tripeptide then is a recognition site for cathepsin.</div>
    <div id="p-0392" num="0535" class="description-paragraph style-scope patent-text">In one embodiment, the amino acid side chain is chemically protected, where appropriate. The side chain protecting group may be a group as discussed below. Protected amino acid sequences are cleavable by enzymes. For example, a dipeptide sequence comprising a Boc side chain-protected Lys residue is cleavable by cathepsin.</div>
    <div id="p-0393" num="0536" class="description-paragraph style-scope patent-text">Protecting groups for the side chains of amino acids are well known in the art and are described in the Novabiochem Catalog, and as described above.</div>
    <div id="p-0394" num="0537" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">L </sup>is of formula IIIb.</div>
    <div id="p-0395" num="0538" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">LL </sup>is formula IIIb′.</div>
    <div id="p-0396" num="0539" class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>are independently selected from H and methyl, or together with the carbon atom to which they are bound form a cyclopropylene or cyclobutylene group.</div>
    <div id="p-0397" num="0540" class="description-paragraph style-scope patent-text">In some embodiments, both R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>are H.</div>
    <div id="p-0398" num="0541" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">L1 </sup>is H and R<sup class="style-scope patent-text">L2 </sup>is methyl.</div>
    <div id="p-0399" num="0542" class="description-paragraph style-scope patent-text">In some embodiments, both R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>are methyl.</div>
    <div id="p-0400" num="0543" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>together with the carbon atom to which they are bound form a cyclopropylene group.</div>
    <div id="p-0401" num="0544" class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">L1 </sup>and R<sup class="style-scope patent-text">L2 </sup>together with the carbon atom to which they are bound form a cyclobutylene group.</div>
    <div id="p-0402" num="0545" class="description-paragraph style-scope patent-text">In the group IIIb, in some embodiments, e is 0. In other embodiments, e is 1 and the nitro group may be in any available position of the ring. In some of these embodiments, it is in the ortho position. In others of these embodiments, it is in the para position.</div>
    <div id="p-0403" num="0546" class="description-paragraph style-scope patent-text">In one particular embodiment, the first aspect of the invention comprises a compound of formula Id:</div>
    <div id="p-0404" num="0547" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00069" num="00069" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1f/5c/cc/b2952681567f17/US10799595-20201013-C00069.png" class="style-scope patent-text"><img id="EMI-C00069" he="71.88mm" wi="147.24mm" file="US10799595-20201013-C00069.TIF" alt="Figure US10799595-20201013-C00069" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="589" height="288" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1f/5c/cc/b2952681567f17/US10799595-20201013-C00069.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00069" attachment-type="cdx" file="US10799595-20201013-C00069.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00069" attachment-type="mol" file="US10799595-20201013-C00069.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0405" num="0548" class="description-paragraph style-scope patent-text">In one particular embodiment, the second aspect of the invention, the Drug linker (D<sup class="style-scope patent-text">L</sup>) is of formula (Id′):</div>
    <div id="p-0406" num="0549" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00070" num="00070" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a7/52/64/1803d4f2251e38/US10799595-20201013-C00070.png" class="style-scope patent-text"><img id="EMI-C00070" he="74.68mm" wi="152.40mm" file="US10799595-20201013-C00070.TIF" alt="Figure US10799595-20201013-C00070" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="610" height="299" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a7/52/64/1803d4f2251e38/US10799595-20201013-C00070.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00070" attachment-type="cdx" file="US10799595-20201013-C00070.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00070" attachment-type="mol" file="US10799595-20201013-C00070.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
Additional Background
</div>
    <div id="p-0407" num="0550" class="description-paragraph style-scope patent-text">In an impact study submitted to the 2014 Research Excellence Framework (REF) in the United Kingdom by University College London (available at http://impactref.ac.uk/casestudies2/refservice.svc/GetCaseStudyPDF/35393), it was commented that:</div>
    <div id="p-0408" num="0551" class="description-paragraph style-scope patent-text">“The next generation of PBD dimers, which are more potent than SG2000, have been developed, including SG2057 and SG2202. They exhibit picomolar/sub-picomolar activity against a range of human tumour cell lines and demonstrate curative activity in human tumour xenograft models.” making reference to:</div>
    <div id="p-0409" num="0552" class="description-paragraph style-scope patent-text">Hartley J A, et al., <i class="style-scope patent-text">DNA interstrand cross</i>-<i class="style-scope patent-text">linking and in vivo antitumor activity of the extended pyrrolo</i>[2,1-<i class="style-scope patent-text">c</i>][1,4]benzodiazepine dimer SG2057. Invest New Drugs. 2012 June; 30(3):950-8. http://dx.doi.org/10.1007/s10637-011-9647-z (herein after “Hartley et al (2012)”) and:</div>
    <div id="p-0410" num="0553" class="description-paragraph style-scope patent-text">“The ability to generate such cytotoxic molecules that display exquisite potency suggested a potential role in strategies aimed at targeting and releasing highly cytotoxic agents directly at a tumour site. An example is as the ‘warhead’ component of an antibody drug conjugate (ADC). The fully synthetic PBD dimers are ideally suited for the role of warhead in an ADC approach.”</div>
    <div id="p-0411" num="0554" class="description-paragraph style-scope patent-text">The Hartley et al (2012) paper comments in its summary that “SG2057 is therefore a highly active antitumour agent, with more potent in vitro activity and superior in vivo activity to SG2000, warranting further development”.</div>
    <div id="p-0412" num="0555" class="description-paragraph style-scope patent-text">SG2057 has the structure:</div>
    <div id="p-0413" num="0556" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00071" num="00071" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bc/49/5c/06efd44ac91aee/US10799595-20201013-C00071.png" class="style-scope patent-text"><img id="EMI-C00071" he="22.78mm" wi="117.60mm" file="US10799595-20201013-C00071.TIF" alt="Figure US10799595-20201013-C00071" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="470" height="91" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bc/49/5c/06efd44ac91aee/US10799595-20201013-C00071.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00071" attachment-type="cdx" file="US10799595-20201013-C00071.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00071" attachment-type="mol" file="US10799595-20201013-C00071.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0414" num="0557" class="description-paragraph style-scope patent-text">Antibody drug conjugates using SG2057 as a warhead were first disclosed in WO 2011/130598. For example, claim 54 of this application includes the formula:</div>
    <div id="p-0415" num="0558" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00072" num="00072" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4c/21/96/f0b53c15fcc70d/US10799595-20201013-C00072.png" class="style-scope patent-text"><img id="EMI-C00072" he="51.82mm" wi="150.03mm" file="US10799595-20201013-C00072.TIF" alt="Figure US10799595-20201013-C00072" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="600" height="207" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4c/21/96/f0b53c15fcc70d/US10799595-20201013-C00072.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00072" attachment-type="cdx" file="US10799595-20201013-C00072.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00072" attachment-type="mol" file="US10799595-20201013-C00072.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
wherein n is from 1 to 24, more preferably 4 to 8. The following drug linkers were exemplified: n=4, 15c; n=8, 15d; n=24, 15e.
</div>
    <div id="p-0416" num="0559" class="description-paragraph style-scope patent-text">Claim 54 of this application also includes the formula:</div>
    <div id="p-0417" num="0560" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00073" num="00073" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f1/b4/66/7720728b1a2996/US10799595-20201013-C00073.png" class="style-scope patent-text"><img id="EMI-C00073" he="58.67mm" wi="153.33mm" file="US10799595-20201013-C00073.TIF" alt="Figure US10799595-20201013-C00073" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="613" height="235" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f1/b4/66/7720728b1a2996/US10799595-20201013-C00073.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00073" attachment-type="cdx" file="US10799595-20201013-C00073.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00073" attachment-type="mol" file="US10799595-20201013-C00073.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0418" num="0561" class="description-paragraph style-scope patent-text">wherein n is from 1 to 24, more preferably 4 to 8. The following drug linkers were exemplified: n=8, 58; n=24, 61.</div>
    <div id="p-0419" num="0562" class="description-paragraph style-scope patent-text">WO 2011/130598 also discloses antibody-drug conjugates including these drug linkers, for example 110 (antiSteap1-15d), example 114 (tastuzumab-15d) and example 115 (tastuzumab-58).</div>
    <div id="p-0420" num="0563" class="description-paragraph style-scope patent-text">WO 2013/055987 discloses the drug linkers 14 and 22:</div>
    <div id="p-0421" num="0564" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00074" num="00074" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/53/d7/88/4d827c1c5e45bb/US10799595-20201013-C00074.png" class="style-scope patent-text"><img id="EMI-C00074" he="105.75mm" wi="107.19mm" file="US10799595-20201013-C00074.TIF" alt="Figure US10799595-20201013-C00074" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="429" height="423" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/53/d7/88/4d827c1c5e45bb/US10799595-20201013-C00074.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00074" attachment-type="cdx" file="US10799595-20201013-C00074.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00074" attachment-type="mol" file="US10799595-20201013-C00074.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
and their use in antibody-drug conjugates.
</div>
    <div id="p-0422" num="0565" class="description-paragraph style-scope patent-text">More recently, the warhead:</div>
    <div id="p-0423" num="0566" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00075" num="00075" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bc/1c/d2/abfcd14d4c0f37/US10799595-20201013-C00075.png" class="style-scope patent-text"><img id="EMI-C00075" he="19.98mm" wi="106.85mm" file="US10799595-20201013-C00075.TIF" alt="Figure US10799595-20201013-C00075" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="427" height="80" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bc/1c/d2/abfcd14d4c0f37/US10799595-20201013-C00075.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00075" attachment-type="cdx" file="US10799595-20201013-C00075.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00075" attachment-type="mol" file="US10799595-20201013-C00075.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
has been used in drug linkers and antibody-drug conjugates. WO 2014/057074 discloses:
</div>
    <div id="p-0424" num="0567" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00076" num="00076" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e4/8d/af/549629a7e3f739/US10799595-20201013-C00076.png" class="style-scope patent-text"><img id="EMI-C00076" he="80.18mm" wi="106.85mm" file="US10799595-20201013-C00076.TIF" alt="Figure US10799595-20201013-C00076" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="427" height="321" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e4/8d/af/549629a7e3f739/US10799595-20201013-C00076.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00076" attachment-type="cdx" file="US10799595-20201013-C00076.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00076" attachment-type="mol" file="US10799595-20201013-C00076.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0425" num="0568" class="description-paragraph style-scope patent-text">The present inventors have surprisingly found that although SG2000 is at least 10 times less cytotoxic than SG2057 (see Hartley et al 2012), particular antibody-drug conjugates, i.e. those of formula Id, appear to show at least comparable activity. These conjugates have been shown to have surprisingly well tolerated in toxicity studies in a variety of species. This leads to the conjugates exhibiting high therapeutic indices and thus are promising clinical candidates.</div>
    <div id="p-0426" num="0569" class="description-paragraph style-scope patent-text">In some embodiments of the present invention, the C11 substituent may be in the following stereochemical arrangement relative to neighbouring groups:</div>
    <div id="p-0427" num="0570" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00077" num="00077" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7e/eb/b3/e682ac58e687e6/US10799595-20201013-C00077.png" class="style-scope patent-text"><img id="EMI-C00077" he="19.73mm" wi="25.06mm" file="US10799595-20201013-C00077.TIF" alt="Figure US10799595-20201013-C00077" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="100" height="79" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7e/eb/b3/e682ac58e687e6/US10799595-20201013-C00077.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00077" attachment-type="cdx" file="US10799595-20201013-C00077.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00077" attachment-type="mol" file="US10799595-20201013-C00077.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0428" num="0571" class="description-paragraph style-scope patent-text">In other embodiments, the C11 substituent may be in the following stereochemical arrangement relative to neighbouring groups:</div>
    <div id="p-0429" num="0572" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00078" num="00078" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/77/af/7f638544e663f9/US10799595-20201013-C00078.png" class="style-scope patent-text"><img id="EMI-C00078" he="19.73mm" wi="25.06mm" file="US10799595-20201013-C00078.TIF" alt="Figure US10799595-20201013-C00078" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="100" height="79" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/77/af/7f638544e663f9/US10799595-20201013-C00078.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00078" attachment-type="cdx" file="US10799595-20201013-C00078.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00078" attachment-type="mol" file="US10799595-20201013-C00078.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0430" num="0573" class="description-paragraph style-scope patent-text">Compounds of particular interest include those of the examples</div>
    <heading id="h-0138" class="style-scope patent-text">EXAMPLES</heading>
    <div id="p-0431" num="0574" class="description-paragraph style-scope patent-text">Flash chromatography was performed using a Biotage Isolera 1™ using gradient elution starting from either 88% hexane/EtOAc or 99.9% DCM/MeOH until all UV active components (detection at 214 and 254 nm) eluted from the column. The gradient was manually held whenever substantial elution of UV active material was observed. Fractions were checked for purity using thin-layer chromatography (TLC) using <figure-callout id="60" label="Merck Kieselgel" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Merck Kieselgel</a></figure-callout> 60 F254 silica gel, with fluorescent indicator on aluminium plates. Visualisation of TLC was achieved with UV light or iodine vapour unless otherwise stated. Extraction and chromatography solvents were bought and used without further purification from VWR U.K. All fine chemicals were purchased from Sigma-Aldrich or TCI Europe unless otherwise stated. Pegylated reagents were obtained from Quanta biodesign US via Stratech UK.</div>
    <div id="p-0432" num="0575" class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">1</sup>H and <sup class="style-scope patent-text">13</sup>C NMR spectra were obtained on a Bruker Avance® 400 spectrometer. Coupling constants are quoted in hertz (Hz). Chemical shifts are recorded in parts per million (ppm) downfield from tetramethylsilane. Spin multiplicities are described as s (singlet), bs (broad singlet), d (doublet), t (triplet), and m (multiplet).</div>
    <div id="p-0433" num="0576" class="description-paragraph style-scope patent-text">The analytical LC/MS conditions (for reaction monitoring and purity determination) were as follows: Positive mode electrospray mass spectrometry was performed using a Shimadzu Nexera®/Prominence® LCMS-2020. Mobile phases used were solvent A (H<sub class="style-scope patent-text">2</sub>O with 0.1% formic acid) and solvent B (CH<sub class="style-scope patent-text">3</sub>CN with 0.1% formic acid). Gradient for routine 3-minute run: Initial composition 5% B held over 25 seconds, then increased from 5% B to 100% B over a 1 minute 35 seconds' period. The composition was held for 50 seconds at 100% B, then returned to 5% B in 5 seconds and held there for 5 seconds. The total duration of the gradient run was 3.0 minutes. Gradient for 15-minute run: Initial composition 5% B held over 1 minute, then increased from 5% B to 100% B over a 9 minute period. The composition was held for 2 minutes at 100% B, then returned to 5% B in 10 seconds and held there for 2 <figure-callout id="50" label="minutes" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">minutes</a></figure-callout> 50 seconds. The total duration of the gradient run was 15.0 minutes. Flow rate was 0.8 mL/minute (for 3-minute run) and 0.6 mL/minute (for 15-minute run). Detection was at 254 nm. Columns: Waters Acquity UPLC® BEH Shield RP18 1.7 μm 2.1×50 mm at 50° C. fitted with Waters Acquity UPLC® BEH Shield RP18 VanGuard Pre-column, 130A, 1.7 μm, 2.1 mm×5 mm (routine 3-minute run); and ACE Excel 2 C18-AR, 2μ, 3.0×100 mm fitted with Waters Acquity UPLC® BEH Shield RP18 VanGuard Pre-column, 130A, 1.7 μm, 2.1 mm×5 mm (15-minute run).</div>
    <div id="p-0434" num="0577" class="description-paragraph style-scope patent-text">The preparative HPLC conditions were as follows: Reverse-phase ultra-fast high-performance liquid chromatography (UFLC) was carried out on a Shimazdzu Prominence® machine using a Phenomenex® Gemini NX 5μ C18 column (at 50° C.) dimensions: 150×21.2 mm. Eluents used were solvent A (H<sub class="style-scope patent-text">2</sub>O with 0.1% formic acid) and solvent B (CH<sub class="style-scope patent-text">3</sub>CN with 0.1% formic acid). All UFLC experiments were performed with gradient conditions: Initial composition 13% B increased to 60% B over a 15 minute period then increased to 100% B over 2 minutes. The composition was held for 1 minute at 100% B, then returned to 13% B in 0.1 minute and held there for 1.9 minutes. The total duration of the gradient run was 20.0 minutes. Flow rate was 20.0 mL/minute and detection was at 254 and 280 nm.</div>
    <div id="h-0139" num="0000" class="description-paragraph style-scope patent-text">Synthesis of Key Intermediates</div>
    <div id="h-0140" num="0000" class="description-paragraph style-scope patent-text">(a) Compound 5a</div>
    <div id="p-0435" num="0578" class="description-paragraph style-scope patent-text">The following compound 5a:</div>
    <div id="p-0436" num="0579" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00079" num="00079" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/63/36/51/2948aeacaa9c95/US10799595-20201013-C00079.png" class="style-scope patent-text"><img id="EMI-C00079" he="27.35mm" wi="69.85mm" file="US10799595-20201013-C00079.TIF" alt="Figure US10799595-20201013-C00079" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="109" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/63/36/51/2948aeacaa9c95/US10799595-20201013-C00079.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00079" attachment-type="cdx" file="US10799595-20201013-C00079.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00079" attachment-type="mol" file="US10799595-20201013-C00079.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
was synthesised as described (for compound 10) in Grinda, M., et al., <i class="style-scope patent-text">ChemMedChem </i>2011 (5), 2137-2141 (DOI: 10.1002/cmdc.201100355).
</div>
    <heading id="h-0141" class="style-scope patent-text">(a) (S)-2-(methoxycarbonyl)-4-methylenepyrrolidinium chloride (I3)</heading>
    <div id="p-0437" num="0580" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00080" num="00080" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d9/85/d6/e5a845dd6befc1/US10799595-20201013-C00080.png" class="style-scope patent-text"><img id="EMI-C00080" he="68.92mm" wi="75.86mm" file="US10799595-20201013-C00080.TIF" alt="Figure US10799595-20201013-C00080" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="303" height="276" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d9/85/d6/e5a845dd6befc1/US10799595-20201013-C00080.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00080" attachment-type="cdx" file="US10799595-20201013-C00080.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00080" attachment-type="mol" file="US10799595-20201013-C00080.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <div id="p-0438" num="0581" class="description-paragraph style-scope patent-text">Commercially available proline derivative (I1) was obtained from Omegachem</div>
    <heading id="h-0142" class="style-scope patent-text">(i) (S)-1-tert-butyl 2-methyl 4-methylenepyrrolidine-1,2-dicarboxylate (I2)</heading>
    <div id="p-0439" num="0582" class="description-paragraph style-scope patent-text">Potassium carbonate (19.92 g, 14 mmol, 3.0 eq.) was added to a stirred solution of the carboxylic acid 11 (10.92 g, 48 mmol, 1.0 eq.) in DMF (270 mL). The resulting white suspension was stirred at room temperature for 30 mins, at which point iodomethane (21.48 g, 9.5 mL, 151 mmol, 3.15 eq.) was added. The reaction mixture was allowed to stir at room temperature for 3 days. The DMF was removed by rotary evaporation under reduced pressure to afford a yellow residue which was partitioned between ethylacetate and water. The organic layer was separated and the aqueous phase was extracted with ethylacetate. The combined organic layers were washed with water brined and dried over magnesium sulphate. The ethylacetate was removed by rotary evaporation under reduced pressure to give the crude product as a yellow oil. The crude product was purified by flash chromatography [85% n-hexane/15% ethylacetate] to afford the product as a colourless oil (10.74 g, 93%).</div>
    <heading id="h-0143" class="style-scope patent-text">(ii) (S)-2-(methoxycarbonyl)-4-methylenepyrrolidinium chloride (I3)</heading>
    <div id="p-0440" num="0583" class="description-paragraph style-scope patent-text">A solution of 4 M hydrochloric acid in dioxane (63 mL, 254.4 mmol, 4.5 eq.) was added to the Boc protected C-ring fragment I2 (13.67 g, 56.6 mmol, 1.0 eq.) at room temperature. Effervescence was observed indicating liberation of CO<sub class="style-scope patent-text">2 </sub>and removal of the Boc group. The product precipitated as a white solid and additional dioxane was added to facilitate stirring the reaction mixture was allowed to stir for an hour and then diluted with diethyl ether. The precipitated product was collected by vacuum filtration and washed with additional diethyl ether. Air drying afforded the desired product as a white powder (9.42 g, 94%).</div>
    <heading id="h-0144" class="style-scope patent-text">(b) ((Propane-1,3-diylbis(oxy))bis(2-amino-5-methoxy-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidin-1-yl)methanone) (I11)</heading>
    <div id="p-0441" num="0584" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00081" num="00081" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/25/5b/2d6ed3c35c4539/US10799595-20201013-C00081.png" class="style-scope patent-text"><img id="EMI-C00081" he="205.23mm" wi="126.83mm" file="US10799595-20201013-C00081.TIF" alt="Figure US10799595-20201013-C00081" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="507" height="821" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/25/5b/2d6ed3c35c4539/US10799595-20201013-C00081.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00081" attachment-type="cdx" file="US10799595-20201013-C00081.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00081" attachment-type="mol" file="US10799595-20201013-C00081.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0145" class="style-scope patent-text">(i) 1′,3′-Bis[2-methoxy-4-(methoxycarbonyl)phenoxy]propane (I5)</heading>
    <div id="p-0442" num="0585" class="description-paragraph style-scope patent-text">Diisopropyl azodicarboxylate (71.3 mL, 73.2 g, 362 mmol) was added drop-wise over a period of 60 min to an overhead stirred solution of methyl vanillate I4 (60 g, 329 mmol) and Ph<sub class="style-scope patent-text">3</sub>P (129.4 g, 494 mmol) in anhydrous THF (800 mL) at 0-5° C. (ice/acetone) under a nitrogen atmosphere. The reaction mixture was allowed to stir at 0-5° C. for an additional 1 h after which time a solution of 1,3-propanediol (11.4 mL, 12.0 g, 158 mmol) in THF (12 mL) was added drop-wise over a period of 20 min. The reaction mixture was allowed to warm to room temperature and stirred for 5 days. The resulting white precipitate I3 was collected by vacuum filtration, washed with THF and dried in a vacuum desiccator to constant weight. Yield=54.68 g (84% based on 1,3-propanediol). Analytical Data: Purity satisfactory by LC/MS 3.20 min (ES+) m/z (relative intensity) 427 ([M+Na]<sup class="style-scope patent-text">+.</sup>, 10); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCl<sub class="style-scope patent-text">3</sub>) δ δ7.64 (dd, 2H, J=1.8, 8.3 Hz), 7.54 (d, 2H, J=1.8 Hz), 6.93 (d, 2H, J=8.5 Hz), 4.30 (t, 4H, J=6.1 Hz), 3.90 (s, 6H), 3.89 (s, 6H), 2.40 (p, 2H, J=6.0 Hz).</div>
    <heading id="h-0146" class="style-scope patent-text">(ii) 1′,3′-Bis[2-methoxy-4-(methoxycarbonyl)-5-nitrophenoxy]Propane (I6)</heading>
    <div id="p-0443" num="0586" class="description-paragraph style-scope patent-text">Solid Cu(NO<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>·3H<sub class="style-scope patent-text">2</sub>O (81.54 g, 337.5 mmol) was added slowly to an overhead stirred slurry of the bis-ester I5 (54.68 g, 135 mmol) in acetic anhydride (650 mL) at 0-5° C. (ice/acetone). The reaction mixture was allowed to stir for 1 h at 0-5° C. and then allowed to warm to room temperature. A mild exotherm (c. 40-50° C.), accompanied by thickening of the mixture and evolution of NO<sub class="style-scope patent-text">2 </sub>was observed at this stage. Additional acetic anhydride (300 mL) was added and the reaction mixture was allowed to stir for 16 h at room temperature. The reaction mixture was poured onto ice (˜1.5 L), stirred and allowed to return to room temperature. The resulting yellow precipitate was collected by vacuum filtration and dried in a desiccator to afford the desired bis-<figure-callout id="16" label="nitro compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nitro compound</a></figure-callout> 16 as a yellow solid. Yield=66.7 g (100%). Analytical Data: Purity satisfactory by LC/MS 3.25 min (ES+) m/z (relative intensity) 517 ([M+Na]<sup class="style-scope patent-text">+.</sup>, 40); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCl<sub class="style-scope patent-text">3</sub>) δ 7.49 (s, 2H), 7.06 (s, 2H), 4.32 (t, 4H, J=6.0 Hz), 3.95 (s, 6H), 3.90 (s, 6H), 2.45-2.40 (m, 2H). See ref Thurston 1996.</div>
    <heading id="h-0147" class="style-scope patent-text">(iii) 1′,3′-Bis(4-carboxy-2-methoxy-5-nitrophenoxy) propane (I7)</heading>
    <div id="p-0444" num="0587" class="description-paragraph style-scope patent-text">A slurry of the methyl ester I6 (66.7 g, 135 mmol) in THF (700 mL) was treated with 1N NaOH (700 mL) and the reaction mixture was allowed to stir vigorously at room temperature. After 4 days stirring, the slurry became a dark coloured solution which was subjected to rotary evaporation under reduced pressure to remove THF. The resulting aqueous residue was acidified to pH 1 with concentrated HCl and the colourless precipitate I7 was collected and dried thoroughly in a vacuum oven (50° C.). Yield=54.5 g (87%). Analytical Data: Purity satisfactory by LC/MS 2.65 min (ES+) m/z (relative intensity) 489 ([M+Na]<sup class="style-scope patent-text">+.</sup>, 30); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, DMSO-d<sub class="style-scope patent-text">6</sub>) δ 7.62 (s, 2H), 7.30 (s, 2H), 4.29 (t, 4H, J=6.0 Hz), 3.85 (s, 6H), 2.30-2.26 (m, 2H).</div>
    <heading id="h-0148" class="style-scope patent-text">(iv) Dimethyl 1,1′-(4,4′-(propane-1,3-diylbis(oxy))bis(5-methoxy-2-nitrobenzoyl))(2S,2's)-bis(4-methylenepyrrolidine-2-carboxylate) (I8)</heading>
    <div id="p-0445" num="0588" class="description-paragraph style-scope patent-text">A catalytic amount of anhydrous DMF (2.4 mL) was added to a stirred suspension of oxalyl chloride (14.7 g, 9.8 mL, 115.8 mmol, 3 eq.) and dimer core I7 (18 g, 38.6 mmol, 1 eq.) in anhydrous DCM (500 mL) at room temperature. Vigorous effervescence was observed after the addition of DMF and the reaction mixture was allowed to stir for 18 h in a round bottom flask fitted with a calcium chloride drying tube. The resulting clear solution was evaporated under reduced pressure and the solid triturated with ether. The solid product was collected by vacuum filtration, washed with additional ether and dried in vacuo at 40° C. for 1.5 h. This solid was then added portion wise to a suspension of the C-ring 3 (15.1 g, 84.9 mmol, 2.2 eq.) and TEA (19.5 g, 27 ml, 119.6 mmol, 5 eq.) in dry DCM (375 mL), maintaining the temperature between −40 and −50° C. with the aid of a dry ice/acetonitrile bath. The reaction mixture was allowed to stir at −40° C. for 1 h and then allowed to warm to room temperature at which point LCMS indicated the complete consumption of the starting material. The reaction mixture was diluted with additional DCM and washed sequentially with aqueous hydrochloric acid (1 M, 2×200 mL), saturated aqueous sodium bicarbonate (2×250 mL), water (250 mL), brine (250 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>). DCM was removed by rotary evaporation under reduced pressure to afford the product as a yellow foam (25.72 g, 94%). Analytical Data: RT 1.59 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 713 ([M+H]<sup class="style-scope patent-text">+.</sup>, 100)</div>
    <heading id="h-0149" class="style-scope patent-text">(v) ((Propane-1,3-diylibis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S)-2-(hydroxymethyl)-4-methylenepyrrolidin-1-yl)methanone) (I9)</heading>
    <div id="p-0446" num="0589" class="description-paragraph style-scope patent-text">Solid lithium borohydride (3.18 g, 146 mmol, 3 eq.) was added in one portion to a solution of the ester I8 (34.72 g, 48.7 mmol, 1 eq.) in dry THF (350 mL) under a nitrogen atmosphere at 0° C. (ice bath). The reaction mixture was allowed to stir at 0° C. for 30 mins and then allowed to warm to room temperature at which point precipitation of an orange gum was observed. The reaction mixture was allowed to stir at room temperature for a further 2 hours and then cooled in an ice bath and treated with water to give a yellow suspension. Hydrochloric acid (1 M) was carefully added until effervescence ceased. The reaction mixture was extracted with ethylacetate (×4) and the combined organic layers were washed with water (×1), brine (×1) and dried (MgSO<sub class="style-scope patent-text">4</sub>). Ethylacetate was removed by rotary evaporation under reduced pressure to give a yellow foam. Purification by flash column chromatography [gradient elution DCM/<figure-callout id="0" label="MeOH" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">MeOH</a></figure-callout> 0% to 5% in 1% increments] gave the product as a pale yellow foam (23.1 g, 72%). Analytical Data: RT 1.23 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 657 ([M+H]<sup class="style-scope patent-text">+.</sup>, 100)</div>
    <heading id="h-0150" class="style-scope patent-text">(vi) ((Propane-1,3-diylibis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidin-1-yl)methanone) (I10)</heading>
    <div id="p-0447" num="0590" class="description-paragraph style-scope patent-text">A solution of the bis-alcohol I9 (10 g, 15.2 mmol, 1 eq.), t-butyldimethylsilylchloride (5.97 g, 39.6 mmol, 2.6 eq.) and imidazole (5.38 g, 79 mmol, 5.2 eq.) in dry DMF (80 ml) was stirred at room temperature for 3 h. The reaction mixture was poured into water (500 mL) to give a yellow precipitate. The mixture was extracted with DCM (4×100 mL) and the combined extracts were washed with water and brine, dried (MgSO<sub class="style-scope patent-text">4</sub>) and evaporated under reduced pressure to give a viscous yellow oil. Purification by column chromatography [biotage isolera, <figure-callout id="60" label="gradient elution hexane" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">gradient elution hexane</a></figure-callout> 60%/<figure-callout id="40" label="EtOAc" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">EtOAc</a></figure-callout> 40% to EtOAc 100%, 8 column volumes 100 g snap Ultra® cartridge] gave the product as a yellow foam (11.8 g, 88%). Analytical Data: RT 2.20 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 885 ([M+H]<sup class="style-scope patent-text">+.</sup>, 100), 907 ([M+Na]<sup class="style-scope patent-text">+.</sup>, 50)</div>
    <heading id="h-0151" class="style-scope patent-text">(vii) ((Propane-1,3-diylbis(oxy))bis(2-amino-5-methoxy-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidin-1-yl)methanone) (I11)</heading>
    <div id="p-0448" num="0591" class="description-paragraph style-scope patent-text">Zinc powder (31.9 g, 488 mmol, 40 eq.) was activated by stirring/sonication with 1M HCl for 10 min. The Zinc was filtered washing with 1M HCl, water (×3) and MeOH (×2). The activated Zinc was added to a solution of the nitro-TBS compound I10 (10.8 g, 12.2 mmol, 1 eq.) in MeOH (88 mL) and 5% formic acid/MeOH solution (440 mL). The temperature rose to 37° C. and the reaction mixture changed from a yellow to a colourless solution. Once the exotherm had subsided (20 min.) the reaction was shown to be complete by LCMS. The reaction mixture was filtered through celite washing with EtOAc. The EtOAc portion was washed with saturated bicarbonate solution (×4) [caution effervescence!], water (×1), brine (×1), dried (MgSO<sub class="style-scope patent-text">4</sub>) and evaporated under reduced pressure to give a yellow solid. Purification by flash column chromatography [n-hexane/<figure-callout id="50" label="EtOAc" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">EtOAc</a></figure-callout> 50/50 v/v to <figure-callout id="100" label="EtOAc" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">EtOAc</a></figure-callout> 100% in 10% increments] gave the product as a yellow foam (9.5 g, 86%). Analytical Data: RT 2.12 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 825 ([M+H]<sup class="style-scope patent-text">+</sup>, 60), 847 ([M+Na]<sup class="style-scope patent-text">+</sup>, 30)</div>
    <heading id="h-0152" class="style-scope patent-text">(c) Alloc-Val-Ala-PABOH (I16)</heading>
    <div id="p-0449" num="0592" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00082" num="00082" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a5/dc/33/164c9d372cbb8e/US10799595-20201013-C00082.png" class="style-scope patent-text"><img id="EMI-C00082" he="187.62mm" wi="75.86mm" file="US10799595-20201013-C00082.TIF" alt="Figure US10799595-20201013-C00082" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="303" height="750" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a5/dc/33/164c9d372cbb8e/US10799595-20201013-C00082.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00082" attachment-type="cdx" file="US10799595-20201013-C00082.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00082" attachment-type="mol" file="US10799595-20201013-C00082.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0153" class="style-scope patent-text">(i) Alloc-Val-OH (I13)</heading>
    <div id="p-0450" num="0593" class="description-paragraph style-scope patent-text">Allyl chloroformate (41 g, 36.2 mL, 0.34 mol, 1.2 eq.) was added dropwise to a stirred solution of L-valine I12 (33.25 g, 0.28 mol, 1 eq.) and potassium carbonate (58.9 g, 0.426 mol, 1.5 eq.) in water (650 mL) and THF (650 mL). The reaction mixture was stirred at room temperature for 18 h. The THF was evaporated under reduced pressure and the remaining solution was extracted with diethyl ether (or MTBE) (×2). The aqueous portion was acidified to pH 2 with conc. HCl and extracted with DCM (×3). The combined organic extracts were washed with brine (×1), dried (MgSO<sub class="style-scope patent-text">4</sub>) and evaporated under reduced pressure to give a colourless oil (57.1 g). This was used in the next step without further purification.</div>
    <heading id="h-0154" class="style-scope patent-text">Alloc-Val-OSu (I14)</heading>
    <div id="p-0451" num="0594" class="description-paragraph style-scope patent-text">To a stirred solution of compound I13 (57.1 g, 0.28 mol, 1 eq.) and N-hydroxysuccinimide (32.68 g, 0.28 mol, 1 eq.) in dry THF (800 mL) was added dicyclohexylcarbodiimide (58.6 g, 0.28 mol, 1 eq.). The reaction mixture was stirred at room temperature for 18 h. The reaction mixture was filtered. The solid was washed with THF and the combined filtrate was concentrated under reduced pressure. The oil/solid residue was re-dissolved in DCM and left to stand at 0° C. for 30 min. The suspension was filtered washing with cold DCM. Evaporation of the filtrate under reduced pressure gave the succinimide ester as a white solid which was used in the next step without further purification.</div>
    <heading id="h-0155" class="style-scope patent-text">(iii) Alloc-Val-Ala-OH (I15)</heading>
    <div id="p-0452" num="0595" class="description-paragraph style-scope patent-text">A solution of Alloc-Val-OSu I14 (11.67 g, 39.0 mmol, 1 eq.) in THF (50 mL) was added to a solution of H-Ala-OH (3.66 g, 41.08 mmoL, 1.05 eq.) and NaHCO<sub class="style-scope patent-text">3 </sub>(3.61 g, 43.03 mmol, 1.1 eq.) in THF (100 mL) and H<sub class="style-scope patent-text">2</sub>O (100 mL). The mixture was stirred at room temperature for 72 h and the THF was evaporated under reduced pressure. The pH was adjusted to 3-4 with citric acid to precipitate a white gum. This was extracted with ethylacetate (6×150 mL) and the combined extracts were washed with H<sub class="style-scope patent-text">2</sub>O (200 mL), brine (200 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>) and evaporated under reduced pressure to give a white solid. Trituration with diethyl ether (xs) afforded the pure product as a white powder (7.93 g, 74%). Analytical Data: RT 2.17 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 295 ([M+Na]<sup class="style-scope patent-text">+.</sup>, 63), 273 ([M+1]<sup class="style-scope patent-text">+.</sup>, 60).</div>
    <heading id="h-0156" class="style-scope patent-text">(iv) Alloc-Val-Ala-PABOH (I16)</heading>
    <div id="p-0453" num="0596" class="description-paragraph style-scope patent-text">EEDQ (4.79 g, 19.3 mmol, 1.05 eq.) was added to a solution of p-aminobenzyl alcohol (2.38 g, 19.3 mmol, 1.05 eq.) and Alloc-Val-Ala-OH I15 (5.02 g, 18.4 mmol, 1.0 eq) in dry THF (100 mL). The mixture was stirred at room temperature for 72 h. The solvent was evaporated under reduced pressure to give a pale brown solid. The solid was triturated with diethyl ether and filtered washing with an excess of diethyl ether. This afforded the product as a white solid (6.2 g, 89%). Analytical Data: RT 2.50 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 400.6 ([M+Na]<sup class="style-scope patent-text">+.</sup>, 50), 378.6 ([M+1]<sup class="style-scope patent-text">+.</sup>, 60).</div>
    <heading id="h-0157" class="style-scope patent-text">Example 1</heading>
    <div id="p-0454" num="0597" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00083" num="00083" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/98/99/bc/feae0a6c00d417/US10799595-20201013-C00083.png" class="style-scope patent-text"><img id="EMI-C00083" he="472.95mm" wi="156.97mm" file="US10799595-20201013-C00083.TIF" alt="Figure US10799595-20201013-C00083" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="628" height="1892" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/98/99/bc/feae0a6c00d417/US10799595-20201013-C00083.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00083" attachment-type="cdx" file="US10799595-20201013-C00083.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00083" attachment-type="mol" file="US10799595-20201013-C00083.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0158" class="style-scope patent-text">(a) (9H-Fluoren-9-yl)methyl (5-(3-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (3)</heading>
    <div id="p-0455" num="0598" class="description-paragraph style-scope patent-text">FmocCl (1.97 g, 7.63 mmol) was added to a stirred mixture of the bis-aniline I11 (6.99 g, 8.48 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(2.25 g, 21.2 mmol) in THF (65 mL) and H<sub class="style-scope patent-text">2</sub>O (65 mL). The mixture was allowed to stir room temperature for 16 hours where analysis by LC/MS revealed desired mono Fmoc product 3 at retention time 2.34 minutes, I %=40, ES+ m/z 1069 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1047 [M+H]<sup class="style-scope patent-text">+. </sup>along with unreacted starting material at retention time 2.15 minutes, I %=12, and bis-Fmoc material at retention time 2.50 minutes, I %=45, ES+ m/z 1291 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1269 [M+H]<sup class="style-scope patent-text">+.</sup>. The layers were separated and the aqueous phase extracted with DCM (2×20 mL) and the combined organic layers washed with H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 50 g, 100 mL per minute) provided the pure mono Fmoc product 3 as an orange foam (2.67 g, 39% yield based on FmocCl, eluting at 50% Hexane/EtOAc) unreacted bis-aniline 2 (1.78 g, eluting at 100% EtOAc) and bis-Fmoc (3.28 g, eluting at 70% Hexane/EtOAc).</div>
    <heading id="h-0159" class="style-scope patent-text">(b) (9H-Fluoren-9-yl)methyl (5-(3-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (4)</heading>
    <div id="p-0456" num="0599" class="description-paragraph style-scope patent-text">Triphosgene (26 mg, 86 μmol) was added to a stirred solution of the mono Fmoc product 3 (250 mg, 0.24 mmol) and TEA (73 μL, 53 mg, 0.53 mmol) in dry DCM (10 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.39 minutes, ES+ m/z 1127 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1105 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional TEA (50 μL, 36 mg, 0.36 mmol) followed by the addition of linker I16 (90 mg, 0.24 mmol). After 4 hours stirring under argon, LC/MS revealed satisfactory conversion to <figure-callout id="4" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 4 at retention time 2.34 minutes, ES+ m/z 1472 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1451 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (60 mL) and washed with saturated aqueous NH<sub class="style-scope patent-text">4</sub>Cl (2×20 mL), H<sub class="style-scope patent-text">2</sub>O (20 mL), brine (30 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="75" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 25 g, 75 mL per minute) provided the pure carbamate 4 (eluting at 28% Hexane/EtOAc) as a yellow foam (257 mg, 74% yield).</div>
    <heading id="h-0160" class="style-scope patent-text">(c) 4-((S)-2-((S)-2-(((Allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl (5-(3-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (5)</heading>
    <div id="p-0457" num="0600" class="description-paragraph style-scope patent-text">Dimethylamine (16.5 mL of a 2.0M solution in THF, 33.0 mmol) was added to a stirred solution of the Fmoc protected compound 4 (2.39 g, 1.65 mmol) in THF (46 mL) at room temperature. After stirring for 1 hour at room temperature, analysis by LC/MS revealed reaction completion with desired product at retention time 2.17 minutes, ES+ m/z 1250 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1228 [M+H]<sup class="style-scope patent-text">+.</sup>, along with Fmoc cleavage by-product at retention time 1.92 minutes and its DMA adduct at retention time 1.10 minutes. The mixture was evaporated in vacuo to give the crude product which was subsequently purified by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) to provide the pure aniline 5 (eluting at 100% EtOAc) as an orange foam (1.87 g, 92% yield).</div>
    <heading id="h-0161" class="style-scope patent-text">(d) Allyl (2S,3S,4S,5R,6S)-6-(4-((((5-(3-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methylenepyrroldine-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)3,4,5-tris(((allyoxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (6)</heading>
    <div id="p-0458" num="0601" class="description-paragraph style-scope patent-text">Triphosgene (161 mg, 0.54 mmol) was added to a stirred solution of the aniline 5 (1.85 g, 1.51 mmol) and pyridine (269 μL, 263 mg, 3.32 mmol) in dry DCM (20 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.21 minutes, ES+ m/z 1308 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1286 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional pyridine (183 μL, 179 mg, 2.27 mmol) and dibutyltin dilaurate (179 μL, 191 mg, 0.30 mmol) followed by the addition of linker 5a (960 mg, 1.51 mmol). After 20 hours stirring under argon, LC/MS revealed satisfactory conversion to carbamate 6 (retention time 2.25 minutes, ES+ m/z 1915 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1892 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was diluted with DCM (60 mL) and washed with saturated NH<sub class="style-scope patent-text">4</sub>Cl (2×20 mL), H<sub class="style-scope patent-text">2</sub>O (20 mL), brine (30 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 6 (eluting at 42% Hexane/EtOAc) as a yellow foam (2.01 g, 70% yield).</div>
    <heading id="h-0162" class="style-scope patent-text">(e) Allyl (2S,3S,4S,5R,6S)-6-(4-((((5-(3-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(hydroxymethyl)-4-methylenepyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(hydroxymethyl)-4-methylenepyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (7)</heading>
    <div id="p-0459" num="0602" class="description-paragraph style-scope patent-text">Glacial acetic acid (18 mL) was added to a stirred solution of the TBS-protected compound 6 (2.12 g, 1.12 mmol) in THF (6 mL) and H<sub class="style-scope patent-text">2</sub>O (6 mL). The reaction mixture was allowed to stir for 18 hours at room temperature after which time analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.79 minutes, ES+ m/z 1663 [M+H]<sup class="style-scope patent-text">+.</sup>, 1686 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a chilled (0-5° C.) saturated solution of NaHCO<sub class="style-scope patent-text">3 </sub>(300 mL). The neutral solution was allowed to warm to room temperature and extracted with EtOAc (3×100 mL), the combined organic layers were washed with H<sub class="style-scope patent-text">2</sub>O (50 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) gave the bis-alcohol 7 (eluting at 93% DCM/MeOH) as a yellowish foam (1.43 g, 77% yield).</div>
    <heading id="h-0163" class="style-scope patent-text">(f) 4-(((2S,3R,4S,5S,6S)-6-((allyloxy)carbonyl)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-nitrobenzyl (11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((S)-2-(((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine 10(5H)-carboxylate (8)</heading>
    <div id="p-0460" num="0603" class="description-paragraph style-scope patent-text">45% IBX (264 mg, 0.43 mmol) was added to a stirred solution of the bis-OH 7 (300 mg, 0.18 mmol) in dry DMSO (5 mL). The mixture was heated to 30° C. under an argon atmosphere and reaction progress monitored by LC/MS. After 24 hours stirring, additional IBX (22 mg, 36 μmol) was added and the mixture stirred for another 24 hours. At this point analysis by LC/MS revealed predominantly a single peak corresponding to desired product at retention time 1.78 minutes, ES+ m/z 1682 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was poured onto water (40 mL), filtered and the precipitate collected, washed with H<sub class="style-scope patent-text">2</sub>O (50 mL) and the filtrate kept to one side. The residue (precipitate) was washed with DCM (120 mL) and the remaining undissolved precipitate washed with saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(60 mL). The combined filtrates were transferred to a separating funnel and the layers separated. The aqueous phase was extracted with DCM (2×20 mL) and the combined organic layers washed with NaHCO<sub class="style-scope patent-text">3 </sub>(2×50 mL), brine (60 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="75" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 25 g, 75 mL per minute) gave the cyclised product 8 (eluting at 94.5% DCM/MeOH) as a white foam (261 mg, 87% yield).</div>
    <heading id="h-0164" class="style-scope patent-text">(g) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((S)-2-((S)-2-amino-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (9)</heading>
    <div id="p-0461" num="0604" class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(18.2 mg, 15.7 μmol) was added to a stirred solution of pyrrolidine (72 μL, 62 mg, 0.87 mmol) and the Alloc/allyl compound 8 (261 mg, 0.16 mmol) in dry DCM (3 mL). The reaction mixture was allowed to stir under an argon atmosphere where a precipitate began to form. After stirring for 30 minutes at room temperature analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.13 minutes, ES+ m/z 1284 [M+H]<sup class="style-scope patent-text">+.</sup>. The solvent was removed by evaporation in vacuo and the resulting residue triturated with diethyl ether followed by additional evaporation in vacuo to provide the <figure-callout id="9" label="crude amine" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude amine</a></figure-callout> 9 as a solid which was carried through to the next step without further purification or analysis.</div>
    <heading id="h-0165" class="style-scope patent-text">(h) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-2-methyl-4,7,35-trioxo-10,13,16,19,22,25,28,31-octaoxa-3,6,34-triazaheptatriacontanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (10)</heading>
    <div id="p-0462" num="0605" class="description-paragraph style-scope patent-text">A solution of MAL-dPEG®8-TFP ester (132 mg, 0.18 mmol) in dry DCM (7 mL) was added to a stirred sample of the amine 9 (202 mg, 0.16 mmol), pyridine (24 μL, 23 mg, 0.3 mmol) and DMF (0.25 mL). The reaction mixture was allowed to stir under argon for 20 hours and began to darken in colour over time. Analysis by LC/MS revealed formation of desired product at retention time 1.38 minutes, ES+) m/z 1857 [M+H]<sup class="style-scope patent-text">+.</sup>, 1880 [M+Na]<sup class="style-scope patent-text">+</sup>, along with unreacted amine at retention time 1.13 minutes. Additional MAL-dPEG®8-TFP ester (66 mg, 0.09 mmol), pyridine (12 μL, 11 mg, 0.15 mmol) and DCM (3 mL) were added and the mixture allowed to stir for a further three days. At this point a satisfactory amount of desired product had formed upon analysis by LC/MS and the solvent was removed by evaporation in vacuo. The crude product was purified by preparative HPLC to give the maleimide 10 as a white solid (55 mg, 19%): LC/MS (15-minute run), retention time 5.93 minutes, ES+ m/z 1857 [M+H]<sup class="style-scope patent-text">+.</sup>, 1880 [M+Na]<sup class="style-scope patent-text">+.</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 10.0 (br s, 2H), 8.25-8.12 (m, 1H), 7.99 (t, 1H, J=5.7 Hz), 7.87 (d, 1H, J=8.9 Hz), 7.73 (br s, 1H), 7.62-7.48 (m, 3H), 7.40 (d, 1H, J=8.7 Hz), 7.22-7.11 (m, 2H), 7.06 (s, 2H), 7.00 (s, 2H), 6.87 (s, 2H), 6.84-6.76 (m, 1H), 6.68-6.52 (m, 2H), 5.45-5.30 (m, 3H), 5.25-5.01 (m, 9H), 4.97-4.82 (m, 2H), 4.42-4.34 (m, 1H), 4.24-4.17 (m, 1H), 4.16-3.92 (m, 8H), 3.87-3.72 (m, 6H), 3.60 (t, 4H, J=7.2 Hz), 3.54-3.42 (m, 30H), 3.39-3.20 (m, 5H), 3.18-3.12 (m, 2H), 2.95-2.82 (m, 2H), 2.57-2.35 (m, 4H), 2.33 (t, 2H, J=7.4 Hz), 2.24-2.13 (m, 2H), 2.03-1.90 (m, 1H), 1.30 (d, 1H, J=7.0 Hz), 0.87 (d, 3H, J=6.7 Hz), 0.83 (d, 3H, J=6.7 Hz).</div>
    <heading id="h-0166" class="style-scope patent-text">Example 2</heading>
    <div id="p-0463" num="0606" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00084" num="00084" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/29/37/f4/09b540929a1e25/US10799595-20201013-C00084.png" class="style-scope patent-text"><img id="EMI-C00084" he="500.89mm" wi="157.56mm" file="US10799595-20201013-C00084.TIF" alt="Figure US10799595-20201013-C00084" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="630" height="2004" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/29/37/f4/09b540929a1e25/US10799595-20201013-C00084.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00084" attachment-type="cdx" file="US10799595-20201013-C00084.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00084" attachment-type="mol" file="US10799595-20201013-C00084.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0167" class="style-scope patent-text">(a) (S)-(2-(((tert-butyldimethylsilyl)oxy)methyl)-4-Methyl-2,3-Dihydro-1H-Pyrrol-1-yl)(4-Hydroxy-5-Methoxy-2-Nitrophenyl)Methanone (12)</heading>
    <div id="p-0464" num="0607" class="description-paragraph style-scope patent-text">LiOAc (2.11 g, 20.7 mmol) was added to a stirred solution of the TIPS compound 11 (12 g, 20.7 mmol) in DMF (67 mL) and H<sub class="style-scope patent-text">2</sub>O (3 mL) at room temperature. A colour change from yellow to red was observed. After 2 hours stirring at room temperature analysis by LC/MS revealed complete conversion to desired product at retention time 1.83 minutes, ES+ m/z 445 [M+Na]<sup class="style-scope patent-text">+.</sup>, 423 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with H<sub class="style-scope patent-text">2</sub>O (300 mL) and extracted with EtOAc (3×150 mL). The combined organic layers were washed 10% w/v citric acid (2×200 mL), H<sub class="style-scope patent-text">2</sub>O (200 mL), brine (200 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the <figure-callout id="12" label="crude product" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude product</a></figure-callout> 12 as a yellow solid (8.74 g, 100% yield). Purity satisfactory, so material carried through to next step without further purification.</div>
    <heading id="h-0168" class="style-scope patent-text">(b) ((Pentane-1,5-diylbis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrol-1-yl)methanone) (13)</heading>
    <div id="p-0465" num="0608" class="description-paragraph style-scope patent-text">1,5-diiodopentane (1.54 mL, 3.35 g, 10.4 mmol) was added to a stirred solution of the phenol 12 (8.74 g, 20.7 mmol), TBAI (750 mg, 2.05 mmol) and K<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(3.15 g, 22.8 mmol) in dry DMF (60 mL). The reaction mixture was heated to 70° C. and stirred under an argon atmosphere for 16 hours at which point analysis by LC/MS revealed substantial product formation at retention time 2.21 minutes, ES+ m/z 935 [M+Na]<sup class="style-scope patent-text">+.</sup>, 913 [M+H]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was allowed to cool to room temperature and the DMF was removed by evaporation in vacuo. The resulting residue was redissolved in EtOAc (200 mL) and the aqueous phase was washed with water (3×40 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) gave the bis-ether 13 (eluting at 60% Hexane/EtOAc) as a yellow foam (6.75 g, 71% yield).</div>
    <heading id="h-0169" class="style-scope patent-text">(c) ((Pentane-1,5-diylbis(oxy))bis(2-amino-5-methoxy-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrol-1-yl)methanone) (14)</heading>
    <div id="p-0466" num="0609" class="description-paragraph style-scope patent-text">Zinc dust (2.79 g, 42.8 mmol) was treated with 1N HCl (50 mL) and stirred for 10 minutes at room temperature. The mixture was then sonicated for 10 minutes and the activated Zinc collected by sinter vacuum filtration then washed with 1N HCl (25 mL), H<sub class="style-scope patent-text">2</sub>O (20 mL), MeOH (20 mL) and dried in vacuo on the sinter filter pad. The activated zinc was added to a vigorously stirred solution of the bis-nitro compound 13 (974 mg, 1.07 mmol) in MeOH (15 mL) at room temperature. The reaction mixture was treated drop-wise with a solution of 5% v/v HCO<sub class="style-scope patent-text">2</sub>H in MeOH (20 mL). A colour change from green to metallic grey and an exotherm to 37° C. were observed. The reaction mixture was allowed to cool to room temperature at which point analysis by LC/MS revealed complete conversion to desired product at retention time 2.19 minutes, ES+ m/z 875 [M+Na]<sup class="style-scope patent-text">+.</sup>, 853 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was filtered through Celite® and the pad washed with EtOAc (75 mL). The filtrate was washed with saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(3×20 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude bis-aniline 14 as a dark orange foam (840 mg, 92% yield). Purity satisfactory, so material carried through to next step without further purification.</div>
    <heading id="h-0170" class="style-scope patent-text">(d) (9H-fluoren-9-yl)methyl(5-((5-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamate (15)</heading>
    <div id="p-0467" num="0610" class="description-paragraph style-scope patent-text">FmocCl (1.50 g, 5.93 mmol) was added to a stirred suspension of the bis-aniline 14 (6.74 g, 7.91 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(2.10 g, 19.8 mmol) in THF (40 mL) and H<sub class="style-scope patent-text">2</sub>O (40 mL). The mixture was allowed to stir at room temperature for 16 hours where analysis by LC/MS revealed desired mono Fmoc product 15 at retention time 2.41 minutes, I %=32, ES+ m/z 1098 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1076 [M+H]<sup class="style-scope patent-text">+. </sup>along with unreacted starting material at retention time 2.22 minutes, I %=30, and bis-Fmoc material at retention time 2.60 minutes, I %=36, ES+ m/z 1321 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1298 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was partitioned between H<sub class="style-scope patent-text">2</sub>O (50 mL) and EtOAc (50 mL), the layers were separated and the organic layer washed with H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure mono Fmoc product 15 as an orange foam (2.43 g, 38% yield based on FmocCl, eluting at 58% Hexane/EtOAc) unreacted bis-aniline 14 (3.06 g, eluting at 40% Hexane/EtOAc) and bis-Fmoc (2.32 g, eluting at 74% Hexane/EtOAc).</div>
    <heading id="h-0171" class="style-scope patent-text">(e) (9H-fluoren-9-yl)methyl(5-((5-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamate (16)</heading>
    <div id="p-0468" num="0611" class="description-paragraph style-scope patent-text">Triphosgene (242 mg, 0.81 mmol) was added to a stirred solution of the mono Fmoc product 15 (2.43 g, 2.26 mmol) and TEA (692 μL, 502 mg, 4.97 mmol) in dry DCM (30 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.38 minutes, ES+ m/z 1156 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1133 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional TEA (472 μL, 342 mg, 3.39 mmol) followed by the addition of linker I16 (852 mg, 2.26 mmol). After 3.5 hours stirring under argon, LC/MS revealed satisfactory conversion to <figure-callout id="16" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 16 at retention time 2.33 minutes, ES+ m/z 1501 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1479 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (50 mL) and washed with saturated aqueous NH<sub class="style-scope patent-text">4</sub>Cl (2×20 mL), brine (30 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 16 (eluting at 46% Hexane/EtOAc) as a yellow foam (2.26 g, 68% yield).</div>
    <heading id="h-0172" class="style-scope patent-text">(f) 4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl (5-((5-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2, 3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamate (17)</heading>
    <div id="p-0469" num="0612" class="description-paragraph style-scope patent-text">Dimethylamine (15.0 mL of a 2.0M solution in THF, 30.6 mmol) was added to a stirred solution of the Fmoc protected compound 16 (2.26 g, 1.65 mmol) in THF (20 mL) at room temperature. After stirring for 1 hour at room temperature, analysis by LC/MS revealed reaction completion with desired product at retention time 2.17 minutes, ES+ m/z 1279 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1257 [M+H]<sup class="style-scope patent-text">+.</sup>, along with Fmoc cleavage by-product at retention time 1.79 minutes and its DMA adduct at retention time 0.97 minutes. The mixture was evaporated in vacuo to give the crude product which was subsequently purified by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) to provide the pure aniline 17 (eluting at 18% Hexane/EtOAc) as an orange foam (1.94 g, 100% yield).</div>
    <heading id="h-0173" class="style-scope patent-text">(g) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-((5-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (18)</heading>
    <div id="p-0470" num="0613" class="description-paragraph style-scope patent-text">Triphosgene (165 mg, 0.55 mmol) was added to a stirred solution of the aniline 17 (1.94 g, 1.54 mmol) and pyridine (274 μL, 268 mg, 3.39 mmol) in dry DCM (20 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.21 minutes, ES+ m/z 1337 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1315 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional pyridine (187 μL, 183 mg, 2.31 mmol) and dibutyltin dilaurate (179 μL, 191 mg, 0.30 mmol) followed by the addition of linker 5a (984 mg, 1.54 mmol). After 18 hours stirring under argon, LC/MS revealed satisfactory conversion to <figure-callout id="18" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 18 at retention time 2.23 minutes, ES+ m/z 1942 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1920 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (30 mL) and washed with saturated NH<sub class="style-scope patent-text">4</sub>Cl (2×20 mL), H<sub class="style-scope patent-text">2</sub>O (20 mL), brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 18 (eluting at 43% Hexane/EtOAc) as a yellow foam (2.17 g, 74% yield).</div>
    <heading id="h-0174" class="style-scope patent-text">(h) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-((5-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(hydroxymethyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(hydroxymethyl)-4-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (19)</heading>
    <div id="p-0471" num="0614" class="description-paragraph style-scope patent-text">Glacial acetic acid (18 mL) was added to a stirred solution of the TBS-protected compound 18 (2.17 g, 1.13 mmol) in THF (6 mL) and H<sub class="style-scope patent-text">2</sub>O (6 mL). The reaction mixture was allowed to stir for 18 hours at room temperature after which time analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.82 minutes, ES+ m/z 1691 [M+H]<sup class="style-scope patent-text">+.</sup>, 1714 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a chilled (0-5° C.) saturated solution of NaHCO<sub class="style-scope patent-text">3 </sub>(300 mL). The neutral solution was allowed to warm to room temperature and extracted with EtOAc (3×100 mL), the combined organic layers were washed with brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) gave the bis-alcohol 19 (eluting at 96.5% DCM/MeOH) as a white foam (1.31 g, 69% yield).</div>
    <heading id="h-0175" class="style-scope patent-text">(i) 4-(((2S,3R,4S,5S,6S)-6-((allyloxy)carbonyl)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-nitrobenzyl(11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate (20)</heading>
    <div id="p-0472" num="0615" class="description-paragraph style-scope patent-text">45% IBX (269 mg, 0.43 mmol) was added to a stirred solution of the bis-OH 19 (300 mg, 0.18 mmol) in dry DMSO (5 mL). The mixture was heated to 30° C. under an argon atmosphere and reaction progress monitored by LC/MS. After 24 hours stirring, additional IBX (22 mg, 36 μmol) was added and the mixture stirred for another 24 hours. At this point analysis by LC/MS revealed formation of product at retention time 1.79 minutes, ES+ m/z 1710 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>solution (100 mL) and extracted with DCM (2×75 mL). The combined organic layers were washed with saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(2×20 mL), H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="75" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 25 g, 75 mL per minute) gave the cyclised product 11 (eluting at 97.4% DCM/MeOH) as a white foam (136 mg, 46% yield).</div>
    <heading id="h-0176" class="style-scope patent-text">(j) Alternate Synthesis of 4-(((2S,3R,4S,5S,6S)-6-((allyloxy)carbonyl)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-nitrobenzyl(11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate (20)</heading>
    <div id="p-0473" num="0616" class="description-paragraph style-scope patent-text">TEMPO (6.6 mg, 42 μmol) and DAIB (125 mg, 0.39 mmol) were added to a stirred solution of the bis-OH 19 (300 mg, 0.18 mmol) in dry DCM (15 mL) at room temperature. The mixture was stirred under an argon atmosphere and reaction progress monitored by LC/MS. After 24 hours stirring, additional TEMPO (6.6 mg, 42 μmol) and DAIB (25 mg, 78 μmol) were added and the mixture stirred for another 24 hours. At this point analysis by LC/MS revealed formation of product at retention time 1.79 minutes, ES+ m/z 1710 [M+Na]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (50 mL) and washed with saturated aqueous sodium thiosulfate (40 mL), saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(30 mL), brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="75" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 25 g, 75 mL per minute) gave the cyclised product 21 (eluting at 96.5% DCM/MeOH) as a white foam (231 mg, 78% yield).</div>
    <heading id="h-0177" class="style-scope patent-text">(k) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((S)-2-(((S)-2-amino-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (21)</heading>
    <div id="p-0474" num="0617" class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(15.8 mg, 13.7 μmol) was added to a stirred solution of pyrrolidine (63 μL, 54 mg, 0.75 mmol) and the Alloc/allyl compound 20 (231 mg, 0.14 mmol) in dry DCM (4 mL). The reaction mixture was allowed to stir under an argon atmosphere where a precipitate began to form. After stirring for 30 minutes at room temperature analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.18 minutes, ES+ m/z 1312 [M+H]<sup class="style-scope patent-text">+.</sup>. The solvent was removed by evaporation in vacuo and the resulting residue triturated with diethyl ether followed by additional evaporation in vacuo to provide the <figure-callout id="12" label="crude amine" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude amine</a></figure-callout> 12 as a solid which was carried through to the next step without further purification or analysis.</div>
    <heading id="h-0178" class="style-scope patent-text">(l) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-2-methyl-4,7,35-trioxo-10,13,16,19,22,25,28,31-octaoxa-3,6,34-triazaheptatriacontanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (22)</heading>
    <div id="p-0475" num="0618" class="description-paragraph style-scope patent-text">A solution of MAL-dPEG®8-TFP ester (122 mg, 0.16 mmol) in dry DCM (5 mL) was added to a stirred sample of the amine 21 (180 mg, 0.16 mmol), pyridine (28 μL, 27 mg, 0.34 mmol) and DMF (0.25 mL). The reaction mixture was allowed to stir under argon for 20 hours and began to darken in colour over time. Analysis by LC/MS revealed formation of desired product at retention time 1.43 minutes, ES− m/z 1884 [M−H]<sup class="style-scope patent-text">+.</sup>, along with unreacted amine at retention time 1.18 minutes. Additional MAL-dPEG®8-TFP ester (66 mg, 0.09 mmol), pyridine (12 μL, 11 mg, 0.15 mmol) and DCM (3 mL) were added and the mixture allowed to stir for a further three days. At this point a satisfactory amount of desired product had formed upon analysis by LC/MS and the solvent was removed by evaporation in vacuo. The crude product was purified by preparative HPLC to give the maleimide 22 as a white solid (55 mg, 19%): LC/MS (15-minute run), retention time 5.82 minutes, ES+ m/z 1886 [M+H]<sup class="style-scope patent-text">+.</sup>, 1908 [M+Na]<sup class="style-scope patent-text">+.</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 9.98 (br s, 2H), 8.25-8.15 (m, 1H), 7.99 (t, 1H, J=5.7 Hz), 7.87 (d, 1H, J=8.7 Hz), 7.69 (br s, 1H), 7.62-7.48 (m, 3H), 7.37 (d, 1H, J=8.9 Hz), 7.21-7.09 (m, 2H), 7.04 (s, 1H), 7.03 (s, 1H), 6.98 (s, 2H), 6.79 (s, 1H), 6.74 (s, 1H), 6.72-6.65 (m, 2H), 6.62-6.58 (m, 2H), 5.63-5.50 (m, 2H), 5.41-5.32 (m, 2H), 5.25-5.05 (m, 4H), 4.93-4.80 (m, 2H), 4.41-4.32 (m, 1H), 4.23-4.16 (m, 1H), 4.00-3.90 (m, 4H), 3.87-3.72 (m, 6H), 3.70-3.60 (m, 2H), 3.58 (t, 4H, J=7.2 Hz), 3.52-3.43 (m, 28H), 3.39-3.20 (m, 5H), 3.18-3.10 (m, 2H), 2.95-2.82 (m, 2H), 2.53-2.34 (m, 4H), 2.31 (t, 2H, J=7.3 Hz), 1.99-1.90 (m, 1H), 1.82-1.68 (m, 4H), 1.73 (s, 6H), 1.60-1.47 (m, 2H), 1.28 (d, 1H, J=7.0 Hz), 0.85 (d, 3H, J=6.8 Hz), 0.81 (d, 3H, J=6.8 Hz).</div>
    <heading id="h-0179" class="style-scope patent-text">Example 3</heading>
    <div id="p-0476" num="0619" class="description-paragraph style-scope patent-text"> <chemistry id="CHEM-US-00085" num="00085" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8d/40/92/dde181a2e6e96c/US10799595-20201013-C00085.png" class="style-scope patent-text"><img id="EMI-C00085" he="496.15mm" wi="157.99mm" file="US10799595-20201013-C00085.TIF" alt="Figure US10799595-20201013-C00085" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="632" height="1985" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8d/40/92/dde181a2e6e96c/US10799595-20201013-C00085.png"></a></div> <attachments class="style-scope patent-text"> <attachment idref="CHEM-US-00085" attachment-type="cdx" file="US10799595-20201013-C00085.CDX" class="style-scope patent-text"> </attachment> <attachment idref="CHEM-US-00085" attachment-type="mol" file="US10799595-20201013-C00085.MOL" class="style-scope patent-text"> </attachment> </attachments> </chemistry> <br class="style-scope patent-text">
Compound 23 is compound 46 in WO2014/057074.
</div>
    <heading id="h-0180" class="style-scope patent-text">(a) (5S,5′S)-(4,4′-(Pentane-1,5-diylbis(oxy))bis(5-methoxy-2-nitrobenzoyl))bis(5-(((tert-butyldimethylsilyl)oxy)methyl)-4,5-dihydro-1H-pyrrole-1,3-diyl)bis(trifluoromethanesulfonate) (24)</heading>
    <div id="p-0477" num="0620" class="description-paragraph style-scope patent-text">Anhydrous 2,6-lutidine (8.90 mL, 8.22 g, 76.7 mmol) was added via syringe to a stirred solution of bis-ketone 23 (5.41 g, 5.90 mmol) in dry DCM (200 mL) at −45° C. (dry ice/acetonitrile) under an argon atmosphere. Anhydrous trifluoromethanesulfonic anhydride (5.96 mL, 10.0 g, 35.5 mmol), taken from a freshly opened ampoule, was then added via syringe, while maintaining the temperature at −40° C. or below. The reaction mixture was allowed to stir at −45° C. for 1 hour at which point analysis by LC/MS revealed conversion to product at retention time retention time 2.23 minutes, ES+ m/z 1203 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1181 [M+H]<sup class="style-scope patent-text">+.</sup>. The cold reaction mixture was immediately diluted with DCM (200 mL) and washed with water (1×200 mL), 5% citric acid solution (2×200 mL), saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(200 mL), brine (300 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) afforded the bis-enol triflate 3 (eluting at 78% Hexane/EtOAc) as a yellow foam (5.02 g, 72% yield).</div>
    <heading id="h-0181" class="style-scope patent-text">(b) ((Pentane-1,5-diylbis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrol-1-yl)methanone) (25)</heading>
    <div id="p-0478" num="0621" class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(196 mg, 0.17 mmol) was added to a stirred mixture of the bis-enol triflate 24 (5.02 g, 4.25 mmol), 4-methoxyphenylboronic acid (1.68 g, 11.1 mmol), Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(1.44 g, 13.6 mmol), EtOH (20 mL), toluene (40 mL) and water (20 mL). The reaction mixture was heated at 30° C. and stirred under an argon atmosphere for 3 hours after which time complete conversion to desired product was observed by LC/MS, retention time 2.23 minutes, ES+ m/z 1120 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1098 [M+H]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was partitioned between EtOAc (200 mL) and H<sub class="style-scope patent-text">2</sub>O (100 mL) and the aqueous layer extracted with EtOAc (3×30 mL). The combined organic layers were washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) afforded bis-C2-aryl compound 25 (eluting at 63% Hexane/EtOAc) as a yellowish foam (3.11 g, 67% yield).</div>
    <heading id="h-0182" class="style-scope patent-text">(c) ((Pentane-1,5-diylbis(oxy))bis(2-amino-5-methoxy-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrol-1-yl)methanone) (26)</heading>
    <div id="p-0479" num="0622" class="description-paragraph style-scope patent-text">Non-activated zinc (4.13 g, 63.1 mmol) was added to a vigorously stirred solution of the bis-nitro compound 25 (1.73 g, 1.58 mmol) in EtOH (15 mL) and EtOAc (15 mL) at room temperature. The reaction mixture was treated with water (1 mL) then drop-wise with a solution of 5% v/v HCO<sub class="style-scope patent-text">2</sub>H in MeOH (19 mL). A colour change from green to metallic grey and an exotherm to 40° C. were observed. The reaction mixture was allowed to cool to room temperature at which point analysis by LC/MS revealed complete conversion to desired product at retention time 2.19 minutes, ES+ m/z 1060 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1038 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was filtered through Celite® and the pad washed with EtOAc (100 mL). The filtrate was washed with saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(3×50 mL) [care: effervescence!], brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude bis-aniline 26 as a dark orange foam (1.56 g, 95% yield). Purity satisfactory, so material carried through to next step without further purification.</div>
    <heading id="h-0183" class="style-scope patent-text">(d) (9H-Fluoren-9-yl)methyl(5-((5-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamate (27)</heading>
    <div id="p-0480" num="0623" class="description-paragraph style-scope patent-text">FmocCl (1.22 g, 4.70 mmol) was added to a stirred suspension of the bis-aniline 26 (6.50 g, 6.27 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(1.66 g, 15.7 mmol) in THF (32 mL) and H<sub class="style-scope patent-text">2</sub>O (32 mL). The mixture was allowed to stir at room temperature for 3 hours where analysis by LC/MS revealed desired <figure-callout id="27" label="mono Fmoc product" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mono Fmoc product</a></figure-callout> 27 at retention time 2.33 minutes, I %=51, ES+ m/z 1282 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1260 [M+H]<sup class="style-scope patent-text">+. </sup>along with unreacted starting material at retention time 2.19 minutes, I %=24, and bis-Fmoc material at retention time 2.47 minutes, I %=24, ES+ m/z 1504 [M+Na]<sup class="style-scope patent-text">+</sup>, 1482 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was partitioned between H<sub class="style-scope patent-text">2</sub>O (50 mL) and EtOAc (75 mL), the layers were separated and the aqueous phase extracted with EtOAc (2×25 mL). The combined organic layers were washed with H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure <figure-callout id="27" label="mono Fmoc product" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mono Fmoc product</a></figure-callout> 27 as an orange foam (3.31 g, 56% yield based on FmocCl, eluting at 53% Hexane/EtOAc) unreacted bis-aniline 26 (2.09 g, eluting at 40% Hexane/EtOAc) and bis-Fmoc (1.39 g, eluting at 68% Hexane/EtOAc).</div>
    <heading id="h-0184" class="style-scope patent-text">(e) (9H-Fluoren-9-yl)methyl(5-((5-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamate (28)</heading>
    <div id="p-0481" num="0624" class="description-paragraph style-scope patent-text">Triphosgene (281 mg, 0.81 mmol) was added to a stirred solution of the mono Fmoc product 27 (3.31 g, 2.63 mmol) and TEA (805 μL, 584 mg, 5.79 mmol) in dry DCM (35 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.35 minutes, ES+ m/z 1340 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1318 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional TEA (549 μL, 398 mg, 3.95 mmol) followed by the addition of linker I16 (992 mg, 2.63 mmol). After 20 hours stirring under argon, LC/MS revealed conversion to desired <figure-callout id="28" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 28 at retention time 2.33 minutes, I %=40, ES+ m/z 1685 [M+Na]<sup class="style-scope patent-text">+.</sup>, along with Fmoc cleaved material 29 at retention time 2.19 minutes, I %=28, ES+ m/z 1463 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1441 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (40 mL) and washed with saturated aqueous NH<sub class="style-scope patent-text">4</sub>Cl (2×30 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the <figure-callout id="28" label="pure carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pure carbamate</a></figure-callout> 28 as a yellow foam (1.64 g, 38% yield, eluting at 40% Hexane/EtOAc) along with Fmoc cleaved product 29 (1.31 g, eluting at 20% Hexane/EtOAc).</div>
    <heading id="h-0185" class="style-scope patent-text">(f) 4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl (5-((5-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamate (29)</heading>
    <div id="p-0482" num="0625" class="description-paragraph style-scope patent-text">Dimethylamine (9.9 mL of a 2.0M solution in THF, 19.7 mmol) was added to a stirred solution of the Fmoc protected compound 28 (1.64 g, 0.99 mmol) in THF (15 mL) at room temperature. After stirring for 1.5 hours at room temperature, analysis by LC/MS revealed reaction completion with desired product at retention time 2.19 minutes, ES+ m/z 1463 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1441 [M+H]<sup class="style-scope patent-text">+.</sup>, along with Fmoc cleavage by product DMA adduct at retention time 0.97 minutes. The mixture was evaporated in vacuo to give the crude product which was subsequently purified by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) to provide the pure aniline 29 (eluting at 20% Hexane/EtOAc) as an orange foam (1.36 g, 96% yield).</div>
    <heading id="h-0186" class="style-scope patent-text">(g) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-((5-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (30)</heading>
    <div id="p-0483" num="0626" class="description-paragraph style-scope patent-text">Triphosgene (198 mg, 0.67 mmol) was added to a stirred solution of the aniline 29 (2.67 g, 1.85 mmol) and pyridine (329 μL, 322 mg, 4.07 mmol) in dry DCM (25 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.22 minutes, ES+ m/z 1521 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1499 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional pyridine (224 μL, 220 mg, 2.78 mmol) and dibutyltin dilaurate (219 μL, 234 mg, 0.37 mmol) followed by the addition of linker 5a (1.18 g, 1.85 mmol). After 16 hours stirring under argon, LC/MS revealed consumption of isocyanate and decrease in signal intensity for linker 5a but no M<sup class="style-scope patent-text">2+</sup> for desired product at retention time 2.23 minutes. The mixture was diluted with DCM (30 mL) and washed with saturated NH<sub class="style-scope patent-text">4</sub>Cl (2×30 mL), brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (Hexane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 30 (eluting at 39% Hexane/EtOAc) as a yellow foam (2.40 g, 62% yield).</div>
    <heading id="h-0187" class="style-scope patent-text">(h) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-((5-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(hydroxymethyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-2-methoxyphenoxy)pentyl)oxy)-2-((S)-2-(hydroxymethyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (31)</heading>
    <div id="p-0484" num="0627" class="description-paragraph style-scope patent-text">Glacial acetic acid (21 mL) was added to a stirred solution of the TBS-protected compound 30 (2.40 g, 1.14 mmol) in THF (7 mL) and H<sub class="style-scope patent-text">2</sub>O (7 mL). The reaction mixture was allowed to stir for 16 hours at room temperature after which time analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.88 minutes, ES+ m/z 1876 [M+H]<sup class="style-scope patent-text">+.</sup>, 1898 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a chilled (0-5° C.) saturated solution of NaHCO<sub class="style-scope patent-text">3 </sub>(350 mL). The neutral solution was allowed to warm to room temperature and partitioned with EtOAc (200 mL). The aqueous phase was extracted with EtOAc (2×50 mL), the combined organic layers were washed with NaHCO<sub class="style-scope patent-text">3 </sub>(2×60 mL), brine (70 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) gave the bis-alcohol 31 (eluting at 95.6% DCM/MeOH) as a yellowish foam (2.07 g, 97% yield).</div>
    <heading id="h-0188" class="style-scope patent-text">(i) 4-(((2S,3R,4S,5S,6S)-6-((allyloxy)carbonyl)-3,4,5-tris((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-nitrobenzyl(11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-(4-methoxyphenyl)-5-oxo-11,11a-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate (32)</heading>
    <div id="p-0485" num="0628" class="description-paragraph style-scope patent-text">Cu(NCCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4</sub>·CF<sub class="style-scope patent-text">3</sub>SO<sub class="style-scope patent-text">3 </sub>(2 mg, 5.3 μmmol) was added to a stirred solution of the bis-OH 31 (100 mg, 53 μmmol) and the Stahl aerobic oxidation TEMPO solution (27 μL of a 0.2M solution in CH<sub class="style-scope patent-text">3</sub>CN, 5.3 μmmol) in CH<sub class="style-scope patent-text">3</sub>CN (1 mL). The reaction mixture was allowed to stir under an air atmosphere (balloon) for 3 hours at which point analysis by LC/MS revealed no apparent change in retention time or ES+. Additional Cu(NCCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4</sub>·CF<sub class="style-scope patent-text">3</sub>SO<sub class="style-scope patent-text">3 </sub>(2 mg, 5.3 μmmol) and Stahl aerobic oxidation TEMPO solution (27 μL of a 0.2M solution in CH<sub class="style-scope patent-text">3</sub>CN, 5.3 μmmol) were added and the reaction mixture allowed to stir for a further 16 hours. Analysis by LC/MS again revealed no change in retention time, however, ES<sup class="style-scope patent-text">+</sup> showed absence of starting material m/z and strong presence of desired product m/z 1894 [M+Na]<sup class="style-scope patent-text">+.</sup>. The solvent was removed by evaporation in vacuo and the resulting residue purified by Isolera™ (DCM/MeOH, <figure-callout id="36" label="SNAP Ultra" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 10 g, 36 mL per minute) to give the cyclised product 32 (eluting at 96.2% DCM/MeOH) as a white foam (91 mg, 92% yield).</div>
    <heading id="h-0189" class="style-scope patent-text">(j) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((S)-2-((S)-2-amino-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (33)</heading>
    <div id="p-0486" num="0629" class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(15.0 mg, 12.8 μmol) was added to a stirred solution of pyrrolidine (59 μL, 50 mg, 0.70 mmol) and the Alloc/allyl compound 32 (240 mg, 0.13 mmol) in dry DCM (5 mL). The reaction mixture was allowed to stir under an argon atmosphere, after stirring for 30 minutes at room temperature analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.31 minutes, ES+ m/z 1496 [M+H]<sup class="style-scope patent-text">+.</sup>. The solvent was removed by evaporation in vacuo and the resulting residue triturated with diethyl ether, sonicated, followed by additional evaporation in vacuo to provide the <figure-callout id="33" label="crude amine" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude amine</a></figure-callout> 33 as a yellow solid which was carried through to the next step without further purification or analysis.</div>
    <heading id="h-0190" class="style-scope patent-text">(k) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-2-methyl-4,7,35-trioxo-10,13,16,19,22,25,28,31-octaoxa-3,6,34-triazaheptatriacontanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4] benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (34)</heading>
    <div id="p-0487" num="0630" class="description-paragraph style-scope patent-text">A solution of MAL-dPEG®8-TFP ester (114 mg, 0.15 mmol) in dry DCM (5 mL) was added to a stirred sample of the amine 33 (191 mg, 0.13 mmol) and pyridine (26 μL, 25 mg, 0.32 mmol). The reaction mixture was allowed to stir under argon for 20 hours and began to darken in colour over time. Analysis by LC/MS revealed formation of desired product at retention time 1.59 minutes (desired m/z for M<sup class="style-scope patent-text">2+</sup> not detected during reaction monitoring) along with unreacted amine at retention time 1.31 minutes. Additional MAL-dPEG®8-TFP ester (114 mg, 0.15 mmol), pyridine (26 μL, 25 mg, 0.32 mmol) and DCM (3 mL) were added and the mixture allowed to stir for a further six days. At this point a satisfactory amount of desired product had formed upon analysis by LC/MS and the solvent was removed by evaporation in vacuo. The crude product was purified by Isolera™ (DCM/MeOH, SNAP Ultra 10 g, 36 mL per minute, eluting at 82% DCM/MeOH) followed by preparative HPLC to give the maleimide 34 as a slightly yellow solid (46 mg, 13%): LC/MS (15-minute run), retention time 6.71 minutes, ES+ m/z 1036 [M<sup class="style-scope patent-text">2+</sup>.+H], 1058 [M<sup class="style-scope patent-text">2+</sup>+Na], 1046 [M+Na]<sup class="style-scope patent-text">2+</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 10.02 (br s, 2H), 8.27-8.16 (m, 1H), 8.01 (t, 1H, J=5.6 Hz), 7.90 (d, 1H, J=8.6 Hz), 7.72 (br s, 1H), 7.60-7.51 (m, 3H), 7.46-7.38 (m, 5H), 7.23-7.15 (m, 2H), 7.11 (s, 1H), 7.09 (s, 1H), 6.99 (s, 2H), 6.92 (d, 2H, J=8.9 Hz), 6.91 (d, 2H, J=8.9 Hz), 6.88-6.77 (m, 6H), 5.70-5.60 (m, 2H), 5.39-5.33 (m, 2H), 5.24-5.09 (m, 4H), 4.96-4.81 (m, 2H), 4.42-4.34 (m, 1H), 4.24-4.17 (m, 1H), 4.04-3.93 (m, 4H), 3.87-3.79 (m, 8H), 3.77 (s, 6H), 3.59 (t, 4H, J=7.3 Hz), 3.52-3.46 (m, 28H), 3.40-3.26 (m, 7H, obscured by H<sub class="style-scope patent-text">2</sub>O), 3.19-3.11 (m, 2H), 2.95-2.82 (m, 2H), 2.53-2.31 (m, 4H), 2.02-1.92 (m, 1H), 1.86-1.73 (m, 4H), 1.62-1.52 (m, 2H), 1.30 (d, 1H, J=7.0 Hz), 0.87 (d, 3H, J=6.7 Hz), 0.83 (d, 3H, J=6.8 Hz).</div>
    <heading id="h-0191" class="style-scope patent-text">Example 4</heading>
    <div id="p-0488" num="0631" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00086" num="00086" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f4/7c/d3/a101a2ac8147e6/US10799595-20201013-C00086.png" class="style-scope patent-text"><img id="EMI-C00086" he="398.44mm" wi="156.80mm" file="US10799595-20201013-C00086.TIF" alt="Figure US10799595-20201013-C00086" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="627" height="1594" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f4/7c/d3/a101a2ac8147e6/US10799595-20201013-C00086.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00086" attachment-type="cdx" file="US10799595-20201013-C00086.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00086" attachment-type="mol" file="US10799595-20201013-C00086.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
      <chemistry id="CHEM-US-00087" num="00087" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3b/5e/46/37bdaded0acedb/US10799595-20201013-C00087.png" class="style-scope patent-text"><img id="EMI-C00087" he="237.49mm" wi="157.73mm" file="US10799595-20201013-C00087.TIF" alt="Figure US10799595-20201013-C00087" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="631" height="950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3b/5e/46/37bdaded0acedb/US10799595-20201013-C00087.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00087" attachment-type="cdx" file="US10799595-20201013-C00087.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00087" attachment-type="mol" file="US10799595-20201013-C00087.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0192" class="style-scope patent-text">(a) 4,4′-((1,3-phenylenebis(methylene))bis(oxy))bis(5-methoxy-2-nitrobenzaldehyde) (36)</heading>
    <div id="p-0489" num="0632" class="description-paragraph style-scope patent-text">1,3-bis(bromomethyl)benzene (5.0 g, 19.1 mmol) was added to a stirred solution of the phenol 35 (7.5 g, 38.2 mmol), TBAI (705 mg, 1.91 mmol) and K<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(5.81 g, 42.0 mmol) in dry DMF (60 mL). The reaction mixture was heated to 70° C. and stirred under an argon atmosphere for 2 hours at which point analysis by LC/MS revealed substantial product formation at retention time 1.67 minutes, ES+ m/z 519 [M+Na]<sup class="style-scope patent-text">+.</sup>, 497 [M+H]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was allowed to cool to room temperature and the DMF was removed by evaporation in vacuo. The resulting residue was diluted with water (300 mL) and the orange precipitate 36 collected by vacuum filtration then washed with H<sub class="style-scope patent-text">2</sub>O, diethyl ether and dried in a vacuum oven to constant weight (9.18 g, 97% yield).</div>
    <heading id="h-0193" class="style-scope patent-text">(b) 4,4′-((1,3-phenylenebis(methylene))bis(oxy))bis(5-methoxy-2-nitrobenzoic acid) (37)</heading>
    <div id="p-0490" num="0633" class="description-paragraph style-scope patent-text">A solution of sodium chlorite (8.44 g, 92.7 mmol, 80% technical grade) and sodium dihydrogenphosphate monobasic (6.2 g, 51.8 mmol) in water (140 mL) was added to a solution of the aldehyde 36 (9.18 g, 18.5 mmol) in tetrahydrofuran (100 mL) at room temperature. Hydrogen peroxide (30% w/w, 53 mL, 518 mmol) was immediately added drop-wise to the vigorously stirred biphasic mixture. Effervescence and an exotherm to 30° C. were observed along with a colour change from orange to pale yellow and dissolution of the suspension. The reaction mixture was cooled in an ice bath and acidified to pH2 with concentrated hydrochloric acid. The reaction mixture was then extracted with EtOAc (4×150 mL) and the combined organic phase washed with brine (2×100 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude acid 37. The solid was triturated with diethyl ether and dried in a vacuum oven to constant weight (9.90 g, &gt;100% yield). Purity satisfactory by LC/MS (retention time 1.56 minutes, ES− m/z 527 [M+H]<sup class="style-scope patent-text">+.</sup>).</div>
    <heading id="h-0194" class="style-scope patent-text">(c) (((1,3-phenylenebis(methylene))bis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S)-2-(hydroxymethyl)pyrrolidin-1-yl)methanone) (38)</heading>
    <div id="p-0491" num="0634" class="description-paragraph style-scope patent-text">DMF (12 drops) was added to a stirred suspension of the bis-nitrobenzoic acid 37 (9.90 g, 18.7 mmol) and oxalyl chloride (4.9 mL, 7.1 g, 56.3 mmol) in anhydrous DCM (130 mL). Following initial effervescence the reaction suspension became a solution and the mixture was allowed to stir at room temperature for 16 hours. The majority of solvent was removed by evaporation in vacuo and the concentrated solution was triturated with diethyl ether. The resulting yellow precipitate (LC/MS sampled in MeOH gave methyl ester at retention time 1.69 minutes, ES+ m/z 579 [M+Na]<sup class="style-scope patent-text">+.</sup>) was collected by vacuum filtration, washed with cold diethyl ether and dried for 1 hour in a vacuum oven at 40° C. The solid acid chloride was added portion-wise to a stirred suspension of (S)-(+)-2-pyrrolidinemethanol (4.35 g, 4.25 mL, 43.0 mmol) and TEA (13.0 mL, 9.46 g, 93.5 mmol) in DCM (100 mL) at −40° C. (dry ice/CH<sub class="style-scope patent-text">3</sub>CN). After 1 hour stirring, the reaction was complete as judged by LC/MS with exclusively desired product at retention time 1.44 minutes, ES+ m/z 717 [M+Na]<sup class="style-scope patent-text">+.</sup>, 695 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (100 mL) and washed with 1N HCl (3×50 mL), saturated NaHCO<sub class="style-scope patent-text">3 </sub>(3×40 mL), brine (70 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and the solvent evaporated in vacuo to give the pure product 38 as a yellow solid (12.7 g, 100% yield).</div>
    <heading id="h-0195" class="style-scope patent-text">(d) (((1,3-phenylenebis(methylene))bis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidin-1-yl)methanone) (39)</heading>
    <div id="p-0492" num="0635" class="description-paragraph style-scope patent-text">TBSCI (8.27 g, 54.9 mmol) was added to a stirred solution of the bis-alcohol 38 (12.7 g, 18.3 mmol) and imidazole (7.47 g, 110 mmol) in dry DCM (100 mL). After stirring at room temperature for 1.5 hours analysis by LC/MS revealed complete conversion to desired product at retention time 2.11 minutes, ES+ m/z 946 [M+Na]<sup class="style-scope patent-text">+.</sup>, 924 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (100 mL) and washed with water (2×75 mL), brine (80 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and the solvent evaporated in vacuo to give the <figure-callout id="39" label="crude product" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude product</a></figure-callout> 39 as a yellow foam (16.7 g, 99% yield). Material sufficiently pure to carry through to next step without further purification</div>
    <heading id="h-0196" class="style-scope patent-text">(e) (((1,3-phenylenebis(methylene))bis(oxy))bis(2-amino-5-methoxy-4,1-phenylene))bis(((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidin-1-yl)methanone) (40)</heading>
    <div id="p-0493" num="0636" class="description-paragraph style-scope patent-text">Non-activated zinc (18.5 g, 282 mmol) was added to a vigorously stirred solution of the bis-nitro compound 39 (6.50 g, 7.10 mmol) in EtOH (65 mL) and EtOAc (65 mL) at room temperature. The reaction mixture was treated with water (6.5 mL) then drop-wise with a solution of 5% v/v HCO<sub class="style-scope patent-text">2</sub>H in EtOH (130 mL). A colour change from green to metallic grey and an exotherm to 37° C. were observed. The reaction mixture was allowed to cool to room temperature at which point analysis by LC/MS revealed complete conversion to desired product at retention time 2.04 minutes, ES+ m/z 885 [M+Na]<sup class="style-scope patent-text">+.</sup>, 863 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was filtered through Celite® and the pad washed with EtOAc (200 mL). The filtrate was washed with saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>(3×100 mL) [care: effervescence!], brine (150 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to provide the crude bis-<figure-callout id="40" label="aniline" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">aniline</a></figure-callout> 40 as a dark orange foam (5.41 g, 89% yield). Purity satisfactory, so material carried through to next step without further purification.</div>
    <heading id="h-0197" class="style-scope patent-text">(f) (9H-fluoren-9-yl)methyl (5-((3-((5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)methyl)benzyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (41)</heading>
    <div id="p-0494" num="0637" class="description-paragraph style-scope patent-text">FmocCl (1.43 g, 5.50 mmol) was added to a stirred suspension of the bis-aniline 40 (6.34 g, 7.35 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(1.95 g, 18.4 mmol) in THF (32 mL) and H<sub class="style-scope patent-text">2</sub>O (32 mL). The mixture was allowed to stir at room temperature for 2 hours where analysis by LC/MS revealed desired mono Fmoc product 41 at retention time 2.24 minutes, I %=41, ES+ m/z 1108 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1086 [M+H]<sup class="style-scope patent-text">+. </sup>along with unreacted starting material at retention time 2.03 minutes, I %=19, and bis-Fmoc material at retention time 2.39 minutes, I %=40, ES+ m/z 1330 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1308 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was partitioned between H<sub class="style-scope patent-text">2</sub>O (50 mL) and EtOAc (50 mL), the layers were separated and the organic layer washed with H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure mono Fmoc product 41 as an orange foam (2.40 g, 40% yield based on FmocCl, eluting at 30% heptane/EtOAc) unreacted bis-aniline 40 (1.72 g, eluting at 100% EtOAc) and bis-Fmoc (1.95 g, eluting at 69% heptane/EtOAc).</div>
    <heading id="h-0198" class="style-scope patent-text">(g) (9H-fluoren-9-yl)methyl(5-((3-((5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)methyl)benzyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (42)</heading>
    <div id="p-0495" num="0638" class="description-paragraph style-scope patent-text">Triphosgene (236 mg, 0.80 mmol) was added to a stirred solution of the mono Fmoc product 41 (2.40 g, 2.21 mmol) and TEA (676 μL, 491 mg, 4.86 mmol) in dry DCM (30 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.27 minutes, ES+ m/z 1166 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1144 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional TEA (461 μL, 335 mg, 3.32 mmol) followed by the addition of linker 116 (835 mg, 2.21 mmol). After 2.5 hours stirring under argon, LC/MS revealed satisfactory conversion to <figure-callout id="9" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 9 at retention time 2.24 minutes, ES+ m/z 1511 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1489 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (50 mL) and washed with saturated aqueous NH<sub class="style-scope patent-text">4</sub>Cl (2×40 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 42 (eluting at 38% heptane/EtOAc) as a yellow foam (2.40 g, 73% yield).</div>
    <heading id="h-0199" class="style-scope patent-text">(h) 4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl (5-((3-((5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)methyl)benzyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (43)</heading>
    <div id="p-0496" num="0639" class="description-paragraph style-scope patent-text">Dimethylamine (16.1 mL of a 2.0M solution in THF, 32.2 mmol) was added to a stirred solution of the Fmoc protected compound 42 (2.40 g, 1.61 mmol) in THF (20 mL) at room temperature. After stirring for 1 hour at room temperature, analysis by LC/MS revealed reaction completion with desired product at retention time 2.07 minutes, ES+ m/z 1289 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1267 [M+H]<sup class="style-scope patent-text">+.</sup>, along with Fmoc cleavage by-product at retention time 1.74 minutes and its DMA adduct at retention time 0.95 minutes. The mixture was evaporated in vacuo to give the crude product which was subsequently purified by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) to provide the pure aniline 43 (eluting at 100% EtOAc) as a white foam (1.77 g, 87% yield).</div>
    <heading id="h-0200" class="style-scope patent-text">(i) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-((3-((5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)methyl)benzyl)oxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (44)</heading>
    <div id="p-0497" num="0640" class="description-paragraph style-scope patent-text">Triphosgene (150 mg, 0.50 mmol) was added to a stirred solution of the aniline 43 (1.77 g, 1.40 mmol) and pyridine (249 μL, 243 mg, 3.08 mmol) in dry DCM (20 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.11 minutes, ES+ m/z 1347 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1325 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional pyridine (170 μL, 166 mg, 2.10 mmol) and dibutyltin dilaurate (165 μL, 177 mg, 0.28 mmol) followed by the addition of linker 5a (891 mg, 1.40 mmol). After 24 hours stirring under argon, LC/MS revealed satisfactory conversion to <figure-callout id="44" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 44 at retention time 2.16 minutes, ES+ m/z 1952 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1930 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (40 mL) and washed with saturated NH<sub class="style-scope patent-text">4</sub>Cl (2×35 mL), brine (30 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 44 (eluting at 32% heptane/EtOAc) as a white solid (2.16 g, 80% yield).</div>
    <heading id="h-0201" class="style-scope patent-text">(j) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-((3-((5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(hydroxymethyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)methyl)benzyl)oxy)-2-((S)-2-(hydroxymethyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (45)</heading>
    <div id="p-0498" num="0641" class="description-paragraph style-scope patent-text">Glacial acetic acid (18 mL) was added to a stirred solution of the TBS-protected compound 44 (2.16 g, 1.12 mmol) in THF (6 mL) and H<sub class="style-scope patent-text">2</sub>O (6 mL). The reaction mixture was allowed to stir for 5 hours at room temperature after which time analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.77 minutes, ES+ m/z 1702 [M+H]<sup class="style-scope patent-text">+.</sup>, 1724 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a chilled (0-5° C.) saturated solution of NaHCO<sub class="style-scope patent-text">3 </sub>(300 mL). The neutral solution was allowed to warm to room temperature and extracted with EtOAc (3×50 mL), the combined organic layers were washed with brine (60 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) gave the bis-alcohol 45 (eluting at 94.8% DCM/MeOH) as a white foam (1.86 g, 98% yield).</div>
    <heading id="h-0202" class="style-scope patent-text">(k) 4-(((2S,3R,4S,5S,6S)-6-((allyloxy)carbonyl)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-nitrobenzyl(11S,11aS)-8-((3-((((11S,11aS)-10-(((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)methyl)benzyl)oxy)-11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate (46)</heading>
    <div id="p-0499" num="0642" class="description-paragraph style-scope patent-text">45% IBX (263 mg, 0.42 mmol) was added to a stirred solution of the bis-OH 45 (300 mg, 0.18 mmol) in dry DMSO (4 mL). The mixture was heated to 30° C. under an argon atmosphere and reaction progress monitored by LC/MS. After 24 hours stirring, additional IBX (2×22 mg, 2×36 μmol) was added and the mixture stirred for another 28 hours. At this point analysis by LC/MS revealed formation of resolved product at retention time 1.72 minutes, ES+ m/z 1698 [M+H]<sup class="style-scope patent-text">+.</sup>, 1720 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>solution (100 mL) and extracted with DCM (2×40 mL). The combined organic layers were washed with brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="75" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 25 g, 75 mL per minute) gave the cyclised product 46 (eluting at 96.5% DCM/MeOH) as a white foam (219 mg, 73% yield).</div>
    <heading id="h-0203" class="style-scope patent-text">(l) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((3-((((11S,11aS)-10-(((4-((S)-2-((S)-2-amino-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)methyl)benzyl)oxy)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (47)</heading>
    <div id="p-0500" num="0643" class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(13.0 mg, 11.1 μmol) was added to a stirred solution of pyrrolidine (51 μL, 43 mg, 0.61 mmol) and the Alloc/allyl compound 46 (189 mg, 0.11 mmol) in dry DCM (2 mL). The reaction mixture was allowed to stir under an argon atmosphere for 30 minutes at room temperature where analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.13 minutes, ES+ m/z 1322 [M+H]<sup class="style-scope patent-text">+.</sup>. The solvent was removed by evaporation in vacuo and the resulting residue triturated with diethyl ether followed by additional evaporation in vacuo to provide the crude amine 47 as a solid which was carried through to the next step without further purification or analysis.</div>
    <heading id="h-0204" class="style-scope patent-text">(m) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((3-((((11S,11aS)-10-(((4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-2-methyl-4,7,35-trioxo-10,13,16,19,22,25,28,31-octaoxa-3,6,34-triazaheptatriacontanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)methyl)benzyl)oxy)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (48)</heading>
    <div id="p-0501" num="0644" class="description-paragraph style-scope patent-text">A solution of MAL-dPEG®8-TFP ester (123 mg, 0.16 mmol) in dry DCM (2 mL) was added to a stirred sample of the amine 47 (147 mg, 0.11 mmol) and pyridine (22 μL, 22 mg, 0.28 mmol). The reaction mixture was allowed to stir under argon for 20 hours and began to darken in colour over time. Analysis by LC/MS revealed formation of desired product at retention time 1.37 minutes, ES+ m/z 1896 [M+H]<sup class="style-scope patent-text">+.</sup>, 1918 [M+Na]. along with trace unreacted amine at retention time 1.13 minutes. Substantial decomposition of product and the solvent was removed by evaporation in vacuo. The crude product was purified by preparative HPLC to give the maleimide 48 as a white solid (75 mg, 36%): LC/MS (15-minute run), retention time 5.48 minutes, ES+ m/z 1896 [M+H]<sup class="style-scope patent-text">+.</sup>, 1918 [M+Na]<sup class="style-scope patent-text">+.</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 9.92 (br s, 2H), 8.20-8.14 (m, 1H), 8.01 (t, 1H, J=5.6 Hz), 7.87 (d, 1H, J=8.7 Hz), 7.73 (br s, 1H), 7.62-7.36 (m, 8H), 7.23-7.15 (m, 2H), 7.11 (s, 1H), 7.09 (s, 1H), 7.00 (s, 2H), 6.99 (s, 1H), 6.94 (s, 1H), 6.62-6.51 (m, 2H), 5.53-5.41 (m, 3H), 5.35-5.85 (m, 9H), 4.41-4.32 (m, 1H), 4.23-4.16 (m, 1H), 4.00-3.90 (m, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 3.61-3.58 (m, 4H), 3.52-3.45 (m, 28H), 3.42-3.23 (m, 9H), 3.18-3.12 (m, 2H), 2.50-2.35 (m, 2H), 2.34-2.31 (m, 2H), 2.10-1.8 (m, 9H), 1.28 (d, 1H, J=7.1 Hz), 0.87 (d, 3H, J=6.7 Hz), 0.83 (d, 3H, J=6.8 Hz).</div>
    <heading id="h-0205" class="style-scope patent-text">Example 5</heading>
    <div id="p-0502" num="0645" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00088" num="00088" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/41/ea/c1/1cc03218053c53/US10799595-20201013-C00088.png" class="style-scope patent-text"><img id="EMI-C00088" he="222.84mm" wi="157.99mm" file="US10799595-20201013-C00088.TIF" alt="Figure US10799595-20201013-C00088" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="632" height="891" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/41/ea/c1/1cc03218053c53/US10799595-20201013-C00088.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00088" attachment-type="cdx" file="US10799595-20201013-C00088.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00088" attachment-type="mol" file="US10799595-20201013-C00088.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
      <chemistry id="CHEM-US-00089" num="00089" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/22/2f/4c/f7cc318441c54b/US10799595-20201013-C00089.png" class="style-scope patent-text"><img id="EMI-C00089" he="115.23mm" wi="157.90mm" file="US10799595-20201013-C00089.TIF" alt="Figure US10799595-20201013-C00089" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="632" height="461" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/22/2f/4c/f7cc318441c54b/US10799595-20201013-C00089.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00089" attachment-type="cdx" file="US10799595-20201013-C00089.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00089" attachment-type="mol" file="US10799595-20201013-C00089.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0206" class="style-scope patent-text">(a) (9H-fluoren-9-yl)methyl(5-(3-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (50)</heading>
    <div id="p-0503" num="0646" class="description-paragraph style-scope patent-text">FmocCl (1.58 g, 6.09 mmol) was added to a stirred mixture of the bis-aniline 49 (6.50 g, 8.12 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(2.15 g, 20.3 mmol) in THF (35 mL) and H<sub class="style-scope patent-text">2</sub>O (35 mL). The mixture was allowed to stir room temperature for 2.5 hours where analysis by LC/MS revealed desired <figure-callout id="50" label="mono Fmoc product" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mono Fmoc product</a></figure-callout> 50 at retention time 2.19 minutes, I %=49, ES+ m/z 1046 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1024 [M+H]<sup class="style-scope patent-text">+. </sup>along with unreacted starting material at retention time 1.96 minutes, I %=19, and bis-Fmoc material at retention time 2.34 minutes, I %=32, ES+ m/z 1270 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1246 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was partitioned between H<sub class="style-scope patent-text">2</sub>O (50 mL) and EtOAc (50 mL), the layers were separated and the aqueous phase was extracted with EtOAc (2×25 mL). The combined organic layers were washed with H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure <figure-callout id="50" label="mono Fmoc product" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mono Fmoc product</a></figure-callout> 50 as an orange foam (3.61 g, 58% yield based on FmocCl, eluting at 61% heptane/EtOAc) unreacted bis-aniline 2 (2.04 g, eluting at 100% EtOAc) and bis-Fmoc (1.71 g, eluting at 30% heptane/EtOAc).</div>
    <heading id="h-0207" class="style-scope patent-text">(b) 4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl (5-(3-(5-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (51)</heading>
    <div id="p-0504" num="0647" class="description-paragraph style-scope patent-text">Triphosgene (377 mg, 1.27 mmol) was added to a stirred solution of the mono Fmoc product 50 (3.61 g, 3.53 mmol) and TEA (1.08 mL, 784 mg, 7.70 mmol) in dry DCM (40 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.23 minutes, ES+ m/z 1104 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1082 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional TEA (737 μL, 535 mg, 5.30 mmol) followed by the addition of linker 116 (1.33 g, 3.53 mmol). After 2.5 hours stirring under argon, LC/MS revealed satisfactory conversion to <figure-callout id="51" label="carbamate" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbamate</a></figure-callout> 51 at retention time 2.21 minutes, ES+ m/z 1449 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1427 [M+H]<sup class="style-scope patent-text">+.</sup>. The mixture was diluted with DCM (50 mL) and washed with saturated aqueous NH<sub class="style-scope patent-text">4</sub>Cl (2×30 mL), H<sub class="style-scope patent-text">2</sub>O (30 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (heptane/EtOAc, SNAP Ultra '100 g, 100 mL per minute) provided the pure carbamate 51 (eluting at 40% Hexane/EtOAc) as a yellow foam (3.34 g, 66% yield).</div>
    <heading id="h-0208" class="style-scope patent-text">(c) 4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl (5-(3-(5-amino-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamate (52)</heading>
    <div id="p-0505" num="0648" class="description-paragraph style-scope patent-text">Dimethylamine (23.4 mL of a 2.0M solution in THF, 46.8 mmol) was added to a stirred solution of the Fmoc protected compound 51 (3.34 g, 2.34 mmol) in THF (15 mL) at room temperature. After stirring under argon for 1 hour at room temperature, analysis by LC/MS revealed reaction completion with desired product at retention time 2.02 minutes, ES+ m/z 1227 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1205 [M+H]<sup class="style-scope patent-text">+.</sup>, along with Fmoc cleavage by-product at retention time 1.72 minutes and its DMA adduct at retention time 0.93 minutes. The mixture was evaporated in vacuo to give the crude product which was subsequently purified by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) to provide the pure aniline 52 (eluting at 100% EtOAc) as an orange foam (2.51 g, 89% yield).</div>
    <heading id="h-0209" class="style-scope patent-text">(d) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-(3-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (53)</heading>
    <div id="p-0506" num="0649" class="description-paragraph style-scope patent-text">Triphosgene (222 mg, 0.75 mmol) was added to a stirred solution of the aniline 52 (2.51 g, 2.08 mmol) and pyridine (370 μL, 362 mg, 4.58 mmol) in dry DCM (30 mL) at room temperature. After stirring for 10 minutes under argon, analysis by LC/MS revealed complete conversion to isocyanate (sampled in MeOH to give methyl carbamate, retention time 2.06 minutes, ES+ m/z 1285 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1263 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was treated with additional pyridine (252 μL, 247 mg, 3.12 mmol) and dibutyltin dilaurate (247 μL, 263 mg, 0.42 mmol) followed by the addition of linker 5a (1.33 g, 2.08 mmol). After 28 hours stirring under argon, LC/MS revealed satisfactory conversion to carbamate 53 (retention time 2.12 minutes, ES+ m/z 1890 [M+Na]<sup class="style-scope patent-text">+.</sup>, 1868 [M+H]<sup class="style-scope patent-text">+.</sup>). The mixture was diluted with DCM (40 mL) and washed with saturated NH<sub class="style-scope patent-text">4</sub>Cl (3×30 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (heptane/EtOAc, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) provided the pure carbamate 53 (eluting at 37% heptane/EtOAc) as a yellow foam (3.12 g, 80% yield).</div>
    <heading id="h-0210" class="style-scope patent-text">(e) Allyl(2S,3S,4S,5R,6S)-6-(4-((((5-(3-(5-((((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)amino)-4-((S)-2-(hydroxymethyl)pyrrolidine-1-carbonyl)-2-methoxyphenoxy)propoxy)-2-((S)-2-(hydroxymethyl)pyrrolidine-1-carbonyl)-4-methoxyphenyl)carbamoyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-carboxylate (54)</heading>
    <div id="p-0507" num="0650" class="description-paragraph style-scope patent-text">Glacial acetic acid (24 mL) was added to a stirred solution of the TBS-protected compound 53 (3.12 g, 1.67 mmol) in THF (8 mL) and H<sub class="style-scope patent-text">2</sub>O (8 mL). The reaction mixture was allowed to stir for 18 hours at room temperature after which time analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.72 minutes, ES+ m/z 1640 [M+H]<sup class="style-scope patent-text">+.</sup>, 1662 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a chilled (0-5° C.) saturated solution of NaHCO<sub class="style-scope patent-text">3 </sub>(450 mL). The neutral solution was allowed to warm to room temperature and extracted with EtOAc (3×80 mL), the combined organic layers were washed with brine (80 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="100" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 100 g, 100 mL per minute) gave the bis-alcohol 54 (eluting at 96.6% DCM/MeOH) as a white foam (2.05 g, 75% yield).</div>
    <heading id="h-0211" class="style-scope patent-text">(f) 4-(((2S,3R,4S,5S,6S)-6-((allyloxy)carbonyl)-3,4,5-tris(((allyloxy)carbonyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-nitrobenzyl(11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((S)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate (55)</heading>
    <div id="p-0508" num="0651" class="description-paragraph style-scope patent-text">45% IBX (273 mg, 0.44 mmol) was added to a stirred solution of the bis-OH 54 (300 mg, 0.18 mmol) in dry DMSO (4 mL). The mixture was heated to 30° C. under an argon atmosphere and reaction progress monitored by LC/MS. After 24 hours stirring, additional IBX (26 mg, 42 μmol) was added and the mixture stirred for another 24 hours. At this point analysis by LC/MS revealed predominantly a single peak corresponding to desired product at retention time 1.68 minutes, ES+ m/z 1658 [M+Na]<sup class="style-scope patent-text">+.</sup>. The reaction mixture was added drop-wise to a chilled saturated aqueous NaHCO<sub class="style-scope patent-text">3 </sub>solution (100 mL) and extracted with DCM (2×40 mL). The combined organic layers were washed with brine (40 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated in vacuo to give the crude product. Purification by Isolera™ (DCM/MeOH, <figure-callout id="75" label="SNAP Ultra" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 25 g, 75 mL per minute) gave the cyclised product 55 (eluting at 97% DCM/MeOH) as a white foam (256 mg, 87% yield).</div>
    <heading id="h-0212" class="style-scope patent-text">(g) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((S)-2-((S)-2-amino-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (56)</heading>
    <div id="p-0509" num="0652" class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(18.1 mg, 15.7 μmol) was added to a stirred solution of pyrrolidine (72 μL, 62 mg, 0.86 mmol) and the Alloc/allyl compound 55 (256 mg, 0.16 mmol) in dry DCM (2 mL). The reaction mixture was allowed to stir under an argon atmosphere where a precipitate began to form. After stirring for 30 minutes at room temperature analysis by LC/MS revealed reaction completion with desired product observed at retention time 1.07 minutes, ES+ m/z 1260 [M+H]<sup class="style-scope patent-text">+.</sup>. The solvent was removed by evaporation in vacuo and the resulting residue triturated with diethyl ether followed by additional evaporation in vacuo to provide the <figure-callout id="56" label="crude amine" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude amine</a></figure-callout> 56 as a solid which was carried through to the next step without further purification or analysis.</div>
    <heading id="h-0213" class="style-scope patent-text">(h) (2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-2-methyl-4,7,35-trioxo-10,13,16,19,22,25,28,31-octaoxa-3,6,34-triazaheptatriacontanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (57)</heading>
    <div id="p-0510" num="0653" class="description-paragraph style-scope patent-text">A solution of MAL-dPEG®8-TFP ester (140 mg, 0.19 mmol) in dry DCM (2 mL) was added to a stirred sample of the amine 56 (198 mg, 0.16 mmol), pyridine (32 μL, 31 mg, 0.39 mmol) and DMF (0.25 mL). The reaction mixture was allowed to stir under argon for 20 hours and began to darken in colour over time. Analysis by LC/MS revealed formation of desired product at retention time 1.31 minutes, ES+ m/z 1834 [M+H]<sup class="style-scope patent-text">+.</sup>, 1857 [M+Na]<sup class="style-scope patent-text">+.</sup>, along with unreacted amine at retention time 1.07 minutes. Additional MAL-dPEG®8-TFP ester (70 mg, 0.09 mmol), pyridine (16 μL, 16 mg, 0.2 mmol) and DCM (2 mL) were added and the mixture allowed to stir for a further 24 hours. The solvent volume was then reduced by 50% by evaporation in vacuo, at this point a satisfactory amount of desired product had formed upon analysis by LC/MS and the solvent was completely removed by evaporation in vacuo. The crude product was purified by preparative HPLC to give the maleimide 56 as a white solid (48 mg, 17%): LC/MS (15-minute run), retention time 5.22 minutes, ES+ m/z 1834 [M+H]<sup class="style-scope patent-text">+.</sup>, 1856 [M+Na]<sup class="style-scope patent-text">+.</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 9.99 (br s, 2H), 8.24-8.17 (m, 1H), 8.01 (t, 1H, J=5.6 Hz), 7.88 (d, 1H, J=8.7 Hz), 7.74 (br s, 1H), 7.64-7.50 (m, 3H), 7.44-7.34 (m, 1H), 7.23-7.13 (m, 2H), 7.06 (s, 2H), 7.00 (s, 2H), 6.86 (s, 1H), 6.79 (s, 1H), 6.59-6.47 (m, 2H), 5.52-5.37 (m, 3H), 5.32-5.02 (m, 4H), 4.98-4.84 (m, 2H), 4.44-4.34 (m, 1H), 4.24-4.19 (m, 1H), 4.17-3.96 (m, 5H), 3.92-3.84 (m, 1H), 3.77 (s, 6H), 3.60 (t, 4H, J=7.3 Hz), 3.54-3.45 (m, 29H), 3.40-3.24 (m, 8H), 3.19-3.12 (m, 2H), 2.57-2.35 (m, 2H), 2.34-2.30 (m, 2H), 2.25-2.12 (m, 2H), 2.10-1.78 (m, 9H), 1.30 (d, 1H, J=6.9 Hz), 0.87 (d, 3H, J=6.7 Hz), 0.83 (d, 3H, J=6.7 Hz).</div>
    <heading id="h-0214" class="style-scope patent-text">Example 6</heading>
    <div id="p-0511" num="0654" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00090" num="00090" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/47/70/1d/6f6e05e66a00fe/US10799595-20201013-C00090.png" class="style-scope patent-text"><img id="EMI-C00090" he="130.47mm" wi="157.65mm" file="US10799595-20201013-C00090.TIF" alt="Figure US10799595-20201013-C00090" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="631" height="522" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/47/70/1d/6f6e05e66a00fe/US10799595-20201013-C00090.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00090" attachment-type="cdx" file="US10799595-20201013-C00090.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00090" attachment-type="mol" file="US10799595-20201013-C00090.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0215" class="style-scope patent-text">(2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-(3-(((11S,11aS)-10-(((4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)propoxy)-11-hydroxy-7-methoxy-2-methylene-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (58)</heading>
    <div id="p-0512" num="0655" class="description-paragraph style-scope patent-text">A solution of 6-maleimidohexanoic acid N-hydroxysuccinimide ester (51 mg, 0.17 mmol) in dry DCM (2 mL) was added to a stirred sample of the amine 9 (141 mg, 0.11 mmol), pyridine (22 μL, 21 mg, 0.33 mmol) and DMF (0.25 mL). The reaction mixture was allowed to stir under argon for 20 hours and began to darken in colour over time. Analysis by LC-MS revealed formation of desired product at retention time 1.42 minutes, ES-m/z 1474 [M−H]<sup class="style-scope patent-text">−.</sup>, along with trace unreacted amine at retention time 1.12 minutes. The solvent was removed by evaporation in vacuo and the resulting residue purified by Isolera™ (DCM/MeOH, <figure-callout id="36" label="SNAP Ultra" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 10 g, 36 mL per minute, eluting at 80% DCM/MeOH) to give 90 mg of enriched 58. Further purification by preparative HPLC gave the maleimide 58, as a white solid (26 mg, 16%): LC-MS (15-minute run), retention time 5.85 minutes, ES+ m/z 1477 [M+H]<sup class="style-scope patent-text">+.</sup>, 1499 [M+Na]<sup class="style-scope patent-text">+.</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 10.0 (br s, 2H), 8.16 (d, 1H, J=7.0 Hz), 7.80 (d, 1H, J=8.6 Hz), 7.74 (br s, 1H), 7.62-7.50 (m, 3H), 7.39 (d, 1H, J=8.7 Hz), 7.22-7.11 (m, 2H), 7.06 (s, 2H), 7.00 (s, 2H), 6.89 (s, 2H), 6.84-6.78 (m, 1H), 6.68-6.56 (m, 2H), 5.45-5.30 (m, 3H), 5.29-5.01 (m, 9H), 4.98-4.85 (m, 2H), 4.42-4.33 (m, 1H), 4.24-3.92 (m, 9H), 3.77 (s, 6H), 3.44 (t, 2H, J=9.5 Hz), 3.39-3.30 (m, 2H), 2.93-2.80 (m, 2H), 2.57-2.35 (m, 2H), 2.23-2.06 (m, 4H) 2.03-1.90 (m, 1H), 1.48 (p, 4H, J=7.3 Hz), 1.30 (d, 3H, J=7.0 Hz), 1.18 (p, 2H, J=7.6 Hz), 0.86 (d, 3H, J=6.7 Hz), 0.83 (d, 3H, J=6.7 Hz).</div>
    <heading id="h-0216" class="style-scope patent-text">Example 7</heading>
    <div id="p-0513" num="0656" class="description-paragraph style-scope patent-text">
      <chemistry id="CHEM-US-00091" num="00091" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fd/51/38/3bc4db3ad84334/US10799595-20201013-C00091.png" class="style-scope patent-text"><img id="EMI-C00091" he="126.49mm" wi="157.65mm" file="US10799595-20201013-C00091.TIF" alt="Figure US10799595-20201013-C00091" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="631" height="506" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fd/51/38/3bc4db3ad84334/US10799595-20201013-C00091.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00091" attachment-type="cdx" file="US10799595-20201013-C00091.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00091" attachment-type="mol" file="US10799595-20201013-C00091.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    <heading id="h-0217" class="style-scope patent-text">(2S,3S,4S,5R,6S)-6-(4-((((11S,11aS)-8-((5-(((11S,11aS)-10-(((4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)propanamido)benzyl)oxy)carbonyl)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-11-hydroxy-7-methoxy-2-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)oxy)methyl)-2-nitrophenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (59)</heading>
    <div id="p-0514" num="0657" class="description-paragraph style-scope patent-text">A solution of 6-maleimidohexanoic acid N-hydroxysuccinimide ester (42 mg, 0.14 mmol) in dry DCM (2 mL) was added to a stirred sample of the amine 21 (118 mg, 0.09 mmol) and pyridine (18 μL, 18 mg, 0.23 mmol). The reaction mixture was allowed to stir under argon for 24 hours and began to darken in colour over time. Analysis by LC-MS revealed formation of desired product at retention time 1.45 minutes, ES− m/z 1502 [M−H]<sup class="style-scope patent-text">−</sup>, along with trace unreacted amine at retention time 1.15 minutes. The solvent was removed by evaporation in vacuo and the resulting residue purified by Isolera™ (DCM/MeOH, <figure-callout id="36" label="SNAP Ultra" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SNAP Ultra</a></figure-callout> 10 g, 36 mL per minute, eluting at 66% DCM/MeOH) to give 76 mg of enriched 59. Further purification by preparative HPLC gave the maleimide 59 as a white solid (27 mg, 20%): LC-MS (15-minute run), retention time 6.13 minutes, ES+ m/z 1505 [M+H]<sup class="style-scope patent-text">+.</sup>, 1527 [M+Na]<sup class="style-scope patent-text">+.</sup>; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, d6-DMSO) δ 9.95 (br s, 2H), 8.15 (d, 1H, J=6.9 Hz), 7.80 (d, 1H, J=8.7 Hz), 7.87 (d, 1H, J=8.7 Hz), 7.71 (br s, 1H), 7.62-7.48 (m, 3H), 7.39 (d, 1H, J=8.6 Hz), 7.21-7.12 (m, 2H), 7.06 (s, 1H), 7.05 (s, 1H), 6.99 (s, 2H), 6.82 (s, 1H), 6.76 (s, 1H), 6.72-6.65 (m, 2H), 6.62 (s, 2H), 5.63-5.50 (m, 2H), 5.48-5.40 (m, 2H), 5.31-5.08 (m, 6H), 4.98-4.82 (m, 3H), 4.43-4.34 (m, 1H), 4.21-4.14 (m, 1H), 4.03-3.86 (m, 4H), 3.79 (s×2, 6H), 3.72-3.61 (m, 2H), 3.38-3.35 (m, 2H), 2.98-2.85 (m, 2H), 2.59-2.42 (m, 2H), 2.23-2.06 (m, 2H), 2.00-1.88 (m, 1H), 1.82-1.68 (m, 4H), 1.74 (s, 6H), 1.61-1.41 (m, 8H), 1.22-1.14 (m, 2H), 1.28 (d, 1H, J=7.0 Hz), 0.86 (d, 3H, J=6.7 Hz), 0.82 (d, 3H, J=6.8 Hz).</div>
    <heading id="h-0218" class="style-scope patent-text">Example 8—Conjugation</heading>
    <div id="h-0219" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-10 (ConjA)</div>
    <div id="p-0515" num="0658" class="description-paragraph style-scope patent-text">A 50 mM solution of DL-dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (80 molar equivalent/antibody, 16 micromoles, 320 μL) to a 12.0 mL solution of antibody, Trastuzumab (30 mg, 200 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.5 mg/mL. The reduction mixture was allowed to react at room temperature for 4-5 hours (or until full reduction is observed by UHPLC) in an orbital shaker with gentle (50 rpm) shaking. The reduced antibody was buffer exchanged, via spin filter centrifugation, into a reoxidation buffer containing PBS and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 20 molar equivalent/antibody, 4 micromoles, 80 μL) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (50 rpm) shaking at an antibody concentration of 1.5 mg/mL (or more DHAA added and reaction left for longer until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was then sterile-filtered and diluted in a conjugation buffer containing PBS and 1 mM EDTA for a final antibody concentration of 1.0 mg/mL. <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10 was added as a DMSO solution (10 molar equivalent/antibody, 1 micromole, in 1.5 mL DMSO) to 13.5 mL of this reoxidised antibody solution (15 mg, 100 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 1.5 hours at room temperature, then the conjugation was quenched by addition of N-acetyl cysteine (15 micromoles, 150 μL at 100 mM), then purified by spin filtration using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 kDa MWCO spin filter, sterile-filtered and analysed.</div>
    <div id="p-0516" num="0659" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjA at 280 nm and 330 nm (<figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of <figure-callout id="10" label="compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">compound</a></figure-callout> 10, consistent with a drug-per-antibody ratio (DAR) of 1.89 molecules of <figure-callout id="10" label="compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">compound</a></figure-callout> 10 per antibody.</div>
    <div id="p-0517" num="0660" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjA at 280 nm shows a monomer purity of 99%. UHPLC SEC analysis gives a concentration of final ConjA at 1.45 mg/mL in 8.5 mL, obtained mass of ConjA is 12.3 mg (82% yield).</div>
    <div id="h-0220" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-22 (ConjB)</div>
    <div id="p-0518" num="0661" class="description-paragraph style-scope patent-text">A 50 mM solution of DL-dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (80 molar equivalent/antibody, 42.7 micromoles, 853 μL) to a 20.0 mL solution of antibody, Trastuzumab (80 mg, 533 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 4.0 mg/mL. The reduction mixture was allowed to react at room temperature for 4-5 hours (or until full reduction is observed by UHPLC) in an orbital shaker with gentle (60 rpm) shaking. The reduced antibody was buffer exchanged, via spin filter centrifugation, into a reoxidation buffer containing PBS and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 20 molar equivalent/antibody, 10.7 micromoles, 213 μL) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (50 rpm) shaking at an antibody concentration of 1.5 mg/mL (or more DHAA added and reaction left for longer until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was then sterile-filtered and diluted in a conjugation buffer containing PBS and 1 mM EDTA for a final antibody concentration of 1.0 mg/mL. Compound 22 was added as a DMSO solution (10 molar equivalent/antibody, 1.33 micromoles, in 2.0 mL DMSO) to 18.0 mL of this reoxidised antibody solution (20 mg, 133 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 1.5 hours at room temperature, then the conjugation was quenched by addition of N-acetyl cysteine (20 micromoles, 200 μL at 100 mM), then purified by spin filtration using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 kDa MWCO spin filter, sterile-filtered and analysed.</div>
    <div id="p-0519" num="0662" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjB at 280 nm and 330 nm (Compound 22 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of Compound 22, consistent with a drug-per-antibody ratio (DAR) of 1.71 molecules of Compound 22 per antibody.</div>
    <div id="p-0520" num="0663" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjB at 280 nm shows a monomer purity of 99%. UHPLC SEC analysis gives a concentration of final ConjB at 1.39 mg/mL in 10.3 mL, obtained mass of ConjB is 14.3 mg (72% yield).</div>
    <div id="h-0221" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-34 (ConjC)</div>
    <div id="p-0521" num="0664" class="description-paragraph style-scope patent-text">A 50 mM solution of DL-dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (80 molar equivalent/antibody, 42.7 micromoles, 853 μL) to a 20.0 mL solution of antibody, Trastuzumab (80 mg, 533 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 4.0 mg/mL. The reduction mixture was allowed to react at room temperature for 4-5 hours (or until full reduction is observed by UHPLC) in an orbital shaker with gentle (60 rpm) shaking. The reduced antibody was buffer exchanged, via spin filter centrifugation, into a reoxidation buffer containing PBS and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 20 molar equivalent/antibody, 10.7 micromoles, 213 μL) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (50 rpm) shaking at an antibody concentration of 1.5 mg/mL (or more DHAA added and reaction left for longer until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was then sterile-filtered and diluted in a conjugation buffer containing PBS and 1 mM EDTA for a final antibody concentration of 1.0 mg/mL. Compound 34 was added as a DMSO solution (10 molar equivalent/antibody, 1.33 micromoles, in 2.0 mL DMSO) to 18.0 mL of this reoxidised antibody solution (20 mg, 133 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 1.5 hours at room temperature, then the conjugation was quenched by addition of N-acetyl cysteine (20 micromoles, 200 μL at 100 mM), then purified by spin filtration using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 kDa</div>
    <div id="p-0522" num="0665" class="description-paragraph style-scope patent-text">MWCO spin filter, and further purified on an AKTA™ Start FPLC using a GE Healthcare HiLoad™ 26/600 column packed with Superdex 200 PG, eluting with 2.5 mL/min PBS. Fractions corresponding to ConjC monomer peak were pooled, concentrated using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 KDa MWCO spin filter, sterile-filtered and analysed.</div>
    <div id="p-0523" num="0666" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjC at 280 nm and 330 nm (Compound 34 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of Compound 34, consistent with a drug-per-antibody ratio (DAR) of 1.66 molecules of Compound 34 per antibody.</div>
    <div id="p-0524" num="0667" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjC at 280 nm shows a monomer purity of 99%. UHPLC SEC analysis gives a concentration of final ConjC at 1.36 mg/mL in 10.4 mL, obtained mass of ConjC is 14.1 mg (71% yield).</div>
    <div id="h-0222" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-10 (ConjD)</div>
    <div id="p-0525" num="0668" class="description-paragraph style-scope patent-text">A 50 mM solution of DL-dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (150 molar equivalent/antibody, 40 micromoles, 800 μL) to a 16.0 mL solution of antibody, Tratuzumab (40 mg, 267 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.5 mg/mL. The reduction mixture was allowed to react at room temperature for 4 hours (or until full reduction is observed by UHPLC) in an orbital shaker with gentle (50 rpm) shaking. The reduced antibody solution was buffer exchanged (to remove all the excess reducing agent), via spin filter centrifugation, into a conjugation buffer containing PBS and 1 mM EDTA for a final antibody concentration of 2.5 mg/mL. <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10 was added as a DMSO solution (25 molar equivalent/antibody, 1.67 micromoles, in 0.4 mL DMSO) to 3.6 mL of this reduced antibody solution (10 mg, 67 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 1.5 hours at room temperature, then the conjugation was quenched by addition of N-acetyl cysteine (8.33 micromoles, 83.3 μL at 100 mM), then purified on an AKTA™ Start FPLC using a GE Healthcare HiLoad™ 26/600 column packed with Superdex 200 PG, eluting with 2.5 mL/min PBS. Fractions corresponding to ConjD monomer peak were pooled, concentrated using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 KDa MWCO spin filter, sterile-filtered and analysed.</div>
    <div id="p-0526" num="0669" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjD at 280 nm and 330 nm (<figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10 specific) shows a mixture of unconjugated light chains, light chains attached to a single molecule of <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10, unconjugated heavy chains and heavy chains attached to up to three molecules of <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10, consistent with a drug-per-antibody ratio (DAR) of 7.47 molecules of <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10 per antibody.</div>
    <div id="p-0527" num="0670" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjD at 280 nm shows a monomer purity of 99%. UHPLC SEC analysis gives a concentration of final ConjD at 1.90 mg/mL in 4.4 mL, obtained mass of ConjA is 8.4 mg (84% yield).</div>
    <div id="h-0223" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-22 (ConjE)</div>
    <div id="p-0528" num="0671" class="description-paragraph style-scope patent-text">A 50 mM solution of DL-dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (150 molar equivalent/antibody, 40 micromoles, 800 mL) to a 16.0 mL solution of antibody, Tratuzumab (40 mg, 267 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.5 mg/mL. The reduction mixture was allowed to react at room temperature for 4 hours (or until full reduction is observed by UHPLC) in an orbital shaker with gentle (50 rpm) shaking.</div>
    <div id="p-0529" num="0672" class="description-paragraph style-scope patent-text">The reduced antibody solution was buffer exchanged (to remove all the excess reducing agent), via spin filter centrifugation, into a conjugation buffer containing PBS and 1 mM EDTA for a final antibody concentration of 2.5 mg/mL. Compound 22 was added as a DMSO solution (25 molar equivalent/antibody, 1.67 micromoles, in 0.4 mL DMSO) to 3.6 mL of this reduced antibody solution (10 mg, 67 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 1.5 hours at room temperature, then the conjugation was quenched by addition of N-acetyl cysteine (8.33 micromoles, 83.3 mL at 100 mM), then purified on an AKTA™ Start FPLC using a GE Healthcare HiLoad™ 26/600 column packed with Superdex 200 PG, eluting with 2.5 mL/min PBS. Fractions corresponding to ConjE monomer peak were pooled, concentrated using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 KDa MWCO spin filter, sterile-filtered and analysed.</div>
    <div id="p-0530" num="0673" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjE at 280 nm and 330 nm (Compound 22 specific) shows a mixture of unconjugated light chains, light chains attached to a single molecule of Compound 22, unconjugated heavy chains and heavy chains attached to up to three molecules of Compound 22, consistent with a drug-per-antibody ratio (DAR) of 7.39 molecules of Compound 22 per antibody.</div>
    <div id="p-0531" num="0674" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjE at 280 nm shows a monomer purity of 96%. UHPLC SEC analysis gives a concentration of final ConjE at 1.93 mg/mL in 4.6 mL, obtained mass of ConjE is 8.9 mg (89% yield).</div>
    <div id="h-0224" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-34 (ConjF)</div>
    <div id="p-0532" num="0675" class="description-paragraph style-scope patent-text">A 50 mM solution of DL-dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (150 molar equivalent/antibody, 10 micromoles, 200 μL) to a 4.0 mL solution of antibody (10 mg, 66.7 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.5 mg/mL. The reduction mixture was allowed to react at room temperature for 4 hours (or until full reduction is observed by UHPLC) in an orbital shaker with gentle (50 rpm) shaking. The reduced antibody solution was buffer exchanged (to remove all the excess reducing agent), via spin filter centrifugation, into a conjugation buffer containing PBS and 1 mM EDTA for a final antibody concentration of 2.5 mg/mL. Compound 34 was added as a DMSO solution (25 molar equivalent/antibody, 1.67 micromoles, in 0.4 mL DMSO) to 3.6 mL of this reduced antibody solution (10 mg, 67 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 0.75 hours at room temperature, then the conjugation was quenched by addition of N-acetyl cysteine (8.33 micromoles, 83.3 μL at 100 mM), then purified on an AKTA™ Start FPLC using a GE Healthcare HiLoad™ 26/600 column packed with Superdex 200 PG, eluting with 2.5 mL/min PBS. Fractions corresponding to ConjF peak were pooled, concentrated using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 KDa MWCO spin filter, re-purified on an AKTA™ Start FPLC using a GE Healthcare HiLoad™ 26/600 column packed with Superdex 200 PG, eluting with 2.5 mL/min PBS. Fractions corresponding to ConjF peak were pooled, concentrated using a 15 <figure-callout id="50" label="mL Amicon Ultracell" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mL Amicon Ultracell</a></figure-callout> 50 KDa MWCO spin filter, sterile-filtered and analysed.</div>
    <div id="p-0533" num="0676" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjF at 280 nm and 330 nm (Compound 34 specific) shows a mixture of unconjugated light chains, light chains attached to a single molecule of Compound 34, unconjugated heavy chains and heavy chains attached to up to three molecules of Compound 34, consistent with a drug-per-antibody ratio (DAR) of 7.41 molecules of</div>
    <div id="h-0225" num="0000" class="description-paragraph style-scope patent-text">Compound 34 Per Antibody.</div>
    <div id="p-0534" num="0677" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjF at 280 nm shows a monomer purity of 0% (100% dimer-trimer). UHPLC SEC analysis gives a concentration of final ConjF at 1.09 mg/mL in 4.4 mL, obtained mass of ConjF is 4.8 mg (48% yield).</div>
    <div id="h-0226" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-58 (ConjG)</div>
    <div id="p-0535" num="0678" class="description-paragraph style-scope patent-text">A 50 mM solution of Dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (120 molar equivalent/antibody, 32 micromoles, 0.64 mL at 50 mM) to a 3.7 mL solution of antibody (40 mg, 0.267 micromoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.0 mg/mL. The reduction mixture was heated at +25° C. for 4 hours (or until full reduction observed by UHPLC) in an orbital shaker with gentle (60 rpm) shaking. After cooling down to room temperature, the reduced antibody was buffer exchanged, via spin filter using 50 KDa MWCO vivaspin, into a reoxidation buffer containing PBS pH 7.4 and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 20 molar equivalent/antibody, 5.3 micromoles, 0.1 mL at 50 mM) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (60 rpm) shaking at an antibody concentration of ˜2.0 mg/mL (or until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was centrifuged for 3 min at 4000 rpm and then sterile-filtered using 0.22 μm membrane filter. Compound 58 was added as a DMSO solution (11 molar equivalent/antibody, 1.46 micromoles, in 0.9 mL DMSO) to 9.1 mL of this reoxidised antibody solution (20 mg, 0.13 micromoles) for a 10% (v/v) final DMSO concentration. The solution was shaken for 3 hours at +25° C. and then the conjugation was quenched with N-acetyl cysteine (7.3 micromoles, 0.07 mL at 100 mM).</div>
    <div id="p-0536" num="0679" class="description-paragraph style-scope patent-text">Excess free drug was removed via spin filter using 50 kDa MWCO vivaspin into buffer containing PBS pH 7.4. Extent of free drug removal was monitored by UHPLC-RP using neat conjugate. After complete removal of free drug, ConjG was filtered using 0.22 μm, Mustang filter under sterile atmosphere and then stored at +4° C.</div>
    <div id="p-0537" num="0680" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of Conjugate at 214 nm and 330 nm (Compound 58 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of Compound 58, consistent with a drug-per-antibody ratio (DAR) of 1.83 molecules of Compound 58 per antibody.</div>
    <div id="p-0538" num="0681" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjG at 280 nm shows a monomer purity of greater than 99%. UHPLC SEC analysis gives a concentration of final ConjG at 1.34 mg/mL in 8.9 mL, obtained mass of ConjG is 11.9 mg (60% yield).</div>
    <div id="h-0227" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-59 (ConjH)</div>
    <div id="p-0539" num="0682" class="description-paragraph style-scope patent-text">Antibody (30 mg) was loaded onto solid support and reduced, reoxidised, conjugated to Compound 59, purified, released from the resin and formulated onto 25 mM Histidine, 200 mM Sucrose, Tween-20 0.02%, pH 6.0 according to the method described in US2014-0037961A1, which is incorporated herein by reference.</div>
    <div id="p-0540" num="0683" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of Conjugate at 214 nm and 330 nm (Compound 59 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of Compound 59, consistent with a drug-per-antibody ratio (DAR) of 1.9 molecules of Compound 59 per antibody.</div>
    <div id="p-0541" num="0684" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjH at 280 nm shows a monomer purity of greater than 97%. UHPLC SEC analysis gives a concentration of final ConjH at 1.49 mg/mL in 7.5 mL, obtained mass of ConjH is 11.2 mg (37% yield).</div>
    <div id="h-0228" num="0000" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-48 (Coq)</div>
    <div id="p-0542" num="0685" class="description-paragraph style-scope patent-text">A 50 mM solution of Dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (80 molar equivalent/antibody, 21.4 micromoles, 0.43 mL at 50 mM) to a 3.7 mL solution of antibody (40 mg, 0.267 micromoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.0 mg/mL. The reduction mixture was heated at +25° C. for 4 hours (or until full reduction observed by UHPLC) in an orbital shaker with gentle (60 rpm) shaking. After cooling down to room temperature, the reduced antibody was buffer exchanged, via spin filter using 50 KDa MWCO vivaspin, into a reoxidation buffer containing PBS pH 7.4 and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 20 molar equivalent/antibody, 5.3 micromoles, 0.1 mL at 50 mM) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (60 rpm) shaking at an antibody concentration of ˜2.0 mg/mL (or until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was centrifuged for 3 min at 4000 rpm and then sterile-filtered using 0.22 μm membrane filter. <figure-callout id="48" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 48 was added as a DMSO solution (11 molar equivalent/antibody, 1.46 micromoles, in 1.7 mL DMSO) to 16.8 mL of this reoxidised antibody solution (20 mg, 0.13 micromoles) for a 10% (v/v) final DMSO concentration. The solution was shaken for 3 hours at +25° C. and then the conjugation was quenched with N-acetyl cysteine (7.3 micromoles, 0.07 mL at 100 mM).</div>
    <div id="p-0543" num="0686" class="description-paragraph style-scope patent-text">Excess free drug was removed via spin filter using 50 kDa MWCO vivaspin into buffer containing PBS pH 7.4. Extent of free drug removal was monitored by UHPLC-RP using neat conjugate. After complete removal of free drug, ADC was filtered using 0.22 μm, Mustang filter under sterile atmosphere and then stored at +4° C.</div>
    <div id="p-0544" num="0687" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of Conjugate at 214 nm and 330 nm (<figure-callout id="48" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 48 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of <figure-callout id="48" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 48, consistent with a drug-per-antibody ratio (DAR) of 1.86 molecules of <figure-callout id="48" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 48 per antibody.</div>
    <div id="p-0545" num="0688" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjI at 280 nm shows a monomer purity of greater than 99%. UHPLC SEC analysis gives a concentration of final ConjI at 1.7 mg/mL in 7.3 mL, obtained mass of ConjI is 12.4 mg (62% yield).</div>
    <div id="p-0546" num="0689" class="description-paragraph style-scope patent-text">Conjugate Tratuzumab-57 (ConjJ)</div>
    <div id="p-0547" num="0690" class="description-paragraph style-scope patent-text">A 50 mM solution of Dithiothreitol (DTT) in phosphate-buffered saline pH 7.4 (PBS) was added (80 molar equivalent/antibody, 21.4 micromoles, 0.43 mL at 50 mM) to a 3.7 mL solution of antibody (40 mg, 0.267 micromoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.0 mg/mL. The reduction mixture was heated at +25° C. for 4 hours (or until full reduction observed by UHPLC) in an orbital shaker with gentle (60 rpm) shaking. After cooling down to room temperature, the reduced antibody was buffer exchanged, via spin filter using 50 KDa MWCO vivaspin, into a reoxidation buffer containing PBS pH 7.4 and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 20 molar equivalent/antibody, 5.3 micromoles, 0.1 mL at 50 mM) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (60 rpm) shaking at an antibody concentration of ˜2.0 mg/mL (or until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was centrifuged for 3 min at 4000 rpm and then sterile-filtered using 0.22 μm membrane filter. <figure-callout id="57" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 57 was added as a DMSO solution (11 molar equivalent/antibody, 1.46 micromoles, in 1.7 mL DMSO) to 16.8 mL of this reoxidised antibody solution (20 mg, 0.13 micromoles) for a 10% (v/v) final DMSO concentration. The solution was shaken for 3 hours at +25° C. and then the conjugation was quenched with N-acetyl cysteine (7.3 micromoles, 0.07 mL at 100 mM).</div>
    <div id="p-0548" num="0691" class="description-paragraph style-scope patent-text">Excess free drug was removed via spin filter using 50 kDa MWCO vivaspin into buffer containing PBS pH 7.4. Extent of free drug removal was monitored by UHPLC-RP using neat conjugate. After complete removal of free drug, ADC was filtered using 0.22 μm, Mustang filter under sterile atmosphere and then stored at +4° C.</div>
    <div id="p-0549" num="0692" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of Conjugate at 214 nm and 330 nm (<figure-callout id="57" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 57 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of <figure-callout id="57" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 57, consistent with a drug-per-antibody ratio (DAR) of 1.87 molecules of <figure-callout id="57" label="Compound" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 57 per antibody.</div>
    <div id="p-0550" num="0693" class="description-paragraph style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel <figure-callout id="4" label="SuperSW mAb HTP" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SuperSW mAb HTP</a></figure-callout> 4 μm 4.6×150 mm column (with a 4 μm 3.0×20 mm guard column) eluting with 0.3 mL/minute sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjJ at 280 nm shows a monomer purity of greater than 100%. UHPLC SEC analysis gives a concentration of final ConjJ at 0.86 mg/mL in 10.3 mL, obtained mass of ConjJ is 8.9 mg (45% yield).</div>
    <heading id="h-0229" class="style-scope patent-text">Example 9</heading>
    <div id="h-0230" num="0000" class="description-paragraph style-scope patent-text">In Vitro Testing of <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10</div>
    <div id="p-0551" num="0694" class="description-paragraph style-scope patent-text">DU145 (2000/well, 72 hour assay) and MDA-MB-361 (5000/well, 144 hour assay) cells were plated in culture medium to tissue culture-treated 96-well plates at a volume of 80 μL per well and allowed to adhere overnight. For warhead dilutions, first a 60× concentration of each dose to be tested was prepared by diluting the test articles in DMSO. The 60× dilutions of warhead were then further diluted to a 5× concentration in either cell culture medium alone or cell culture medium containing 5× β-glucuronidase enzyme (Sigma Cat # G0799-25KU). 20 μL of cell culture medium containing test article+/−enzyme was added to cells in triplicate wells, and the final dose curve ranged from 6.4 nM to 61 pM in a stepwise 1:4 serial dilution series. DMSO alone diluted to the culture medium was used as the controls. The treated cells were cultured at 37° C./5% CO<sub class="style-scope patent-text">2 </sub>for 72 to 144 hours (depending on established growth kinetics of each particular cell line). At the end of the assay, CellTiter-Glo® (CTG) Luminescent Viability Assay (Promega) was used to determine relative cytotoxicity. 100 μL of CTG reagent was added to each well, and plates were incubated for 10 minutes at room temperature with gentle shaking, absorbance of each sample was read at 560 nM using an EnVision luminometer (Perkin Elmer). The percent cell viability was calculated by the following formula:
<br class="style-scope patent-text">
(average luminescence of treated samples/average luminescence of control samples)×100.
</div>
    <div id="p-0552" num="0695" class="description-paragraph style-scope patent-text">IC<sub class="style-scope patent-text">50 </sub>values were determined using logistic non-linear regression analysis with GraphPad Prism software.</div>
    <div id="p-0553" num="0696" class="description-paragraph style-scope patent-text"> <tables id="TABLE-US-00002" num="00002" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> <figure-callout id="10" label="Compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 10</td> <td class="description-td style-scope patent-text">No glucuronidase</td> <td class="description-td style-scope patent-text">With glucuronidase</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">DU145 - IC<sub class="style-scope patent-text">50</sub> </td> <td class="description-td style-scope patent-text">6.84 </td> <td class="description-td style-scope patent-text">μM</td> <td class="description-td style-scope patent-text">201 </td> <td class="description-td style-scope patent-text">nM</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">MDA-MB-361 - IC<sub class="style-scope patent-text">50</sub> </td> <td class="description-td style-scope patent-text">778 </td> <td class="description-td style-scope patent-text"> <figure-callout id="32" label="nM" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nM</a></figure-callout> </td> <td class="description-td style-scope patent-text">32 </td> <td class="description-td style-scope patent-text">nM</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td> </tr>  </tbody></table> </patent-tables> </tables> <br class="style-scope patent-text">
In Vitro Testing of ConjA
</div>
    <div id="p-0554" num="0697" class="description-paragraph style-scope patent-text">A similar method was used as described above with MDA-MB-361 (HER2 high, 5000 cells/well, 144 hr assay) and MCF-7 cells (HER2 low, 1500 cells/well, 144 hr assay). Cell plating density and duration of the assay were determined based on established growth kinetics of each particular cell line. A 5× concentration of each dose of ADC to be tested was prepared by diluting the test articles in culture medium. Twenty μL of ADC was added to the cells in triplicate wells with a final dose curve ranging from 3 μg/mL to 11 pg/mL in a 1:4 serial dilution series. The treated cells were cultured at 37° C./5% CO<sub class="style-scope patent-text">2 </sub>for 144 hours and the CellTiter-Glo® (CTG) Luminescent Viability Assay (Promega) was used to determine relative cytotoxicity as described above.</div>
    <div id="p-0555" num="0698" class="description-paragraph style-scope patent-text"> <tables id="TABLE-US-00003" num="00003" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">IC<sub class="style-scope patent-text">50</sub> </td> <td class="description-td style-scope patent-text">MDA-MB-361</td> <td class="description-td style-scope patent-text">MCF-7</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">ConjA</td> <td class="description-td style-scope patent-text">14.5 ng/mL</td> <td class="description-td style-scope patent-text">~3 μg/mL</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr>  </tbody></table> </patent-tables> </tables> <br class="style-scope patent-text">
Testing of ConjB and ConjC in Cells with siRNA Knock Down of β-Glucuronidase
</div>
    <div id="p-0556" num="0699" class="description-paragraph style-scope patent-text">HER2-overexpressing SKOV3 cells were subjected to reverse transfection to knock down GUSB expression levels. First, a 4× stock of RNAiMAX (final concentration of 0.125 ul/well, Life Technologies) and a 4× stock of siRNA oligos (Non-targeting/Negative siRNA, GAPDH siRNA and GUSB siRNA final concentration of 100 nM/well, Life Technologies) were prepared in OptiMEM medium. An RNAiMAX/OptiMEM only mixture was included as the lipid control. The 4× RNAiMAX solution and 4× siRNA solutions were brought to 2× by mixing in a one to one ratio, and the RNAiMAX/siRNA mixture was left to incubate at room temperature for 20 minutes. After incubation, 40 μl of the RNAiMAX/siRNA mixtures and lipid control were added per well to tissue culture-treated 96-well plates and 40 μl of cell solution was added onto the lipid/siRNA mixture, with a final plating density of 2000 cells/well. Plates were cultured at 37° C./5% CO<sub class="style-scope patent-text">2 </sub>for 72 hours at which <figure-callout id="20" label="point" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">point</a></figure-callout> 20 μl of a 5× concentration of each dose of ConjB/ConjC was added to the cells in duplicate wells with a final dose curve ranging from 10 μg/mL to 0.15 ng/mL in a 1:4 serial dilution series. The ADC treated cells were cultured at 37° C./5% CO<sub class="style-scope patent-text">2 </sub>for an additional 72 hours and the CellTiter-Glo® (CTG) Luminescent Viability Assay (Promega) was used to determine relative cytotoxicity as described above. Efficiency of the siRNA knock down was determined by RNA expression levels and measurement of β-glucuronidase enzyme activity.</div>
    <div id="p-0557" num="0700" class="description-paragraph style-scope patent-text">The results are shown in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref> (ConjB) and <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref> (ConjC), wherein the followed symbols are used:</div>
    <div id="p-0558" num="0701" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00004" num="00004" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table style-scope patent-text" width="100%">
            <thead class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="2" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="2"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/75/7c/06/5bc164d04058df/US10799595-20201013-P00001.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00001" he="3.22mm" wi="4.91mm" file="US10799595-20201013-P00001.TIF" alt="Figure US10799595-20201013-P00001" img-content="character" img-format="tif" orientation="portrait" inline="no" width="20" height="13" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/75/7c/06/5bc164d04058df/US10799595-20201013-P00001.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">Untrasfected</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/64/15/51/5d63558f812824/US10799595-20201013-P00002.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00002" he="2.79mm" wi="5.33mm" file="US10799595-20201013-P00002.TIF" alt="Figure US10799595-20201013-P00002" img-content="character" img-format="tif" orientation="portrait" inline="no" width="21" height="11" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/64/15/51/5d63558f812824/US10799595-20201013-P00002.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">Lipid Only</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/82/32/b9fdcd7a8c2ccf/US10799595-20201013-P00003.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00003" he="2.79mm" wi="4.23mm" file="US10799595-20201013-P00003.TIF" alt="Figure US10799595-20201013-P00003" img-content="character" img-format="tif" orientation="portrait" inline="no" width="17" height="11" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/82/32/b9fdcd7a8c2ccf/US10799595-20201013-P00003.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">Ne siRNA oligo2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/65/e8/f6/bbf4fb5393d295/US10799595-20201013-P00004.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00004" he="3.22mm" wi="4.23mm" file="US10799595-20201013-P00004.TIF" alt="Figure US10799595-20201013-P00004" img-content="character" img-format="tif" orientation="portrait" inline="no" width="17" height="13" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/65/e8/f6/bbf4fb5393d295/US10799595-20201013-P00004.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">GUSB oligo3</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/2c/ad/ff10a0f18fb1d9/US10799595-20201013-P00005.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00005" he="3.22mm" wi="4.91mm" file="US10799595-20201013-P00005.TIF" alt="Figure US10799595-20201013-P00005" img-content="character" img-format="tif" orientation="portrait" inline="no" width="20" height="13" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/2c/ad/ff10a0f18fb1d9/US10799595-20201013-P00005.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">GAPDH oligo2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/be/e5/7b/363c9c67f83f58/US10799595-20201013-P00006.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00006" he="2.79mm" wi="2.79mm" file="US10799595-20201013-P00006.TIF" alt="Figure US10799595-20201013-P00006" img-content="character" img-format="tif" orientation="portrait" inline="no" width="11" height="11" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/be/e5/7b/363c9c67f83f58/US10799595-20201013-P00006.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">Neg2 siRNA tox</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/44/dc/6e/a3f088a708c6c5/US10799595-20201013-P00007.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00007" he="3.22mm" wi="2.79mm" file="US10799595-20201013-P00007.TIF" alt="Figure US10799595-20201013-P00007" img-content="character" img-format="tif" orientation="portrait" inline="no" width="11" height="13" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/44/dc/6e/a3f088a708c6c5/US10799595-20201013-P00007.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">GUSB siRNA tox</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">
                  <div class="patent-image small-patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/94/46/26/0f0bd5354b39e3/US10799595-20201013-P00008.png" class="style-scope patent-text"><img id="CUSTOM-CHARACTER-00008" he="3.22mm" wi="2.79mm" file="US10799595-20201013-P00008.TIF" alt="Figure US10799595-20201013-P00008" img-content="character" img-format="tif" orientation="portrait" inline="no" width="11" height="13" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/94/46/26/0f0bd5354b39e3/US10799595-20201013-P00008.png"></a></div>
                </td>
                <td class="description-td style-scope patent-text">GAPDH siRNA tox</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="2" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="2"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div id="p-0559" num="0702" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00005" num="00005" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%">
            <thead class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IC<sub class="style-scope patent-text">50 </sub> </td>
                <td class="description-td style-scope patent-text">Untrans-</td>
                <td class="description-td style-scope patent-text">Neg siRNA</td>
                <td class="description-td style-scope patent-text">Lipid </td>
                <td class="description-td style-scope patent-text">GUSB </td>
                <td class="description-td style-scope patent-text">GAPDH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">(ng/mL)</td>
                <td class="description-td style-scope patent-text">fected</td>
                <td class="description-td style-scope patent-text">oligo2</td>
                <td class="description-td style-scope patent-text">only</td>
                <td class="description-td style-scope patent-text">oligo3</td>
                <td class="description-td style-scope patent-text">oligo2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ConjB</td>
                <td class="description-td style-scope patent-text">12.66</td>
                <td class="description-td style-scope patent-text">18.19</td>
                <td class="description-td style-scope patent-text">13.1</td>
                <td class="description-td style-scope patent-text">26.05</td>
                <td class="description-td style-scope patent-text">27.84</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ConjC</td>
                <td class="description-td style-scope patent-text">4.871</td>
                <td class="description-td style-scope patent-text">13.07</td>
                <td class="description-td style-scope patent-text">5.818</td>
                <td class="description-td style-scope patent-text">31.59</td>
                <td class="description-td style-scope patent-text">23.00</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div id="p-0560" num="0703" class="description-paragraph style-scope patent-text">Also noticeable is the much higher maximum kill for ConjC.</div>
    <heading id="h-0231" class="style-scope patent-text">Example 10—In Vitro Testing</heading>
    <div id="p-0561" num="0704" class="description-paragraph style-scope patent-text">Medium from sub-confluent (80-90% confluency) cell culture in a T75 flask was aspirated and the flask rinsed with PBS (about 20 ml) and emptied. Trypsin-EDTA (5 ml) was added, the flask returned to the 37° C. gassed incubator for up to about 5 minutes, then rapped sharply to dislodge and dissociate cells from the plastic. The cell suspension was transferred to a sterile 50 ml screw-top centrifuge tube, diluted with growth medium to a final volume of 15 ml, then centrifuged (400 g for 5 min). The supernatant was aspirated and the pellet re-suspended in 10 ml culture medium. Repeated pipetting may be necessary to produce monodisperse cell suspensions. The cell concentration and viability are measured of trypan blue cell stained cells, and counted using the LUNA-11™ Automated Cell Counter. Cells were diluted to 2×10<sup class="style-scope patent-text">5</sup>/ml, dispensed (50 μl/well) into 96 well flat bottom plates and incubated overnight before use.</div>
    <div id="p-0562" num="0705" class="description-paragraph style-scope patent-text">A stock solution (1 ml) of antibody drug conjugate (ADC) (20 μg/ml) was made by dilution of filter-sterilised ADC into cell culture medium. A set of 8×10-fold dilutions of stock ADC were made in a 24 well plate by serial transfer of 100 μl onto 900 μl of cell culture medium.</div>
    <div id="p-0563" num="0706" class="description-paragraph style-scope patent-text">ADC dilution was dispensed (50 μl/well) into 4 replicate wells of the 96-well plate, containing 50 μl cell suspension seeded the previous day. Control wells received 50 μl cell culture medium. The 96-well plate containing cells and ADCs was incubated at 37° C. in a CO<sub class="style-scope patent-text">2</sub>-gassed incubator for the exposure time.</div>
    <div id="p-0564" num="0707" class="description-paragraph style-scope patent-text">At the end of the incubation period, cell viability was measured by MTS assay. MTS (Promega) was dispensed (20 μl per well) into each well and incubated for 4 hours at 37° C. in the CO<sub class="style-scope patent-text">2</sub>-gassed incubator. Well absorbance was measured at 490 nm. Percentage cell survival was calculated from the mean absorbance in the 4 ADC-treated wells compared to the mean absorbance in the 4 control untreated wells (100%). IC<sub class="style-scope patent-text">50 </sub>was determined from the doses-response data using Graph Pad Prism using the non-linear curve fit algorithm: sigmoidal, 4PL X is log(concentration).</div>
    <div id="p-0565" num="0708" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00006" num="00006" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%">
            <thead class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ADC </td>
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Cell Line</td>
                <td class="description-td style-scope patent-text">Description</td>
                <td class="description-td style-scope patent-text">Exposure</td>
                <td class="description-td style-scope patent-text">Cell growth medium</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MDA MB 468</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="4" label="HER2" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">HER2</a></figure-callout> </td>
                <td class="description-td style-scope patent-text">4 days</td>
                <td class="description-td style-scope patent-text">RPMI 1640 with glutamax, </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">negative,</td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">10% (v/v) HyClone ™</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Breast </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Fetal Bovine Serum</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">carcinoma</td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NCIN87</td>
                <td class="description-td style-scope patent-text">Gastric </td>
                <td class="description-td style-scope patent-text">7 days</td>
                <td class="description-td style-scope patent-text">RPMI 1640 with glutamax, </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> <figure-callout id="10" label="carcinoma" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carcinoma</a></figure-callout> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">10% (v/v) HyClone ™ </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Fetal Bovine Serum</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div id="p-0566" num="0709" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00007" num="00007" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">IC<sub class="style-scope patent-text">50 </sub>(nM) in:</td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ADC</td>
                <td class="description-td style-scope patent-text">MDMA MB 468</td>
                <td class="description-td style-scope patent-text">NCI-N87</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjA</td>
                <td class="description-td style-scope patent-text">&gt;100</td>
                <td class="description-td style-scope patent-text">0.263</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjB</td>
                <td class="description-td style-scope patent-text">&gt;100</td>
                <td class="description-td style-scope patent-text">0.0222</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjC</td>
                <td class="description-td style-scope patent-text">68</td>
                <td class="description-td style-scope patent-text">0.0013</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjD</td>
                <td class="description-td style-scope patent-text">&gt;100</td>
                <td class="description-td style-scope patent-text">0.185</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjE</td>
                <td class="description-td style-scope patent-text">&gt;100</td>
                <td class="description-td style-scope patent-text">0.0023</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjF</td>
                <td class="description-td style-scope patent-text">81</td>
                <td class="description-td style-scope patent-text">0.0003</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div id="p-0567" num="0710" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00008" num="00008" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%">
            <thead class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ADC</td>
                <td class="description-td style-scope patent-text">EC<sub class="style-scope patent-text">50 </sub>(μg/ml)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjA</td>
                <td class="description-td style-scope patent-text">0.0133</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjB</td>
                <td class="description-td style-scope patent-text">0.00141</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjC</td>
                <td class="description-td style-scope patent-text">0.00000187</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjD</td>
                <td class="description-td style-scope patent-text">0.00271</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjE</td>
                <td class="description-td style-scope patent-text">0.00000203</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjF</td>
                <td class="description-td style-scope patent-text">3 × 10<sup class="style-scope patent-text">−16</sup> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjG</td>
                <td class="description-td style-scope patent-text">0.00369</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjH</td>
                <td class="description-td style-scope patent-text">0.000496</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjI</td>
                <td class="description-td style-scope patent-text">0.00844</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ConjJ</td>
                <td class="description-td style-scope patent-text">0.0829</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <heading id="h-0232" class="style-scope patent-text">Example 11—Xenograft Testing</heading>
    <div id="h-0233" num="0000" class="description-paragraph style-scope patent-text">NCI-N87 Xenografted Mice</div>
    <div id="p-0568" num="0711" class="description-paragraph style-scope patent-text">Female severe combined immune-deficient mice (Fox Chase SCID®, C.B-17/Icr-Prkdcscid, Charles River) were ten weeks old with a body weight (BW) range of 16.5 to 21.1 grams on Day 1 of the study. The animals were fed ad libitum water (reverse osmosis, 1 ppm Cl), and NIH 31 Modified and Irradiated Lab Diet® consisting of 18.0% crude protein, 5.0% crude fat, and 5.0% crude fibre. The mice were housed on irradiated Enricho'cobs™ Laboratory Animal Bedding in static micro-isolators on a 12-hour light cycle at 20-22° C. (68-72° F.) and 40-60% humidity. CR Discovery Services specifically complies with the recommendations of the <i class="style-scope patent-text">Guide for Care and Use of Laboratory Animals </i>with respect to restraint, husbandry, surgical procedures, feed and fluid regulation, and veterinary care. The animal care and use program at CR Discovery Services is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), which assures compliance with accepted standards for the care and use of laboratory animals.</div>
    <div id="h-0234" num="0000" class="description-paragraph style-scope patent-text">Tumour Cell Culture</div>
    <div id="p-0569" num="0712" class="description-paragraph style-scope patent-text">Human NCI-N87 gastric carcinoma lymphoma cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin sulfate and 25 μg/mL gentamicin. The cells were grown in tissue culture flasks in a humidified incubator at 37° C., in an atmosphere of 5% CO<sub class="style-scope patent-text">2 </sub>and 95% air.</div>
    <div id="h-0235" num="0000" class="description-paragraph style-scope patent-text">In Vivo Implantation and Tumour Growth</div>
    <div id="p-0570" num="0713" class="description-paragraph style-scope patent-text">The NCI-N87 cells used for implantation were harvested during log phase growth and Re-suspended in phosphate buffered saline (PBS) containing 50% Matrigel™ (BD Biosciences). On the day of tumour implant, each test mouse was injected subcutaneously in the right flank with 1×10<sup class="style-scope patent-text">7 </sup>cells (0.1 mL cell suspension), and tumour growth was monitored as the average size approached the target range of 100 to 150 mm<sup class="style-scope patent-text">3</sup>. Fourteen days later, designated as Day 1 of the study, mice were sorted according to calculated tumour size into groups each consisting of ten animals with individual tumour volumes ranging from 108 to 144 mm<sup class="style-scope patent-text">3 </sup>and group mean tumour volumes of 115 mm<sup class="style-scope patent-text">3</sup>.</div>
    <div id="p-0571" num="0714" class="description-paragraph style-scope patent-text">Tumours were measured in two dimensions using calipers, and volume was calculated using the formula:</div>
    <div id="p-0572" num="0715" class="description-paragraph style-scope patent-text"> <maths id="MATH-US-00001" num="00001" class="style-scope patent-text"> <math overflow="scroll" class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mi class="style-scope patent-text">Tumour</mi> <mo class="style-scope patent-text">⁢</mo> <mstyle class="style-scope patent-text"> <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace> </mstyle> <mo class="style-scope patent-text">⁢</mo> <mi class="style-scope patent-text">Volume</mi> <mo class="style-scope patent-text">⁢</mo> <mstyle class="style-scope patent-text"> <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace> </mstyle> <mo class="style-scope patent-text">⁢</mo> <mrow class="style-scope patent-text"> <mo class="style-scope patent-text">(</mo> <msup class="style-scope patent-text"> <mi class="style-scope patent-text">mm</mi> <mn class="style-scope patent-text">3</mn> </msup> <mo class="style-scope patent-text">)</mo> </mrow> </mrow> <mo class="style-scope patent-text">=</mo> <mfrac class="style-scope patent-text"> <mrow class="style-scope patent-text"> <msup class="style-scope patent-text"> <mi class="style-scope patent-text">w</mi> <mn class="style-scope patent-text">2</mn> </msup> <mo class="style-scope patent-text">⁢</mo> <mi class="style-scope patent-text">xl</mi> </mrow> <mn class="style-scope patent-text">2</mn> </mfrac> </mrow> </math> </maths> <br class="style-scope patent-text">
where w=width and 1=length, in mm, of the tumour. Tumour weight may be estimated with the assumption that 1 mg is equivalent to 1 mm<sup class="style-scope patent-text">3 </sup>of tumour volume.
<br class="style-scope patent-text">
Treatment
</div>
    <div id="p-0573" num="0716" class="description-paragraph style-scope patent-text">Treatment began on Day 1 in groups of 10 mice (n=10) with established subcutaneous NCI-N87 tumours (108-144 mm<sup class="style-scope patent-text">3</sup>). Trastuzumab-10 (ConjA) was administered intravenously once on Day 1 (qd×1). A vehicle-treated group served as the control group for efficacy analysis. Tumours were measured twice per week until the study was ended on Day 79. Each mouse was euthanized when its tumour reached the endpoint volume of 800 mm<sup class="style-scope patent-text">3 </sup>or on the final day, whichever came first. The time to endpoint (TTE) was calculated for each mouse.</div>
    <div id="p-0574" num="0717" class="description-paragraph style-scope patent-text">Treatment outcome was determined from percent tumour growth delay (% TGD), defined as the percent increase in median TTE for treated versus control mice, with differences between groups deemed statistically significant at P≤0.05 using logrank survival analysis. Mice were monitored for complete regression (CR) and partial regression (PR) responses.</div>
    <div id="p-0575" num="0718" class="description-paragraph style-scope patent-text">Treatment tolerability was assessed by body weight measurements and frequent observation for signs of treatment-related side effects. Treatment tolerability was assessed by body weight measurements and frequent observation for signs of treatment-related side effects. All regimens were well tolerated. The median TTE for vehicle-treated controls was 50.7 days, establishing a maximum possible TGD of 28.3 days (56%) for the 79-day study.</div>
    <div id="p-0576" num="0719" class="description-paragraph style-scope patent-text">The minimum effective dose was defined as the minimum dosage required to produce tumour stasis for twenty-eight days after test article administration. Based on visual inspection of the mean and median tumour volume plots and percent change of tumour volume from Day 1, trastuzumab-10 (ConjA) at 1.0 mg/kg, appeared to be the dosage that achieved a response consistent with the minimum effective dose</div>
    <div id="p-0577" num="0720" class="description-paragraph style-scope patent-text">Two of the 0.3 mg/kg group animals were end of study survivors with an MTV of 708 mm<sup class="style-scope patent-text">3</sup>. Eight of the 1.0 mg/kg group animals were end of study survivors with an MTV of 650 mm<sup class="style-scope patent-text">3</sup>. The results are illustrated in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>.</div>
    <div id="h-0236" num="0000" class="description-paragraph style-scope patent-text">JIMT-1 Xenografted Mice</div>
    <div id="h-0237" num="0000" class="description-paragraph style-scope patent-text">Mice</div>
    <div id="p-0578" num="0721" class="description-paragraph style-scope patent-text">Female severe combined immunodeficient mice (Fox Chase SCID®, CB17/Icr-Prkdcscid/IcrIcoCrl, Charles River) were ten weeks old with a body weight (BW) range of 15.1 to 22.2 g on Day 1 of the study.</div>
    <div id="h-0238" num="0000" class="description-paragraph style-scope patent-text">Tumour Cell Culture</div>
    <div id="p-0579" num="0722" class="description-paragraph style-scope patent-text">JIMT-1 human breast carcinoma cells were grown in DMEM containing 10% fetal bovine serum, 100 units/mL penicillin G sodium, 100 μg/mL streptomycin sulphate, 25 μg/mL gentamicin, and 2 mM glutamine. Cell cultures were maintained in tissue culture flasks in a humidified incubator at 37° C., in an atmosphere of 5% CO<sub class="style-scope patent-text">2 </sub>and 95% air.</div>
    <div id="h-0239" num="0000" class="description-paragraph style-scope patent-text">In Vivo Implantation and Tumour Growth</div>
    <div id="p-0580" num="0723" class="description-paragraph style-scope patent-text">The JIMT-1 cells used for implantation were harvested during exponential growth and re-suspended in 50% Matrigel (BD Biosciences): 50% phosphate buffered saline at a concentration of 5×10<sup class="style-scope patent-text">7 </sup>cells/mL. On the day of tumour implant, each test mouse was injected subcutaneously in the right flank with 1×10<sup class="style-scope patent-text">7 </sup>cells (0.2 mL cell suspension), and tumour growth was monitored as the average size approached the target range of 100 to 150 mm<sup class="style-scope patent-text">3</sup>. Tumours were measured in two dimensions using calipers, and volume was calculated using the formula:</div>
    <div id="p-0581" num="0724" class="description-paragraph style-scope patent-text"> <maths id="MATH-US-00002" num="00002" class="style-scope patent-text"> <math overflow="scroll" class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mi class="style-scope patent-text">Tumour</mi> <mo class="style-scope patent-text">⁢</mo> <mstyle class="style-scope patent-text"> <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace> </mstyle> <mo class="style-scope patent-text">⁢</mo> <mi class="style-scope patent-text">Volume</mi> <mo class="style-scope patent-text">⁢</mo> <mstyle class="style-scope patent-text"> <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace> </mstyle> <mo class="style-scope patent-text">⁢</mo> <mrow class="style-scope patent-text"> <mo class="style-scope patent-text">(</mo> <msup class="style-scope patent-text"> <mi class="style-scope patent-text">mm</mi> <mn class="style-scope patent-text">3</mn> </msup> <mo class="style-scope patent-text">)</mo> </mrow> </mrow> <mo class="style-scope patent-text">=</mo> <mfrac class="style-scope patent-text"> <mrow class="style-scope patent-text"> <msup class="style-scope patent-text"> <mi class="style-scope patent-text">w</mi> <mn class="style-scope patent-text">2</mn> </msup> <mo class="style-scope patent-text">⁢</mo> <mi class="style-scope patent-text">xl</mi> </mrow> <mn class="style-scope patent-text">2</mn> </mfrac> </mrow> </math> </maths> <br class="style-scope patent-text">
where w=width and l=length, in mm, of the tumour. Tumour weight may be estimated with the assumption that 1 mg is equivalent to 1 mm<sup class="style-scope patent-text">3 </sup>of tumour volume.
<br class="style-scope patent-text">
Treatment
</div>
    <div id="p-0582" num="0725" class="description-paragraph style-scope patent-text">Treatment began on Day 1 in groups of 10 mice (n=10) with established subcutaneous JIMT-1 tumours with volume range (88-196 mm<sup class="style-scope patent-text">3</sup>) and group mean timour volume of 120 to 122 mm<sup class="style-scope patent-text">3</sup>. Trastuzumab-10 (ConjA) was administered intravenously once on Day 1 (qd×1). A vehicle-treated group served as the control group for efficacy analysis. Tumours were measured twice per week until the study was ended on Day 59. Each mouse was euthanized when its tumour reached the endpoint volume of 1000 mm<sup class="style-scope patent-text">3 </sup>or on the final day, whichever came first. The time to endpoint (TTE) was calculated for each mouse.</div>
    <div id="p-0583" num="0726" class="description-paragraph style-scope patent-text">Treatment outcome was determined from percent tumour growth delay (% TGD), defined as the percent increase in median TTE for treated versus control mice, with differences between groups deemed statistically significant at P≤0.05 using logrank survival analysis. Mice were monitored for complete regression (CR) and partial regression (PR) responses. Treatment tolerability was assessed by body weight measurements and frequent observation for signs of treatment-related side effects. All regimens were well tolerated. The median TTE for vehicle-treated controls was 48.4 days, establishing a maximum possible TGD of 10.6 days (22%) for the 59-day study. All ADC regimens tested produced significant survival benefit compared to vehicle-treated controls (P&lt;0.01).</div>
    <div id="p-0584" num="0727" class="description-paragraph style-scope patent-text">The minimum effective dose was defined as the minimum dosage required to produce tumour stasis for twenty-eight days after test article administration. Based on visual inspection of the mean and median tumour volume plots and percent change of tumour volume from Day 1, trastuzumab-10 (ConjA) at 1.0 mg/kg, appeared to be the dosage that achieved a response consistent with the minimum effective dose.</div>
    <div id="p-0585" num="0728" class="description-paragraph style-scope patent-text">A dose-dependent effect was observed where the 0.3 mg/kg group median tumour volume slowly increased through Day 34 then progressed thereafter, while the 1.0 mg/kg group showed static median tumour volume through Day 38 which progressed thereafter. The median TTE for the 0.3 mg/kg group was 56.9 days corresponding to a significant TGD of 8.5 days (18%) versus the control (P&lt;0.05). The 0.3 mg/kg group had no objective regression responses. Five of the 0.3 mg/kg group animals were end of study survivors with an MTV of 486 mm<sup class="style-scope patent-text">3</sup>.</div>
    <div id="p-0586" num="0729" class="description-paragraph style-scope patent-text">The median TTE for the 1.0 mg/kg group was a maximal 59.0 days corresponding to a significant TGD of 10.6 days (22%) versus the control (P&lt;0.001). The 1.0 mg/kg group had no objective regression responses. Nine of the 1.0 mg/kg group animals were ‘end of study’ survivors with an MTV of 446 mm3. The 0.3 and 1.0 mg/kg groups were significantly different from one another (P&lt;0.05).</div>
    <div id="p-0587" num="0730" class="description-paragraph style-scope patent-text">The results are illustrated in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 4</figref>.</div>
    <heading id="h-0240" class="style-scope patent-text">Example 12—Toxicity Studies/Therapeutic Index</heading>
    <div id="h-0241" num="0000" class="description-paragraph style-scope patent-text">Rat Study:</div>
    <div id="p-0588" num="0731" class="description-paragraph style-scope patent-text">A single dose toxicity study was used to determine the maximum tolerated dose (MTD) and safety profile of Trastuzumab-10 (ConjA). Male Sprague Dawley rats (ENVIGO) were dosed once by slow bolus intravenous injection via the tail vein with vehicle control (25 mM Histidine, 200 mM Sucrose, pH 6.0) or test material (ConjA). Parameters evaluated during the study included mortality, physical examinations, cageside observations, body weights, body weight changes, clinical pathology (clinical chemistry, hematology, and coagulation), and gross pathology findings. All animals in groups 1-6 were terminated on Study Day (SD) 29, except one animal in <figure-callout id="6" label="Group" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Group</a></figure-callout> 6 who was terminated on Study Day (SD) 25.</div>
    <div id="p-0589" num="0732" class="description-paragraph style-scope patent-text">
      <tables id="TABLE-US-00009" num="00009" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%">
            <thead class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Male Rats</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Dose</td>
                <td class="description-td style-scope patent-text">Dose</td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Main Study</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Group </td>
                <td class="description-td style-scope patent-text">Treatment</td>
                <td class="description-td style-scope patent-text">Route</td>
                <td class="description-td style-scope patent-text">(mg/kg) </td>
                <td class="description-td style-scope patent-text">Frequency</td>
                <td class="description-td style-scope patent-text">N</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
            
          </tbody></table>
          <figure-callout id="0" label="Control IV" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">
                </a></figure-callout><figure-callout id="4" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">
                </a></figure-callout><figure-callout id="6" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">
                </a></figure-callout><figure-callout id="8" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">
                </a></figure-callout><figure-callout id="12" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">
                </a></figure-callout><table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">1</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="0" label="Control IV" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Control</a></figure-callout> </td> <td class="description-td style-scope patent-text">IV</td>  <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">0</td>
                <td class="description-td style-scope patent-text">Single</td>
                <td class="description-td style-scope patent-text">5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">2</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="4" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ConjA</a></figure-callout> </td> <td class="description-td style-scope patent-text">IV</td>  <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">4</td>
                <td class="description-td style-scope patent-text">Single</td>
                <td class="description-td style-scope patent-text">5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">3</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="6" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ConjA</a></figure-callout> </td> <td class="description-td style-scope patent-text">IV</td>  <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">6</td>
                <td class="description-td style-scope patent-text">Single</td>
                <td class="description-td style-scope patent-text">5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">4</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="8" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ConjA</a></figure-callout> </td> <td class="description-td style-scope patent-text">IV</td>  <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">8</td>
                <td class="description-td style-scope patent-text">Single</td>
                <td class="description-td style-scope patent-text">5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">5</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="12" label="ConjA IV" filenames="US10799595-20201013-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ConjA</a></figure-callout> </td> <td class="description-td style-scope patent-text">IV</td>  <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">12</td>
                <td class="description-td style-scope patent-text">Single</td>
                <td class="description-td style-scope patent-text">5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">6</td>
                <td class="description-td style-scope patent-text">ConjA</td>
                <td class="description-td style-scope patent-text">IV</td>
                <td class="description-td style-scope patent-text">14</td>
                <td class="description-td style-scope patent-text">Single</td>
                <td class="description-td style-scope patent-text">5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="6" align="left" id="FOO-00001" class="description-td style-scope patent-text" colspan="6">Control = 25 mM Histidine-HCl, 200 mM sucrose, pH 6.0</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    <div id="p-0590" num="0733" class="description-paragraph style-scope patent-text">Tolerability was determined based on toxicity end points, including decreased absolute reticulocytes, white blood cells and cellular components, as well as macroscopic and microscopic lesions in the lungs. The major finding at dose levels of ≥4 mg/kg were histopathological observations of lung lesions. At the 4 mg/kg dose, findings were mild and considered reversible. As the dose increased, the lung lesions were of increasing severity and were not considered reversible. Based on this finding, the maximum tolerated dose (MTD) in the rat after a single dose of ConjA was determined to be 6 mg/kg.</div>
    <div id="h-0242" num="0000" class="description-paragraph style-scope patent-text">Therapeutic Index</div>
    <div id="p-0591" num="0734" class="description-paragraph style-scope patent-text">The Therapeutic Index can be calculated by dividing the maximum tolerated single dose (MTD) of non-targeted ADC in rat, by the minimal effective single dose (MED) of the a targeted ADC. The MED is the single dose necessary to achieve tumour stasis in an in vivo model at 28 days (for NCI-N87 xenograft).</div>
    <div id="p-0592" num="0735" class="description-paragraph style-scope patent-text">Thus for conjugates of <figure-callout id="10" label="compound" filenames="US10799595-20201013-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">compound</a></figure-callout> 10, the therapeutic index is the MTD of 6 mg/kg divided by the MED which is 1.0 mg/kg (see above), giving a Therapeutic Index of 6.</div>
    <div id="p-0593" num="0736" class="description-paragraph style-scope patent-text">All documents and other references mentioned above are herein incorporated by reference.</div>
    
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(26)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM271821880" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <claim-statement class="style-scope patent-text">The invention claimed is:</claim-statement>
    <div class="claim style-scope patent-text"> <div id="CLM-00001" num="00001" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">1. A compound of formula I:</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00092" num="00092" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4b/71/b1/bcbe73ca8e07f0/US10799595-20201013-C00092.png" class="style-scope patent-text"><img id="EMI-C00092" he="120.48mm" wi="76.20mm" file="US10799595-20201013-C00092.TIF" alt="Figure US10799595-20201013-C00092" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="305" height="482" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4b/71/b1/bcbe73ca8e07f0/US10799595-20201013-C00092.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00092" attachment-type="cdx" file="US10799595-20201013-C00092.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00092" attachment-type="mol" file="US10799595-20201013-C00092.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">or a pharmaceutically acceptable salt thereof, wherein:</div>
        <div class="claim-text style-scope patent-text">the square brackets indicate the NO<sub class="style-scope patent-text">2 </sub>group is optional;</div>
        <div class="claim-text style-scope patent-text">D represents either group D1 or D2:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00093" num="00093" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/73/ea/df/12c4294bc221c8/US10799595-20201013-C00093.png" class="style-scope patent-text"><img id="EMI-C00093" he="46.14mm" wi="69.85mm" file="US10799595-20201013-C00093.TIF" alt="Figure US10799595-20201013-C00093" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="185" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/73/ea/df/12c4294bc221c8/US10799595-20201013-C00093.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00093" attachment-type="cdx" file="US10799595-20201013-C00093.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00093" attachment-type="mol" file="US10799595-20201013-C00093.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">the dotted line indicates the optional presence of a double bond between C2 and C3;</div>
        <div class="claim-text style-scope patent-text">when there is a double bond present between C2 and C3, R<sup class="style-scope patent-text">2 </sup>is selected from the group consisting of:
<div class="claim-text style-scope patent-text">(ia) phenyl, naphthyl, azulenyl or C<sub class="style-scope patent-text">5-10 </sub>heteroaryl, optionally substituted by one or more substituents selected from the group consisting of: halo, nitro, cyano, —OR<sup class="style-scope patent-text">B</sup>, carboxy, C(═O)OR<sup class="style-scope patent-text">B</sup>, C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl and bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene, wherein R<sup class="style-scope patent-text">B </sup>is selected from a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group or a phenyl, naphthyl, azulenyl, anthracenyl, phenanthrenyl, napthacenyl, pyrenyl, or C<sub class="style-scope patent-text">5-20 </sub>heteroaryl;</div>
<div class="claim-text style-scope patent-text">(ib) C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl;</div>
<div class="claim-text style-scope patent-text">(ic) C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl;</div>
</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00094" num="00094" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e1/d0/77/0441e49261bf4d/US10799595-20201013-C00094.png" class="style-scope patent-text"><img id="EMI-C00094" he="19.30mm" wi="69.85mm" file="US10799595-20201013-C00094.TIF" alt="Figure US10799595-20201013-C00094" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="77" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e1/d0/77/0441e49261bf4d/US10799595-20201013-C00094.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00094" attachment-type="cdx" file="US10799595-20201013-C00094.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00094" attachment-type="mol" file="US10799595-20201013-C00094.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein each of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">2 </sup>group is no more than 5;</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00095" num="00095" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c4/38/3d/94a58ca8fdc411/US10799595-20201013-C00095.png" class="style-scope patent-text"><img id="EMI-C00095" he="15.07mm" wi="69.85mm" file="US10799595-20201013-C00095.TIF" alt="Figure US10799595-20201013-C00095" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="60" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c4/38/3d/94a58ca8fdc411/US10799595-20201013-C00095.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00095" attachment-type="cdx" file="US10799595-20201013-C00095.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00095" attachment-type="mol" file="US10799595-20201013-C00095.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein one of R<sup class="style-scope patent-text">15a </sup>and R<sup class="style-scope patent-text">15b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00096" num="00096" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/59/03/e5/f2dd4501b53c1d/US10799595-20201013-C00096.png" class="style-scope patent-text"><img id="EMI-C00096" he="17.78mm" wi="69.85mm" file="US10799595-20201013-C00096.TIF" alt="Figure US10799595-20201013-C00096" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="71" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/59/03/e5/f2dd4501b53c1d/US10799595-20201013-C00096.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00096" attachment-type="cdx" file="US10799595-20201013-C00096.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00096" attachment-type="mol" file="US10799595-20201013-C00096.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">where R<sup class="style-scope patent-text">14 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl;
<div class="claim-text style-scope patent-text">when there is a single bond present between C2 and C3,</div>
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">2 </sup>is selected from H, OH, F, diF and</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00097" num="00097" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/26/cb/70/84bf3894407c36/US10799595-20201013-C00097.png" class="style-scope patent-text"><img id="EMI-C00097" he="14.48mm" wi="17.19mm" file="US10799595-20201013-C00097.TIF" alt="Figure US10799595-20201013-C00097" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="69" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/26/cb/70/84bf3894407c36/US10799595-20201013-C00097.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00097" attachment-type="cdx" file="US10799595-20201013-C00097.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00097" attachment-type="mol" file="US10799595-20201013-C00097.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">where R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>are independently selected from H, F, C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C<sub class="style-scope patent-text">1-4 </sub>alkyl amido and C<sub class="style-scope patent-text">1-4 </sub>alkyl ester; or, when one of R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>is H, the other is selected from nitrile and a C<sub class="style-scope patent-text">1-4 </sub>alkyl ester;
<div class="claim-text style-scope patent-text">D′ represents either group D′1 or D′2:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00098" num="00098" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/dc/b6/ce/b14ca0f7ce5d0d/US10799595-20201013-C00098.png" class="style-scope patent-text"><img id="EMI-C00098" he="45.38mm" wi="69.93mm" file="US10799595-20201013-C00098.TIF" alt="Figure US10799595-20201013-C00098" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="182" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/dc/b6/ce/b14ca0f7ce5d0d/US10799595-20201013-C00098.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00098" attachment-type="cdx" file="US10799595-20201013-C00098.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00098" attachment-type="mol" file="US10799595-20201013-C00098.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">wherein the dotted line indicates the optional presence of a double bond between C2′ and C3′;</div>
        <div class="claim-text style-scope patent-text">when there is a double bond present between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>is selected from the group consisting of:</div>
        <div class="claim-text style-scope patent-text">(iia) phenyl, naphthyl, azulenyl or C<sub class="style-scope patent-text">5-10 </sub>heteroaryl, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, —OR<sup class="style-scope patent-text">B</sup>, carboxy, —C(═O)OR<sup class="style-scope patent-text">B</sup>, C<sub class="style-scope patent-text">1-7 </sub>alkyl, C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl and bis-oxy-C<sub class="style-scope patent-text">1-3 </sub>alkylene, wherein R<sup class="style-scope patent-text">B </sup>is selected from a C<sub class="style-scope patent-text">1-7 </sub>alkyl group, a C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl group or a phenyl, naphthyl, azulenyl, anthracenyl, phenanthrenyl, napthacenyl, pyrenyl or C<sub class="style-scope patent-text">5-20 </sub>heteroaryl;</div>
        <div class="claim-text style-scope patent-text">(iib) C<sub class="style-scope patent-text">1-5 </sub>saturated aliphatic alkyl;</div>
        <div class="claim-text style-scope patent-text">(iic) C<sub class="style-scope patent-text">3-6 </sub>saturated cycloalkyl;</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00099" num="00099" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a9/64/2e/f984e1ed30abf0/US10799595-20201013-C00099.png" class="style-scope patent-text"><img id="EMI-C00099" he="19.30mm" wi="69.93mm" file="US10799595-20201013-C00099.TIF" alt="Figure US10799595-20201013-C00099" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="77" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a9/64/2e/f984e1ed30abf0/US10799595-20201013-C00099.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00099" attachment-type="cdx" file="US10799595-20201013-C00099.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00099" attachment-type="mol" file="US10799595-20201013-C00099.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are independently selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12 </sup>group is no more than 5;</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00100" num="00100" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/70/03/8d/ce2c483da8b50e/US10799595-20201013-C00100.png" class="style-scope patent-text"><img id="EMI-C00100" he="14.05mm" wi="69.93mm" file="US10799595-20201013-C00100.TIF" alt="Figure US10799595-20201013-C00100" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="56" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/70/03/8d/ce2c483da8b50e/US10799595-20201013-C00100.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00100" attachment-type="cdx" file="US10799595-20201013-C00100.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00100" attachment-type="mol" file="US10799595-20201013-C00100.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein one of R<sup class="style-scope patent-text">25a </sup>and R<sup class="style-scope patent-text">25b </sup>is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00101" num="00101" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/5d/a0/846590662f0c31/US10799595-20201013-C00101.png" class="style-scope patent-text"><img id="EMI-C00101" he="13.55mm" wi="69.93mm" file="US10799595-20201013-C00101.TIF" alt="Figure US10799595-20201013-C00101" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="54" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/5d/a0/846590662f0c31/US10799595-20201013-C00101.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00101" attachment-type="cdx" file="US10799595-20201013-C00101.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00101" attachment-type="mol" file="US10799595-20201013-C00101.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">where R<sup class="style-scope patent-text">24 </sup>is selected from: H; C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl; C<sub class="style-scope patent-text">2-3 </sub>alkenyl; C<sub class="style-scope patent-text">2-3 </sub>alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl;
<div class="claim-text style-scope patent-text">when there is a single bond present between C2′ and C3′,</div>
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">12 </sup>is selected from H, OH, F, diF and</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00102" num="00102" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/20/41/26fcbaf68588e0/US10799595-20201013-C00102.png" class="style-scope patent-text"><img id="EMI-C00102" he="10.75mm" wi="14.65mm" file="US10799595-20201013-C00102.TIF" alt="Figure US10799595-20201013-C00102" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="59" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/20/41/26fcbaf68588e0/US10799595-20201013-C00102.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00102" attachment-type="cdx" file="US10799595-20201013-C00102.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00102" attachment-type="mol" file="US10799595-20201013-C00102.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">where R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are independently selected from H, F, C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C<sub class="style-scope patent-text">1-4 </sub>alkyl amido and C<sub class="style-scope patent-text">1-4 </sub>alkyl ester; or, when one of R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>is H, the other is selected from nitrile and a C<sub class="style-scope patent-text">1-4 </sub>alkyl ester;
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">6 </sup>and R<sup class="style-scope patent-text">9 </sup>are independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR′, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
<div class="claim-text style-scope patent-text">where R and R′ are independently selected from C<sub class="style-scope patent-text">1-12 </sub>alkyl, C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl and phenyl, naphthyl, azulenyl, anthracenyl, phenanthrenyl, napthacenyl, pyrenyl or C<sub class="style-scope patent-text">5-20 </sub>heteroaryl;</div>
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">7 </sup>is selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR′, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
<div class="claim-text style-scope patent-text">R″ is a C<sub class="style-scope patent-text">3-12 </sub>alkylene group, which chain may be interrupted by one or more heteroatoms selected from O, S, NR<sup class="style-scope patent-text">N2 </sup>(where R<sup class="style-scope patent-text">N2 </sup>is H or C<sub class="style-scope patent-text">1-4 </sub>alkyl), and/or aromatic rings selected from benzene or pyridine;</div>
<div class="claim-text style-scope patent-text">Y and Y′ are selected from O, S, or NH;</div>
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup> are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7 </sup>and R<sup class="style-scope patent-text">9 </sup>respectively;</div>
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">11b </sup>is selected from OH, OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A </sup>is C<sub class="style-scope patent-text">1-4 </sub>alkyl; and</div>
<div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">L </sup>is a linker for connection to a cell binding agent, which is:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00103" num="00103" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/29/28/c2/fc9d2484ab141d/US10799595-20201013-C00103.png" class="style-scope patent-text"><img id="EMI-C00103" he="26.92mm" wi="69.93mm" file="US10799595-20201013-C00103.TIF" alt="Figure US10799595-20201013-C00103" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="108" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/29/28/c2/fc9d2484ab141d/US10799595-20201013-C00103.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00103" attachment-type="cdx" file="US10799595-20201013-C00103.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00103" attachment-type="mol" file="US10799595-20201013-C00103.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">wherein</div>
        <div class="claim-text style-scope patent-text">Q is:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00104" num="00104" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/7f/e7/cd9257cb550657/US10799595-20201013-C00104.png" class="style-scope patent-text"><img id="EMI-C00104" he="14.82mm" wi="33.70mm" file="US10799595-20201013-C00104.TIF" alt="Figure US10799595-20201013-C00104" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="135" height="59" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/7f/e7/cd9257cb550657/US10799595-20201013-C00104.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00104" attachment-type="cdx" file="US10799595-20201013-C00104.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00104" attachment-type="mol" file="US10799595-20201013-C00104.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">where Q<sup class="style-scope patent-text">X </sup>is such that Q is an amino-acid residue, a dipeptide residue or a tripeptide residue;
<div class="claim-text style-scope patent-text">X is:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00105" num="00105" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c8/f8/58/9bf5fe176b087e/US10799595-20201013-C00105.png" class="style-scope patent-text"><img id="EMI-C00105" he="16.34mm" wi="64.69mm" file="US10799595-20201013-C00105.TIF" alt="Figure US10799595-20201013-C00105" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="259" height="65" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c8/f8/58/9bf5fe176b087e/US10799595-20201013-C00105.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00105" attachment-type="cdx" file="US10799595-20201013-C00105.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00105" attachment-type="mol" file="US10799595-20201013-C00105.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">where a=0 to 5, b=0 to 16, c=0 or 1, =0 to 5;</div>
        <div class="claim-text style-scope patent-text">G<sup class="style-scope patent-text">L </sup>is selected from:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00106" num="00106" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9a/0d/d7/19e9f9ede3b802/US10799595-20201013-C00106.png" class="style-scope patent-text"><img id="EMI-C00106" he="229.28mm" wi="69.93mm" file="US10799595-20201013-C00106.TIF" alt="Figure US10799595-20201013-C00106" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="917" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9a/0d/d7/19e9f9ede3b802/US10799595-20201013-C00106.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00106" attachment-type="cdx" file="US10799595-20201013-C00106.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00106" attachment-type="mol" file="US10799595-20201013-C00106.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <chemistry id="CHEM-US-00107" num="00107" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bf/d0/cd/4cf17da97ef1f2/US10799595-20201013-C00107.png" class="style-scope patent-text"><img id="EMI-C00107" he="234.78mm" wi="69.93mm" file="US10799595-20201013-C00107.TIF" alt="Figure US10799595-20201013-C00107" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="939" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bf/d0/cd/4cf17da97ef1f2/US10799595-20201013-C00107.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00107" attachment-type="cdx" file="US10799595-20201013-C00107.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00107" attachment-type="mol" file="US10799595-20201013-C00107.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">where Ar is phenylene;</div>
        <div class="claim-text style-scope patent-text">wherein the heterocyclyl group in C<sub class="style-scope patent-text">3-7 </sub>heterocyclyl contains 1 to 4 ring heteroatoms selected from N, O and S;</div>
        <div class="claim-text style-scope patent-text">wherein the heterocyclyl group in C<sub class="style-scope patent-text">3-20 </sub>heterocyclyl contains 1 to 10 ring heteroatoms selected from N, O and S; and</div>
        <div class="claim-text style-scope patent-text">wherein the heteroaryl group in C<sub class="style-scope patent-text">5-10 </sub>heteroaryl contains 1 to 4 ring heteroatoms selected from N, O and S</div>
        <div class="claim-text style-scope patent-text">wherein the heteroaryl group in C<sub class="style-scope patent-text">5-20 </sub>heteroaryl contains 1 to 10 ring heteroatoms selected from N, O and S.</div>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00002" num="00002" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">2. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein:
<div class="claim-text style-scope patent-text">a) both Y and Y′ are O; and/or</div>
<div class="claim-text style-scope patent-text">b) R″ is C<sub class="style-scope patent-text">3-7 </sub>alkylene or a group of formula:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00108" num="00108" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/74/f7/61/935fc9c8952d6d/US10799595-20201013-C00108.png" class="style-scope patent-text"><img id="EMI-C00108" he="13.72mm" wi="35.39mm" file="US10799595-20201013-C00108.TIF" alt="Figure US10799595-20201013-C00108" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="142" height="55" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/74/f7/61/935fc9c8952d6d/US10799595-20201013-C00108.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00108" attachment-type="cdx" file="US10799595-20201013-C00108.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00108" attachment-type="mol" file="US10799595-20201013-C00108.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">where r is 1 or 2; and/or</div>
        <div class="claim-text style-scope patent-text">c) R<sup class="style-scope patent-text">9 </sup>is H; and/or</div>
        <div class="claim-text style-scope patent-text">d) R<sup class="style-scope patent-text">6 </sup>is H; and/or</div>
        <div class="claim-text style-scope patent-text">e) R<sup class="style-scope patent-text">7 </sup>is selected from H, OH and OR or a C<sub class="style-scope patent-text">1-4 </sub>alkyloxy group.</div>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00003" num="00003" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">3. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein:
<div class="claim-text style-scope patent-text">a) D is D1, there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">5-7 </sub>aryl group, wherein R<sup class="style-scope patent-text">2 </sup>optionally bears one to three substituent groups selected from methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl; or</div>
<div class="claim-text style-scope patent-text">b) D is D1, there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is a C<sub class="style-scope patent-text">8-10 </sub>aryl group, wherein R<sup class="style-scope patent-text">2 </sup>optionally bears one to three substituent groups selected from methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl; or</div>
<div class="claim-text style-scope patent-text">c) D is D1, there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is methyl, ethyl or propyl; or</div>
<div class="claim-text style-scope patent-text">d) there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is cyclopropyl; or</div>
<div class="claim-text style-scope patent-text">e) wherein D is D1, there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is a group of formula:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00109" num="00109" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7a/98/1d/5378f20923e500/US10799595-20201013-C00109.png" class="style-scope patent-text"><img id="EMI-C00109" he="16.43mm" wi="21.17mm" file="US10799595-20201013-C00109.TIF" alt="Figure US10799595-20201013-C00109" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="85" height="66" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7a/98/1d/5378f20923e500/US10799595-20201013-C00109.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00109" attachment-type="cdx" file="US10799595-20201013-C00109.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00109" attachment-type="mol" file="US10799595-20201013-C00109.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">wherein:
<div class="claim-text style-scope patent-text">i) the total number of carbon atoms in the R<sup class="style-scope patent-text">2 </sup>group is no more than 4; and/or</div>
<div class="claim-text style-scope patent-text">ii) one of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>is H, with the other two groups being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl; or</div>
<div class="claim-text style-scope patent-text">iii) two of R<sup class="style-scope patent-text">11</sup>, R<sup class="style-scope patent-text">12 </sup>and R<sup class="style-scope patent-text">13 </sup>are H, with the other group being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl; or</div>
</div>
        <div class="claim-text style-scope patent-text">f) D is D1, there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is the group:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00110" num="00110" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/20/94/6f/1f2e8d68d418d9/US10799595-20201013-C00110.png" class="style-scope patent-text"><img id="EMI-C00110" he="12.28mm" wi="26.42mm" file="US10799595-20201013-C00110.TIF" alt="Figure US10799595-20201013-C00110" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="106" height="49" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/20/94/6f/1f2e8d68d418d9/US10799595-20201013-C00110.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00110" attachment-type="cdx" file="US10799595-20201013-C00110.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00110" attachment-type="mol" file="US10799595-20201013-C00110.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">or
<div class="claim-text style-scope patent-text">g) D is D1, there is a double bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is a group of formula:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00111" num="00111" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4d/a7/75/7d857593ff221c/US10799595-20201013-C00111.png" class="style-scope patent-text"><img id="EMI-C00111" he="14.90mm" wi="21.17mm" file="US10799595-20201013-C00111.TIF" alt="Figure US10799595-20201013-C00111" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="85" height="60" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4d/a7/75/7d857593ff221c/US10799595-20201013-C00111.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00111" attachment-type="cdx" file="US10799595-20201013-C00111.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00111" attachment-type="mol" file="US10799595-20201013-C00111.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">wherein R<sup class="style-scope patent-text">14 </sup>is selected from H, methyl, ethyl, ethenyl and ethynyl.</div>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00004" num="00004" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">4. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein
<div class="claim-text style-scope patent-text">a) D is D1, there is a single bond between C2 and C3, and R<sup class="style-scope patent-text">2 </sup>is H; or</div>
<div class="claim-text style-scope patent-text">b) D is D1, there is a single bond between C2 and C3, R<sup class="style-scope patent-text">2 </sup>is</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00112" num="00112" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a9/d0/8f/b099c809ede9e8/US10799595-20201013-C00112.png" class="style-scope patent-text"><img id="EMI-C00112" he="14.48mm" wi="16.51mm" file="US10799595-20201013-C00112.TIF" alt="Figure US10799595-20201013-C00112" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="66" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a9/d0/8f/b099c809ede9e8/US10799595-20201013-C00112.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00112" attachment-type="cdx" file="US10799595-20201013-C00112.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00112" attachment-type="mol" file="US10799595-20201013-C00112.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">and R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>are both H; or
<div class="claim-text style-scope patent-text">c) D is D1, there is a single bond between C2 and C3, R<sup class="style-scope patent-text">2 </sup>is</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00113" num="00113" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/87/56/67/2919b50ffa5029/US10799595-20201013-C00113.png" class="style-scope patent-text"><img id="EMI-C00113" he="14.39mm" wi="17.19mm" file="US10799595-20201013-C00113.TIF" alt="Figure US10799595-20201013-C00113" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="69" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/87/56/67/2919b50ffa5029/US10799595-20201013-C00113.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00113" attachment-type="cdx" file="US10799595-20201013-C00113.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00113" attachment-type="mol" file="US10799595-20201013-C00113.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">and R<sup class="style-scope patent-text">16a </sup>and D<sup class="style-scope patent-text">16b </sup>are both methyl; or
<div class="claim-text style-scope patent-text">d) D is D1, there is a single bond between C2 and C3, R<sup class="style-scope patent-text">2 </sup>is</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00114" num="00114" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/86/f3/ba/e7898ec264c0b4/US10799595-20201013-C00114.png" class="style-scope patent-text"><img id="EMI-C00114" he="14.48mm" wi="17.19mm" file="US10799595-20201013-C00114.TIF" alt="Figure US10799595-20201013-C00114" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="69" height="58" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/86/f3/ba/e7898ec264c0b4/US10799595-20201013-C00114.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00114" attachment-type="cdx" file="US10799595-20201013-C00114.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00114" attachment-type="mol" file="US10799595-20201013-C00114.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">one of R<sup class="style-scope patent-text">16a </sup>and R<sup class="style-scope patent-text">16b </sup>is H, and the other is selected from C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00005" num="00005" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">5. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein:
<div class="claim-text style-scope patent-text">a) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">5-7 </sub>aryl group, wherein R<sup class="style-scope patent-text">12 </sup>optionally bears one to three substituent groups selected from methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl; or</div>
<div class="claim-text style-scope patent-text">b) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is a C<sub class="style-scope patent-text">8-10 </sub>aryl group, wherein R<sup class="style-scope patent-text">12 </sup>optionally bears one to three substituent groups selected from methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl; or</div>
<div class="claim-text style-scope patent-text">c) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is methyl, ethyl or propyl; or</div>
<div class="claim-text style-scope patent-text">d) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is cyclopropyl; or</div>
<div class="claim-text style-scope patent-text">e) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is a group of formula:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00115" num="00115" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/92/e4/6604b296b397b4/US10799595-20201013-C00115.png" class="style-scope patent-text"><img id="EMI-C00115" he="16.34mm" wi="18.03mm" file="US10799595-20201013-C00115.TIF" alt="Figure US10799595-20201013-C00115" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="72" height="65" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/92/e4/6604b296b397b4/US10799595-20201013-C00115.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00115" attachment-type="cdx" file="US10799595-20201013-C00115.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00115" attachment-type="mol" file="US10799595-20201013-C00115.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">wherein:
<div class="claim-text style-scope patent-text">i) the total number of carbon atoms in the R<sup class="style-scope patent-text">12 </sup>group is no more than 3;</div>
<div class="claim-text style-scope patent-text">ii) one of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>is H, with the other two groups being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl; or</div>
<div class="claim-text style-scope patent-text">iii) two of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23 </sup>are H, with the other group being selected from H, C<sub class="style-scope patent-text">1-3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl, C<sub class="style-scope patent-text">2-3 </sub>alkynyl and cyclopropyl; or</div>
</div>
        <div class="claim-text style-scope patent-text">f) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is the group:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00116" num="00116" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/16/9e/bb/a3b76090cebcec/US10799595-20201013-C00116.png" class="style-scope patent-text"><img id="EMI-C00116" he="12.28mm" wi="26.42mm" file="US10799595-20201013-C00116.TIF" alt="Figure US10799595-20201013-C00116" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="106" height="49" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/16/9e/bb/a3b76090cebcec/US10799595-20201013-C00116.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00116" attachment-type="cdx" file="US10799595-20201013-C00116.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00116" attachment-type="mol" file="US10799595-20201013-C00116.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">or
<div class="claim-text style-scope patent-text">g) D′ is D′1, there is a double bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is a group of formula:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00117" num="00117" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7d/42/89/d744d4a91c045e/US10799595-20201013-C00117.png" class="style-scope patent-text"><img id="EMI-C00117" he="10.16mm" wi="18.03mm" file="US10799595-20201013-C00117.TIF" alt="Figure US10799595-20201013-C00117" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="72" height="41" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7d/42/89/d744d4a91c045e/US10799595-20201013-C00117.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00117" attachment-type="cdx" file="US10799595-20201013-C00117.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00117" attachment-type="mol" file="US10799595-20201013-C00117.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein R<sup class="style-scope patent-text">24 </sup>is selected from H, methyl, ethyl, ethenyl and ethynyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00006" num="00006" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">6. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein
<div class="claim-text style-scope patent-text">a) D′ is D′1, there is a single bond between C2′ and C3′, and R<sup class="style-scope patent-text">12 </sup>is H; or</div>
<div class="claim-text style-scope patent-text">b) D′ is D′1, there is a single bond between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>is</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00118" num="00118" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/16/93/58/185e2d049de812/US10799595-20201013-C00118.png" class="style-scope patent-text"><img id="EMI-C00118" he="10.75mm" wi="14.05mm" file="US10799595-20201013-C00118.TIF" alt="Figure US10799595-20201013-C00118" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="56" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/16/93/58/185e2d049de812/US10799595-20201013-C00118.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00118" attachment-type="cdx" file="US10799595-20201013-C00118.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00118" attachment-type="mol" file="US10799595-20201013-C00118.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">and R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are both H; or
<div class="claim-text style-scope patent-text">c) D′ is D′1, there is a single bond between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>is</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00119" num="00119" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/24/10/87be0e5956a14b/US10799595-20201013-C00119.png" class="style-scope patent-text"><img id="EMI-C00119" he="10.75mm" wi="14.65mm" file="US10799595-20201013-C00119.TIF" alt="Figure US10799595-20201013-C00119" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="59" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/24/10/87be0e5956a14b/US10799595-20201013-C00119.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00119" attachment-type="cdx" file="US10799595-20201013-C00119.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00119" attachment-type="mol" file="US10799595-20201013-C00119.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">and R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>are both methyl; or
<div class="claim-text style-scope patent-text">d) D′ is D′1, there is a single bond between C2′ and C3′, R<sup class="style-scope patent-text">12 </sup>is</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00120" num="00120" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a6/b2/af/f37a7d58b4b0ea/US10799595-20201013-C00120.png" class="style-scope patent-text"><img id="EMI-C00120" he="10.75mm" wi="14.65mm" file="US10799595-20201013-C00120.TIF" alt="Figure US10799595-20201013-C00120" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="59" height="43" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a6/b2/af/f37a7d58b4b0ea/US10799595-20201013-C00120.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00120" attachment-type="cdx" file="US10799595-20201013-C00120.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00120" attachment-type="mol" file="US10799595-20201013-C00120.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">one of R<sup class="style-scope patent-text">26a </sup>and R<sup class="style-scope patent-text">26b </sup>is H, and the other is selected from C<sub class="style-scope patent-text">1-4 </sub>saturated alkyl, C<sub class="style-scope patent-text">2-3 </sub>alkenyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00007" num="00007" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">7. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein:
<div class="claim-text style-scope patent-text">a) R<sup class="style-scope patent-text">6′ </sup>is selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7′</sup> is selected from the same groups as R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9′</sup> is selected from the same groups as R<sup class="style-scope patent-text">9 </sup>and Y′ is selected from the same groups as Y; and/or</div>
<div class="claim-text style-scope patent-text">b) R<sup class="style-scope patent-text">6′</sup> is the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7′</sup> is the same groups as R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9′ </sup>is the same groups as R<sup class="style-scope patent-text">9 </sup>and Y′ is the same groups as Y; and/or</div>
<div class="claim-text style-scope patent-text">c) R<sup class="style-scope patent-text">12 </sup>is the same group as R<sup class="style-scope patent-text">2</sup>.</div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00008" num="00008" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">8. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, which is of formula Ia-1, Ia-2 or Ia-3:</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00121" num="00121" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f7/0f/59/0d46e8dae91987/US10799595-20201013-C00121.png" class="style-scope patent-text"><img id="EMI-C00121" he="192.96mm" wi="144.19mm" file="US10799595-20201013-C00121.TIF" alt="Figure US10799595-20201013-C00121" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="577" height="772" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f7/0f/59/0d46e8dae91987/US10799595-20201013-C00121.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00121" attachment-type="cdx" file="US10799595-20201013-C00121.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00121" attachment-type="mol" file="US10799595-20201013-C00121.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">where R<sup class="style-scope patent-text">2a </sup>and R<sup class="style-scope patent-text">12a </sup>are the same and are selected from:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00122" num="00122" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/a2/a0/1841400327201a/US10799595-20201013-C00122.png" class="style-scope patent-text"><img id="EMI-C00122" he="131.40mm" wi="69.93mm" file="US10799595-20201013-C00122.TIF" alt="Figure US10799595-20201013-C00122" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="526" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/a2/a0/1841400327201a/US10799595-20201013-C00122.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00122" attachment-type="cdx" file="US10799595-20201013-C00122.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00122" attachment-type="mol" file="US10799595-20201013-C00122.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">1a </sup>is selected from methyl and benzyl;</div>
        <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">L </sup>and R<sup class="style-scope patent-text">11b </sup>are as defined in <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>.</div>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00009" num="00009" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">9. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein both R<sup class="style-scope patent-text">2 </sup>and R<sup class="style-scope patent-text">12 </sup>comprise no more than 3 carbon atoms.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00010" num="00010" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">10. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein R<sup class="style-scope patent-text">llb </sup>is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A </sup>is C<sub class="style-scope patent-text">1-4 </sub>alkyl, optionally wherein R<sup class="style-scope patent-text">A </sup>is methyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00011" num="00011" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">11. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein Q<sup class="style-scope patent-text">X </sup>is:
<div class="claim-text style-scope patent-text">a) an amino acid residue selected from Phe, Lys, Val, Ala, Cit, Leu, Ile, Arg, and Trp; or</div>
<div class="claim-text style-scope patent-text">b) a dipeptide residue selected from:
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Lys-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Ala-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Val-Lys-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Ala-Lys-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>_Val-Cit-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Cit-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Leu-Cit-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Ile-Cit-<sup class="style-scope patent-text">NH</sup>,</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Phe-Arg-<sup class="style-scope patent-text">NH</sup>, and</div>
<div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">CO</sup>-Trp-Cit-<sup class="style-scope patent-text">NH</sup>; or</div>
</div>
<div class="claim-text style-scope patent-text">c) a tripeptide residue.</div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00012" num="00012" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">12. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein
<div class="claim-text style-scope patent-text">a) a is 0 to 3; and/or</div>
<div class="claim-text style-scope patent-text">b) b is 0 to 12; and/or</div>
<div class="claim-text style-scope patent-text">c) d is 0 to 3.</div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00013" num="00013" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">13. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein a is 0, c is 1 and d is 2, and b is from 0 to 8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00014" num="00014" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">14. A compound according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein the compound is of formula
<div class="claim-text style-scope patent-text">Id:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00123" num="00123" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/15/2d/cb/6b2df8379f89d7/US10799595-20201013-C00123.png" class="style-scope patent-text"><img id="EMI-C00123" he="71.80mm" wi="148.67mm" file="US10799595-20201013-C00123.TIF" alt="Figure US10799595-20201013-C00123" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="595" height="287" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/15/2d/cb/6b2df8379f89d7/US10799595-20201013-C00123.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00123" attachment-type="cdx" file="US10799595-20201013-C00123.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00123" attachment-type="mol" file="US10799595-20201013-C00123.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00015" num="00015" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">15. A conjugate of formula I:
<div class="claim-text style-scope patent-text"> <br class="style-scope patent-text">L-(D<sup class="style-scope patent-text">L</sup>)<sub class="style-scope patent-text">p</sub>  (I)
</div>
<div class="claim-text style-scope patent-text">wherein L is a Ligand unit, D<sup class="style-scope patent-text">L </sup>is a Drug Linker unit of formula I′:</div>
</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00124" num="00124" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e1/6c/8e/1b07e6f5482c8f/US10799595-20201013-C00124.png" class="style-scope patent-text"><img id="EMI-C00124" he="55.96mm" wi="128.78mm" file="US10799595-20201013-C00124.TIF" alt="Figure US10799595-20201013-C00124" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="515" height="224" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e1/6c/8e/1b07e6f5482c8f/US10799595-20201013-C00124.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00124" attachment-type="cdx" file="US10799595-20201013-C00124.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00124" attachment-type="mol" file="US10799595-20201013-C00124.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">wherein D, R<sup class="style-scope patent-text">2</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">11b</sup>, Y, R″, Y′, D′, R<sup class="style-scope patent-text">6′</sup>, R<sup class="style-scope patent-text">7′</sup>, R<sup class="style-scope patent-text">9′</sup>, and R<sup class="style-scope patent-text">12</sup>, including the presence or absence of double bonds between C2 and C3 and C2′ and C3′ respectively, are as defined in <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>;</div>
        <div class="claim-text style-scope patent-text">wherein p is an integer from 1 to 20;</div>
        <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">LL </sup>is a linker for connection to a cell binding agent, which is:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00125" num="00125" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/57/e4/11/386d4b5c67e47b/US10799595-20201013-C00125.png" class="style-scope patent-text"><img id="EMI-C00125" he="26.92mm" wi="69.93mm" file="US10799595-20201013-C00125.TIF" alt="Figure US10799595-20201013-C00125" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="108" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/57/e4/11/386d4b5c67e47b/US10799595-20201013-C00125.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00125" attachment-type="cdx" file="US10799595-20201013-C00125.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00125" attachment-type="mol" file="US10799595-20201013-C00125.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">where Q and X are as defined in <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref> and G<sup class="style-scope patent-text">LL </sup>is selected from:</div>
      </div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00126" num="00126" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f8/93/08/2c2ee46f323fbe/US10799595-20201013-C00126.png" class="style-scope patent-text"><img id="EMI-C00126" he="188.64mm" wi="69.93mm" file="US10799595-20201013-C00126.TIF" alt="Figure US10799595-20201013-C00126" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="755" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f8/93/08/2c2ee46f323fbe/US10799595-20201013-C00126.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00126" attachment-type="cdx" file="US10799595-20201013-C00126.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00126" attachment-type="mol" file="US10799595-20201013-C00126.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <chemistry id="CHEM-US-00127" num="00127" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c4/c6/9b/fd0b764fd938aa/US10799595-20201013-C00127.png" class="style-scope patent-text"><img id="EMI-C00127" he="187.45mm" wi="69.93mm" file="US10799595-20201013-C00127.TIF" alt="Figure US10799595-20201013-C00127" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="280" height="750" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c4/c6/9b/fd0b764fd938aa/US10799595-20201013-C00127.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00127" attachment-type="cdx" file="US10799595-20201013-C00127.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00127" attachment-type="mol" file="US10799595-20201013-C00127.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
        <div class="claim-text style-scope patent-text">where Ar is phenylene.</div>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00016" num="00016" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">16. A conjugate according to <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref>, wherein
<div class="claim-text style-scope patent-text">G<sup class="style-scope patent-text">LL </sup>is selected from G<sup class="style-scope patent-text">LL1-1 </sup>and G<sup class="style-scope patent-text">LL1-2</sup>.</div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00017" num="00017" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">17. A conjugate according to <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref>, wherein D<sup class="style-scope patent-text">L </sup>is of formula (Id′):</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00128" num="00128" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/22/83/2e/756a0ce47ab7f9/US10799595-20201013-C00128.png" class="style-scope patent-text"><img id="EMI-C00128" he="71.97mm" wi="144.27mm" file="US10799595-20201013-C00128.TIF" alt="Figure US10799595-20201013-C00128" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="577" height="288" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/22/83/2e/756a0ce47ab7f9/US10799595-20201013-C00128.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00128" attachment-type="cdx" file="US10799595-20201013-C00128.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00128" attachment-type="mol" file="US10799595-20201013-C00128.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00018" num="00018" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">18. A conjugate according to <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref>, wherein the Ligand Unit is an antibody or an active fragment thereof.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00019" num="00019" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">19. The conjugate according to <claim-ref idref="CLM-00018" class="style-scope patent-text">claim 18</claim-ref>, wherein the antibody or antibody fragment is an antibody or antibody fragment for a tumour-associated antigen, optionally wherein the antibody or antibody fragment is an antibody which binds to one or more tumor-associated antigens or cell-surface receptors selected from (1)-(88):
<div class="claim-text style-scope patent-text">(1) BMPR1B;</div>
<div class="claim-text style-scope patent-text">(2) E16;</div>
<div class="claim-text style-scope patent-text">(3) STEAP1;</div>
<div class="claim-text style-scope patent-text">(4) 0772P;</div>
<div class="claim-text style-scope patent-text">(5) MPF;</div>
<div class="claim-text style-scope patent-text">(6) Napi3b;</div>
<div class="claim-text style-scope patent-text">(7) Sema 5b;</div>
<div class="claim-text style-scope patent-text">(8) PSCA hlg;</div>
<div class="claim-text style-scope patent-text">(9) ETBR;</div>
<div class="claim-text style-scope patent-text">(10) MSG783;</div>
<div class="claim-text style-scope patent-text">(11) STEAP2;</div>
<div class="claim-text style-scope patent-text">(12) TrpM4;</div>
<div class="claim-text style-scope patent-text">(13) CRIPTO;</div>
<div class="claim-text style-scope patent-text">(14) CD21;</div>
<div class="claim-text style-scope patent-text">(15) CD79b;</div>
<div class="claim-text style-scope patent-text">(16) FcRH2;</div>
<div class="claim-text style-scope patent-text">(17) HER2;</div>
<div class="claim-text style-scope patent-text">(18) NCA;</div>
<div class="claim-text style-scope patent-text">(19) MDP;</div>
<div class="claim-text style-scope patent-text">(20) IL20R-alpha;</div>
<div class="claim-text style-scope patent-text">(21) Brevican;</div>
<div class="claim-text style-scope patent-text">(22) EphB2R;</div>
<div class="claim-text style-scope patent-text">(23) ASLG659;</div>
<div class="claim-text style-scope patent-text">(24) PSCA;</div>
<div class="claim-text style-scope patent-text">(25) GEDA;</div>
<div class="claim-text style-scope patent-text">(26) BAFF-R;</div>
<div class="claim-text style-scope patent-text">(27) CD22;</div>
<div class="claim-text style-scope patent-text">(28) CD79a;</div>
<div class="claim-text style-scope patent-text">(29) CXCR5;</div>
<div class="claim-text style-scope patent-text">(30) HLA-DOB;</div>
<div class="claim-text style-scope patent-text">(31) P2X5;</div>
<div class="claim-text style-scope patent-text">(32) CD72;</div>
<div class="claim-text style-scope patent-text">(33) LY64;</div>
<div class="claim-text style-scope patent-text">(34) FcRH1;</div>
<div class="claim-text style-scope patent-text">(35) IRTA2;</div>
<div class="claim-text style-scope patent-text">(36) TENB2;</div>
<div class="claim-text style-scope patent-text">(37) PSMA—FOLH1;</div>
<div class="claim-text style-scope patent-text">(38) SST;</div>
<div class="claim-text style-scope patent-text">(38.1) SSTR2;</div>
<div class="claim-text style-scope patent-text">(38.2) SSTR5;</div>
<div class="claim-text style-scope patent-text">(38.3) SSTR1;</div>
<div class="claim-text style-scope patent-text">(38.4) SSTR3;</div>
<div class="claim-text style-scope patent-text">(38.5) SSTR4;</div>
<div class="claim-text style-scope patent-text">(39) ITGAV;</div>
<div class="claim-text style-scope patent-text">(40) ITGB6;</div>
<div class="claim-text style-scope patent-text">(41) CEACAM5;</div>
<div class="claim-text style-scope patent-text">(42) MET;</div>
<div class="claim-text style-scope patent-text">(43) MUC1;</div>
<div class="claim-text style-scope patent-text">(44) CA9;</div>
<div class="claim-text style-scope patent-text">(45) EGFRvIII;</div>
<div class="claim-text style-scope patent-text">(46) CD33;</div>
<div class="claim-text style-scope patent-text">(47) CD19;</div>
<div class="claim-text style-scope patent-text">(48) IL2RA;</div>
<div class="claim-text style-scope patent-text">(49) AXL;</div>
<div class="claim-text style-scope patent-text">(50) CD30—TNFRSF8;</div>
<div class="claim-text style-scope patent-text">(51) BCMA-TNFRSF17;</div>
<div class="claim-text style-scope patent-text">(52) CT Ags—CTA;</div>
<div class="claim-text style-scope patent-text">(53) CD174 (Lewis Y)—FUT3;</div>
<div class="claim-text style-scope patent-text">(54) CLEC14A;</div>
<div class="claim-text style-scope patent-text">(55) GRP78—HSPA5;</div>
<div class="claim-text style-scope patent-text">(56) CD70;</div>
<div class="claim-text style-scope patent-text">(57) Stem Cell specific antigens;</div>
<div class="claim-text style-scope patent-text">(58) ASG-5;</div>
<div class="claim-text style-scope patent-text">(59) ENPP3;</div>
<div class="claim-text style-scope patent-text">(60) PRR4;</div>
<div class="claim-text style-scope patent-text">(61) GCC-GUCY2C;</div>
<div class="claim-text style-scope patent-text">(62) Liv-1—SLC39A6;</div>
<div class="claim-text style-scope patent-text">(63) 5T4;</div>
<div class="claim-text style-scope patent-text">(64) CD56—NCMA1;</div>
<div class="claim-text style-scope patent-text">(65) CanAg;</div>
<div class="claim-text style-scope patent-text">(66) FOLR1;</div>
<div class="claim-text style-scope patent-text">(67) GPNMB;</div>
<div class="claim-text style-scope patent-text">(68) TIM-1—HAVCR1;</div>
<div class="claim-text style-scope patent-text">(69) RG-1/Prostate tumor target Mindin—Mindin/RG-1;</div>
<div class="claim-text style-scope patent-text">(70) B7-H4—VTCN1;</div>
<div class="claim-text style-scope patent-text">(71) PTK7;</div>
<div class="claim-text style-scope patent-text">(72) CD37;</div>
<div class="claim-text style-scope patent-text">(73) CD138—SDC1;</div>
<div class="claim-text style-scope patent-text">(74) CD74;</div>
<div class="claim-text style-scope patent-text">(75) Claudins—CLs;</div>
<div class="claim-text style-scope patent-text">(76) EGFR;</div>
<div class="claim-text style-scope patent-text">(77) Her3;</div>
<div class="claim-text style-scope patent-text">(78) RON—MST1R;</div>
<div class="claim-text style-scope patent-text">(79) EPHA2;</div>
<div class="claim-text style-scope patent-text">(80) CD20—MS4A1;</div>
<div class="claim-text style-scope patent-text">(81) Tenascin C—TNC;</div>
<div class="claim-text style-scope patent-text">(82) FAP;</div>
<div class="claim-text style-scope patent-text">(83) DKK-1;</div>
<div class="claim-text style-scope patent-text">(84) CD52;</div>
<div class="claim-text style-scope patent-text">(85) CS1—SLAMF7;</div>
<div class="claim-text style-scope patent-text">(86) Endoglin—ENG;</div>
<div class="claim-text style-scope patent-text">(87) Annexin Al—ANXA1;</div>
<div class="claim-text style-scope patent-text">(88) V-CAM (CD106)—VCAM1.</div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00020" num="00020" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">20. The conjugate of <claim-ref idref="CLM-00018" class="style-scope patent-text">claim 18</claim-ref> wherein the antibody or antibody fragment is a cysteine-engineered antibody.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00021" num="00021" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">21. The conjugate according to <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref> wherein p is an integer from 1 to 8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00022" num="00022" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">22. A composition comprising a mixture of conjugates according to <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref>, wherein the average p in the mixture of conjugate compounds is about 1 to about 8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00023" num="00023" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">23. A pharmaceutical composition comprising the conjugate of <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref> a pharmaceutically acceptable diluent, carrier or excipient.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00024" num="00024" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">24. A method of inhibiting growth of carcinoma cells which comprises contacting cancer cells with the pharmaceutical composition of <claim-ref idref="CLM-00023" class="style-scope patent-text">claim 23</claim-ref>, wherein the carcinoma cells are gastric carcinoma cells or breast carcinoma cells, and whereby growth of the cancer cells is inhibited.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00025" num="00025" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">25. The method of <claim-ref idref="CLM-00024" class="style-scope patent-text">claim 24</claim-ref>, wherein the carcinoma cells are in a human.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00026" num="00026" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">26. The method of <claim-ref idref="CLM-00024" class="style-scope patent-text">claim 24</claim-ref>, which further comprises contacting the carcinoma cells with a chemotherapeutic agent.</div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (406)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3361742A/en"><a id="link" href="#" class="style-scope state-modifier">US3361742A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1964-12-07</span>
                    <span class="td style-scope patent-result">1968-01-02</span>
                    <span class="td style-scope patent-result">Hoffmann La Roche</span>
                    <span class="td style-scope patent-result">5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3523941A/en"><a id="link" href="#" class="style-scope state-modifier">US3523941A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1967-03-06</span>
                    <span class="td style-scope patent-result">1970-08-11</span>
                    <span class="td style-scope patent-result">Hoffmann La Roche</span>
                    <span class="td style-scope patent-result">Benzodiazepine compounds and process for their preparation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3524849A/en"><a id="link" href="#" class="style-scope state-modifier">US3524849A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1967-10-27</span>
                    <span class="td style-scope patent-result">1970-08-18</span>
                    <span class="td style-scope patent-result">Hoffmann La Roche</span>
                    <span class="td style-scope patent-result">Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR2027356A1/en"><a id="link" href="#" class="style-scope state-modifier">FR2027356A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1968-12-30</span>
                    <span class="td style-scope patent-result">1970-09-25</span>
                    <span class="td style-scope patent-result">Fujisawa Pharmaceutical Co</span>
                    <span class="td style-scope patent-result">Benzodiazepinone antibiotics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB1299198A/en"><a id="link" href="#" class="style-scope state-modifier">GB1299198A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1968-12-30</span>
                    <span class="td style-scope patent-result">1972-12-06</span>
                    <span class="td style-scope patent-result">Fujisawa Pharmaceutical Co</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepinone derivatives 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3794644A/en"><a id="link" href="#" class="style-scope state-modifier">US3794644A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1969-06-26</span>
                    <span class="td style-scope patent-result">1974-02-26</span>
                    <span class="td style-scope patent-result">Fujisawa Pharmaceutical Co</span>
                    <span class="td style-scope patent-result">Pyrrolo-benzodiazepinone compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS5382792A/en"><a id="link" href="#" class="style-scope state-modifier">JPS5382792A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1976-12-28</span>
                    <span class="td style-scope patent-result">1978-07-21</span>
                    <span class="td style-scope patent-result">Microbial Chem Res Found</span>
                    <span class="td style-scope patent-result">Novel antibiotics mazethramycins and process their preparation 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4185016A/en"><a id="link" href="#" class="style-scope state-modifier">US4185016A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1977-12-27</span>
                    <span class="td style-scope patent-result">1980-01-22</span>
                    <span class="td style-scope patent-result">The Green Cross Corporation</span>
                    <span class="td style-scope patent-result">Pyrrolo benzodiazepine compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB2053894A/en"><a id="link" href="#" class="style-scope state-modifier">GB2053894A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1979-07-17</span>
                    <span class="td style-scope patent-result">1981-02-11</span>
                    <span class="td style-scope patent-result">Green Cross Corp</span>
                    <span class="td style-scope patent-result">Benzodiazepines processes for producing them and compositions containing them 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS57131791A/en"><a id="link" href="#" class="style-scope state-modifier">JPS57131791A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1980-12-31</span>
                    <span class="td style-scope patent-result">1982-08-14</span>
                    <span class="td style-scope patent-result">Fujisawa Pharmaceut Co Ltd</span>
                    <span class="td style-scope patent-result">Benzodiazepine derivative and its preparation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4353827A/en"><a id="link" href="#" class="style-scope state-modifier">US4353827A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1981-02-27</span>
                    <span class="td style-scope patent-result">1982-10-12</span>
                    <span class="td style-scope patent-result">Hoffmann-La Roche Inc.</span>
                    <span class="td style-scope patent-result">Diazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4382032A/en"><a id="link" href="#" class="style-scope state-modifier">US4382032A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1981-02-27</span>
                    <span class="td style-scope patent-result">1983-05-03</span>
                    <span class="td style-scope patent-result">Hoffmann-La Roche Inc.</span>
                    <span class="td style-scope patent-result">Diazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4386028A/en"><a id="link" href="#" class="style-scope state-modifier">US4386028A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1981-02-27</span>
                    <span class="td style-scope patent-result">1983-05-31</span>
                    <span class="td style-scope patent-result">Hoffmann-La Roche Inc.</span>
                    <span class="td style-scope patent-result">Imidazo[1,5a][1,4]benzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS58180487A/en"><a id="link" href="#" class="style-scope state-modifier">JPS58180487A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-04-16</span>
                    <span class="td style-scope patent-result">1983-10-21</span>
                    <span class="td style-scope patent-result">Kyowa Hakko Kogyo Co Ltd</span>
                    <span class="td style-scope patent-result">Antibiotic dc-81 and its preparation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4427587A/en"><a id="link" href="#" class="style-scope state-modifier">US4427587A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-11-10</span>
                    <span class="td style-scope patent-result">1984-01-24</span>
                    <span class="td style-scope patent-result">Bristol-Myers Company</span>
                    <span class="td style-scope patent-result">Total synthesis of antitumor antibiotics BBM-2040A and BBM-2040B 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4427588A/en"><a id="link" href="#" class="style-scope state-modifier">US4427588A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-11-08</span>
                    <span class="td style-scope patent-result">1984-01-24</span>
                    <span class="td style-scope patent-result">Bristol-Myers Company</span>
                    <span class="td style-scope patent-result">Process for conversion of oxotomaymycin to tomaymycin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR2586683A1/en"><a id="link" href="#" class="style-scope state-modifier">FR2586683A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-08-29</span>
                    <span class="td style-scope patent-result">1987-03-06</span>
                    <span class="td style-scope patent-result">Centre Nat Rech Scient</span>
                    <span class="td style-scope patent-result">New neothramycin derivatives, process for their preparation and their application as medicaments 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4701325A/en"><a id="link" href="#" class="style-scope state-modifier">US4701325A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-02-17</span>
                    <span class="td style-scope patent-result">1987-10-20</span>
                    <span class="td style-scope patent-result">The Green Cross Corporation</span>
                    <span class="td style-scope patent-result">Injectable aqueous solution containing hydrogensulfite and/or sulfite and anticancerous benzodiazepine compound 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4816567A/en"><a id="link" href="#" class="style-scope state-modifier">US4816567A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-04-08</span>
                    <span class="td style-scope patent-result">1989-03-28</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Recombinant immunoglobin preparations 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4923984A/en"><a id="link" href="#" class="style-scope state-modifier">US4923984A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-08-05</span>
                    <span class="td style-scope patent-result">1990-05-08</span>
                    <span class="td style-scope patent-result">Shionogi &amp; Co., Ltd.</span>
                    <span class="td style-scope patent-result">Pyrrolo(1,4)benzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1991002536A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1991002536A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-08-23</span>
                    <span class="td style-scope patent-result">1991-03-07</span>
                    <span class="td style-scope patent-result">Scripps Clinic And Research Foundation</span>
                    <span class="td style-scope patent-result">Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992007574A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992007574A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-10-25</span>
                    <span class="td style-scope patent-result">1992-05-14</span>
                    <span class="td style-scope patent-result">Tanox Biosystems, Inc.</span>
                    <span class="td style-scope patent-result">Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992017497A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992017497A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1992-10-15</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Human pf4a receptors and their use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992019620A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992019620A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-05-07</span>
                    <span class="td style-scope patent-result">1992-11-12</span>
                    <span class="td style-scope patent-result">Centre National De La Recherche Scientifique (Cnrs)</span>
                    <span class="td style-scope patent-result">Novel derivatives of pyrrolo [1, 4]-benzodiazepines, method of preparation and medicaments containing them 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0522868A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0522868A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-07-12</span>
                    <span class="td style-scope patent-result">1993-01-13</span>
                    <span class="td style-scope patent-result">SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI &amp;amp; CO. LTD.</span>
                    <span class="td style-scope patent-result">A human endothelin receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH053790A/en"><a id="link" href="#" class="style-scope state-modifier">JPH053790A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-04-19</span>
                    <span class="td style-scope patent-result">1993-01-14</span>
                    <span class="td style-scope patent-result">Fujisawa Pharmaceut Co Ltd</span>
                    <span class="td style-scope patent-result">Dehydropeptidase-i 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993018045A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1993018045A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-03-09</span>
                    <span class="td style-scope patent-result">1993-09-16</span>
                    <span class="td style-scope patent-result">Cancer Research Campaign Technology Limited</span>
                    <span class="td style-scope patent-result">Anti-cancer pyrrolobenzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1994010312A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1994010312A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-23</span>
                    <span class="td style-scope patent-result">1994-05-11</span>
                    <span class="td style-scope patent-result">Chugai Seiyaku Kabushiki Kaisha</span>
                    <span class="td style-scope patent-result">Gene coding for megakaryocyte potentiator 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5362852A/en"><a id="link" href="#" class="style-scope state-modifier">US5362852A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-09-27</span>
                    <span class="td style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Pfizer Inc.</span>
                    <span class="td style-scope patent-result">Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1994028931A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1994028931A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-06-11</span>
                    <span class="td style-scope patent-result">1994-12-22</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Methods for treating inflammatory disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1995004718A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1995004718A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-08-04</span>
                    <span class="td style-scope patent-result">1995-02-16</span>
                    <span class="td style-scope patent-result">Zeneca Limited</span>
                    <span class="td style-scope patent-result">4-methyleneproline derivatives as fungicides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5418241A/en"><a id="link" href="#" class="style-scope state-modifier">US5418241A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-09-28</span>
                    <span class="td style-scope patent-result">1995-05-23</span>
                    <span class="td style-scope patent-result">Synthelabo</span>
                    <span class="td style-scope patent-result">Piperidine derivatives, their preparation and their application in therapeutics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5440021A/en"><a id="link" href="#" class="style-scope state-modifier">US5440021A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1995-08-08</span>
                    <span class="td style-scope patent-result">Chuntharapai; Anan</span>
                    <span class="td style-scope patent-result">Antibodies to human IL-8 type B receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5561119A/en"><a id="link" href="#" class="style-scope state-modifier">US5561119A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-04-30</span>
                    <span class="td style-scope patent-result">1996-10-01</span>
                    <span class="td style-scope patent-result">Laboratoires Hoechst</span>
                    <span class="td style-scope patent-result">Glycosylated prodrugs, their method of preparation and their uses 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1996030514A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1996030514A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-03-31</span>
                    <span class="td style-scope patent-result">1996-10-03</span>
                    <span class="td style-scope patent-result">University Of Washington</span>
                    <span class="td style-scope patent-result">Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5583024A/en"><a id="link" href="#" class="style-scope state-modifier">US5583024A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-12-02</span>
                    <span class="td style-scope patent-result">1996-12-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Recombinant expression of Coleoptera luciferase 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1997007198A2/en"><a id="link" href="#" class="style-scope state-modifier">WO1997007198A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-11</span>
                    <span class="td style-scope patent-result">1997-02-27</span>
                    <span class="td style-scope patent-result">Genetics Institute, Inc.</span>
                    <span class="td style-scope patent-result">Dna sequences and secreted proteins encoded thereby 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5621002A/en"><a id="link" href="#" class="style-scope state-modifier">US5621002A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-09</span>
                    <span class="td style-scope patent-result">1997-04-15</span>
                    <span class="td style-scope patent-result">Behringwerke Aktiengesellschaft</span>
                    <span class="td style-scope patent-result">Prodrugs for enzyme mediated activation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5644033A/en"><a id="link" href="#" class="style-scope state-modifier">US5644033A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-12-22</span>
                    <span class="td style-scope patent-result">1997-07-01</span>
                    <span class="td style-scope patent-result">Health Research, Inc.</span>
                    <span class="td style-scope patent-result">Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1997044452A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1997044452A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-17</span>
                    <span class="td style-scope patent-result">1997-11-27</span>
                    <span class="td style-scope patent-result">Schering Corporation</span>
                    <span class="td style-scope patent-result">Human b-cell antigens, related reagents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5700670A/en"><a id="link" href="#" class="style-scope state-modifier">US5700670A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-04-13</span>
                    <span class="td style-scope patent-result">1997-12-23</span>
                    <span class="td style-scope patent-result">Mitsubishi Chemical Corporation</span>
                    <span class="td style-scope patent-result">Method for producing optically active ester of γ-substituted-β-hydroxybutyric acid 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998013059A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998013059A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-27</span>
                    <span class="td style-scope patent-result">1998-04-02</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5773223A/en"><a id="link" href="#" class="style-scope state-modifier">US5773223A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-02</span>
                    <span class="td style-scope patent-result">1998-06-30</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5792616A/en"><a id="link" href="#" class="style-scope state-modifier">US5792616A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-05-29</span>
                    <span class="td style-scope patent-result">1998-08-11</span>
                    <span class="td style-scope patent-result">The United States Of America</span>
                    <span class="td style-scope patent-result">Antibodies to human cripto protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998037193A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998037193A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-20</span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Zcytor7 cytokine receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998040403A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998040403A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">1998-09-17</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Psca: prostate stem cell antigen 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0875569A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0875569A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-04-28</span>
                    <span class="td style-scope patent-result">1998-11-04</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Corporation</span>
                    <span class="td style-scope patent-result">A human sodium dependent phosphate transporter (IPT-1) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998051824A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998051824A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-05-15</span>
                    <span class="td style-scope patent-result">1998-11-19</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting disease of the urinary tract 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998051805A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998051805A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-05-15</span>
                    <span class="td style-scope patent-result">1998-11-19</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting diseases of the prostate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5854399A/en"><a id="link" href="#" class="style-scope state-modifier">US5854399A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-08-23</span>
                    <span class="td style-scope patent-result">1998-12-29</span>
                    <span class="td style-scope patent-result">The United States Of America As Represented By The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Antibodies specific for human cripto-related polypeptide CR-3 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5869445A/en"><a id="link" href="#" class="style-scope state-modifier">US5869445A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-03-17</span>
                    <span class="td style-scope patent-result">1999-02-09</span>
                    <span class="td style-scope patent-result">University Of Washington</span>
                    <span class="td style-scope patent-result">Methods for eliciting or enhancing reactivity to HER-2/neu protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999028468A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1999028468A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-02</span>
                    <span class="td style-scope patent-result">1999-06-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Modulating b lymphocyte chemokine/receptor interactions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999046284A2/en"><a id="link" href="#" class="style-scope state-modifier">WO1999046284A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-03-13</span>
                    <span class="td style-scope patent-result">1999-09-16</span>
                    <span class="td style-scope patent-result">The Burnham Institute</span>
                    <span class="td style-scope patent-result">Molecules that home to various selected organs or tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5976551A/en"><a id="link" href="#" class="style-scope state-modifier">US5976551A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-15</span>
                    <span class="td style-scope patent-result">1999-11-02</span>
                    <span class="td style-scope patent-result">Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale</span>
                    <span class="td style-scope patent-result">Altered major histocompatibility complex (MHC) determinant and method of using the determinant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999058658A2/en"><a id="link" href="#" class="style-scope state-modifier">WO1999058658A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-13</span>
                    <span class="td style-scope patent-result">1999-11-18</span>
                    <span class="td style-scope patent-result">Epimmune, Inc.</span>
                    <span class="td style-scope patent-result">Expression vectors for stimulating an immune response and methods of using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000003291A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000003291A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-07-08</span>
                    <span class="td style-scope patent-result">2000-01-20</span>
                    <span class="td style-scope patent-result">E Ink Corporation</span>
                    <span class="td style-scope patent-result">Methods for achieving improved color in microencapsulated electrophoretic devices 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012130A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Corporation</span>
                    <span class="td style-scope patent-result">Rp105 agonists and antagonists 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012508A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012508A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolbenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012507A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012507A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012509A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012509A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Collections of compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012506A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012506A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Collections of compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000014228A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000014228A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-09-03</span>
                    <span class="td style-scope patent-result">2000-03-16</span>
                    <span class="td style-scope patent-result">Japan Science And Technology Corporation</span>
                    <span class="td style-scope patent-result">Neutral amino acid transporter and gene thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000020579A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000020579A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-02</span>
                    <span class="td style-scope patent-result">2000-04-13</span>
                    <span class="td style-scope patent-result">Mcmaster University</span>
                    <span class="td style-scope patent-result">Spliced form of erbb-2/neu oncogene 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000022129A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000022129A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-13</span>
                    <span class="td style-scope patent-result">2000-04-20</span>
                    <span class="td style-scope patent-result">Arena Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Non-endogenous, constitutively activated human g protein-coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000032752A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000032752A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-02</span>
                    <span class="td style-scope patent-result">2000-06-08</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Psca: prostate stem cell antigen and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000036107A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000036107A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2000-06-22</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000040614A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000040614A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-30</span>
                    <span class="td style-scope patent-result">2000-07-13</span>
                    <span class="td style-scope patent-result">Beth Israel Deaconess Medical Center, Inc.</span>
                    <span class="td style-scope patent-result">Characterization of the soc/crac calcium channel protein family 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000044899A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000044899A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-01-29</span>
                    <span class="td style-scope patent-result">2000-08-03</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Her-2/neu fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000053216A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2000053216A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-05</span>
                    <span class="td style-scope patent-result">2000-09-14</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Biologicals S.A.</span>
                    <span class="td style-scope patent-result">Use of casb616 polypeptides and polynucleotides for cancer treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000055351A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000055351A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-12</span>
                    <span class="td style-scope patent-result">2000-09-21</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Human colon cancer associated gene sequences and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6153408A/en"><a id="link" href="#" class="style-scope state-modifier">US6153408A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-15</span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale</span>
                    <span class="td style-scope patent-result">Altered major histocompatibility complex (MHC) determinant and methods of using the determinant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000075655A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000075655A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-03</span>
                    <span class="td style-scope patent-result">2000-12-14</span>
                    <span class="td style-scope patent-result">Takeda Chemical Industries, Ltd.</span>
                    <span class="td style-scope patent-result">Screening method with the use of cd100 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001000244A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001000244A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-25</span>
                    <span class="td style-scope patent-result">2001-01-04</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001016318A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001016318A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-01</span>
                    <span class="td style-scope patent-result">2001-03-08</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001016104A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2001016104A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-27</span>
                    <span class="td style-scope patent-result">2001-03-08</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Cyclopropylindole derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6214345B1/en"><a id="link" href="#" class="style-scope state-modifier">US6214345B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-05-14</span>
                    <span class="td style-scope patent-result">2001-04-10</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Co.</span>
                    <span class="td style-scope patent-result">Lysosomal enzyme-cleavable antitumor drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6218519B1/en"><a id="link" href="#" class="style-scope state-modifier">US6218519B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-04-12</span>
                    <span class="td style-scope patent-result">2001-04-17</span>
                    <span class="td style-scope patent-result">Pro-Neuron, Inc.</span>
                    <span class="td style-scope patent-result">Compounds and methods for the selective treatment of cancer and bacterial infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001038490A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001038490A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-29</span>
                    <span class="td style-scope patent-result">2001-05-31</span>
                    <span class="td style-scope patent-result">The Trustees Of Columbia University In The City Of New York</span>
                    <span class="td style-scope patent-result">ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001040309A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001040309A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-10-29</span>
                    <span class="td style-scope patent-result">2001-06-07</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-prostate stem cell antigen (psca) antibody compositions and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001040269A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001040269A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-30</span>
                    <span class="td style-scope patent-result">2001-06-07</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for therapy and diagnosis of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001041787A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2001041787A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-10</span>
                    <span class="td style-scope patent-result">2001-06-14</span>
                    <span class="td style-scope patent-result">Epimmune Inc.</span>
                    <span class="td style-scope patent-result">INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001046232A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001046232A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2001-06-28</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Soluble interleukin-20 receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001045746A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001045746A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-24</span>
                    <span class="td style-scope patent-result">2001-06-28</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for prolonging elimination half-times of bioactive compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001046261A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2001046261A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2001-06-28</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Method for treating inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001048204A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2001048204A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2001-07-05</span>
                    <span class="td style-scope patent-result">Agresearch Limited</span>
                    <span class="td style-scope patent-result">Mutated bmp1b receptor as regulator of ovulation rate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001053463A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001053463A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-21</span>
                    <span class="td style-scope patent-result">2001-07-26</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6268488B1/en"><a id="link" href="#" class="style-scope state-modifier">US6268488B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-25</span>
                    <span class="td style-scope patent-result">2001-07-31</span>
                    <span class="td style-scope patent-result">Barbas, Iii Carlos F.</span>
                    <span class="td style-scope patent-result">Prodrug activation using catalytic antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001057188A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001057188A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-03</span>
                    <span class="td style-scope patent-result">2001-08-09</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001062794A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001062794A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">2001-08-30</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">18607, a human calcium channel 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001066689A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001066689A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-07</span>
                    <span class="td style-scope patent-result">2001-09-13</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001072830A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001072830A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-31</span>
                    <span class="td style-scope patent-result">2001-10-04</span>
                    <span class="td style-scope patent-result">Ipf Pharmaceuticals Gmbh</span>
                    <span class="td style-scope patent-result">Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001072962A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001072962A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-24</span>
                    <span class="td style-scope patent-result">2001-10-04</span>
                    <span class="td style-scope patent-result">Fahri Saatcioglu</span>
                    <span class="td style-scope patent-result">Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001075177A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001075177A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-03</span>
                    <span class="td style-scope patent-result">2001-10-11</span>
                    <span class="td style-scope patent-result">The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Tumor markers in ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001077172A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001077172A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-07</span>
                    <span class="td style-scope patent-result">2001-10-18</span>
                    <span class="td style-scope patent-result">Arena Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Non-endogenous, constitutively activated known g protein-coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001088133A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001088133A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-18</span>
                    <span class="td style-scope patent-result">2001-11-22</span>
                    <span class="td style-scope patent-result">Lexicon Genetics Incorporated</span>
                    <span class="td style-scope patent-result">Human semaphorin homologs and polynucleotides encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001090304A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001090304A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-19</span>
                    <span class="td style-scope patent-result">2001-11-29</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acids, proteins, and antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001094641A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001094641A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-09</span>
                    <span class="td style-scope patent-result">2001-12-13</span>
                    <span class="td style-scope patent-result">Idec Pharmaceuticals Corporation</span>
                    <span class="td style-scope patent-result">Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20010055751A1/en"><a id="link" href="#" class="style-scope state-modifier">US20010055751A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2001-12-27</span>
                    <span class="td style-scope patent-result">Reiter Robert E</span>
                    <span class="td style-scope patent-result">PSCA: Prostate stem cell antigen and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001098351A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001098351A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-16</span>
                    <span class="td style-scope patent-result">2001-12-27</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">G-protein coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002002587A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002002587A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-10</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">B7-like polynucleotides, polypeptides, and antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002002634A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002002634A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-10</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">Human extracellular matrix and cell adhesion polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002002624A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002002624A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-10</span>
                    <span class="td style-scope patent-result">Amgen, Inc.</span>
                    <span class="td style-scope patent-result">B7-like molecules and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002006317A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002006317A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-17</span>
                    <span class="td style-scope patent-result">2002-01-24</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002006339A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002006339A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-03</span>
                    <span class="td style-scope patent-result">2002-01-24</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Proteins and nucleic acids encoding same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002010187A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002010187A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-27</span>
                    <span class="td style-scope patent-result">2002-02-07</span>
                    <span class="td style-scope patent-result">Mayo Foundation For Medical Education And Research</span>
                    <span class="td style-scope patent-result">B7-h3 and b7-h4, novel immunoregulatory molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002010382A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002010382A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-28</span>
                    <span class="td style-scope patent-result">2002-02-07</span>
                    <span class="td style-scope patent-result">Ulrich Wissenbach</span>
                    <span class="td style-scope patent-result">Trp8, trp9 and trp10, markers for cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002012341A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002012341A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-03</span>
                    <span class="td style-scope patent-result">2002-02-14</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Her-2/neu fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002014503A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002014503A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-14</span>
                    <span class="td style-scope patent-result">2002-02-21</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002013847A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002013847A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-14</span>
                    <span class="td style-scope patent-result">2002-02-21</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Methods for diagnosis and therapy of hematological and virus-associated malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002016429A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002016429A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-24</span>
                    <span class="td style-scope patent-result">2002-02-28</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002016413A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002016413A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-24</span>
                    <span class="td style-scope patent-result">2002-02-28</span>
                    <span class="td style-scope patent-result">Glaxosmithkline Biologicals S.A.</span>
                    <span class="td style-scope patent-result">Cripto tumour polypeptide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020034749A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020034749A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-11-18</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Billing-Medel Patricia A.</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting diseases of the breast 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002022660A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002022660A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-11</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002022153A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002022153A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002022636A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002022636A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Isis Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Antisense modulation of her-2 expression 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002022808A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002022808A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-18</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Biogen, Inc.</span>
                    <span class="td style-scope patent-result">Cripto mutant and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6362331B1/en"><a id="link" href="#" class="style-scope state-modifier">US6362331B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-30</span>
                    <span class="td style-scope patent-result">2002-03-26</span>
                    <span class="td style-scope patent-result">Council Of Scientific And Industrial Research</span>
                    <span class="td style-scope patent-result">Process for the preparation of antitumor agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002024909A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002024909A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-18</span>
                    <span class="td style-scope patent-result">2002-03-28</span>
                    <span class="td style-scope patent-result">Biogen, Inc.</span>
                    <span class="td style-scope patent-result">Receptor nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020042366A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020042366A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2002-04-11</span>
                    <span class="td style-scope patent-result">Penny Thompson</span>
                    <span class="td style-scope patent-result">Method for treating inflammation 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002030268A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002030268A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-13</span>
                    <span class="td style-scope patent-result">2002-04-18</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002038766A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002038766A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-07</span>
                    <span class="td style-scope patent-result">2002-05-16</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Human tumor necrosis factor receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002054940A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002054940A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-12</span>
                    <span class="td style-scope patent-result">2002-07-18</span>
                    <span class="td style-scope patent-result">University Of Medicine &amp; Dentistry Of New Jersey</span>
                    <span class="td style-scope patent-result">Bone morphogenetic protein-2 in the treatment and diagnosis of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002059377A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002059377A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-24</span>
                    <span class="td style-scope patent-result">2002-08-01</span>
                    <span class="td style-scope patent-result">Protein Design Labs</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002061087A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002061087A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-12-19</span>
                    <span class="td style-scope patent-result">2002-08-08</span>
                    <span class="td style-scope patent-result">Lifespan Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002060317A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002060317A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-30</span>
                    <span class="td style-scope patent-result">2002-08-08</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of pancreatic cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002064798A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002064798A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-12</span>
                    <span class="td style-scope patent-result">2002-08-22</span>
                    <span class="td style-scope patent-result">Bionomics Limited</span>
                    <span class="td style-scope patent-result">Dna sequences differentially expressed in tumour cell lines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002072596A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002072596A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-09</span>
                    <span class="td style-scope patent-result">2002-09-19</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">Steap-related protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002071928A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002071928A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-14</span>
                    <span class="td style-scope patent-result">2002-09-19</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002078524A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002078524A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-28</span>
                    <span class="td style-scope patent-result">2002-10-10</span>
                    <span class="td style-scope patent-result">Zycos Inc.</span>
                    <span class="td style-scope patent-result">Translational profiling 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002081646A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002081646A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-06</span>
                    <span class="td style-scope patent-result">2002-10-17</span>
                    <span class="td style-scope patent-result">Mannkind Corporation</span>
                    <span class="td style-scope patent-result">Epitope sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020150573A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020150573A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-10</span>
                    <span class="td style-scope patent-result">2002-10-17</span>
                    <span class="td style-scope patent-result">The Rockefeller University</span>
                    <span class="td style-scope patent-result">Anti-Igalpha-Igbeta antibody for lymphoma therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002083866A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002083866A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-17</span>
                    <span class="td style-scope patent-result">2002-10-24</span>
                    <span class="td style-scope patent-result">The Board Of Trustees Of The University Of Arkansas</span>
                    <span class="td style-scope patent-result">Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002086443A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002086443A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-18</span>
                    <span class="td style-scope patent-result">2002-10-31</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002088172A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002088172A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-30</span>
                    <span class="td style-scope patent-result">2002-11-07</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pentapeptide compounds and uses related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002088170A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002088170A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-26</span>
                    <span class="td style-scope patent-result">2002-11-07</span>
                    <span class="td style-scope patent-result">Biogen, Inc.</span>
                    <span class="td style-scope patent-result">Cripto blocking antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002089747A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002089747A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-09</span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002092836A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002092836A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-11</span>
                    <span class="td style-scope patent-result">2002-11-21</span>
                    <span class="td style-scope patent-result">Sloan-Kettering Institute For Cancer Research</span>
                    <span class="td style-scope patent-result">Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002094852A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002094852A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-24</span>
                    <span class="td style-scope patent-result">2002-11-28</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Taci-immunoglobulin fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002099074A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002099074A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-05</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Exelixis, Inc.</span>
                    <span class="td style-scope patent-result">Slc7s as modifiers of the p53 pathway and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002099122A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002099122A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-05</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Exelixis, Inc.</span>
                    <span class="td style-scope patent-result">Modifiers of the p53 pathway and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002098358A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002098358A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-04</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002101075A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002101075A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-13</span>
                    <span class="td style-scope patent-result">2002-12-19</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020193567A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020193567A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-11</span>
                    <span class="td style-scope patent-result">2002-12-19</span>
                    <span class="td style-scope patent-result">Genetics Institute, Inc.</span>
                    <span class="td style-scope patent-result">Secreted proteins and polynucleotides encoding them 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002102235A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002102235A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2002-12-27</span>
                    <span class="td style-scope patent-result">Eos Biotechnology Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003000842A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003000842A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-04</span>
                    <span class="td style-scope patent-result">2003-01-03</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Novel proteins and nucleic acids encoding same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003002717A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003002717A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-28</span>
                    <span class="td style-scope patent-result">2003-01-09</span>
                    <span class="td style-scope patent-result">Schering Corporation</span>
                    <span class="td style-scope patent-result">Biological activity of ak155 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003003906A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003003906A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-03</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Diagnostic and screening methods for bladder cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003003984A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003003984A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-05</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Novel proteins and nucleic acids encoding same 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003004529A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003004529A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-02</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Licentia Ltd.</span>
                    <span class="td style-scope patent-result">Ephrin-tie receptor materials and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003004989A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003004989A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-21</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003009814A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003009814A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-25</span>
                    <span class="td style-scope patent-result">2003-02-06</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6518404B1/en"><a id="link" href="#" class="style-scope state-modifier">US6518404B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-10-17</span>
                    <span class="td style-scope patent-result">2003-02-11</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Human endothelin-bombesin receptor antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003014294A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003014294A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-03</span>
                    <span class="td style-scope patent-result">2003-02-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Tacis and br3 polypeptides and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003016494A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003016494A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-16</span>
                    <span class="td style-scope patent-result">2003-02-27</span>
                    <span class="td style-scope patent-result">Vitivity, Inc.</span>
                    <span class="td style-scope patent-result">Diagnosis and treatment of vascular disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003016475A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003016475A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-14</span>
                    <span class="td style-scope patent-result">2003-02-27</span>
                    <span class="td style-scope patent-result">The General Hospital Corporation</span>
                    <span class="td style-scope patent-result">Nucleic acid and amino acid sequences involved in pain 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003018621A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003018621A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-23</span>
                    <span class="td style-scope patent-result">2003-03-06</span>
                    <span class="td style-scope patent-result">Oxford Biomedica (Uk) Limited</span>
                    <span class="td style-scope patent-result">Genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003023013A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003023013A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-13</span>
                    <span class="td style-scope patent-result">2003-03-20</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003022995A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003022995A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-06</span>
                    <span class="td style-scope patent-result">2003-03-20</span>
                    <span class="td style-scope patent-result">Agensys, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1295944A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1295944A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-19</span>
                    <span class="td style-scope patent-result">2003-03-26</span>
                    <span class="td style-scope patent-result">Otsuka Pharmaceutical Co., Ltd.</span>
                    <span class="td style-scope patent-result">GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030060612A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030060612A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-10-28</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003025228A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2003025228A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-18</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Proteologics, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for treating hcap associated diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003025148A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003025148A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-19</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003024392A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003024392A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-18</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003025138A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003025138A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-17</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003026577A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003026577A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-24</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">P-amidobenzylethers in drug delivery agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030064397A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030064397A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-22</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">Transmembrane protein differentially expressed in prostate and lung tumors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030065143A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030065143A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-30</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003026493A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003026493A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-28</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Bing Yang</span>
                    <span class="td style-scope patent-result">Diagnosis and treatment of diseases caused by mutations in cd72 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030062401A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030062401A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-29</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Hasz Wayne Charles</span>
                    <span class="td style-scope patent-result">Method of providing wear-resistant coatings, and related articles 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003029421A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003029421A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-03</span>
                    <span class="td style-scope patent-result">2003-04-10</span>
                    <span class="td style-scope patent-result">Origene Technologies, Inc.</span>
                    <span class="td style-scope patent-result">Regulated breast cancer genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003029277A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003029277A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-03</span>
                    <span class="td style-scope patent-result">2003-04-10</span>
                    <span class="td style-scope patent-result">Rigel Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Modulators of lymphocyte activation and migration 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003029262A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003029262A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-29</span>
                    <span class="td style-scope patent-result">2003-04-10</span>
                    <span class="td style-scope patent-result">Vanderbilt University</span>
                    <span class="td style-scope patent-result">The human mob-5 (il-24) receptors and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003034984A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003034984A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-19</span>
                    <span class="td style-scope patent-result">2003-05-01</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003035846A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003035846A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-24</span>
                    <span class="td style-scope patent-result">2003-05-01</span>
                    <span class="td style-scope patent-result">National Jewish Medical And Research Center</span>
                    <span class="td style-scope patent-result">Structure of tall-1 and its cognate receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030091580A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030091580A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2003-05-15</span>
                    <span class="td style-scope patent-result">Mitcham Jennifer L.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030096961A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030096961A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-01</span>
                    <span class="td style-scope patent-result">2003-05-22</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030096743A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030096743A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-24</span>
                    <span class="td style-scope patent-result">2003-05-22</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">p-Amidobenzylethers in drug delivery agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003042661A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003042661A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-13</span>
                    <span class="td style-scope patent-result">2003-05-22</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003043583A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003043583A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-20</span>
                    <span class="td style-scope patent-result">2003-05-30</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Treatment of immunological disorders using anti-cd30 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003045422A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2003045422A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-29</span>
                    <span class="td style-scope patent-result">2003-06-05</span>
                    <span class="td style-scope patent-result">Genset S.A.</span>
                    <span class="td style-scope patent-result">Agonists and antagonists of prolixin for the treatment of metabolic disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003048202A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003048202A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-03</span>
                    <span class="td style-scope patent-result">2003-06-12</span>
                    <span class="td style-scope patent-result">Asahi Kasei Pharma Corporation</span>
                    <span class="td style-scope patent-result">Nf-kappab activating genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119125A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119125A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-16</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030118592A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030118592A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-17</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genecraft, Inc.</span>
                    <span class="td style-scope patent-result">Binding domain-immunoglobulin fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119121A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119121A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119122A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119122A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-11</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119126A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119126A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-16</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119128A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119128A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-20</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119130A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-17</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119131A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119131A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-20</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119129A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119129A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-10</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030124579A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030124579A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-05</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030124140A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030124140A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003054152A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003054152A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-10</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003055439A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003055439A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-18</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Her2/neu target antigen and use of same to stimulate an immune response 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003055443A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003055443A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-31</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">Alcon, Inc.</span>
                    <span class="td style-scope patent-result">Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030129192A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030129192A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030134790A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030134790A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-11</span>
                    <span class="td style-scope patent-result">2003-07-17</span>
                    <span class="td style-scope patent-result">University Of Medicine And Dentistry Of New Jersey</span>
                    <span class="td style-scope patent-result">Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003060612A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2003060612A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-16</span>
                    <span class="td style-scope patent-result">2003-07-24</span>
                    <span class="td style-scope patent-result">Japan Science And Technology Agency</span>
                    <span class="td style-scope patent-result">Moving image holography reproducing device and color moving image holography reproducing device 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030143557A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030143557A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-25</span>
                    <span class="td style-scope patent-result">2003-07-31</span>
                    <span class="td style-scope patent-result">Reinhold Penner</span>
                    <span class="td style-scope patent-result">Methods of screening for TRPM4b modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003062401A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003062401A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-22</span>
                    <span class="td style-scope patent-result">2003-07-31</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the detection, diagnosis and therapy of hematological malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6602677B1/en"><a id="link" href="#" class="style-scope state-modifier">US6602677B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-09-19</span>
                    <span class="td style-scope patent-result">2003-08-05</span>
                    <span class="td style-scope patent-result">Promega Corporation</span>
                    <span class="td style-scope patent-result">Thermostable luciferases and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030157089A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030157089A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2003-08-21</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030165504A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030165504A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-24</span>
                    <span class="td style-scope patent-result">2003-09-04</span>
                    <span class="td style-scope patent-result">Retter Marc W.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003072036A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003072036A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-02-21</span>
                    <span class="td style-scope patent-result">2003-09-04</span>
                    <span class="td style-scope patent-result">Duke University</span>
                    <span class="td style-scope patent-result">Treatment methods using anti-cd22 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003072035A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003072035A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-02-22</span>
                    <span class="td style-scope patent-result">2003-09-04</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the treatment of immune related diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1347046A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1347046A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-22</span>
                    <span class="td style-scope patent-result">2003-09-24</span>
                    <span class="td style-scope patent-result">Research Association for Biotechnology</span>
                    <span class="td style-scope patent-result">Full-length cDNA sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003077836A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003077836A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-06</span>
                    <span class="td style-scope patent-result">2003-09-25</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the detection, diagnosis and therapy of hematological malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003081210A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003081210A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Sunesis Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Identification of kinase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030186372A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030186372A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-11</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030185830A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030185830A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003083047A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003083047A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-01</span>
                    <span class="td style-scope patent-result">2003-10-09</span>
                    <span class="td style-scope patent-result">Exelixis, Inc.</span>
                    <span class="td style-scope patent-result">MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003083074A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003083074A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-28</span>
                    <span class="td style-scope patent-result">2003-10-09</span>
                    <span class="td style-scope patent-result">Idec Pharmaceuticals Corporation</span>
                    <span class="td style-scope patent-result">Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003083041A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003083041A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-22</span>
                    <span class="td style-scope patent-result">2003-10-09</span>
                    <span class="td style-scope patent-result">Biogen, Inc.</span>
                    <span class="td style-scope patent-result">Cripto-specific antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030194704A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030194704A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-03</span>
                    <span class="td style-scope patent-result">2003-10-16</span>
                    <span class="td style-scope patent-result">Penn Sharron Gaynor</span>
                    <span class="td style-scope patent-result">Human genome-derived single exon nucleic acid probes useful for gene expression analysis two 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003087768A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003087768A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-12</span>
                    <span class="td style-scope patent-result">2003-10-23</span>
                    <span class="td style-scope patent-result">Mitokor</span>
                    <span class="td style-scope patent-result">Targets for therapeutic intervention identified in the mitochondrial proteome 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003087306A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003087306A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-05</span>
                    <span class="td style-scope patent-result">2003-10-23</span>
                    <span class="td style-scope patent-result">Agensys, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003088808A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003088808A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-16</span>
                    <span class="td style-scope patent-result">2003-10-30</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003089904A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003089904A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-17</span>
                    <span class="td style-scope patent-result">2003-10-30</span>
                    <span class="td style-scope patent-result">Baylor College Of Medicine</span>
                    <span class="td style-scope patent-result">Aib1 as a prognostic marker and predictor of resistance to encocrine therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003089624A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003089624A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-25</span>
                    <span class="td style-scope patent-result">2003-10-30</span>
                    <span class="td style-scope patent-result">Uab Research Foundation</span>
                    <span class="td style-scope patent-result">Fc receptor homolog, reagents, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030206918A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030206918A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-11-06</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003093444A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003093444A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-03</span>
                    <span class="td style-scope patent-result">2003-11-13</span>
                    <span class="td style-scope patent-result">Incyte Corporation</span>
                    <span class="td style-scope patent-result">Transporters and ion channels 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030219806A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030219806A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003097803A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003097803A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-15</span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224411A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224411A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-03-13</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Stanton Lawrence W.</span>
                    <span class="td style-scope patent-result">Genes that are up- or down-regulated during differentiation of human embryonic stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224454A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224454A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-30</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Ryseck Rolf Peter</span>
                    <span class="td style-scope patent-result">Human solute carrier family 7, member 11 (hSLC7A11) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6660856B2/en"><a id="link" href="#" class="style-scope state-modifier">US6660856B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-08</span>
                    <span class="td style-scope patent-result">2003-12-09</span>
                    <span class="td style-scope patent-result">Kaohsiung Medical University</span>
                    <span class="td style-scope patent-result">Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine analogues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6660742B2/en"><a id="link" href="#" class="style-scope state-modifier">US6660742B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-19</span>
                    <span class="td style-scope patent-result">2003-12-09</span>
                    <span class="td style-scope patent-result">Taiho Pharmaceutical Co. Ltd.</span>
                    <span class="td style-scope patent-result">Compositions and methods of the use thereof achiral analogues of CC-1065 and the duocarmycins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003101400A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003101400A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">2003-12-11</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003101283A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003101283A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">2003-12-11</span>
                    <span class="td style-scope patent-result">Incyte Corporation</span>
                    <span class="td style-scope patent-result">Diagnostics markers for lung cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030232350A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030232350A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-13</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030232056A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030232056A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003104275A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003104275A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-06</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Oncotherapy Science, Inc.</span>
                    <span class="td style-scope patent-result">Genes and polypeptides relating to human colon cancers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003104270A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003104270A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-06</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Ingenium Pharmaceuticals Ag</span>
                    <span class="td style-scope patent-result">Dudulin 2 genes, expression products, non-human animal model: uses in human hematological disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003104399A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003104399A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-07</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003105758A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003105758A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-12</span>
                    <span class="td style-scope patent-result">2003-12-24</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004001004A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004001004A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-21</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">Johns Hopkins University School Of Medicine</span>
                    <span class="td style-scope patent-result">Membrane associated tumor endothelium markers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004000221A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004000221A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-20</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Compositions and methods for modulating lymphocyte activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004000997A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004000997A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-19</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Therapeutic polypeptides, nucleic acids encoding same, and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040001827A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040001827A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-28</span>
                    <span class="td style-scope patent-result">2004-01-01</span>
                    <span class="td style-scope patent-result">Dennis Mark S.</span>
                    <span class="td style-scope patent-result">Serum albumin binding peptides for tumor targeting 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040005538A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040005538A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-11</span>
                    <span class="td style-scope patent-result">2004-01-08</span>
                    <span class="td style-scope patent-result">Xiaojiang Chen</span>
                    <span class="td style-scope patent-result">Three-dimensional structure of complement receptor type 2 and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040005563A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040005563A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2004-01-08</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004005598A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004005598A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-03</span>
                    <span class="td style-scope patent-result">2004-01-15</span>
                    <span class="td style-scope patent-result">Saurer Gmbh &amp; Co. Kg</span>
                    <span class="td style-scope patent-result">Drafting assembly for spinning machines comprising a compacting device 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004009622A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004009622A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-19</span>
                    <span class="td style-scope patent-result">2004-01-29</span>
                    <span class="td style-scope patent-result">Cellzome Ag</span>
                    <span class="td style-scope patent-result">Protein complexes of cellular networks underlying the development of cancer and other diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040018194A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040018194A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">2004-01-29</span>
                    <span class="td style-scope patent-result">Francisco Joseph A.</span>
                    <span class="td style-scope patent-result">Recombinant anti-CD30 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004011611A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004011611A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-25</span>
                    <span class="td style-scope patent-result">2004-02-05</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Taci antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040022727A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040022727A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-18</span>
                    <span class="td style-scope patent-result">2004-02-05</span>
                    <span class="td style-scope patent-result">Martin Stanton</span>
                    <span class="td style-scope patent-result">Aptamer-toxin molecules and methods for using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004015426A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004015426A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-06</span>
                    <span class="td style-scope patent-result">2004-02-19</span>
                    <span class="td style-scope patent-result">Bayer Healthcare Ag</span>
                    <span class="td style-scope patent-result">Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004016225A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004016225A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-19</span>
                    <span class="td style-scope patent-result">2004-02-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1394274A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1394274A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-06</span>
                    <span class="td style-scope patent-result">2004-03-03</span>
                    <span class="td style-scope patent-result">Genox Research, Inc.</span>
                    <span class="td style-scope patent-result">Methods of testing for bronchial asthma or chronic obstructive pulmonary disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040044179A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040044179A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-25</span>
                    <span class="td style-scope patent-result">2004-03-04</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004020583A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004020583A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-27</span>
                    <span class="td style-scope patent-result">2004-03-11</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Polynucleotide predictor set for identifying protein tyrosine kinase modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004020595A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004020595A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-29</span>
                    <span class="td style-scope patent-result">2004-03-11</span>
                    <span class="td style-scope patent-result">Five Prime Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Novel human polypeptides encoded by polynucleotides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040052793A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040052793A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-22</span>
                    <span class="td style-scope patent-result">2004-03-18</span>
                    <span class="td style-scope patent-result">Carter Paul J.</span>
                    <span class="td style-scope patent-result">Caspase activivated prodrugs therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004022778A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004022778A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-05</span>
                    <span class="td style-scope patent-result">2004-03-18</span>
                    <span class="td style-scope patent-result">Garvan Institute Of Medical Research</span>
                    <span class="td style-scope patent-result">Methods of diagnosis and prognosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004022709A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004022709A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-06</span>
                    <span class="td style-scope patent-result">2004-03-18</span>
                    <span class="td style-scope patent-result">Mannkind Corporation</span>
                    <span class="td style-scope patent-result">Epitope sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004027049A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004027049A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-20</span>
                    <span class="td style-scope patent-result">2004-04-01</span>
                    <span class="td style-scope patent-result">Astral, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004113151A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004113151A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-27</span>
                    <span class="td style-scope patent-result">2004-04-15</span>
                    <span class="td style-scope patent-result">Sankyo Co Ltd</span>
                    <span class="td style-scope patent-result">Oncogene and its application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004031238A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004031238A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-03</span>
                    <span class="td style-scope patent-result">2004-04-15</span>
                    <span class="td style-scope patent-result">Mcgill Univeristy</span>
                    <span class="td style-scope patent-result">Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004032828A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004032828A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-31</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004032842A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004032842A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-04</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Van Andel Research Institute</span>
                    <span class="td style-scope patent-result">Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004040000A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004040000A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-09</span>
                    <span class="td style-scope patent-result">2004-05-13</span>
                    <span class="td style-scope patent-result">Nura, Inc</span>
                    <span class="td style-scope patent-result">G protein coupled receptors and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004042346A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004042346A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-24</span>
                    <span class="td style-scope patent-result">2004-05-21</span>
                    <span class="td style-scope patent-result">Expression Diagnostics, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for diagnosing and monitoring transplant rejection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004043963A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004043963A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">2004-05-27</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004044178A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004044178A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-13</span>
                    <span class="td style-scope patent-result">2004-05-27</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for diagnosing dysplasia 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004043361A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004043361A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-08</span>
                    <span class="td style-scope patent-result">2004-05-27</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the treatment of natural killer cell related diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004045516A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004045516A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004045520A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004045520A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">Musc Foundation For Research Development</span>
                    <span class="td style-scope patent-result">Complement receptor 2 targeted complement modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004046342A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004046342A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-20</span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc.</span>
                    <span class="td style-scope patent-result">Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004045553A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004045553A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">The Board Of Trustees Of The University Of Arkansas</span>
                    <span class="td style-scope patent-result">Ca125 gene and its use for diagnostic and therapeutic interventions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004048938A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004048938A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-26</span>
                    <span class="td style-scope patent-result">2004-06-10</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004047749A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004047749A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-21</span>
                    <span class="td style-scope patent-result">2004-06-10</span>
                    <span class="td style-scope patent-result">University Of Utah Research Foundation</span>
                    <span class="td style-scope patent-result">Purinergic modulation of smell 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004053079A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004053079A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-06</span>
                    <span class="td style-scope patent-result">2004-06-24</span>
                    <span class="td style-scope patent-result">Diadexus, Inc.</span>
                    <span class="td style-scope patent-result">Compositions, splice variants and methods relating to ovarian specific genes and proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040121940A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040121940A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-23</span>
                    <span class="td style-scope patent-result">2004-06-24</span>
                    <span class="td style-scope patent-result">De Groot Franciscus Marinus Hendrikus</span>
                    <span class="td style-scope patent-result">Elongated and multiple spacers in activatible produgs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6759509B1/en"><a id="link" href="#" class="style-scope state-modifier">US6759509B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-11-05</span>
                    <span class="td style-scope patent-result">2004-07-06</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Branched peptide linkers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004058309A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004058309A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-23</span>
                    <span class="td style-scope patent-result">2004-07-15</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040138269A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040138269A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-11</span>
                    <span class="td style-scope patent-result">2004-07-15</span>
                    <span class="td style-scope patent-result">Sugen, Inc.</span>
                    <span class="td style-scope patent-result">Substituted pyrroles as kinase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1439393A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1439393A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-13</span>
                    <span class="td style-scope patent-result">2004-07-21</span>
                    <span class="td style-scope patent-result">Bayer Healthcare LLC</span>
                    <span class="td style-scope patent-result">Detection methods using TIMP 1 for colon cancer diagnosis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004063355A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004063355A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-10</span>
                    <span class="td style-scope patent-result">2004-07-29</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004063362A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004063362A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-10</span>
                    <span class="td style-scope patent-result">2004-07-29</span>
                    <span class="td style-scope patent-result">Cyclacel Limited</span>
                    <span class="td style-scope patent-result">Cell cycle progression proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004063709A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004063709A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-08</span>
                    <span class="td style-scope patent-result">2004-07-29</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065576A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004065576A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-15</span>
                    <span class="td style-scope patent-result">2004-08-05</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for the treatment of urological disorder using differential expressed polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065577A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004065577A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-14</span>
                    <span class="td style-scope patent-result">2004-08-05</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Polynucleotides and polypeptides associated with the nf-kb pathway 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004074320A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004074320A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-02-14</span>
                    <span class="td style-scope patent-result">2004-09-02</span>
                    <span class="td style-scope patent-result">Sagres Discovery, Inc.</span>
                    <span class="td style-scope patent-result">Therapeutic targets in cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040197325A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040197325A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-20</span>
                    <span class="td style-scope patent-result">2004-10-07</span>
                    <span class="td style-scope patent-result">Debbie Law</span>
                    <span class="td style-scope patent-result">Antibodies against GPR64 and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040249130A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040249130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-18</span>
                    <span class="td style-scope patent-result">2004-12-09</span>
                    <span class="td style-scope patent-result">Martin Stanton</span>
                    <span class="td style-scope patent-result">Aptamer-toxin molecules and methods for using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6835807B1/en"><a id="link" href="#" class="style-scope state-modifier">US6835807B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-22</span>
                    <span class="td style-scope patent-result">2004-12-28</span>
                    <span class="td style-scope patent-result">Daiichi Pharmaceuticals Co., Ltd.</span>
                    <span class="td style-scope patent-result">Drug complex and drug delivery system 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005023814A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005023814A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-09-11</span>
                    <span class="td style-scope patent-result">2005-03-17</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Synthesis of protected pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6884799B2/en"><a id="link" href="#" class="style-scope state-modifier">US6884799B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-03-31</span>
                    <span class="td style-scope patent-result">2005-04-26</span>
                    <span class="td style-scope patent-result">Council Of Scientific And Industrial Research</span>
                    <span class="td style-scope patent-result">Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005040170A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005040170A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-10-22</span>
                    <span class="td style-scope patent-result">2005-05-06</span>
                    <span class="td style-scope patent-result">Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005042535A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005042535A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-10-22</span>
                    <span class="td style-scope patent-result">2005-05-12</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005079479A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005079479A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-02-17</span>
                    <span class="td style-scope patent-result">2005-09-01</span>
                    <span class="td style-scope patent-result">Absalus, Inc.</span>
                    <span class="td style-scope patent-result">Super-humanized antibodies against respiratory syncytial virus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005082023A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005082023A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-02-23</span>
                    <span class="td style-scope patent-result">2005-09-09</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Heterocyclic self-immolative linkers and conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085260A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085260A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-09</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085250A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085250A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085177A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085177A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Biaryl amino acids and their use in dna binding oligomers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085259A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085259A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085251A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085251A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005105113A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005105113A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-04-27</span>
                    <span class="td style-scope patent-result">2005-11-10</span>
                    <span class="td style-scope patent-result">Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) [S.A.S.]</span>
                    <span class="td style-scope patent-result">Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005110423A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2005110423A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-05-13</span>
                    <span class="td style-scope patent-result">2005-11-24</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine therapeutic agents useful in the treatment of leukaemias 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050271615A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050271615A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-30</span>
                    <span class="td style-scope patent-result">2005-12-08</span>
                    <span class="td style-scope patent-result">Doron Shabat</span>
                    <span class="td style-scope patent-result">Self-immolative dendrimers releasing many active moieties upon a single activating event 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060116422A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060116422A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">2006-06-01</span>
                    <span class="td style-scope patent-result">De Groot Franciscus Marinus H</span>
                    <span class="td style-scope patent-result">Prodrugs built as multiple self-elimination-release spacers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2006111759A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2006111759A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2006-10-26</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007039752A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2007039752A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-05</span>
                    <span class="td style-scope patent-result">2007-04-12</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c] [1, 4] benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007044515A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2007044515A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-07</span>
                    <span class="td style-scope patent-result">2007-04-19</span>
                    <span class="td style-scope patent-result">Exelixis, Inc.</span>
                    <span class="td style-scope patent-result">Azetidines as mek inhibitors for the treatment of proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20070154906A1/en"><a id="link" href="#" class="style-scope state-modifier">US20070154906A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-05</span>
                    <span class="td style-scope patent-result">2007-07-05</span>
                    <span class="td style-scope patent-result">Spirogen Ltd.</span>
                    <span class="td style-scope patent-result">Methods to identify therapeutic candidates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1813614A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1813614A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-01-25</span>
                    <span class="td style-scope patent-result">2007-08-01</span>
                    <span class="td style-scope patent-result">Sanofi-Aventis</span>
                    <span class="td style-scope patent-result">Cytotoxic agents comprising new tomaymycin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20070185336A1/en"><a id="link" href="#" class="style-scope state-modifier">US20070185336A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-03</span>
                    <span class="td style-scope patent-result">2007-08-09</span>
                    <span class="td style-scope patent-result">Degussa Ag</span>
                    <span class="td style-scope patent-result">Process for preparing n-protected 4-ketoproline derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008010101A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008010101A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-07-18</span>
                    <span class="td style-scope patent-result">2008-01-24</span>
                    <span class="td style-scope patent-result">Sanofi-Aventis</span>
                    <span class="td style-scope patent-result">Antagonist antibody against epha2 for the treatment of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008022152A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008022152A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-08-14</span>
                    <span class="td style-scope patent-result">2008-02-21</span>
                    <span class="td style-scope patent-result">Xencor, Inc.</span>
                    <span class="td style-scope patent-result">Optimized antibodies that target cd19 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008047242A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008047242A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-10-19</span>
                    <span class="td style-scope patent-result">2008-04-24</span>
                    <span class="td style-scope patent-result">Sanofi-Aventis</span>
                    <span class="td style-scope patent-result">Novel anti-cd38 antibodies for the treatment of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080092940A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080092940A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-12-24</span>
                    <span class="td style-scope patent-result">2008-04-24</span>
                    <span class="td style-scope patent-result">Showa Denko K.K.</span>
                    <span class="td style-scope patent-result">Production Method of Thermoelectric Semiconductor Alloy, Thermoelectric Conversion Module and Thermoelectric Power Generating Device 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101171257A/en"><a id="link" href="#" class="style-scope state-modifier">CN101171257A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2008-04-30</span>
                    <span class="td style-scope patent-result">斯皮罗根有限公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines compound 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008050140A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008050140A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-10-27</span>
                    <span class="td style-scope patent-result">2008-05-02</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Compounds for treatment of parasitic infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080112961A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080112961A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-10-09</span>
                    <span class="td style-scope patent-result">2008-05-15</span>
                    <span class="td style-scope patent-result">Macrogenics, Inc.</span>
                    <span class="td style-scope patent-result">Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008070593A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008070593A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-12-01</span>
                    <span class="td style-scope patent-result">2008-06-12</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Variant target binding agents and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080206239A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080206239A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-02-03</span>
                    <span class="td style-scope patent-result">2008-08-28</span>
                    <span class="td style-scope patent-result">Antitope Limited</span>
                    <span class="td style-scope patent-result">Human Antibodies And Proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080213289A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080213289A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-31</span>
                    <span class="td style-scope patent-result">2008-09-04</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Recombinant anti-cd30 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2019104A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2019104A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-07-19</span>
                    <span class="td style-scope patent-result">2009-01-28</span>
                    <span class="td style-scope patent-result">Sanofi-Aventis</span>
                    <span class="td style-scope patent-result">Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7521541B2/en"><a id="link" href="#" class="style-scope state-modifier">US7521541B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-23</span>
                    <span class="td style-scope patent-result">2009-04-21</span>
                    <span class="td style-scope patent-result">Genetech Inc.</span>
                    <span class="td style-scope patent-result">Cysteine engineered antibodies and conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2009052249A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2009052249A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-10-19</span>
                    <span class="td style-scope patent-result">2009-04-23</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2009060208A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2009060208A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2009-05-14</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2009060215A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2009060215A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2009-05-14</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Polyamides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090148942A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090148942A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-19</span>
                    <span class="td style-scope patent-result">2009-06-11</span>
                    <span class="td style-scope patent-result">Mcdonagh Charlotte</span>
                    <span class="td style-scope patent-result">Humanized anti-cd70 binding agents and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2009117531A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2009117531A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-03-18</span>
                    <span class="td style-scope patent-result">2009-09-24</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Auristatin drug linker conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090274713A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090274713A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-04-30</span>
                    <span class="td style-scope patent-result">2009-11-05</span>
                    <span class="td style-scope patent-result">Immunogen Inc.</span>
                    <span class="td style-scope patent-result">Cross-linkers and their uses 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2010010347A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2010010347A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-22</span>
                    <span class="td style-scope patent-result">2010-01-28</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20100028346A1/en"><a id="link" href="#" class="style-scope state-modifier">US20100028346A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-16</span>
                    <span class="td style-scope patent-result">2010-02-04</span>
                    <span class="td style-scope patent-result">Immunogen Inc.</span>
                    <span class="td style-scope patent-result">Novel synergistic effects 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2010043877A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2010043877A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2010-04-22</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2010043880A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2010043880A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2010-04-22</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7723485B2/en"><a id="link" href="#" class="style-scope state-modifier">US7723485B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-08</span>
                    <span class="td style-scope patent-result">2010-05-25</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20100203007A1/en"><a id="link" href="#" class="style-scope state-modifier">US20100203007A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-05</span>
                    <span class="td style-scope patent-result">2010-08-12</span>
                    <span class="td style-scope patent-result">Immunogen Inc.</span>
                    <span class="td style-scope patent-result">Novel benzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2010095031A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2010095031A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-23</span>
                    <span class="td style-scope patent-result">2010-08-26</span>
                    <span class="td style-scope patent-result">Glenmark Pharmaceuticals S.A.</span>
                    <span class="td style-scope patent-result">Humanized antibodies that bind to cd19 and their uses 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110039969A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110039969A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-05-11</span>
                    <span class="td style-scope patent-result">2011-02-17</span>
                    <span class="td style-scope patent-result">The General Hospital Corporation</span>
                    <span class="td style-scope patent-result">Methods for making oxidation resistant polymeric material 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011023883A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011023883A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-08-25</span>
                    <span class="td style-scope patent-result">2011-03-03</span>
                    <span class="td style-scope patent-result">Sanofi-Aventis</span>
                    <span class="td style-scope patent-result">Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2298817A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2298817A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-03</span>
                    <span class="td style-scope patent-result">2011-03-23</span>
                    <span class="td style-scope patent-result">Alexion Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Hybrid antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110070227A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110070227A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-09-18</span>
                    <span class="td style-scope patent-result">2011-03-24</span>
                    <span class="td style-scope patent-result">Anna-Marie Novotney-Barry</span>
                    <span class="td style-scope patent-result">Treatment of Autoimmune and Inflammatory Diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011038159A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2011038159A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-09-24</span>
                    <span class="td style-scope patent-result">2011-03-31</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Dr5 ligand drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110091372A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110091372A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-09-01</span>
                    <span class="td style-scope patent-result">2011-04-21</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Dual Variable Domain Immunoglobulins and Uses Thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110195021A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110195021A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-02-10</span>
                    <span class="td style-scope patent-result">2011-08-11</span>
                    <span class="td style-scope patent-result">Immunogen Inc.</span>
                    <span class="td style-scope patent-result">Cd20 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110195022A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110195022A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-02-10</span>
                    <span class="td style-scope patent-result">2011-08-11</span>
                    <span class="td style-scope patent-result">Immunogen Inc.</span>
                    <span class="td style-scope patent-result">Cd20 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011100227A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011100227A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-02-09</span>
                    <span class="td style-scope patent-result">2011-08-18</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011130598A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011130598A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2011-10-20</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011130613A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011130613A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2011-10-20</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Targeted pyrrolobenzodiazapine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011128650A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011128650A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2011-10-20</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Intermediates useful for the synthesis of pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011130616A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011130616A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2011-10-20</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines used to treat proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011130615A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2011130615A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2011-10-20</span>
                    <span class="td style-scope patent-result">Dr. Reddy's Laboratories Ltd.</span>
                    <span class="td style-scope patent-result">Preparation of lacosamide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011133039A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2011133039A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-21</span>
                    <span class="td style-scope patent-result">2011-10-27</span>
                    <span class="td style-scope patent-result">Syntarga B.V.</span>
                    <span class="td style-scope patent-result">Novel conjugates of cc-1065 analogs and bifunctional linkers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012014147A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012014147A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-07-26</span>
                    <span class="td style-scope patent-result">2012-02-02</span>
                    <span class="td style-scope patent-result">Sanofi</span>
                    <span class="td style-scope patent-result">Anticancer derivatives, preparation thereof and therapeutic use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012064733A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2012064733A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-11-09</span>
                    <span class="td style-scope patent-result">2012-05-18</span>
                    <span class="td style-scope patent-result">Medimmune, Llc</span>
                    <span class="td style-scope patent-result">Antibody scaffold for homogenous conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012112708A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012112708A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-02-15</span>
                    <span class="td style-scope patent-result">2012-08-23</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Cytotoxic benzodiazepine derivatives and methods of preparation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20120233172A1/en"><a id="link" href="#" class="style-scope state-modifier">US20120233172A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-03-07</span>
                    <span class="td style-scope patent-result">2012-09-13</span>
                    <span class="td style-scope patent-result">Aptare, Inc.</span>
                    <span class="td style-scope patent-result">System to catalog and search point-in-time instances of a file system 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8321774B2/en"><a id="link" href="#" class="style-scope state-modifier">US8321774B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-04-09</span>
                    <span class="td style-scope patent-result">2012-11-27</span>
                    <span class="td style-scope patent-result">Siemens Aktiengesellschaft</span>
                    <span class="td style-scope patent-result">Method for fail-safe transmission, safety switching device and control unit 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013041606A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013041606A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-20</span>
                    <span class="td style-scope patent-result">2013-03-28</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013053872A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013053872A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013053873A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013053873A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055990A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055987A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055987A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055993A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055993A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013053871A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013053871A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20130244171A1/en"><a id="link" href="#" class="style-scope state-modifier">US20130244171A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-03-19</span>
                    <span class="td style-scope patent-result">2013-09-19</span>
                    <span class="td style-scope patent-result">Fuji Xerox Co., Ltd.</span>
                    <span class="td style-scope patent-result">Polyester resin for toner, electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013164592A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013164592A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-30</span>
                    <span class="td style-scope patent-result">2013-11-07</span>
                    <span class="td style-scope patent-result">Ucl Business Plc</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013164593A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013164593A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-30</span>
                    <span class="td style-scope patent-result">2013-11-07</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20130304357A1/en"><a id="link" href="#" class="style-scope state-modifier">US20130304357A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-14</span>
                    <span class="td style-scope patent-result">2013-11-14</span>
                    <span class="td style-scope patent-result">Southwest Research Institute</span>
                    <span class="td style-scope patent-result">Diesel Engine Operation for Fast Transient Response and Low Emissions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013177481A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013177481A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-25</span>
                    <span class="td style-scope patent-result">2013-11-28</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Benzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5382792B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5382792B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-08-14</span>
                    <span class="td style-scope patent-result">2014-01-08</span>
                    <span class="td style-scope patent-result">独立行政法人理化学研究所</span>
                    <span class="td style-scope patent-result">
  Method for simultaneously measuring primary and secondary photosensitivity anisotropy in optical second-order nonlinear thin film, apparatus for executing the method, and program for causing computer to execute the method
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014011518A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014011518A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">2014-01-16</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Immunoconjugates comprising anti-cd22 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014011519A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014011519A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">2014-01-16</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Immunoconjugates comprising anti-cd79b antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014022679A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2014022679A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-08-02</span>
                    <span class="td style-scope patent-result">2014-02-06</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-etbr antibodies and immunoconjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014031566A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014031566A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-08-22</span>
                    <span class="td style-scope patent-result">2014-02-27</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Cytotoxic benzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057113A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057113A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine - anti-psma antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057072A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057072A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057114A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057114A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-psma antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057122A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057122A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-cd22 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057118A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057118A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-cd22 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057074A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057074A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057120A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057120A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057117A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057117A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057073A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057073A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057115A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057115A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-her2 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057119A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057119A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014080251A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014080251A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-11-24</span>
                    <span class="td style-scope patent-result">2014-05-30</span>
                    <span class="td style-scope patent-result">Hangzhou Dac Biotech Co., Ltd.</span>
                    <span class="td style-scope patent-result">Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014096368A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014096368A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2014-06-26</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014096365A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014096365A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2014-06-26</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014130879A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2014130879A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-02-22</span>
                    <span class="td style-scope patent-result">2014-08-28</span>
                    <span class="td style-scope patent-result">Stem Centrx, Inc.</span>
                    <span class="td style-scope patent-result">Novel antibody conjugates and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014140174A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014140174A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2014-09-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014140862A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2014140862A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2014-09-18</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20140294868A1/en"><a id="link" href="#" class="style-scope state-modifier">US20140294868A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2014-10-02</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014174111A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014174111A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-04-26</span>
                    <span class="td style-scope patent-result">2014-10-30</span>
                    <span class="td style-scope patent-result">Pierre Fabre Medicament</span>
                    <span class="td style-scope patent-result">Axl antibody-drug conjugate and its use for the treatment of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015031693A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015031693A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-28</span>
                    <span class="td style-scope patent-result">2015-03-05</span>
                    <span class="td style-scope patent-result">Stem Centrx, Inc.</span>
                    <span class="td style-scope patent-result">Engineered anti-dll3 conjugates and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052533A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052533A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052532A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052532A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052334A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052334A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Maersk Olie Og Gas A/S</span>
                    <span class="td style-scope patent-result">Seismic data processing method and apparatus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052335A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052335A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Cellectis</span>
                    <span class="td style-scope patent-result">Methods and kits for detecting nucleic acid sequences of interest using dna-binding protein domain 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052322A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052322A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052535A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052535A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052332A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052332A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Continental Automotive Gmbh</span>
                    <span class="td style-scope patent-result">Injection valve and method for the operation of an injection valve 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052333A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052333A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-10</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Wwinn B.V.</span>
                    <span class="td style-scope patent-result">Module, system and method for detecting acoustical failure of a loudspeaker 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052321A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052321A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052534A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052534A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015095124A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015095124A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-12-16</span>
                    <span class="td style-scope patent-result">2015-06-25</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">Peptidomimetic compounds and antibody-drug conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015159076A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015159076A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-15</span>
                    <span class="td style-scope patent-result">2015-10-22</span>
                    <span class="td style-scope patent-result">Cancer Research Technology Limited</span>
                    <span class="td style-scope patent-result">Humanized anti-tn-muc1 antibodies and their conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160075787A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160075787A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">2016-03-17</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-cll-1 antibodies and immunoconjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160074527A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160074527A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-17</span>
                    <span class="td style-scope patent-result">2016-03-17</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and antibody disulfide conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2016037644A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2016037644A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-10</span>
                    <span class="td style-scope patent-result">2016-03-17</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20170239365A1/en"><a id="link" href="#" class="style-scope state-modifier">US20170239365A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">2017-08-24</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2188297B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2188297B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-08-01</span>
                    <span class="td style-scope patent-result">2012-02-01</span>
                    <span class="td style-scope patent-result">Council of Scientific &amp; Industrial Research</span>
                    <span class="td style-scope patent-result">Pyrrolo [2,1-c][1, 4] benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (451)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Adair; et al., "Antibody-drug conjugates-a perfect synergy," Exp. Opin. Biol. Ther. (2012), pp. 1-16.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Adair; et al., "Antibody-drug conjugates—a perfect synergy," Exp. Opin. Biol. Ther. (2012), pp. 1-16.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Adams et al., "Molecular modelling of a sequence-specific DNA-binding agent based on the pyrrolo[2,1-c][1,4]benzodiazepines," Pharm. Pharmacol. Commun. (1999) 5:555-560.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Aird, R.E. et al., "ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136," Pharmacogenomics Journal (2008) 8(4):289-296.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Alley, M.C. et al., ""SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations,"" Cancer Res. (2004) 64:6700-6706.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Alley, M.C., "Efficacy evaluations of SJG-136 (NSC 694501), a novel pyrrolobenzodiazepine dimer with broad spectrum antitumor activity," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2002) 43:63.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Alley, S. C., "Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates" Bioconjugate Chem 2008, 19, 759-765.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Althius, T. H. and Hess, H. J., "Synthesis and Identification of the Major Metabolites of Prazosin Formed in Dog and Rat," J. Medicinal Chem. (1977) 20(1):146-148.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Altuvia et al., "Ranking potential binding peptides to MHC molecules by a computational threading approach." J. Mol. Biol., 249, 244-250 (1995).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Amiel J., et al., "Heterozygous endothelin receptor B {EDNRB) mutations in isolated Hirschsprung disease," Hum. Mol. Genet. 5, 355-357, 1996.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Amir et al., "Self-Immolative Dendrimers," (2003) Angew. Chem. Int. Ed. 42:4494-4499.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Amsberry, et al, "The Lactonization of 2′-Hydroxyhydrocinnamic Acid Amides: A Potential Prodrug for Amines," (1990) J. Org. Chem. 55:5867-5877.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Antonow, D. et al., ""Synthesis of DNA-Interactive Pyrrolo [2,1-c][1,4] benzodiazepines (PBDs)"" Chemical Reviews, 2011, 111(4):2815-2864.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Antonow, D. et al., "Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agents."J Med Chem. Apr. 8, 2010;53(7):2927-41.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Antonow, D. et al.,"Parallel synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) library," J. Comb. Chem. (2007) 9:437-445.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Arai H., et al., ""Molecular cloning of human endothelin receptors and their expressiOn in vascular endothelial cells and smooth muscle cells,"" Jpn. Circ. J. 56, 1303-1307, 1992.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Arai H., et al., "The Human Endotbelin-B Receptor Gene. Structural Organization and Chromosomal Assignment," J. Biol. Chem. 268, 3463-3470, 1993.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Arima et al., "Studies on Tomaymycin, a New Antibiotic. I. Isolation and Properties of Tomaymycin," J. Antibiotics (1972) 25:437-444.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Arnould, S., ""Impact on the cell cycle and involvement of ATM, ATR, chk1 and chk2 kinases in the cytotoxicity of SJG-136, a new pyrrolobenzodiazepine dimer,"" Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:1298, Abstract No. 5618.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Arnould, S., "Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling," Mol. Canc. Therap. 5(6):1602-1609 (2006).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Attie T., et al., "Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease," Hum. Mol. Genet. 4, 2407-2409, 1995.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Auricchio A., et al., "Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population," Hum. Mol. Genet. 5:351-354, 1996.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Axup et al., "Synthesis of site-specific antibody-drug conjugates using unnatural amino acids." Proc Natl Acad Sci U S A. Oct. 2, 2012; 109(40)1 6101-6.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Bahrenberg et al., ""Reduced Expression of PSCA, a Member of the LY-6 Family of Cell Surface Antigens, in Bladder, Esophagus, and Stomach Tumors,"" Biochem. Biophys. Res. Commun. (2000) 275(3):783-788.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Banker, G.S. et al., "Modern Pharmaceutics", Third edition, Marcel Dekker, New York (1996) 451 and 596.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Barel M., et al., "Evidence for a new transcript of the Epstein-Barr virus/C3d receptor (CR2, CD21) which is due to alternative exon usage," Mol. Immunol. 35, 1025-1031, 1998.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Barella et al., "Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation," (1995) Biochem. J. 309:773-779.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Barnett T., et al., "Carcinoembryonic Antigen Family: Characterization of cDNAs Coding for NCA and CEA and Suggestion of Nonrandom Sequence Variation in Their Conserved Loop-Domains," Genomics 3, 59-66, 1988.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Batisse, et al., "A new delivery system for Auristatin in STxB-drug conjugate therapy." European J. Medicinal Chemistry, 2015, 95: 483-491.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Beck et al., "DNA Sequence Analysis of 66 kb of the Human MHC Class II Region Encoding a Cluster of Genes for Antigen Processing," (1992) J. Mol. Biol. 228:433-441.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Beck et al., "Evolutionary Dynamics of Non-coding Sequences Within the Class II Region of the Human MHC," (1996) J. Mol. Biol. 25 255:1-13.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Berge et al., "Pharmaceutical Salts," J. Pharm. Sci. (1977) 66:1-19.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Berry, J. M. et al., "Solid-phase synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines," Tetrahedron Letters (2000) 41:6171-6174.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Berry, J.M. et al., "Synthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrug," Bioorg. Med. Chem. Lett. (2002) 12:1413-1416.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Blanc et al., "SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies," Clin Cancer Res., 2011, 17(20):6448-58.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Blumberg H., et al., ""Interleukin 20: Discovery, Receptor Identification, and Role in Epidermal Function,"" Cell 104, 9-19, 2001.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Bose et al., "New Approaches to Pyrrolo[2,1-c][1,4]benzodiazepines: Synthesis, DNA-binding and cytotoxicity of DC-81," Tetrahedron, 48, 751-758 (1992).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Bose, D.S. et al., "Effect of linker length on DNA-binding affinity, cross-linking efficiency and cytotoxicity of C8 linked pyrrolobenzodiazepine dimers," J. Chem. Soc. Chem. Commun. (1992) 20:1518-1520.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Bose, D.S. et al., "Rational Design of a Highly Efficient Irreversible DNA Interstrand Cross-Linking Agent Based on the Pyrrolobenzodiazepine Ring System," J. Am. Chem. Soc., 114, 4939-4941 (1992).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Bourgeois C., et al., "Endothelin-1 and ETA Receptor Expression in Vascular Smooth Muscle Cells from Human Placenta: A New ETA Receptor Messenger Ribonucleic Acid Is Generated by Alternative Splicing of Exon 3," J. Clin. Endocrinol. Metab. 82, 3116-3123, 1997.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Brand et al., Prospect for anti-HER2 receptor therapy in breast cancer. Anticancer Res. Jan.-Feb. 2006;26(1B):463-70.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Brinster et al., "Introits increase transcriptional efficiency in transgenic mice,"(1988) Proc. Natl. Acad. Sci. USA 85:836-840.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Buchman et al., "Comparison of Intron-Dependent and Intron-Independent Gene Expression," (1988) Mol. Cell. Biol. 8:4395-4405.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Buhrow, S.A., "LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501)," J. Chromat. B: Anal. Tech. Biomed. Life Sci. (2006) 840(1):56-62.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Burke, P.J. et al., "Anti-CD70 antibody-drug conjugates containing pyrrolobenzodiazepine dimers demonstrate robust antitumor activity," AACR National Meeting, Apr. 2012, Chicago, Illinois, Abstract No. 4631.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Burke, P.J. et al., "Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system," Bioorg. Med. Chem. Lett., Apr. 2009, 19(10):2650-2653.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Calcutt, M.W., "Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study," J. Mass Spectrom. (2008) 43(1):42-52.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Carl et al., "A Novel Connector Linkage Applicable in Prodrug Design," (1981) J. Med. Chem. 24:479-480.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Carlsson et al., "Protein Thiolation and Reversible Protein-Protein Conjugation," (1978) Biochem. J. 173:723-737.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Carter, P., "Potent antibody therapeutics by design," (2006) Nature Reviews Immunology 6:343-357.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Casset et al., "A peptide mimetic of an anti-CD4 monoclonal antibody by rational design." Biochem Biophys Res Commun. Jul. 18, 2003; 307(1):198-205.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      CellTiter-Glo Luminescent Cell Viability Assay, Promega Corp. Technical Bulletin TB288, dated Jan. 13, 2012 (14 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Chakravarty et al., "Plasmin-Activated Prodrugs for Cancer Chemotherapy. 2. Synthesis and Biological Activity of Peptidyl Derivatives of Doxorubicin," (1983) J. Med. Chern. 26:638-644.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Chan, J. and Watt, V.M., "eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases," Oncogene 6 (6), 1057-1061 (1991).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Chang et al., "Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers," Proc. Natl. Acad. Sci. U.S.A. 93 (1):136-140 (1996).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Chen, Z. et al., ""A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1- c][1,4]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents,"" Biorg. Med. Chem. Lett. (2004) 14:1547-1549.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cheung, A., "Direct liquid chromatography determination of the reactive imine SJG-136 (NSC 694501)," J. Chromat. B: Anal. Techn. Biomed. Life Sci. (2005) 822(1-2):10-20.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Child et al., "Translational Control by an Upstream Open Reading Frame in the HER-2/neu Transcript," (1999) J. Bioi. Chern. 274: 24335-24341.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cho et al., "Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab," Nature 421, 756-760, 2003.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ciccodicola, et al., "Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells," EMBO J. 8 (7):1987-1991 (1989).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ciccodicola, et al., "Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells," EMBO J. 8 (7):1987-1991 (1989).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cipolla, L., "Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs," Anti-Cancer Agents in Medicinal Chemistry (Jan. 2009) 9(1):1-31.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Clackson et al., "Making antibody fragments using phage display libraries," (1991) Nature, 352:624-628.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Clark H.F., et al., "The Secreted Protein Discovery Initiative (SPDI], a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment," Genome Res. 13, 2265-2270, 2003.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Clingen, P.H., "The role of nucleotide excision repair and homologous recomination in the sensitivity of mammalian cells to the minor groove crosslinking pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136 (NSC694501)," Proceedings of the American Association for Cancer Research Annual Meeting (Jul. 2003) 44:524.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Clingen, P.H., "The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136," Nucl. Acids Res. (2005) 33(10):3283-3291.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Clinical Trial, "Translational research: 4 ways to fix the clinical trial." 2011, http://www.nature.com/news/2011/110928/ful1/477526a.html.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Collins, "Generation and initial analysis of more than 15,000 full-length human and mouse eDNA sequences," Proc. Natl. Acad. Sci. U.S.A. 99 (26):16899-16903 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cooper, N. et al., "Synthesis of novel PBDs as anti-tumour agents," Chem. Commun. (2002) 16:1764-1765.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cooper, N., "Design, Synthesis and Evaluation of Novel C2-Aryl Pyrrolobenzodiazepines as Potential Anticancer Agents," Thesis submitted to School of Pharmacy, University of London, Dated Oct. 5, 2006.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Corey et al., "LuCap35: a new model of prostate cancer progression to androgen independence." The Prostate 2003; 55:239-46.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Courtney, S. M. et al., "A new convenient procedure for the synthesis of pyrrolo[2,1-c][1,4]benzodiazepines", Tetrahedron Letters, vol. 34, No. 33, 5327-28 (1993).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Coussens L., et al., "Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location With neu Oncogene," Science (1985) 230(4730):1132-1139.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cragg et al., "The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis," Blood (2002) 100 (9):3068-3076.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Cree et al., "Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay," (1995) AntiCancer Drugs 6:398-404.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Crouch et al., "The use⋅ of ATP bioluminescence as a measure of cell proliferation and cytotoxicity," (1993) J. Immunol. Meth. 160:81-88.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dall'Acqua, W. F. et al., "Antibody humanization by framework shuffling" Methods, 36, 43-60 (2005).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dattolo, G. et al., "Polycondensed nitrogen heterocycles. IX. 5,6-dihydro-7H-pyrrolo[1,2- d][1,4]benzodiazepin-6-one," J. Heterocyclic. Chem. (1980) 17:701-703.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Davis et al., "Identification of a family of Fe receptor homo logs with preferential B cell expression," (2001) Proc. Natl. Acad. Sci. USA 98(17):9772-9777.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      De Groot et al., "Cascade-Release Dendrimers "Liberate All End Groups upon a Single Triggering Event in the Dendritic Core,"" (2003) Angew. Chern. Int. Ed. 42:4490-4494.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      De Groot et al., "Elongated Multiple Electronic Cascade and Cyclization Spacer Systems in Activatible Anticancer Prodrug for Enhanced Drug Release," (2001) J. Org. Chern. 66:8815-8830.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      De Pascalis et al., "Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody." J Immunol. Sep. 15, 2002;169(6):3076-84.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dennis et al., (2002) "Albumin Binding As a General Strategy for Improving the Pharmacokinetics of Proteins" J Biol Chem. 277:35035-35043.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dijke, P., et al., "Characterization of Type I Receptors for Transforming Growth Factor-beta and Activin," Science 264 (5155):101-104 (1994).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dobner et al., "Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma," (1992) Eur. J. Immunol. 22:2795-2799.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dong, Q. et al., "Reductive cleavage of TROC groups under neutral conditions with cadmium-lead couple," Tetrahedron Lett. (1995) 36(32):5681-5682.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dono et al., "Isolation and Characterization of the CRI PTO Autosomal Gene and Its X-linked Related Sequence," Am. J. Hum. Genet. 49:555-565, 1991.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dornan et al., "Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma," (2009) Blood 114(13):2721-2729.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Doronina et al., "Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity," (2006) Bioconj. Chem. 17:114-124.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Doronina, S.O. et al., "Development of potent monoclonal antibody auristatin conjugates for cancer therapy," Nature Biotech. (2003) 21:778-784.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dorwald, F.Z., Side Reactions in Organic Synthesis: a Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmbH &amp; Co., KGaA (2005) Preface.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Doyle, M., "Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer," J. Antimicrob. Chemo., Aug. 2009, 64(5):949-959.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dubowchik et al, "Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin." Bioorg Med Chem Lett. Dec. 1, 1998; 8(23):3341-6.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dubowchik et al, "Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin." Bioorganic &amp; Medicinal Chemistry Letters, 8:3347-3352, (1998).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dubowchik et al., "Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity," Bioconjugate Chem. (2002) 13, 855-869.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dubowchik et al., "Monomethoxytrityl (MMT) as a Versatile Amino Protecting Group for Complex Prodrugs of Anticancer Compounds Sensitive to Strong Acids, Bases and Nucleophiles," (1997) Tetrahedron Letters. 38:5257-5260.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dumoutier L., et al., "Cutting Edge: STAT Activation by IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types," J. Immunol. 167, 3545-3549, 2001.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Dupont, C. et al., "Synthesis of rhazinilam analogue acting as an inhibitor of tubulin assembly," Tetrahedron Lett. (2000) 41:5853-5856.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ehsani A., et al., "Characterization of a New Allele of the Human ERBB2 Gene by Allele-Specific Competition Hybridization," (1993) Genomics 15, 426-429.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Eliel et al., Stereochemistry of Organic Compounds, John Wiley &amp; Sons, Inc., New York (1994).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Elshourbagy N.A., et al., "Molecular Characterization and Regulation of the Human Endothelin Receptors," J. Biol. Chem. 268, 3873-3879, 1993.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Erickson et al., "Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing," (2006) Cancer Res. 66(8): 4426-4433.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Farmer, J.D. et al., "DNA binding properties of a new class of linked anthramycin analogs,", Chemical Abstracts, Abstract No. 239940r, vol. 114, No. 25, 25 899-903 (1991).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Farmer, J.D. et al., "Synthesis and DNA crosslinking ability of a dimeric anthramycin analog," Tetrahedron Letters (1988) 29(40):5105-5108, Abstract only.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Feild, J.A., et al., "Cloning and Functional Characterization of a Sodium-Dependent Phosphate Transporter Expressed in Human Lung and Small Intestine," (1999) Biochem. Biophys. Res. Commun. 258 (3):578-582.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fey, T. et al., "Silica-supported TEMPO catalyst: synthesis and application in the anelli oxidation of alcohols," J. Org. Chem. (2001) 66:8154-8159.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fields, G. and Noble, R. (1990) "Solid phase peptide synthesis utilizing 9-fluoroenylmethoxycarbonyl amino acids", Int. J. Peptide Protein Res. 35:161-214.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Firsching, A. et al., "Antiproliferative and angiostatic activity of suramin analogues," Cancer Res. (1995) 55:4957-4961.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Flanagan et al., "The ephrins and Eph receptors in neural development," Annu. Rev. Neurosci. 21:309-345 (1998).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Flygare, "Antibody-drug conjugates for the treatment of cancer," Chem. Biol. &amp; Drug Design (2013) 81(1):113-121.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Foloppe, M.P. et al., "DNA-binding properties of pyrrolo[2,1-c][1,4]benzodiazephine N10-C11 amidines," Eur. J. Med. Chem., 31, 407-410 (1996).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fox et al., "cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases," Oncogene 10 (5):897-905 (1995).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fuchs S., et al., "Functional Characterization of Three Mutations of the Endothelin B Receptor Gene in Patients With Hirschsprung's Disease: Evidence for Selective Loss of Gi Coupling," Mol. Med. 7, 115-124, 2001.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fujisaku et al., "Genomic Organization and Polymorphisms of the Human C3d/Epstein-Barr Virus Receptor," (1989) J. Biol. Chem. 264 (4):2118-2125.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fujisawa Pharmaceutical Co. Ltd., "Benzodiazepine derivatives," SciFinder Scholar, 2-3 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fujisawa Pharmaceutical Co., Ltd., Abstract No. 139983k, "Benzodiazepine derivatives", Chemical Abstracts, vol. 99, No. 17, 603 (1983).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fujisawa Pharmaceutical Co., Ltd., Abstract No. 72145x, "Benzodiazepine derivatives", Chemical Abstracts, vol. 98, No. 9, 638 (1983).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Fukuyama, T. et al., "Total Synthesis of (+)-Porothramycin B," Tetrahedron Letters, vol. 34, 16, 2577-2580 (1993).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gallmeier, E., "Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options," Gastroenterology (2006) 130(7):2145-2154.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gary S.C., et al., "cDNA cloning chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma," Gene 256, 139-147, 2000.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gaugitsch, H.W., et al., "A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA.," (1992) J. Biol. Chem. 267 (16):11267-11273.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gavezzotti, A., "Are crystal structures predictable?" Acc. Chem. Res. (1994) 27:309-314.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Geiser et al "Automation of solid-phase peptide synthesis" in Macromolecular Sequencing and Synthesis, Alan R. Liss, Inc., 1988, pp. 199-218.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. 11038674 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. 20 NM_006424 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AB040878 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AF116456 (1999).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AF179274 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AF361486 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AF369794 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AF397453 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AF455138 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AJ297436 (2008).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AK026467 (2006).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AK089756 (2010).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AK090423 (2006).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AK090475 (2006).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AL834187 (2008).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AX092328 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AY158090 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AY260763 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AY275463 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AY358085 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession no. AY358628 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AY358907 (2003).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. AY506558 (2004).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. BC017023 (2006).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. CAA76847.1 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. CAF85723 (2004).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. CQ782436 (2004).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. M11730 (1995).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. M18728 (1995).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. M26004 (1993).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_000626 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_001178098.1 (2012).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_001203 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_003212 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_003486 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_004442 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_005823 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_012449 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_017636 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NM_030764 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. Np 002111.1 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_001171569.1 (1992).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_001194 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_001707.1 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_001773.1 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_001774.10 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_002552.2 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_003203 (2013).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_005573.1 (2007).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Genbank accession No. NP_112571.1 (2007).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Geoghegan &amp; Stroh, "Site-Directed Conjugation of Nonpeptide Groups to Peptides and Proteins via Periodate Oxidation of a 2-Amino Alcohol. Application to Modification at N-Terminal Serine," (1992) Bioconjugate Chem. 3:138-146.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Getz Et al., "A Comparison between the Sulfhydryl Reductants Tris(2-carboxyethyl)phosphine and Dithiothreitol for Use in Protein Biochemistry," (1999) Anal. Biochem. vol. 273:73-80.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Glynne-Jones et al., "TENB2, a proteogl ycan identified in prostate cancer that is associated with disease progression and androgen independence," (2001) Int J Cancer. Oct. 15; 94(2): 178-184.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gordon et al., "Somatic hypermutation of the B cell receptor genes B29 (Igβ, CD79b) and mb1 (Igα, CD79a)," PNAS, Apr. 11, 2003, vol. 100, No. 7, 4126-4131.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Greene, T.W. and Wuts, P.G.M., Protective Groups in Organic Synthesis, John Wiley &amp; Sons, 2nd ed., Ch 7, 315-345 (1991).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Greene, T.W. et al., Protective Groups in Organic Synthesis, John Wiley &amp; Sons (1999) 3rd Edition, 23-200.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Greene, T.W. et al., Protective Groups in Organic Synthesis, John Wiley &amp; Sons (1999) 3rd Edition, 503-549.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S. et al., "Synthesis of a novel C2/C2′-exo unsaturated pyrrolobenzodiazepine cross-linking agent with remarkable DNA binding affinity and cytotoxicity," Chemical Communications, 797-798 (1999).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S.J. et al., "Design, Synthesis and Evaluation of a Novel Pyrrolobenzodiazepine DNA-Interactive Agent with Highly Efficient Cross-Linking Ability and Potent Cytotoxicity", J. Med. Chem., 44: 737-748 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S.J. et al., "Effect of C2/C3-endo unsaturation on the cytotoxicity and DNA-binding reactivity of pyrrolo-[2,1-c][1,4]-benzodiazepines," Bioorg. Med. Chem. Lett. (2000) 10(16):1849-1851.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S.J. et al., "Effect of C2-exo Unsaturation on the Cytotoxicity and DNA-Binding Reactivity of Pyrrolo[2,1-c]1,4]benzodiazepines", Bioorganic &amp; Medicinal Chemistry Letters, 10: 1845-1847 (2000).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S.J. et al., "Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8′ ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers," J. Med. Chem. (2004) 1161-1174.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S.J. et al., "Synthesis of the first example of a C2-C3/C2′-C3′-endo unsaturated pyrrolo[2,1- c][1,4]benzodiazepine dimer," Biorg. Med. Chem. Lett. (2001) 11:2859-2862.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gregson, S.J. et al., "Synthesis of the first examples of A-C8/C-C2 amide-linked pyrrolo[2,1-c][1,4]benzodiazepine dimers," Biorg. Med. Chem. Lett. (2003) 13:2277-2280.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Gu Z., et al., "Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer," Oncogene 19, 1288-1296, 2000.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Guichard, S.M., "Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136," Eur. J. Cancer (2005) 41(12):1811-1818.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Guiotto, A. et al., "Synthesis of novel C7-aryl substituted pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) via Pro-N10-troc protection and suzuki coupling," Bioorganic &amp; Medicinal Chemistry Letters, 8, No. 21, 3017-3018 (1998).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Guselnikov et al., "A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1," Immunogenetics 54 (2):87-95 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ha et al., "molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene," (1992) J. Immunol. 148(5):1526-1531.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hadjivassileva, T., "Antibacterial activity of pyrrolobenzodiazepine dimers, a novel group of DNA-binding compounds," Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Oct.-Nov. 2004) 44:202.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hadjivassileva, T., "Interactions of pyrrolobenzodiazepine dimers and duplex DNA from methicillin-resistant Staphylococcus aureus," Int. J. Antimicrob. Agents (2007) 29(6):672-678.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hadjivassileva, T., "Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria," J. Antimicrob. Chemo. (2005) 56(3):513-518.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Haendler B., et al., "Molecular Cloning of Human Endothelin (ET) Receptors ETA and ETB," J. Cardiovasc. Pharmacal. 20, s1-S4, 1992.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Haisma et al., "Comparison of two antracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer." Cell biophysics, Humana Press Inc. 1994, 24/25: 185-192.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hamaguchi, A., "DNA cross-linking and in vivo antitumour activity of the extended pyrrolo[2,1- c][1,4]benzodiazepine dimer SG2057 (DRG-16)," EJC Supplements (Nov. 2006) 4(12):96.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hamann P. "Monoclonal antibody-drug conjugates," (2005) Expert Opin. Ther. Patents 15(9):1087-1103.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hamblett et al., "Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate," (2004) Clin. Cancer Res. 10:7063-7070.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Handbook of Food Additives, 2nd Ed. (eds. M. Ash and I. Ash), Synapse Information Resources, Inc., Endicott, New York, USA (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Handbook of Pharmaceutical Excipients, 2nd edition, 1994, Edited by Ainley Wade and Paul J. Weller.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hara et al., "DC 102, a new glycosidic pyrrolo(1,4)benzodiazepine antibiotic produced by streptomyces sp.", J. Antibiotics, 41, 702-704 (1988).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley J A: "The development of pyrrolobenzodiazepines as antitumour agents", Expert Opinion on Investigational Drugs, Ashley Publications Ltd., vol. 28, No. 6, Jan. 1, 2011, pp. 733-744.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A. et al., "Abstract 2856: pyrrolobenzodiazepine (PBD) dimers-potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors," Cancer Res. (2013) 78(8)Supp 1:2856.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A. et al., "SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activity," Cancer Res., Sep. 2010, 70(17):6849-6858.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A. et al., "SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity," Cancer Res. (2004) 64:6693-6699.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A. et al., "Abstract 2856: pyrrolobenzodiazepine (PBD) dimers—potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors," Cancer Res. (2013) 78(8)Supp 1:2856.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A., "In vitro antitumor activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501)," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2002) 43:489.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A., "SJG-136 (NSC-D694501)-a novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2000) 41:425.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hartley, J.A., "SJG-136 (NSC-D694501)—a novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2000) 41:425.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hashimoto et al., "Chromosomal localization, genomic structure, and allelic polymorphism of the human CD79a (Ig-alpha/mb-1) gene," (1994) Immunogenetics 40(4 ):287-295.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hay et al., "A 2-nitroimidazole carbamate prodrug of 5-amin0-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydr0-3h-benz[e]indole (amino-seco-cbi-tmi) for use with adept and gdept," (1999) Bioorg. Med. Chem. Lett. 9:2237-2242.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Herdwijn et al., "Synthesis of trans(+ )6-phenoxyacetamido-1-methylene- 3,3-dicarboxymethyl-1-carbapenam," Canadian Journal of Chemistry. 1982, 60, 2903-2907.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hermanson, G.T., "Heterobifunctional Cross-linkers," (1996) Bioconjugate Techniques; Academic Press: New York, p. 228-286.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hochhauser, D., "Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors," Clin. Cancer Res., Mar. 2009, 15(6):2140-2147.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hochlowski, J. et al., "Abbeymycin, a new anthramycin-type antibiotic produced by a streptomycete," J. Antibiotics, 40, 145-148 (1987).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hofstra R.M.W., et al., "A homozygous mUtation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome)" Nat. Genet. 12, 445-447, 1996.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hofstra R.M.W., et al., "Mutations in Hirschsprung Disease: When Does a Mutation Contribute to the Phenotype," Eur. J. Hum. Genet. 5, 180-185, 1997.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Horie et al., "Identification and Characterization of TMEFF2, a Novel Surviv Factor for Hippocampal and Mesencephalic Neurons," (2000) Genomics 67: 146-152.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Howard, P.W. et al., "Design, synthesis and biological evaluation of ZC-423, a novel C2-aryl substituted pyrrolobenzodiazepine (PBD) dimer," Clinical Cancer Research (2005) 11(23):9015S-9016S (A205).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Howard, P.W. et al., "Synthesis of a novel C2/C2′-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate," Bioorg. Med. Chem., Sep. 2009, In Press, 4 pages now: Sep. 2009, 19:6463-6466.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Howard, P.W. et al., "The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1- c][1,4]benzodiazepine dimers," EJC Supplements (2006) 4(12):95-Poster Abstract 301.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Howard, P.W. et al., "The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1- c][1,4]benzodiazepine dimers," EJC Supplements (2006) 4(12):95—Poster Abstract 301.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Howard, P.W., "Design, synthesis and biological evaluation of novel C2-aryl-substituted pyrrolo[2,1- c][1,4]benzodiazepine monomers," Proceedings of the American Association for Cancer Research Annual Meeting (Apr. 2006) 47:132.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hubert, R.S., et al., "STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors," (1999) Proc. Natl. Acad. Sci. U.S.A. 96 (25):14523-14528.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hurley, L. and Needham-Vandevanter, D., "Covalent Binding of Antitumor Antibiotics in the Minor Groove of DNA. Mechanism of Action of CC-1065 and the yrrolo(1,4)benzodiazepines," Acc. Chem. Res., 19, 230-237 (1986).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ide et al., "Cloning of human bone morphogenetic protein type IB receptor (BMPRIB) and its expression in prostate cancer in comparison with other BMPRs," Oncogene (1997) 14, 1377-1382.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Iida, H. et al. "Design and synthesis of pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-polyaminoalkyl conjugates by the use of SNA4 reaction 2-nitro-5-fluorobenzoate precursor as key reaction," Heterocycles (2004) 62:693-711.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/EP2012/070233 dated Jan. 28, 2013 (8 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/EP2013/071346 dated Feb. 5, 2014 (11 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/EP2014/054958 dated Jul. 2, 2014 (13 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/GB2015/052629 dated Nov. 2, 2015 (12 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/US2011/032664 dated Aug. 19, 2011 (13 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/US2011/032668 dated May 26, 2011 (12 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      International Search Report and Written Opinion for Application No. PCT/US2015/050634 dated Jan. 29, 2016 (14 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Itoh et al., "Sibanomicin, a new pyrrolo(1,4)benzodiazepine antitumor antibiotic produced by a micromonospora sp." J. Antibiotics, 41, 1281-1284 (1988).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Janjigian, Y.Y., "A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors," Cancer Chemotherapy and Pharmacology , Aug. 2009, 65(5):833-838.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jeffrey et al., "Development and properties of beta-glucuronide linkers for monoclonal antibody-drug conjugates." Bioconjugate Chemistry, 5, 2006, 17, 831-840. (Abstract).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jeffrey, S.C. et al., "Development of Pyrrolobenzodiazepine-Based Antibody-Drug Conjugates for Cancer," AACR Annual Meeting 2013, Abstract No. 4321.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jeffrey, S.C., "Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates," J. Med. Chem. (2005) 48(5):1344-1358.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jespers, L. S., "Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen" Nature Biotech., 12, 899-903 (1994).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jia, L., "Interspecies differences in pharmacokinetics and time-dissociated toxicokinetics of SJG-136," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:487.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jia, L., "Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:452-453.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Johnson &amp; Goldin, "The clinical impact of screening and other experimental tumor studies." Cancer Treat Rev. Mar. 1975; 2(1):1-31.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Jordan, V.C., "Tamoxifen: a most unlikely pioneering medicine," Nature Reviews: Drug Discovery (2003) 2:205-213.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Junutula et al., "Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs," (2008) Jour of Immun. Methods 332:41-52.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Junutula, et al., "Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index," 2008b Nature Biotech., 26(8):925-932.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal et a., "Pyrrolo[2,1-c][1,4]benzodiazepine-β-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies" Bioorganic &amp; Medicinal Chemistry Letters 2008, 18:3769-3773.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal et al., "Synthesis and DNA-binding affinity of A-C8/C-C2 alkoxyamido-linked pyrrolo[2,1- c][1,4]benzodiazepine dimers" Biorg. Med. Chem. Lett. (2003) 13(22): 3955-3958.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A. et al., "Design, synthesis and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity," J. Med. Chem. (2002) 45:4679-4688.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A., "Development of pyrrolo[2,1-c][1,4]benzodiazepine beta-galactoside prodrugs for selective therapy of cancer by ADEPT and PMT," Chemmedchem (2008) 3:794-802.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A., "Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1- c][1,4]benzodiazepine-naphthalamide conjugates linked through piperazine side-armed alkane spacers," Bioorg. Med. Chem. (2008) 16(15):7218-7224.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A., "Remarkable enhancement in the DNA-binding ability of C2-fluoro substituted pyrrolo[2,1- c][1,4]benzodiazepines and their anticancer potential," Bioorg. Med. Chem., Jan. 2009, 17(4):1557-1572.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A., "Synthesis of fluorinated analogues of SJG-136 and their DNA-binding potential," Bioorg. Med. Chem. Lett (2004) 14(22):5699-5702.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A., et al., "An Efficient Synthesis of Pyrrolo[2,1-c][1,4] Benzodiazepine Antibiotics via Reductive Cyclization," Bioorg. Med. Chem. Ltrs, 7, No. 14, 1825-1828 (1997).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, A., et al., "Synthesis of Pyrrolo [2,1-c][1,4]-Benzodiazepene Antibiotics: Oxidation of Cyclic Secondary Amine with TPAP", Tetrahedron, v. 53, No. 9, 3223-3230 (1997).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kamal, et al., "Synthesis of pyrrolo[2,1-c][1,4]benzodiazepines via reductive cyclization of w-azido carbonyl compounds by TMSI: an efficient preparation of antibiotic DC-81 and its dimers," Biorg. Med. Chem. Lett. (2000) 10:2311-2313.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kaneko, T. et al., "Bicyclic and tricyclic analogues of anthramycin," J. Med. Chem. (1985) 28:388-392.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kang, G.-D. et al., "Synthesis of a novel C2-aryl substituted 1,2-unsaturated pyrrolobenzodiazepine," Chem. Commun. (2003) 1680-1689.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kasahara et al., "Nucleotide sequence of a chimpanzee DOB eDNA clone," (1989) Immunogenetics 30(1):66-68.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      King et al., "Facile synthesis of maleimide bifunctional Jinkers," (2002) Tetrahedron Letters 43:1987-1990.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kingsbury et al., ""Novel Peptide Delivery System Involving Peptidase Activated Prodrugs as Antimicrobial Agents. Synthesis and Biological Activity of Peptidyl Derivatives of 5 Fluorouracil,"" (1984) J. Med. Chern. 27:1447-1451.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kohler et al., "Continuous cultures of fused cells secreting antibody of predefined specificity," (1975) Nature 256:495-497.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kohn, K., "Anthramycin," Antibiotics III, Springer-Verlag, NY, 3-11 (1975).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kojima et al., "Molecular Cloning and Expression of Megakaryocyte Potentiating Factor eDNA," The Journal of Biological Chemistry, vol. 270, No. 37, Issue of Sep. 15, pp. 21984-21990, 1995.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Konishi, M. et al., "Chicamycin, a new antitumor antibiotic II. Structure determination of chicamycins A and B," J. Antibiotics, 37, 200-206 (1984).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kovtun et al., "Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target Antigen," (2006) Cancer Res. 66(6):3214-3121.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kuhns J.J., et al., "Poor Binding of a HER-2/neu Epitope (GP2) to HLA-A2.1 Is due to a Lack of Interactions with the Center of the Peptide," J. Biol. Chem. 274, 36422-36427, 1999.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kunimoto et al., "Mazethramycin, a new member of anthramycin group antibiotics," J. Antibiotics, 33, 665-667 (1980).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Kurebayashi et al., "Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin.6," (1999) Brit. Jour. Cancer 79(5-6):707-717.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lambert, "Drug-conjugated monoclonal antibodies for the treatment of cancer," (2005) Current Opin. In Pharmacal. 5:543-549.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Langley, D.R. and Thurston, D.E., "A versatile and efficient synthesis of carbinolamine-containing pyrrolo[1,4]benzodiazepines via the cyclization of N-92-aminobenzoyl)pyrrolidine-2-carboxaldehyde diethyl thioacetals: total synthesis of prothracarcin," J. Org. Chem., 52, 91-97 (1987).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Langlois, N. et al., "Synthesis and cytotoxicity on sensitive and doxorubicin-resistant cell lines of new pyrrolo[2,1-c][1,4]benzodiazepines related to anthramycin," J. Med. Chem. (2001) 44:3754-3757.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Larhammar et al., "Sequence of Gene and eDNA Encoding Murine Major Histocompatibility Complex Class II Gene AP2*," (1985) J. Biol. Chem. 260(26):14111-14119.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Launay et al., "TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization," Cell 109 (3):397-407 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Law et al., "Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates," (2006) Cancer Res. 66(4):2328-2337.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lazar et al., "A molecular immunology approach to antibody humanization and functional optimization" Molecular Immunology, 2007, 44(8), 1986-1998.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Le et al., "Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system," (1997) FEBS Lett. 418(1-2):195-199.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leabman; et al., "Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys." MAbs. Nov.-Dec. 2013; 5(6):896-903.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leber, J.D. et al., "A revised structure for sibiromycin," J. Am. Chem. Soc., 110, 2992-2993 (1988).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leimgruber, W. et al., "Isolation and characterization of anthramycin, a new antitumor antibiotic," J. Am. Chem. Soc., 87, 5791-5793 (1965).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leimgruber, W. et al., "The structure of anthramycin," J. Am. Chem. Soc., 87, 5793-5795 (1965).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leimgruber, W. et al., "Total synthesis of anthramycin," J. Am. Chem. Soc., 90, 5641-5643 (1968).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leonard et al., "Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma," J. Clin. Oncology (2003) 21(16):3051-3059.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leonard et al., "Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies," Oncogene (2007) 26:3704-3713.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Leung et al., "Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2," Mol. Immunol. (1995) 32(17-18):1413-1427.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Levenson et al., "MCF-7: The First Hormone-responsive Breast Cancer Cell Line," (1997) Cancer Res. 57(15):3071-3078.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lewis Phillips et al., "Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate," Cancer Res, 2008, 68: (22).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lewis Phillips et al., "Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody—Cytotoxic Drug Conjugate," Cancer Res, 2008, 68: (22).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Liang et al., "The Gene for a Novel Transmembrane Protein Containing Epidermal Growth Factor and Follistatin Domains Is Frequently Hypermethylated in Human Tumor Cells," (2000) Cancer Res. 60:4907-4912.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Linden et al., "Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab," J. Clin. Cancer Res. (2005) 11:5215-5222.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lonberg, "Fully Human antibodies from transgenic mouse and phage display platforms" Curr. Opinion, 20(4), 450-459 (2008).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lown et al., "Molecular Mechanism of Binding of Pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid-anthramycin and tomaymycin," Biochem. Pharmacol. (1979), 28 (13), 2017-2026.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Lown et al., "Molecular Mechanism of Binding of Pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid—anthramycin and tomaymycin," Biochem. Pharmacol. (1979), 28 (13), 2017-2026.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Manfre et al., "Syntheses of Proline Analogues as Potential Mechanism-Based Inhibitors of Proline Dehydrogenase: 4-Methylene-L-, (E)- and (Z)-4-(Fluoromethylene)-L-, cis- and trans-5-Ethynyl-(±)-, and cis- and trans-5-Vinyl-L-proline," J. Org. Chem. 1992, 57, 2060-2065.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Marin, D., "Voltammetric studies of the interaction of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) monomers and dimers with DNA," J. Electroanal. Chem. (2006) 593(1-2):241-246.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Marks et al., "By-passing Immunization, Human Antibodies from V-gene Libraries Displayed on Phage," (1991) J. Mol. Biol., 222:581-597.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Martin, C. et al., "Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies," Biochem. (2005) 44(11):4135-4147.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Mastroberardino et al., "Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family," Nature 395 (6699):288-291 (1998).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Matsumoto, K. et al., "Synthesis of polyaminoalkyl substituted conjugates of pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-polyaminoalkyl involving SNA4 reaction of 2-nitro-5-fluorobenzoate precursors," Heterocycles (2000) 52(3):1015-1020.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      McDonagh, "Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment," (2006) Protein Eng. Design &amp; Sel. 19(7): 299-307.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Mendoza et al., "Inhibition of Ligand-mediated HER2 Activation in Androgen-independent Prostate Cancer," (2002) Cancer Res. 62:5485-5488.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Miller et al., "Design, Construction, and in Vitro Analyses of Multivalent Antibodies," (2003) Jour. of Immunology 170:4854-4861.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Miller et al., "IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells," Blood 99 (8):2662-2669 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Miura et al., "Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64)." Genomics. Dec. 15, 1996; 38(3):299-304.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Miura et al., "RPIOS Is Associated With MD-1 and Transmits an Activation Signal in Human B Cells," (1998) Blood 92:2815-2822.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Moore M., et al., "Molecular cloning of the eDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes," Proc. Natl. Acad. Sci. U.S.A. 84, 9194-9198, 1987.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Mori, M. et al., "Total syntheses of prothracarcin and tomaymycin by use of palladium catalyzed carbonylation," Tetrahedron (1986) 42(14):3793-3806.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Morrison et al., "Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains," (1984) Proc. Natl. Acad. Sci. USA, 81:6851-6855.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Mountzouris, J.A. et al., "Comparison of a DSB-120 DNA interstrand cross-linked adduct with the corresponding bis-Tomamycin adduct," J. Med. Chem. (1994) 37:3132-3140.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Muller et al., "Cloning and sequencing of the eDNA encoding the human homologue of the murine immunoglobulin-associated protein B29," (1992) Eur. J. Immunol. 22 (6): 1621-1625.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Mungall A.J., et al., "The DNA sequence and analysis of human chromosome 6," Nature 425, 805-811, 2003.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nadler et al., "B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes," Journal of Immunology, 1983, 131(1):244-250.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nagasaka, T. and Koseki, Y, "Stereoselective Synthesis of Tilivalline," Journal of Organic Chemistry, vol. 63, No. 20, 6797-6801 (1998).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nagasaka, T. et al., "Stereoselective Synthesis of Tilivalline," Tetrahedron Letters, 30:14, 1871-1872 (1989).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nagase T., et al., "Prediction of the Coding Sequences of Unidentified Human Genes. XVII. The Complete Sequences of 100 New eDNA Clones from Brain Which Code for Large Proteins in vitro," (2000) DNA Res. 7 (2):143-150.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nakamuta M., et al., "Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor," Biochem. Biophys. Res. Commun. 177, 34-39, 1991.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nakayama et al., "Altered Gene Expression upon BCR Cross-Linking in Burkitt's Lymphoma B Cell Line," (2000) Biochem. Biophys. Res. Commun. 277(1):124-127.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Narayanaswamy, M., "A novel HPLC/MS assay to measure DNA interstrand cross-linking efficacy in oligonucleotides of varying sequence," EJC Supplements (Nov. 2006) 4(12):92-93.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Narayanaswamy, M., "An assay combinding high-performance liquid chromatography and mass spectrometry to measure DNA interstrand cross-linking efficiency in oligonucleotides of varying sequences," Anal. Biochem. (2008) 374(1):173-181.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Narayanaswamy, M., "Use of HPLC-MS to characterize novel mono and intrastrand cross-linked DNA adducts formed by the sequence-selective DNA-interactive agent SJG-136," Proceedings of the American Association for Cancer Research Annual Meeting (Apr. 2007) 48:760-761.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Narukawa, Y., "General and efficient synthesis of 2-alkylcarbapenems synthesis of dethia carba analogs of clinically useful carbapenems via palladium-catalyzed cross-coupling reaction," Tetrahedron (1997) 53:539-556.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Naruse et al., "The HLA-DOB gene displays limited polymorphism with only one amino acid substitution," (2002) Tissue Antigens 59:512-519.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Neuberger and Williams, "The intron requirement for immunoglobulin gene expression is dependent upon the promoter," (1988) Nucleic Acids Res. 16:6713-6724.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nicolaou et al., "Calicheamicin θ: A Rationally Designed Molecule with Extremely Potent and Selective DNA Cleaving Properties and Apoptosis Inducing Activity," Angew Chem. Intl. Ed. Engl. (1994) 33:183-186.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Nilius et al., "Voltage Dependence of the Ca2+ -activated Cation Channel TRPM4," The Journal of Biological Chemistry, vol. 278, No. 33, Issue of Aug. 15, pp. 30813-30820, 2003.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ogawa Y., et al., "Molecular Cloning of a Non-Isopeptide-Selective Human Endothelin Receptor," Biochem. Biophys. Res. Commun. 178, 248-255, 1991.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Okamoto Y., et al. "Palmitoylation of Human Endothelin B," Biol. Chem. 272, 21589-21596, 1997.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      O'Neil, Chemical Abstract No. 171573p, "The synthesis of Functionalized Pyrrolo-[2,1-c][1,4]-Benzodiazepines", Chemical Abstracts, vol. 126, No. 13, 618 (1997).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      O'Neil, I.A. et al., "DPPE: A Convenient Replacement for Triphenylphosphine in the Staudinger and Mitsunobu Reactions", Tetrahedron Letters, vol. 39, No. 42, 7787-7790 (1998).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      O'Neil, I.A., et al., "The Synthesis of Functionalized Pyrrolo-[2,1-c][1,4]-Benzodiazepines," Synlett, 75-78 (1997).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Parrish-Novak J., et al., "Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes," J. Biol. Chem. 277, 47517-47523, 2002.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Paul, Fundamental Immunology, 3rd Edition, pp. 292-295.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Payne, G. "Progress in immunoconjugate cancer therapeutics," (2003) Cancer Cell 3:207-212.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      PCT/US2012/059864 International Search Report and Written Opinion dated Dec. 21, 2012 (7 pages).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Pepper, C., "Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells," Br. J. Cancer (2007) 97(2):253-259.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Pepper, C.J. et al., "The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill," Cancer Res. (2004) 64:6750-6755.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Phillips et al., "Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate," (2008) Cancer Res. 68(22):9280-9290.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Pingault V., et al., "SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism," (2002) Hum. Genet. 111, 198-206.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Pletnev S., et al., "Characterization of the Recombinant Extracellular Domains of Human Interleukin-20 Receptors and Their Complexe with Interleukin-19 and Interleukin-20," (2003) Biochemistry 42:12617-12624.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Porkaa et al., "Cloning and Characterization of a Novel Six-Transmembrane Protein STEAP2, Expressed in Normal and Malignant Prostate," Lab. Invest. 82 (11):1573-1582 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Prasad et al.,"Human LAT1, a Subunit of System L Amino Acid Transporter: Molecular Cloning and Transport Function," Biochem. Biophys. Res. Commun. 255 (2), 283-288 (1999).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Preud'Homme et al., "Structure and expression of the mb-1 transcript in human lymphoid cells," (1992) Clin. Exp. Immunol. 90(1):141-146.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Puffenberger E.G., et al., "A Missense Mutation of the Endothelin-B Receptor Gene in Multigenic Hirschsprung's Disease," Cell 79, 1257-1266, 1994.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Purser, et al., "Fluorine in Medicinal Chemistry." Chem. Soc. Rev., 2008, 37, 320-330.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Puzanov, I., "Phase I and pharmacokinetic trial of SJG-136 administered on a daily x5 schedule," EJC Supplements (Nov. 2006) 4(12):93.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Quintas-Cardama, A., "Sequencing of subcloned PCR products facilitates earlier detetction of BCR-ABL1 and other mutants compared to direct sequencing of the ABL1 kinase domain," Leukemia (2008) 22(4):877-878.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rahman et al. "Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates." J Antimicrob Chemother. Jul. 2012; 67(7):1683-96.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rahman, K.M., "Effect of microwave irradiation on covalent ligand-DNA interactions," Chem. Commun. (Cambridge, UK), Apr. 2009, 20:2875-2877.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rahman, K.M., "Rules of DNA adduct formation for pyrrolobenzodiazepine (PBD) dimers," Proceedings of the American Association for Cancer Research Annual Meeting (Apr. 2010) 51:851.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rahman, K.M., "The pyrrolobenzodiazepine dimer SJG-136 forms sequence-dependent intrastrand DNA cross-lins and monoalkylated adducts in addition to interstrand cross-links," J. Am. Chem. Soc., Sep. 2009, 131(38):13756-13766.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rao et al., "Influence of diet on mammary cancer in transgenic mice bearing an oncogene expressed in mammary tissue," (1997) Breast Cancer Res. and Treatment 45:149-158.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Reid, J.M., "LC-MS/MS assay and rat pharmacokinetics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:1248.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Reiter R.E., et al., "Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer," Proc. Natl. Acad. Sci. U.S.A. 95, 1735-1740, 1998.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Remmers et al., "Conformations of complexes between pyrrolo[1,4]benzodiazepines and DNA segments," J Med Chem. Dec. 1986;29(12):2492-2503.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rich, I.N., "Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay," Toxicological Sci. (2005) 87(2):427-441.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rodrigues et al., "Synthesis and beta-lactamase-mediated activation of a cephalosporin-taxol prodrug," (1995) Chemistry Biology 2:223-227.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Roguska et al., "A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing," Protein Eng, 1996, 9(10):895-904.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Roguska et al., "Humanization of murine monoclonal antibodies through variable domain resurfacing," PNAS, 1994, 91(3):969-973.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Ross et al., "Prostate Stem Cell Antigen as Therapy Target: Tissue Expression and in Vivo Efficacy of an Immunoconjugate," (2002) Cancer Res. 62:2546-2553.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Rudikoff et al., Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. Mar. 1982; 79(6):1979-83.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sagnou, M.J. et al., "Design and Synthesis of Novel Pyrrolobenzodiazepine (PDB) Prodrugs for ADEPT and GDEPT," Bioorganic &amp; Medicinal Chemistry Letters, 10, 2083-2086 (2000).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sakaguchi et al., "8 lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties," (1988) EMBO J. 7(11):3457-3464.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sakamoto A, Yanagisawa M., et al., "Cloning and Functional Expression of Human cDNA for the ETB Endothelin Receptor," Biochem. Biophys. Res. Commun. 178, 656-663, 1991.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sanderson et al., "In vivo Drug-Linker Stability of an Anti-CD30 Dipeptide-Linked Auristatin Immunoconjugate," (2005) Clin. Cancer Res. 11:843-852.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Scholler et al., "Soluble member(s) of the mesothelin/ megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma," Proc. Natl. Acad. Sci. USA vol. 96, pp. 11531-11536, Sep. 1999.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Schroder and Lubke, The Peptides, vol. 1. pp. 76-136 (1965) Academic Press.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Schweikart, K., "In vitro myelosuppression of SJG-136, a pyrrolobenzodiazepine dimer: comparison to bizelesin," Proceedings of the American Association for Cancer Research Annual Meeting (Mar. 2004) 45:486.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Segawa et al., "Growth-related Renal Type II Na/Pi Cotransporter," The Journal of Biolocjcal Chemistry, vol. 277. No. 22, Issue of May 31, pp. 19665-19672, 2002.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Semba K., et al., "A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1 /epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma," 15 Proc. Natl. Acad. Sci. U.S.A 82, 6497-6501, 1985.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Servenius et al., "Class II Genes of the Human Major Histocompatibility Complex, the DOBeta Gene Is a Divergent Member of the Class II P Gene Family," (1987) J. Biol. Chem. 262:8759-8766.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Shamis et al., "Bioactivation of Self-Immolative Dendritic Prodrugs by Catalytic Antibody 38C2," (2004) J . Am. Chem. Soc. 126:1726-1731.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sharkey et al., "Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies," Mol. Cancer Ther. (2012) 11(1):224-234.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sheikh F., et al., "Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 21," (2004) J.Immunol, 172, 2006-2010.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Shen et al., "Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates," (2012) Nature Biotech., 30(2):184-191.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Shimizu, K et al., "Prothracarcin, a Novel Antitumor Antibiotic," J. Antibiotics, 35, 972-978 (1982).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sinha S.K., et al., "Characterization of the EBV /C3d Receptor on the Human Jurkat T Cell Line: Evidence for a Novel Transcript," (1993) J. Immunol. 150, 5311-5320.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Smellie, M. et al., "Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents," Br. J. Cancer (1994) 70:48-53.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Smellie, M. et al., "Sequence selective recognition of duplex DNA through covalent interstrand cross-linking," Biochem. (2003) 42:8232-8239.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Smith, P. K. et al., "Measurement of protein using bicinchoninic acid." Anal Biochem. Oct. 1985; 150(1):76-85.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Souillac, P. et al., "Characterization of delivery systems, differential scanning calorimetry," Encyclopedia of Controlled Drug Delivery (1999) 212-227 (pp. 217-218).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Storm et al., "Effect of Small Changes in Orientation on Reaction Rate," (1972) J. Amer. Chem. Soc. 94:5815-5825.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Strausberg et al., "Generation and initial analysis of more than 15,000 full-length human and mouse Edna sequences," (2002) Proc. Natl. Acad. Sci USA 99:16899-16903.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Suggitt, M., "The hollow fibre model-facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare," Int. J. Oncol. (2006) 29(6):1493-1499.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Suggitt, M., "The hollow fibre model—facilitating anti-cancer pre-clinical pharmacodynamics and improving animal welfare," Int. J. Oncol. (2006) 29(6):1493-1499.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Suggs, J.W. et al., "Synthesis and structure of anthramycin analogs via hydride reduction of dilactams," Tetrahedron Letters, 26, No. 40, 4871-4874 (1985).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sun et al., "Enabling ScFvs as Multi-Drug Carriers: A Dendritic Approach," (2003) Bioorganic &amp; Medicinal Chemistry 11:1761-1768.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sun et al., "Syntheses of Dendritic Linkers Containing Chlorambucil Residues for the Preparation of Antibody-Multidrug Immunoconjugates," (2002) Bioorganic &amp; Medicinal Chemistry Letters 12:2213-2215.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sun et al., "Syntheses of Dendritic Linkers Containing Chlorambucil Residues for the Preparation of Antibody—Multidrug Immunoconjugates," (2002) Bioorganic &amp; Medicinal Chemistry Letters 12:2213-2215.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Sutherland, M.S.K. et al., "SGN-CD33A: a novel CD33-directed antibody-drug conjugate, utilizing pyrrolobenzodiazepine dimers, demonstrates preclinical anti-tumor activity against multi-drug resistant human AML," American Society of Hematology (Dec. 8-12, 2012) Atlanta, Georgia, Abstract No. 3589.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Svensson P.J., et al., "Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B)," Hum. Genet. 103, 145-148, 1998.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Swiercz J.M., et al., "Plexin-81 /RhoGEF-mediated Rho A activation involves the receptor tyrosine kinase ErbB-2," J. Cell Biol. 165, 869-880, 2004.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Syrigos and Epenetos, "Antibody Directed Enzyme Prodrug Therapy (ADEPT): A Review of the Experimental and Clinical Considerations," (1999) Anticancer Research 19:605-614.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Takeuchi, T. et al., "Neothramycins A and B, New Antitumor Antibiotics," J. Antibiotics, 29, 93-96 (1976).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tawaragi Y., et al., "Primary structure of nonspecific crossreacting antigen (NCA), a member of carcinoembryonic antigen (cea) gene family, deduced from cdna sequence," Biochem. Biophys. Res. Commun. 150, 89-96, 1988.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tercel, M. et al., "Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores," J. Med. Chem. (2003) 46:2132-2151.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thompson J.S., et al., "Baff-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF," Science 293 (5537), 2108-2111 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, "Advances in the study of Pyrrolo[2,1-c][1,4] benzodiazepine (PBD) Antitumour Antibiotics", Molecular Aspects of Anticancer Drug-DNA Interaction, Neidle, S. and Waring, M.J., Eds.; Macmillan Press Ltd, 1:54-88 (1993).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, D.E. and Bose, D.S., "Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines," Chem. Rev., 94:433-465 (1994).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, D.E. and Thompson, A.S., "The molecular recognition of DNA," Chem. Brit., 26, 767-772 (1990).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, D.E. et al., "Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c][1,4]benzodiazepines", Journal of Medicinal Chemistry, 42:1951-1964 (1999).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, D.E. et al., "Synthesis of a novel GC-specific covalent-binding DNA affinity-cleavage agent based on pyrrolobenzodiazepines (PBDs)," Chemical Communications, 563-565 (1996).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, D.E. et al., "Synthesis of Sequence-selective C8-linked Pyrrolo [2,1-c][1,4] Benzodiazepine DNA Interstrand Cross-linking Agent," J. Org. Chem., 61:8141-8147 (1996).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Thurston, D.E., "Nucleic acid targeting: therapeutic strategies for the 21st century," Brit. J. Cancer (1999) 80(1):65-85.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tiberghien, A.C. et al., "Application of the stille coupling reaction to the synthesis of C2-substituted endo-exo unsaturated pyrrolo[2,1-c][1,4]benzodiazepines (PBDs)," Biorg. Med. Chem. Lett. (2004) 14:5041-5044.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tiberghien, A.C., "Application of the stille coupling reaction to the synthesis of C2-substituted endo-exo unsaturated pyrrolo[2,1-c][1,4]benzodiazepines (PBDs)," Bioorg. Med. Chem. Lett. (2008) 18(6):2073-2077.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Toki et al., "Protease-Mediated Fragmentation of p-Amidobenzyl Ethers: A New Strategy for the Activation of Anticancer Prodrugs," (2002) J. Org. Chem. 67:1866-1872.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tonnelle et al., "DO Beta a new chain gene in HLA-D with a distinct regulation of expression," (1985) EMBO J. 4(11):2839-2847.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Touchman et al., "The Genomic Region Encompassing the Nephropathic Cystinosis Gene (CTNS): Complete Sequencing of a 200-kb Segment and Discovery of a Novel Gene within the Common Cystinosis-Causing Deletion," (2000) Genome Res. 10:165-173.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tozuka et al., "Studies on tomaymycin. II. Total synthesis of the antitumor antibiotics, E-and Z-tomaymycins," J. Antibiotics (Tokyo) (1983) 36:276-282.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Trail et al., "Monoclonal antibody drug immunoconjugates for targeted treatment of cancer," (2003) Cancer Immunol. Immunother. 52:328-337.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tsunakawa, M. et al., "Porothramycin, a new antibiotic of the anthramycin group: Production, isolation, structure and biological activity," J. Antibiotics, 41:1366-1373 (1988).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Tsutsumi M., et al., "Novel endothelin B receptor transcripts with the potential of generating a new receptor," Gene 228, 43-49, 1999.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Uchida et al., "A Novel Epidermal Growth Factor-like Molecule Containing Two Follistatin Modules Stimulates Tyrosine Phosphorylation of erbB-4 in MKN28 Gastric Cancer Cells," (1999) Biochem. Biophys. Res. Commun. 266:593-602.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Umezawa, H. et al. "Mazethramycins," SciFinder Scholar, 2-3 (2002).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Umezawa, H. et al., Chemical Abstract No. 4427a, "Mazethramycins" Chemical Abstracts, vol. 90, No. 1, 428 (1979).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Verheij J.B., et al., "ABCD Syndrome Is Caused by a Homozygous Mutation in the EDNRB Gene," Am. J. Med. 15 Genet. 108, 223-225, 2002.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Vippagunta, S.R. et al., "Crystalline solids," Adv. Drug Delivery Rev. (2001) 48:3-26.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Von Hoegen et al., "Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA," (1990) J. Immunol. 144(12):4870-4877.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wang, J.H., "Determination of antitumor agent AJG-136 in human serum by HPLC with tandem mass spectrometric detection (HPLC-MS/MS)," Abstracts of Papers American Chemical Society (Mar. 13, 2005) 229(1):U119.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Webster et al., "Mammary tumorigenesis and metastasis in transgenic mice," (1994) Semin. Cancer Biol. 5:69-76.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Weidner-Wells, M.A. et al., "Photochemical approach to the synthesis of the pyrrolo[1,4]benzodiazepine antibiotics," J. Org. Chem. (1989) 54:5746-5758.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Weis J.J., et al., "Identification of a partial eDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: Homology with the receptor for fragments C3b and C4b of the third and fourth components of complement," Proc. Natl. Acad. Sci. U.S.A. 83, 5639-5643, 1986.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Weis J.J., et al., "Structure of the human b lymphocyte receptor for c3d and the epstein-barr virus and relatedness to other members of the family of C3/C4 binding proteins," J. Exp. Med. 167, 1047-1066, 1988.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wells, G. et al., "Design, synthesis and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates," J. Med. Chem. (2006) 49:5442-5461.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wikipedia, "How many types of cancer are there?", 2012, 3 pages; http://wiki.answers.com/Q/How-many-different-types_of_cancer_ are_there.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wikipedia, "Management of Cancer," 2012, 1 page; http://en.wikipedia.org/wiki/Management of cancer.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilkinson "Eph Receptors and Ephrins: Regulators of Guidance and Assembly," Int. Rev. Cytol. 196:177-244 (2000).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilkinson, G.P., "Pharmacokinetics and intracellular pharmacological characteristics of the novel pyrrolobenzodiazepine (PBD) dimer SJG-136," Proceedings of the American Association for Cancer Research Annual Meeting (Jul. 2003) 44:320.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilkinson, G.P., "Pharmacokinetics, metabolism and glutathione reactivity of SJG-136," Br. J. Cancer (2003) 88(Supp. 1):S29.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilkinson, G.P., "Preliminary pharmacokinetic and bioanalytical studies of SJG-136 (NSC 694501), a sequence-selective pyrrolobenzodiazepine dimer DNA-cross-linking agent," Investigational New Drugs (2004) 22(3):231-240.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilson et al., "eDNA Cloning of the B Cell Membrane Protein CD22: A Mediator of B-B Cell Interactions," (1991) J. Exp. Med. 173:137-146.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilson, S.C. et al., "Design and Synthesis of a Novel Epoxide-Containing Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) via a New Cyclization Procedure," Tetrahedron Letters, 36, No. 35, 6333-6336 (1995).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wilson, S.C. et al., "Design, Synthesis, and Evaluation of a Novel Sequence-Selective Epoxide-Containing DNA Cross-Linking Agent Based on the Pyrrolo[2,1-c][1,4]benzodiazepine System", J. Med. Chem. 42: 4028-4041 (1999).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wolff, M.E., Burger's Medicinal Chemistry, 4th Edition, Part I, Wiley: New York (1979) 336-337.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wolff, M.E., Burger's Medicinal Chemistry, 5th Edition, Part I, John Wiley &amp; Sons (1995) 975-977.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Workman, P. et al., "United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition)," Br. J. Cancer (1998) 77(1):1-10.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Wu et al., "Arming antibodies: prospects and challenges for immunoconjugates," (2005) Nature Biotech. 23(9):1137-1145.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Xie et al., "In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer," (2006) Expert. Opin Biol. Ther. 6(3):281-291.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Xie, G. et al., "Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerasel, and biological evaluation," J. Med. Chem. (1996) 39:1049-1055.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Xu et al., "Molecular Cloning, Functional Characterization, Tissue Distribution, and Chromosomal Localization of a Human, Small Intestinal Sodium-Phosphate (Na + -Pi) Transporter (SLC34A2)," Genomics 62 (2):281-284 (1999).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Xu, M.J., et al., "Molecular Cloning and Characterization of SPAP1, an Inhibitory Receptor," (2001) Biochem. Biophys. Res. Commun. 280 (3):768-775.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Xu, X.Z., et al., "Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform," Proc. Natl. Acad. Sci. U.S.A. 98 (19):10692-10697 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Yamaguchi, N., et al., "A Novel Cytokine Exhibiting Megakaryocyte Potentiating Activity From a Human Pancreatic Tumor Cell Line HPC-Y5," Biol. Chem. 269 (2), 805-808 (1994).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Yamamoto T., et al., "Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor," Nature 319, 230-234, 1986.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Yang et al., "Murine Six-Transmembrane Epithelial Antigen of the Prostate, Prostate Stem Cell Antigen, and Prostate-specific Membrane Antigen: Prostate-specific Cell-Surface Antigens Highly Expressed in Prostate Cancer of Transgenic Adenocarcinoma Mouse Prostate Mice," Cancer Research, 61, 5857-5860. Aug. 1, 2001.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Yin &amp; Lloyd, "Molecular Cloning of the CA125 Ovarian Cancer Antigen," J. Biol. Chem. 276 (29):27371-27375 (2001).
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Younes et al., "Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma," J Clin Oncol., 2012, 30(22):2776-82.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Yu et al., "Human mb-1 gene: complete edna sequence and its expression in b cells bearing membrane Ig of various isotypes," (1992) J. Immunol. 148(2) 633-637.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Zammarchi et al., "Pre-Clinical Development of Adct-402, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate (ADC) Targeting CD19-Expressing B-Cell Malignancies," Blood, 2015, 126:1564, Abstract.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (23)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11370801B2/en"><a id="link" href="#" class="style-scope state-modifier">US11370801B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-04-18</span>
                    <span class="td style-scope patent-result">2022-06-28</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113599533A/en"><a id="link" href="#" class="style-scope state-modifier">CN113599533A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2021-11-05</span>
                    <span class="td style-scope patent-result">乐高化学生物科学股份有限公司</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugates comprising branched linkers and methods related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2017089894A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2017089894A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2017-06-01</span>
                    <span class="td style-scope patent-result">Legochem Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Conjugates comprising peptide groups and methods related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20180079452A/en"><a id="link" href="#" class="style-scope state-modifier">KR20180079452A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2018-07-10</span>
                    <span class="td style-scope patent-result">주식회사 레고켐 바이오사이언스</span>
                    <span class="td style-scope patent-result">
  Conjugates comprising self-sacrificial groups and methods for their preparation
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JOP20190080A1/en"><a id="link" href="#" class="style-scope state-modifier">JOP20190080A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-10-14</span>
                    <span class="td style-scope patent-result">2019-04-11</span>
                    <span class="td style-scope patent-result">Bayer Pharma AG</span>
                    <span class="td style-scope patent-result">Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112019020136A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112019020136A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-03-29</span>
                    <span class="td style-scope patent-result">2020-04-22</span>
                    <span class="td style-scope patent-result">Legochem Biosciences Inc</span>
                    <span class="td style-scope patent-result">
  prodrug of pyrrolobenzodiazepine dimer and compound of ligand-ligand conjugate of the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201806022D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201806022D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-04-12</span>
                    <span class="td style-scope patent-result">2018-05-30</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2019266406A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2019266406A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-09</span>
                    <span class="td style-scope patent-result">2020-11-26</span>
                    <span class="td style-scope patent-result">Legochem Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods related to anti-CD19 antibody drug conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20210283141A1/en"><a id="link" href="#" class="style-scope state-modifier">US20210283141A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-25</span>
                    <span class="td style-scope patent-result">2021-09-16</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2019276833A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2019276833A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-29</span>
                    <span class="td style-scope patent-result">2020-11-26</span>
                    <span class="td style-scope patent-result">Intocell, Inc.</span>
                    <span class="td style-scope patent-result">Novel benzodiazepine derivatives and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2022512716A/en"><a id="link" href="#" class="style-scope state-modifier">JP2022512716A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-10-19</span>
                    <span class="td style-scope patent-result">2022-02-07</span>
                    <span class="td style-scope patent-result">メドイミューン・リミテッド</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine complex
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20220096641A1/en"><a id="link" href="#" class="style-scope state-modifier">US20220096641A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-03</span>
                    <span class="td style-scope patent-result">2022-03-31</span>
                    <span class="td style-scope patent-result">Legochem Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine dimer compound with improved safety and use thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020180121A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020180121A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-03-06</span>
                    <span class="td style-scope patent-result">2020-09-10</span>
                    <span class="td style-scope patent-result">주식회사 레고켐 바이오사이언스</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugates including antibody against human dlk1, and use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP4013494A1/en"><a id="link" href="#" class="style-scope state-modifier">EP4013494A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-12</span>
                    <span class="td style-scope patent-result">2022-06-22</span>
                    <span class="td style-scope patent-result">Regeneron Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Macrophage stimulating 1 receptor (mst1r) variants and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20210028544A/en"><a id="link" href="#" class="style-scope state-modifier">KR20210028544A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-09-04</span>
                    <span class="td style-scope patent-result">2021-03-12</span>
                    <span class="td style-scope patent-result">주식회사 레고켐 바이오사이언스</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugate comprising antibody binding to antibody against human ROR1 and its use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2021080608A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2021080608A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-25</span>
                    <span class="td style-scope patent-result">2021-04-29</span>
                    <span class="td style-scope patent-result">Medimmune, Llc</span>
                    <span class="td style-scope patent-result">Branched moiety for use in conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB202015226D0/en"><a id="link" href="#" class="style-scope state-modifier">GB202015226D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-09-25</span>
                    <span class="td style-scope patent-result">2020-11-11</span>
                    <span class="td style-scope patent-result">Adc Therapeutics S A</span>
                    <span class="td style-scope patent-result">Pyrrol obenzodiazepine-antibody conugates and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB202105186D0/en"><a id="link" href="#" class="style-scope state-modifier">GB202105186D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-04-12</span>
                    <span class="td style-scope patent-result">2021-05-26</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2023088963A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2023088963A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-11-19</span>
                    <span class="td style-scope patent-result">2023-05-25</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Anti-il-13ralpha2 conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2023088966A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2023088966A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-11-19</span>
                    <span class="td style-scope patent-result">2023-05-25</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Anti-psma conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20230190939A1/en"><a id="link" href="#" class="style-scope state-modifier">US20230190939A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-12-21</span>
                    <span class="td style-scope patent-result">2023-06-22</span>
                    <span class="td style-scope patent-result">Intocell, Inc.</span>
                    <span class="td style-scope patent-result">Antibody drug conjugates comprising toxins with polar groups and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP4230222A1/en"><a id="link" href="#" class="style-scope state-modifier">EP4230222A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-02-17</span>
                    <span class="td style-scope patent-result">2023-08-23</span>
                    <span class="td style-scope patent-result">Oxsonics Limited</span>
                    <span class="td style-scope patent-result">Combination therapy with an anti-axl antibody-pbd conjugate and nanocups 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2023160982A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2023160982A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-02-28</span>
                    <span class="td style-scope patent-result">2023-08-31</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Dosage regimen 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10799595B2/en"><a id="link" href="#" class="style-scope state-modifier">US10799595B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-10-13</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10543279B2/en"><a id="link" href="#" class="style-scope state-modifier">US10543279B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-01-28</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates and their use for the treatment of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10420777B2/en"><a id="link" href="#" class="style-scope state-modifier">US10420777B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-09-24</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9567340B2/en"><a id="link" href="#" class="style-scope state-modifier">US9567340B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-02-14</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11370801B2/en"><a id="link" href="#" class="style-scope state-modifier">US11370801B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-06-28</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20230143309A1/en"><a id="link" href="#" class="style-scope state-modifier">US20230143309A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-05-11</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10695439B2/en"><a id="link" href="#" class="style-scope state-modifier">US10695439B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-06-30</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20190307890A1/en"><a id="link" href="#" class="style-scope state-modifier">US20190307890A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-10</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10392393B2/en"><a id="link" href="#" class="style-scope state-modifier">US10392393B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-27</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA038267B1/en"><a id="link" href="#" class="style-scope state-modifier">EA038267B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-08-02</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201617466D0/en"><a id="link" href="#" class="style-scope state-modifier">GBGB1617466.6A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2016-10-14</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        GB1617466.6<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2016-10-14</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2018069490A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/EP2017/076162</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2017-10-13</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-04-10</span>
                    <span class="td nowrap style-scope patent-result">FEPP</span>
                    <span class="td nowrap style-scope patent-result">Fee payment procedure</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-06-04</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: MEDIMMUNE LIMITED, UNITED KINGDOM</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOWARD, PHILIP WILSON;GREGSON, STEPHEN JOHN;REEL/FRAME:049358/0489</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171031</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-02-12</span>
                    <span class="td nowrap style-scope patent-result">STPP</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent application and granting procedure in general</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: NON FINAL ACTION MAILED</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-05-18</span>
                    <span class="td nowrap style-scope patent-result">STPP</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent application and granting procedure in general</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-08-21</span>
                    <span class="td nowrap style-scope patent-result">STPP</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent application and granting procedure in general</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-09-23</span>
                    <span class="td nowrap style-scope patent-result">STCF</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent grant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PATENTED CASE</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-11-09</span>
                    <span class="td nowrap style-scope patent-result">CC</span>
                    <span class="td nowrap style-scope patent-result">Certificate of correction</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2024-03-19</span>
                    <span class="td nowrap style-scope patent-result">MAFP</span>
                    <span class="td nowrap style-scope patent-result">Maintenance fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 4</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu">·</span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Anatomy</div>
          
            <div class="item style-scope dropdown-menu">Chemical class</div>
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          
            <div class="item style-scope dropdown-menu">Chemical group</div>
          
            <div class="item style-scope dropdown-menu">Diseases</div>
          
            <div class="item style-scope dropdown-menu">Drugs</div>
          
            <div class="item style-scope dropdown-menu">Effects</div>
          
            <div class="item style-scope dropdown-menu">Human genes</div>
          
            <div class="item style-scope dropdown-menu">Inorganic materials</div>
          
            <div class="item style-scope dropdown-menu">Methods</div>
          
            <div class="item style-scope dropdown-menu">Natural products</div>
          
            <div class="item style-scope dropdown-menu">Nutrition</div>
          
            <div class="item style-scope dropdown-menu">Polymers</div>
          
            <div class="item style-scope dropdown-menu">Proteins</div>
          
            <div class="item style-scope dropdown-menu">Species</div>
          
            <div class="item style-scope dropdown-menu">Substances</div>
          
            <div class="item style-scope dropdown-menu">Toxicity</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pyrrolo[2,3-i][1,2]benzodiazepine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">compounds</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">54</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">—ORB</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">180</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">77</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">74</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">methyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">72</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">mixture</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">72</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(C1-C7) alkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">71</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">substituent group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">68</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">heterocyclic group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">64</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">61</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">61</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">linker group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">61</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">57</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">56</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">56</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">51</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">39</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">38</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">38</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Pyridine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">37</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">37</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(C2-C3) alkenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">methoxy group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">32</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">32</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">binding agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cyclopropyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">halogen group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ligand</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ethyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">26</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(C1-C4) alkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">24</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(C2-C3) alkynyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">24</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkylene group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">24</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbon atom</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">24</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Mucin-1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">amino acid group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">thienyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fragment</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hydrogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pyridine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pyridyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Mucin-1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Nucleotide pyrophosphatase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nitro group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">B-cell receptor CD22</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Interleukin-2 receptor subunit alpha</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">HLA class II histocompatibility antigen gamma chain</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Integrin alpha-V</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Myeloid cell surface antigen CD33</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Transmembrane glycoprotein NMB</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Dipeptides</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Tenascin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cyano group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cycloalkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">heteroaryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">heteroatom</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">B-lymphocyte antigen CD19</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">CAMPATH-1 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">CD70 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Dickkopf-related protein 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens HLA class II histocompatibility antigen gamma chain</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Integrin alpha-V</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Inactive tyrosine-protein kinase 7</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Leukocyte antigen CD37</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Tenascin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Tyrosine-protein kinase receptor UFO</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fluoro group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Benzene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">C-type lectin domain family 14 member A</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens CD70 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Leukocyte antigen CD37</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Transmembrane glycoprotein NMB</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Immunoglobulin Fragments</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Immunoglobulin Fragments</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Metalloreductase STEAP2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">propyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ephrin type-A receptor 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens B-lymphocyte antigen CD19</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Interleukin-2 receptor subunit alpha</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Metalloreductase STEAP2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Nucleotide pyrophosphatase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Vascular cell adhesion protein 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">oxygen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sulfur</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">vinyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Carcinoembryonic antigen-related cell adhesion molecule 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens C-type lectin domain family 14 member A</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Myeloid cell surface antigen CD33</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Proline-rich protein 4</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carboxy group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chloro group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">naphthyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nitriles</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">CD52 Antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Dickkopf-related protein 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens B-cell receptor CD22</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Inactive tyrosine-protein kinase 7</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Tomoregulin-2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Tomoregulin-2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Tumor necrosis factor receptor superfamily member 13C</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">morpholin-4-yl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Teratocarcinoma-derived growth factor 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Vascular cell adhesion protein 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Integrin beta-6</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Prostate stem cell antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Teratocarcinoma-derived growth factor 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alpha-acetylene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ethynyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pharmaceutical composition</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(C1-C12) alkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">B-cell differentiation antigen CD72</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Brevican core protein</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">CD180 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Complement receptor type 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fc receptor-like protein 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens CD180 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Integrin beta-6</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Somatostatin receptor type 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Carcinoembryonic antigen-related cell adhesion molecule 6</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fc receptor-like protein 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fc receptor-like protein 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 6</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Fc receptor-like protein 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Nectin-4</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Receptor tyrosine-protein kinase erbB-2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">P2X purinoceptor 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Receptor tyrosine-protein kinase erbB-2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Somatostatin receptor type 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Tumor necrosis factor receptor superfamily member 13C</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cytotoxic agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">stem cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Annexin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Annexin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Bone morphogenetic protein receptor type-1B</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Brevican</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">C-X-C chemokine receptor type 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cell Surface Receptors</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cell Surface Receptors</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fc receptor-like protein 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Folate receptor alpha</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">HLA class II histocompatibility antigen, DO beta chain</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens C-X-C chemokine receptor type 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Complement receptor type 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Fc receptor-like protein 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Folate receptor alpha</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens HLA class II histocompatibility antigen, DO beta chain</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Metalloreductase STEAP1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Somatostatin receptor type 3</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Metalloreductase STEAP1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Mus musculus Sema3b gene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">P2X purinoceptor 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Somatostatin receptor type 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Somatostatin receptor type 3</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Somatostatin receptor type 4</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">epidermal growth factor receptor VIII</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inhibitory effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pharmaceutical excipient</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">prostate neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">salts</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">somatostatin receptor subtype-4</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">somatostatin receptor type 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">azulenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Carcinoma</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">C5-C10 heteroaryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">anthracenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phenanthrenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pyrenyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Prostate stem cell antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phenylene group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(C1-C4)alkoxy group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Breast cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Breast neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">EPHA2 gene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens B-cell differentiation antigen CD72</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Bone morphogenetic protein receptor type-1B</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Somatostatin receptor type 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Somatostatin receptor type 5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Nectin-4</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antineoplastic agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">breast carcinoma</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">diluting agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">epidermal growth factor receptor activity proteins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">epidermal growth factor receptor activity proteins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gastric cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gastric carcinoma</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">stomach carcinoma</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2786814091" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2786814091" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=954635832" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>